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 Avant-Propos 
 
 
 
 
 
 
Cher lecteur, 
 
Vous voici à l’orée d’un mémoire d’habilitation à diriger les recherches, dont l’objectif est 
de revisiter ma vie d’enseignant-chercheur.  
Mon application a été de vous rendre le moins fastidieux et le plus cohérent possible cet odyssée au 
travers d’une vingtaine d’années d’enseignements et de recherche qui ont été riches en interfaces et 
évolutions. Dans un premier temps, un résumé de mon parcours comme enseignant et comme 
chercheur sera complété par mes perspectives de recherche. Suivra  mon curriculum vitae détaillant 
exhaustivement mon cursus, mes enseignements, mes responsabilités administratives, mes activités 
d’expertise et de conseil et survolant mes activités recherche, compilant mes encadrements et mes 
publications-communications. Par la suite, je réaliserai un bilan plus approfondi de ma recherche. Je 
conclurai par les perspectives de recherche que j’aimerais poursuivre dans les années à venir. 
 
Débutons cet odyssée ! 
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 Résumé	des	activités	du	Dr	Cécile	
Duclairoir	Poc	en	vue	de	soutenir	
l’habilitation	à	diriger	les	recherches	
 
Titulaire d’un DEUG Sciences et Structure de la Matière préparé à l’antenne universitaire 
naissante de Cherbourg (Université de Caen Normandie, 1993), j’ai poursuivi mon cursus 
universitaire, à Caen, en chimie, puis chimie des matériaux en me spécialisant en physico-chimie des 
interfaces. Effectivement mes recherches doctorales, sous la direction des Pr E NAKACHE et AM 
ORECCHIONI, ont débuté en 1997 au sein de l’équipe Polymères et Interfaces d’un laboratoire de 
Chimie, Laboratoire de Chimie Moléculaire Thio-organique LCMT UMR-CNRS 6507 de 
l’Université de Caen Normandie. Elles ont ciblé des biomolécules. J’ai étudié la physico-chimie, 
voire la structure de ces macromolécules naturelles afin de les valoriser sous une forme galénique 
toujours d’actualité : l’encapsulation. J’ai ensuite évalué la faisabilité de leur vectorisation en y 
incorporant des molécules actives. 
 Les compétences développées en galénique et en formulation cosmétique m’ont permis 
d’assurer des formations intra-entreprises dès 1997 et comme enseignante vacataire à l’Université de 
Caen Normandie (1998-1999), à l’Ecole d'ingénieurs de Cherbourg (1999-2000) et à l’Université de 
Rouen Normandie pour un DESTU dispensé à l’IUT d’Evreux (2001). 
Suite à mon recrutement par l’Université de Rouen Normandie, comme ATER (2001), puis maître de 
conférences (2002), j’ai intégré l’équipe de formation du DUT Génie Biologique. Mon service 
statutaire concerne les domaines des industries pharmaceutiques et cosmétiques et leurs 
problématiques qualité. Ces enseignements sont réalisés en partie au sein de la Halle Technologique 
de Pharmacie Industrielle dont j’ai la responsabilité depuis 2001. Au cours des années, j’ai fait 
bénéficier de ce plateau technique unique à d’autres formations : le DUT Packaging naissant (2003-
2015), l’IUP/ Master Ingénierie de la Santé IQBio (UFR Sciences et Techniques, Université de Rouen 
Normandie ; 2003-à ce jour), l’ESITech (Ecole d’ingénieurs co-habilitée Université de Rouen 
Normandie-INSA de Rouen ;  2015-à ce jour), mais aussi à des formations préparatoires au Certificat 
de Qualification Professionnelle pour les salariés de l’industrie pharmaceutique (partenariat avec 
l’AFPI de l’Eure, labellisé par les entreprises du médicament). Depuis 2011, je dispense des 
enseignements davantage centrés sur ma recherche aux étudiants des 2 parcours du Master 
Microbiologie (co-accrédité Universités de Rouen Normandie et Caen Normandie).  
Quant à mon implication administrative, elle est effective. Ma participation a pu être 
ponctuelle : responsabilité de parcours DUT ou de formation (2 licences professionnelles) ; 
représentativité dans diverses commissions (conseil de département, d’institut, jurys de VAE, de 
DUT, de LP). Cependant un engagement fort sur le long terme est démontré par ma coordination des 
stages en Génie Biologique depuis 2001 ou ma représentation de l’Université de Rouen Normandie 
depuis 2013 auprès de formations en soins infirmiers (IFSI d’Evreux, DRDJSCS de Normandie). 
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Parmi mes autres charges administratives, j’assure depuis 2013 des expertises de dossiers Crédit 
d’Impôt Recherche et Jeune Entreprise Innovante. 
 Les occupations précédentes sont importantes et nécessaires, mais moins motivantes que la 
recherche. Dès mon recrutement par l’Université de Rouen Normandie en 2001, je me suis intéressée 
aux biosurfactants bactériens au sein du Laboratoire de Microbiologie du Froid, EA 2123, dirigé alors 
par le Pr. N ORANGE qui a évolué en EA 4312 nommée Laboratoire de Microbiologie du Froid – 
Signaux et MicroEnvironnement (LMDF-SME), puis en 2011 en Laboratoire de Microbiologie-
Signaux et Microenvironnement (LMSM, EA 4312) dirigé actuellement par le Pr M FEUILLOLEY. 
La production de ces molécules amphiphiles modifie la physico-chimie de la surface bactérienne et, 
par conséquent, influence son adaptation à son micro-environnement, voire sa virulence. Au long des 
années, ma formation en microbiologie s’étoffant, j’ai élargi mon champ de recherche débutant par 
l’identification et l’établissement des conditions de sécrétion des biosurfactants. J’ai ensuite évalué 
leur implication dans le comportement adhésif bactérien, dans la virulence bactérienne, voire leur rôle 
dans la communication bactérienne en participant alors à une collaboration avec le Dr M.N. Bellon-
Fontaine (UBHM, UMR INRA AgroParitech, Massy). Parallèlement, j’ai étudié une possible 
valorisation de ces biomolécules en bioremédiation de sédiments estuariens avec le Laboratoire 
COBRA UMR CNRS 6014 (Université de Rouen Normandie). 
Suite à ma participation à une étude sur la qualité de l’air, un questionnement est apparu : les bactéries 
aéroportées ne seraient-elles pas l’interface catalysée par la pollution automobile déclenchant chez 
l’humain de pneumopathies bactériennes exacerbées en période de forte pollution ? Après avoir étudié 
l’impact sur la physiologie d’une souche aéroportée de Pseudomonas fluorescens à des expositions 
au NO2, marqueur de pollution automobile, nous avons approfondi le sujet pour évaluer l’impact de 
ce même stress chimique au niveau de la paroi bactérienne, interface da la bactérie avec son 
microenvironnement. Y a-t’il simple diffusion du NO2 sans autre réponse bactérienne, comme le 
sous-entend l’approche traditionnelle de l’immuno-suppression humaine provoquée par la pollution ? 
Ou la bactérie met-elle en œuvre une réponse plus ou moins complexe dont l’un des sites est sa paroi, 
interface avec l’environnement extérieur? 
Parallèlement, j’ai eu l’opportunité de collaborer sur une autre thématique de sécurité sanitaire, 
concernant les produits cosmétiques. L’objectif était de documenter le vieillissement de 
nanoparticules (NPs) de TiO2 en lotion solaire sur deux bactéries représentatives du microbiote 
cutané. Suite à la formulation de deux lotions solaires modèles contenant des NPs hydrophiles ou 
hydrophobes, la croissance bactérienne a été étudiée lors de deux scenarii soit mimant le stockage du 
produit, soit lors de l’application de la formule solaire sur la peau. Désirant évaluer le cas d’une 
biocontamination ponctuelle d’un cosmétique lors de sa production ou lors du prélèvement 
consommateur avant application, une souche P. fluorescens d’origine aéroportée a été mise en contact 
avec de NPs de TiO2 hydrophiles. La membrane bactérienne s’en trouve-t’elle impactée, voire 
perméabilisée ? 
Ainsi les pistes de ces recherches convergent vers la réponse bactérienne au niveau de sa paroi, 
interface entre la bactérie et son microenvironnement. Ces travaux m’ont permis d’encadrer 11 
étudiants Bac +2/3, 19 Bac+4, 6 Master 2, 3 doctorants et 3 post-doctorants.  
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J’aimerais poursuivre cette approche de la réponse membranaire bactérienne en 
approfondissant, voire en fragmentant les stress étudiés. En documentant leur conséquences 
physiologiques, métaboliques, génétiques, nous pourrons appréhender les mécanismes stratégiques 
implémentés. En sécurité sanitaire de l’air, la caractérisation de l’adaptation bactérienne au NO2 sera 
poursuivie au travers de la réponse membranaire. Le doctorant recruté (RIN 2018-2021) a pour 
objectif d’en évaluer les conséquences et d’en décoder les mécanismes sous-tendant grâce aux 
collaborations nationales et internationales. A la suite d’exposition de mélanges NO2/NO, nous 
espérons déconvoluer les stratégies bactériennes (dont membranaires) mises en œuvre en condition 
de stress nitrosant en phase gaz. Ce stress est souvent intégré au stress oxydant qui est l’un des 
principaux acteurs des mécanismes antimicrobiens. Dans un premier temps, afin d’éviter les ROS 
(espèces réactives oxydantes) en solution, je débuterai par l’effet des rayonnements UV (producteurs 
de ROS) sur la réponse bactérienne, thématique d’un financement Cifre déposé à l’été 2018 avec 
BASF Beauty Care Solutions France SAS. Fin 2018, j’aimerais déposer auprès de l’ANSES une 
version amendée du projet NanoToxBactR. Cette étude de faisabilité concerne un test original 
d’évaluation de toxicité de NPs, via leur effet antibactérien en aérosol. Pour compléter mes 
compétences, je collaborerai avec l’équipe NanoCARE (GPM UMR CNRS 6634, Université de 
Rouen Normandie-INSA de Rouen) et, de nouveau, avec le CERTAM. Poursuivant ma collaboration 
avec le département matériaux du LIST (Luxembourg), j’explorerai les conséquences du contact 
nanomatériau imprégné/ bactérie sur son homéostasie membranaire et les répercussions 
métaboliques, voire génétiques. Cette expertise accumulée me permettra d’aborder, à plus long terme, 
l’interaction bactérie/matrice cosmétique solaire, préoccupant l’industrie cosmétique. Un tel modèle 
nécessite une fragmentation de ce système en « contacts élémentaires » de la bactérie avec les divers 
partenaires : globule d’émulsion, irradiation solaire, filtre physique type NP. Les stratégies 
bactériennes mises en place via sa membrane pourront être évaluées, en identifiant la participation 
relative de chaque partenaire. 
Toute cette trajectoire scientifique a été possible et ne pourra se poursuivre que grâce à des 
encadrements de stagiaires et de doctorants et à des réponses positives aux programmes de 
financements que j’ai déjà pu obtenir et que je développerai activement dans les années à venir. 
Mon objectif est de poursuivre ma quête sur le rôle de la membrane bactérienne, interface 
intelligente et sélective entre la bactérie et son microenvironnement !  
 
Evreux, le 5 septembre 2018 
 
 
 
 
 
 
Cécile DUCLAIROIR 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
5 
DUCLAIROIR POC 
Cécile 
Maître de conférences 
Université de Rouen 
 
 
 
Née le 16 juillet 1973  
à Clermont-Fd (63) 
Mariée, 1 enfant 
31 rue Saint Louis 
27000 EVREUX 
 : +33 613 426 051 
 : cecile.poc@univ-rouen.fr 
 
Laboratoire De Microbiologie 
Signaux et Microenvironnement 
EA 4312 
CSSN, Bureau I109;  
55 rue Saint Germain, 27000 Evreux 
 
Halle Technologique de 
Pharmacie Industrielle 
IUT d'Evreux 
CS 40486 
27004 Evreux Cedex 
 
 CURSUS/FORMATION  
1997-2000 Doctorat en Sciences des Matériaux à l’Université de Caen soutenu le 4 octobre 
2000, obtenu avec mention très honorable. 
Mai 1998  Formation à la diffusion de neutrons aux petits angles, lors des Journées de la 
Diffusion Neutronique 7, à Albé (Vosges) 
1996-1997       DEA de Sciences de Matériaux à l’Université de Caen (mention assez-bien, 1ère 
session)  
1996-1998       Maîtrise de Chimie option "Catalyse et Propriétés des Interfaces" à l’Université de 
Caen (session de juin)  
1993-1995 Licence de Chimie à l’Université de Caen (session de juin) 
1991-1993       DEUG A voie ASP (Sciences-Physiques) option Sciences pour l’Ingénieur à 
l’Université de Caen (session de juin) 
 
 PARCOURS PROFESSIONNEL 
2016-à ce jour Titulaire de la Prime d’Encadrement Doctorale et de Recherche 
2002-à ce jour Maître de Conférences, Laboratoire de Microbiologie du Froid- Signaux et 
MicroEnvironnement, EA 4312, Université de Rouen 
"Mécanismes adaptatifs bactériens, en particulier membranaires, lors de stress 
physique lié à une matrice complexe (émulsion, nanoparticules, nanomatériau)" 
"Impact de stress : thermique et chimique (HAP, substance P et NOx) sur la 
virulence bactérienne" 
"Evolution de la virulence bactérienne lors d’interactions biotiques ou abiotiques"  
"Production et caractérisation de biosurfactants bactériens, facteurs de virulence" 
"Qualité microbiologique de l’air urbain" 
"Qualité microbiologique de produits cosmétiques" 
2001-2002  Agent Temporaire d’Enseignement et de Recherche, Laboratoire de Microbiologie 
du Froid (actuel LMSM, EA 4312), Université de Rouen Normandie 
"Evaluation de propriétés de surface de souches bactériennes, en particuliers Pseudomonas" 
2001    Vacataire en galénique pour le Diplôme d’Etudes Scientifiques et Techniques 
d’Université Industrie Pharmaceutique, Institut Universitaire Technologique d’Evreux, 
Université de Rouen Normandie. 
1996-2000 Doctorante, Equipe Polymères et Interfaces, UMR CNRS 6507, ISMRa-Caen 
"Elaboration de nanoparticules de biopolymères (chitosane et gliadines, protéines du blé) et 
encapsulation de diverses substances actives (vitamine, parfum et bactéricide tensio-actif)" 
en collaboration avec le laboratoire de Pharmacie galénique et biopharmacie de Rouen, 
l’INRA de Nantes, le Laboratoire Léon Brillouin du CEA-Saclay dans le cadre d’échanges 
de chercheurs du Réseau Régional Normand Matériaux-Polymères-Plasturgie. 
1996  Technicienne, Département d’Applications Techniques, Société Française 
HOECHST, Lillebonne (76). Etude physico-mécanique, détermination de la transition 
vitreuse au moyen des différentes méthodes de choc et la stabilité de coloration du 
polypropylène chargé en colorant  
6 
 
 FONCTIONS EN ENSEIGNEMENT & ADMINISTATIF PEDAGOGIQUE 
 AU SEIN DE NORMANDIE UNIVERSITE 
 
 Au sein de l’Institut Universitaire Technologique d’Evreux, Université de Rouen 
Normandie 
 
2017 à ce jour Membre du Conseil d’Institut de l’Institut Universitaire Technologique d’Evreux  
2017 à ce jour Membre du Section Locale Hygiène Sécurité Conditions de Travail 
Environnement, Institut Universitaire Technologique d’Evreux. 
2015- à ce jour Membre du jury de Validation de la Licence Professionnelle Toxicologie et 
Gestion des risques toxiques, Institut Universitaire Technologique d’Evreux. 
2001-à ce jour Responsable pédagogique de la Halle Technologique de pharmacie Industrielle 
Sept-oct 2014  Formations préparatoires au Certificat de qualification professionnelle pour les 
salariés de l’industrie pharmaceutique (CQP Pharma) réalisées par C DUCLAIROIR 
POC, partenariat avec l’AFPI de l’Eure, formations labellisées par le LEEM  
2007-2012  Vice-présidente et membre du jury de Validation des Acquis de l’Expérience, 
Institut Universitaire Technologique d’Evreux. 
2007-2012   Membre du jury de Validation des Licences Professionnelles, Institut Universitaire 
Technologique d’Evreux. 
2007-2010  Responsable pédagogique de la Licence Professionnelle Gestion de la Production 
Option : Animateur Qualité, Département de Génie Biologique, Institut Universitaire 
Technologique d’Evreux en partenariat avec la CCI de l’Eure au sein de l’Institut Européen 
de la Qualité Totale. 
2003-2006  Participation aux jurys de validation des DUT, Institut Universitaire Technologique 
d’Evreux. 
 
• Département Génie Biologique 
2015- à ce jour Membre du Conseil de Perfectionnement de la Licence Professionnelle 
Toxicologie et Gestion des risques toxiques  
2015- à ce jour Responsable des modules d’enseignement et enseignante en Licence 
Professionnelle Toxicologie et Gestion des risques toxiques  
o M32 : Gestion des Risques en production 
o M42 : Aspects Réglementaires et normatifs 
2001-à ce jour Responsable des modules et enseignante en DUT Génie Biologique concernant les 
industries pharmaceutiques et cosmétiques et la qualité afférente 
o Option Industries Agro-alimentaires et Biologique : M321I03, 
M41I06C, M33I01C et M42I01C 
o Option Analyses Biochimiques et Biologiques : M33B01, M41B06, 
M42B01. 
2001-à ce jour Co-responsable des stages du DUT Génie Biologique options Industries Agro-
alimentaires et Biologiques  et Analyses Biochimiques et Biologiques  
2013-2017  Membre du Conseil de Département Génie Biologique 
2006-2007           Responsable pédagogique de la Licence Professionnelle Biotechnologique 
Option : Modélisation et Validation, cohabilitée avec l’université de Cergy-Pontoise  
2003-2006        Responsable pédagogique de la 2ème Année Génie Biologique Option : Industries 
Agro-alimentaires et Biologiques Adaptation locale : Industries Pharmaceutiques 
2001     Vacataire en galénique pour le Diplôme d’Etudes Scientifiques et Techniques 
d’Université Industrie Pharmaceutique, Institut Universitaire Technologique d’Evreux, Université de 
Rouen Normandie. 
  
• Département Génie du Conditionnement et de l’Emballage (créé en 2003) 
2003-2015 Enseignante sur les interactions contenu-contenant en bio-industries  
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 Au sein de l’UFR Sciences et Techniques, Université de Rouen Normandie 
2017- à ce jour Responsable du module Sécurité microbiologique : normes et qualité du Master 2 
Biosciences Microbiologie option Microbiologie industrielle et Biotechnologie (MIB), 
co-habilités avec l’Université de Caen Normandie <site Mont St Aignan, 76>. 
2017- à ce jour  Enseignante en Interaction surfaces abiotiques du Master 1 Microbiologie <site 
Mont St Aignan, 76>. 
2012-à ce jour Tuteur de stages d’initiation à la recherche en Master 1 Biosciences 
Microbiologie, Université de Rouen Normandie. 
2012- à ce jour Enseignante en Microbiologie, Master 2 Biosciences Microbiologie, cohabilité avec 
Université de Caen Normandie, subdivisé depuis 2017 en 2 options : Microbiologie 
industrielle et Biotechnologie (MIB) et Mécanismes Moléculaires Microbiens (MMM) 
<site Mont St Aignan, 76>. 
2011- à ce jour Membre des jurys de soutenance de Master 2 Microbiologie Microbiologie 
industrielle et Biotechnologie (MIB), cohabilité avec l’Université de Caen Normandie 
2003-à ce jour  Enseignante en Microbiologie pharmaceutique, en Master 1 Professionnel 
Biosciences, Ingénierie Qualité Bioproduits <Antenne d’Evreux, 27> ; 
2012-2016  Enseignante en Qualité dans les bio-industries en Licence 3 SVT Ingéniérie de la 
Santé <Antenne d’Evreux, 27> ; 
2003-2015  Enseignante en Management de la Qualité en bio-industries, en Master 2 
Professionnel Biosciences, Ingénierie Qualité Bioproduits <Antenne d’Evreux, 27>. 
 
 Au sein de l’ESITech, Ecole d’ingénieurs co-habilitée Université de Rouen 
Normandie-INSA de Rouen (créée en septembre 2014) <site St Etienne du Rouvray, 76>. 
2018- à ce jour  Membre du Conseil de Perfectionnement de l’ESITech 
2015- à ce jour  Responsable des modules d’enseignement et enseignante de 2ème année Spécialité 
Technologie du Vivant 
o TV41‐Génie des procédés 
o TV42‐Formulation 
 Au sein de l’UFR Sciences et Techniques, Université de Caen Normandie 
1999-2000 Chargée de Travaux Pratiques de chimie, Ecole d’Ingénieurs de Cherbourg (EIC) 
<Site de Cherbourg>. 
1998-1999 Chargée de Travaux Dirigés, Institut de Biologie et Biochimie appliquées 
<CampusI, Caen>. 
 
 EN DEHORS DE NORMANDIE UNIVERSITE 
2016- à ce jour Membre du jury régional d'attribution du Diplôme d'Etat d'Infirmier, 
DRDJSCS de Normandie  
2013- à ce jour Membre du Conseil Pédagogique et de la Commission d’Attribution des Crédits 
de l’Institut de Formation paramédical de l’Eure. 
2006-2010  Enseignante en Connaissance des Entreprises Industrielles de la Santé et Projet tutoré 
de la Licence Professionnelle Biotechnologique option Production et Diagnostic, 
Université de Cergy-Pontoise <site St Martin>. 
1996-2006 Formatrice au cours de 6 formations permanentes intra muros de la Société L’Oréal 
d’Initiation aux Agents de Surfaces (tensio-actifs). 
 
 FONCTIONS ADMINISTRATIVES RECHERCHE 
2001-2004  Qualifiée aux fonctions de maîtres de conférences des sections CNU : 31, 32 et 39 
(actuellement 85). 
2002-2013 Membre de la 39ème section du CNU, devenue la 85ème. 
Septembre 2013 Intégration de la 64ème section du CNU.  
 
 Au sein de Normandie Université 
2017  Vice-présidente du comité de sélection pour le recrutement du maître de 
conférences emploi n°1287 (section 64), IUT d’Evreux, Génie Biologique / LMSM, 
Université de Rouen Normandie. 
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2017  Membre du comité de sélection pour le recrutement du maître de conférences 
emploi n°325 (sections 31 et 33), UFR Sciences et Technique / Laboratoire URCOM, 
Université du Havre Normandie. 
2015-2017  Référent de thèse pour l’Ecole Doctorale Normande de Chimie – ED 508, 
Université du Havre Normandie. 
2015-2016  Membre des jurys de soutenance à mi-parcours des thèses de l’Ecole Doctorale 
Normande de Biologie Intégrative Santé Environnement ED 497 de l’Université 
de Rouen Normandie. 
2015  Membre du comité de sélection pour le recrutement du maître de conférences 
emploi n°586 (section 65), ESITech / LMSM, Université de Rouen Normandie. 
20 Nov 2015 Membre du jury de la soutenance du Doctorat Européen en Microbiologie de 
Tatiana KONDAKOVA de l’Université de Rouen, intitulé “Pseudomonas adaptation 
to stress factors: role of membrane lipids and Pseudomonas fluorescens response to 
NO2”. 
2013- à ce jour Membre suppléent de la Commission consultative de spécialites d'établissement 
de la 64ème section du Conseil National des Universités (CNU), Université de Rouen 
Normandie. 
Normandie. 
2004-2006  Membre de la commission de spécialistes 39ème section CNU (actuelle 85ème), 
Université de Rouen Normandie. 
 Au sein du Laboratoire de Microbiologie Signaux Microenvironnement EA4312 
2012-à ce jour Membre du conseil du laboratoire LMSM, EA 4312, Université de Rouen  
 
• Recherche de financement pour mes thématiques de recherche  
Janvier 2018  Soumission d’une demande d’allocation doctorale au concours du Réseau 
d’Intérêts Normand Normandie Biomédicale et Chimie axe Sécurité sanitaire, bien-
être et aliments durables intitulée « NOxBBEE : NOx, polluants automobiles : 
détermination de Biomarqueurs Bactériens d’Exposition Environnementale par inhalation», 
porteur C DUCLAIROIR POC, Direction LMSM (Encadrement : Pr N ORANGE 
50%- Dr C DUCLAIROIR POC 50%) concrétisée par le recrutement de T 
CHAUTRAND au 1er septembre 2018. Obtention. 
Novembre 2017 Soumission d’une lettre d’intention pour une étude de faisabilité en réponse aux 
Appels à projets de recherche sur la santé environnement et la santé au travail intitulé 
« Développement d’un outil bactérien rapide et robuste d’identification des dangers liés à 
l’inhalation de nanomatériaux » par C DUCLAIROIR POC (budget 50k€ dont 1 an de 
post-doc). Non retenu. 
Octobre 2017  Participation à la soumission d’une ANR portée par M FEUILLOLEY intitulée 
«LipiDyn : Dynamique adaptative des lipides membranaires des bactéries à Gram négatif : 
relations environnementales et évolutives» (budget 681,42k€, durée 48 mois). Non 
retenue. 
Mars 2015  Soumission d’une demande d’allocation doctorale au concours du Groupe 
Régional de Recherches Haut-Normand Sécurité Sanitaire SéSa intitulée « NO2BactAIR 
: Exposition au polluant automobile NO2, adaptation d’une BACTérie Aéroportée via son 
homéostasIe membranaire et sa viRulence», porteur C DUCLAIROIR POC, Direction 
LMSM (Pr N ORANGE 50%- Dr C DUCLAIROIR POC 50%) concrétisé par le 
recrutement de S DEPAYRAS au 1er octobre 2015. Obtention. 
Mars 2015  Soumission d’un projet au concours du Groupe Régional de Recherches Haut-
Normand Sécurité Sanitaire SéSa intitulée « NitroBactAIR : Qualité de l’air : stress 
Nitrosant provoqué par les polluants automobiles (NOx) et adaptation d’une Bactérie 
Aéroportée via son homéostasIe membranaire et sa viRulence.», porteur C DUCLAIROIR 
POC (budget 31,5k€ sur 3 ans). Obtention. 
Janvier 2014 Soumission d’un projet en réponse aux Appels à projets de recherche sur la santé 
environnement et la santé au travail intitulé « Impact de NO2 gaz sur la virulence d’une 
bactérie aéroportée : stratégies de dénitrification et de mobilité membranaire » par C 
DUCLAIROIR POC (budget 50k€ dont 1 an de post-doc). Non retenu. 
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Mars 2012  Soumission d’une demande d’allocation doctorale au concours de Groupe 
Régional de Recherches Haut-Normand Sécurité Sanitaire et Environnement SSE 
intitulée « Impact de marqueurs de pollution que sont NO et NO2 sur la physiologie et la 
virulence de Pseudomonas », porteur C DUCLAIROIR POC, Co-direction LMSM (Pr 
N Orange)/ CERTAM (Dr F Dionnet), concrétisé par le recrutement de T Kondakova 
au 1er octobre 2012. Obtention. 
Janvier 2012 Soumission d’une ANR Jeunes Chercheuses et Jeunes Chercheurs par C 
DUCLAIROIR POC intitulée «Impact du stress nitrosant sur l’expression de la virulence 
d’une bactérie aérienne via la régulation lipidique et des systèmes de sécrétion» (budget 
241k€) labellisée par le pôle de compétitivité MOV’EO. Non retenue. 
Nov. 2011  Soumission d’une lettre d’intention pour un projet en réponse aux Appels à 
projets de recherche sur la santé environnement et la santé au travail intitulé « Impact 
des NOx sur la virulence d'aérosols bactériens» par N ORANGE, C DUCLAIROIR POC, 
A GROBOILLOT (budget 200k€ dont 7 mois de post-doc). Non retenue. 
 
• Participation à des axes transversaux de recherche du LMSM EA 4312 
2013-2017   Contribution aux travaux de thèse de Laura ROWENCZYK intitulés 
« Vieillissement de nanoparticules de TiO2 en lotion solaire : évolution de leur impact sur 
des germes représentatifs du microbiote cutané » codirigée par l’URCOM (Pr M GRISEL), 
Université du Havre Normandie et par le LMSM (Pr M FEUILLOLEY)-Université de 
Rouen Normandie, soutenue le 7 décembre 2016 au Havre. 
Depuis 2015 Contribution aux travaux de thèse de Davina DESPLAN codirigée par l’UMR 
8029 SATIE (Pr P GRIESMAR), Université de Cergy-Pontoise et par le LMSM (Pr N 
ORANGE)-Université de Rouen Normandie <soutenance prévue décembre 2017> 
   Mais aussi des participations ponctuelles aux travaux des diverses thèses 
suivantes 
  
 
 ENCADREMENTS 
 Encadrement de 11 étudiants au cours d’un stage de niveau 1er cycle 
universitaire de l’Université de Rouen Normandie. 
 Encadrement de 6 étudiants au cours d’un stage de Master 1 de l’Université de 
Rouen Normandie, de Lille 
 Encadrement de 12 étudiants au cours d’un stage de Master 1 d’immersion en 
laboratoire de l’Université de Rouen Normandie 
 Encadrement d’1 élève-ingénieur au cours d’un stage d’immersion de 6 mois 
en laboratoire de l’ESITech, Rouen 
Nom Prénom Directeur(s) de 
thèse 
Date de début 
de thèse
Date de soutenance 
(pour les diplômés)
HILLION Mélanie FEUILLOLEY M. nov.-09 11/01/13
DAGORN Audrey FEUILLOLEY M. oct.-09 01/02/13
MIJOUIN Lily FEUILLOLEY M. nov.-09 18/12/13
DECOIN Victorien ORANGE N.,               MERIEAU A. oct.-11 01/11/14
ROSAY Thibaut LESOUHAITIER O. oct.-12 14/12/15
N'DIAYE Awa FEUILLOLEY M. oct.-13 oct-2016
GALLIQUE Mathias MERIEAU A. oct.-14 déc-2017
GANNESEN Andrei PLAKUNOV V FEUILLOLEY M. oct.-15 en cours
BORREL Valérie FEUILLOLEY M.     KONTO Y. janv.-16 en cours
LE TOQUIN Esther ORANGE N.,               CEA Marcoul oct.-15 en cours
CLABAUT Maximilien FEUILLOLEY M. CHEVALIER S. déc.-17 en cours
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 Encadrement de 6 étudiants au cours d’un stage de Master 2 de l’Université de 
Rouen Normandie. 
 Co-encadrement de 3 doctorantes en Microbiologie de l’Université de Rouen 
Normandie 
 Co-encadrement de 3 chercheurs post-doctorants. 
 La liste exhaustive des encadrements est dressée en annexe 1. 
 RAYONNEMENT ET VULGARISATION 
La diffusion de mes travaux de recherche peut s’adresser à mes pairs, comme être vulgarisée afin 
d’informer, voire de faire découvrir la science. 
 Membre de sociétés savantes 
 American Society for Microbiology <2014-2017> 
 Groupements De Recherche CNRS 
• Combavir <2012-2013> 
• Cosmactifs GDR 3711 <depuis sa création en septembre 2015> 
Membre du bureau <depuis mars 2018>, participation à l’écriture du dossier renouvellement <été 2018> 
 Réseau d’Intérêts Normand (RIN) 
• RIN Normandie Biomédicale et Chimie CBS  
o principalement axe Sécurité sanitaire, bien-être et aliments 
durables (SESAL) <2017-à ce jour> préalablement SéSa (Sécurité Sanitaire), puis SSE 
(Sécurité sanitaire et Environnement)<2010-2017> 
o IRIB HN (Institut de Recherche et d’Innovation Biomédicale de 
Haute Normandie) <2014- à ce jour> 
• TERA (Territoire, Environnement, Risques, Agronomie) - SCALE (Sciences 
appliquées à environnement) <2010-2014> 
• EEM (Energie, Electronique, Matériaux) - Energie : Performances 
environnementales et effets sur l’environnement <2012-2015> 
 
 Actrice de collaborations scientifiques 
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 Organisation de colloques scientifiques 
 Participation à l’organisation du 3rd day of Institute for Research and Innovation 
in Biomedecine, Caugé, Normandie, 20 juin 2014 
 Coorganisatrice du colloque Intelligence Economique de la PFT Normandie 
Sanitaire "Lutte contre la contrefaçon et Sécurisation des savoirs des bioindustries", Evreux, 
18 novembre 2014. 
 Organisatrice du symposium recherche "Membranes cellulaires", Evreux, 19 
novembre 2015 
o "Multiples roles of cardiolipin in biomembranes"  
Pr  Angela Corcelli, Coordinatore Centro Interdipartimentale di Ricerche sulla Pace, Dipartimento 
Scienze Mediche di Base Neuroscienze e Organi di Senso, Università degli Studi di Bari,  Bari Italy  
o " Ice nucleation activity in fungi" 
Dr Janine Frölich, Max Planck Institute for Chemistry, research group leader in Multiphase Chemistry 
Department, Mainz, Germany 
o "Microbial Adaptation to Toxic Organic Solvents and other 
Forms of Stress - Mechanisms and Applications" 
 Dr Hermann Heipieper, Head of the group Microbial Processes, Department Environmental 
Biotechnology 
Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany 
 Coorganisatrice du 3ème Colloque du GDR Cosm’actifs (GDR 3711) "Hot spots 
de la Cosmétomique", Rennes, 27-28 novembre 2018. 
 
 PRODUCTION SCIENTIFIQUE 
 30 Publications dans des revues internationales ou nationales avec comité de 
lecture répertoriées par l’AERES ou dans les bases de données internationales (ISI Web of 
Knowledge, Pub Med…), 
 4 chapitres de livre, 
 2 articles de diffusion de connaissance, 
 33 communications orales avec actes dans un congrès international ou 
national, dont 2 plénières internationales. 
 44 communications par affiche avec actes dans des congrès internationaux ou 
nationaux.  
Cette production scientifique est compilée en annexe 2. 
 
FONCTIONS EN VALORISATION & TRANSFERT DE TECHNOLOGIE 
2002-2010 Consultante au sein du CRITT ADIPpharm, Anticiper et Développer l’Innovation 
de votre Projet pharmaceutique, Evreux pour les projets galéniques et aspects qualité. 
2003- 2010 Secrétaire du bureau du CRITT ADIPpharm, Evreux. 
2004- à ce jour Experte pour la Plate-Forme Technologique “Normandie Sécurité Sanitaire”, pour la 
Plate-Forme Mutualisée d’Innovation Cosmetomics@Normandie et la Société Biogalenys 
(Evreux, 27) 
 
 EXPERTISES 
2010- à ce jour Reviewer pour des publications internationales à comité de lecture :Plant and Soil ; 
International Journal of Food, Research in Microbiology, FEMS Microbiology Letters ; 
2012- à ce jour Experte pour le Crédit d’Impôt Recherche et Jeune Entreprise Innovante pour le 
gouvernement français 
 
 DIVERS 
Promotion de l’enseignement des sciences : forums régionaux, conférences en lycée 
2017-2018  Formation CERPEP d’enseignants du secondaire sur les « Technologies émergentes 
sur la conservation des bioproduits : du laboratoire au monde industriel »  
2018  Formation « Savoir manipuler les bouteilles de gaz » 
2005- à ce jour Sauveteur Secouriste du travail  
2005- à ce jour Habilitation à la conduite d’autoclave  
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Annexe 1 
 
Encadrements réalisés  
par C Duclairoir Poc 
 
Signification des abréviations: 
Imm : immersion en laboratoire  
L: diplôme préparé d’un niveau 1er cycle universitaire  Ing : diplôme préparé ingénieur 
M1: diplôme préparé Master 1     M2: diplôme préparé Master 2 
D: diplôme préparé doctorat      PD: statut post-doc 
M2_1 : Sandra N’Goya, DEA Microbiologie, Rouen (Septembre 2002- Septembre 2003)  
Co-encadrement par N Orange & C Poc 
Pseudomonas fluorescens : Etude de leur potentialité à produire des biosurfactants et impact sur leur 
comportement bioadhésif 
M1_1 : Mathieu SABATTIER, MasterI Ingénierie de la santé, Evreux (Avril-juin 2002) 
Mise en place du SMQ de la HTPI Evreux 
L1: Bruno JEHL, DUT Génie Biologique option IAB, Evreux (Avril-juin 2002) 
Recherche de facteurs influençant la production de biosurfactant sur la souche hospitalière de 
Pseudomonas fluorescens 
D1: Sandra N’GOYA, Thèse en Microbiologie, Université de Rouen (Septembre 2003-2007)  
Co-encadrement par N Orange, MN Bellon-Fontaine, T Meylheuc & C Poc 
Etude de la production de biosurfactants par les Pseudomonas fluorescens , de sa conséquence sur la 
surface bactérienne et sur son potentiel adhésif (soutenue le 24 septembre 2007) 
M1_2: Marie-Hélène AUDEON, Master1 Ingénierie de la santé, Evreux (Mai-juin 2006)  
Caractérisation de quelques bactéries par la mise en évidence de leur production de biosurfactant de 
nature ionique déterminée et par caractérisation physico-chimique de leur membrane externe 
L2 : Marion COUVE, L3 Ingénierie de la Santé, Evreux (Mai-Juillet 2008)° 
Co-dirigé par A Groboillot & C Poc 
Influence des HAP sur la physiologie de Pseudomonas fluorescens DSS73 et de son mutant 
M1_3 : Etienne LENOBLE, Master1 Ingénierie de la Santé, Evreux (Mai-Juin 2008) 
Co-dirigé par A Groboillot & C Poc  
Mise en place d’une base de données concernant les bactéries de l’air dans le cadre du projet PUC2MP 
L3 : Sahed SELIM, L3 Ingénierie de la Santé, Evreux (Mai-Juillet 2009) 
dirigé par F Koltalo  et appui technique sur l’aspect biosurfactant C Poc  
Analyse de polluants de type hydrocarbure aromatique polycyclique à l’interface eau/sédiment. 
Désorption par agents tensio-actifs 
L4 : Jessica BLONDEL, L3 Ingénierie de la Santé, Evreux (Mai-Juillet 2009) 
Etude de la production de biosurfactants et du comportement adhésif de deux souches Pseudomonas 
fluorescens de niches écologiques différentes 
L5 : Philadelphia GRESSENT, L3 Ingénierie de la Santé, Evreux (Mai-Juillet 2009)  
Etude  du comportement adhésif de deux souches nosocomiales de Pseudomonas fluorescens 
productrice et non–productrice de biosurfactant. 
PD1 : Maddalena MORETTI, Post-doc (Mars-octobre 2009) 
Co-dirigé par A Groboillot & C Poc 
Identification fongique des campagnes de prélèvement du projet PUC2MP 
L6 : Pricilla Morice, BTS Bioanalyse et contrôles, Evreux (Novembre-décembre 2009) 
Co-dirigé par M Moretti & C Poc 
Identification bactérienne et fongique des campagnes de prélèvement du projet PUC2MP 
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M2_2 : Seyed Mohsen HOSSEINI, M2R Microbiologie, Rouen (Janvier- mars 2010) 
Co-encadrement A Merieau & C Poc 
Etude de la régulation et de la production de CLP «viscosinamide-like» par deux souches de 
Pseudomonas fluorescens hospitalières: MFN1032 et MFY162 
L7 : Célia Augé, L3 Ingénierie de la Santé, Evreux (Mai-juillet 2010) 
Co- encadrement par A Groboillot & C Poc 
Influence des hydrocarbures aromatiques aromatiques polycycliques (HAP) sur la physiologie d’une 
souche productrice de biosurfactant dans le cadre d’un projet de restauration de sédiments pollués par 
des HAP. 
PD2: Julien VERDON, Post-doc (Octobre 2010-Août 2011)  
Co-dirigé par A Groboillot & C Poc 
Financement FEDER Virulence 
NOx influence on outdoor bacterial air quality 
M1_4: Hervé TOUCOUROU, Master1 Ingénierie de la santé, Evreux (Mai-Juillet 2012° 
Caractérisation de biosurfactants produits par des souches de Pseudomonas collectées dans l’air  
M1_5: Lylia DRICI, Master 1 Pro Protéomique, Lille (Mars-Juillet 2012) 
Co-dirigé par J Verdon & C Poc 
Mise en place de l’analyse des protéines bactériennes à l’aide d’un spectromètre de masse MALDI 
TOF/TOF. 
L8 & L9: Rachel DUCHESNE & Mélanie LE GOFF, stages volontaires L3 Biologie, Rouen (Mai-Juin 
2012)  
Co-dirigées par J Verdon & C Poc 
M2_3: Hervé TOUCOUROU, Master 2 Pro Ingénérie de la santé, Evreux (Février-Juillet 2012) 
Impact de l’exposition de souches de Pseudomonas à des polluants atmosphériques: Etude 
physiologique et mise au point d’un test cytotoxique vis-àvis de Dictyostelium discoideum 
PD3: Maryse BONNIN JUSSERAND, Post-doc (Janvier-Août 2012)  
Co-dirigé par A Groboillot & C Poc 
Financement FEDER Virulence 
NOx influence on outdoor bacterial air quality 
D2: Tatiana KONDAKOVA, Thèse en Microbiologie, Université de Rouen Normandie (Octobre 2012-
Septembre 2015)   
Co-direction par N Orange & F Dionnet  
Encadrement scientifique : C Poc 
Financement GRR SSE 
Impact de marqueurs de pollution que sont NO et NO2 sur la physiologie et la virulence de Pseudomonas. 
M1 Imm_1-> M1 Imm_4 : A HAMON, F OUSALEM, W ODJO et S COCHENNEC, Stage M1 
immersion en laboratoire, Rouen (printemps 2013)  
Characterization of surface properties of Pseudomonas fluorescens MFAF76a strain and its GFP 
transformed 
M1_6: Ishac Si Hadj Mohand, Master 1 Microbiologie, Rouen (Mai-Juin 2013) 
Caractérisation des propriétés de surface de deux souches Pseudomonas fluorescens: l’aéroportée 
MFAF76a et l’hospitalière MFN1032 et de leurs transformées chromophores. 
M1 Imm_5-> M1 Imm_8 : T CLAMENS, A DUPUIS, S HAULARD et R VERGER, Stage M1 
immersion en laboratoire, Rouen (printemps 2014)  
Elaboration d’un protocole de séparation de protéines à pH basique  
M2_4 : Andry TSIFERANA, Master 2 Master Pro Biosciences, Ingénierie Qualité Bioproduits, 
Rouen (Février-Juillet 2014) 
Impacts de l’exposition de Pseudomonas aéroportées aux NOx sur leur profil protéomique et leur 
virulence 
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M2_5 : Chloé CATOVIC, Master 2 Recherche Microbiologie, Rouen (Janvier-Juin 2015) 
Co-encadrement par T Kondakova & C Poc 
Etude de la réponse bactérienne moléculaire et physiologique de Pseudomonas fluorescens suite à son 
exposition au NO2, polluant atmosphérique 
D_3 : Ségolène DEPAYRAS, Thèse GRR SeSa, Université de Rouen Normandie (Octobre 2015- 
soutenance prévue décembre 2018) 
Co-encadrement 50%  CDP avec direction du Pr N Orange 
NitroBactAIR : Qualité de l’air : stress Nitrosant provoqué par les polluants automobiles (NOx) et 
adaptation d’une Bactérie Aéroportée via son homéostasIe membranaire et sa viRulence 
M1 Imm_9-> M1 Imm_10 : P HOULLEMARE et E LIEVIN, stage M1 immersion en laboratoire, 
Rouen (printemps 2016)  
Co-encadrement: Cécile Duclairoir-Poc & Ségolène Depayras 
Evaluation par cytométrie en flux de l’influence des NOx sur Pseudomonas fluorescens 
M2_6 : Marine RINGUEDÉ, Master 2 Microbiologie, Rouen (Janvier-Juillet 2017) 
Evaluation de l’innocuité en utilisation d’une formule solaire contenant comme filtre UV des 
nanoparticules de TiO2 et contaminée par une souche de Pseudomonas fluorescens aéroportée. 
L10: Sarah MAERTEN, BTS 2A, Lycée Léopold Sedar Senghor, Evreux (Mai-Juillet 2017) 
Co-encadrement: Cécile Duclairoir-Poc & Ségolène Depayras 
Etude d’un système de communication chez P.fluorescens : Le Quorum Sensing 
Ing1_1 : Candice AUGER, stage d’immersion en laboratoire s’étalant sur 6mois (de plus de 600h), 
ESITech 1ère année d’ingénieurs, Rouen (Fevrier-Juillet 2018) 
Co-encadrement: Cécile Duclairoir-Poc & Ségolène Depayras 
Dans le cadre de l'étude de l'impact de marqueurs de pollution automobile (oxydes d'azote) sur la 
physiologie et la virulence de souches de Pseudomonas : Réponse membranaire de mutants d’une 
Pseudomonas fluorescens aéroportée suite à l’exposition à deux polluants automobiles NOx en synergie. 
M1 Imm_11-> M1 Imm_12 : J MARTEL et F FECAMP, stage M1 immersion en laboratoire, Rouen 
(Printemps 2018) 
Mise au point de protocole de lipidomique HPTLC MALDI sur extraits bactériens 
L11 : Mathieu CLAIRET, BTS 2A, Lycée Léopold Sedar Senghor, Evreux (Mai-Juillet 2018) 
Évaluation de l'activité antibactérienne de nanomatériaux à base d'argent 
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Annexe 2 
 
Publications et communications 
de C Duclairoir Poc 
 
 30 publications dans des revues internationales ou nationales avec 
comité de lecture répertoriées par l’AERES ou dans les bases de données internationales (ISI 
Web of Knowledge, Pub Med…). 
P1- Formation of Gliadin Nanoparticles: Influence of the Solubility Parameter of the 
Gliadin Solvent 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, Colloid and Interface Science. (1998) 276 : 
321-327. 
P2- Gliadin Nanoparticles : Formation ; All-trans Retinoic Acid Entrapment and 
Release, Size Optimization 
C Duclairoir, JM Irache, E Nakache, A-M Orecchioni, C Chabenat, Y Popineau, Polymer International,. 
(1999) 79 :327-333. 
P3- Maîtrise de la taille de nanoparticules de gliadines de blé par la détermination de 
leur paramètre de solubilité 
A-M Orecchioni, C Duclairoir, E Nakache, Annales Pharmaceutiques Françaises. (2001) 59 : 402-406. 
P4- α-tocopherol encapsulation and in vitro release from wheat gliadin nanoparticles 
C Duclairoir, A-M Orecchioni, P Depraetere, E Nakache, Journal of Microencapsulation. (2002), 19 : 
53-60. 
P5- Polymer Nanoparticles Characterization in Aqueous Suspension 
C Duclairoir, E Nakache, International Journal of Polymer Analysis and Characterization. (2002) 7 : 
284-313. 
P6- Biopolymeric colloidal carriers for encapsulation or controlled release 
D. Renard, P. Robert, L. Lavenant, D. Melcion, Y. Popineau, J. Guéguen, C. Duclairoir, E. Nakache, C. 
Sanchez and C. Schmitt, International Journal of Pharmaceutics. (2002) 242( 1-2) :  163-166. 
P7- Evaluation of Gliadins Nanoparticles as Drug Delivery Systems: a Study of Three 
Different Drugs 
C Duclairoir, A-M Orecchioni, P Depraetere, F Osterstock, E Nakache, International Journal of 
Pharmaceutics. (2003) 253: 133-144. 
P8- Gliadin characterization by SANS and gliadin nanoparticle growth modelization.  
A-M Orecchioni, C Duclairoir, Denid Renard and E Nakache., Journal of nanoscience and 
nanotechnology. (2006) 6 :3171-3178. 
 P9- Phenotypic variation in the Pseudomonas fluorescens clinical strain MFN1032 
G Rossignol, D Sperandio , J Guerillon, C Duclairoir Poc, E Soum-Soutera, N Orange, MGJ Feuilloley, 
A Merieau. Res Microbiol. (2009) 160(5):337-44 
 P10- Pollution des sédiments de dragage : Procédés de bioremédiation alliés à 
l’électromigration. 
F Portet-Koltalo, M Ammami, A Benamar, A Groboillot, N Orange. C Duclairoir Poc Spectra Analyse. 
(2010) 277 : 54-58. 
 P11- Déséquestration de polluants de type hydrocarbures aromatiques polycycliques à 
l’interface de sédiments au moyen de tensioactifs d¹origine biologique. " 
F Portet-Koltalo, M Ammami, A Benamar, A Groboillot, N Orange. C Duclairoir Poc Spectra Analyse. 
(2011) 278 : 21-27. 
 P12- Novel Application of Cyclolipopeptide Amphisin: Faisability Study as Additive to 
Remediate PAHs Contaminated Sediments. 
16 
A Groboillot, F Koltalo, F Lederf, M Feuilloley, N Orange, C Duclairoir Poc, Int. J. Mol. Sci. (2011) 12 
: 1787-1806  
 P13- Caenorhabditis elegans as a model to monitor air bacterial quality" 
C Duclairoir Poc, A Groboillot, O Lesouhaitier, M Feuilloley, J-P Morin, N Orange, BMC Res. Notes. 
(2011) 4:503. 
 P14- The Major Outer Membrane Protein Oprf is Required for Rhamnolipid 
Production in Pseudomonas aeruginosa 
E Bouffartigues, G Gicquel, A Bazire, L Fito-Boncompte, L Taupin, O Maillot, A Groboillot, C Poc-
Duclairoir, N Orange, M Feuilloley, A Dufour, S Chevalier. J. Bacteriol. Parasitol. (2011)  2 : 118; DOI 
: 10.4172/2155-9597.1000118 
 P15- Influence of growth temperature on cyclolipopeptides production and on adhesion 
behaviour in environmental strains of Pseudomonas fluorescens. 
C Duclairoir Poc, T Meylheuc, S Ngoya, A Groboillot, J Bodilis, L Taupin, A Merieau, M Feuilloley, 
N Orange. J. Bacteriol. Parasitol. (2011) S1-002. http://dx.doi.org/10.4172/2155-9597.S1-002. 
 P16- Gamma-aminobutyric acid acts as a specific virulence regulator in Pseudomonas 
aeruginosa 
A Dagorn, M Hillion, A Chapalain, O Lesouhaitier, C Duclairoir Poc, J Vieillard, S Chevalier, L Taupin, 
F Le Derf, MGJ Feuilloley, Microbiology. (2013) 159:339-351 
 P17- Investigation of the release of PAHs from artificially contaminated sediments 
using cyclolipopeptidic biosurfactants 
F Portet-Koltalo, MT Ammami, A Benamar, H Wang, F Le Derf, C Duclairoir-Poc, Journal of 
Hazardous Materials. (2013) 261:593– 601. 
 P18- Effect of GABA, a bacterial metabolite, on Pseudomonas fluorescens surface 
properties and cytotoxicity 
A Dagorn, A Chapalain, L Mijouin, M Hillion, C Duclairoir-Poc, S Chevalier, L Taupin, N Orange, 
MGJ Feuilloley, Int. J. Mol. Sci. (2013) 14 : 12186-12204; DOI : 10.3390/ijms140612186. 
 P19- Effects of a Skin Neuropeptide (Substance P) on Cutaneous Microflora 
L Mijouin, M Hillion, Y Ramdani, T Jaouen, C Duclairoir-Poc, ML Gueye, E Lati, F Yvergnaux, A 
Driouich, L Lefeuvre, L Misery, MGJ Feuilloley, PLoS ONE. (2013) 8(11): e78773 ; DOI : 
10.1371/journal.pone.0078773:. 
 P20- Airborne fluorescent pseudomonads : what potential for virulence ? 
C Duclairoir Poc, J Verdon, A Groboillot, M Barreau, H Toucourou, L Mijouin, C Leclerc, C Hulen, T 
Kondakova JP Morin, MGJ Feuilloley, A Merieau, N Orange, International Journal of Current 
microbiology and applied sciences.(2014) 3(8) : 708-722. 
 P21- A new tool for studying bacterial lipidome: HPTLC-MALDI-TOF Imaging 
enlightening virulence traits of the airborne Pseudomonas fluorescens MFAF76a  
T Kondakova, N Merlet-Machour, M Chapelle, D Preterre, F Dionet, MJ Feuilloley, N Orange, C 
Duclairoir Poc, Research in Microbiology. (2015) 166 : 1-8; DOI : 10.1016/j.resmic.2014.11.003 
 P22- Application of biosurfactants and periodic voltage gradient for enhanced 
electrokinetic remediation of metals and PAHs in dredged marine sediments 
M T Ammami, F Portet-Koltalo, A Benamar, C Duclairoir Poc, H Wang, F Le Derf, Chemosphere. 
(2015) 125 : 1–8. 
 P23- Surface functionalization of cyclic olefin copolymer witharyldiazonium salts: A 
covalent grafting method 
F Brisset, J Vieillard, B Berton, S Morin-Grognet,C Duclairoir-Poc, F Le Derf, Applied Surface Science. 
(2015) 329 : 337–346. 
 P24- Glycerophospholipid synthesis and functions in Pseudomonas: eukaryotic lipid 
exploitation 
T Kondakova; F D'Heygère ; M J. Feuilloley; N Orange; H J Heipieper; C Duclairoir Poc, Chemistry 
and Physics of Lipids. (2015) 190:27-42; DOI : 10.1016/j.chemphyslip.2015.06.006. 
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 P25- A Pseudomonas fluorescens type 6 secretion system is related to mucoidy, motility 
and bacterial competition 
V Decoin, M Gallique, C Barbey, F Le Mauff, C Duclairoir Poc, MGJ Feuilloley, N Orange, A Merieau, 
BMC Microbiology. (2015) 15(1); DOI: 10.1186/s12866-015-0405-9. 
 P26- Response to Gaseous NO2 Air Pollutant of P. fluorescens Airborne Strain 
MFAF76a and Clinical Strain MFN1032 
T Kondakova, C Catovic, M Barreau, M Nusser, G Brenner-Weiss, M Feuilloley, F Dionnet, N Orange, 
C Duclairoir Poc, Front Microbiol. ( 2016) 7:379; DOI : 10.3389/fmicb.2016.00379. 
 P27- Development of preservative-free nanoparticles-based emulsions: Effects of NP 
surface properties and sterilization process. 
L Rowenczyk, C Picard, C Duclairoir Poc, N Hucher, N Orange, M Feuilloley, M Grisel. Int J Pharm. 
(2016) 510(1) : 125-34; DOI : 10.1016/j.ijpharm.2016.06.014. 
 P28- Skin-bacteria communication: Involvement of the neurohormone Calcitonin 
Gene Related Peptide (CGRP) in the regulation of Staphylococcus epidermidis virulence. 
A N'Diaye, C Leclerc, T Kentache, J Hardouin, C Duclairoir Poc, Y Konto-Ghiorghi, S Chevalier, O 
Lesouhaitier, MG Feuilloley. Sci Rep. (2016) 6: 35379; DOI : 10.1038/srep35379. 
 P29- Impact of coated TiO2-nanoparticles used in sunscreens on two representative 
strains of the human microbiota: Effect of the particle surface nature and aging 
L Rowenczyk, C Duclairoir Poc, M Barreau, C Picard, N Hucher, N Orange, M Grisel, M Feuilloley. 
Colloids and Surfaces B: Biointerfaces. (2017)158 : 339-348; DOI : 10.1016/j.colsurfb.2017.07.013. 
 P30- Impact of gaseous NO2 on P. fluorescens strain in the membrane adaptation and 
virulence. 
S Depayras, T Kondakova, N Merlet-Machour, H J Heipieper, M Barreau, C Catovic, M Feuilloley, N 
Orange, C Duclairoir Poc, Int. J. Environ. Impacts. (2018), 1(3) : 1–10. 
 Chapitres de livre: 4  
 Ch1- Creation of biopolymeric colloidal carriers dedicated to controlled release 
applications 
D Renard, P Robert, L Lavenant, D Melcion, Y Popineau, J Gueguen, C Duclairoir, E Nakache, C 
Sanchez and C Schmitt 
In Plant biopolymer science: food and non-food applications p.119-124, Denis Renard, Guy Della Valle, 
Yves Popineau, eds, Royal Society of Chemistry (Great Britain 2002) 
 Ch2- Plant protein-based nanoparticles 
A-M Orecchioni, C Duclairoir, J Manuel Irache and E Nakache, 
in "Nanotechnologies for the life sciences" vol.2, Biological and pharmaceutical nanomaterials, p.117-
144, Challa S. S. R. Kumar Ed., Wiley-VCH Verlag Gmbh&Co. KGaA, Weinheim (2006) 
Ch3- HPTLC-MALDI TOF MS Imaging analysis of phospholipids  
T Kondakova, N Merlet Machour, C Duclairoir Poc 
In Neuromethods: Lipidomics, vol. 125 Chapter 12; Paul L. Wood (ed.); Series Editor: Wolfgang Walz, 
eds, Springer (Germany 2017), DOI 10.1007/978-1-4939-6946-3_12. 
Ch4- The hidden face of Nitrogen oxides species – from toxicity effect to potential cure? 
S Depayras, T Kondakova, H J. Heipieper, M Feuilloley, N Orange and C Duclairoir Poc 
In Emerging Pollutants - Some Strategies for the Quality Preservation of Our Environment", p.19-44, 
edited by Sonia Soloneski and Marcelo L. Larramendy, Ed. IntechOpen, London (United Kingdom, 
2018); http://dx.doi.org/10.5772/intechopen.75822 
 Publications de revue ou de diffusion de connaissance : 2 
 Pdc1- Encapsulation et applications industrielles 
C Duclairoir, L’Actualité Chimique. (2000)  6 : 24-27. 
 Pdc2- Particules Urbaines et Céréalières, Microorganismes Mycotoxines et Pesticides 
JP Morin, D Preterre, F Gouriou, V Delmas, A François, N Orange, A Groboillot, C Duclairoir-Poc, M 
Moretti, O Maillot, O Lesouhaitier, Pollution atmosphérique. (2013)217; URL : 
http://lodel.irevues.inist.fr/pollution-atmospherique/index.php?id=759. 
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 Publications de compte-rendu de congrés : 77 
 Conférence plénière internationale : 2 
CInt1-"Polymer Nanoparticles Characterization in Aqueous Suspension" 
C Duclairoir, E Nakache, International Symposium of Polymer Analysis and Characterization, 26-30 
juin 1999, la Rochelle-France. 
CInt2- Response of commensal Staphylococci to sub-lethal concentrations of skin 
antimicrobial peptides 
Cécile Duclairoir-Poc, FEMS, Leipzig, Germany, July 21-25th 2013. 
 
 Communications orales : 31 
C1- Nanoparticules de gliadines obtenues par coacervation 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, Journée de l’Ecole Doctorale Normande de 
Chimie-Biologie, 27 mars 1997, Caen. 
C2- Elaboration de nanoparticules de gliadines par coacervation 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, Rencontre de la Société Française de Chimie 
(section Basse-Normandie-Sarthe), 30 mai 1997, Caen.  
C3- Nanoparticules de polymère végétal 
C Duclairoir, E Nakache, A-M Orecchioni, H Marchais, Journées GFP Ouest-SFC, 15-17 octobre 1997, 
Thiais.  
C4- Préparation de nanoparticules de polymère végétal. Optimisation de leur taille 
C Duclairoir, E Nakache, A-M Orecchioni, H Marchais, Congrès Annuel du GFP, 18-20 novembre 1997, 
Louvain-La-Neuve, Belgique. 
C5- Encapsulation de vitamines dans des nanoparticules de protéines végétales 
C Duclairoir, E Nakache, A-M Orecchioni, J Irache, Y Popineau, D Renard, Journées GFP-Ouest, 2-3 
juin 1999, Alençon. 
C6- Nanoparticules de protéines végétales : caractérisation structurale et potentialités 
d’encapsulation 
C Duclairoir, D Renard, A-M Orecchioni, Y Popineau, E Nakache, Journées d’Etudes des Polymères, 
5-10 septembre 1999, Trégastel. 
C7- Impact de la production de biosurfactants sur la réactivité de souches de 
Pseudomonas fluorescens vis-à-vis d’un micro-environnement solide.  
S Ngoya, C Duclairoir, N Orange. 9ème journée de l’Ecole doctorale Normande chimie-biologie, 17 mars 
2006, Rouen.  
C8- Caractérisation des biosurfactants chez plusieurs souches de Pseudomonas 
fluorescens provenant d’environnements différents,  
S Ngoya, C Duclairoir, N Orange. BIOADH’ 2007, 09 mars 2007, Strasbourg. 
C9- Analyse de la biodiversité de la flore bactérienne et fongique d’environnements 
aériens en zones urbaines et portuaire 
M Moretti, A Groboillot, C Duclairoir-Poc, O Maillot, O Lesouhaitier, J. P Morin., M. G. J.Feuilloley, 
N Orange. MicrobAERO 2009, 6-8 octobre 2009, Narbonne. 
C10- Pseudomonas fluorescens : Interactions potentielles de la microflore bactérienne 
avec la neurophysiologie humaine.  
L Mijouin, M Hillion, A Dagorn, A-S Blier, A Madi, T Jaouen, W Veron, N Connil, C Poc, A Groboillot, 
O Lesouhaitier, N Orange, S Chevalier, MGJ Feuilloley. 17ème Journée Scientifique de l’IFRMP23, 
Mont-Saint-Aignan, 17 juin 2011. 
C11- Extracellular gamma aminobutyric acid (GABA) regulates Pseudomonas 
virulence.  
A Dagorn, A Chapalain, O Lesouhaitier, C Poc, J Vieillard, S Chevalier, L Taupin, F Le Derf, N Orange, 
MGJ Feuilloley. Journée de l’EdNBISE, Rouen, 23 mars 2012. 
C12- NitroBactAIR : Impact du stress nitrosant sur l’expression de la virulence d’une 
bactérie aéroportée 
C Duclairoir Poc, Plénière MOVE’O, 7 novembre 2012, Rouen.  
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C13- Impact du stress nitrosant sur l’expression de la virulence d’une bactérie 
aéroportée  
C Duclairoir Poc, déjeuner-débat des professionnels de l'Automobile intitulé "L'automobile et 
l'Environnement sous la loupe des Scientifiques" Automobile Club de France, mardi 12 février 2013; 
Paris. 
C14- Response of commensal Staphylococci to sub-lethal concentrations of skin 
antimicrobial peptides.  
M Hillion, L Mijouin , C Leneveu, E Gerault , T Jaouen , L Lefeuvre , N Orange, G Redziniak , C 
Duclairoir-Poc, MJG Feuilloley. 5th FEMS Congress of European Microbiologists. July 21-25th 2013, 
Leipzig, Germany. 
C15- Etude de la virulence de Pseudomonas aéroportées à l’aide d’un nouvel outil 
lipidomique 
T Kondakova , N Merlet-Machour, D Preterre, F Dionnet, N Orange, C Duclairoir Poc, Journées 
Interdisciplinaires Qualité Air-8ème édition, 10-11 février 2014, Villeneuve d'Ascq. 
C16- Study of Pseudomonas airborne virulence using a new lipidomic tools  
T Kondakova, N Merlet-Machour, D Preterre, F Dionnet, N Orange, C Duclairoir-Poc. 17ième Journée 
de l’EdNBISE, 10 avril 2014, Le Havre. 
C17- Bacterial phospholipid adaptation to human temperature.  
T Kondakova, N Merlet-Machour, J Bodilis, F Dionnet,M Feuilloley, O Orange, HJ Heipieper, C 
Duclairoir Poc. 13th Euro Fed Lipid Congress, 27-30 September 2015, Florence, Italy. 
C18- Aging of coated TiO2 nanoparticles in oil-in-water emulsion : bactericidal toxicity  
L Rowenczyk, C Picard, C Duclairoir-Poc, N Hucher, N Orange, M Feuilloley and M Grisel, Journées 
Nord-Ouest Européennes des Jeunes Chercheurs, 11-12 Mai 2015, Rouen. 
C19- Evaluation du potentiel applicatif en cosmétique de biosurfactants microbiens 
secrétés par des souches de Pseudomonas fluorescent aéroportées  
S Depayras, C Duclairoir-Poc, 1er colloque du GDR Cosm’actifs, Moulin d’Andé, 26-27 Septembre 
2018, Andé, France. 
C20- Aging of TiO2-nanoparticle surface in cosmetic emulsions: their impact on 
bacteria of the cutaneous microbiota  
L Rowenczyk , C Picard, C Duclairoir-Poc, N Hucher, N Orange, M Feuilloley and M Grisel, 1er 
colloque du GDR Cosm’actifs, Moulin d’Andé, 26-27 Septembre 2018, Andé, France. 
C21- Impact of gaseous NO2 on P. fluorescens strain in the membrane adaptation and 
virulence 
S Depayras, T Kondakova, N Merlet-Machour, HJ Heipieper, M Barreau, C Catovic, M Feuilloley, N 
Orange, C Duclairoir-Poc, WIT Air Pollution , 25 -27 April 2017, Cadiz, Spain. 
C22- Développement de formulations sans conservateurs pour des modèles de crèmes 
solaires contenant des dispersions TiO2 nanoparticulaires. Effet des processus de stérilisation sur 
la stabilité.  
L Rowenczyk, C Picard, C Duclairoir-Poc, N Hucher, N Orange, M Feuilloley, M Grisel. 2ème colloque 
du GDR Cosm’actifs, 25 & 26 Septembre 2017, Domaine de Chalès, Nouan le Fuzelier, France. 
C23- Impact des nanoparticules de TiO2 passivées formulées en lotion solaire sur des 
bactéries cutanées ou aéroportée biocontaminante,  
L Rowenczyk, M Ringuedé, M Barreau, C Picard, N Hucher, M Grisel, M Feuilloley, N Orange et C 
Duclairoir-Poc. 2ème colloque du GDR Cosm’actifs, 25 & 26 Septembre 2017, Domaine de Chalès, 
Nouan le Fuzelier, France. 
C24- Impact of gaseous NO2 on P. fluorescens strain in the membrane adaptation and 
virulence 
S Depayras, T Kondakova, N Merlet-Machour, HJ Heipieper, M Barreau, C Catovic, Feuilloley M, 
Orange N, Duclairoir-Poc C, Congrès de la Société Française de Microbiologie 2017, 09-11 Octobre 
2017, Paris. 
C25- Interactions [nano]particules et micro-organismes cutanés 
N Hucher, C Duclairoir-Poc. Inauguration de la plate-forme d’Innovations Cosmetomics, 3 octobre 
2017, Evreux.  
C26- Production de viscosinamides par la souche clinique de Pseudomonas fluorescens 
MFN1032: Implication dans le développement du biofilm. 
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D Depayras, A Merieau, M Barreau, T Kondakova, C Barbey, M Feuilloley, N Orange, C Duclairoir 
Poc. Colloque Bioadh’2017, Domaine de Frémigny, 15 & 16 Novembre 2017, Bouray sur Juine, France. 
C27- Nitrogen dioxide: from a simple diffusible gas to a potential antibacterial against 
P. fluorescens? 
S Depayras, T Kondakova, HJ Heipieper, M Feuilloley, N Orange, C Duclairoir Poc, 21ème Journée de 
l’EdNBISE, 22-23 mars 2018, Rouen. 
C28- Microenvironment impact on Cutibacterium acnes: growth, virulence and biofilm 
formation of acneic and non-acneic strains. 
V Borrel, Y Konto-Ghiorghi, L Lefeuvre, C Duclairoir-Poc, MGJ Feuilloley, 21ème Journée de 
l’EdNBISE, 22-23 mars 2018, Rouen. 
C29- NO2: simple gaz diffusible ou agent antibactérien anti- P. fluorescens potentiel? 
S Depayras, T Kondakova, HJ Heipieper, J Hardouin, M Feuilloley, N Orange, C Duclairoir Poc, Mini-
colloque Pseudomonas, 17-18septembre 2018, Marseille. 
C30- Régulation et Rôle de CmpX chez Pseudomonas aeruginosa 
E Bouffartigues, D Tortuel, O Maillot, A David, J Omnes, A Tahiroui, CO Azuama, L Taupin, S 
Depayras, C Duclairoir Poc, HJ Heipieper, A Dufour, O Lesouhaitier, N Orange, MGJ. Feuilloley, P 
Cornelis, S Chevalier, Mini-colloque Pseudomonas, 17-18septembre 2018, Marseille. 
C31- Nitrogen dioxide: from a simple diffusible gas to a potential antibacterial against 
P. fluorescens? 
S Depayras, T Kondakova, HJ Heipieper, M Feuilloley, N Orange, C Duclairoir Poc, Congrés SFM 
2018, 1-3 octobre 2018, Paris. 
 
 Affiches : 44 
A1- Elaboration de nanoparticules de gliadines par coacervation 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, Rencontre de la Société Française de Chimie 
(section Basse-Normandie-Sarthe), 30 mai 1997, Caen-France.  
A2-Elaboration de nanoparticules de gliadines de blé 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni congrès international SFC97, 7-12 septembre 
1997, Bordeaux-France.  
A3-Influence du paramètre de solubilité sur la taille des nanoparticules de gliadines 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, 12th Annual meeting of the GTRV, décembre 
1997, Bruxelles-Belgique. 
A4- Wheat Gluten Nanopaticles as Drug Carriers : Encapsulation Mechanism and Size 
Optimization 
A-M Orecchioni, J M Irache, C Duclairoir, E Nakache, Symposium on Natural Origin Substances in 
Drug Formulation, 4-6 novembre 1998, Beijing-Japan. 
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Lors de la rédaction de ce mémoire d’habilitation à diriger les recherches, mon laboratoire 
de rattachement a pour thématique clef le « Rôle de la communication et des facteurs 
environnementaux ou eucaryotes dans l’adaptation et la virulence bactérienne. ». Ces divers mots 
clefs semblent à première vue éloignés des centres d’intérêt de la jeune étudiante en DEUG Sciences 
et Structure de la Matière que j’étais au siècle dernier. Cependant ce parcours transdisciplinaire allant 
des sciences dites « dures » au monde du vivant m’a permis d’évoluer des interfaces et phénomènes 
physico-chimiques à l’enveloppe microbienne. A force de communication, mon adaptation s’est 
réalisée au travers de différents environnements : de la matière abiotique à biotique. Ainsi ai-je 
quelques traits communs avec nos chères souches modèles, les Pseudomonas fluorescens ! Le mot 
interface sous divers aspects a rythmé ma recherche comme un leitmotiv, comme vous pourrez le 
découvrir dans les pages qui vont suivre. 
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 Bilan	de	mes	recherches	
 
Mes recherches doctorales, sous la direction des Pr E NAKACHE et AM ORECCHIONI, ont 
débuté au sein de l’équipe Polymères et Interfaces d’un laboratoire de Chimie, Laboratoire de Chimie 
Moléculaire Thio-organique LCMT UMR-CNRS 6507, à l’Université de Caen et ont ciblé des 
biomolécules. J’ai appréhendé la physico-chimie, voire la structure de ces macromolécules naturelles, 
afin de les valoriser sous une forme galénique toujours d’actualité : l’encapsulation. Puis j’ai évalué 
la faisabilité de la vectorisation en y incorporant des molécules actives.  
Suite à mon recrutement par l’Université de Rouen, comme ATER (2001), puis comme maître de 
conférences (2002), je me suis intéressée dans un premier temps aux biosurfactants (BSs) bactériens 
-autres biomolécules- au sein du Laboratoire de Microbiologie du Froid, EA 2123, devenu 
Laboratoire de Microbiologie du Froid – Signaux et MicroEnvironnement (LMDF-SME) EA 4312, 
puis en 2011 en Laboratoire de Microbiologie-Signaux et Microenvironnement (LMSM, EA 4312) 
dirigés par le Pr. N ORANGE, puis par le Pr M FEUILLOLEY. La production des BSs, molécules 
amphiphiles, modifie la physico-chimie de la surface bactérienne et, par conséquent, influence son 
adaptation à son micro-environnement, voire sa virulence. Au long des années, ma formation en 
microbiologie s’étoffant, j’ai élargi mon champ de recherche débutant par l’identification et 
l’établissement des conditions de sécrétion des BSs. J’ai ensuite évalué leur implication dans le 
comportement adhésif bactérien, dans la virulence bactérienne, voire leur rôle dans la communication 
bactérienne. Parallèlement, j’ai collaboré à une possible valorisation de ces biomolécules en 
bioremédiation des sédiments estuariens.  
Suite à ma participation à une étude sur la qualité de l’air, un questionnement est apparu : les bactéries 
aéroportées ne seraient-elles pas l’interface catalysée par la pollution automobile déclenchant chez 
l’humain des pneumopathies bactériennes exacerbées en période de forte pollution. Après avoir étudié 
l’impact sur la physiologie d’une souche aéroportée de Pseudomonas fluorescens d’expositions au 
NO2, marqueur de pollution automobile, nous avons approfondi cette thématique pour évaluer 
l’impact de ce même stress chimique au niveau de la paroi bactérienne, interface de la bactérie avec 
son microenvironnement. Y a-t’il simple diffusion du NO2 sans autre réponse bactérienne, comme le 
sous-entend l’approche traditionnelle de l’immuno-suppression humaine provoquée par la pollution ? 
Ou la bactérie met-elle en œuvre une réponse plus ou moins complexe localisée dans sa paroi, 
interface avec l’environnement extérieur? 
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Figure 1 :  Synoptiques de mes travaux en recherche. A : Synthèse thématique. B : 
Encadrements, financements et collaborations. 
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Parallèlement j’ai eu l’opportunité de collaborer sur une autre thématique de sécurité sanitaire, 
concernant les produits cosmétiques. L’objectif était de documenter le vieillissement de 
nanoparticules (NPs) de TiO2 en lotion solaire sur deux bactéries représentatives du microbiote 
cutané. Suite à la formulation de deux lotions solaires modèles contenant des NPs hydrophiles ou 
hydrophobes, la croissance bactérienne a été étudiée lors de deux scenarii mimant soit le stockage du 
produit, soit l’application de la formule solaire sur la peau. Désirant évaluer le cas d’une 
biocontamination ponctuelle d’un cosmétique lors de sa production ou lors du prélèvement 
consommateur avant application, une souche P. fluorescens d’origine aéroportée a été mise en contact 
avec de NPs de TiO2 hydrophiles. La membrane bactérienne s’en trouve-t’elle impactée, voire 
perméabilisée ? 
Ces diverses recherches ont été mises en œuvre au travers d’encadrements, de collaborations, dont le 
synoptique est présenté en Figure 1. 
 
I) Interface : quelle réalité physique ? 
Dans un premier temps, quelle réalité physique désigne le terme « interface » ? Le dictionnaire 
Le Grand Robert (2017) indique pour cet anglicisme « Surface de séparation entre deux phases 
distinctes (solide-liquide, solide-gaz, liquide-gaz) ». D’après l’Encyclopædia Universalis, une 
interface peut être définie, d’une façon plus générale, comme étant la zone qui sépare deux milieux 
condensés qui peuvent différer par leur composition et / ou structure chimique (BOUQUET and 
LANGERON, n.d.).  
Deux différences apparaissent. L’interface a-t’elle 2 ou 3 dimensions ? Est-elle d’épaisseur nulle ou 
correspond-elle à un volume « transitoire » où localement les propriétés commencent à être 
différentes de celles des deux phases dites en contact, tout en formant un gradient (un continuum de 
l’une à l’autre) ? Ici, nous plaçant à terme à l’échelle bactérienne, nous resterons sur la vision 
classique d’une interface d’épaisseur nulle, évitant le chausse-trappe d’interphase qui pourrait être à 
l’origine de quiproquo entre chimistes et biologistes ! 
Le second point de litige concerne la nature des phases en contact. Dans le cadre de ce mémoire, nous 
prendrons en compte tous les systèmes évoqués par le dictionnaire Le Grand Robert, complétés par 
le contact de deux liquides non miscibles, donc zone de forte hétérogénéité à courte distance. 
Débutons donc notre périple ! 
 
II) Création d’interfaces à l’aide de biomolécules 
 Au cours de ma recherche doctorale (DEA et thèse), je me suis intéressée au chitosane, 
polysaccharide extrait de crustacés ou champignons, mais aussi aux gliadines, protéines extraites du 
gluten de blé. Ces études ont bénéficié du soutien financier du réseau Matériaux-Polymères-Plasturgie 
Normand. Le cœur de ces travaux a reposé sur la solubilité de ces deux biomolécules dans différents 
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systèmes de solvants. Plus particulièrement pour les gliadines, grâce à une collaboration avec les Dr 
RENARD (Laboratoire de Physico-chimie des Macromolécules, INRA de Nantes) et. POPINEAU 
(Laboratoire de Biochimie et Biotechnologies des Protéines, INRA de Nantes), fournisseur de ces 
protéines, nous avons mené la caractérisation des protéines solubilisées par diffusion dynamique et 
statique de la lumière grâce à des mesures en diffusion de neutrons aux petits angles, effectuées au 
sein du Laboratoire Léon Brillouin du CEA-Saclay. Pour cela, j’ai suivi une formation préalable lors 
des Journées de la Société Neutronique Française à Albé (Vosges) en juillet 1997. Ces expériences 
de diffusion de neutrons aux petits angles ont permis d'apprécier, pour les différentes fractions 
protéiques (α, β, γ et ω-gliadine), leur conformation et leur influence sur le comportement en solution 
de deux extraits « bruts », mélanges de ces diverses fractions polluées faiblement par des gluténines. 
Cette étude en milieu deutéré a mis en lumière un comportement similaire pour les fractions α, β et 
γ- gliadine de masse moléculaire très proche (25-40 kDa) et constituants majoritaires des extraits 
bruts, alors que les ω-gliadines (65-80 kDa) se comportent davantage comme les gluténines (80-100 
kDa). La solubilité des fractions les plus légères n’est pas modifiée par la présence des ω-gliadines, 
ni des gluténines. En bilan, meilleure est la solubilité des gliadines, plus expansée est leur 
conformation en solution (Orecchioni et al., 2006). 
La solubilité des deux extraits en milieu hydroalcoolique deutéré par diffusion de neutrons aux petits 
angles a été confrontée à l’étude similaire en turbidimétrie en eau/éthanol. Ces deux approches 
expérimentales désignent la même composition en solvants comme optimum de solubilisation, qui 
s’avère dépendante de la composition relative en α, β et γ- gliadines (Orecchioni et al., 2006).  
La voie de valorisation pressentie pour ces extraits bruts de gliadines était la formation par 
précipitation de particules, intéressant le domaine de l’encapsulation (Duclairoir, 2000; Duclairoir et 
al., 1999; Orecchioni et al., 2007; Denis Renard et al., 2002a, 2002b; D Renard et al., 2002; Renard 
and Reddy, 2007). Le procédé mis en œuvre a été la coacervation simple (Duclairoir et al., 1998; 
Orecchioni et al., 2006; Denis Renard et al., 2002a; D Renard et al., 2002). Ainsi la séparation de 
phase est induite par le phénomène physico-chimique de sursaturation menant au « compactage » du 
biopolymère par désolvatation rendant le milieu moins favorable à la solubilité des macromolécules. 
Ce procédé interfacial peut être obtenu par divers stress dont la variation de la composition du milieu 
en solvant qui a été mis en œuvre (Duclairoir et al., 1998, 1999; Orecchioni et al., 2001, 2006, 2007; 
Denis Renard et al., 2002a; Renard and Reddy, 2007).  
J’ai optimisé le procédé en étudiant l'influence de divers paramètres expérimentaux sur la taille des 
particules, me conférant une expertise granulométrique de tout type d’objet en solution de quelques 
nanomètres à quelques millimètres (Duclairoir and Nakache, 2002). La taille des nanoparticules 
optimisées a été d’un diamètre de l'ordre de 900 nm (Duclairoir et al., 2002, 1999, 1998). 
La modélisation de la formation des nanoparticules a été montrée comme une nucléation très rapide, 
voire instantanée lors de la première phase de la désolvatation des gliadines, puis l’intégration de 
nouvelles macromolécules à leur surface assurant la croissance particulaire (Orecchioni et al., 2006). 
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L’étude de valorisation a aboutie à la faisabilité de l’encapsulation et le relargage de 4 actifs de 
polarité différente : la vitamine A (Duclairoir et al., 1999), la vitamine E hydrophobe (Duclairoir et 
al., 2003, 2002), l’extrait de lavande peu polaire et le chlorure de benzalkonium, un amphiphile 
cationique (Duclairoir et al., 2003; D Renard et al., 2002). L’encapsulation est d’autant plus 
intéressante que le principe actif présente une polarité similaire aux protéines hydrophobes. Le 
relargage se réalise en deux phases. Dans un premier temps, suite au processus de désolvatation, une 
partie du principe actif, quelle que soit sa nature chimique, se trouve en surface des particules et donc 
se désorbe par un relargage rapide, qualifié d’“effet burst”. Le relargage se poursuit plus lentement, 
car il est tributaire de la migration du principe actif au sein de la particule assimilable à une sphère 
homogène jusqu’à sa surface, interface avec le milieu extérieur (Duclairoir et al., 2003; D Renard et 
al., 2002). 
 
Production scientifique correspondante : P1-P8 ; Ch1-ch2 ; Pdc1 ; CInt1 ; C1-C6 ; A1-A11. 
 
Cette caractérisation de biopolymères en solution m’a ouvert une porte sur la physico-chimie des 
biomolécules. Depuis mon intégration en 2001 à l’actuel LMSM, les biomolécules que sont les 
biosurfactants (BSs) m’ont permis de découvrir et d’apprivoiser le monde du vivant et plus 
particulièrement les bactéries et leurs réponses à leur microenvironnement.  
 
III) Biosurfactants, exoproduits bactériens amphiphiles  
Les BSs bactériens, comme les surfactants synthétiques, sont des molécules amphiphiles, 
dénommées aussi amphipathiques, ou bien, plus rarement, amphilyophiles ou amphipolaires. Elles 
sont constituées d’une partie présentant une affinité pour l’eau, mais aussi une seconde partie plus 
hydrophobe. Les anglo-saxons désignent par le substantif « amphiphiles », équivalent à 
« surfactants », les tensioactifs, alors qu’« amphiphilic » ou « amphipathic » sont les adjectifs 
correspondants. 
Cette nature chimique ambivalente confère aux tensioactifs leur capacité à se localiser 
préférentiellement à toute interface, abiotique (solide, gaz, liquide) ou biotique (organismes 
producteurs ou non producteurs). Si leur concentration est telle que la saturation des interfaces 
disponibles est obtenue, alors l’excès de molécules amphiphiles s’organise pour former des 
microdomaines de polarité opposée à celle de la phase continue sous la forme de micelles. La 
Concentration Micellaire Critique (CMC) correspond à la concentration de tensioactifs nécessaire à 
la saturation des diverses interfaces (Van Hamme et al., 2006). 
Les BSs intéressent grandement les industriels pour leur image de produit « naturel » liée à leur faible 
toxicité, leur haute biodégradibilité, leur coût modique surtout lors de valorisation de sous-produits 
bioindustriels (Martinotti et al., 2013). Ces biomolécules amphiphiles peuvent être des matières 
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premières de nombreux produits : médicaments (Satpute et al., 2016), aliments (Nitschke and Silva, 
2018), cosmétiques, pesticides (Sitaraman, 2015), lubrifiants (Das et al., 2014), dépolluants 
environnementaux (bioremédiation de pollution aux hydrocarbures ou métaux lourds) (Mao et al., 
2015; Novik and Kiseleva, 2015; Santos et al., 2017). 
Par définition, les BSs sont des biomolécules amphiphiles produites à la surface ou excrétées par de 
nombreux êtres vivants, principalement microbiens. Cette production est dépendante de la souche et 
de son microenvironnement (pH, agitation, température, oxygène disponible…) (Desai and Banat, 
1997). Les BSs sont habituellement classés selon leur structure chimique assurant leur amphiphilie. 
Ainsi la partie hydrophobe est constituée d’une chaîne lipidique (insaturée, linaire ou plus complexe), 
alors que la partie hydrophile peut être glucidique ou peptidique. Les BSs comprennent 
principalement  
• des glycolipides (Rosenberg and Ron, 1999) : rhamnolipides (de Araujo et al., 2016; Kiran et 
al., 2016), les tréhalolipides (Soberón-Chávez et al., 2005), les sophorolipides (Hirata et al., 
2009) ; 
• des lipopeptides-lipoprotéines : non cycliques (Seghal Kiran et al., 2010) et cyliques -les 
CLPs- dont, plus particulièrement, la surfactine (Loiseau et al., 2015; Ongena and Jacques, 
2008), l’amphisine, la viscosine (Nielsen et al., 2002; Nielsen and Sorensen, 2003; 
Raaijmakers et al., 2006)… ; 
• des lipides (acides gras, lipides neutres, phospholipides) (Desai and Banat, 1997) ; 
• des polymères tensioactifs : emulsan, liposan (Calvo et al., 2009) ; des particules tensioactives 
(toute ou partie  cellulaire du microorganisme) (Desai and Banat, 1997). 
Leur rôle dans la physiologie microbienne, et plus particulièrement bactérienne, a été documenté de 
plus en plus largement ces vingt dernières années (Ron and Rosenberg, 2001). 
Les BSs s’avèrent incontournables pour toute forme de vie communautaire (biofilms, films 
surfaciques, agrégats…), ils interviennent dans la transition du mode planctonique au mode sessile. 
Effectivement les microorganismes interagissent avec leur micro-environnement en modulant les 
phénomènes interfaciaux existant via leur production de BSs. Ainsi, ces molécules amphiphiles 
agissent comme des médiateurs. Dans la nature, ils peuvent avoir un rôle physiologique en améliorant 
la biodisponibilité des nutriments, en favorisant leur solubilisation, voire leur assimilation. Ainsi, les 
bactéries dégradant des hydrocarbures produisent souvent des BSs favorisant une meilleure 
biodégradation de ces composés. Ils peuvent être aussi impliqués dans la mobilité bactérienne, mais 
aussi participer aux mécanismes cellulaires tels que la communication et la différenciation. Ils 
prennent part à la formation des biofilms, interagissent avec d’autres exoproduits microbiens 
(protéines, enzymes…) en modifiant leur conformation, leur spécificité et, par conséquent, en 
modulant leur activité (Singh et al., 2007). Ainsi les BSs secrétés par les microorganismes leur 
permettent la régulation des transferts de nutriments, de déchets, de molécules de communication, 
mais aussi impactent les interactions hôtes-microorganismes et donc participent à la virulence 
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microbienne. De plus, ils influencent la croissance microbienne en réduisant la disponibilité des 
substrats nutritifs, en modifiant le pH et en séquestrant des métabolites toxiques (Van Hamme et al., 
2006).  
Les espèces bactériennes productrices de BSs comptent parmi elles l’espèce Pseudomonas qui était 
le modèle de prédilection du laboratoire lors de mon intégration comme ATER, puis maître de 
conférences. 
 
A) Production de cyclolipopeptides par de nombreuses souches de 
P. fluorescens de toute niche environnementale 
Beaucoup de travaux dans la littérature traitent des rhamnolipides, BSs produits, entre autres, 
par P. aeruginosa (de Araujo et al., 2016; Kiran et al., 2016). Comme l’indique leur nom, ces BSs 
sont constitués d’unités osidiques comme partie hydrophile, liés à une chaine carbonée hydrophobe. 
Cependant ce savoir n’est pas transposable à l’espèce P. fluorescens dont j’ai pu caractériser un 
certain nombre des souches de diverses origines. Effectivement certaines des souches Pseudomonas 
fluorescent spp. sont connues pour produire des cyclolipopeptides (CLPs) (Kruijt et al., 2009; Poc et 
al., 2011; Raaijmakers et al., 2010; Rokni-Zadeh et al., 2011a; Roongsawang et al., 2003) dont la 
surfactine (Loiseau et al., 2015; Ongena and Jacques, 2008; Rivardo et al., 2009; Vlamakis et al., 
2013). Ce BS est caractérisé par sa queue lipidique formée d’un cycle de 7 acides aminés (Nielsen et 
al., 2002). Selon les souches Pseudomonas spp., d’autres familles de CLPs sont décrites avec des 
chaînes apolaires carbonées plus ou moins longues, reliées à des peptides cyclisés dont le nombre 
d’acides aminés varie selon l’organisme et les conditions de culture. Cependant, les acides aminés 
habituellement constitutifs de ces CLPs comptent parmi eux l’acide aspartique (Asp ou E), l’acide 
glutamique (Glu ou E), la glutamine (Gln ou Q), l’isoleucine (Ile ou I), la leucine (Leu ou L), la sérine 
(Ser ou S), la thréonine (Thr ou T) et la valine (Val ou V) (Ongena and Jacques, 2008). Parmi ces 
CLPs, sont déjà identifiées l’amphisine, la viscosine (Bak et al., 2015; Kruijt et al., 2009; Nielsen et 
al., 1999; Raaijmakers et al., 2010, 2006; Roongsawang et al., 2003) … 
Depuis mon intégration à l’Université de Rouen, j’ai eu l’opportunité de caractériser les CLPs 
produits par des souches de Pseudomonas issues de trois compartiments : la rhizosphère, l’air et les 
patients atteints de pneumopathies. Le Tableau 1 synthétise ces identifications. 
 
(1) Origine rhizosphérique 
 Lors du travail doctoral du Dr NGOYA (2003-2007), que j’ai co-encadré avec le Pr 
ORANGE et l’unité de recherche en Bioadhésion et Hygiène des Matériaux, INRA de Massy (Pr 
BELLON-FONTAINE et Dr MEYLHEUC), nous avons évalué la production de BSs sur une 
trentaine de souches Pseudomonas fluorescens issues de la rhizosphère. Puis, ce panel a été réduit à 
13 souches plus spécifiques. Leur production de BS a été observée à deux températures : 8°C (mimant 
les conditions de stockage en chambre froide) et 17°C (optimum de production des BSs et température 
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en salle d’opération hospitalière). Après une longue mise au point des conditions de production, nous 
avons mis en évidence, dans ces conditions, la production de 22 BSs différents identifiés et 
caractérisés par HPLC-MS comme des cyclolipopeptides (CLPs) apparentés à l’amphisine, à la 
viscosine et à la viscosinamide. 7 ont été identifiés pour la première fois. Ces familles de CLPs sont 
caractérisées par le nombre d’acides aminés formant la tête polaire et impliqués dans le cycle, ainsi 
que par le nombre de carbones de la queue hydrophobe dont la substitution peut être variable. La tête 
hydrophile des apparentés de l’amphisine (amphisine-like), de la viscosine et de la viscosinamide 
(viscosine-like) est constituée de deux résidus aminés reliés à la queue apolaire, complétés par un 
cycle comprenant, respectivement, 11 et 9 acides aminés. J’ai pu proposer une technique 
d’identification rapide entre ces 3 familles de BSs en croisant leur charge ionique et leur signature 
hémolytique. 
La température de croissance à 17°C s’est avérée être davantage favorable à la production de CLPs 
en abondance et en quantité qu’à celle à 8°C. 
Production scientifique correspondante : P15 ; C7-C8 ; A12 ; A15. 
Encadrements : L4-L5 ; M1-2 ; M2-1 ; D1. 
 
(2) Origine aéroportée 
Avec le Dr GROBOILLOT et le Pr ORANGE, j’ai co-dirigé, depuis 2008, le volet micro-
organisme du projet Particules Urbaines et Céréalières, Microorganismes Mycotoxines et Pesticides 
(PUC2MP) financé par l’AFSSET. Ce projet sera présenté plus largement ultérieurement. Il a été 
l’occasion de constituer une souchothèque de microorganismes aéroportés parmi lesquelles 15 
souches de Pseudomonas spp. ont été étudiées pour leur potentiel de production de BSs à l’aide du 
tensiomètre Krüss DSA30, financé par le FEDER Virulence Pseudomonas. 4 souches se sont avérées 
productrices de BSs. Suite à la mise au point d’un protocole de purification avec l’aide du Dr 
KOLTALO (COBRA, Université de Rouen), les caractéristiques physico-chimiques de ces BS 
purifiés ont été évaluées. Ces biomolécules ont été caractérisées comme des CLPs : la souche 
MFAF88 produisant des amphisine-like, MFAO2 des putisolvine-like et MFAD21c et MFAH4a des 
CLPs non connus. Plus récemment, grâce à une collaboration avec l’EBI, université de Poitiers (Pr 
BERJEAUD et Dr VERDON) lors de la thèse de S DEPAYRAS (thèse 2015- soutenance prévue en 
2018), les BSs ont pu être plus finement identifiés, d’autant que la famille des CLPs a été complétée 
par les apparentés PPZPM, constitués de 10 acides aminés dont 8 formant un cycle polaire (Weisshoff 
et al., 2014). Les CLPs produits par les souches MFAD21c et MFAH4a appartiennent à cette nouvelle 
famille. 
En conclusion, la niche « air » recèle des souches Pseudomonas aéroportées productrices de CLPs de 
structures variées. La production ne semble pas spécifique à un habitat particulier. 
Production scientifique correspondante : P14; P20 ; Pdc2 ; C19 ; A21 ; A26 ; A30. 
Encadrements : M1_4 ; D3 ; PD2. 
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Tableau 1 :  Les diverses souches productrices de BSs, que j’ai eu l’occasion d’étudier et de 
caractériser. 
(3) Origine clinique 
Le panel bactérien du travail doctoral du Dr NGOYA (2003-2007) contenait aussi trois 
souches P. fluorescens cliniques, à l’origine de pneumopathies. MF2256 s’est avérée non productrice 
de BS, alors que MFN1032 et MFY162 produisent des CLPs de la famille de la viscosinamide, peu 
étudiée (Geudens et al., 2014; Nielsen et al., 1999). Une approche de la régulation de la production 
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des CLP par modélisation informatique a été effectuée lors d’une collaboration avec des 
bioinformaticien l’I3S du CNRS de Sophia-Antipolis (Richard et al., 2012). 
Depuis quelques années, la biosynthèse des CLPs a été décrite et repose sur les peptides synthases 
non ribosomiales (NRPSs). Ces systèmes multifonctionnels sont constitués de plusieurs modules dont 
le nombre est fonction de celui des acides aminés constituants les CLP. Effectivement un premier 
module initie la n-acylation entre le premier acide aminé et la queue acide gras β-hydroxylé via un 
domaine NRPS de condensation (C1) qui est réputé spécifique à ces BSs. Puis la chaîne peptidique 
s’accroit par l’action consécutive de modules NRPS d’élongation. Après le clivage d’un domaine 
thioesterase, une intracyclisation se produit et permet la libération du CLP (Rokni-Zadeh et al., 2011b; 
Zhao et al., 2016). Suite au financement FEDER SSE LMSM d’un séquençage de la souche P. 
fluorescens MFN1032, le Dr MERIEAU a confirmé par bioinformatique la présence des gènes NRPS 
codant le domaine C1 de lipoinitiation des CLPs. Son étude phylogénique sur ce domaine C1 a mis 
en évidence une très forte homologie entre celui de la souche P. fluorescens MFN1032 et celui de la 
souche rhizosphérique P. fluorescens DR54, productrice de viscosinamide et apparentés (Geudens et 
al., 2014; Nielsen et al., 1999). S DEPAYRAS a établi la production de 4 viscosinamides-like par la 
souche P. fluorescens MFN1032 à 28°C en milieu pauvre (Davis medium), dont le CLP majoritaire 
est la viscosinamide A. Sa production s’est révélée effective dès la phase exponentielle de croissance 
par imagerie HPTLC MALDI-TOF (high-performance thin-layer chromatography couplée matrix-
assisted laser desorption ionization), dont le développement a été réalisé lors de la thèse du Dr 
KONDAKOVA (2012-2015) au LMSM qui sera évoquée ultérieurement. 
Production scientifique correspondante : P9 ; C8 ; C26 ; A42 ; A44. 
Encadrements : L1 ; M1_4; M2_1 ; M2_2; D1-D3.  
 
Prise dans son intégralité, cette étude confirme que la production des CLPs n’est pas liée à un 
habitat particulier. De plus, la structure chimique des CLPs est spécifique à chaque Pseudomonas 
fluorescent producteur, mais est aussi dépendante des conditions de production. Ainsi le Tableau 1 
récapitule l’ensemble des CLPs identifiés ou pressentis. Une telle variété soulève une interrogation 
sur leur utilité pour leurs organismes producteurs, mais aussi de leur valorisation potentielle.  
 
B)  Valorisation de CLPs en réponse à une pollution 
environnementale 
Parmi les traitements de dépollutions de sols pollués par des hydrocarbures poly-insaturés 
(HAP), l’utilisation de tensioactifs est reconnue comme efficace, car elle s’appuie sur des procédés 
de lavage des sols (Lim et al., 2016). Les rhamnolipides ainsi que la surfactine, un CLP, sont 
traditionnellement étudiés en bioremédiation. Dans le cadre des projets interreg RESSOLV, puis 
SCALE, en collaboration avec le Dr KOLTALO du LASOC (devenu équipe SIMA de l’UMR 
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COBRA, Université de Rouen Normandie), nous avons étudié l’alternative qu’est le cyclolipopeptide 
anionique : l’amphisine, ayant une activité tensio-active plus importante que les BSs précédemment 
cités. Mon rôle était de produire ce BS, mais aussi, en collaboration avec les Dr GROBOILLOT et Pr 
ORANGE, d‘évaluer, sur la physiologie de la souche bactérienne productrice d’amphisine, P. 
fluorescens DSS73, l’impact de la présence de différents HAP modèles : naphtalène, phénantrène, 
pyrène et fluorène (Groboillot et al., 2011). D’autre part, le Dr F KOLTALO a comparé une autre 
famille de CLPs, la viscosine et le Massetolide E avec les surfactants synthétiques lors de la 
remédiation de sédiments pollués par séparation électrocinétique, afin de désorber les polluants HAP 
et métaux lourds (Ammami et al., 2015; Portet-Koltalo et al., 2013, 2011, 2010). Les BSs s’avèrent 
plus efficaces lors de la remédiation des métaux lourds que des HAP, mais moins efficaces que les 
surfactants synthétiques. Cependant il pourrait être intéressant de tester de plus fortes concentrations 
de ces BSs pour favoriser la formation de micelles évacuant les contaminants.  
Production scientifique correspondante : P10-P12 ; P17 ; P22 ; A16 ; A19. 
Encadrements : L2-L3 ; L7. 
 
C)  Rôle des BSs : élément de la réponse adaptative de 
Pseudomonas à leur microenvironnement 
Toute production microbienne ne peut être gratuite au vu du coût énergétique correspondant 
(Ferenci, 2007). Aussi nous avons évalué le potentiel adaptatif bactérien lié aux BSs. Tout d’abord 
nous avons examiné l’impact des BSs sur la physiologie en termes de capacité à coloniser, via la 
mobilité bactérienne et la formation de biofilm, puis comme réponse bactérienne à des stress 
abiotiques et biotiques. Commençons à enquêter sur l’apport des BSs dans l’habileté de la bactérie à 
se mouvoir. 
 
(1) Physiologie bactérienne 
(a) Mobilité 
Les BSs, comme leurs homologues synthétiques, par leur constitution sont connus pour réduire les 
frictions entre bactéries et n’importe quelle surface et peuvent faciliter leur déplacement. Ils s’avèrent 
impliqués aussi bien lors de mode de mobilité active, i.e. motilité, (swarming, gliding) ou passive 
(sliding) (Harshey, 2003). Le gliding n’a été décrit que pour certaines espèces microbiennes et parmi 
le phylum Bacteroidetes, pour l’espèce Flavobacterium johnsoniae, fortement éloignée des 
Pseudomonas spp. Ce mouvement fluide généralement le long du plus grand axe microbien, sur 
gélose de 1 à 1,5% d’agar, est obtenu grâce aux BSs excrétés et par la complexation de sulfolipides 
de la membrane externe (Harshey, 2003) permettant une « focal-adhesion » à la surface abiotique 
(Kearns, 2010). Cependant cette motilité ne semble pas concerner les micro-organismes que j’ai pu 
étudier. Le swarming, autre mode de motilité, est défini comme un déplacement bactérien collectif et 
rapide sur une surface semi-solide, résultant de la force motrice liée à la rotation flagellaire (Kearns, 
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2010). Elle se caractérise par une activité intercellulaire, ainsi qu'une différenciation morphologique 
des cellules (Tremblay and Déziel, 2008) en présence d’exoproduits, le plus fréquemment des BSs 
(Kearns, 2010). Il est détectable sur gélose de 0,5 à 2% d’agar (Harshey, 2003; Tremblay and Déziel, 
2008) en milieu riche, mais son observation est largement dépendante de l’espèce (Kearns, 2010) et 
des conditions expérimentales (Tremblay and Déziel, 2008). Le déplacement passif de glisse (sliding 
ou spreading) a été décrit comme favorisé par les BSs, confortés par la présence de polysaccharides, 
en l’absence de tout appendice moteur fonctionnel tel que flagelle ou pili. Il est visuellement 
observable en milieu gélosé contenant 0,2 à 0,7% d’agar. Les forces d’expansion lors de la croissance 
bactérienne se combine avec l’abaissement de tension de surface liée aux BSs (Harshey, 2003; 
Kearns, 2010). Alsohim et al. (Alsohim et al., 2014) indiquent que les deux mobilités peuvent se 
cumuler, rendant les interprétations délicates, surtout que la prépondérance de l’une ou l’autre est 
soumise aux conditions expérimentales, pouvant de plus être impactée par la qualité de l’eau ou de 
l’agar utilisée lors de la préparation des milieux gélosés. Cette étude est d’autant plus intéressante 
qu’elle étudie la mobilité de la souche P. fluorescens SBW25 productrice de viscosine, CLP différent 
de la viscosinamide, l’acide aminé Glu se substituant à Gln. La viscosine s’avère indispensable pour 
le sliding, qualifié de spidery spreading, i.e. diffusion fractale. Le swarming est dépendant de 
flagelle(s) fonctionnel(s), mais la viscosine, optionnelle, accélère la vitesse de diffusion sur la surface 
semi-solide. Elle serait responsable du front humide précédent la zone du swarming, mais aussi de la 
morphologie plus ou moins accidentée du front de diffusion.  
 
Figure 2 : Mobilités bactériennes impliquant les BSs. A : mobilité active – 
motilité ; B : mobilité passive  adapté de Kearns (Kearns, 2010). 
L’ensemble des souches de P. fluorescens que j’ai pu étudier présentait une mobilité de type swarm, 
(communication personnelle). Cependant les morphologies des zones de diffusion et de leur front 
pouvaient être très variables. Ainsi toutes les non productrices, comme la souche aéroportée 
MFAF76a (Duclairoir Poc et al., 2014), présentent un zone de diffusion circulaire, alors que des 
festons, voire des dendrites se forment pour les productrices de biosurfactants. Ainsi est visible le 
« film d’eau » contenant probablement la viscoinamide et précédant le front de diffusion lié au swarm 
de la souche clinique MFN1032. 
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L’ensemble de ces mobilités, passive ou active, ont un rôle significatif dans la colonisation 
des surfaces par les bactéries qui débute toujours par une étape d’adhésion. 
 
(b) Adhésion 
Pour d’étudier l’impact des BSs dans l’adhésion bactérienne, j’ai évalué l’adhésion de deux 
souches rhizosphériques productrices de BSs couplées à un mutant non producteur. Il s’agit des P. 
fluorescens PFA7b et DSS73 produisant des CLPs de type viscosine et amphisine respectivement, et 
de Pf1 Vis- et DSS73-15C2, leurs mutants relatifs. Les conditions optimales de production de BSs 
ont été constatées à 17°C en milieu DMB. Le temps de contact pour l’adhésion est défini comme un 
temps de génération. 
Le phénomène d’adhésion se concrétise par des interactions à plus ou moins longue portée et 
des détachements du support abiotique, tous gouvernés, en partie, par les propriétés de surface des 
bactéries. L’hydrophilie de chaque souche sauvage et de son mutant s’avère similaire suite à des tests 
Microbial Adhesion To Solvents (MATS) ciblés, comme présenté Figure 3, éliminant ainsi un biais 
possible. De plus, la souche sauvage adhère moins à la surface de la microplaque que son mutant 
quels que soient les CLPs qu’elle produit. Donc les CLPs pénaliseraient l’adhésion de leur propre 
producteur.  
 
Figure 3 : Evaluation de l’adhésion bactérienne en microplaque à 17°C en DMM, 
après un temps de génération pour les souches rhizosphériques PFA7b et DSS73 et 
leur mutant respectif non producteur de BS, ainsi que leur hydrophobie. L’adhésion 
est normalisée par rapport à celle de PFA7b. 
Cependant, une mutation qui abolit l’expression d’un gène localisé dans une non ribosomique 
peptide synthétase (NRPS) ne peut pas uniquement ciblée la production de CLP, mais peut 
implémenter d’autres modifications pouvant impacter l’adhésion, telles que la production 
d’exopolysaccharides (EPS) (Alsohim et al., 2014).  
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La souche clinique P. fluorescens MFN1032 présente des variants spontanés, dont V1 et V3 sont non 
producteurs de viscosinamides (Rossignol et al., 2009). Mettant à profit ce panel de souches, j’ai 
caractérisé le rôle des viscosinamides dans l’adhésion bactérienne et la formation de biofilm. Ces 
études ont été menées à 2 températures : l’optimum de production de BSs (17°C) et la température 
optimale de croissance de ces souches (28°C). La température de croissance n’a pas d’impact sur 
l’hydrophilie des souches. Cependant leur hydrophilie est différente, conséquences de mutations 
génétiques chez les variants par rapport à la souche sauvage (Richard et al., 2012).  
Quelle que soit la température d’incubation, les CLPs amoindrissent l’adhésion des deux mutants par 
rapport à la souche sauvage. 
En résumé, l’étape d’adhésion entre bactérie et surface n’est pas favorisée par les CLPs. Ils 
peuvent la contrecarrer selon la température d’expérience ou la niche écologique des souches 
Pseudomonas fluorescens étudiées. 
 
(c) Biofilm 
Après l’adhésion, la colonisation bactérienne à une surface se poursuit par l’élaboration d’un 
biofilm qui est le lieu d’un comportement bactérien coopératif, conduisant à des phénotypes 
différenciés d’où son hétérogénéité de structure. Les bactéries aux divers phénotypes sont enchassées 
dans une matrice extracellulaire composée principalement d’exopolysaccharides (EPS) (Stoodley et 
al., 2002). 
Les CLPs ne semblent pas impacter le développement du biofilm bactérien en microplaques 
à 17°C. Au contraire à 28°C, ils semblent favoriser son développement : le biofilm de MFN1032 
contient plus de deux fois plus de bactéries que ceux de ses variants. L’apport exogène de CLPs 
n’augmente pas l’importance du biofilm des variants aux deux températures 17 et 28°C. Cependant 
l’efficacité de l’ajout de BSs est plus variable à 28°C. La tendance n‘est pas similaire à 28°C pour 
ces mêmes variants. Quant à la souche sauvage, suite à cet ajout, ses biofilms sont aussi amoindris 
aux deux températures. (Bonnichsen et al., 2015), les viscosinamides favoriseraient la dispersion du 
biofilm en le dissolvant comme la viscosine produite dissout les biofilms de la souche P. fluorescens 
SBW25 (Bonnichsen et al., 2015; Raaijmakers et al., 2010). Viscosine est considérée comme un 
catalyseur du départ des bactéries du biofilm existant suite à des altérations de l’hydrophilie de leur 
surface et de la structure matricielle du biofilm. (Bonnichsen et al., 2015). Ces résultats font échos 
aux contradictions de la littérature sur l’implication des CLPs au cours de la colonisation bactérienne. 
Ainsi les sessilines de Pseudomonas CMR12 (D’aes et al., 2014) ou les viscosine et apparentés de P. 
fluorescens SBW25 (de Bruijn et al., 2007) favorisent la formation du biofilm en conditions 
d’incubation statiques. Au contraire un mutant de SBW25 déficient en viscosine montre une 
augmentation du biofilm (Bonnichsen et al., 2015), comme d’autres Pseudomonas productrices 
d’arthrofactine, orfamide et putisolvine (D’aes et al., 2010; Kruijt et al., 2009; Roongsawang et al., 
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2003). Les viscosinamides semblent participer à l’édification du biofilm en fonction des températures 
d’incubation, mais ils favorisent aussi systématiquement sa dispersion. 
Afin de poursuivre nos investigations, nous avons eu recours à un transformant de la souche 
MFN1032, portant le gène gfp, MFN1032gfp (Decoin et al., 2014). Le transformant et la souche 
sauvage présentent la même hydrophobie, la même charge de surface et la même acidité-basicité de 
Lewis, réputées gouverner l’adhésion, les interactions et le détachement bactérien avec les surfaces 
abiotiques (Gallardo-Moreno et al., 2011). La cinétique de croissance de MFN1032gfp a été réalisée 
pendant 48h à 28°C en DMB sur lame de verre, sa rigidité favorisant le biofilm microbien (Saha et 
al., 2013). Le biofilm a été observé par microscopie confocale à 2, 24 et 48h, Figure 4A. 
 
Figure 4 :  Formation de biofilm de MFN1032gfp sur lame de verre à 28°C en 
DMB. A : coupe longitudinale à 2, 24 et 48h, B : coupe transversale à 24h. 
Dès 2h de croissance, des structures en forme de champignon, Figure 4B, apparaissent. Elles sont 
liées à l’hétérogénéité des mobilités bactériennes, en particuliers le swarm nécessitant la production 
de BSs (Mann and Wozniak, 2012). Ces superstructures restent jusqu’à 24h alors que le biofilm 
s’épaissit (doublement par rapport à celui de 2h). A 48h, la hauteur de biofilm chute 
significativement ; cette dispersion pourrait correspondre à la perte de ces suprastructures. Un tel 
process a été décrit pour P. aeruginosa, lié aux rhamnolipides via la motilité, les interactions cellule-
cellule, la différenciation et la formation de canaux hydriques (Mann and Wozniak, 2012). D’autre 
part la viscosine, chez P. fluorescens SBW25, a été suggérée comme promoteur de la dispersion du 
biofilm (Bonnichsen et al., 2015), comme la putisolvine, produite par une souche P. putida (Cárcamo-
Oyarce et al., 2015). A l’instar, les viscosinamides pourraient rester à la surface de leurs bactéries 
productrices, favorisant l’échappement individuel de ces mêmes bactéries du biofilm. Jusqu’ici ce 
phénomène n’a été décrit qu’après plusieurs jours et non 2h comme pour P. fluorescens MFN1032 
(Bonnichsen et al., 2015; Cárcamo-Oyarce et al., 2015; Mann and Wozniak, 2012). Quant aux 
proéminences, elles pourraient être provoquées par les conditions stressantes : limitation d’un ou 
plusieurs nutriments du milieu minimum (Barraud et al., 2015; Cárcamo-Oyarce et al., 2015; Davies, 
2011; Petrova and Sauer, 2016). De plus, leur disparition marque l’étape finale du développement du 
biofilm ; les bactéries sont « relâchées » de l’intérieur du biofilm par les canaux hydriques (Davies, 
2011) 
Pour confirmer cette potentielle implication des BSs dans la formation de biofilm, une 
cinétique similaire a été réalisée sur des filtres Anapore™ transparents au microscope confocal, 
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augmentant la surface de contact entre filtre/biofilm mimant davantage le développement de P. 
fluorescens MFN1032 au sein des poumons, son lieu d’isolement (Chapalain et al., 2008). De plus ce 
type de support « souple » m’a permis d’envisager un suivi cinétique de l’hydrophobie de la face 
externe du biofilm à l’aide de la technique de la goutte captive via l’angle de contact θ, Figure 5A.  
 
Figure 5 : Formation de biofilm de MFN1032gfp sur filtre Anapore à 28°C en 
DMB. A : méthode de la bulle captive ; B : cinétique de l’évolution de l’hydrophobie 
et du rapport biovolume polysaccharide/biomasse ; C : Suivi de la formation du 
biofilm en microscopie confocale et par transcriptomique ciblée. 
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Les BSs sont à même d’impacter l’hydrophilie de surface, comme intrinsèquement ils se localisent 
aux interfaces ou dès la création de nouvelles surfaces, ils s’y implantent. In vitro la surfactine, autre 
cyclolipopeptide, interagit avec l’enveloppe bactérienne en profondeur au niveau de la tête des 
phospholipides (Otzen, 2017), modifiant ainsi l’hydrophobie cellulaire, donc du biofilm. Cependant 
l’hydrophobie de biofilm peut refléter aussi l’évolution de la composition en surface du biofilm c’est-
à-dire le ratio matrice polysaccharidique/ biomasse (Barraud et al., 2015; Cárcamo-Oyarce et al., 
2015; Davies, 2011; Petrova and Sauer, 2016). 
La littérature fait mention de quelques mesures d’hydrophobie de biofilm (Baumgarten et al., 
2012b; Feng et al., 2016), mais uniquement via la méthode de la goutte posée qui implique un 
dessèchement du biofilm, voire sa restructuration (Gallardo-Moreno et al., 2011), donc un stress du 
tapis bactérien. La bulle captive évalue l’angle de contact θ que forme la bulle d’air mise en contact 
avec le biofilm bactérien immergé en sérum physiologique, comme présenté en Figure5A avec des 
biais moindres qu’avec la goutte posée (Gallardo-Moreno et al., 2011). 
L’implémentation innovante de la bulle captive nous a permis d’établir l’évolution sur 48h de 
l’hydrophobie du biofilm se développant à 28°C en DMB, Figure 5B, parallèlement à sa 
caractérisation en microscopie confocale, Figure5C. Pour affiner notre compréhension, les 
polysaccharides ont été localisés par coloration spécifique des motifs β-glucosidiques via le 
calcofluor (Harris and Fincher, 2009). Leur proportion a été quantifiée relativement à la biomasse par 
le rapport des biovolumes respectifs du calcofluor (polysaccharides) et de la biomasse, représenté en 
Figure5B. 
La Figure 5B&C montre l’évolution du biofilm pendant 48 h à 28°C sous différents aspects. Bien que 
le biofilm croît, son épaisseur n’augmente pas linéairement dans le temps (Figure 5C). Toutefois, 
cette cinétique de formation n’est pas en cohérence avec la croissance obtenue sur lame de verre. La 
rugosité du filtre étant supérieure à celle de la lame de verre, l’adhérence bactérienne est accrue sur 
les surfaces les plus rugueuses et leurs défauts favorisant le contact filtre/bactéries (Song et al., 2015). 
La première étape, transitoire, commence par une phase très précoce de l’adhérence (Figure 5C: 0 & 
1h) ; un certain nombre de bactéries recouvre le filtre, mais sans s’y fixer. Aussi le rapport 
polysaccharide/biomasse chute. De plus l’hydrophilie augmente de 129° à 158°, car les bactéries P. 
fluorescens MFN1032, plutôt hydrophobes, s’en détachent. Globalement la surface du biofilm est 
hydrophile, mais des fluctuations d’hydrophobie sont observées, lors des premiers temps d’adhésion. 
Les colonies grossissent et s’étendent durant l’attachement irréversible comme en témoignent 
l’augmentation du rapport polysaccharide/biomasse, mais aussi de la surexpression des adhésines, 
protéines en amont de la biosynthèse de la matrice polysaccharidique (Barraud et al., 2015). 
L’épaisseur maximale atteinte est 8µm tout en laissant des zones non couvertes du filtre (Figure 5B 
& C: 2 & 3h). A 4h, le biofilm bactérien est à confluence, mais son épaisseur se réduit à 5µm. Les 
polysaccharides atteignent leur maximum de production, confortent la densification du biofilm (de 
Araujo et al., 2016) et entrainent une augmentation d’hydrophobie (Figure 5B: 4h). Comme la 
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surfactine (Vlamakis et al., 2013) ou la viscosine (Bonnichsen et al., 2015), les viscosinamides 
pourraient stimuler la production de polysaccharides (de Araujo et al., 2016). L’écart type de 
l’hydrophobie se trouve doublé entre 4 et 5 h ; elle atteint 24 % à 5 h attestant de l’instabilité de 
l’interface. Ceci pourrait être rapproché d’un réarrangement cellulaire tel que des bactéries libérées 
du biofilm par les canaux hydriques (Davies, 2011) Cependant cette instabilité pourrait aussi avoir 
pour origine la production, même débutante de BSs (Figure 5B: 5h). Le mélange de viscosinamides 
homologues pourrait augmenter cette instabilité par leur diversité de structure. La surexpression à 
24h des gènes en liaison avec les pili, les flagelles, les BSs et la dispersion du biofilm indiquerait une 
synergie entre ces deux phénomènes (Figure 5C: 24h), simultanément à un rapport matrice 
polysaccharidique/ biomasse fléchissant. Le biofilm observé à 6 h est moins dense qu’auparavant et 
quelques proéminences sont apparues, mais la hauteur atteint au maximum 10 µm. Le biofilm mature 
est atteint après 24h, alors que sa hauteur maximale moyenne est d’environ 22 µm (Figure 5C : 24 & 
48h). Aucune évolution n’est observée après 24h. Ces observations sont cohérentes avec le cycle de 
vie d’un biofilm (Barraud et al., 2015; Davies, 2011; Petrova and Sauer, 2016). Néanmoins, 
l’interruption de l’expérience après 48h pourrait biaiser l’observation de la dernière phase, c'est-à-
dire l’altération du biofilm par la dissémination bactérienne.  
Ainsi, ces bactéries peuvent rester en interaction avec leur microenvironnement : surface 
abiotique ou hôte, i.e. cellules ou organismes Aussi l’impact des CLPs sur les interactions avec des 
partenaires biotiques semble intéressant à étudier. 
Production scientifique correspondante : P15 ; C26 ; A12 ; A42 ; A44. 
Encadrements : L4-L5 ; M1-6 ; M2_1-M2_2 ; D1 ; D3. 
 
(2) Réponse au stress biologique provoqué par un hôte  
Au vu de l’isolement de P. fluorescens MFN1032 suite à une pathologie pulmonaire 
(Rossignol et al., 2008; Sperandio et al., 2010), une étude en cytotoxicité a été réalisée vis-à-vis de 
pneumocytes A549.  
Ce modèle de toxicologie in vitro a pour objectif de se rapprocher du mode de contamination 
par voie pulmonaire pouvant provoquer une pneumopathie. Ainsi cette lignée cellulaire a été exposée 
à la souche P. fluorescens MFN1032, mais aussi à son surnageant de culture stérile, contenant des 
viscosinamides. 
La croissance bactérienne a été réalisée à 28°C, température optimale de croissance de cette 
souche (Chapalain et al., 2008), mais aussi à 37°C, température humaine. Le contact des bactéries 
avec les pneumocytes entraine une lyse cellulaire limitée (au plus 30% à 28°C, comme représenté 
Figure 6). Il pourrait être dû au système de sécrétion de type 3, SST3, identifié par ma collègue, le Dr 
A MERIEAU, chez P. fluorescens MFN1032 (Sperandio et al., 2012). Au contraire le contact 
surnageant/ A549 est bien plus dévastateur. Plus de la moitié des pneumocytes s’en trouve lysée, mais 
l’action du SST3 ne peut être envisagée. 
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Figure 6 :  Cytotoxicité envers des pneumocytes A549. A : souche MFN1032, B : 
son surnageant de culture en DMB, C : solution de CLPs purifiés.   (* : 
P=0,05 ;** : P=0,01 ; *** : P=0,001). 
A cette température de 28°C, la sécrétion d’exoproduits tels que les CLPs est plus importante 
qu’à 37°C, ce qui se traduit par une réduction de la virulence de la souche clinique à 37°C. Les 
mécanismes d’interactions bactéries/A549 sont donc liés aux exoproduits, dont les viscosinamides, 
les enzymes, les LPS (Picot et al., 2004) ou les sidérophores (Rossignol et al., 2008). Pour confirmer 
l’action des CLPs, un extrait purifié a été mis en contact et a entrainé une lyse pneumocytaire de 34%, 
prouvant leur participation active dans la virulence de la souche P. fluorescens MFN1032. Ainsi les 
viscosinamides, comme CLPs, confirment leur capacité à interagir avec les membranes ou protéines 
d’organismes vivants (Otzen, 2017). 
Production scientifique correspondante : P20 ; C26 ; A26 ; A30 ; A42 ; A44. 
Encadrements : M2_3 ; D3. 
 
(3) Communication cell-to-cell 
Ces viscosinamides ne pourraient-ils pas prendre part au « bavardage bactérien », i.e. Quorum 
Sensing –QS- (Bjarnsholt et al., 2011) ? Les CLPs pourraient agir comme des molécules de 
signalisation (D’aes et al., 2014), cependant leur implication dans le QS reste mystérieuse (Cárcamo-
Oyarce et al., 2015; D’aes et al., 2014; Fazli et al., 2014; Vlamakis et al., 2013b). La production de 
molécules de signalisation, N-AcylHomoserine Lactones (NAHLs), a été évaluée chez la souche 
MFN1032, mise en présence de deux souches biosenseurs: Agrobacterium tumefaciens NTI, révélant 
la production de NAHLs de C6 à C12 (McClean et al., 1997) et Chromobacterium violaceum CV026, 
indicateur pour ceux de C4 à C8 (Farrand et al., 1996), en collaboration avec mes collègues les Dr A 
MERIEAU et C BARBEY.  
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Figure 7 :  Evaluation de la production de molécules de signalisation, N-
AcylHomoserine Lactones (NAHLs) de la souche MFN1032 à l’aide des biosenseurs 
C. violaceum CV026 (A &C) et A. tumefaciens NTI (B &D). A & B : sans contact ; 
C&D : avec contact. 
A la Figure 7, la souche clinique ne provoque pas leur coloration (pas d’activation du senseur), 
aussi elle ne semble produire aucun type de NAHLs, ce qui n’est pas contradictoire avec la littérature 
très contrastée des molécules de signalisation chez les Pseudomonas fluorescent. Ainsi les souches 
P. fluorescens 07A and 041 ne produisent pas de telles molécules (Martins et al., 2014). De plus, la 
production de CLPs est parfois indépendante de NAHLs produits (Bonnichsen et al., 2015; De Bruijn 
et al., 2008). Les BSs présentent une structure similaire aux NAHLs et partagent leur efficacité à 
faibles concentrations (Primo et al., 2015). Cependant ils s’avèrent beaucoup plus diffusibles 
(Williams et al., 2007). 
De plus la souche P. fluorescens 2-79 est reportée utilisant une forme en C6 trihydroxylée comme 
signal de quorum (Khan et al., 2005). Ainsi les viscosinamides étant moins diffusibles que les 
NAHLs, les essais ont été réitérés en mettant en contact direct la souche MFN1032 et les biosenseurs. 
Une réponse positive d’A. tumefaciens NTI suite à ce contact direct, Figure 7D, indique que 
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MFN1032 produits des composés similaires aux NAHLs. Ne serait-ce pas les viscosinamides qui 
seraient impliquées comme médiatrices d’une communication cellule-cellule ? Beaucoup de zones 
d’ombre persistent ! 
Production scientifique correspondante : A42 ; A44. 
Encadrements : M2_3 ; D3. 
 
Que les bactéries aient une croissance planctonique ou sessile, en interaction avec une 
interface abiotique ou biotique, les BSs, dont les CLPs, sont effectivement un des éléments de la 
réponse adaptative des Pseudomonas à leur microenvironnement. Cependant cette réponse ne 
s’exprime pas uniquement via ces biomolécules. Quand il s’agit de se développer, voire de survivre, 
la bactérie doit faire face à un microenvironnement. Même si celui-ci est des plus favorables à son 
développement, la bactérie doit contrecarrer l’intrusion d’autres organismes en s’en défendant. Aussi 
avons-nous décidé avec un certain nombre de mes collègues du LMSM d’explorer la virulence 
bactérienne comme une approche de leur réponse adaptative pour une niche écologie rarement 
étudiée : l’air extérieur. 
IV) Evaluation de la virulence bactérienne : approche originale 
en qualité de l’air 
Avec le Dr A GROBOILLOT et le Pr N ORANGE, j’ai co-ordonné, entre 2008 et 2010, le 
volet micro-organisme du projet Particules Urbaines et Céréalières, Microorganismes Mycotoxines 
et Pesticides (PUC2MP), saisine financée par l’AFSSET. Ce travail a été rendu possible grâce une 
collaboration entre Air Normand, agence de surveillance de la qualité de l’air en Haute-Normandie à 
l’époque (V DELMAS, A FRANCOIS), le CERTAM (Centre d’Etudes et de Recherche en 
Aérothermique Moteur, Dr F DIONNET, Dr D PRETERRE D et Dr F GOURIOU) et les laboratoires 
de l’Université de Rouen : unité U644 de l’INSERM (Pr J-P MORIN) et notre équipe. 
Cette saisine avait pour objectif d’évaluer l’impact sanitaire de poussières de déchargements 
céréaliers en fonction des pressions environnementales (température, pollution…). L’identification 
par microbiologie pasteurienne, métabolique et par biologie moléculaire des diverses communautés 
bactériennes et fongiques a mobilisé, en plus des 3 enseignants-chercheurs que nous étions, 3 
techniciens (permanent : O MAILLOT et contractuels : E GERAULT et S PIRES), 3 stagiaires, dont 
un post-doctorant (Dr M MORETTI), spécialiste fongique. Suite aux 9 prélèvements d’air 
«céréaliers» ou urbains, une souchothèque a été constituée contenant 280 souches fongiques et plus 
de 2000 bactéries aéroportées.  
Afin d’appréhender l’aspect sanitaire de cette biocharge bactérienne, la virulence de souches 
représentatives de chaque grande famille bactérienne lors des divers prélèvements a été évaluée grâce 
au test alternatif toxicologique du nématode Caenorhabditis elegans, implémenté au sein de notre 
laboratoire par mon collègue le Dr O LESOUHAITIER. Ce modèle cytotoxique in vitro de type 
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« Slow killing » est d’autant plus pertinent qu’il est adapté à de nombreux pathogènes humains 
(Darby, 2005) et, plus particulièrement, pour des pathologies pulmonaires (Rea et al., 2010). Les 
bactéries sont une source de nourriture pour ces nématodes. Plus la cinétique de survie des C. elegans 
est longue, moins la souche bactérienne est virulente vis-à-vis de ce modèle. Afin de comparer les 
cinétiques obtenues pour les différentes souches, une approche analytique a consisté à considérer la 
durée nécessaire pour que la moitié de la population des vers ait disparu, cette valeur est qualifiée de 
DL50. Pseudomonas aeruginosa PAO1 (par la suite PAO1) est utilisée comme témoin de virulence 
(DL50 de l’ordre de 6 jours) et la souche Escherichia coli OP50 (par la suite OP50) comme témoin 
non virulent avec une DL50 d’environ 16 jours. La Figure 8 présente une des comparaisons de telles 
cinétiques de survie. 
 
Figure 8 :  Cinétiques de survie de C. elegans pour quelques souches bactériennes 
prélevées dans l’air urbain à Rouen ou à Evreux en période estivale ou hivernale. 
Souche OP50 : témoin de non-virulence ; Souche PAO1 : témoin de virulence. 
Traditionnellement les souches ayant une DL50 se situant entre 9 et 14 jours sont considérées de 
virulence intermédiaire, donc sans grand danger sanitaire pour des personnes en bonne santé, non 
immuno-déprimées. Suite à l’étude de virulence des souches représentatives, les populations 
bactériennes prélevées au niveau des silos ne présentent pas un danger plus important que celui de 
l’air urbain. (Morin et al., 2013). 
Le test de survie de C. elegans a été adapté pour une culture globale de la population bactérienne 
récoltée lors du prélèvement, comme présenté Figure 9.  
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Figure 9 : Stratégie pour évaluer la virulence de bactéries aéroportées. 
La cinétique de survie paraît constituer un bon indicateur de la virulence de l’ensemble des souches 
prélevées, comme présenté à la Figure 10.  
 
Figure 10 : Comparaison de la survie des nématodes C. elegans exposés aux 
bactéries à jour 9. 
Ainsi l’établissement fastidieux de chacune des cinétiques de survie du nématode vis-à-vis de chaque 
isolat purifié ne s’avère pas nécessaire. Cette approche originale a permis de proposer un nouvel outil 
de surveillance de la qualité biologique de l’air (Duclairoir Poc et al., 2011). 
Afin d’améliorer la fiabilité du traitement des données de survie du modèle nématode, avec 
mes collègues Dr A GROBOILLOT et O LESOUHAITIER, nous participons au projet régional PIFS 
(Plateforme Probabilités, Informatique Fondamentale et Statistique) dirigé par le Dr V BARBU 
(Laboratoire de Mathématiques Raphaël Salem, UMR 6085 CNRS de l’Université de Rouen-
Normandie) qui désire travailler sur la modélisation de la survie en biologie.  
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D’autre part, lors des prélèvements hivernaux au cours de déchargements céréaliers sur les quais 
rouennais, les P. fluorescens et apparentées s’avèrent être présentes et prépondérantes (Duclairoir Poc 
et al., 2014). Malgré le caractère psychotrophe de l’espèce, quelques unes de ces souches aéroportées 
sont capables de se développer à 37°C, comme d’autres souches cliniques telles que P. fluorescens, 
MFN1032, rendant envisageable leur implication lors d’infections pulmonaires. Dans le cadre du 
FEDER « Pseudomonas Virulence », un post-doctorant, Dr VERDON, que je co-encadrais avec ma 
collègue Dr A GROBOILLOT, a caractérisé le biophysiome, à 30 et 37°C, de ces souches aéroportées 
(croissance, facteurs de virulence : mobilité, formation de biofilm, production d’exoproduits, 
systèmes de sécrétion), mais aussi leur sensibilité aux antibiotiques. Ainsi, au sein du panel bactérien, 
deux souches aéroportées modèles ont été sélectionnées : P. fluorescens MFAF76a et P. putida 
MFA88, au vu de la similarité de leur biophysiome avec la souche P. fluorescens MFN1032, témoin 
clinique. Parallèlement avec l’aide d’une stagiaire spécialisée en protéomique (M1_5), le Dr 
VERDON a établi l’exoprotéome de ces  souches aéroportées dans différentes conditions (culture à 
28 ou à 37°C et phase de croissance fin d’exponentielle ou stationnaire avancée). Ces facteurs de 
virulence précédemment déterminés ont été corroborés à l’aide de trois modèles cytotoxiques : 
nématode Caenorhabditis elegans, amibe Dictyostelium discoideum et la lignée cellulaire 
pneumocytaire A549.  
 
Figure 11 : Cytotoxicité des souches aéroportées MFAF76a, MFAF88 et  
 clinique MFN1032 à l’aide de 3 types de modèle. A : C. elegans ; B : D. 
discoideum ; C : Pneumocytes A549. (* : P=0,05 ;** : P=0,01 ; *** : P=0,001). 
L’approche via le test C. elegans s’est avérée peu discriminante, Figure 11A, d’autant que la 
survie des nématodes est favorisée par la production de CLP bactériens (Bjørnlund et al., 2009), dont 
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les souches P. fluorescens MFN1032 et P. putida MFA88 sont productrices (Duclairoir Poc et al., 
2014). D. discoideum mime l’interaction des macrophages humains avec les microorganismes en vue 
d’établir leur virulence (Pukatzki et al., 2006) en un test de courte durée (Carilla-Latorre et al., 2008). 
La souche MFN1032 présente une virulence uniquement à 30°C, Figure 11B, qui est corrélée à 
l’activité du système de sécrétion de type 3 (SST3) identifiée à 28°C (Sperandio et al., 2012), mais 
qui n’est plus fonctionnel à 37°C. L’absence de virulence observée pour les deux souches aéroportées 
vis-à-vis de D. discoideum laisse à penser que les souches MFAF76a et MFAF88 ne possèderaient 
pas ce type de SST3 fonctionnel à 30 et 37°C.  
Mises en contact direct avec les pneumocytes A549, les trois souches ne démontrent aucune virulence 
significative, Figure 11C1. Cependant leurs surnageants de culture stérilisés provoquent une lyse 
patente des pneumocytes, mais variable selon les conditions. Grâce à leur sécrétion, Figure 11C2, les 
souches aéroportées MFAF76a et MFAF88 induisent une réponse inflammatoire des cellules 
pulmonaires, spécialement à 37°C, aussi le risque sanitaire correspondant n’est pas à négliger 
(Duclairoir Poc et al., 2014). De plus, dans une approche sanitaire rigoureuse, plusieurs modèles 
toxicologiques doivent être mis en œuvre simultanément afin de corroborer leurs résultats, pour éviter 
tout biais lié à des modèles peu sensibles ou trop spécifiques. 
Production scientifique correspondante : P13 ; P20 ; Pdc2 ; C9 ; A13-A14 ; A18 ; A26 ; A30. 
Encadrements : L6 ; M1_3 ; M2_3 ; PD1. 
 
Cette incursion dans le domaine de l’air extérieur doublée de l’intérêt pour la sécurité sanitaire 
m’a naturellement menée à m’interroger à l’impact de différents stress sur la physiologie bactérienne, 
voire sa virulence. Aussi ma curiosité scientifique m’a entrainée à approfondir la concrétisation de la 
réponse bactérienne en me focalisant de plus en plus sur l’interface qu’est la membrane bactérienne 
lors de modifications de son microenvironnement lors de stress chimiques ou physiques.  
 
V) Impact de stress sur l’adaptation et la virulence bactérienne 
A) Stress biologique 
(1) Signaux eucaryotes 
(a)  Acide γ-aminobutyrique (GABA) 
Les BSs sont une des réponses bactériennes adaptatives à la pression environnementale, 
comme nous l’avons développé plus spécifiquement pour les CLPs. Pour l’espèce Pseudomonas 
aeruginosa, le rôle de ses BSs, les rhamnolipides, a été largement documenté dans l’adhésion 
bactérienne et la virulence (Fazli et al., 2014). Les thèses des Dr A Chapalain et A Dagorn (encadrées 
par les Pr S CHEVALIER et M FEUILOLEY) se sont intéressées à la communication entre bactéries 
de l’espèce Pseudomonas grâce à l’acide gamma aminobutyrique (GABA). Ce neurotransmetteur des 
animaux, et aussi molécule de défense chez les plantes, permet la communication inter-règnes et 
50 
présente la particularité d’être produit par certaines espèces bactériennes, dont les Pseudomonas 
(Lesouhaitier et al., 2009). Lors de notre étude, P. fluorescens MF37, en présence de faible de 
concentration de GABA, voit sa virulence modifiée comme chez P. aeruginosa PAO1, mais les 
mécanismes impliqués, modifications de surface et changement de profil de sécrétion, apparaissent 
différents chez ces deux espèces. Effectivement, j’ai établi que P. fluorescens MF37 n’est pas 
productrice de BS et sa virulence est reliée à la production d’exoproduits et aux variations structurales 
des liposaccharides. Cette altération des LPS a été pressentie au travers de la variation des propriétés 
de la surface bactérienne que j’ai évaluée à l’aide de tests Microbial Adhesion To Solvents (MATS) 
(Dagorn et al., 2013a). Un autre mécanisme de virulence a été démontré pour P. aeruginosa PAO1 
qui produit des rhamnolipides. Cette production est modulée par le faible ajout de GABA. Suite à une 
fine analyse tensiométrique, j’ai pu aider à mettre en évidence l’évolution de l’activité tensioactive 
des rhamnolipides, dénotant une modification de leur nature liée à l’ajout de GABA (Dagorn et al., 
2013b). Ainsi clairement la virulence de P. aeruginosa est contrôlée via la production de ses BSs par 
le GABA, molécule de communication inter-règnes.  
 
(b) Substance P 
La peau est un microbiome au sein duquel la flore bactérienne endogène est soumise à une 
multitude de signaux eucaryotes potentiellement capables d’en faire varier la virulence, avec les 
réactions inflammatoires cutanées bien connues des personnes à peau sensible. Le LMSM a 
commencé à explorer l’existence d’un lien entre signaux eucaryotes et virulence de ces bactéries 
cutanées dans le cadre du contrat FUI « Skin O Flor ». Dans ce contexte, l’effet de la substance P, 
molécule eucaryote cutanée (Lesouhaitier et al., 2009), a été évaluée sur la modulation de la virulence 
d’une bactérie endogène, Bacillus cereus.  
 
Figure 12 : Pelage de la S layer de B. cereus par la substance P. A: Coupe de 
microcopie électronique de la surface bactérienne intacte. B, C& D : Clichés de 
détachement de la S Layer (→) suite au traitement par la substance P. E : Affinité 
relative aux solvants de la souche B. cereus non-traitée et traitée par la substance P. 
(* : P=0,05 ;** : P=0,01 ; *** : P=0,001). Adaptée de Mijouin (Mijouin et al., 2013). 
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Ma contribution a confirmé le mécanisme de relargage de facteurs de virulence : les protéines 
de la S layer bactérienne. Effectivement le phénomène de pelage de cette S layer, visualisée par 
microscopie à balayage (MEB) en Figure 12A-D, a été corrélée aux variations de polarité surfacique 
de B. cereus que j’ai quantifiées au travers de tests MATS, Figure 12E. Ce pelage de la S layer conduit 
à une augmentation de virulence bactérienne (Mijouin et al., 2013). 
 
(c) Calcitonin Gene Related Peptide (CGRP) 
Au LMSM, une autre molécule de signalisation eucaryote a été étudiée la Calcitonin Gene 
Related Peptide (CGRP). Elle est co-localisée et co-secrétée avec la Substance P dans la peau 
(Lesouhaitier et al., 2009). Son impact a été caractérisé sur une bactérie cutanée Staphylococcus 
epidermidis. Aucune variation parmi les facteurs de virulence secrétés n’est démontrée, alors que les 
propriétés de la surface bactérienne que j’ai quantifiées sont altérées. Cette augmentation 
d’hydrophobie bactérienne a été corrélée à une moindre adhésion de cette souche S. epidermidis sur 
kératinocytes (N’Diaye et al., 2016). Ainsi S. epidermidis est capable d’intégrer le signal CGRP et 
d’adapter en conséquence sa virulence. 
Production scientifique correspondante : P16 ; P18-P19 ; P28 ; CInt2 ; C10-C11 ; C14 ; C30 ; A17 ; 
A20 ; A22-A25 ; A27-A29 ; A32 ; A34. 
 
(2) Systèmes de sécrétion  
En plus des stress biologiques liés aux sécrétions cellulaires eucaryotes, les bactéries doivent 
aussi faire face aux microorganismes sécréteurs. Comme décrit précédemment, la souche P. 
fluorescens MFN1032 présente un système de sécrétion de type SST3 fonctionnel à 28°C (Sperandio 
et al., 2012). Elle possède, de plus, selon des études bioinformatiques, un système de sécrétion de 
type 6, SST6. Les SST6 sont des nanomachines dédiés à l’injections d’effecteurs, directement de la 
bactérie à la cellule cible (Gallique et al., 2017). Au LMSM, j’ai collaboré à la caractérisation d’une 
autre souche P. fluorescens environnementale : MFE01. Elle présente un SST6 très actif. 
Lors d’une co-culture avec la souche P. fluorescens MFE01, MFN1032 est confinée par 
MFE01 qui l’entoure Figure 15A-C. Ce phénomène n’est pas reproduit par le mutant de délétion 
MFE01∆hcp1, mutant du SST6, mais conservé chez le mutant MFE01∆hcp2 qui endigue le swarming 
de MFN1032, Figure 15 A&B. Les gènes hcp1 et hcp2 codent pour deux protéines Hcp différentes, 
présentes chez la souche MFE01, mais absente pour MFN1032, Figure 15D. 
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Figure 13 : Effet de P. fluorescens MFE01 et de ses mutants en co-culture 
bactérienne. A: Plan expérimental : P. fluorescens MFN1032 entourée 
concentriquement par MFE01 et ses mutants. B: Swimming de MFN1032 en co-
culture avec MFE01 ou ses mutants. C: Survie de MFN1032 (histogramme) et 
diamètres de swarm de MFN1032 (□). D: Elution sur SDS-PAGE des surnageants 
concentrés de culture en phase exponentielle de MFE07, MFE01 et MFN1032 à 28°C 
et MFE01 à 37°C. La protéine Hcp, majoritaire à 28°C, a été identifiée par 
spectrométrie de masse. (* : P=0,05). Adaptée de Decoin (Decoin et al., 2015). 
Ces protéines sont constitutives du SST6 et en démontrent la fonctionnalité lors d’interactions avec 
des hôtes par contact direct. La souche MFE01 est capable en réponse à son microenvironnement 
d’adopter une stratégie antibactérienne. En relation avec Hcp1, elle limite la mobilité d’autres 
souches. Par Hcp2, elle exerce une activité bactéricide (Decoin et al., 2015). 
Production scientifique correspondante : P25 ; A31. 
 
Le SST6 est présent chez certaines de nos souches aéroportées, aussi avec ma collègue le Dr 
MERIEAU, nous aimerions confirmer leur activité et évaluer leur expression en situation de stress 
exogène chimique, par exemple. 
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B)  Stress chimique : la pollution diésel promeut-elle la virulence 
bactérienne via sa propre réponse adaptative ? 
Pour poursuivre la dynamique initiée par le projet qualité de l’air et intéressée par l’aspect 
pulmonaire suite à l’adaptation du modèle cytotoxique A549, j’ai proposé de poursuivre dans une 
démarche de sécurité sanitaire en étudiant, à l’aide de quelques souches de Pseudomonas collectées, 
l’influence de polluants tels que les oxydes d’azote sur leur physiologie, leur potentiel d’adaptation 
et leur virulence.  
«La pollution est la plus grande cause environnementale de maladies et de décès dans le monde 
aujourd'hui, responsable d’environ 9 millions de décès prématurés» a statué dernièrement la 
commission du Lancet (Landrigan et al., 2018). Parmi ces contaminants, les oxydes d’azote, NOx, et 
plus particulièrement le dioxyde d’azote, NO2, sont nommément identifiés comme des polluants très 
préoccupants pour la santé publique par l’OMS (WHO Regional Office for Europe, 2013) et 
marqueurs de la pollution automobile (Air quality in Europe — 2017 report, 2017). Ainsi dès 2012, 
l’ANSES a fait une de ses priorités les conséquences du NO2 pour la qualité de l’air. Or ce dernier 
est réputé pour favoriser le développement d’infections pulmonaires, principalement bactériennes 
(Latza et al., 2009). 
Traditionnellement les épidémiologistes expliquent l’augmentation de pneumopathies d’origine 
bactérienne par une immunodépression humaine consécutive au caractère irritant des polluants sur 
les tissus pulmonaires facilitant ainsi la colonisation bactérienne (Silveyra et al., 2017). Notre 
approche a été de documenter une argumentation alternative : la pollution pourrait augmenter 
(aggraver) la virulence bactérienne per se ce qui favoriserait l’infection plus aisée de l’hôte humain 
par les bactéries en contact avec la pollution. Lors d’une étude au sein de services d’urgences 
européens, les Pseudomonas spp. s’avèrent l’un des genres bactériens prépondérants (14%) de ces 
cas pulmonaires et qui accroissent le taux de mortalité (Vincent et al., 2006).  
 
Nous avions envisagé différentes approches d’exposition : culture liquide bactérienne, 
aérosolisation ou monocouche bactérienne. Au vu de la question sanitaire à laquelle nous voulions 
répondre, nous avons favorisé l’approche par contact le plus direct polluant gaz/ bactérie, surtout en 
s’affranchissant au maximum du facteur eau qui pourrait facilement interférer et altérer la répétabilité 
de notre système d’étude. Ainsi le périmètre de notre approche aurait été modifié en ne nous limitant 
plus au stress nitrosant, mais en élargissant au stress oxydant plus globalisant. Cette réflexion s’est 
accompagnée d’un dépôt de lettre d’intention auprès de l’ANSES au printemps 2011, non retenue. 
Cependant notre projet a été financé au travers du projet Européen-Etat-Région Virulence 
Pseudomonas finançant 18 mois de stagiaire postdoctoral (les Dr J VERDON et M BONNIN-
JUSSERAND) et 40k€ d’équipement. Grâce à cette dotation, le LMSM a pu acquérir un tensiomètre 
Krüss DSA30 qui a soutenu toute la caractérisation des BSs évoquée lors des parties précédentes, 
mais aussi les fournitures pour le prototype d’exposition, dont la conception et la réalisation 
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n’auraient pu avoir lieu sans l’appui du CERTAM et les mains expertes des Dr F GOURIOU et D 
PRETERRE. 
 
Le genre bactérien Pseudomonas est connu pour contrecarrer le stress nitrosant provoqué par NO2 et 
son congénère NO grâce à la mise en œuvre de stratégies de dénitrification impactant leur 
perméabilité membranaire et leur régulation protéique (Arai, 2011; Van Alst et al., 2007). Le 
phénomène plus global qu’est le stress oxydant, entraine une modulation de la régulation lipidique et 
de la virulence. Suite à ces stress, les biomolécules (ADN, lipides, protéines) subissent des dommages 
délétères (Spiro, 2007). Après un travail de sélection des modèles bactériens d’intérêt et de leur 
caractérisation en parallèle du témoin clinique P. fluorescens MFN1032 mené par le Dr J VERDON, 
une seconde post-doctorante, le Dr M BONNIN-JUSSERAND a défriché la méthodologie 
d’exposition, dont la préparation du matériel biologique, et a réalisé des essais préliminaires avec un 
mélange (NO/NO2/O2/N2). Parallèlement, pressentant que, suite aux expositions, les bactéries 
pourraient ne subir que des variations modérées de virulence, avec un étudiant de Master 2 (M2_3), 
j’ai adapté un test cytotoxique vis-à-vis des amibes Dictyostelium discoideum permettant d’avoir une 
quantification graduée de virulence bactérienne. 
Concomitamment, au début 2012, j’ai déposé un dossier ANR Jeune Chercheur-Jeune Chercheuse 
intitulé NitroBactAIR, ayant obtenu la labellisation du pôle de compétitivité MOV’EO, mais non 
retenu pour financement par l’ANR. Profitant de ce dossier, j’ai postulé au printemps pour une bourse 
de thèse en région Haute-Normandie. Ainsi à partir d’octobre 2013, j’ai été la responsable scientifique 
de la thèse de T KONDAKOVA, financée par le GRR SSE et sous la co-direction du LMSM (Pr N 
ORANGE) et du CERTAM (Dr F DIONNET). Ce projet a visé tout d'abord à compléter les outils 
d’étude de la virulence et plus spécifiquement du stress nitrosant par la mise au point de la 
caractérisation des lipides bactériens par HPTLC couplée au MALDI-TOF/TOF (lipidome) de 
souches de P. fluorescens, puis de réaliser des expositions bactériennes. 
 
(1) Implémentation de l’imagerie HPTLC-MALDI TOF MS et application à l’étude du lipidome 
de bactéries P. fluorescens 
La technique innovante d’analyse des lipides par HPTLC couplée au MALDI-TOF/TOF a été adaptée 
aux lipides bactériens et décrite à la Figure 14 (Kondakova et al., 2015b, 2017). Ainsi une expertise 
a été acquise sur le lipidome des Pseudomonas spp. (Kondakova et al., 2015a). Cette concrétisation 
a été permise grâce à l’expertise du dépouillement spectral du Dr N MERLET-MACHOUR de l’UMR 
COBRA (Université de Rouen-Normandie).  
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Figure 14 : Principe de la lipodomique couplant analyse des acides gras et imagerie 
HPTLC-MALDI TOF MS 
 
 
Figure 15 : Lipidome de la souche P. fluorescens MFAF76a selon les phase et 
température de croissance. A : profil d’une courbe de croissance bactérienne. B : 
Profils HPTLC-MSI en phase exponentielle (Pexpo) et stationaire (Pstat) à 28 et 37°C. 
C : spectre MSMS du phospholipide inconnu, UGP. D : Synthèse de l’analyse 
lipidomique selon les phases et températures de croissance. 
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Les lipidomes de la souche aéroportée P. fluorescens MFAF76a et de son témoin clinique 
MFN1032 ont été établis en fonction des conditions de croissance : température (28 et 37°C) et phase 
physiologique exponentielle (Pexpo) et statique (Pstat), rappelées en Figure 15A. Les profils HPTLC 
MALDI TOF MSI de MFAF76a sont présentés en Figure 15B.  
Trois familles lipidiques sont systématiquement identifiées : la phosphatidylcholine (PC ; Rf 
0.24±0.01 – colorée en rouge), la phosphatidyléthanolamine (PE ; Rf 0.43±0.02 – en bleu) et le 
phosphatidylglycérol (PG ; Rf 0.62±0.03 – en jaune) (Kondakova et al., 2015b). Les PE et PG sont 
les lipides ʺcommunsʺ dans le lipidome bactérien et jouent un rôle incontournable dans la 
structuration de la paroi bactérienne (Kondakova et al., 2015a). Par contre, la présence de la PC est 
inhabituelle dans le lipidome des procaryotes (Fuchs et al., 2007) et est un composant majeur de la 
membrane des eucaryotes. C’est également le phospholipide principal du plasma, constituants des 
lipoprotéines et du cholestérol (Cole et al., 2012). Il est cependant rarement retrouvé dans le lipidome 
bactérien (uniquement pour environ 10% des espèces bactériennes) (Cole et al., 2012; Kondakova et 
al., 2015a). 
Un quatrième spot est observé avec un Rf 0.26±0.02, (Figure 15B, coloré en vert). Les données 
accumulées par MS et MS tandem, présentées à la Figure 15C, ne nous a pas encore permis 
l’identification complète de ce phospholipide, codé UGP pour unknown glycerophospholipid. La 
fragmentation suite à la MSMS semble typique de celle décrite pour les phospholipides par Al-Saad 
(Al-Saad et al., 2003), avec des réarrangements spécifiques pour la tête polaire (HG). Certains des 
pics présents en MSMS sont similaires à ceux du PG. La similitude des acides gras a été confirmée 
par notre collaborateur le Dr H HEIPIEPER, Figure 15D, mais le m/z est nettement plus important 
que celui du PG, et pourrait laisser pressentir des Phosphatidylinositol 4,5-bisphosphates (PIP) qui 
possèdent eux habituellement 4 chaînes d’acides gras. Cependant la fragmentation n’est pas 
compatible avec de tels PLs. 
D’autre part un autre PL, la cardiolipine (CL) est fréquemment constitutive des membranes 
bactériennes (Grimard et al., 2014) dont celles de certaines Pseudomonas (Fouchard et al., 2005; 
Kondakova et al., 2015a). Cependant sa détection peut être aléatoire selon le type de technique 
d’analyse mise en œuvre (Romantsov and Wood, 2017), même si l’approche couche mince assure sa 
révélation (Cronan, 2003). La biosynthèse de la CL est décrite chez les bactéries via la réaction de 
deux molécules de PG (Kondakova et al., 2015a; Ortega et al., 2017), ou, plus rarement à partir de 
PG et PE (Dowhan et al., 2017). L’analyse in silico du génome de P. fluorescens MFAF76a, Figure 
16, réalisée dernièrement par S DEPAYRAS, a visé à mieux caractériser cette voie métabolique chez 
P. fluorescens MFAF76a et a mis en évidence l’existence de la machinerie de production de la CL, 
sans que sa production ne soit effectivement observée.  
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Figure 16 : Analyse in silico de P. fluorescens MFAF76a concernant le 
métabolisme des glycérophospholipides. 
Ce faisceau de données couplé à la valeur de m/z de 905 nous interroge et nous permet d’émettre 
l’hypothèse que l’UGP pourrait être un « hybride » de la CL, il pourrait ne compter que 3 chaînes 
d’acides gras au lieu des 4 usuelles. L’UGP1 pourrait avoir la structure présentée en Figure 17, 
correspondant à un m/z de 905. Grâce à une collaboration avec le Pr A CORCELLI (Università degli 
Studi di Bari, Italie), nous espérons mener à bien cette identification. 
 
Figure 17 : Structure hypothétique de l’UGP1  
D’autre part, cet UGP ne s’avère qu’être produit en phase stationaire à 28°C et 37°C, mais sa 
révélation n’est pas toujours systématique. Un profil similaire est obtenu pour P.fluorescens 
MFN1032 à l’exception d’un cinquième spot supplémentaire au Rf 0,50 qui correspond à la 
viscosinamide A (communication personnelle). 
Pour compléter ce lipidome, l’analyse des acides gras a été réalisée par T KONDAKOVA au 
Helmoltz Institute, chez le Dr H HEIPIEPER (Leipzig, Allemagne), ce qui lui a permis d’obtenir le 
label de doctorat européen. Comme le montre le lipidome de la souche aéroportée à la Figure 15D, la 
composition globale en PLs ne varie ni avec la température, ni avec la phase de croissance. Cependant 
des modifications à la marge concernent les longueurs de chaînes latérales, qui se traduisent par une 
augmentation du degré de saturation à 37°C par rapport à 28°C. Ce phénomène est connu chez les 
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Pseudomonas spp. pour préserver leur stabilité membranaire (Mansilla et al., 2004). Ainsi pour 
endiguer une élévation de la température, ces bactéries synthétisent davantage d’acides gras saturés 
pour maîtriser les propriétés de leur bicouche lipidique. 
Production scientifique correspondante : P21 ; P24 ; Ch3 ; C15-C17 ; A35 ; A37 ; A38. 
Encadrements : M1 Imm_11->M1 Imm_12 ; D2-D3. 
 
(2) Mise en place de l’exposition bactérienne  
(a) Matériel biologique 
Lors de ses travaux doctoraux (2012-2015), le Dr T KONDAKOVA a finalisé un système 
original, Figure 18, mettant en contact direct les bactéries avec le gaz polluant (Kondakova et al., 
2016), contrairement à d’autres installations exposant des cultures bactériennes liquides (Spiro, 
2008).  
Suite à une préculture en milieu pauvre (Davies Minimum Broth), les bactéries sont ensemencées sur 
des filtres à hauteur de 3.107 bactéries par filtre sous la forme d’une monocouche, qui, après avoir été 
déposée sur une gélose DMA, est incubée pendant 4h. Ensuite, les filtres sont transférés sur une gélose 
qui sera alors déposée dans une des chambres d’exposition. 
Le système d’exposition permet d’exposer la même culture dans deux chambres d’exposition 
thermostatées et à humidité contrôlée : une première est sous flux d’air synthétique et la seconde sous 
atmosphère polluée, soit de l’air synthétique additionné du polluant choisi. 
 
Figure 18 : Procédé d’exposition de bactéries en monocouche à un polluant gazeux. 
Ainsi, ce système permet l’exposition concomitante de bactéries issues de la même culture en 
présence ou non de polluant(s), de façon à mimer l’exposition réelle aux polluants atmosphériques. 
(b) Choix et concentration en polluant 
Parmi ces contaminants, les oxydes d’azote, NOx, et plus particulièrement le dioxyde d’azote, 
NO2, sont nommément identifiés comme des polluants très préoccupants pour la santé publique par 
l’OMS (WHO Regional Office for Europe, 2013) et marqueurs de la pollution automobile (Air quality 
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in Europe — 2017 report, 2017). D’origine principalement anthropogénique, les oxydes d’azote sont 
loin d’être des molécules inconnues dans le monde biologique. Effectivement les NOx interagissent 
avec de nombreux matériaux biologiques ; ainsi ils provoquent l’altération de membranes biologiques 
et de nombreuses biomolécules telles que les protéines, les lipides voire l’ADN, entraînant de 
nombreuses pathologies. Dans le chapitre ”The hidden face of Nitrogen oxides species – from toxicity 
effect to potential cure?” du livre « Emerging Pollutents » (Depayras et al., 2018a), nous avons 
compilé les méfaits des radicaux libres NO et NO2, liés à leur électron non-apparié (Figure 19A), 
mais aussi leur potentiel en thérapie humaine. Cependant, en qualité de l’air, depuis 2012, l’Agence 
nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (ANSES) a fait une 
de ses priorités les conséquences du NO2 sur la santé humaine. Or ce dernier est réputé pour favoriser 
le développement d’infections pulmonaires, principalement bactériennes (Latza et al., 2009). 
L’impact d’un polluant aéroporté est fonction de sa concentration et de la durée d’exposition. Suite à 
des revues, les organismes sanitaires de référence ont émis des limites toxicologiques (Figure 19B 
&C) pour chacun de ces deux radicaux desquelles les instances gouvernementales se sont inspirées 
pour établir des limites environnementales (Figure 19D & E). 
 
Figure 19 : Caractéristiques clefs des NOx. A: leur structure de Lewis et facteur de 
conversion. B: seuils du NO (ppm) (Bisson et al., 2011); C: seuils du NO2 (ppm) 
(Bisson et al., 2011); D et E: Valeurs limites du NO et du NO2 respectivement (Air 
quality in Europe — 2017 report, 2017); ppm: partie par million; ND: non déterminée. 
Concernant les références toxicologiques, l’effet létal correspond aux concentrations en NO ou NO2 
en deçà desquelles aucune mortalité n’est observée chez la population exposée. Quant aux effets 
réversibles ou irréversibles, ils décrivent le constat de pathologies humaines réversibles ou 
irréversibles dans la population exposée.  
Les moyennes horaires d’exposition en NO2 pouvaient excéder 940 µg/m3 (0,5 ppm) à proximité d’un 
trafic chargé (Svartengren et al., 2000). Depuis une quinzaine d’année, la réglementation est devenue 
davantage contraignante suite aux signatures de la convention de Genève et des protocoles de Kyoto, 
Gothenburg et Paris (Europe and Unece, 2015). Ainsi cette moyenne horaire en habitacle automobile 
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a été évaluée entre 200 à 250 µg/m3 (>0,1 ppm) de NO2 (Morin et al., 2009). Cependant la lettre 
Recherche N°21 de l’ADEME indique des pics de concentrations en NOx 9 fois supérieures à celles 
à l’extérieur de l’habitacle (Adème, 2017).  
Les concentrations choisies en NO2 lors de cette étude, dans un premier temps, ont pour objectif de 
décrire 3 cas très différents (Kondakova et al., 2016) : 
* une situation « environnementale » où la qualité de l’air est saine: 0,1 ppm ; 
* une situation critique où des effets réversibles sur la santé humaine peuvent se produire : 
5 ppm,  
* et enfin une situation toxique pour laquelle des effets irréversibles seraient observés en 
santé humaine : 45 ppm. 
Dans la suite de cette étude, d’autres concentrations seront envisagées, dont la concentration de 0,2 
ppm pouvant correspondre à une concentration en NOx observable ponctuellement dans un habitacle 
automobile dans un tunnel parisien (Morin et al., 2009) ! 
Production scientifique correspondante : P21 ; Ch4 ; A33 ; A35. 
Encadrements : D2-D3 ; PD2-PD3. 
 
(3) Impact du NO2 sur la physiologie et la virulence des souches P. fluorescens aéroportée 
MFAF76a et clinique MFN1032 
La seconde partie des travaux doctoraux du Dr T KONDAKOVA a été de caractériser l’impact 
de l’exposition au NO2 sur le biophysiome des souches P. fluorescens aéroportée MFAF76a et 
clinique MFN1032. Afin de poursuivre ces travaux présentés lors de la soutenance du doctorat 
européen du Dr T KONDAKOVA (20 Novembre 2015), j’ai déposé une lettre d’intention auprès de 
l’ANSES dès janvier 2014 intitulée «Impact du NO2 gaz sur la virulence d’une bactérie aéroportée : 
stratégies de dénitrification et de mobilité membranaire », non retenue. Suite au dépôt d’une demande 
régionale d’allocation doctorale, sélectionnée et financée par le GRR haut-normand SéSa (Sécurité 
Sanitaire), j’assure la responsabilité scientifique et le co-encadrement, avec le Pr N ORANGE, de S 
DEPAYRAS depuis septembre 2015 (soutenance d’ici fin 2018) sur la consolidation et 
l’approfondissement des résultats précédemment acquis. 
(a) Approche lipidomique 
Mettant à profit l’implémentation de l’imagerie HPTLC MALDI TOF MS complétée par 
l’analyse des acides gras lors de ses séjours en Allemagne auprès du Dr H HEIPIEPER (Helmoltz 
Institute, Leipzig, Allemagne), le Dr T KONDAKOVA a caractérisé les lipidomes de la souche P. 
fluorescens aéroportée MFAF76a et de son témoin clinique MFN1032 suite à leur exposition à trois 
concentrations : 0,1 ; 5 et 45 ppm en NO2. La Figure 20 met en évidence que seul le lipidome résultant 
de l’exposition à 45 ppm est significativement altéré par rapport à celui du témoin (exposition à l’air 
synthétique).  
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Figure 20 : Lipidome des souches P. fluorescens MFAF76a et MFN1032 suite à leur 
exposition à 0 ; 0,1 ; 5 et 45ppm de NO2. Synthèse de l’analyse lipidomique : profils 
HPTLC-MSI et analyse des acide gras. 
La disparition de l’UGP est constatée pour les deux souches étudiées à 45 ppm de NO2. Quant aux 
autres familles de phospholides, PE, PC et PG restent présentes, mais leur profil en acides gras se 
trouve modifié selon la concentration en NO2. La souche aéroportée laisserait entrevoir que les 
longeurs de chaînes seraient moindres aux fortes teneurs en NO2 pour PC et PG au contraire de PE, 
la réponse de la souche clinique n’est pas aussi tranchée. Tout en étant le produit de nombreuses 
biomolécules essentielles (acides gras, acide phosphatidyl, diacylglycérol), PE est connu pour être le 
phospolipide prépondérant chez les Pseudomonas, structurant leur membrane bactérienne et 
principalement cytoplasmique (Grimard et al., 2014). Aussi pour assurer sa survie en évitant la 
déstablilisation de sa propre paroi, la bactérie peut être amenée à privilégier la variété de ce PL 
(longueur de chaînes, insaturation) par rapport à d’autres PLs minoritaires. L’existence de chaînes 
d’acide gras en C18 est uniquement observée pour PE lors du stress drastique qu’est l’exposition à 45 
ppm de NO2. Ceci pourrait s’expliquer par le coût énergétique non négligeable que représente 
l’allongement des chaînes d’acide gras de 2 C (C16->C18) (Marella et al., 2018). Cet allongement n’est 
qu’uniquement observé pour le PE, PL primordial du point de vue prépondérance et structuration au 
niveau membranaire (Grimard et al., 2014; Kondakova et al., 2015a). Cependant l’altération des 
chaînes grasses reste modérée, aucune modification drastique des spectres de MS n’a démontré la 
réaction du NO2 avec les lipides conduisant à l’apparition d’adduits hydroperoxydes, alcools ou 
aldéhydes (Möller et al., 2008). Ceci est largement décrit chez les eucaryotes, connus pour leurs 
teneurs membranaires importantes en acides gras polyinsaturés (Augusto et al., 2002), ce qui n’est 
pas la caractéristique des deux bactéries étudiées, qui ne possèdent que des monoinsaturations (Figure 
20). 
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Figure 21 : Degré de saturation en acides gras des souches P. fluorescens 
MFAF76a et MFN1032 suite à leur exposition à 0 ; 0,1 ; 5 et 45 ppm de NO2. NS : non 
signicatif (P>0,05) 
Le degré de saturation des acides gras, selon la souche et la concentration en NO2, présenté en Figure 
21, n’évolue pas, par conséquent la libre diffusion du NO2 est confirméee au travers de la membrane 
bactérienne, confortant la simulation de Signorelli démontrant que les lipides membranaires ne font 
pas obstacle au transport du NO2 (Signorelli et al., 2011).  
Au vu de son caractère lipophile, le NO2 pourrait s’accumuler dans la membrane (Fukuto et al., 2000). 
Bien que ne réagissant pas avec les lipides, il pourrait réagir avec d’autres constituants (protéines, 
liposaccharides) (Cheng et al., 2013). Aussi nous avons envisagé d’évaluer les propriétés de surface 
à l’aide du test Microbial Adhesion To Solvents (MATS) suite aux expositions uniquement pour la 
souche aéroportée MFAF76a, incapable de produire des BSs qui pourraient modifier par leur 
ad(/b)sorption les propriétés pariétales bactériennes.  
 
Figure 22 : Affinité relative aux solvants de la souche P. fluorescens MFAF76a 
exposée, respectivement à l’air synthétique et à 45 ppm de NO2. 
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Par souci de clarté, seules les affinités aux solvants sont présentées Figure 22 lors d’exposition en 
absence de NO2 et à 45ppm. La surface de la souche MFAF76a reste hydrophile quelle que soit la 
concentration d’exposition au NO2, confortant l’absence de changement drastique des charges 
présentes sur la paroi membranaire externe. Cette réponse au NO2 est différente de celle provoquée à 
la membrane bactérienne par les solvants organiques (octanol, par exemple) qui impactent les 
lipopolysaccharides (LPS) et modifient la charge globale de la surface bactérienne (Baumgarten et 
al., 2012a). Cependant la diminution du caractère basique de Lewis (couple décane/acétate d’éthyle) 
indique que des accepteurs de doublets non liants sont moins nombreux en surface suite à l’exposition 
à 45 ppm en NO2. Cela pourrait s’expliquer par des modifications impactant aussi bien les protéines 
membranaires que les lipides, d’autant que l’adaptation bactérienne en réponse aux oxydes d’azote 
peut s’exprimer par une surproduction de protéines membranaires telles que les pompes à efflux 
(Fetar et al., 2011), mais aussi par le glissement/ translocation des PLs entre cytosol et membrane 
externe (Sanyal and Menon, 2009). Ainsi cette diminution pourrait être en partie imputable à la 
substitution entre des PLs zwiterrioniques (pas de changement global de charge), mais avec des 
caractéristiques acido-basiques différentes. PE et PC sont des PLs zwitterioniques présents chez la 
souche aéroportée MFAF76a, mais PC est moins électroaccepteur que PE (Romantsov and Wood, 
2017), par conséquent sa présence pourrait être favorisée dans la membrane externe après exposition 
à 45 ppm de NO2, sans oublier la prépondérance du PE et la diminution drastique , voire disparition 
de l’UGP.  
Dans tous les cas, l’exposition au NO2 chez les P. fluorescens étudiées provoque une réponse 
impactant visiblement leur homéostasie membranaire via, entre autres, leurs PLs. 
 
(b) Réponse des 2 souches via leur comportement social et leur résistance aux 
antibiotiques aux 3 concentrations de NO2  
Pour poursuivre notre évaluation de l’impact du polluant automobile NO2 sur la virulence 
bactérienne, notre attention s’est portée sur une analyse fine des phénotypes de comportement social 
(motilité, biofilm) et de résistance aux antibiotiques sur les deux souches de Pseudomonas 
fluorescens : l’environnementale MFAF76a et la témoin MFN1032, souche clinique. Les trois 
concentrations : 0,1 ; 5 et 45 ppm en NO2 ont été étudiées pour évaluer des situations, respectivement, 
« environnementale », critique et toxique (cf choix et concentration en polluant). Seule la 
concentration dite « toxique » (45 ppm) a conduit à des variations phénotypiques significatives, aussi 
elles seront les seules présentées par la suite. 
(i) Impact	du	NO2	sur	le	comportement	social	bactérien	
La première étape de formation des biofilms correspond à l’adhésion et nécessite des appendices 
tels que flagelles et pili de type IV (Caiazza et al., 2007), caractérisables via la motilité bactérienne 
de type swimming et swarming. Le NO2 gazeux réduit significativement la motilité des deux souches 
(swim et swarm si existant), Figure 23 (Kondakova et al., 2016). 
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Figure 23 :  Motilité swim et swarm des souches P. fluorescens MFAF76a et 
MFN1032 exposées, respectivement à l’air synthétique et à 45ppm de NO2. 
 (* : P=0,05 ;** : P=0,01 ; *** : P=0,001). 
Cette sédentarisation accrue des deux souches devrait faciliter leur capacité à former des biofilms. 
Suite à l’exposition à 45ppm de NO2, les deux souches forment des biofilms, mais une densification 
du biofilm est observée Figure 24 : augmentatio du biovolume pour les deux souches, alors que la 
souche MFAF76a triple l’épaisseur de son biofilm. Aucune modification patente de celui de 
MFN1032 n’est observée (Kondakova et al., 2016). Même si la réponse diffère, le NO2 impacte le 
biofilm des deux souches, à l’instar du NO chez P. aeruginosa (Barraud et al., 2015), suggérant une 
similitude des mécanismes d’action des NOx vis-vis des Pseudomonas. 
En présence de NO, la formation de biofilm est corrélée à une augmentation de la production de bis-
(3’, 5’)-cyclic dimeric guanosine monophosphate, c-di-GMP (Ha and O’Toole, 2015). Suite à 
l’exposition au NO2, aucune variation de sa concentration intracellulaire n’est notée chez les deux 
souches. Par conséquent, le NO2 n’induit pas exactement la même réponse que le NO gazeux 
provoque chez P. aeruginosa (Cutruzzolà and Frankenberg-Dinkel, 2016; Li et al., 2013), via la 
production des enzymes DipA, MucR, NdbA and BdlA (Petrova and Sauer, 2016; Roy et al., 2012). 
L’analyse transcriptomique des gènes respectifs, suite à l’exposition des 2 souches d’intérêt à 45 ppm 
de NO2, n’a révélé aucune altération de leur expression (Kondakova et al., 2016).  
 
Figure 24 : Biofilm des deux souches P. fluorescens exposées, respectivement à l’air 
synthétique et à 45 ppm de NO2. A : souche MFAF76a. B : souche MFN1032. 
 C : Quantification du bis-(3’, 5’)-cyclic dimeric guanosine 
monophosphate (c-di-GMP). (NS : non significatif P>0,05). 
65 
D’autre part, cette exposition au NO2 engendre davantage d’agrégats bactériens, présentés Figure 25. 
Présent chez les 2 souches productrice ou non de biosurfactant, ce phénomène, en plus de densifier 
le biofilm, pourrait être relié au stress périétal. Effectivement l’augmentation d’agrégats a été 
observée lors de la délétion de la porine membranaire majoritaire OprF chez P. aeruginosa H103 
(Bouffartigues et al., 2015).  
 
Figure 25 : Exemple d’agrégats bactériens observés chez la souche MFAF76a après 
exposition à 45ppm de NO2. 
Par conséquent, le NO2 perturbe bien l’intégrité membranaire des souches étudiées en modifiant leur 
capacité à former des biolfims.  
 
(ii) Impact	du	NO2	 sur	 la	 résistance	des	 souches	environnementale	et	
clinique	aux	antibiotiques		
Si son intégrité membranaire est modifiée, le microorganisme peut voir sa résistance aux 
antibiotiques modulée. Or le NO induit l’expression des gènes mexEF-oprN (Fetar et al., 2011) et 
module ainsi la résistance aux antibiotiques fluoroquinolones, chloramphenicol and aminoglycosides 
(Gusarov et al., 2009; McCollister et al., 2011; van Sorge et al., 2013), que nous avons, par 
conséquent, étudiée. 
Le NO2 favorise l’expression de la pompe à efflux MexEF-OprN, de type RND - Resistance-
Nodulation-Division- transporteurs intramembranaires, impliquée dans l’antibiorésistance aux 
fluoroquinolones (e.g. ciprofloxacine) (Köhler et al., 1997). Ainsi, suite à l’exposition à 45 ppm de 
NO2, l’expression des différents gènes est accrue entre 3,5 et plus de 100 fois pour certains d’entre 
eux et, de plus, la pompe est fonctionnelle comme le démontre la résistance plus importante à la 
ciprofloxacine, Figure 26 (Kondakova et al., 2016). 
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Figure 26 : Virulence des deux souches P. fluorescens MFAF76a et MFN1032 
exposées. A : Résistance à 2 antibiotiques suite à l’exposition à l’air synthétique et à 
45ppm de NO2. B : Quantification de leur expression génomique de mexE, mexF et 
oprN suite à l’exposition au NO2. (* : P=0,05 ;** : P=0,01 ; *** : P=0,001). 
Un second antibiotique a été étudié le chloramphénicol antimicrobien nitroaromatique, substrat de la 
pompe MexEF-OprN (Köhler et al., 1997; Sobel et al., 2005). La résistance à cet antibiotique, 
présentée Figure 26, est doublée suite à l’exposition (Kondakova et al., 2016). 
Aussi, même si le NO2 diffuse librement au travers de la membrane bactérienne, celle-ci possède un 
ou plusieurs mécanismes de résistance, voire de détoxification. 
Une des voies de dénitrification du NO2 chez les Pseudomonas spp. implémente la réduction 
du NO2 via les enzymes nitrite réductases (NIR), impliquant le cytochrome respiratoire cd1 (Arai et 
al., 2005; Shiro, 2012). Il s’avère qu’in silico nos deux souches sont dénuées des gènes codant pour 
les enzymes NIR, mais, comme la majorité des P. fluorescens, présentent l’opéron nirBD codant des 
nitrites réductases assimilatrice (NAS) (Redondo-Nieto et al., 2013). Ainsi les souches MFAF76a et 
MFN1032 possèdent la machinerie pouvant réduire les nitrates en nitrites, puis en ammonium (Jeter, 
1984; Moreno-Vivián et al., 1999). Cependant, la production de l’ARN messager NirBD n’est pas 
modifiée par la présence du polluant (Kondakova et al., 2016). Par conséquent les deux souches 
n’utilisent pas cette voie d’assimilation des oxydes azotés lors de ces expositions.  
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Comme le NO2 reste chimiquement proche de NO, dont les voies de détoxication ont largement été 
explorées, notre intérêt s’est porté sur la voie la plus connue de détoxification du NO, transformé en 
nitrates via l’action de la flavohémoglobine (FlavoHb) (Hmp chez Escherichia coli et Fhp chez P. 
aeruginosa) (Arai et al., 2005; Corker and Poole, n.d.). Testée chez les deux souches suite à 
l’exposition au NO2, l’expression du gène homologue à hmp a été observée et est multipliée par 25 
pour MFAF76a et 23 pour MFN1032, Figure 27 (Kondakova et al., 2016).  
  
Figure 27 : Quantification de l’expression du gène hmp, codant pour la 
flavohémoglobine, par les souches P. fluorescens MFAF76a et MFN1032 exposées 
 à 45ppm de NO2. (**: P=0,01). 
La flavohémoglobine est donc activée suite à une exposition à 45ppm en NO2 de ces P. fluorescens. 
Ainsi le NO2 pourrait activer un mécanisme mis habituellement en œuvre par le NO. Une 
détoxification par le NO2 activant Hmp a déjà été reportée, aussi le NO2 a été tenu pour être réduit en 
NO (Poole et al., 1996).  
A l’issue de travaux de thèse du Dr T KONDAKOVA en novembre 2015, l’hypothèse a été émise 
qu’après exposition à 45ppm de NO2, le polluant, ayant diffusé dans le cytosol, pourrait être 
transformé en partie par Hmp en nitrates. Ces derniers, avec les autres produits de dégradation, 
pourraient être expulsés à l’extérieur des P. fluorescens à l’aide de la pompe RND MexEF-oprN (cf 
la surexpression de mexE, mexF et oprN). 
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Figure 28 : Stratégie hypothétique mise en œuvre par les souches P. fluorescens 
étudiées suite à leur exposition à 45ppm de NO2 gazeux, proposée par T Kondakova 
lors de sa soutenance de thèse le 20 novembre 2015. 
Dans tous les cas, l’exposition à 45ppm en NO2 provoque une réponse complexe des P. fluorescens 
MFAF76a et MFN1032 impactant sans conteste leur intégrité membranaire de diverses manières 
(variabilité des phospholipides, altération de la motilité bactérienne et surproduction de la pompe 
MexEF-OprN), complétée par un des mécanismes de détoxification. Cette réponse nécessite un coût 
énergétique fort important, voire fatal. Les travaux de S DEPAYRAS (thèse débutée en 2015) ont 
débuté par l’étude de la viabilité bactérienne suite au stress NO2. Ses travaux se sont principalement 
focalisés sur la souche aéroportée et non productrice de biosurfactant MFAF76a. 
(iii) Impact	du	NO2	sur	la	viabilité	de	P. fluorescens	aéroportée	MFAF76a		
La densité bactérienne est traditionnellement quantifiée à l’aide de la densité optique (DO) de la 
suspension à 580 nm suite à l’établissement de la correspondance DO et dénombrement cultural 
bactérien (Unité formant colonies-UFC), directement proportionnels via la loi de Beer-Lambert. La 
quantification de la population bactérienne grâce à la DO, réalisée en quelques minutes, est rapide et 
économique par rapport au dénombrement cultural bactérien nécessitant plus d’une journée. La 
viabilité bactérienne correspond, ici, à quantifier le nombre de bactéries ayant été exposées au NO2 
et encore vivantes. Une pigmentation jaune de la biocharge apparait plus ou moins intense selon les 
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souches lors de leur exposition au NO2 et biaise la lecture de la DO. D’autre part, selon nos études, 
le NO2 entraîne des modifications au niveau de la membrane bactérienne, dont l’incurvation et la 
composition peuvent mener à la déformation de la cellule, rendant caduque l’application de la loi de 
Beer-Lambert. Aussi la viabilité a été établie par dénombrement cultural. Suite à leur exposition à 45 
ppm, la souche MFAF76a a sa viabilité diminuée (perte d’un log), Figure 29A (Depayras et al., 
2018b). 
 
Figure 29 : Impacts physiologiques suite à l’exposition à 45ppm NO2 de P. 
fluorescens MFAF76a. A : viabilité. B : suivi de croissance en DMB à 28°C.  
 (**: P=0,01 ). 
Quelque soient les biais expérimentaux évoqués, cette perte de viabilité signifie soit la présence de 
bactéries viables, mais non cultivables, soit la mort cellulaire. Quant à la croissance de MFAF76a, le 
temps de latence est augmenté d’une demi-heure suite à l’exposition, mais sans impact sur le temps 
de génération (Figure 29B). Le NO2 ne semble pas impacter significativement le métabolisme 
bactérien relatif à la division cellulaire, mais d’autres voies métaboliques le sont, corroborant les 
diverses altérations phénotypiques que nous avons déjà établies. 
Pour approfondir cette approche viabilité après exposition au NO2, la permabilisation membranaire a 
été évaluée grâce au test Live Dead (Depayras et al., 2018b). Il permet de discriminer les membranes 
cellulaires intactes (correspondant aux bactéries vivantes, colorées en vert) de celles endommagées 
(i.e. bactéries incultivables, voire mortes, colorées en rouge), Figure 30. 
Suite à l’analyse d’image des champs d’observation par microscopie confocale des bactéries  colorées 
par le kit Live Dead, la perméabilisation membranaire de MFAF76a est augmentée d’environ 50% 
par la présence du polluant, diminuant par conséquent de moitié la population viable bactérienne. 
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Figure 30 : Impact de 45 ppm de NO2 sur la perméabilisation membranaire de P. 
fluorescens MFAF76a. Quantification par analyse d’image de clichés de microscopie 
confocale. (**: P=0,01 ).  
Nos travaux démontrent, chez les souches P. fluorescens étudiées, 
• que NO2 impacte fortement la viabilité bactérienne  
• que, chez les bactéries viables, même s’il diffuse librement au travers de la membrane 
bactérienne, le métabolisme se trouve modifié par la présence du NO2  
 au niveau lipidique, dont les phospholipides membranaires 
 de son comportement social (appendices membranaires, protéine 
membranaire OprN) 
 de sa résistance aux antibiotiques (pompe membranaire MexEF-OprN) 
 et de détoxification originale par activation de la flavohémoglobine, 
inhabituelle chez les P. fluorescens. 
Le plus souvent, la réponse bactérienne au NO2 passe par l’intervention de la membrane bactérienne, 
voire plus précisément son homéostasie.  
En parallèle des expositions à faible concentration en NO2  (0,2 ppm) ont été effectuées sur la souche 
aéroportée et son témoin clinique en phase exponentielle et stationnaire de croissance. Les tests 
physiologiques post-exposition ont permis d’observer peu, voire pas, de toxicité du NO2 dans de telles 
conditions de concentration, mais aussi peu de perméabilisation membranaire. Aussi, pour l’instant, 
l’exclusivité de nos efforts se maintient sur l’exposition de la souche aéroportée à 45ppm de NO2. 
Production scientifique correspondante : P26 ; P30; Ch4 ; C12-C13 ; C21 ; C24 ; C27 ; C29 ; A36 ; 
A39 ; A43. 
Encadrements : L8-L9 ; M1_5 ; M1 Imm_1->M1 Imm_12 ; M1_6 ; M2_4->M2_5 ; D2-D3 ; PD3. 
(4) Impact du NO2 sur l’homéostasie membranaire de la souche P. fluorescens aéroportée 
MFAF76a  
Afin de mieux cerner l’ampleur de cette réponse, S DEPAYRAS a systématisé les approches 
« omics » : génomique, transcriptomique pour expliciter les phénotypes observés précédemment.  
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(a) Impact du NO2 sur la réponse de P. fluorescens aéroportée MFAF76a à l’aide 
d’analyses « omics »  
L’analyse in silico du génome de P. fluorescens MFAF76a réalisée dernièrement par S 
DEPAYRAS, a permis d’identifier certains gènes par homologie à des souches Pseudomonas déjà 
séquencées et annotées, principalement P. fluorescens A506 et F113. Les gènes ciblés ont leur 
expression impliquée dans les mécanismes de détoxification des NOx, du stress pariétal, d’antibio-
résistance, mais aussi dans la formation des appendices membranaires (flagelle, pili), de la matrice 
extracellulaire, sans oublier des systèmes de sécrétion. 
Ensuite l’expression d’une trentaine de gènes chez P. fluorescens MFAF76 a été quantifiée 
en phases exponentielle et stationnaire de croissance en absence et en présence de 45ppm et de 0,2 
ppm de NO2, Tableau 2.  
 
Catégorie Sous-catégorie 
Souche P. fluorescens 
MFAF76a 
Motilité 
Flagelle 5 
Pili type IV 4 
Biosurfactant Massetolides 1 
Antibiorésistance β-lactame 10 
Dénitrification  4 
Biofilm 
Alginate 3 
Adhésine 1 
Système de sécrétion 
SST3 0 
SST6 1 
QS phénazine 0 
Stress pariétal  3 
Total 32 
Tableau 2 :  Nombre de gènes dont l’expression a été ciblée lors des expositions en absence 
et en présence de 45 ppm et de 0,2 ppm de NO2 en phase exponentielle et stationnaire 
de croissance. 
Seuls les échantillons obtenus après exposition à 45 ppm de NO2 ont permis de montrer des 
modifications significatives dans l’expression de gènes. Les gènes surexprimés significativement, 
Figure 31, sont
 
notamment impliqués dans la formation et le fonctionnement du flagelle (flaA, flgE, 
fliA, fliF), la production d’alginate (algD, oprF), la réponse au stress pariétal (oprF, oprN), l’antibio-
résistance (pompe à efflux : mexE, mexF, oprN) et la détoxification (hmp).  
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Figure 31 : Gènes de P. fluorescens MFAF76a dont l’expression est 
significativement surexprimée suite à une exposition à 45 ppm de NO2. A : Phase 
exponentielle de croissance. B : Phase stationnaire de croissance. (NS : P> 0,005 ; * : 
P=0,05 ;** : P=0,01 ; *** : P=0,001 ; **** : P=0,0001 ). 
Une analyse en protéomique, i.e. la concétisation de l’expression génomique sous la forme 
de la production des protéines correspondantes, a été menée en parallèle en collaboration avec le Dr 
J HARDOUIN, PBS UMR 6270, Université de Rouen Normandie. Elle a confirmé en partie ces 
données, Figure 32.  
 
Figure 32 :  Comparaison de l’expression protéique, décrite par grandes familles 
fonctionnelles, de P. fluorescens MFAF76a lors d’une exposition à 45ppm de NO2 
versus air synthétique selon la phase de croissance.     
 A : Phase exponentielle. B : Phase stationnaire. 
Pour les deux phases de croissance, le profil protéique se voit modifié suite à l’exposition à 45 ppm 
de NO2. Ces résultats très préliminaires, Figure 32, indiquent des modulations et pas uniquement des 
surproductions protéiques. Aussi les surexpressions génétiques ne se concrétisent pas uniquement en 
une production augmentée des protéines correspondantes, mais peuvent conduire aussi à des 
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répressions de certaines, voire des interconnexions plus complexes. Une analyse plus fouillée des 
résultats de protéomique est en cours, cependant, nous pouvons déjà explorer les pistes présentes dans 
la littérature et cohérentes avec les résultats déjà compilés. 
 
(b) Eléments de réponse à propos de l’impact du NO2, polluant automobile sur la 
réponse adaptative de P. fluorescens 
La compilation de l’ensemble de ces données nous mène actuellement au schéma synthétique 
Figure 33. 
 
Figure 33 : Récapitulatif des données acquises et réponse bactérienne supposée 
suite à l’exposition à 45ppm de NO2 d’après notre avancée actuelle. 
Le degré de saturation des acides gras indique que le NO2 diffuse librement au travers de la 
membrane. Une partie ou la totalité du NO2 entré dans le cytosol pourrait être pris en charge par 
l’enzyme de détoxification flavohémoglobine qui le convertit en produits de dégradation azotés (NX) 
moins toxiques pour la bactérie. Comme pour NO, les nitrates (NO3-) pourraient comptés parmi ces 
NX qui seront sûrement métabolisés en d’autres composés plus élémentaires. Ce mécanisme de 
détoxification par la flavohémoglobine est connu pour permettre la réparation chez E. coli des 
dommages du stress nitrosant au niveau des lipides membranaires (Bonamore et al., 2003). Si ce 
même mécanisme est présent chez P. fluorescens, il pourrait masquer l’apparition d’adduits 
hydroperoxydes, alcools ou aldéhydes (Möller et al., 2008) qui seraient « corrigés » en se concrétisant 
par les modifications lipidiques que nous avons constatées et confirmées par l’altération du caractère 
de base de Lewis. La membrane voit aussi son homéostasie modifiée par la surexpression d’un certain 
nombre de porines (OprF et OprN) qui sont des protéines de la membrane externe contribuant à la 
stabilisation membranaire et permettant le passage de solutés (Henderson et al., 2016). Chez P. 
aeruginosa, OprF est un canal aqueux non spécifique pour les ions (Bellido et al., 1992). En condition 
anaérobie, elle pourrait potentiellement assurer le transport de nitrates et nitrites (Hassett et al., 2002). 
Dans ces mêmes conditions, la formation de biofilm est accentuée et s’effectue dans une matrice 
d’exoproduits polymériques, principalement des exopolysaccharides (Yoon et al., 2002). Suite à 
l’exposition au NO2, les P. fluorescens étudiées pourraient éliminer les nitrates et d’autres produits 
de dégradation via la porine OprF tout en favorisant la formation de biofilms et d’agrégats que nous 
avons observée. De plus, OprF assure l’intégrité de la membrane bactérienne via ses interconnexions 
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de régulation d’expression avec d’autres porines et le peptidoglycane (Chevalier et al., 2017). La 
synthèse des alginates, impliqués dans le peptidoglycane et exopolysaccharides, est sous le contrôle 
du promoteur algD (Hay et al., 2014) qui se trouve être surexprimé par l’exposition au NO2. AlgD 
impacte aussi indirectement la production des flagelles en la réprimant (Hay et al., 2014), confortant 
la réduction de la motilité observée. Ceci est en contradiction avec la surexpression des gènes flgA, 
flgE. Flag et FlgE contribuent à la présence de flagelles. Cette surexpression n’implique pas la 
fonctionnalité des flagelles. La transcription de flgA et flgE sont sous le contrôle de FliA, de même 
que la transcription d’OprD. Or il s’avère que cette même porine a son production réprimée lors d’une 
surproduction de la pompe à efflux MexEF-OprN (Köhler et al., 1999). Cette surproduction de ce 
complexe macromoléculaire enchâssé dans la membrane externe est un élément supplémentaire de 
perturbation de l’homéostasie membranaire et contrebalancerait la perte de l’UGP. Elle pourrait être 
à l’origine de l’efflux des NX, voire de leurs produits de dégradation plus complète dans le 
microenvironnement de la bactérie. De plus, ces efflux entraineraient l’entrée de proton (H+) dans le 
cytosol, qui pourrait modifier le potentiel de membrane, entrainant des dysfonctionnements des 
protéines membranaires le régulant. De telles modifications ont concouru chez P. aeruginosa une 
susceptibilité accrue à des antibiotiques (Pan et al., 2017), comme nous l’avons aussi constatée. 
En résumé, le marqueur de pollution automobile NO2 catalyse une augmentation de la virulence 
bactérienne avec un stress pariétal notable. Cependant beaucoup de zones d’ombres persistent. 
Production scientifique correspondante : C 28 ; C30. 
Encadrements : Ing1_1 ; D3. 
 
C) Stress physique : impact d’une matrice cosmétique complexe 
Profitant du développement d’un autre axe de sécurité sanitaire au LMSM concernant les 
produits cosmétiques, j’ai eu l’opportunité d’étudier les interactions des bactéries avec la matrice 
complexe qu’est un produit cosmétique. Tout laboratoire cosmétique se doit d’étudier et de 
communiquer sur l’innocuité de son produit commercialisé en Europe. Le règlement cosmétique 
européen 1223/2009 (Règlement (CE) no 1223/2009 du Parlement européen et du Conseil du 30 
novembre 2009 relatif aux produits cosmétiques, 2009), appliqué depuis juillet 2013, impose aux 
producteurs la transparence, mais aussi un effort de recherche pour enrichir le dossier d’information 
produit de toute étude illustrant l’innocuité (chimique, physique, microbiologique) de leurs produits. 
La majorité des matrices cosmétiques peuvent être définies comme une dispersion d’un liquide en 
fines gouttelettes dans un milieu continu liquide (Doumeix, 2011). Deux grandes familles coexistent 
les émulsions dites Huile-dans-Eau (H/E) et celles Eau-dans-Huile (E/H). Ces dernières E/H sont 
connues pour limiter la prolifération de microorganismes (Schubert and Engel, 2004), car l’huile, 
phase dispersante, crée un milieu anaérobie et rend l’eau indisponible pour les germes. Mais ces 
formes laissent un résidu « huileux, gras » sur la peau, peu vendeur auprès du consommateur. Aussi 
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les émulsions cosmétiques H/E sont les plus retrouvées sur le marché, mais présentent une stabilité 
microbiologique plus fragile.  
Ce monde des émulsions pourrait paraître fort éloigné, voire incohérent avec mes préoccupations 
précédentes sur l’homéostasie membranaire. Revenons à la définition d’interface. Elle correspond à 
la séparation entre deux milieux non miscibles et différant en composition et/ou structure chimique. 
Ainsi les microorganismes en suspension dans une des phases de l’émulsion perçoivent l’interface 
formée par le milieu non miscible comme un stress physique. Le contact avec les gouttelettes peut 
entrainer la déstabilisation membranaire et la lyse rapide des cellules (Hamouda and Baker, 2000). 
De même l’interface créée par un milieu plus dense comme la surface solide de nanoparticules peut 
induire une réponse adaptative des bactéries et plus spécifiquement au niveau de leur paroi (Persat, 
2017). D’où mon intérêt pour ces sujets en cours de développement et encore peu documentés in situ, 
i.e. en produit cosmétique. 
 
(1) Impact du microenvironnement sur Cutibacterium acnes  
L’Acne vulgaris (i.e. acné) est l’une des maladies cutanées les plus répandues (White, 1998). 
Le Gram positif Propionibacterium acnes, dénommé dorénavant Cutibacterium acnes - C. acnes, est 
considéré comme un des fréquents promoteurs de l’acné (Scholz and Kilian, 2016). Récemment, V 
BORREL, co-encadrée par le Pr FEUILLOLEY et le Dr KONTO-GHIORGHI, a développé un milieu 
mimant le sébum qui, lors de l’acné, est hypersécrété et s’accumule au niveau du follicule pilo-sébacé. 
Ce milieu, appelé SLM pour Sebum Like Medium, est à base du milieu classique Brain Heart Infusion 
medium (BHI) complété par du squalène, de la trioléine et de l’acide oléique. Il constitue une 
émulsion. 
La croissance de deux souches de C. acnes RT4 (acnéique) et RT6 (non-acnéique) a été réalisée en 
SLM, BHI et RCM (Reinforced Clostridial Medium), milieu traditionnel de ces bactéries. Leur 
croissance diverge selon les milieux, Figure 34A. La souche acnéique RT4 se développe plus 
facilement en SLM et plus rapidement en SLM et RCM qu’en BHI. Au contraire la non-acnéique, 
RT6 croit davantage et plus rapidement en RCM qu’en BHI et ne fait que se « maintenir » en SLM. 
Ces résultats conformes au profil virulent (acné) des souches pourraient être liés à une hydrophilie 
bactérienne plus ou moins importante. Suite aux tests MATS en BHI et RCM, milieux homogènes, 
Figure 34B, RT4, l’acnéique est plus hydrophobe que la non acnéique RT6. Aussi sa croissance au 
sein d’une émulsion, comme SLM, est favorisée. La stabilité du profil d’acido-basicité de Lewis de 
RT6 dans les deux milieux conforte sa faible affinité pour la phase lipophile donc SLM, surtout la 
forme émulsion (Hamouda et al., 2001), et sa préférence pour le RCM.  
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Figure 34 : Caractérisations physiologiques des souches C. acnes RT4 (acnéique) et 
RT6 (non acnéique). A : Cinétiques de croissance à 37°C selon les milieux.  
 B : Affinités aux solvants selon le milieu.  
Production scientifique correspondante : C28. 
 
(2) Impact d’une matrice cosmétique complexe de type lotion solaire sur la croissance de 
deux souches modèles cutanées : Staphyloccocus aureus MFP 05 et Pseudomonas fluorescens 
MFP04 
Les cosmétiques peuvent modifier de façon radicale, voire irréversible la composition et la 
diversité du microbiote cutané, d’autant plus s’ils sont utilisés régulièrement. Ainsi quelques études 
ont été menées sur l’impact à long terme de l’utilisation quotidienne de cosmétiques sur la peau 
(Urban et al., 2016). Les lotions solaires ont la caractéristique de protéger la peau contre les effets 
néfastes d’une exposition solaire due aux rayonnements UVB (les coups de soleil), mais aussi une 
protection contre le vieillissement cellulaire relatif aux UVA, voire aux UV artificiels (Debacq-
Chainiaux et al., 2012). Parmi les alternatives offertes aux formulateurs de l’industrie cosmétique, le 
seul filtre UV inorganique que l’Europe autorise sont les nanoparticules (NPs) de l’oxyde de titane 
(TiO2) à condition de mentionner [nano] sur l’étiquette produit (Règlement (CE) no 1223/2009 du 
Parlement européen et du Conseil du 30 novembre 2009 relatif aux produits cosmétiques, 2009). Plus 
récemment, les NPs de ZnO , moins utilisées, ont été permises (Journal officiel de l’Union 
européenne, 2017). Leur pouvoir anti-rayonnement provient de leurs propriétés optiques, mais 
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demeurent aussi transparentes après application cutanée (Stark et al., 2015; Wawrzynczak et al., 
2016). 
La thèse régionale NanoBact du Dr L ROWENCZYK s’est déroulée de 2014 à 2017 en co-
direction entre l’URCOM, de l’Université du Havre (Pr M GRISEL, Dr C PICARD et Dr N 
HUCHET) et le LMSM (Pr M FEUILLOLEY et moi-même). Suite à la formulation de deux lotions 
solaires modèles contenant des NPs hydrophiles ou hydrophobes (Rowenczyk et al., 2016), la 
croissance de deux bactéries représentatives de la peau humaine Staphyloccocus aureus MFP 05 et 
Pseudomonas fluorescens MFP04 (Hillion et al., 2013) a été étudiée lors de deux scenarii mimant 
soit le stockage du produit (formule fraîche), soit lors de l’application de la formule solaire sur la 
peau (formule vieillie), Figure 35A (Rowenczyk et al., 2017). 
 
Figure 35 : Impact de la formulation cosmétique sur la croissance de bactéries 
cutanées. A : Protocole synthétique. B et C : Croissance de la souche Staphyloccocus 
aureus MFP05 en formule fraîche et vieillie respectivement. 
Pour les deux souches cutanées, la population diminue progressivement suite à leur 
inoculation en formule fraîche. La Figure 35B présente la croissance de Staphyloccocus aureus 
MFP05. Cette diminution ne semble pas imputable à la présence des NPs, ni de leur hydrophilie, mais 
peut être reliée à l’effet bactéricide de l’émulsion galénique quelle que soit son type (Teixeira et al., 
2007). Quant à la croissance en formule vieillie, les deux souches survivent, à l’exception de S. aureus 
MFP05 en présence des NPs hydrophobes favorisant leur développement (Rowenczyk et al., 2017).  
Production scientifique correspondante : P27 ; C22 ; C25 ; 
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Encadrements : Contribution aux travaux de thèse de Laura ROWENCZYK, soutenue le 7 décembre 
2016 au Havre. 
Ma curiosité a été piquée par ce résultat et je m’interrogeais sur l’impact réel des NPs sur 
physiologie, voire sur l’homéostasie membranaire bactérienne. 
(3) Etude préliminaire de la réponse adaptative bactérienne interagissant avec des NPs 
(a)  Impact du stress de NPs hydrophiles sur la croissance les bactéries cutanées 
Staphyloccocus aureus MFP05 et Pseudomonas fluorescens MFP04 
Le Dr L ROWENCZYK a poursuivi ses travaux doctoraux en démontrant que la surface des NPs 
se modifiait au cours du vieillissement du cosmétique en absorbant divers constituants de l’émulsion 
(Rowenczyk et al., 2016). Aussi il nous est apparu intéressant d’étudier l’impact des particules 
hydrophiles brutes et extraites de formules fraîche et vieillie sur la croissance des deux souches S. 
aureus MFP05 et P. fluorescens MFP04. Les NPs hydrophobes ont été écartées au vu du biais que 
représente l’ajout d’un tensio-actif nécessaire à la dispersion de ces NPs, mais que les bactéries 
pourraient métaboliser et surtout qui biaiserait les propriétés de surface des NPs et des bactéries ! 
Le mode opératoire, présenté en Figure 36A, mime le devenir après bains de mer et de soleil : les NPs 
en contact avec les bactéries (Rowenczyk et al., 2017). 
 
Figure 36 : Impact de NPs hydrophiles sur la croissance de bactéries cutanées. A : 
Protocole synthétique. B et C : Croissance des souches Staphyloccocus aureus MFP05 
et P. fluorescens MFP04, respectivement, en présence de NPs brutes et extraites de 
formules fraîche et vieillie. D : Polarité des diverses NPs. 
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Le temps de génération augmente, Figure 36B et C, systématiquement en présence des NPs 
hydrophiles, par conséquent elles ont un effet inhibiteur sur les souches cutanées (Hamouda et al., 
2001; Teixeira et al., 2007). Cependant l’importance de l’inhibition de la croissance est fonction du 
vécu des NPs en émulsion. Les NPs issues de la formule fraîche inhibent moins la croissance 
bactérienne que les NPs brutes ou celles extraites de formulation vieillie. Figure 36D présente la 
polarité de surface des diverses NPs présentant une répartition similaire aux temps de croissance selon 
le type de NPs. Ainsi les nanoparticules hydrophiles de TiO2 étalées sur la peau n’ont pas le même 
impact sur les bactéries cutanées selon le degré de vieillissement d’une lotion solaire (Rowenczyk et 
al., 2017). 
La présentation de ces résultats a permis à L ROWENZYCK d’obtenir son doctorat le 7 décembre 
2016, mais aussi de gagner le prix du meilleur poster de la Société Française de Cosmétologie ; elle 
s’est vu décerner son inscription complète au congrès international IFSCC à Orlando à l’automne 
2016 (30 octobre-2 novembre 2016). D’autre part, ces travaux ont été communiqués lors des Journées 
du GDR Cosm’actifs 2017 (25-26 septembre 2017) lors de deux communications orales l’une réalisée 
par le Dr N HUCHET et l’autre par moi-même. Ils ont été aussi le support d’une conférence plénière 
que j’ai réalisée en tandem avec le Dr N HUCHET lors de l’inauguration de la plateforme 
d’innovation Cosmetomics@Evreux, le 3 octobre 2017.  
Production scientifique correspondante : P29 ; C18 ; C20 ;  C23 ; C25 ; A41 ; 
Encadrements : Contribution aux travaux de thèse de Laura ROWENCZYK, soutenue le 7 décembre 
2016 au Havre. 
 
(b) Impact du stress de NPs hydrophiles sur la physiologie de la Pseudomonas 
fluorescens aéroportée MFAF76a 
Désirant évaluer le cas d’une biocontamination ponctuelle d’un cosmétique lors de sa 
production ou lors du prélèvement consommateur avant application, la souche P. fluorescens 
aéroportée MFAF76a (Duclairoir Poc et al., 2014) a été mise en contact avec des formules modèles 
contenant ou pas de NPs de TiO2 hydrophiles (Rowenczyk et al., 2017, 2016), Figure 37A. Leurs 
propriétés optiques, leur conférant leur pouvoir anti-rayonnement UV, perturbent toute mesure 
spectrophotométrique, aussi seules les approches par dénombrement cultural sont envisageables 
(Planchon et al., 2013). Ma récente participation au travail doctoral de D DESPLAN co-dirigée par 
les Pr GRIESMAR (SATIE, Université de Cergy-Pontoise) et Pr ORANGE (LMSM, Université de 
Rouen) concourra au développement d’une nouvelle technique de caractérisation in situ de la 
croissance bactérienne par le suivi des propriétés mécaniques et électriques de la biomasse. Par 
ailleurs, nous sommes en cours de développement d’une méthodologie par cytométrie de flux, 
nécessitant d’utiliser, par conséquent des souches portant un chromophore, d’où l’utilisation de la 
souche MFAF76abpf, i.e. transformant de la souche aéroportée portant la protéine fluorescente bleue, 
pour cette étude.  
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Parallèlement, par dénombrement cultural, l’effet inhibiteur des NPs de TiO2 hydrophiles sur 
la croissance de la souche est constatée, Figure 37B, déjà observé pour E. coli (Foster et al., 2011; 
Planchon et al., 2013; Wang et al., 2017).    
 
Figure 37 : Caractérisation de la physiologie et des phénotypes de P. fluorescens 
aéroportée MFAF76a en absence et présence de NPs hydrophiles brutes. A : 
Protocole synthétique. B : Croissance bactérienne C : Résistance au chloramphénicol 
D : Affinités bactériennes aux divers solvants. 
D’autre part, la variation de virulence bactérienne a été évaluée en comparant l’antibiorésistance des 
bactéries inoculées dans des formulations avec ou sans NP vis-à-vis du chloramphénicol, qui est un 
antibiotique nitroaromatique et un surbstrat tranporté par la pompe MexEF-OprN (Köhler et al., 1997; 
Sobel et al., 2005). A la Figure 37C, la présence des NPs hydrophiles favorise la résistance de la 
bactérie au chloramphénicol et par conséquent laisse à penser à la suractivité des pompes MexEF-
OprN, c’est-à-dire une perméabilisation de l’enveloppe bactérienne, voire potentiellement une 
altération membranaire liée à la porine OprN. Les NPs impactent les propriétés surfaciques de la 
bactérie qui devient plus hydrophile et son acidité de Lewis se transforme en basicité, Figure 37D. 
De telles modifications ont déjà été rapportées et pouvent aboutir à la mort cellulaire (Foster et al., 
2011). L’homéostasie membranaire se trouve altérée par les NPs hydrophile de TiO2 étudiées et 
présentes dans cette matrice cosmétique complexe. 
Production scientifique correspondante : C23 ; C25. 
Encadrements : M2_6.  
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 Mes	perspectives	de	recherche	
 
La synthèse de mes travaux ayant été réalisée, maintenant quel regard puis-je porter vers 
l’avenir ? Des voies se dessinent. Il s’agit de l’aspect sécurité sanitaire déclinée au moins dans deux 
domaines : la niche air et le produit cosmétique dans son contexte cutané. L’autre angle d’approche, 
dans lequel je désire poursuivre, concerne la réponse bactérienne via les mécanismes mis en œuvre 
par sa paroi bactérienne, interface de la bactérie avec son microenvironnement. Dans les quelques 
pages qui vont suivre, je vais vous développer comment je pense pouvoir développer ces différents 
projets, synthétisés Figure 38. Leur nombre pourrait vous faire craindre que je me puisse m’égarer 
dans des chemins de traverse. Actuellement je pressens une similitude sur l’ensemble de ces thèmes 
et c’est cette ligne de force que j’aimerais confirmer, voire documenter par la suite de mes travaux. 
 
Figure 38 : Synthèses de mes perspectives de recherche à ce jour. 
 
I) Sécurité sanitaire de l’air : adaptation bactérienne aux NOx 
Comme déjà évoqué précédemment, la pollution est une préoccupation sanitaire de première 
importance. Le marqueur de pollution automobile NO2 restera au moins encore quelques décennies 
d’actualité, bien que des « résultats encourageants de diminution des niveaux des polluants de l’air 
ont été notés entre 2010 et 2015 (Air quality in Europe — 2017 report, 2017). Certains organismes 
gouvernementaux ou non (e.g. WHO, EEA, et INERIS) désirent réduire drastiquement le parc des 
véhicules diésel suite aux protocoles de Kyoto, Gothenburg et accord de Paris, signés respectivement 
en 1997, 1999 et 2015. Néanmoins perdureront les autres sources de pollutions en NO2 : production 
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et distribution d’énergie, industries, transport non routier, agriculture, et les secteurs du commerce, 
des institutions ou des ménages, ces sources représentent actuellement plus de 60% de cette pollution 
(Air quality in Europe — 2017 report, 2017; Depayras et al., 2018a). 
Traditionnellement les épidémiologistes expliquent l’augmentation de pneumopathies d’origine 
bactérienne par une immunodépression humaine consécutive au caractère irritant des polluants sur 
les tissus pulmonaires facilitant ainsi la colonisation bactérienne (Silveyra et al., 2017). Notre 
approche a été de documenter une argumentation alternative : la pollution pourrait augmenter 
(aggraver) la virulence bactérienne per se ce qui favoriserait l’infection plus aisée de l’hôte humain 
par les bactéries en contact avec la pollution. En amont d’une approche intégrative de l’exposition 
environnementale d’un humain tout au long de sa vie de type exposome (Wild et al., 2013), le modèle 
bactérien reste un outil unicellulaire beaucoup plus simple de mise en œuvre, par rapport à des 
organismes plus complexes. De plus sa réponse à un quelconque stress reste appréhendable 
relativement aisément dans sa globalité par des approches phénotypiques, macroscopiques ou ciblées, 
aussi bien physiologiques qu’«omics» (protéomique, lipidomique, transcriptomique, génomique, 
voire métabolomique). Ainsi l’identification de biomarqueurs bactériens suite à l’exposition aux NOx 
peut venir documenter la toxicité par inhalation du NO2, du NO et/ou leur synergie, en amont d’une 
évaluation du risque sanitaire aéroporté. Cette connaissance du stress nitrosant induit en phase gaz 
pourrait trouver un potentiel applicatif en médecine, en industrie automobile (habitacle). 
Suite à l’approche physiologique, transcriptomique, protéomique et lipidomique menée par S 
DEPAYRAS suite à l’exposition de la souche aéroportée MFAF76a à 45ppm de NO2, cette doctorante 
a désiré clôturer ses travaux (soutenance prévue d’ici fin 2018), avec l’aide d’une étudiante Ingénieur, 
par la réalisation de mutants de délétion, complémentation et surexpression concernant trois gènes. 
Actuellement seuls deux jeux ont été concrétisés, ceux d’oprN et de hmp. L’intérêt pour oprN est lié 
à son implication dans l’homéostasie de la membrane bactérienne. Quant à hmp, il est lui relié à la 
production de protéines impliquées dans l’adaptation du métabolisme respiratoire, voire à la 
détoxification. Ainsi les mutants de délétion, complémentation et surexpression ont été obtenus 
MFAF76a∆oprN, MFAF76a∆oprN+oprN et MFAF76a+oprN respectivement pour oprN et pour hmp 
MFAF76a∆hmp, MFAF76a∆hmp+hmp et MFAF76a+hmp, sans oublier les témoins avec le vecteur 
vide correspondant. D’ici la fin de ses travaux doctoraux, S DEPAYRAS devrait pouvoir caractériser 
la réponse physiologique de ces mutants à 45ppm de NO2 par l’évaluation de leur survie (cultivabilité, 
cinétique de croissance, test de perméabilité) et ainsi vérifier l’implication de ces gènes dans la 
réponse au stress nitrosant. 
A moyen terme, je vais poursuivre ces travaux, grâce à une allocation doctorale financée au travers 
du Réseau d’Intérêt Normand (RIN) Sécurité Sanitaire, bien-être et ALiments durables (SéSAL) par 
la région Normandie. Le doctorant, recruté début septembre 2018, s’attellera, entre septembre 2018 
et Août 2021, à déterminer des Biomarqueurs Bactériens d’Exposition Environnementale (BE2) par 
inhalation de NOx, polluants automobiles (NOxBBEE). Effectivement, au vu des résultats acquis, 
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des biomarqueurs bactériens tels que l’homéostasie membranaire, comportement social bactérien, 
voire les lipides sont clairement pertinents.  
Ainsi, en complément des mutants déjà élaborés par S DEPAYRAS, j’aimerais étoffer la 
banque de mutants en vue de choisir les BE2 au NO2 gazeux par inhalation. Deux voies métaboliques 
semblent très attrayantes suite à notre précédente étude protéomique : la synthèse de 
glycérophospholipides (GPs) et le chimiotactisme. D’autant plus que concernant les GPs, j’aimerais 
concrétiser l’identification (avec le Pr A CORCELLI de l’Università degli Studi di Bari, Italie), voire 
comprendre la biosynthèse de l’UGP. En d’autres termes, cela me permettrait de poursuivre mon 
approfondissement de l’adaptation de la membrane bactérienne à l’exposition au NO2. Quant au 
chimiotactisme, il est largement impliqué dans le comportement social bactérien. Son évaluation peut 
être obtenue, chez la souche aéroportée MFAF76a, par la caractérisation de phénotypes : biofilm, 
appendices cellulaires (pili, flagelles). 
Il faudra peut-être prévoir des mutants à mutation multiple. Effectivement l’absence de réponse 
physiologique discriminante aux concentrations inférieures ou de 5 ppm en NO2 laisse présager un 
mécanisme d’adaptation multi-échelle de la souche MFAF76a. Il pourrait être implémenté 
simultanément au niveau de plusieurs gènes. Cette mutation multiple pourra être encore plus 
complexe à mettre en œuvre qu’une « simple » mutation. 
 Dans un second temps, le doctorant sera amené à évaluer la réponse des divers mutants qu’il 
aura pu obtenir suite à leur exposition à 45 ppm de NO2. Une approche multi-échelle (physiologique, 
motilité, biofilm, antibiorésistance, protéomique, lipidomique, transcriptomique) sera adaptée selon 
le gène étudié. Ainsi nous poursuivrons nos collaborations : en région, avec la plateforme 
PRIMACEN pour la protéomique (Dr J HARDOUIN) et pour l’observation des appendices 
cellulaires (flagelles) via la microscopie électronique (Dr M-L GUEYE) et, à l’internationale avec le 
Pr H HEIPIEPER (Helmoltz Institute, Leipzig, Allemagne) pour l’approche lipodomique via les 
acides gras. Suite à la compilation des divers résultats, un faisceau de régulation devrait apparaître ; 
ainsi des voies métaboliques préférentiellement mises en œuvre devraient être mises en évidence. Au 
sein de ces voies activées, nous sélectionnerons les BE2. De plus, grâce à la comparaison des réponses 
de mutants de délétion ad hoc, les mécanismes de réponse au NO2 gazeux et leur synergie pourront 
être finement établis. 
Par la suite, l’exposition de la souche MFAF76a sera menée sur une gamme de concentration en NO2 
mimant l’environnement urbain (0,2 ppm) jusqu’à sa toxicité (45 ppm). Ainsi seront étudiées les 
relations entre la concentration du polluant automobile et les BE2. De cette manière, la concentration 
en polluant activant la réponse bactérienne ou concentration minimale « effective » devrait être 
établie. Cette concentration biologiquement active en NO2 sera confirmée à l’aide de l’exposition des 
mutants à la même gamme de concentrations et documentera la toxicité par inhalation de ce polluant 
préoccupant. 
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Par la suite, une étude similaire sera envisagée avec le NO gazeux à l’aide de la souche MFAF76a et 
de sa collection de mutants. L’approche multi-échelle précédemment évoquée pourrait être enrichie 
à l’aide d’analyses RNAseq ciblées voire métabolomiques, grâce aux équipements respectivement 
acquis par le RIN 2017 et demandé lors du RIN 2018. Grâce à ce dernier équipement, je collaborerai 
avec un nouveau partenaire normand le Pr R DELEPEE, Plateforme PRISM et laboratoire Aliments 
Bioprocédés Toxicologie Environnements (ABTE), équipe Toxicologie de l'Environnement Milieux 
Aériens et Cancers (ToxEMAC) de l’Université de Caen Normandie. Après corrélation des résultats 
ainsi obtenus et ceux observés avec NO2, au maximum 2 mutants seront retenus pour envisager les 
expositions à des mélanges de NO/NO2. 
Parallèlement, des essais de destruction des germes exposés les plus virulents seront développés à 
l’aide de techniques athermiques, par exemple la photocatalyse. L’objectif serait d’explorer des 
potentiels applicatifs aussi bien en médecine, qu’en industrie, voire en industrie automobile. 
 
Ainsi à plus long terme, la mise en œuvre d’exposition à des mélanges de NO/NO2 devrait 
nous permettre d’affiner la connaissance du stress nitrosant et de découpler le rôle de chacun de ces 
composés azotés. Une étude, même restreinte, à l’aide de P. fluorescens MFN1032 pourrait être fort 
informative, quant à l’impact des NOx sur la synthèse des biosurfactants ou du rôle de ces exoproduits 
dans la détoxification bactérienne. 
Quant à l’impact des NOx sur des bactéries, ces travaux aideront à la définition du lien entre NOx -
polluants automobiles-, l'homéostasie membranaire et la modulation de la virulence bactérienne. 
Ensuite l'origine chimique ou bactérienne de l'immuno-supression humaine pourra être établie dans 
le cas d’infections pulmonaires bactériennes en présence d’air pollué. De plus, cette démarche, en 
amont d’évaluation du risque sanitaire aéroporté, permettra de documenter la toxicité par inhalation 
de ces polluants préoccupants. Les concentrations biologiquement actives déterminées pourraient 
contribuer à long terme à l’établissement des valeurs toxicologiques en qualité de l’air. Un 
prolongement industriel serait d’améliorer la qualité de l’atmosphère dans l’habitacle automobile, 
lieu d’exposition quotidien et important aux NOx. Une implémentation industrielle pourrait être 
relative à la lutte contre les biofilms de biocontaminants aéroportés en milieu industriel. Quant aux 
perspectives thérapeutiques, elles pourraient concerner la lutte d’infections opportunistes soit à 
l’encontre des Pseudomonas spp. en dégradant leur paroi, soit en utilisant leurs modes d’action contre 
d’autres pathogènes en tirant avantage du stress nitrosant. Une meilleure compréhension du mode 
d’action des RNS (reactive nitrogen spieces) intéresse le monde médical dans son défi contre les 
stratégies d’antibiorésistance développées par les microorganismes (Jamil et al., 2017; Pelgrift and 
Friedman, 2013). 
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II) Adaptation de bactéries en contact avec un milieu dense 
Suite à la thèse du Dr L ROWENZYCK en codirection avec l’URCOM, Université du Havre 
(Pr M GRISEL, les Dr C PICARD et N HUCHER) et aux travaux ultérieurs, ma curiosité avait été 
attisée par l’impact des interfaces denses (globules d’émulsion ou nanoparticules) sur la physiologie 
bactérienne et encore plus intriguée par leurs altérations potentielles envers l’enveloppe bactérienne. 
D’autant que, suite à son attachement à des NPs de fer valence 0 (Fe0), Pseudomonas stutzeri met en 
place deux mécanismes de défense prépondérants (Saccà et al., 2014). L’un est d’adapter 
l’homéostasie membranaire via une répression protéique permettant de maîtriser l’absorption en fer 
et le second est de contrecarrer les espèces oxydantes (ROS) en les piégeant dans les replis 
« inhabituels » de protéines surproduites telles que des chaperones, des protéines de choc chaud ou 
de superoxide dismutases (SOD). De nombreuses NPs de nature différente sont reportées comme 
pouvant prévenir de la formation de biofilms bactériens, voire les éliminer. Le pouvoir antibactérien 
des NPs est fréquemment sous-tendu par 4 processus : 1) perturbation de la membrane bactérienne, 
2) génération de ROS; 3) diffusion à travers la membrane bactérienne; et 4) induction d’activités 
antibactérienne au sein de la cellule, dont des interactions avec l’ADN et les protéines (Wang et al., 
2017). 
N’ayant pas encore finalisé la mise au point de la méthodologie alternative de dénombrement 
bactérien en matrice complexe par cytométrie de flux, je me suis réorientée vers une mise en contact 
des NPs sous forme aérosol avec les bactéries. Cette approche originale pouvant être intéressante en 
approche de sécurité sanitaire concernant les nanomatériaux (NMx) dont les NPs, qui attirent 
l’attention de nombreux organismes sanitaires français comme internationaux (Etat des 
connaissances relatif aux nanoparticules de dioxyde de titane et d’oxyde de zinc dans les produits 
cosmétiques en termes de pénétration cutanée, de génotoxicité et de cancérogenèse, 2011; European 
Commission and Directorate General for Health & Consumers, 2013; Sccs and Chaudhry, 2015; 
Scientific Committee on Consumer Safety (SCCS) and Chaudhry, 2016). De plus, la terminologie de 
« nano-antimicrobial » démontre l’intérêt croissant porté aux NMx, au sens large, pour contrecarrer 
l’antibiorésistance croissante d‘un certain nombre de micro-organismes pathogènes (Jamil et al., 
2017; Wang et al., 2017). 
Aussi ai-je en novembre 2017 déposé une lettre d’intention intitulée NanoToxBactR auprès 
de l’ANSES. 
 
A) NanoToxBactR : étude de faisabilité d’un test cytotoxicité des 
NPs 
NanoToxBactR correspond à une étude de faisabilité d’un test cytotoxicité sous forme d’une 
monocouche de la bactérie aéroportée P. fluorescens MFAF76a pour identifier les dangers des 
nanoparticules (NPs) inhalées. L’objectif serait de mettre à disposition de la communauté un outil 
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sensible, « rapide » et « simple ». Ainsi, à l’aide de matériel biologique bactérien, une réponse à la 
mise en contact NPs/bactéries pourrait être obtenue en moins de 24h sans culture, par la quantification 
de bioindicateur(s) pertinent(s) ne nécessitant aucun post-traitement biochimique et n’entrainant 
aucun biais quantitatif lié à la présence de NPs (Bitounis et al., 2016). 
L’originalité de ce travail réside, en partie, dans le contact des NPs aérosolisées avec la monocouche 
bactérienne conservée sur gélose, et non en milieu liquide, pour mimer l’exposition pulmonaire où 
les NPs s’accumulent engendrant une réponse inflammatoire (Geiser et al., 2017; Khatri et al., 2017) 
et stress oxydant (Das and Patra, 2017; Khatri et al., 2017; Wang et al., 2017). Habituellement les 
concentrations en NPs sont limitées par leur solubilité en phase aqueuse, ici l’élément limitatif sera 
leur surface spécifique par rapport à celle offerte par la monocouche. Les 2 aérocontaminants choisis 
sont des NPs de noir de carbone (NPnC), de type céramique, et de cuivre (NPCu), de type métallique. 
Les NPCu, souvent utilisées comme pigment, dopant électronique ou catalyseur (Rager et al., 2016; 
Stark et al., 2015). Elles sont aussi connues comme antibactérien, car le cuivre endommage la 
membrane bactérienne et dégrade son ADN (Vincent et al., 2018). Elles sont fréquemment mises en 
œuvre dans des procédés industriels par des salariés certes équipés de protections individuelles, mais 
dont l’efficacité reste relative pour des nanoobjets de quelques dizaines de nanomètres (Honnert and 
Grzebyk, 2013). Quant aux NPnC, elles relèvent davantage de la qualité de l’air extérieur, car elles 
miment souvent les suies automobiles (Morin et al., 2009; Stark et al., 2015). De plus, elles sont 
largement utilisées en cosmétique comme base colorante (0,001 à 10%) pour des soins, des vernis et 
de nombreux cosmétiques pour les yeux (mascaras, fards…) (Scientific Committee on Consumer 
Safety (SCCS) and Chaudhry, 2016). L’adaptation du système d’exposition précédemment décrit 
pourrait être réalisée par nos collaborateurs du CERTAM (les Dr D Préterre & F Gouriou, St Etienne 
du Rouvray, 76) en y introduisant des aérosols de NPCu ou NPnC générés en amont du système et 
contrôlés par un granulomètre.  
Les monocouches avant et après exposition seraient caractérisées à l’aide de microscopie et 
d’imagerie par microsonde ionique SIMS. La quantité de NPs déposées selon la surface de la 
monocouche bactérienne, non hydratée, pourrait être évaluée par microscopie confocale. La qualité 
du dépôt (homogénéité, répartition des NPs) sur la charge bactérienne serait observée par confocal, 
MEB et SIMS. Cette technique lourde et innovante sur des matrices biologiques nous serait accessible 
au travers d’une collaboration avec l’équipe NanoCARE du GPM UMR CNRS 6634 de l’Université 
de Rouen Normandie-INSA de Rouen (les Dr A Cabin Flaman & A Delaune, D Gibouin). 
Dans un premier temps sera établie la concentration nécessaire pour recouvrir intégralement 
la couche bactérienne qui sera définie comme concentration maximale pour chacune des NPs. Puis 
l’exposition de la monocouche bactérienne sera réalisée à 2 autres concentrations. Parallèlement à la 
caractérisation des dépôts, les phénotypes bactériens de viabilité, morphologie et perméabilité seront 
évalués, et corroborés à l’aide d’une étude de transcriptomique ciblée. 
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Les travaux de Sacca (Saccà et al., 2014) sur l’exposition de suspension de P. stutzeri 
planctoniques à des NPs de Fe0 nous confortent dans notre approche phénotypique et 
transcriptomique, mais aussi sur nos choix de biomarqueurs : viabilité bactérienne et perméabilisation 
membranaire. 
Cette étude NanoToxBactR confirmerait, en premier lieu, la pertinence du critère perméabilité 
membranaire des bactéries suite à leur exposition aux NPs comme indication de la toxicité 
particulaire. Actuellement ce type d’évaluation semble biaisée par les interférences que provoquent 
les NPs lors des dosages biochimiques ou spectrophotométriques, compromettant leur robustesse 
(Bitounis et al., 2016). Ainsi cet outil robuste serait applicable à tout aérosol de NPs, indépendamment 
de ses caractéristiques (métallique, céramique, greffé, enrobé…). A plus long terme, il pourrait aussi 
selon la durée ou la fréquence d’exposition aider à statuer pour des expositions chroniques et/ou 
cumulées en pollution de l'air (Geiser et al., 2017). 
Malheureusement, ce projet n’a pas été retenu par l’ANSES. Nous affinons notre stratégie en vue 
d’une nouvelle soumission fin 2018. 
B) Evaluation de l’activité antibactérienne de nanomatériaux NMx 
d’argent 
En Novembre 2017, j’ai présenté une communication intitulée « Production de viscosinamides par la 
souche clinique de Pseudomonas fluorescens MFN1032: Implication dans le développement du 
biofilm » à Bioadh2017, où j’ai fait la connaissance du Dr M MORENO (Luxembourg Institute of 
Science and Technology, Département Recherche et Technologie en matériaux). Ce chercheur 
fonctionnalise des surfaces de matériaux à l’aide de nanoparticules d’argent par procédé plasma 
qu’elle développe et se trouve vivement intéressée pour évaluer leur activité antibactérienne. 
En cours de rédaction de la lettre d’intention NanoToxBactR à l’ANSES, dont je ne connaissais pas 
l’issue, je désirais étudier l’impact du contact de NPs / bactérie sur la physiologie et la perméabilité 
membranaire bactérienne. Les “silver nanomaterials” sont définis comme tout matériau contenant de 
l’argent dont l’activité est accrue grâce à la structure nanométrique (Marambio-Jones and Hoek, 
2010). Un nanomatériau (NM) est un matériau dont au moins une de ses dimensions ou une de ses 
unités tridimensionnelles est nanométrique (1-100nm) (Wang et al., 2017). Par son procédé, Figure 
39, le Dr M MORENO produit des surfaces présentant des clusters nanométriques d’argent métallique 
Ag0.  
 
Figure 39 : Procédé d’obtention des nanomatériaux (NMx) d’argent, réalisé par le 
Dr M MORENO. 
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L’argent est utilisé depuis des siècles comme antibactérien avec une utilisation moindre depuis la 
découverte des antibiotiques. Cependant un regain d’intérêt existe suite aux phénomènes 
d’antibiorésistance développés par de nombreux pathogènes (Chen and Schluesener, 2008; Jamil et 
al., 2017; Wang et al., 2017) et de nombreux nano-antibiotiques sont développés (Jamil et al., 2017; 
Marambio-Jones and Hoek, 2010; Zheng et al., 2018), voire industrialisés largement (habillement, 
biens de consommation, de soin, de santé…). Cette utilisation est si présente que la dissémination des 
NMx, plus particulièrement des silver NMx, dans l’environnement préoccupent les instances 
sanitaires européennes (Hartemann et al., 2015; Kapuścińska and Nowak, 2016). 
L’activité antibactérienne des silver NMx se réalise via la libération d’ions argent Ag+, forme oxydée 
d’Ag0 facilement obtensible à pH acide. Ils interagissent directement avec la membrane. Le transport 
de NPAg (d’environ 80nm) a été constaté au travers de la membrane de P. aeruginosa et est reliée à 
l’expression de la pompe membranaire MexAB-OprM (Picard et al., 2018; Xu et al., 2004), dont le 
diamètre maximal est dix fois plus petit (Phan et al., 2010). Des zones d’ombres persistent. D’autre 
part, les Ag+ réagissent aussi avec l’oxygène de l’air ou de l’eau et induisent la production extra- et 
intracellulaire de ROS, plus spécifiquement d’ions et de radicaux hydroxyles (Wang et al., 2017). Ils 
peuvent entraîner, sélectivement ou concomitamment, une augmentation de la perméabilité 
membranaire, une perte de force motrice protonique induisant une perte énergétique de la bactérie 
avec un efflux phosphate, une fuite du cytosol, des modifications protéiques, lipidiques, voire une 
perturbation de la réplication de l’ADN (Das and Patra, 2017; Marambio-Jones and Hoek, 2010; 
Wang et al., 2017). 
De plus la toxicité des silver matériaux est liée à leurs propres caractéristiques intrinsèques : taille, 
forme, cristallinité, chimie, mais aussi selon les caractéristiques propres à son microenvironnement 
aqueux ou non (Marambio-Jones and Hoek, 2010). Habituellement l’activité antibactérienne est 
quantifiée par une mise en contact des NMx en suspension dans une suspension bactérienne (Das and 
Patra, 2017; Marambio-Jones and Hoek, 2010), qui est biaisée par les interférences provoquées par 
les NPs lors des dosages (Bitounis et al., 2016). Une autre quantification est de déposer la suspension 
de nanomatériaux sur un tapis bactérien (Zodrow et al., 2009). Ces protocoles ne sont pas 
envisageables pour les échantillons matriciels et monofaces fournis par le Dr MORENO. Récemment 
un stagiaires de BTS a adapté le protocole présenté Figure 40 de la norme ISO 22196 :2011 intitulée 
Plastiques -- Mesurage de l'action antibactérienne sur les surfaces en plastique. 
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Figure 40 : Protocole d’évaluation de l’activité antibactérienne par dépôt de 
suspension bactérienne sur la face de NMx. 
Le Dr MORENO a fourni deux lots préparés lors de conditions de plasma impactant la quantité et la 
qualité des dépôts de NPsAg, qui sont en cours de caractérisation. Quant à leur activité 
antimicrobienne, les essais préliminaires à l’aide de la souche P. fluorescens MFAF76a retranscrivent 
aussi cette différence d’état de surface. 
Dans la seconde partie du stage de BTS à l’automne 2018, des essais complémentaires vont 
permettre de conforter ce protocle. La mise au point de la méthodologie alternative de dénombrement 
bactérien par cytométrie de flux pourrait être effective alors. Aussi nous pourrions envisager de 
développer un protocole alternatif grâce à la souche MFAF76abfp, i.e. portant une protéine 
fluorescente bleue. Il éviterait les fastidieux dénombrements sur boîtes de Petri et serait affranchi du 
biais lié à la présence potentielle de NMx. Cette approche nous permettrait aussi d’évaluer 
grossièrement la proportion de bactéries partiellement, totalement ou non perméabilisées (Chau et al., 
2008). Ainsi nous pourrions discriminer les conditions de préparation plasma représentatives d’un 
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panel large d’activité antimicrobienne au travers d’une sélection de traitements plasma définis et 
caractérisés. 
Au vu des mécanismes décrits dans la littérature, nous pourrons mettre à profit l’expérience 
accumulée sur le stress membranaire, mais aussi le stress oxydant, qui inclut le stress nitrosant. Ainsi 
des approches transcriptomiques ciblées dans un premier temps seront envisagées. Elles pourront être 
affinées par la suite par des approches complémentaires omics, voire la mise en œuvre de mutants 
pour affiner la connaissance des mécanismes mis en œuvre par P. fluorescens MFAF76a en contact 
avec les silver nanomatéraiux développés par le Dr M MORENO. 
 
C) Evaluation de l’activité antibactérienne de NPs en matrice 
cosmétique 
Les opportunités précédentes concernant les NMx ne m’ont pas détournée de l’approche en 
sécurité sanitaire des produits cosmétiques, d’autant que les autorités sanitaires européennes imposent 
depuis mai 2018 une analyse de risque lors du dépôt de nouveaux ingrédients cosmétiques de type 
NM (SCCS, 2017). 
Le contact bactérie/matrice cosmétique que j’ai eu l’opportunité de caractériser a impacté la 
physiologie bactérienne au niveau viabilité et/ou homéostasie membranaire. Pour appréhender les 
synergies mises en œuvre lors de la réponse bactérienne, il me semble nécessaire d’étudier les 
différents partenaires présents dans le microenvironnement bactérien qu’est la lotion solaire. Elle 
consiste en la dispersion de gouttelettes (émulsion) contenant des particules solides dispersées, les 
NPs de TiO2 comme filtres inorganiques. Il s’agit donc d’un système à phases multiples qui apparait 
encore plus complexe qu’une simple émulsion. De plus, les NPs de TiO2 protègent la peau lors 
d’exposition aux rayonnements UV (Wawrzynczak et al., 2016), mais alors produisent des ROS (Das 
and Patra, 2017; Wang et al., 2017; Yadav et al., 2016). Ces propriétés photocatalytiques peuvent 
avoir des conséquences sur la réponse bactérienne, même en absence de rayonnement (Jamil et al., 
2017; Pelgrift and Friedman, 2013). 
Aussi pour envisager la réponse bactérienne au sein de cette matrice complexe, une scission 
en plusieurs problématiques s’impose : le contact avec l’émulsion et le contact avec le système 
photocatalytique. Ce dernier point nécessite d’être à nouveau fragmenté en l’impact du rayonnement 
et celui du filtre solaire. Au cœur de la lotion solaire, ce filtre photocatalytique génèrera des ROS qui 
inévitablement vont déclencher des adaptations bactériennes : métaboliques, membranaires, voire 
génétiques. Ces conséquences se concrétiseront, en partie, macroscopiquement sous la forme 
d’activité antibactérienne. Cette activité, dans ce système complexe, reflètera aussi l’interaction avec 
l’émulsion. Aussi, par ces études, j’entends caractériser l’origine des diverses contributions à la 
réponse bactérienne in situ, i.e. en produit cosmétique. 
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(1) Evaluation de l’activité antibactérienne des émulsions 
Les nano-émulsions (émulsions dont le diamètre moyen des globules est inférieur au 
micromètre) sont réputées d’une activité antimicrobienne plus importante que les émulsions, liée à 
leur granulométrie plus fine (Teixeira et al., 2007). Suite à une revue fournie, El Kadri et al. (Kadri 
et al., 2017) contestent que les survie et croissance bactérienne soient impactées par la granulométrie 
de l’émulsion, voire que la membrane soit dégradée lors de ce contact (Hamouda et al., 2001; 
Hamouda and Baker, 2000; Teixeira et al., 2007). L’analogie avec l’interaction bactérie/NM laisserait 
penser qu’en contact direct avec une interface plus dense, la bactérie pourrait voir sa perméabilité 
membranaire modifiée (changements structuraux phospholipidiques, protéiques, altération de 
l’activité respiratoire). Cette réponse membranaire pourrait impactée la communication de la bactérie, 
voire aboutir à la mort cellulaire (Das and Patra, 2017; Wang et al., 2017). Le débat reste ouvert ! 
Les travaux doctoraux de D DESPLAN (soutenance prévue fin 2018) avec nos collaborateurs du 
laboratoire SATIE (Université de Cergy-Pontoise) ont implémenté une nouvelle technique de 
caractérisation in situ de la croissance bactérienne par le suivi des propriétés mécaniques et 
électriques de l’échantillon. Ainsi les propriétés rhéologiques : G’ (module élastique) et G’’ (module 
visco-élastique) permettent de suivre la croissance bactérienne (G’’), mais aussi les modifications 
organisationnelles à l’interface bactérie/matrice.  
A moyen terme, l’impact de l’encombrement stérique que représente un globule d’émulsion à la 
surface bactérienne (e.g. P. fluorescens MFAF76a) pourra être caractérisé par cette approche micro-
rhéologique innovante. J’espère pouvoir la compléter par des approches transcriptomiques ciblées 
quantifiant l’expression de gènes liés aux ROS, à la perméabilité membranaire, à l’activité 
respiratoire, mais aussi des gènes méchano-senseurs (Chevalier et al., 2018; Cox et al., 2018; Persat, 
2017). L’expérience acquise au cours de l’approche qualité de l’air sera aisément transposable dans 
ce contexte. De plus l’activité antimicrobienne de l’émulsion pourrait être évaluée en fonction de la 
densité de la phase globulaire, i.e. selon le foisonnement / l’entassement moléculaire en interface de 
la membrane bactérienne. Ainsi des outils omics (protéomique, lipidomique, transcriptomique, voire 
métabolomique ciblées) seront couplés à la micro-rhéologie, qui, je l’espère, nous permettra de 
clarifier les mécanismes bactériens mis en œuvre selon la densité du milieu avec lequel la bactérie 
crée une interface. 
 
(2) Evaluation de l’activité antibactérienne du rayonnement UV 
Une lotion solaire a pour objet de protéger contre les rayonnements solaires, parmi lesquels les 
rayonnements UV provoquent les plus grands dommages cutanés. Ils se subdivisent en UVA (320-
400 nm), UVB (290-320 nm) et UVC (100-290 nm). Même si ces derniers concernent peu ou prou le 
consommateur, car ils n’atteignent pas la surface terrestre (Yadav et al., 2016). Bien que ces UVC 
soient réputés antibactériens, l’attention est portée davantage sur les UVB plus abondants et moins 
pénétrants dans la peau que les UVA plus énergétiques (Gamalier et al., 2017). Les UV induisent des 
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modifications lipidiques, protéiques (Santos et al., 2013) modifiant la perméabilité membranaire. 
L’ADN est aussi impacté par oxydation des acides nucléiques. De plus, l’irradiation UV peut 
accélérer la sécrétion de vésicules, signe avant-coureur de la lyse cellulaire bactérienne (Gamalier et 
al., 2017). 
Une demande de financement de bourse doctorale Cifre a été déposée en juillet 2018 auprès de 
l’ANRT s’intéressant aux interactions bactérie/ irradiation UV. Ce travail collaboratif avec 
l’entreprise BASF Beauty Care Solutions France SAS, que je co-encadrerai avec le Pr M 
FEUILLOLEY, pourra contribuer à une meilleure connaissance des stratégies mises en œuvre par la 
bactérie dans diverses conditions d’irradiation UV, aussi bien au niveau membranaire, métabolique, 
voire génétique. Cette approche multi-échelle sera argumentée à l’aide des données physiologiques, 
protéomiques, lipidomiques, transcriptomiques et métabolomiques, que le futur doctorant acquerra. 
 
(3) Evaluation de l’activité antibactérienne de NPs en matrice cosmétique 
Dans la logique de la thèse du Dr L ROWENZYCK en codirection avec l’URCOM, Université 
du Havre, il semblerait intéressant d’approfondir l’impact de la présence de filtre physique 
cosmétique. Actuellement TiO2 et le ZnO sont autorisés (Journal officiel de l’Union européenne, 
2017; Stark et al., 2015; Yadav et al., 2016). Ces dernières années une littérature abondante de leur 
interaction avec les bactéries est parue (Anupama et al., 2018; Das and Patra, 2017; Planchon et al., 
2013; Wang et al., 2017), dont certaines en présence d’irradiation UV ou non (Mathur et al., 2017; 
Qiu et al., 2017). A ma connaissance, seuls les travaux de L Rowenczyk ont amorcé une étude in situ 
des interactions bactéries/ NPs en matrice complexe de type produit industriel (Rowenczyk et al., 
2017) que j’aimerais approfondir. Des travaux récents implémentent les approches omics dans ce 
contexte contact bactérie/NP TiO2 simple. Une partie des bactéries survivent à ce contact en adaptant 
leur métabolisme : une sous production protéique, mais une augmentation des métabolites liés au 
métabolisme énergétique et à la croissance bactérienne (Planchon et al., 2017). Une étude in silico du 
contact d’un biofilm de P. aeruginosa avec des NPsTiO2 décrit que le gène dont l’expression serait 
en premier impacté serait katA qui interagit ensuite avec rpoS, rpoA, dnaK et hfq. rpoS, rpoA sont 
reliés à la biosynthèse des ARN, mais aussi l’expression de rpoS impacte la motilité, la virulence et 
la communication bactérienne. Quant à dnaK et hfq, ils sont impliqués dans la synthèse protéique et 
la réponse au stress. La protéine DnaK forme un complexe ternaire avec NirC et FliC (Anupama et 
al., 2018). FliC est une protéine structurante du flagelle, donc relative à la motilité (Acuña et al. 2015), 
déjà évoquée dans la réponse au NO2. De même que pour NirC qui chez P. aeruginosa est une nitrite 
réductase (Kondakova et al., 2016). 
Ces résultats prédictifs ne sont pas directement transposables au cas du contact bactéries/ NPs en 
matrice complexe. Cependant nos approches omics ciblant ces différents gènes nous permettront 
d’infirmer, voire d’amender ce réseau qui présente des similitudes avec nos projets précédents et ceux 
présentés dans ce projet de recherche.  
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III) Feuille de route ! 
Les divers aspects de ces perspectives scientifiques, synthétisés Figure 38, ne seront pas 
développés simultanément, mais de façon séquentielle au gré de l’obtention de financements, mais 
aussi des avancées scientifiques, les nôtres ou celles d’autres chercheurs. Nous avons déjà à 
disposition de nombreux moyens, d’autres seront accessibles au sein de collaborations régionales, 
nationales et internationales, dont un certain nombre est déjà fonctionnel et d’autres sont à mettre en 
œuvre ou à créer, comme indiqué en Figure 41. 
 
Figure 41 : Financements et collaborations acquis ou envisagés (indiqué par
 ? xxx ?) pour réaliser mes perspectives de recherche.  
Ces thématiques de sécurité sanitaire mobilisent nos organismes gouvernementaux, qui 
imposent de nouvelles contraintes aux citoyens que nous sommes, mais aussi aux industriels. Aussi 
des demandes de financements aussi bien publics que privés semblent tout à fait motivables et 
concrétisables. D’ores et déjà, le retour du BTS ayant amorcé le travail sur les NMx est prévu à 
l’automne. Notre nouveau doctorant T CHAUTRAND, financé jusqu’en 2021 par le RIN CBS 
SeSAL, sur la thématique sécurité sanitaire de l’Air, sera chaperonné par l’actuelle doctorante S 
DEPAYRAS, bénéficiant d’un poste ATER jusqu’en août 2019. La compilation des résultats de cette 
thèse débutante avec les deux précédentes (T KONDAKOVA et S DEPAYRAS) permettra d’asseoir, 
dans les prochaines années, la construction d’un projet ANR de type ERA-NET Cofund en Résistance 
antimicrobienne. D’ici-là, je serai amenée à contacter de nouveaux partenaires nationaux et 
internationaux. Je pourrai m’appuyer sur le réseau Pseudomonas, GDR en cours de réactivation, mais 
aussi saisir des opportunités au cours de futurs congrès internationaux. 
Suite à sa soutenance fin 2018/début 2019, S DEPAYRAS s’intéressera à la mise au point de 
la méthode alternative de dénombrement bactérien en matrice complexe contenant des 
nanoparticules. Courant de l’automne 2018, nous aurons obtenu le retour de l’ANRT concernant le 
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financement de la bourse doctorale CIFRE en collaboration avec BASF Beauty Care Solutions France 
SAS. Ainsi, d’ici fin 2018, devrait débuter l’étude de la réponse bactérienne aux rayonnements UV. 
Quant au contact bactérie/nanomatériau, notre collaboration avec le Dr MORENO s’étoffera à 
l’automne avec de nouveaux essais réalisés lors d’un stage BTS. Pour l’aspect nanoparticules, 
j’envisage de soumettre une lettre d’intention amendée au sujet de NanoToxBactR au prochain appel 
à projets recherche de l’ANSES. Cette expertise cumulée à l’expérience acquise au travers des 
collaborations avec les laboratoires URCOM (Université du Havre Normandie) et SATIE (Université 
de Cergy-Pontoise) et la société BASF Beauty Care Solutions France SAS pourraient me permettre 
de participer au montage d’un projet FUI, ANR ou projet européen type H2020 permettant de 
documenter la sécurité sanitaire des produits cosmétiques contenant des nanoparticules par rapport 
au microbiote cutané, mais aussi l’impact de la pollution sur l’usage des cosmétiques. 
Fondamentalement, mon intérêt pour les interfaces a été un fil rouge tout au long de ma vie 
de chercheur. Ayant débuté par les interfaces physico-chimiques, comprendre comment la membrane 
bactérienne est une plate-forme intelligente et sélective d’interactions du micro-organisme avec son 
microenvironnement m’enthousiasme. De plus, je cherche à appréhender les stratégies membranaires, 
métaboliques et génétiques en réponse à des stress exogènes. 
Je poursuis ce chemin qui se trace au gré des interfaces ! En avant pour de nouvelles 
aventures ! 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
95 
 Bibliographie 
Adème, 2017. Caractériser et améliorer la qualité de l’air dans les habitacles; qualitifier et limiter les 
particules émises hors échappement par les véhicules. Adème Vous Lett. Rech. 3–4. 
Air quality in Europe — 2017 report (Publication No. 13/2017), 2017. , EEA Report. European 
Environment Agency, Luxembourg. https://doi.org/10.2800/850018 
Al-Saad, K.A., Siems, W.F., Hill, H.H., Zabrouskov, V., Knowles, N.R., 2003. Structural analysis 
of phosphatidylcholines by post-source decay matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry. J. Am. Soc. Mass Spectrom. 14, 373–382. https://doi.org/10.1016/S1044-
0305(03)00068-0 
Alsohim, A.S., Taylor, T.B., Barrett, G.A., Gallie, J., Zhang, X.-X., Altamirano-Junqueira, 
A.E., Johnson, L.J., Rainey, P.B., Jackson, R.W., 2014. The biosurfactant viscosin produced by P 
seudomonas fluorescens SBW25 aids spreading motility and plant growth promotion: Viscosin 
mediates sliding motility and plant protection. Environ. Microbiol. 16, 2267–2281. 
https://doi.org/10.1111/1462-2920.12469 
Ammami, M.T., Portet-Koltalo, F., Benamar, A., Duclairoir-Poc, C., Wang, H., Le Derf, F., 
2015. Application of biosurfactants and periodic voltage gradient for enhanced electrokinetic 
remediation of metals and PAHs in dredged marine sediments. Chemosphere 125, 1–8. 
https://doi.org/10.1016/j.chemosphere.2014.12.087 
Anupama, R., Sajitha Lulu, S., Mukherjee, A., Babu, S., 2018. Cross-regulatory network in 
Pseudomonas aeruginosa biofilm genes and TiO2 anatase induced molecular perturbations in key 
proteins unraveled by a systems biology approach. Gene 647, 289–296. 
https://doi.org/10.1016/j.gene.2018.01.042 
Arai, H., 2011. Regulation and Function of Versatile Aerobic and Anaerobic Respiratory Metabolism 
in Pseudomonas aeruginosa. Front. Microbiol. 2. https://doi.org/10.3389/fmicb.2011.00103 
Arai, H., Hayashi, M., Kuroi, A., Ishii, M., Igarashi, Y., 2005. Transcriptional Regulation of the 
Flavohemoglobin Gene for Aerobic Nitric Oxide Detoxification by the Second Nitric Oxide-
Responsive Regulator of Pseudomonas aeruginosa. J. Bacteriol. 187, 3960–3968. 
https://doi.org/10.1128/JB.187.12.3960-3968.2005 
Augusto, O., Bonini, M.G., Amanso, A.M., Linares, E., Santos, C.C., De Menezes, S.L., 2002. 
Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic. Biol. 
Med. 32, 841–859. 
Bak, F., Bonnichsen, L., Jørgensen, N.O., Nicolaisen, M.H., Nybroe, O., 2015. The biosurfactant 
viscosin transiently stimulates n-hexadecane mineralization by a bacterial consortium. Appl. 
Microbiol. Biotechnol. 99, 1475–1483. 
Barraud, N., Kjelleberg, S., Rice, S.A., 2015. Dispersal from Microbial Biofilms. Microbiol. Spectr. 
3. 
96 
Baumgarten, T., Sperling, S., Seifert, J., von Bergen, M., Steiniger, F., Wick, L.Y., Heipieper, 
H.J., 2012a. Membrane Vesicle Formation as a Multiple-Stress Response Mechanism Enhances 
Pseudomonas putida DOT-T1E Cell Surface Hydrophobicity and Biofilm Formation. Appl. Environ. 
Microbiol. 78, 6217–6224. https://doi.org/10.1128/aem.01525-12 
Baumgarten, T., Vazquez, J., Bastisch, C., Veron, W., Feuilloley, M.G., Nietzsche, S., Wick, 
L.Y., Heipieper, H.J., 2012b. Alkanols and chlorophenols cause different physiological adaptive 
responses on the level of cell surface properties and membrane vesicle formation in Pseudomonas 
putida DOT-T1E. Appl. Microbiol. Biotechnol. 93, 837–845. 
Bellido, F., Martin, N.L., Siehnel, R.J., Hancock, R.E., 1992. Reevaluation, using intact cells, of 
the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability. 
J. Bacteriol. 174, 5196–5203. https://doi.org/10.1128/jb.174.16.5196-5203.1992 
Bisson, M., Bureau, J., Del Gratta, F., Lefevre, J., Levilain, A., 2011. Oxydes d’azote NOx (No. 
DRC-11-117259-10320A), Fiche de données toxicologiques et environnementales des substances 
chimiques. INERIS, France. 
Bitounis, D., Pourchez, J., Forest, V., Boudard, D., Cottier, M., Klein, J.-P., 2016. Detection and 
analysis of nanoparticles in patients: A critical review of the status quo of clinical nanotoxicology. 
Biomaterials 76, 302–312. https://doi.org/10.1016/j.biomaterials.2015.10.061 
Bjarnsholt, T., Tolker-Nielsen, T., Givskov, M., 2011. Interfering with “Bacterial Gossip,” in: 
Biofilm Highlights. Springer, pp. 163–188. 
Bjørnlund, L., Rønn, R., Péchy-Tarr, M., Maurhofer, M., Keel, C., Nybroe, O., 2009. Functional 
GacS in Pseudomonas DSS73 prevents digestion by Caenorhabditis elegans and protects the 
nematode from killer flagellates. ISME J. 3, 770–779. https://doi.org/10.1038/ismej.2009.28 
Bonamore, A., Gentili, P., Ilari, A., Schininà, M.E., Boffi, A., 2003. Escherichia coli 
Flavohemoglobin Is an Efficient Alkylhydroperoxide Reductase. J. Biol. Chem. 278, 22272–22277. 
https://doi.org/10.1074/jbc.M301285200 
Bonnichsen, L., Svenningsen, N.B., Rybtke, M., de Bruijn, I., Raaijmakers, J.M., Tolker-
Nielsen, T., Nybroe, O., 2015. Lipopeptide biosurfactant viscosin enhances dispersal of 
Pseudomonas fluorescens SBW25 biofilms. Microbiology 161, 2289–2297. 
Bouffartigues, E., Moscoso, J.A., Duchesne, R., Rosay, T., Fito-Boncompte, L., Gicquel, G., 
Maillot, O., Bénard, M., Bazire, A., Brenner-Weiss, G., Lesouhaitier, O., Lerouge, P., Dufour, 
A., Orange, N., Feuilloley, M.G.J., Overhage, J., Filloux, A., Chevalier, S., 2015. The absence of 
the Pseudomonas aeruginosa OprF protein leads to increased biofilm formation through variation in 
c-di-GMP level. Front. Microbiol. 6. https://doi.org/10.3389/fmicb.2015.00630 
BOUQUET, S., LANGERON, J.-P., n.d. INTERFACES. 
Caiazza, N.C., Merritt, J.H., Brothers, K.M., O’Toole, G.A., 2007. Inverse Regulation of Biofilm 
Formation and Swarming Motility by Pseudomonas aeruginosa PA14. J. Bacteriol. 189, 3603–3612. 
https://doi.org/10.1128/JB.01685-06 
97 
Calvo, C., Manzanera, M., Silva-Castro, G.A., Uad, I., González-López, J., 2009. Application of 
bioemulsifiers in soil oil bioremediation processes. Future prospects. Sci. Total Environ. 407, 3634–
3640. https://doi.org/10.1016/j.scitotenv.2008.07.008 
Cárcamo-Oyarce, G., Lumjiaktase, P., Kümmerli, R., Eberl, L., 2015. Quorum sensing triggers 
the stochastic escape of individual cells from Pseudomonas putida biofilms. Nat. Commun. 6. 
Carilla-Latorre, S., Calvo-Garrido, J., Bloomfield, G., Skelton, J., Kay, R.R., Ivens, A., 
Martinez, J.L., Escalante, R., 2008. Dictyostelium transcriptional responses to Pseudomonas 
aeruginosa: common and specific effects from PAO1 and PA14 strains. BMC Microbiol. 8, 109. 
https://doi.org/10.1186/1471-2180-8-109 
Chapalain, A., Rossignol, G., Lesouhaitier, O., Merieau, A., Gruffaz, C., Guerillon, J., Meyer, 
J.-M., Orange, N., Feuilloley, M.G.J., 2008. Comparative study of 7 fluorescent pseudomonad 
clinical isolates. Can. J. Microbiol. 54, 19–27. https://doi.org/10.1139/W07-110 
Chau, F., Lefort, A., Fantin, B., 2008. Intérêt et applications de la cytométrie de flux en 
bactériologie médicale. Antibiotiques 10, 226–231. https://doi.org/10.1016/j.antib.2008.08.006 
Chen, X., Schluesener, H.J., 2008. Nanosilver: A nanoproduct in medical application. Toxicol. Lett. 
176, 1–12. https://doi.org/10.1016/j.toxlet.2007.10.004 
Cheng, S., Lian, B., Liang, J., Shi, T., Xie, L., Zhao, Y.-L., 2013. Site selectivity for protein 
tyrosine nitration: insights from features of structure and topological network. Mol. Biosyst. 9, 2860–
2868. 
Chevalier, S., Bouffartigues, E., Bazire, A., Tahrioui, A., Duchesne, R., Tortuel, D., Maillot, O., 
Clamens, T., Orange, N., Feuilloley, M.G.J., Lesouhaitier, O., Dufour, A., Cornelis, P., 2018. 
Extracytoplasmic function sigma factors in Pseudomonas aeruginosa. Biochim. Biophys. Acta BBA 
- Gene Regul. Mech. https://doi.org/10.1016/j.bbagrm.2018.04.008 
Chevalier, S., Bouffartigues, E., Bodilis, J., Maillot, O., Lesouhaitier, O., Feuilloley, M.G.J., 
Orange, N., Dufour, A., Cornelis, P., 2017. Structure, function and regulation of Pseudomonas 
aeruginosa porins. FEMS Microbiol. Rev. 41, 698–722. https://doi.org/10.1093/femsre/fux020 
Cole, L.K., Vance, J.E., Vance, D.E., 2012. Phosphatidylcholine biosynthesis and lipoprotein 
metabolism. Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids 1821, 754–761. 
https://doi.org/10.1016/j.bbalip.2011.09.009 
Corker, H., Poole, R.K., 2003. Nitric oxide formation by Escherichia coli: dependence on nitrite 
reductase, the NO-sensing regulator Fnr and flavohemoglobin Hmp 37. 
Cox, C.D., Bavi, N., Martinac, B., 2018. Bacterial Mechanosensors. Annu. Rev. Physiol. 80, 71–
93. https://doi.org/10.1146/annurev-physiol-021317-121351 
Cronan, J.E., 2003. Bacterial Membrane Lipids: Where Do We Stand? Annu. Rev. Microbiol. 57, 
203–224. https://doi.org/10.1146/annurev.micro.57.030502.090851 
Cutruzzolà, F., Frankenberg-Dinkel, N., 2016. Origin and Impact of Nitric Oxide in Pseudomonas 
aeruginosa Biofilms. J. Bacteriol. 198, 55–65. https://doi.org/10.1128/JB.00371-15 
98 
D’aes, J., De Maeyer, K., Pauwelyn, E., Höfte, M., 2010. Biosurfactants in plant-Pseudomonas 
interactions and their importance to biocontrol. Environ. Microbiol. Rep. 2, 359–372. 
https://doi.org/10.1111/j.1758-2229.2009.00104.x 
D’aes, J., Kieu, N.P., Léclère, V., Tokarski, C., Olorunleke, F.E., De Maeyer, K., Jacques, P., 
Höfte, M., Ongena, M., 2014. To settle or to move? The interplay between two classes of cyclic 
lipopeptides in the biocontrol strain Pseudomonas CMR12a. Environ. Microbiol. 16, 2282–2300. 
Dagorn, A., Chapalain, A., Mijouin, L., Hillion, M., Duclairoir-Poc, C., Chevalier, S., Taupin, 
L., Orange, N., Feuilloley, M., Dagorn, A., Chapalain, A., Mijouin, L., Hillion, M., Duclairoir-
Poc, C., Chevalier, S., Taupin, L., Orange, N., Feuilloley, M.G.J., 2013a. Effect of GABA, a 
Bacterial Metabolite, on Pseudomonas fluorescens Surface Properties and Cytotoxicity. Int. J. Mol. 
Sci. 14, 12186–12204. https://doi.org/10.3390/ijms140612186 
Dagorn, A., Hillion, M., Chapalain, A., Lesouhaitier, O., Duclairoir Poc, C., Vieillard, J., 
Chevalier, S., Taupin, L., Le Derf, F., Feuilloley, M.G.J., 2013b. Gamma-aminobutyric acid acts 
as a specific virulence regulator in Pseudomonas aeruginosa. Microbiology 159, 339–351. 
https://doi.org/10.1099/mic.0.061267-0 
Darby, C., 2005. Interactions with microbial pathogens. WormBook. 
Das, B., Patra, S., 2017. Antimicrobials, in: Nanostructures for Antimicrobial Therapy. Elsevier, pp. 
1–22. https://doi.org/10.1016/B978-0-323-46152-8.00001-9 
Das, P., Yang, X.-P., Ma, L.Z., 2014. Analysis of biosurfactants from industrially viable 
Pseudomonas strain isolated from crude oil suggests how rhamnolipids congeners affect 
emulsification property and antimicrobial activity. Front. Microbiol. 5. 
https://doi.org/10.3389/fmicb.2014.00696 
Davies, D.G., 2011. Biofilm Dispersion, in: Biofilm Highlights. Springer, pp. 1–28. 
de Araujo, L.V., Guimarães, C.R., da Silva Marquita, R.L., Santiago, V.M., de Souza, M.P., 
Nitschke, M., Freire, D.M.G., 2016. Rhamnolipid and surfactin: Anti-adhesion/antibiofilm and 
antimicrobial effects. Food Control 63, 171–178. 
de Bruijn, I., de Kock, M.J., Yang, M., de Waard, P., van Beek, T.A., Raaijmakers, J.M., 2007. 
Genome-based discovery, structure prediction and functional analysis of cyclic lipopeptide 
antibiotics in Pseudomonas species. Mol. Microbiol. 63, 417–428. 
De Bruijn, I., De Kock, M.J.D., De Waard, P., Van Beek, T.A., Raaijmakers, J.M., 2008. 
Massetolide A biosynthesis in Pseudomonas fluorescens. J. Bacteriol. 190, 2777–2789. 
Debacq-Chainiaux, F., Leduc, C., Verbeke, A., Toussaint, O., 2012. UV, stress and aging. 
Dermatoendocrinol. 4, 236–240. https://doi.org/10.4161/derm.23652 
Decoin, V., Barbey, C., Bergeau, D., Latour, X., Feuilloley, M.G., Orange, N., Merieau, A., 2014. 
A type VI secretion system is involved in Pseudomonas fluorescens bacterial competition. PLoS One 
9, e89411. 
99 
Decoin, V., Gallique, M., Barbey, C., Le Mauff, F., Poc, C.D., Feuilloley, M.G., Orange, N., 
Merieau, A., 2015. A Pseudomonas fluorescens type 6 secretion system is related to mucoidy, 
motility and bacterial competition. BMC Microbiol. 15, 72. https://doi.org/10.1186/s12866-015-
0405-9 
Depayras, S., Kondakova, T., Heipieper, H.J., Feuilloley, M.G., Orange, N., Duclairoir-Poc, C., 
2018a. The Hidden Face of Nitrogen Oxides Species: From Toxic Effects to Potential Cure?, in: 
Soloneski, S., Larramendy, M.L. (Eds.), Emerging Pollutants - Some Strategies for the Quality 
Preservation of Our Environment. InTech. https://doi.org/10.5772/intechopen.75822 
Depayras, S., Kondakova, T., Merlet-Machour, N., Heipieper, H.J., Barreau, M., Catovic, C., 
Feuilloley, M., Orange, N., Duclairoir-Poc, C., 2018b. Impact of gaseous NO 2 on P. fluorescens 
strain in the membrane adaptation and virulence. Int. J. Environ. Impacts Manag. Mitig. Recovery 1, 
183–192. https://doi.org/10.2495/EI-V1-N2-183-192 
Desai, J.D., Banat, I.M., 1997. Microbial production of surfactants and their commercial potential. 
| Microbiology and Molecular Biology Reviews. Microbiol. Mol. Biol. Rev. 61, 47–64. 
Doumeix, O., 2011. Opérations unitaires en génie biologique: Les émulsions. SCÉRÉN-CNDP-
CRDP [Aquitaine]. 
Dowhan, W., Bogdanov, M., Mileykovskaya, E., Vitrac, H., 2017. Functional roles of individual 
membrane phospholipids in Escherichia coli and Saccharomyces cerevisiae. Biog. Fat. Acids Lipids 
Membr. 1–22. 
Duclairoir, C., 2000. Encapsulation et applications industrielles. Actual. Chim. 8, 24–27. 
Duclairoir, C., Irache, J.M., Nakache, E., Orecchioni, A.-M., Chabenat, C., Popineau, Y., 1999. 
Gliadin nanoparticles: formation, all- trans-retinoic acid entrapment and release, size optimization. 
Polym. Int. 48, 327–333. https://doi.org/10.1002/(SICI)1097-0126(199904)48:4<327::AID-
PI165>3.0.CO;2-Y 
Duclairoir, C., Nakache, E., 2002. Polymer Nanoparticle Characterization in Aqueous Suspensions. 
Int. J. Polym. Anal. Charact. 7, 284–313. https://doi.org/10.1080/10236660213159 
Duclairoir, C., Nakache, E., Marchais, H., Orecchioni, A.-M., 1998. Formation of gliadin 
nanoparticles: Influence of the solubility parameter of the protein solvent. Colloid Polym. Sci. 276, 
321–327. https://doi.org/10.1007/s003960050246 
Duclairoir, C., Orecchioni, A.M., Depraetere, P., Nakache, E., 2002. α-Tocopherol encapsulation 
and in vitro release from wheat gliadin nanoparticles. J. Microencapsul. 19, 53–60. 
https://doi.org/10.1080/02652040110055207 
Duclairoir, C., Orecchioni, A.-M., Depraetere, P., Osterstock, F., Nakache, E., 2003. Evaluation 
of gliadins nanoparticles as drug delivery systems: a study of three different drugs. Int. J. Pharm. 253, 
133–144. https://doi.org/10.1016/S0378-5173(02)00701-9 
100 
Duclairoir Poc, C., Groboillot, A., Lesouhaitier, O., Morin, J.-P., Orange, N., Feuilloley, M.J., 
2011. Caenorhabditis elegans : a model to monitor bacterial air quality. BMC Res. Notes 4, 503. 
https://doi.org/10.1186/1756-0500-4-503 
Duclairoir Poc, C., Verdon, J., Groboillot, A., Barreau, M., Mijouin, L., Leclerc, C., Maillot, 
O., Kondakova, T., Hulen, C., Morin, J.-P., Feuilloley, M.G., Merieau, A., Orange, N., 2014. 
Airborne fluorescent pseudomonads : What potential for virulence? Int. J. Curr. Microbiol. Appl. Sci. 
3, 708–722. 
Etat des connaissances relatif aux nanoparticules de dioxyde de titane et d’oxyde de zinc dans 
les produits cosmétiques en termes de pénétration cutanée, de génotoxicité et de cancérogenèse 
(Rapport relatif aux nanomatériaux dans les produits cosmétiques No. Saisine 2008 BCT0001), 2011. 
. Afssaps, Paris. 
Europe, F., Unece, F.A.O., 2015. State of Europe’s forests 2015, in: Ministerial Conference on the 
Protection of Forests in Europe. p. 314. 
European Commission, Directorate General for Health & Consumers, 2013. Opinion on 
Titanium Dioxide (nano form): COLIPA n° S75. European Commission, Luxembourg. 
Farrand, S.K., Hwang, I., Cook, D.M., 1996. The tra region of the nopaline-type Ti plasmid is a 
chimera with elements related to the transfer systems of RSF1010, RP4, and F. J. Bacteriol. 178, 
4233–4247. 
Fazli, M., Almblad, H., Rybtke, M.L., Givskov, M., Eberl, L., Tolker-Nielsen, T., 2014. 
Regulation of biofilm formation in Pseudomonas and Burkholderia species. Environ. Microbiol. 16, 
1961–1981. 
Feng, J., Lamour, G., Xue, R., Mirvakliki, M.N., Hatzikiriakos, S.G., Xu, J., Li, H., Wang, S., 
Lu, X., 2016. Chemical, physical and morphological properties of bacterial biofilms affect survival 
of encased Campylobacter jejuni F38011 under aerobic stress. Int. J. Food Microbiol. 238, 172–182. 
Ferenci, T., 2007. Bacterial Physiology, Regulation and Mutational Adaptation in a Chemostat 
Environment, in: Advances in Microbial Physiology. Elsevier, pp. 169–315. 
https://doi.org/10.1016/S0065-2911(07)53003-1 
Fetar, H., Gilmour, C., Klinoski, R., Daigle, D.M., Dean, C.R., Poole, K., 2011. mexEF-oprN 
Multidrug Efflux Operon of Pseudomonas aeruginosa : Regulation by the MexT Activator in 
Response to Nitrosative Stress and Chloramphenicol. Antimicrob. Agents Chemother. 55, 508–514. 
https://doi.org/10.1128/AAC.00830-10 
Foster, H.A., Ditta, I.B., Varghese, S., Steele, A., 2011. Photocatalytic disinfection using titanium 
dioxide: spectrum and mechanism of antimicrobial activity. Appl. Microbiol. Biotechnol. 90, 1847–
1868. https://doi.org/10.1007/s00253-011-3213-7 
Fouchard, S., Abdellaoui-MaÃ¢ne, Z., Boulanger, A., Llopiz, P., Neunlist, S., 2005. Influence of 
growth conditions on Pseudomonas fluorescens strains: A link between metabolite production and 
101 
the PLFA profile. FEMS Microbiol. Lett. 251, 211–218. 
https://doi.org/10.1016/j.femsle.2005.08.003 
Fuchs, B., Schiller, J., Süß, R., Schürenberg, M., Suckau, D., 2007. A direct and simple method 
of coupling matrix-assisted laser desorption and ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) to thin-layer chromatography (TLC) for the analysis of phospholipids from egg 
yolk. Anal. Bioanal. Chem. 389, 827–834. https://doi.org/10.1007/s00216-007-1488-4 
Fukuto, J.M., Cho, J.Y., Switzer, C.H., 2000. The chemical properties of nitric oxide and related 
nitrogen oxides, in: Nitric Oxide. Elsevier, pp. 23–40. 
Gallardo-Moreno, A.M., Navarro-Pérez, M.L., Vadillo-Rodríguez, V., Bruque, J.M., González-
Martín, M.L., 2011. Insights into bacterial contact angles: Difficulties in defining hydrophobicity 
and surface Gibbs energy. Colloids Surf. B Biointerfaces 88, 373–380. 
Gallique, M., Bouteiller, M., Merieau, A., 2017. The Type VI Secretion System: A Dynamic 
System for Bacterial Communication? Front. Microbiol. 8. https://doi.org/10.3389/fmicb.2017.01454 
Gamalier, J.P., Silva, T.P., Zarantonello, V., Dias, F.F., Melo, R.C.N., 2017. Increased production 
of outer membrane vesicles by cultured freshwater bacteria in response to ultraviolet radiation. 
Microbiol. Res. 194, 38–46. https://doi.org/10.1016/j.micres.2016.08.002 
Geiser, M., Jeannet, N., Fierz, M., Burtscher, H., 2017. Evaluating Adverse Effects of Inhaled 
Nanoparticles by Realistic In Vitro Technology. Nanomaterials 7, 49. 
https://doi.org/10.3390/nano7020049 
Geudens, N., De Vleeschouwer, M., Fehér, K., Rokni-Zadeh, H., Ghequire, M.G.K., Madder, 
A., De Mot, R., Martins, J.C., Sinnaeve, D., 2014. Impact of a Stereocentre Inversion in Cyclic 
Lipodepsipeptides from the Viscosin Group: A Comparative Study of the Viscosinamide and 
Pseudodesmin Conformation and Self-Assembly. ChemBioChem 15, 2736–2746. 
https://doi.org/10.1002/cbic.201402389 
Grimard, V., Lensink, M., Debailleul, F., Ruysschaert, J., Govaert, C., Remaut, H., Fronzes, R., 
2014. The role of lipid composition on bacterial membrane protein conformation and function, in: 
Bacterial Membranes: Structural and Molecular Biology. Caister Academic Press, pp. 195–224. 
Groboillot, A., Portet-Koltalo, F., Le Derf, F., Feuilloley, M.J.G., Orange, N., Duclairoir Poc, 
C., 2011. Novel Application of Cyclolipopeptide Amphisin: Feasibility Study as Additive to 
Remediate Polycyclic Aromatic Hydrocarbon (PAH) Contaminated Sediments. Int. J. Mol. Sci. 12, 
1787–1806. https://doi.org/10.3390/ijms12031787 
Gusarov, I., Shatalin, K., Starodubtseva, M., Nudler, E., 2009. Endogenous Nitric Oxide Protects 
Bacteria Against a Wide Spectrum of Antibiotics. Science 325, 1380–1384. 
https://doi.org/10.1126/science.1175439 
Ha, D.-G., O’Toole, G.A., 2015. c-di-GMP and its Effects on Biofilm Formation and Dispersion: a 
Pseudomonas Aeruginosa Review. Microbiol. Spectr. 3. https://doi.org/10.1128/microbiolspec.MB-
0003-2014 
102 
Hamouda, T., Baker, J.R., 2000. Antimicrobial mechanism of action of surfactant lipid preparations 
in enteric Gram-negative bacilli. J. Appl. Microbiol. 89, 397–403. https://doi.org/10.1046/j.1365-
2672.2000.01127.x 
Hamouda, T., Myc, A., Donovan, B., Shih, A.Y., Reuter, J.D., Baker, J.R., 2001. A novel 
surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, 
enveloped viruses and fungi. Microbiol. Res. 156, 1–7. https://doi.org/10.1078/0944-5013-00069 
Harris, P.J., Fincher, G.B., 2009. Chapter 4.6 - Distribution, Fine Structure and Function of 
(1,3;1,4)-β-Glucans in the Grasses and Other Taxa, in: Bacic, A., Fincher, G.B., Stone, B.A. (Eds.), 
Chemistry, Biochemistry, and Biology of 1-3 Beta Glucans and Related Polysaccharides. Academic 
Press, San Diego, pp. 621–654. https://doi.org/10.1016/B978-0-12-373971-1.00021-2 
Harshey, R.M., 2003. Bacterial Motility on a Surface: Many Ways to a Common Goal. Annu. Rev. 
Microbiol. 57, 249–273. https://doi.org/10.1146/annurev.micro.57.030502.091014 
Hartemann, P., Hoet, P., Proykova, A., Fernandes, T., Baun, A., De Jong, W., Filser, J., 
Hensten, A., Kneuer, C., Maillard, J.-Y., Norppa, H., Scheringer, M., Wijnhoven, S., 2015. 
Nanosilver: Safety, health and environmental effects and role in antimicrobial resistance. Mater. 
Today 18, 122–123. https://doi.org/10.1016/j.mattod.2015.02.014 
Hassett, D.J., Cuppoletti, J., Trapnell, B., Lymar, S.V., Rowe, J.J., Sun Yoon, S., Hilliard, G.M., 
Parvatiyar, K., Kamani, M.C., Wozniak, D.J., Hwang, S.-H., McDermott, T.R., Ochsner, U.A., 
2002. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in 
chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. 
Adv. Drug Deliv. Rev. 54, 1425–1443. https://doi.org/10.1016/S0169-409X(02)00152-7 
Hay, I.D., Wang, Y., Moradali, M.F., Rehman, Z.U., Rehm, B.H.A., 2014. Genetics and regulation 
of bacterial alginate production: Regulation of bacterial alginate. Environ. Microbiol. 16, 2997–3011. 
https://doi.org/10.1111/1462-2920.12389 
Henderson, J.C., Zimmerman, S.M., Crofts, A.A., Boll, J.M., Kuhns, L.G., Herrera, C.M., 
Trent, M.S., 2016. The Power of Asymmetry: Architecture and Assembly of the Gram-Negative 
Outer Membrane Lipid Bilayer. Annu. Rev. Microbiol. 70, 255–278. 
https://doi.org/10.1146/annurev-micro-102215-095308 
Hillion, M., Mijouin, L., Jaouen, T., Barreau, M., Meunier, P., Lefeuvre, L., Lati, E., Chevalier, 
S., Feuilloley, M.G.J., 2013. Comparative study of normal and sensitive skin aerobic bacterial 
populations. MicrobiologyOpen 2, 953–961. https://doi.org/10.1002/mbo3.138 
Hirata, Y., Ryu, M., Oda, Y., Igarashi, K., Nagatsuka, A., Furuta, T., Sugiura, M., 2009. Novel 
characteristics of sophorolipids, yeast glycolipid biosurfactants, as biodegradable low-foaming 
surfactants. J. Biosci. Bioeng. 108, 142–146. https://doi.org/10.1016/j.jbiosc.2009.03.012 
Honnert, B., Grzebyk, M., 2013. Manufactured Nano-objects: An Occupational Survey in Five 
Industries in France. Ann. Occup. Hyg. https://doi.org/10.1093/annhyg/met058 
103 
Jamil, B., Bokhari, H., Imran, M., 2017. Mechanism of Action: How Nano-Antimicrobials Act? 
Curr. Drug Targets 18, 363–373. https://doi.org/10.2174/1389450116666151019101826 
Jeter, R.M., 1984. Chromosomal Location and Function of Genes Affecting Pseudomonas aeruginosa 
Nitrate Assimilation 157, 5. 
Journal officiel de l’Union européenne, 2017. RÈGLEMENT  (UE)  2017/  1413  DE  LA  
COMMISSION  -  du  3  août  2017  -  modifiant  l’annexe IV  du règlement  (CE)  no 1223/  2009  
du  Parlement  européen  et  du  Conseil  relatif  aux  produits  cosmétiques. 
Kadri, H.E., Devanthi, P.V.P., Overton, T.W., Gkatzionis, K., 2017. Do oil-in-water (O/W) nano-
emulsions have an effect on survival and growth of bacteria? Food Res. Int. 101, 114–128. 
https://doi.org/10.1016/j.foodres.2017.08.064 
Kapuścińska, A., Nowak, I., 2016. Silver nanoparticles as a challenge for modern cosmetology and 
pharmacology, in: Nanobiomaterials in Galenic Formulations and Cosmetics. Elsevier, pp. 395–417. 
https://doi.org/10.1016/B978-0-323-42868-2.00015-2 
Kearns, D.B., 2010. A field guide to bacterial swarming motility. Nat. Rev. Microbiol. 8, 634–644. 
https://doi.org/10.1038/nrmicro2405 
Khan, S.R., Mavrodi, D.V., Jog, G.J., Suga, H., Thomashow, L.S., Farrand, S.K., 2005. 
Activation of the phz operon of Pseudomonas fluorescens 2-79 requires the LuxR homolog PhzR, N-
(3-OH-hexanoyl)-L-homoserine lactone produced by the LuxI homolog PhzI, and a cis-acting phz 
box. J. Bacteriol. 187, 6517–6527. 
Khatri, M., Bello, D., Martin, J., Bello, A., Gore, R., Demokritou, P., Gaines, P., 2017. Chronic 
upper airway inflammation and systemic oxidative stress from nanoparticles in photocopier 
operators: Mechanistic insights. NanoImpact 5, 133–145. 
https://doi.org/10.1016/j.impact.2017.01.007 
Kiran, G.S., Ninawe, A.S., Lipton, A.N., Pandian, V., Selvin, J., 2016. Rhamnolipid 
biosurfactants: evolutionary implications, applications and future prospects from untapped marine 
resource. Crit. Rev. Biotechnol. 36, 399–415. 
Köhler, T., Michea-Hamzehpour, M., Epp, S.F., Pechere, J.-C., 1999. Carbapenem Activities 
against Pseudomonas aeruginosa: Respective Contributions of OprD and Efflux Systems. 
Antimicrob. Agents Chemother. 43, 4. 
Köhler, T., Michéa-Hamzehpour, M., Henze, U., Gotoh, N., Curty, L.K., Pechère, J.C., 1997. 
Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of 
Pseudomonas aeruginosa. Mol. Microbiol. 23, 345–354. 
Kondakova, T., Catovic, C., Barreau, M., Nusser, M., Brenner-Weiss, G., Chevalier, S., 
Dionnet, F., Orange, N., Poc, C.D., 2016. Response to Gaseous NO2 Air Pollutant of P. fluorescens 
Airborne Strain MFAF76a and Clinical Strain MFN1032. Front. Microbiol. 7. 
https://doi.org/10.3389/fmicb.2016.00379 
104 
Kondakova, T., D’Heygère, F., Feuilloley, M.J., Orange, N., Heipieper, H.J., Duclairoir Poc, C., 
2015a. Glycerophospholipid synthesis and functions in Pseudomonas. Chem. Phys. Lipids 190, 27–
42. https://doi.org/10.1016/j.chemphyslip.2015.06.006 
Kondakova, T., Machour, N.M., Poc, C.D., 2017. HPTLC-MALDI TOF MS Imaging Analysis of 
Phospholipids, in: Wood, P. (Ed.), Lipidomics, Neuromethods. Springer New York, New York, NY, 
pp. 163–173. https://doi.org/10.1007/978-1-4939-6946-3_12 
Kondakova, T., Merlet-Machour, N., Chapelle, M., Preterre, D., Dionnet, F., Feuilloley, M., 
Orange, N., Duclairoir Poc, C., 2015b. A new study of the bacterial lipidome: HPTLC-MALDI-
TOF imaging enlightening the presence of phosphatidylcholine in airborne Pseudomonas fluorescens 
MFAF76a. Res. Microbiol. 166, 1–8. https://doi.org/10.1016/j.resmic.2014.11.003 
Kruijt, M., Tran, H., Raaijmakers, J.M., 2009. Functional, genetic and chemical characterization 
of biosurfactants produced by plant growth-promoting Pseudomonas putida 267. J. Appl. Microbiol. 
107, 546–556. 
Landrigan, P.J., Fuller, R., Acosta, N.J.R., Adeyi, O., Arnold, R., Basu, N. (Nil), Baldé, A.B., 
Bertollini, R., Bose-O’Reilly, S., Boufford, J.I., Breysse, P.N., Chiles, T., Mahidol, C., Coll-Seck, 
A.M., Cropper, M.L., Fobil, J., Fuster, V., Greenstone, M., Haines, A., Hanrahan, D., Hunter, 
D., Khare, M., Krupnick, A., Lanphear, B., Lohani, B., Martin, K., Mathiasen, K.V., McTeer, 
M.A., Murray, C.J.L., Ndahimananjara, J.D., Perera, F., Potočnik, J., Preker, A.S., Ramesh, 
J., Rockström, J., Salinas, C., Samson, L.D., Sandilya, K., Sly, P.D., Smith, K.R., Steiner, A., 
Stewart, R.B., Suk, W.A., van Schayck, O.C.P., Yadama, G.N., Yumkella, K., Zhong, M., 2018. 
The Lancet Commission on pollution and health. The Lancet 391, 462–512. 
https://doi.org/10.1016/S0140-6736(17)32345-0 
Latza, U., Gerdes, S., Baur, X., 2009. Effects of nitrogen dioxide on human health: Systematic 
review of experimental and epidemiological studies conducted between 2002 and 2006. Int. J. Hyg. 
Environ. Health 212, 271–287. https://doi.org/10.1016/j.ijheh.2008.06.003 
Lesouhaitier, O., Veron, W., Chapalain, A., Madi, A., Blier, A.-S., Dagorn, A., Connil, N., 
Chevalier, S., Orange, N., Feuilloley, M., 2009. Gram-Negative Bacterial Sensors for Eukaryotic 
Signal Molecules. Sensors 9, 6967–6990. https://doi.org/10.3390/s90906967 
Li, Y., Heine, S., Entian, M., Sauer, K., Frankenberg-Dinkel, N., 2013. NO-Induced Biofilm 
Dispersion in Pseudomonas aeruginosa Is Mediated by an MHYT Domain-Coupled 
Phosphodiesterase. J. Bacteriol. 195, 3531–3542. https://doi.org/10.1128/jb.01156-12 
Lim, M.W., Lau, E.V., Poh, P.E., 2016. A comprehensive guide of remediation technologies for oil 
contaminated soil — Present works and future directions. Mar. Pollut. Bull. 109, 14–45. 
https://doi.org/10.1016/j.marpolbul.2016.04.023 
Loiseau, C., Schlusselhuber, M., Bigot, R., Bertaux, J., Berjeaud, J.-M., Verdon, J., 2015. 
Surfactin from Bacillus subtilis displays an unexpected anti-Legionella activity. Appl. Microbiol. 
Biotechnol. 99, 5083–5093. https://doi.org/10.1007/s00253-014-6317-z 
105 
Mann, E.E., Wozniak, D.J., 2012. Pseudomonas biofilm matrix composition and niche biology. 
FEMS Microbiol. Rev. 36, 893–916. 
Mansilla, M.C., Cybulski, L.E., Albanesi, D., de Mendoza, D., 2004. Control of Membrane Lipid 
Fluidity by Molecular Thermosensors. J. Bacteriol. 186, 6681–6688. 
https://doi.org/10.1128/JB.186.20.6681-6688.2004 
Mao, X., Jiang, R., Xiao, W., Yu, J., 2015. Use of surfactants for the remediation of contaminated 
soils: A review. J. Hazard. Mater. 285, 419–435. https://doi.org/10.1016/j.jhazmat.2014.12.009 
Marambio-Jones, C., Hoek, E.M.V., 2010. A review of the antibacterial effects of silver 
nanomaterials and potential implications for human health and the environment. J. Nanoparticle Res. 
12, 1531–1551. https://doi.org/10.1007/s11051-010-9900-y 
Marella, E.R., Holkenbrink, C., Siewers, V., Borodina, I., 2018. Engineering microbial fatty acid 
metabolism for biofuels and biochemicals. Curr. Opin. Biotechnol. 50, 39–46. 
https://doi.org/10.1016/j.copbio.2017.10.002 
Martinotti, M.G., Allegrone, G., Cavallo, M., Fracchia, L., 2013. Biosurfactants, in: Sustainable 
Development in Chemical Engineering Innovative Technologies. Wiley-Blackwell, pp. 199–240. 
https://doi.org/10.1002/9781118629703.ch9 
Martins, M.L., Uelinton, M.P., Riedel, K., Vanetti, M.C., Mantovani, H.C., Araújo, E.F. de, 
2014. Lack of AHL-based quorum sensing in Pseudomonas fluorescens isolated from milk. Braz. J. 
Microbiol. 45, 1039–1046. 
Mathur, A., Bhuvaneshwari, M., Babu, S., Chandrasekaran, N., Mukherjee, A., 2017. The effect 
of TiO2 nanoparticles on sulfate-reducing bacteria and their consortium under anaerobic conditions. 
J. Environ. Chem. Eng. 5, 3741–3748. https://doi.org/10.1016/j.jece.2017.07.032 
McClean, K.H., Winson, M.K., Fish, L., Taylor, A., Chhabra, S.R., Camara, M., Daykin, M., 
Lamb, J.H., Swift, S., Bycroft, B.W., others, 1997. Quorum sensing and Chromobacterium 
violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine 
lactones. Microbiology 143, 3703–3711. 
McCollister, B.D., Hoffman, M., Husain, M., Vázquez-Torres, A., 2011. Nitric Oxide Protects 
Bacteria from Aminoglycosides by Blocking the Energy-Dependent Phases of Drug Uptake. 
Antimicrob. Agents Chemother. 55, 2189–2196. https://doi.org/10.1128/AAC.01203-10 
Mijouin, L., Hillion, M., Ramdani, Y., Jaouen, T., Duclairoir-Poc, C., Follet-Gueye, M.-L., Lati, 
E., Yvergnaux, F., Driouich, A., Lefeuvre, L., Farmer, C., Misery, L., Feuilloley, M.G.J., 2013. 
Effects of a Skin Neuropeptide (Substance P) on Cutaneous Microflora. PLOS ONE 8, e78773. 
https://doi.org/10.1371/journal.pone.0078773 
Möller, M.N., Lancaster Jr, J.R., Denicola, A., 2008. The interaction of reactive oxygen and 
nitrogen species with membranes. Curr. Top. Membr. 61, 23–42. 
106 
Moreno-Vivián, C., Cabello, P., Martínez-Luque, M., Blasco, R., Castillo, F., 1999. Prokaryotic 
Nitrate Reduction: Molecular Properties and Functional Distinction among Bacterial Nitrate 
Reductases. J. Bacteriol. 181, 6573–6584. 
Morin, J.-P., Gouriou, F., Preterre, D., Bobbia, M., Delmas, V., 2009. Évaluation de l’exposition 
aux polluants atmosphériques des conducteurs de véhicules automobiles par la mise en œuvre de 
mesures dynamiques dans l’habitacle du véhicule. Arch. Mal. Prof. Environ. 70, 184–192. 
https://doi.org/10.1016/j.admp.2008.10.024 
Morin, J.-P., Preterre, D., Gouriou, F., Delmas, V., François, A., Orange, N., Grosboillot, A., 
Duclairoir-Poc, C., Moretti, M., Maillot, O., Lesouhaitier, O., 2013. Particules urbaines et 
céréalières, micro-organismes, mycotoxines et pesticides [WWW Document]. 
Httpirevuesinistfrpollution-Atmospherique. http://dx.doi.org/10.4267/pollution-atmospherique.759 
N’Diaye, A.R., Leclerc, C., Kentache, T., Hardouin, J., Poc, C.D., Konto-Ghiorghi, Y., 
Chevalier, S., Lesouhaitier, O., Feuilloley, M.G.J., 2016. Skin-bacteria communication: 
Involvement of the neurohormone Calcitonin Gene Related Peptide (CGRP) in the regulation of 
Staphylococcus epidermidis virulence. Sci. Rep. 6, 35379. 
Nielsen, T.H., Christophersen, C., Anthoni, U., Sørensen, J., 1999. Viscosinamide, a new cyclic 
depsipeptide with surfactant and antifungal properties produced by Pseudomonas fluorescens DR54. 
J. Appl. Microbiol. 87, 80–90. https://doi.org/10.1046/j.1365-2672.1999.00798.x 
Nielsen, T.H., Sorensen, D., Tobiasen, C., Andersen, J.B., Christophersen, C., Givskov, M., 
Sorensen, J., 2002. Antibiotic and Biosurfactant Properties of Cyclic Lipopeptides Produced by 
Fluorescent Pseudomonas spp. from the Sugar Beet Rhizosphere. Appl. Environ. Microbiol. 68, 
3416–3423. https://doi.org/10.1128/AEM.68.7.3416-3423.2002 
Nielsen, T.H., Sorensen, J., 2003. Production of Cyclic Lipopeptides by Pseudomonas fluorescens 
Strains in Bulk Soil and in the Sugar Beet Rhizosphere. Appl. Environ. Microbiol. 69, 861–868. 
https://doi.org/10.1128/AEM.69.2.861-868.2003 
Nitschke, M., Silva, S.S. e, 2018. Recent food applications of microbial surfactants. Crit. Rev. Food 
Sci. Nutr. 58, 631–638. https://doi.org/10.1080/10408398.2016.1208635 
Novik, G., Kiseleva, V.S. and E., 2015. An Insight Into Beneficial Pseudomonas bacteria. Microbiol. 
Agric. Hum. Health. https://doi.org/10.5772/60502 
Ongena, M., Jacques, P., 2008. Bacillus lipopeptides: versatile weapons for plant disease biocontrol. 
Trends Microbiol. 16, 115–125. https://doi.org/10.1016/j.tim.2007.12.009 
Orecchioni, A.-M., Duclairoir, C., Irache, J.M., Nakache, E., 2007. Plant Protein-based 
Nanoparticles, in: Kumar, C.S.S.R. (Ed.), Nanotechnologies for the Life Sciences. Wiley-VCH 
Verlag GmbH & Co. KGaA, Weinheim, Germany. https://doi.org/10.1002/9783527610419.ntls0016 
Orecchioni, A.M., Duclairoir, C., Nakache, E., 2001. Maîtrise de la taille de nanoparticules de 
gliadines de blé par la détermination de leur paramètre de solubilité. Ann. Pharm. Fr. 59, 402–406. 
107 
Orecchioni, A.-M., Duclairoir, C., Renard, D., Nakache, E., 2006. Gliadin Characterization by 
Sans and Gliadin Nanoparticle Growth Modelization. J. Nanosci. Nanotechnol. 6, 3171–3178. 
https://doi.org/10.1166/jnn.2006.455 
Ortega, A., Segura, A., Bernal, P., Pini, C., Daniels, C., Ramos, J.-L., Krell, T., Matilla, M.A., 
2017. Membrane Composition and Modifications in Response to Aromatic Hydrocarbons in Gram-
Negative Bacteria, in: Krell, Tino (Ed.), Cellular Ecophysiology of Microbe, Handbook of 
Hydrocarbon and Lipid Microbiology. Springer International Publishing, Cham, pp. 1–12. 
https://doi.org/10.1007/978-3-319-20796-4_48-1 
Otzen, D.E., 2017. Biosurfactants and surfactants interacting with membranes and proteins: Same 
but different? Biochim. Biophys. Acta BBA - Biomembr. 1859, 639–649. 
https://doi.org/10.1016/j.bbamem.2016.09.024 
Pan, X., Dong, Y., Fan, Z., Liu, C., Xia, B., Shi, J., Bai, F., Jin, Y., Cheng, Z., Jin, S., Wu, W., 
2017. In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside 
Antibiotics. Front. Cell. Infect. Microbiol. 7. https://doi.org/10.3389/fcimb.2017.00083 
Pelgrift, R.Y., Friedman, A.J., 2013. Nanotechnology as a therapeutic tool to combat microbial 
resistance. Adv. Drug Deliv. Rev., Nanotechnology and drug resistance 65, 1803–1815. 
https://doi.org/10.1016/j.addr.2013.07.011 
Persat, A., 2017. Bacterial mechanotransduction. Curr. Opin. Microbiol., Cell regulation 36, 1–6. 
https://doi.org/10.1016/j.mib.2016.12.002 
Petrova, O.E., Sauer, K., 2016. Escaping the biofilm in more than one way: desorption, detachment 
or dispersion. Curr. Opin. Microbiol. 30, 67–78. 
Phan, G., Benabdelhak, H., Lascombe, M.-B., Benas, P., Rety, S., Picard, M., Ducruix, A., 
Etchebest, C., Broutin, I., 2010. Structural and Dynamical Insights into the Opening Mechanism of 
P. aeruginosa OprM Channel. Structure 18, 507–517. https://doi.org/10.1016/j.str.2010.01.018 
Picard, M., Tikhonova, E.B., Broutin, I., Lu, S., Verchère, A., Zgurskaya, H.I., 2018. 
Biochemical Reconstitution and Characterization of Multicomponent Drug Efflux Transporters, in: 
Yamaguchi, A., Nishino, K. (Eds.), Bacterial Multidrug Exporters: Methods and Protocols, Methods 
in Molecular Biology. Springer New York, New York, NY, pp. 113–145. 
https://doi.org/10.1007/978-1-4939-7454-2_8 
Picot, L., Mezghani-Abdelmoula, S., Chevalier, S., Merieau, A., Lesouhaitier, O., Guerillon, J., 
Cazin, L., Orange, N., Feuilloley, M.G.J., 2004. Regulation of the cytotoxic effects of Pseudomonas 
fluorescens by growth temperature. Res. Microbiol. 155, 39–46. 
https://doi.org/10.1016/j.resmic.2003.09.014 
Planchon, M., Ferrari, R., Guyot, F., Gélabert, A., Menguy, N., Chanéac, C., Thill, A., 
Benedetti, M.F., Spalla, O., 2013. Interaction between Escherichia coli and TiO2 nanoparticles in 
natural and artificial waters. Colloids Surf. B Biointerfaces 102, 158–164. 
https://doi.org/10.1016/j.colsurfb.2012.08.034 
108 
Planchon, M., Léger, T., Spalla, O., Huber, G., Ferrari, R., 2017. Metabolomic and proteomic 
investigations of impacts of titanium dioxide nanoparticles on Escherichia coli. PLOS ONE 12, 
e0178437. https://doi.org/10.1371/journal.pone.0178437 
Poc, C.D., Meylheuc, T., Ngoya, S., Groboillot, A., Bodilis, J., Taupin, L., Mérieau, A., 
Feuilloley, M., Orange, N., 2011. Influence of growth temperature on cyclopeptides production and 
on adhesion behaviour in environmental strains of Pseudomonas fluorescens. J. Bacteriol. Parasitol. 
1, 002. 
Poole, R.K., Anjum, M.F., Membrillo-Hernández, J., Kim, S.O., Hughes, M.N., Stewart, V., 
1996. Nitric oxide, nitrite, and Fnr regulation of hmp (flavohemoglobin) gene expression in 
Escherichia coli K-12. J. Bacteriol. 178, 5487–5492. https://doi.org/10.1128/jb.178.18.5487-
5492.1996 
Portet-Koltalo, F., Ammami, M.T., Benamar, A., Duclairoir-Poc, C., Groboillot, A., Orange, 
N., 2011. Déséquestration de polluants de type hydrocarbures aromatiques polycycliques à l’interface 
de sédiments au moyen d’un tensioactif original d’origine biologique 8. 
Portet-Koltalo, F., Ammami, M.T., Benamar, A., Poc, C.D., Groboillot, A., Orange, N., 2010. 
Pollution des sédiments de dragage-Procédés de bioremédiation alliés à l’électromigration. Spectra 
Anal. 277, 54–58. 
Portet-Koltalo, F., Ammami, M.T., Benamar, A., Wang, H., Le Derf, F., Duclairoir-Poc, C., 
2013. Investigation of the release of PAHs from artificially contaminated sediments using 
cyclolipopeptidic biosurfactants. J. Hazard. Mater. 261, 593–601. 
https://doi.org/10.1016/j.jhazmat.2013.07.062 
Primo, E.D., Ruiz, F., Masciarelli, O., Giordano, W., 2015. Biofilm Formation and Biosurfactant 
Activity in Plant-Associated Bacteria, in: Bacterial Metabolites in Sustainable Agroecosystem. 
Springer, pp. 337–349. 
Pukatzki, S., Ma, A.T., Sturtevant, D., Krastins, B., Sarracino, D., Nelson, W.C., Heidelberg, 
J.F., Mekalanos, J.J., 2006. Identification of a conserved bacterial protein secretion system in Vibrio 
cholerae using the Dictyostelium host model system. Proc. Natl. Acad. Sci. 103, 1528–1533. 
https://doi.org/10.1073/pnas.0510322103 
Qiu, T.A., Meyer, B.M., Christenson, K.G., Klaper, R.D., Haynes, C.L., 2017. A mechanistic 
study of TiO2 nanoparticle toxicity on Shewanella oneidensis MR-1 with UV-containing simulated 
solar irradiation: Bacterial growth, riboflavin secretion, and gene expression. Chemosphere 168, 
1158–1168. https://doi.org/10.1016/j.chemosphere.2016.10.085 
Raaijmakers, J.M., de Bruijn, I., de Kock, M.J.D., 2006. Cyclic Lipopeptide Production by Plant-
Associated Pseudomonas spp.: Diversity, Activity, Biosynthesis, and Regulation. Mol. Plant. 
Microbe Interact. 19, 699–710. https://doi.org/10.1094/MPMI-19-0699 
109 
Raaijmakers, J.M., De Bruijn, I., Nybroe, O., Ongena, M., 2010. Natural functions of lipopeptides 
from Bacillus and Pseudomonas: more than surfactants and antibiotics. FEMS Microbiol. Rev. 34, 
1037–1062. 
Rager, M.S., Aytug, T., Veith, G.M., Joshi, P., 2016. Low-Thermal-Budget Photonic Processing of 
Highly Conductive Cu Interconnects Based on CuO Nanoinks: Potential for Flexible Printed 
Electronics. ACS Appl. Mater. Interfaces 8, 2441–2448. https://doi.org/10.1021/acsami.5b12156 
Rea, S.L., Graham, B.H., Nakamaru‐Ogiso, E., Kar, A., Falk, M.J., 2010. Bacteria, yeast, worms, 
and flies: Exploiting simple model organisms to investigate human mitochondrial diseases. Dev. 
Disabil. Res. Rev. 16, 200–218. https://doi.org/10.1002/ddrr.114 
Redondo-Nieto, M., Barret, M., Morrissey, J., Germaine, K., Martínez-Granero, F., Barahona, 
E., Navazo, A., Sánchez-Contreras, M., Moynihan, J.A., Muriel, C., Dowling, D., O’Gara, F., 
Martín, M., Rivilla, R., 2013. Genome sequence reveals that Pseudomonas fluorescens F113 
possesses a large and diverse array of systems for rhizosphere function and host interaction. BMC 
Genomics 14, 54. https://doi.org/10.1186/1471-2164-14-54 
Règlement (CE) no 1223/2009 du Parlement européen et du Conseil du 30 novembre 2009 relatif 
aux produits cosmétiques, 2009. , Règlement européen. 
Renard, D., Reddy, T., 2007. Polymères d’origine biologique pour la microencapsulation. Lavoisier: 
Paris, France. 
Renard, Denis, Robert, P., Lavenant, L., Melcion, D., Popineau, Y., Guéguen, J., Duclairoir, C., 
Nakache, E., Sanchez, C., Schmitt, C., 2002a. Creation of biopolymeric colloidal carriers dedicated 
to controlled release applications, in: Plant Biopolymer Science. pp. 119–124. 
Renard, D, Robert, P., Lavenant, L., Melcion, D., Popineau, Y., Guéguen, J., Duclairoir, C., 
Nakache, E., Sanchez, C., Schmitt, C., 2002. Biopolymeric colloidal carriers for encapsulation or 
controlled release applications. Int. J. Pharm. 242, 163–166. https://doi.org/10.1016/S0378-
5173(02)00143-6 
Renard, Denis, Valle, G.D., Popineau, Y., 2002b. Plant Biopolymer Science: Food and Non-food 
Applications. Royal Society of Chemistry. 
Richard, A., Rossignol, G., Comet, J.-P., Bernot, G., Guespin-Michel, J., Merieau, A., 2012. 
Boolean Models of Biosurfactants Production in Pseudomonas fluorescens. PLoS ONE 7, e24651. 
https://doi.org/10.1371/journal.pone.0024651 
Rivardo, F., Turner, R.J., Allegrone, G., Ceri, H., Martinotti, M.G., 2009. Anti-adhesion activity 
of two biosurfactants produced by Bacillus spp. prevents biofilm formation of human bacterial 
pathogens. Appl. Microbiol. Biotechnol. 83, 541–553. https://doi.org/10.1007/s00253-009-1987-7 
Rokni-Zadeh, H., Mangas-Losada, A., De Mot, R., 2011a. PCR detection of novel non-ribosomal 
peptide synthetase genes in lipopeptide-producing Pseudomonas. Microb. Ecol. 62, 941–947. 
https://doi.org/10.1007/s00248-011-9885-9 
110 
Rokni-Zadeh, H., Mangas-Losada, A., De Mot, R., 2011b. PCR Detection of Novel Non-ribosomal 
Peptide Synthetase Genes in Lipopeptide-Producing Pseudomonas. Microb. Ecol. 62. 
https://doi.org/10.1007/s00248-011-9885-9 
Romantsov, T., Wood, J.M., 2017. Contributions of membrane lipids to bacterial cell homeostasis 
upon osmotic challenge. Biog. Fat. Acids Lipids Membr. 1–23. 
Ron, E.Z., Rosenberg, E., 2001. Natural roles of biosurfactants. Minireview. Environ. Microbiol. 3, 
229–236. https://doi.org/10.1046/j.1462-2920.2001.00190.x 
Roongsawang, N., Hase, K., Haruki, M., Imanaka, T., Morikawa, M., Kanaya, S., 2003. Cloning 
and characterization of the gene cluster encoding arthrofactin synthetase from Pseudomonas sp. 
MIS38. Chem. Biol. 10, 869–880. 
Rosenberg, E., Ron, E.Z., 1999. High- and low-molecular-mass microbial surfactants. Appl. 
Microbiol. Biotechnol. 52, 154–162. https://doi.org/10.1007/s002530051502 
Rossignol, G., Merieau, A., Guerillon, J., Veron, W., Lesouhaitier, O., Feuilloley, M.G., Orange, 
N., 2008. Involvement of a phospholipase C in the hemolytic activity of a clinical strain of 
Pseudomonas fluorescens. BMC Microbiol. 8, 189. https://doi.org/10.1186/1471-2180-8-189 
Rossignol, G., Sperandio, D., Guerillon, J., Duclairoir Poc, C., Soum-Soutera, E., Orange, N., 
Feuilloley, M.G.J., Merieau, A., 2009. Phenotypic variation in the Pseudomonas fluorescens clinical 
strain MFN1032. Res. Microbiol. 160, 337–344. https://doi.org/10.1016/j.resmic.2009.04.004 
Rowenczyk, L., Duclairoir-Poc, C., Barreau, M., Picard, C., Hucher, N., Orange, N., Grisel, M., 
Feuilloley, M., 2017. Impact of coated TiO2 -nanoparticles used in sunscreens on two representative 
strains of the human microbiota: Effect of the particle surface nature and aging. Colloids Surf. B 
Biointerfaces 158, 339–348. https://doi.org/10.1016/j.colsurfb.2017.07.013 
Rowenczyk, L., Picard, C., Duclairoir-Poc, C., Hucher, N., Orange, N., Feuilloley, M., Grisel, 
M., 2016. Development of preservative-free nanoparticles-based emulsions: Effects of NP surface 
properties and sterilization process. Int. J. Pharm. 510, 125–134. 
https://doi.org/10.1016/j.ijpharm.2016.06.014 
Roy, A.B., Petrova, O.E., Sauer, K., 2012. The Phosphodiesterase DipA (PA5017) Is Essential for 
Pseudomonas aeruginosa Biofilm Dispersion. J. Bacteriol. 194, 2904–2915. 
https://doi.org/10.1128/JB.05346-11 
Saccà, M.L., Fajardo, C., Martinez-Gomariz, M., Costa, G., Nande, M., Martin, M., 2014. 
Molecular Stress Responses to Nano-Sized Zero-Valent Iron (nZVI) Particles in the Soil Bacterium 
Pseudomonas stutzeri. PLOS ONE 9, e89677. https://doi.org/10.1371/journal.pone.0089677 
Saha, N., Monge, C., Dulong, V., Picart, C., Glinel, K., 2013. Influence of polyelectrolyte film 
stiffness on bacterial growth. Biomacromolecules 14, 520–528. 
Santos, A.L., Moreirinha, C., Lopes, D., Esteves, A.C., Henriques, I., Almeida, A., Domingues, 
M.R.M., Delgadillo, I., Correia, A., Cunha, Â., 2013. Effects of UV Radiation on the Lipids and 
111 
Proteins of Bacteria Studied by Mid-Infrared Spectroscopy. Environ. Sci. Technol. 47, 6306–6315. 
https://doi.org/10.1021/es400660g 
Santos, D.K.F., Meira, H.M., Rufino, R.D., Luna, J.M., Sarubbo, L.A., 2017. Biosurfactant 
production from Candida lipolytica in bioreactor and evaluation of its toxicity for application as a 
bioremediation agent. Process Biochem. 54, 20–27. https://doi.org/10.1016/j.procbio.2016.12.020 
Sanyal, S., Menon, A.K., 2009. Flipping Lipids: Why an’ What’s the Reason for? ACS Chem. Biol. 
4, 895–909. https://doi.org/10.1021/cb900163d 
Satpute, S.K., Kulkarni, G.R., Banpurkar, A.G., Banat, I.M., Mone, N.S., Patil, R.H., 
Cameotra, S.S., 2016. Biosurfactant/s from Lactobacilli species: Properties, challenges and potential 
biomedical applications. J. Basic Microbiol. 56, 1140–1158. 
https://doi.org/10.1002/jobm.201600143 
SCCS, 2017. Checklists for Applicants Submitting Dossiers on Cosmetic Ingredients, 
SCCS/1588/17. European Commission, Luxembourg. 
Sccs, Chaudhry, Q., 2015. Opinion of the Scientific Committee on Consumer safety (SCCS) – 
Revision of the opinion on the safety of the use of titanium dioxide, nano form, in cosmetic products. 
Regul. Toxicol. Pharmacol. 73, 669–670. https://doi.org/10.1016/j.yrtph.2015.09.005 
Scholz, C.F.P., Kilian, M., 2016. The natural history of cutaneous propionibacteria, and 
reclassification of selected species within the genus Propionibacterium to the proposed novel genera 
Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. 
Int. J. Syst. Evol. Microbiol. 66, 4422–4432. https://doi.org/10.1099/ijsem.0.001367 
Schubert, H., Engel, R., 2004. Product and Formulation Engineering of Emulsions. Chem. Eng. Res. 
Des., In Honour of Professor Alvin W. Nienow 82, 1137–1143. 
https://doi.org/10.1205/cerd.82.9.1137.44154 
Scientific Committee on Consumer Safety (SCCS), Chaudhry, Q., 2016. Opinion of the Scientific 
Committee on Consumer safety (SCCS) – Second revision of the opinion on carbon black, nano-
form, in cosmetic products. Regul. Toxicol. Pharmacol. 79, 103–104. 
https://doi.org/10.1016/j.yrtph.2016.02.021 
Seghal Kiran, G., Anto Thomas, T., Selvin, J., Sabarathnam, B., Lipton, A.P., 2010. 
Optimization and characterization of a new lipopeptide biosurfactant produced by marine 
Brevibacterium aureum MSA13 in solid state culture. Bioresour. Technol. 101, 2389–2396. 
https://doi.org/10.1016/j.biortech.2009.11.023 
Shiro, Y., 2012. Structure and function of bacterial nitric oxide reductases. Biochim. Biophys. Acta 
BBA - Bioenerg. 1817, 1907–1913. https://doi.org/10.1016/j.bbabio.2012.03.001 
Signorelli, S., Möller, M.N., Coitiño, E.L., Denicola, A., 2011. Nitrogen dioxide solubility and 
permeation in lipid membranes. Arch. Biochem. Biophys. 512, 190–196. 
https://doi.org/10.1016/j.abb.2011.06.003 
112 
Silveyra, P., Fuentes, N., Rivera, L., 2017. Understanding the Intersection of Environmental 
Pollution, Pneumonia, and Inflammation: Does Gender Play a Role?, in: Chroneos, Z.C. (Ed.), 
Contemporary Topics of Pneumonia. InTech. https://doi.org/10.5772/intechopen.69627 
Singh, A., Van Hamme, J.D., Ward, O.P., 2007. Surfactants in microbiology and biotechnology: 
Part 2. Application aspects. Biotechnol. Adv. 25, 99–121. 
https://doi.org/10.1016/j.biotechadv.2006.10.004 
Sitaraman, R., 2015. Pseudomonas spp. as models for plant-microbe interactions. Front. Plant Sci. 
6. https://doi.org/10.3389/fpls.2015.00787 
Sobel, M.L., Neshat, S., Poole, K., 2005. Mutations in PA2491 (mexS) Promote MexT-Dependent 
mexEF-oprN Expression and Multidrug Resistance in a Clinical Strain of Pseudomonas aeruginosa. 
J. Bacteriol. 187, 1246–1253. https://doi.org/10.1128/JB.187.4.1246-1253.2005 
Soberón-Chávez, G., Lépine, F., Déziel, E., 2005. Production of rhamnolipids by Pseudomonas 
aeruginosa. Appl. Microbiol. Biotechnol. 68, 718–725. https://doi.org/10.1007/s00253-005-0150-3 
Song, F., Koo, H., Ren, D., 2015. Effects of Material Properties on Bacterial Adhesion and Biofilm 
Formation. J. Dent. Res. 94, 1027–1034. https://doi.org/10.1177/0022034515587690 
Sperandio, D., Decoin, V., Latour, X., Mijouin, L., Hillion, M., Feuilloley, M.G.J., Orange, N., 
Merieau, A., 2012. Virulence of the Pseudomonas fluorescens clinical strain MFN1032 towards 
Dictyostelium discoideum and macrophages in relation with type III secretion system. BMC 
Microbiol. 12, 223. https://doi.org/10.1186/1471-2180-12-223 
Sperandio, D., Rossignol, G., Guerillon, J., Connil, N., Orange, N., Feuilloley, M.G., Merieau, 
A., 2010. Cell-associated hemolysis activity in the clinical strain of Pseudomonas fluorescens 
MFN1032. BMC Microbiol. 10, 124. https://doi.org/10.1186/1471-2180-10-124 
Spiro, S., 2008. Metalloregulatory proteins and nitric oxide signalling in bacteria: Table 1. Biochem. 
Soc. Trans. 36, 1160–1164. https://doi.org/10.1042/bst0361160 
Spiro, S., 2007. Regulators of bacterial responses to nitric oxide. FEMS Microbiol. Rev. 31, 193–
211. https://doi.org/10.1111/j.1574-6976.2006.00061.x 
Stark, W.J., Stoessel, P.R., Wohlleben, W., Hafner, A., 2015. Industrial applications of 
nanoparticles. Chem. Soc. Rev. 44, 5793–5805. https://doi.org/10.1039/c4cs00362d 
Stoodley, P., Sauer, K., Davies, D.G., Costerton, J.W., 2002. Biofilms as Complex Differentiated 
Communities. Annu. Rev. Microbiol. 56, 187–209. 
https://doi.org/10.1146/annurev.micro.56.012302.160705 
Svartengren, M., Strand, V., Bylin, G., Järup, L., Pershagen, G., 2000. Short-term exposure to 
air pollution in a road tunnel enhances the asthmatic response to allergen. Eur. Respir. J. 15, 716–
724. 
Teixeira, P.C., Leite, G.M., Domingues, R.J., Silva, J., Gibbs, P.A., Ferreira, J.P., 2007. 
Antimicrobial effects of a microemulsion and a nanoemulsion on enteric and other pathogens and 
biofilms. Int. J. Food Microbiol. 118, 15–19. https://doi.org/10.1016/j.ijfoodmicro.2007.05.008 
113 
Tremblay, J., Déziel, E., 2008. Improving the reproducibility of Pseudomonas aeruginosa swarming 
motility assays. J. Basic Microbiol. 48, 509–515. https://doi.org/10.1002/jobm.200800030 
Urban, J., Fergus, D.J., Savage, A.M., Ehlers, M., Menninger, H.L., Dunn, R.R., Horvath, J.E., 
2016. The effect of habitual and experimental antiperspirant and deodorant product use on the armpit 
microbiome. PeerJ 4, e1605. https://doi.org/10.7717/peerj.1605 
Van Alst, N.E., Picardo, K.F., Iglewski, B.H., Haidaris, C.G., 2007. Nitrate Sensing and 
Metabolism Modulate Motility, Biofilm Formation, and Virulence in Pseudomonas aeruginosa. 
Infect. Immun. 75, 3780–3790. https://doi.org/10.1128/IAI.00201-07 
Van Hamme, J.D., Singh, A., Ward, O.P., 2006. Physiological aspects: Part 1 in a series of papers 
devoted to surfactants in microbiology and biotechnology. Biotechnol. Adv. 24, 604–620. 
https://doi.org/10.1016/j.biotechadv.2006.08.001 
van Sorge, N.M., Beasley, F.C., Gusarov, I., Gonzalez, D.J., von Köckritz-Blickwede, M., Anik, 
S., Borkowski, A.W., Dorrestein, P.C., Nudler, E., Nizet, V., 2013. Methicillin-resistant 
Staphylococcus aureus Bacterial Nitric-oxide Synthase Affects Antibiotic Sensitivity and Skin 
Abscess Development. J. Biol. Chem. 288, 6417–6426. https://doi.org/10.1074/jbc.M112.448738 
Vincent, J.-L., Sakr, Y., Sprung, C.L., Ranieri, V.M., Reinhart, K., Gerlach, H., Moreno, R., 
Carlet, J., Le Gall, J.-R., Payen, D., 2006. Sepsis in European intensive care units: Results of the 
SOAP study*. Crit. Care Med. 34, 344. https://doi.org/10.1097/01.CCM.0000194725.48928.3A 
Vincent, M., Duval, R.E., Hartemann, P., Engels-Deutsch, M., 2018. Contact killing and 
antimicrobial properties of copper. J. Appl. Microbiol. 124, 1032–1046. 
https://doi.org/10.1111/jam.13681 
Vlamakis, H., Chai, Y., Beauregard, P., Losick, R., Kolter, R., 2013. Sticking together: building 
a biofilm the Bacillus subtilis way. Nat. Rev. Microbiol. 11, 157–168. 
Wang, L., Hu, C., Shao, L., 2017. The antimicrobial activity of nanoparticles: present situation and 
prospects for the future. Int. J. Nanomedicine 12, 1227–1249. https://doi.org/10.2147/IJN.S121956 
Wawrzynczak, A., Feliczak-Guzik, A., Nowak, I., 2016. Nanosunscreens: from nanoencapsulated 
to nanosized cosmetic active forms, in: Nanobiomaterials in Galenic Formulations and Cosmetics. 
Elsevier, pp. 25–46. https://doi.org/10.1016/B978-0-323-42868-2.00002-4 
Weisshoff, H., Hentschel, S., Zaspel, I., Jarling, R., Krause, E., Pham, T.L., 2014. PPZPMs--a 
novel group of cyclic lipodepsipeptides produced by the Phytophthora alni associated strain 
Pseudomonas sp. JX090307--the missing link between the viscosin and amphisin group. Nat. Prod. 
Commun. 9, 989–996. 
White, G.M., 1998. Recent findings in the epidemiologic evidence, classification, and subtypes of 
acne vulgaris. J. Am. Acad. Dermatol. 39, S34–S37. https://doi.org/10.1016/S0190-9622(98)70442-
6 
WHO Regional Office for Europe, 2013. Review of evidence on health aspects of air pollution – 
REVIHAAP Project: Technical Report. WHO Regional Office for Europe, Copenhagen. 
114 
Wild, C.P., Scalbert, A., Herceg, Z., 2013. Measuring the exposome: A powerful basis for 
evaluating environmental exposures and cancer risk. Environ. Mol. Mutagen. 54, 480–499. 
https://doi.org/10.1002/em.21777 
Williams, P., Winzer, K., Chan, W.C., Camara, M., 2007. Look who’s talking: communication 
and quorum sensing in the bacterial world. Philos. Trans. R. Soc. B Biol. Sci. 362, 1119–1134. 
https://doi.org/10.1098/rstb.2007.2039 
Xu, X.-H.N., Brownlow, W.J., Kyriacou, S.V., Wan, Q., Viola, J.J., 2004. Real-Time Probing of 
Membrane Transport in Living Microbial Cells Using Single Nanoparticle Optics and Living Cell 
Imaging †. Biochemistry 43, 10400–10413. https://doi.org/10.1021/bi036231a 
Yadav, H.K.S., Kasina, S., Raizaday, A., 2016. Sunscreens, in: Nanobiomaterials in Galenic 
Formulations and Cosmetics. Elsevier, pp. 201–230. https://doi.org/10.1016/B978-0-323-42868-
2.00009-7 
Yoon, S.S., Hennigan, R.F., Hilliard, G.M., Ochsner, U.A., Parvatiyar, K., Kamani, M.C., Allen, 
H.L., DeKievit, T.R., Gardner, P.R., Schwab, U., Rowe, J.J., Iglewski, B.H., McDermott, T.R., 
Mason, R.P., Wozniak, D.J., Hancock, R.E.W., Parsek, M.R., Noah, T.L., Boucher, R.C., 
Hassett, D.J., 2002. Pseudomonas aeruginosa Anaerobic Respiration in Biofilms. Dev. Cell 3, 593–
603. https://doi.org/10.1016/S1534-5807(02)00295-2 
Zhao, A., Zhu, J., Ye, X., Ge, Y., Li, J., 2016. Inhibition of biofilm development and spoilage 
potential of Shewanella baltica by quorum sensing signal in cell-free supernatant from Pseudomonas 
fluorescens. Int. J. Food Microbiol. 230, 73–80. https://doi.org/10.1016/j.ijfoodmicro.2016.04.015 
Zheng, K., Setyawati, M.I., Leong, D.T., Xie, J., 2018. Antimicrobial silver nanomaterials. Coord. 
Chem. Rev. 357, 1–17. https://doi.org/10.1016/j.ccr.2017.11.019 
Zodrow, K., Brunet, L., Mahendra, S., Li, D., Zhang, A., Li, Q., Alvarez, P.J.J., 2009. 
Polysulfone ultrafiltration membranes impregnated with silver nanoparticles show improved 
biofouling resistance and virus removal. Water Res. 43, 715–723. 
https://doi.org/10.1016/j.watres.2008.11.014 
 
  
114 
Yoon, S.S., Hennigan, R.F., Hilliard, G.M., Ochsner, U.A., Parvatiyar, K., Kamani, M.C., Allen, 
H.L., DeKievit, T.R., Gardner, P.R., Schwab, U., Rowe, J.J., Iglewski, B.H., McDermott, T.R., 
Mason, R.P., Wozniak, D.J., Hancock, R.E.W., Parsek, M.R., Noah, T.L., Boucher, R.C., Hassett, 
D.J., 2002. Pseudomonas aeruginosa Anaerobic Respiration in Biofilms. Dev. Cell 3, 593–603. 
https://doi.org/10.1016/S1534-5807(02)00295-2 
Zhao, A., Zhu, J., Ye, X., Ge, Y., Li, J., 2016. Inhibition of biofilm development and spoilage 
potential of Shewanella baltica by quorum sensing signal in cell-free supernatant from Pseudomonas 
fluorescens. Int. J. Food Microbiol. 230, 73–80. https://doi.org/10.1016/j.ijfoodmicro.2016.04.015 
Zheng, K., Setyawati, M.I., Leong, D.T., Xie, J., 2018. Antimicrobial silver nanomaterials. Coord. 
Chem. Rev. 357, 1–17. https://doi.org/10.1016/j.ccr.2017.11.019 
Zodrow, K., Brunet, L., Mahendra, S., Li, D., Zhang, A., Li, Q., Alvarez, P.J.J., 2009. Polysulfone 
ultrafiltration membranes impregnated with silver nanoparticles show improved biofouling resistance 
and virus removal. Water Res. 43, 715–723. https://doi.org/10.1016/j.watres.2008.11.014 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
I 
Publications et communications 
de C Duclairoir Poc 
 
 30 publications dans des revues internationales ou nationales avec 
comité de lecture répertoriées par l’AERES ou dans les bases de données internationales (ISI 
Web of Knowledge, Pub Med…). 
P1- Formation of Gliadin Nanoparticles: Influence of the Solubility Parameter of the 
Gliadin Solvent 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, Colloid and Interface Science. (1998) 276 : 
321-327. 
P2- Gliadin Nanoparticles : Formation ; All-trans Retinoic Acid Entrapment and 
Release, Size Optimization 
C Duclairoir, JM Irache, E Nakache, A-M Orecchioni, C Chabenat, Y Popineau, Polymer International,. 
(1999) 79 :327-333. 
P3- Maîtrise de la taille de nanoparticules de gliadines de blé par la détermination de 
leur paramètre de solubilité 
A-M Orecchioni, C Duclairoir, E Nakache, Annales Pharmaceutiques Françaises. (2001) 59 : 402-406. 
P4- α-tocopherol encapsulation and in vitro release from wheat gliadin nanoparticles 
C Duclairoir, A-M Orecchioni, P Depraetere, E Nakache, Journal of Microencapsulation. (2002), 19 : 
53-60. 
P5- Polymer Nanoparticles Characterization in Aqueous Suspension 
C Duclairoir, E Nakache, International Journal of Polymer Analysis and Characterization. (2002) 7 : 
284-313. 
P6- Biopolymeric colloidal carriers for encapsulation or controlled release 
D. Renard, P. Robert, L. Lavenant, D. Melcion, Y. Popineau, J. Guéguen, C. Duclairoir, E. Nakache, C. 
Sanchez and C. Schmitt, International Journal of Pharmaceutics. (2002) 242( 1-2) :  163-166. 
P7- Evaluation of Gliadins Nanoparticles as Drug Delivery Systems: a Study of Three 
Different Drugs 
C Duclairoir, A-M Orecchioni, P Depraetere, F Osterstock, E Nakache, International Journal of 
Pharmaceutics. (2003) 253: 133-144. 
P8- Gliadin characterization by SANS and gliadin nanoparticle growth modelization.  
A-M Orecchioni, C Duclairoir, Denid Renard and E Nakache., Journal of nanoscience and 
nanotechnology. (2006) 6 :3171-3178. 
 P9- Phenotypic variation in the Pseudomonas fluorescens clinical strain MFN1032 
G Rossignol, D Sperandio , J Guerillon, C Duclairoir Poc, E Soum-Soutera, N Orange, MGJ Feuilloley, 
A Merieau. Res Microbiol. (2009) 160(5):337-44 
 P10- Pollution des sédiments de dragage : Procédés de bioremédiation alliés à 
l’électromigration. 
F Portet-Koltalo, M Ammami, A Benamar, A Groboillot, N Orange. C Duclairoir Poc Spectra Analyse. 
(2010) 277 : 54-58. 
 P11- Déséquestration de polluants de type hydrocarbures aromatiques polycycliques à 
l’interface de sédiments au moyen de tensioactifs d¹origine biologique. " 
F Portet-Koltalo, M Ammami, A Benamar, A Groboillot, N Orange. C Duclairoir Poc Spectra Analyse. 
(2011) 278 : 21-27. 
 P12- Novel Application of Cyclolipopeptide Amphisin: Faisability Study as Additive to 
Remediate PAHs Contaminated Sediments. 
II 
A Groboillot, F Koltalo, F Lederf, M Feuilloley, N Orange, C Duclairoir Poc, Int. J. Mol. Sci. (2011) 12 
: 1787-1806  
 P13- Caenorhabditis elegans as a model to monitor air bacterial quality" 
C Duclairoir Poc, A Groboillot, O Lesouhaitier, M Feuilloley, J-P Morin, N Orange, BMC Res. Notes. 
(2011) 4:503. 
 P14- The Major Outer Membrane Protein Oprf is Required for Rhamnolipid 
Production in Pseudomonas aeruginosa 
E Bouffartigues, G Gicquel, A Bazire, L Fito-Boncompte, L Taupin, O Maillot, A Groboillot, C 
Poc-Duclairoir, N Orange, M Feuilloley, A Dufour, S Chevalier. J. Bacteriol. Parasitol. (2011)  2 : 
118; DOI : 10.4172/2155-9597.1000118 
 P15- Influence of growth temperature on cyclolipopeptides production and on adhesion 
behaviour in environmental strains of Pseudomonas fluorescens. 
C Duclairoir Poc, T Meylheuc, S Ngoya, A Groboillot, J Bodilis, L Taupin, A Merieau, M Feuilloley, 
N Orange. J. Bacteriol. Parasitol. (2011) S1-002. http://dx.doi.org/10.4172/2155-9597.S1-002. 
 P16- Gamma-aminobutyric acid acts as a specific virulence regulator in Pseudomonas 
aeruginosa 
A Dagorn, M Hillion, A Chapalain, O Lesouhaitier, C Duclairoir Poc, J Vieillard, S Chevalier, L Taupin, 
F Le Derf, MGJ Feuilloley, Microbiology. (2013) 159:339-351 
 P17- Investigation of the release of PAHs from artificially contaminated sediments 
using cyclolipopeptidic biosurfactants 
F Portet-Koltalo, MT Ammami, A Benamar, H Wang, F Le Derf, C Duclairoir-Poc, Journal of 
Hazardous Materials. (2013) 261:593– 601. 
 P18- Effect of GABA, a bacterial metabolite, on Pseudomonas fluorescens surface 
properties and cytotoxicity 
A Dagorn, A Chapalain, L Mijouin, M Hillion, C Duclairoir-Poc, S Chevalier, L Taupin, N Orange, 
MGJ Feuilloley, Int. J. Mol. Sci. (2013) 14 : 12186-12204; DOI : 10.3390/ijms140612186. 
 P19- Effects of a Skin Neuropeptide (Substance P) on Cutaneous Microflora 
L Mijouin, M Hillion, Y Ramdani, T Jaouen, C Duclairoir-Poc, ML Gueye, E Lati, F Yvergnaux, A 
Driouich, L Lefeuvre, L Misery, MGJ Feuilloley, PLoS ONE. (2013) 8(11): e78773 ; DOI : 
10.1371/journal.pone.0078773:. 
 P20- Airborne fluorescent pseudomonads : what potential for virulence ? 
C Duclairoir Poc, J Verdon, A Groboillot, M Barreau, H Toucourou, L Mijouin, C Leclerc, C Hulen, T 
Kondakova JP Morin, MGJ Feuilloley, A Merieau, N Orange, International Journal of Current 
microbiology and applied sciences.(2014) 3(8) : 708-722. 
 P21- A new tool for studying bacterial lipidome: HPTLC-MALDI-TOF Imaging 
enlightening virulence traits of the airborne Pseudomonas fluorescens MFAF76a  
T Kondakova, N Merlet-Machour, M Chapelle, D Preterre, F Dionet, MJ Feuilloley, N Orange, C 
Duclairoir Poc, Research in Microbiology. (2015) 166 : 1-8; DOI : 10.1016/j.resmic.2014.11.003 
 P22- Application of biosurfactants and periodic voltage gradient for enhanced 
electrokinetic remediation of metals and PAHs in dredged marine sediments 
M T Ammami, F Portet-Koltalo, A Benamar, C Duclairoir Poc, H Wang, F Le Derf, Chemosphere. 
(2015) 125 : 1–8. 
 P23- Surface functionalization of cyclic olefin copolymer witharyldiazonium salts: A 
covalent grafting method 
F Brisset, J Vieillard, B Berton, S Morin-Grognet,C Duclairoir-Poc, F Le Derf, Applied Surface Science. 
(2015) 329 : 337–346. 
 P24- Glycerophospholipid synthesis and functions in Pseudomonas: eukaryotic lipid 
exploitation 
T Kondakova; F D'Heygère ; M J. Feuilloley; N Orange; H J Heipieper; C Duclairoir Poc, Chemistry 
and Physics of Lipids. (2015) 190:27-42; DOI : 10.1016/j.chemphyslip.2015.06.006. 
III 
 P25- A Pseudomonas fluorescens type 6 secretion system is related to mucoidy, motility 
and bacterial competition 
V Decoin, M Gallique, C Barbey, F Le Mauff, C Duclairoir Poc, MGJ Feuilloley, N Orange, A Merieau, 
BMC Microbiology. (2015) 15(1); DOI: 10.1186/s12866-015-0405-9. 
 P26- Response to Gaseous NO2 Air Pollutant of P. fluorescens Airborne Strain 
MFAF76a and Clinical Strain MFN1032 
T Kondakova, C Catovic, M Barreau, M Nusser, G Brenner-Weiss, M Feuilloley, F Dionnet, N Orange, 
C Duclairoir Poc, Front Microbiol. ( 2016) 7:379; DOI : 10.3389/fmicb.2016.00379. 
 P27- Development of preservative-free nanoparticles-based emulsions: Effects of NP 
surface properties and sterilization process. 
L Rowenczyk, C Picard, C Duclairoir Poc, N Hucher, N Orange, M Feuilloley, M Grisel. Int J Pharm. 
(2016) 510(1) : 125-34; DOI : 10.1016/j.ijpharm.2016.06.014. 
 P28- Skin-bacteria communication: Involvement of the neurohormone Calcitonin 
Gene Related Peptide (CGRP) in the regulation of Staphylococcus epidermidis virulence. 
A N'Diaye, C Leclerc, T Kentache, J Hardouin, C Duclairoir Poc, Y Konto-Ghiorghi, S Chevalier, O 
Lesouhaitier, MG Feuilloley. Sci Rep. (2016) 6: 35379; DOI : 10.1038/srep35379. 
 P29- Impact of coated TiO2-nanoparticles used in sunscreens on two representative 
strains of the human microbiota: Effect of the particle surface nature and aging 
L Rowenczyk, C Duclairoir Poc, M Barreau, C Picard, N Hucher, N Orange, M Grisel, M Feuilloley. 
Colloids and Surfaces B: Biointerfaces. (2017)158 : 339-348; DOI : 10.1016/j.colsurfb.2017.07.013. 
 P30- Impact of gaseous NO2 on P. fluorescens strain in the membrane adaptation and 
virulence. 
S Depayras, T Kondakova, N Merlet-Machour, H J Heipieper, M Barreau, C Catovic, M Feuilloley, N 
Orange, C Duclairoir Poc, Int. J. Environ. Impacts. (2018), 1(3) : 1–10. 
 Chapitres de livre: 4  
 Ch1- Creation of biopolymeric colloidal carriers dedicated to controlled release 
applications 
D Renard, P Robert, L Lavenant, D Melcion, Y Popineau, J Gueguen, C Duclairoir, E Nakache, C 
Sanchez and C Schmitt 
In Plant biopolymer science: food and non-food applications p.119-124, Denis Renard, Guy Della Valle, 
Yves Popineau, eds, Royal Society of Chemistry (Great Britain 2002) 
 Ch2- Plant protein-based nanoparticles 
A-M Orecchioni, C Duclairoir, J Manuel Irache and E Nakache, 
in "Nanotechnologies for the life sciences" vol.2, Biological and pharmaceutical nanomaterials, p.117-
144, Challa S. S. R. Kumar Ed., Wiley-VCH Verlag Gmbh&Co. KGaA, Weinheim (2006) 
Ch3- HPTLC-MALDI TOF MS Imaging analysis of phospholipids  
T Kondakova, N Merlet Machour, C Duclairoir Poc 
In Neuromethods: Lipidomics, vol. 125 Chapter 12; Paul L. Wood (ed.); Series Editor: Wolfgang Walz, 
eds, Springer (Germany 2017), DOI 10.1007/978-1-4939-6946-3_12. 
Ch4- The hidden face of Nitrogen oxides species – from toxicity effect to potential cure? 
S Depayras, T Kondakova, H J. Heipieper, M Feuilloley, N Orange and C Duclairoir Poc 
In Emerging Pollutants - Some Strategies for the Quality Preservation of Our Environment", p.19-44, 
edited by Sonia Soloneski and Marcelo L. Larramendy, Ed. IntechOpen, London (United Kingdom, 
2018); http://dx.doi.org/10.5772/intechopen.75822 
 Publications de revue ou de diffusion de connaissance : 2 
 Pdc1- Encapsulation et applications industrielles 
C Duclairoir, L’Actualité Chimique. (2000)  6 : 24-27. 
 Pdc2- Particules Urbaines et Céréalières, Microorganismes Mycotoxines et Pesticides 
JP Morin, D Preterre, F Gouriou, V Delmas, A François, N Orange, A Groboillot, C Duclairoir-Poc, M 
Moretti, O Maillot, O Lesouhaitier, Pollution atmosphérique. (2013)217; URL : 
http://lodel.irevues.inist.fr/pollution-atmospherique/index.php?id=759. 
IV 
 
 Publications de compte-rendu de congrés : 77 
 Conférence plénière internationale : 2 
CInt1-"Polymer Nanoparticles Characterization in Aqueous Suspension" 
C Duclairoir, E Nakache, International Symposium of Polymer Analysis and Characterization, 26-30 
juin 1999, la Rochelle-France. 
CInt2- Response of commensal Staphylococci to sub-lethal concentrations of skin 
antimicrobial peptides 
Cécile Duclairoir-Poc, FEMS, Leipzig, Germany, July 21-25th 2013. 
 
 Communications orales : 31 
C1- Nanoparticules de gliadines obtenues par coacervation 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, Journée de l’Ecole Doctorale Normande de 
Chimie-Biologie, 27 mars 1997, Caen. 
C2- Elaboration de nanoparticules de gliadines par coacervation 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, Rencontre de la Société Française de Chimie 
(section Basse-Normandie-Sarthe), 30 mai 1997, Caen.  
C3- Nanoparticules de polymère végétal 
C Duclairoir, E Nakache, A-M Orecchioni, H Marchais, Journées GFP Ouest-SFC, 15-17 octobre 1997, 
Thiais.  
C4- Préparation de nanoparticules de polymère végétal. Optimisation de leur taille 
C Duclairoir, E Nakache, A-M Orecchioni, H Marchais, Congrès Annuel du GFP, 18-20 novembre 1997, 
Louvain-La-Neuve, Belgique. 
C5- Encapsulation de vitamines dans des nanoparticules de protéines végétales 
C Duclairoir, E Nakache, A-M Orecchioni, J Irache, Y Popineau, D Renard, Journées GFP-Ouest, 2-3 
juin 1999, Alençon. 
C6- Nanoparticules de protéines végétales : caractérisation structurale et potentialités 
d’encapsulation 
C Duclairoir, D Renard, A-M Orecchioni, Y Popineau, E Nakache, Journées d’Etudes des Polymères, 
5-10 septembre 1999, Trégastel. 
C7- Impact de la production de biosurfactants sur la réactivité de souches de 
Pseudomonas fluorescens vis-à-vis d’un micro-environnement solide.  
S Ngoya, C Duclairoir, N Orange. 9ème journée de l’Ecole doctorale Normande chimie-biologie, 17 mars 
2006, Rouen.  
C8- Caractérisation des biosurfactants chez plusieurs souches de Pseudomonas 
fluorescens provenant d’environnements différents,  
S Ngoya, C Duclairoir, N Orange. BIOADH’ 2007, 09 mars 2007, Strasbourg. 
C9- Analyse de la biodiversité de la flore bactérienne et fongique d’environnements 
aériens en zones urbaines et portuaire 
M Moretti, A Groboillot, C Duclairoir-Poc, O Maillot, O Lesouhaitier, J. P Morin., M. G. J.Feuilloley, 
N Orange. MicrobAERO 2009, 6-8 octobre 2009, Narbonne. 
C10- Pseudomonas fluorescens : Interactions potentielles de la microflore bactérienne 
avec la neurophysiologie humaine.  
L Mijouin, M Hillion, A Dagorn, A-S Blier, A Madi, T Jaouen, W Veron, N Connil, C Poc, A Groboillot, 
O Lesouhaitier, N Orange, S Chevalier, MGJ Feuilloley. 17ème Journée Scientifique de l’IFRMP23, 
Mont-Saint-Aignan, 17 juin 2011. 
C11- Extracellular gamma aminobutyric acid (GABA) regulates Pseudomonas 
virulence.  
A Dagorn, A Chapalain, O Lesouhaitier, C Poc, J Vieillard, S Chevalier, L Taupin, F Le Derf, N Orange, 
MGJ Feuilloley. Journée de l’EdNBISE, Rouen, 23 mars 2012. 
C12- NitroBactAIR : Impact du stress nitrosant sur l’expression de la virulence d’une 
bactérie aéroportée 
C Duclairoir Poc, Plénière MOVE’O, 7 novembre 2012, Rouen.  
V 
C13- Impact du stress nitrosant sur l’expression de la virulence d’une bactérie 
aéroportée  
C Duclairoir Poc, déjeuner-débat des professionnels de l'Automobile intitulé "L'automobile et 
l'Environnement sous la loupe des Scientifiques" Automobile Club de France, mardi 12 février 2013; 
Paris. 
C14- Response of commensal Staphylococci to sub-lethal concentrations of skin 
antimicrobial peptides.  
M Hillion, L Mijouin , C Leneveu, E Gerault , T Jaouen , L Lefeuvre , N Orange, G Redziniak , C 
Duclairoir-Poc, MJG Feuilloley. 5th FEMS Congress of European Microbiologists. July 21-25th 2013, 
Leipzig, Germany. 
C15- Etude de la virulence de Pseudomonas aéroportées à l’aide d’un nouvel outil 
lipidomique 
T Kondakova , N Merlet-Machour, D Preterre, F Dionnet, N Orange, C Duclairoir Poc, Journées 
Interdisciplinaires Qualité Air-8ème édition, 10-11 février 2014, Villeneuve d'Ascq. 
C16- Study of Pseudomonas airborne virulence using a new lipidomic tools  
T Kondakova, N Merlet-Machour, D Preterre, F Dionnet, N Orange, C Duclairoir-Poc. 17ième Journée 
de l’EdNBISE, 10 avril 2014, Le Havre. 
C17- Bacterial phospholipid adaptation to human temperature.  
T Kondakova, N Merlet-Machour, J Bodilis, F Dionnet,M Feuilloley, O Orange, HJ Heipieper, C 
Duclairoir Poc. 13th Euro Fed Lipid Congress, 27-30 September 2015, Florence, Italy. 
C18- Aging of coated TiO2 nanoparticles in oil-in-water emulsion : bactericidal toxicity  
L Rowenczyk, C Picard, C Duclairoir-Poc, N Hucher, N Orange, M Feuilloley and M Grisel, Journées 
Nord-Ouest Européennes des Jeunes Chercheurs, 11-12 Mai 2015, Rouen. 
C19- Evaluation du potentiel applicatif en cosmétique de biosurfactants microbiens 
secrétés par des souches de Pseudomonas fluorescent aéroportées  
S Depayras, C Duclairoir-Poc, 1er colloque du GDR Cosm’actifs, Moulin d’Andé, 26-27 Septembre 
2018, Andé, France. 
C20- Aging of TiO2-nanoparticle surface in cosmetic emulsions: their impact on 
bacteria of the cutaneous microbiota  
L Rowenczyk , C Picard, C Duclairoir-Poc, N Hucher, N Orange, M Feuilloley and M Grisel, 1er 
colloque du GDR Cosm’actifs, Moulin d’Andé, 26-27 Septembre 2018, Andé, France. 
C21- Impact of gaseous NO2 on P. fluorescens strain in the membrane adaptation and 
virulence 
S Depayras, T Kondakova, N Merlet-Machour, HJ Heipieper, M Barreau, C Catovic, M Feuilloley, N 
Orange, C Duclairoir-Poc, WIT Air Pollution , 25 -27 April 2017, Cadiz, Spain. 
C22- Développement de formulations sans conservateurs pour des modèles de crèmes 
solaires contenant des dispersions TiO2 nanoparticulaires. Effet des processus de stérilisation sur 
la stabilité.  
L Rowenczyk, C Picard, C Duclairoir-Poc, N Hucher, N Orange, M Feuilloley, M Grisel. 2ème colloque 
du GDR Cosm’actifs, 25 & 26 Septembre 2017, Domaine de Chalès, Nouan le Fuzelier, France. 
C23- Impact des nanoparticules de TiO2 passivées formulées en lotion solaire sur des 
bactéries cutanées ou aéroportée biocontaminante,  
L Rowenczyk, M Ringuedé, M Barreau, C Picard, N Hucher, M Grisel, M Feuilloley, N Orange et C 
Duclairoir-Poc. 2ème colloque du GDR Cosm’actifs, 25 & 26 Septembre 2017, Domaine de Chalès, 
Nouan le Fuzelier, France. 
C24- Impact of gaseous NO2 on P. fluorescens strain in the membrane adaptation and 
virulence 
S Depayras, T Kondakova, N Merlet-Machour, HJ Heipieper, M Barreau, C Catovic, Feuilloley M, 
Orange N, Duclairoir-Poc C, Congrès de la Société Française de Microbiologie 2017, 09-11 Octobre 
2017, Paris. 
C25- Interactions [nano]particules et micro-organismes cutanés 
N Hucher, C Duclairoir-Poc. Inauguration de la plate-forme d’Innovations Cosmetomics, 3 octobre 
2017, Evreux.  
C26- Production de viscosinamides par la souche clinique de Pseudomonas fluorescens 
MFN1032: Implication dans le développement du biofilm. 
VI 
D Depayras, A Merieau, M Barreau, T Kondakova, C Barbey, M Feuilloley, N Orange, C Duclairoir 
Poc. Colloque Bioadh’2017, Domaine de Frémigny, 15 & 16 Novembre 2017, Bouray sur Juine, France. 
C27- Nitrogen dioxide: from a simple diffusible gas to a potential antibacterial against 
P. fluorescens? 
S Depayras, T Kondakova, HJ Heipieper, M Feuilloley, N Orange, C Duclairoir Poc, 21ème Journée de 
l’EdNBISE, 22-23 mars 2018, Rouen. 
C28- Microenvironment impact on Cutibacterium acnes: growth, virulence and biofilm 
formation of acneic and non-acneic strains. 
V Borrel, Y Konto-Ghiorghi, L Lefeuvre, C Duclairoir-Poc, MGJ Feuilloley, 21ème Journée de 
l’EdNBISE, 22-23 mars 2018, Rouen. 
C29- NO2: simple gaz diffusible ou agent antibactérien anti- P. fluorescens potentiel? 
S Depayras, T Kondakova, HJ Heipieper, J Hardouin, M Feuilloley, N Orange, C Duclairoir Poc, Mini-
colloque Pseudomonas, 17-18septembre 2018, Marseille. 
C30- Régulation et Rôle de CmpX chez Pseudomonas aeruginosa 
E Bouffartigues, D Tortuel, O Maillot, A David, J Omnes, A Tahiroui, CO Azuama, L Taupin, S 
Depayras, C Duclairoir Poc, HJ Heipieper, A Dufour, O Lesouhaitier, N Orange, MGJ. Feuilloley, P 
Cornelis, S Chevalier, Mini-colloque Pseudomonas, 17-18septembre 2018, Marseille. 
C31- Nitrogen dioxide: from a simple diffusible gas to a potential antibacterial against 
P. fluorescens? 
S Depayras, T Kondakova, HJ Heipieper, M Feuilloley, N Orange, C Duclairoir Poc, Congrés SFM 
2018, 1-3 octobre 2018, Paris. 
 
 Affiches : 44 
A1- Elaboration de nanoparticules de gliadines par coacervation 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, Rencontre de la Société Française de Chimie 
(section Basse-Normandie-Sarthe), 30 mai 1997, Caen-France.  
A2-Elaboration de nanoparticules de gliadines de blé 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni congrès international SFC97, 7-12 septembre 
1997, Bordeaux-France.  
A3-Influence du paramètre de solubilité sur la taille des nanoparticules de gliadines 
C Duclairoir, E Nakache, H Marchais, A-M Orecchioni, 12th Annual meeting of the GTRV, décembre 
1997, Bruxelles-Belgique. 
A4- Wheat Gluten Nanopaticles as Drug Carriers : Encapsulation Mechanism and Size 
Optimization 
A-M Orecchioni, J M Irache, C Duclairoir, E Nakache, Symposium on Natural Origin Substances in 
Drug Formulation, 4-6 novembre 1998, Beijing-Japan. 
A5- Elaboration of Nanoparticles from Vegetal Polymer : Size Optimization Study 
C Duclairoir, E Nakache, A-M Orecchioni, J Irache, Y Popineau, Symposium International sur les 
Polymères en Milieu Dispersé, 11-16 avril 1999, Lyon-France. 
A6- Nanoparticles Preparation by Vesicle Polymerization or by Controlled 
Coacervation 
E Nakache, N Poulain, C Duclairoir, A-M Orecchioni, Gordon Research Conferences, 27 juin- 2 juillet 
1999, Cambridge-USA. 
A7- Solvent Effect on the Size Optimization of Submicronic Wheat Proteins Drug 
Carriers 
A-M Orecchioni, D Renard, C Duclairoir, Y Popineau, E Nakache, 12th International Symposium on 
Microencapsulation, 6-8 septembre 1999, London-United Kingdom. 
A8- Development of Carbohydrate Polymer-Based Submicron Colloidal System in 
Reverse Micelles 
A-M Orecchioni, C Duclairoir, E Nakache, Lipid and Surfactant Dispersed System, 26-28 octobre 1999, 
Moscow, CEI. 
A9- Vitamin E Encapsulation and Release from Wheat Protein Nanoparticles 
A-M Orecchioni, C Duclairoir, P Depraetere, Y Popineau, E Nakache, 3rd Word Meeting on 
pharmaceutics, Biopharmaceutics Pharmaceutical Technology, 3-6 avril 2000, Berlin-Deutschland. 
VII 
A10- Encapsulation de l'alpha-tocophérol au sein de suspensions colloïdales 
nanométriques de gliadines de blé 
A-M Orecchioni, C Duclairoir, E Nakache, XXIV Congresso internazionale della societa farmaceutica 
del mediterraneo latino, 20-23 septembre 2000, Assisi-Italia. 
A11- Elaboration de nanoparticules de protéines végétales et application comme 
système de liberation contrôlée de vitamine E 
C Duclairoir, D Renard, P Depraetere, Y Popineau, A-M Orecchioni, E Nakache, 19èmes Journées du 
club émulsion, 6-7 novembre 2000, Bordeaux-France.  
 A12- Biofilm, biosurfactant, temperature : dependency for 9 wild Pseudomonas 
fluorescens environmental strains and for two of their biosurfactant non-producing mutants. 
C Duclairoir-Poc, T Meylheuc, S Ngoya, A Groboillot , L Taupin, A Merieau, MGJ Feuilloley, N Orange 
Eurobiofilms, First European Congress on Microbial Biofilms, September 2 – 5 2009, Rome, Italy. 
 A13- Analyse de la biodiversité de la flore bactérienne et fongique d’environnements 
aériens en zones urbaines et portuaire. 
M Moretti, A Groboillot., C Duclairoir-Poc, O Maillot, O Lesouhaitier, JP Morin, MGJ Feuilloley, N 
Orange MicrobAERO2009, 6 – 8 octobre 2009 Narbonne. 
 A14- Evaluation de la qualité microbiologique de l’air de deux zones urbaines en 
Haute-Normandie.  
C Duclairoir-Poc, A Groboillot, O Maillot, M Moretti, O Lesouhaitier, MGJ Feuilloley, JP Morin, N 
Orange 1er Congrès Européen sur les Pathologies Environnementales. 9-10 octobre 2009, Rouen. 
 A15- Influence de la température sur le comportement adhésif et sur la production de 
biosurfactant chez Pseudomonas fluorescens d’origine environnementale.  
C Duclairoir-Poc, T Meylheuc, S Ngoya, A Groboillot , L Taupin, A Merieau, MGJ Feuilloley, N Orange 
Bioadh 2009, 17-19 Novembre 2009, Le Mans. 
 A16- Déséquestration de polluants de type hydrocarbures aromatiques polycycliques à 
l’interface eau/sédiments à l’aide de tensioactifs d’origine synthétique ou biologique. 
F Portet-Koltalo, S Sahed, A Groboillot, C Duclairoir-Poc, N Orange. SEP 2009, 30 nov-3 décembre 
2009, Marseille. 
 A17- GABA and benzodiazepine receptors ligands: Promising molecules as bacterial 
virulence inhibitors.  
A Dagorn, A Chapalain, S Chevalier, C Poc, N Orange, V Papadopoulos, MGJ Feuilloley 3ème rencontres 
normandes en Chimie-Biologie-Santé: La biologie, inspiratrice de nouveaux medicaments. 10 décembre 
2009, Rouen. 
 A18- Evaluation de la qualité bactérienne d’écosystèmes aériens en zones urbaines et 
portuaires grâce à deux approches : Les antibiogrammes et les tests de virulence vis-à-vis de 
Caenorhabditis elegans. 
A Groboillot, C Duclairoir-Poc, O Maillot, M Moretti, O Lesouhaitier, MGJ Feuilloley, JP Morin, N 
Orange. VIIIème Congrès de la SFM, 2-4 juin 2010, Marseille. 
 A19- Effect of a cyclolipopeptidic biosurfactant on PAHs sorption by sediments. 
F Portet-Koltalo, F.; Ammami, M.T.; Benamar, A.; Duclairoir-Poc, C.; Le Derf, F. 12th European 
Meeting on Environmental Chemistry (EMEC 12), 7-10 decembre 2011, Clermont-Ferrand. 
A20- Pseudomonas fluorescens, a member of the gut-brain-skin axis. 
M Hillion, L Mijouin, A Dagorn , T Rosay, A Madi., T Jaouen., N Connil, C Poc, A Groboillot, O 
Lesouhaitier, N Orange, S Chevalier, MGJ Feuilloley. 1ère journée scientifique de l’Institut de Recherche 
et d’Innovation Biomedicale (IRIB), 1er juin 2012, Rouen. 
 A21- Pseudomonas aéroportées : Caractérisation phénotypique et évaluation de leur 
potentiel virulent à l’aide de différents modèles. 
C Duclairoir Poc, J Verdon, A Groboillot, O Lesouhaitier, O Maillot, M Barreau, N Orange. Congrès de 
la Société Française de Microbiologie 2013, Février 2013, Lille. 
 A22- L’acide gamma-aminobutyrique (GABA) module la virulence et la cytotoxicité 
des Pseudomonas 
A Dagorn, M Hillion., A Chapalain., O Lesouhaitier, C Duclairoir-Poc, S Chevalier, MJG Feuilloley. 
Congrès de la Société Française de Microbiologie 2013, Février 2013, Lille. 
A23- La Substance P, un mediateur entre microflore et homéostasie cutanée 
VIII 
L Mijouin, M Hillion, T Jaouen, C Duclairoir-Poc, MJG Feuilloley, Y Ramdani. Congrès de la Société 
Française de Microbiologie 2013, Février 2013, Lille. 
 A24- Another paradigm in antibacterial treatments : Why a diplomatic approach 
should be more efficient than weapons of mass destruction ?  
M Hillion, L Mijouin, A Dagorn, C Leneveu, AS Blier, A Madi, T Jaouen, T Rosay, K Biaggini, N 
Connil, C Poc, A Groboillot, C Hulen, N Lomri, O Lesouhaitier, N Orange, MGJ Feuilloley. ESF-EMBO 
Symposium Bacterial Networks. 16-21 March 2013, Pultusk, Poland. 
 A25- Regulation of Pseudomonas cytotoxicity and virulence by gamma aminobutyric 
acid (GABA), an inter-kingdom communication signal.  
A Dagorn, A Chapalain, L Mijouin, M Hillion, C Duclairoir-Poc, J Vieillard, S Chevalier, L Taupin, F 
Le Derf, N Orange, MGJ Feuilloley. 2nd Scientific meeting of Institute for Research and Innovation in 
Biomedicine (IRIB), June 21th 2013, Rouen. 
 A26- Air: a potential biohazard niche for fluorescent Pseudomonads. 
C Duclairoir Poc, J Verdon, A Groboillot, M Barreau, H Toucourou, L Mijouin, O Maillot, C Hulen, O 
Lesouhaitier, JP Morin, MGJ Feuilloley, A Merieau, N Orange. 5th FEMS Congress of European 
Microbiologists, 19-23 July 2013, Leipzig, Germany.  
 A27- Regulation of Pseudomonas aeruginosa virulence by Gamma-aminobutyric Acid 
A. Dagorn, M. Hillion, A. Chapalain, O. Lesouhaitier, C. Duclairoir-Poc, N. Orange, S. Chevalier, M. 
Feuilloley. 5th FEMS Congress of European Microbiologists, 19-23 July 2013, Leipzig, Germany. 
 A28- The virulence of cutaneous bacteria can be locally regulated by Substance P, a 
skin neuropeptide. 
L. Mijouin, M. Hillion, Y. Ramdani, T. Jaouen, M.-L. Follet-Gueye, C. Duclairoir-Poc, M.G.J. 
Feuilloley. 5th FEMS Congress of European Microbiologists, 19-23 July 2013, Leipzig, Germany. 
 A29- Pseudomonas cytotoxicity and virulence are regulated by gamma aminobutyric 
acid (GABA).  
Dagorn A, Chapalain A, Mijouin L, Hillion M, Duclairoir-Poc C, Vieillard J, Chevalier S, Taupin L, Le 
Derf F, Orange N, Feuilloley MGJ. 16ème journée de l'école doctorale EdNBISE, 11-12 juillet 2013, 
Caen. 
 A30- Airborne fluorescent pseudomonads: in vitro assessment for identification of a 
potentiel biohazard. 
C Duclairoir Poc, J Verdon, A Groboillot, M Barreau, H Toucourou, L Mijouin, O Maillot, C Hulen, O 
Lesouhaitier, JP Morin, MGJ Feuilloley, A Merieau, N Orange, Pseudomonas 2013, September 2013, 
Lausanne. 
 A31- New role for T6SS in the Pseudomonas fluorescens strain MFE01. 
V Decoin, D Sperandio, D Bergeau, C Barbey, C Duclairoir-Poc, X Latour, N Orange, A Merieau, 
Pseudomonas 2013, September 2013, Lausanne. 
 A32- Gamma-aminobutyric Acid (GABA) modulates Pseudomonas cytotoxicity and 
virulence. 
A. Dagorn, A Chapalain, L Mijouin, M. Hillion, C. Duclairoir-Poc, J Vieillard, S. Chevalier, L Taupin, 
F Le Derf, N. Orange, M. Feuilloley, Pseudomonas 2013, September 2013, Lausanne. 
 A33- Evaluation of Pseudomonas aerosolisation for physiological studies. 
F Gouriou, P Penalva, S Berthout, C Duclairoir-Poc, A Agoulon, D Preterre, F Dionnet, MGJ Feuilloley, 
N Orange, A Groboillot, Pseudomonas 2013, September 2013, Lausanne. 
A34 -La Substance P, une cible nouvelle pour un contrôle optimal des interactions 
peau/microbiote cutané  
L Mijouin., M Hillion, Y Ramdani, T Jaouen, C Duclairoir-Poc, ML Follet-Gueye, E Lati, F Yvergnaux, 
A Driouich, L Lefeuvre, MGJ Feuilloley. Cosminnov 2013, 8-9 octobre 2013, Orléans. 
A35 -Lipidome of airborne Pseudomonas sp. by HPTLC-MALDI-TOF MSI : 
remarkable presence of eucaryotic lipid – phosphatidylcholine 
T Kondakova, N Merlet-Machour, D Preterre, F Dionnet, N Orange, C Duclairoir Poc, 3ème day of 
Institute for Research and Innovation in Biomedecine, 20 juin 2014, Caugé, Normandie. 
A36 – Effet des NOx sur une souche de Pseudomonas fluorescens du microbiote cutané 
F Ousalem, C Barbey, M Barreau, C Duclairoir-Poc, F Gouriou, A Groboillot, MJG Feuilloley, 11ème 
congrès national de la Société Française de Microbiologie, 24 et 25 mars 2015, Paris. 
A37- Effect of temperature on Pseudomonas phospholipid composition.  
IX 
T Kondakova, N Merlet-Machour, J Bodilis, F Dionnet, M Feuilloley, N Orange, HJ Heipieper, C 
Duclairoir Poc. 18ème Journée de l'Ecole Doctorale EdNBISE, 26 - 27 mars 2015, Rouen. 
A38 – Pseudomonas fluorescens lipidome screening : effect of temperature and growth 
phase on Pseudomonas phospholipids  
T Kondakova, N. Merlet-Machour, J. Bodilis, F Dionnet, M Feuilloley, N Orange, HJ Heipieper, C 
Duclairoir Poc. 6th FEMS Congress of European Microbiologists. June 7-11th 2015, Maastricht, 
Netherlands. 
A39- The nitrogen dioxide increases Pseudomonas fluorescens biofilm formation: 
identification of the bacterial response to air pollutant. 
T Kondakova, T Kentache, A Garreau, M Barreau, A Groboillot, J Hardouin, F Dionnet, M Feuilloley, 
N Orange, HJ Heipieper, C Duclairoir Poc. 6th FEMS Congress of European Microbiologists. June 7-
11th 2015, Maastricht, Netherlands. 
A40- Bacterial phospholipid adaptation to human temperature. 
T Kondakova, N Merlet-Machour, J Bodilis, F Dionnet, M Feuilloley, N Orange, HJ Heipieper, C 
Duclairoir Poc. Euro Fed Lipid Congress, 27-30 September 2015, Florence, Italy. 
A41- Impact of nanoparticles used in cosmetics on skin microflora representative 
bacteria. 
L Rowenczyk, C Picard, C Duclairoir Poc, N Hucher, N Orange, M Feuilloley, M Grisel. Journées Paul 
Marty SFC, 8-9 décembre 2015, Paris. Prix du meilleur poster. 
A42- Investigation in the potential roles of viscosinamides produced by P. fluorescens 
S Depayras, A Merieau, M Barreau, T Kondakova, C Barbey, H Toucourou, M Feuilloley, N Orange, C 
Duclairoir-Poc. 7th FEMS Congress of European Microbiologists. July 9-13th 2017, Valencia, Spain. 
A43- Impact of gaseous NO2 on P. fluorescens strain in the membrane adaptation and 
virulence 
S Depayras, T Kondakova, N Merlet-Machour, HJ Heipieper, M Barreau, C Catovic, M Feuilloley, N 
Orange, C Duclairoir-Poc. 7th FEMS Congress of European Microbiologists. July 9-13th 2017, Valencia, 
Spain. 
A44- Investigation in the potential roles of viscosinamides produced by P. fluorescens 
S Depayras, A Merieau, M Barreau, T Kondakova, C Barbey, H Toucourou, M Feuilloley, N Orange, C 
Duclairoir-Poc. Congrès de la Société Française de Microbiologie 2017, 09-11 Octobre 2017, Paris. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
Colloid Polym Sci 276 :321—327 (1998)
( Steinkopff Verlag 1998 ORIGINAL CONTRIBUTION
C. Duclairoir
E. Nakache
H. Marchais
A.-M. Orecchioni
Formation of gliadin nanoparticles:
Influence of the solubility parameter
of the protein solvent
Received: 9 September 1997
Accepted: 16 December 1997
C. Duclairoir ) E. Nakache ( )
Groupe Polyme`res-Interfaces
LCMT, UMR 6507, ISMRa
6 boulevard du Mare´chal Juin
F-14050 Caen Ce´dex
France
H. Marchais ) A.-M. Orecchioni
Laboratoire de Pharmacie Gale´nique
et Biopharmacie
Universite´ de Rouen
76803 Saint-Etienne du Rouvray Ce´dex
France
Abstract Nanoparticles are produced
from gliadin, a wheat gluten fraction,
by precipitation in a non-solvent. In
order to control their size, the solvent
effect is studied by solubilizing the
protein in different mixtures whose
solubility parameters are close or
equal to the gliadin parameter, d
G
.
The determination of d
G
is performed
by turbidity. The size of the nano-
particles is evaluated by QELS (quasi-
elastic light scattering). The study of
the size as a function of the solubility
parameter of the protein solvent
allows the determination of the
optimal conditions for nano-
particle formation.
Key words Nanoparticles — gliadin —
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Introduction
Nanoparticles obtained from natural or synthetic poly-
mers are currently attracting much interest as specific
carriers in pharmacy, in cosmetology, in the agro-chemical
industry and in other industrial fields [1—3]. For biological
applications, vegetal particles have been derived from pro-
teins [4, 5], such as gliadin extracted from gluten of wheat
and vicillin or legumin extracted from pea seeds. Their
potential appears to be large, especially in the targeting of
active principles.
The formation of gliadin nanoparticles by desolvata-
tion method in a non-solvent mixture, as well as their
loading and controlled release capacity of all trans-retinoic
acid have recently been shown [5]. It is concluded that the
coacervate formation is very sensitive to environmental
parameters and to the structural characteristics of the
protein.
In this paper, we propose to understand the influence
of the environmental parameters by a thermodynamical
approach. The solubility parameters will be used to opti-
mize the preparation of gliadin nanoparticles with the aim
of estimating their size.
Theory
Mixing enthalpy DMH of polymer/solvent system
Flory [6] evaluated the mixing enthalpy for a regular
system, i.e., for real polymer/solvent mixtures in the case of
a weak thermic effect. The total energy of the interaction
DE
12
is a function of the elementary interaction energies of
solvent/solvent (E
11
), of polymer segment/polymer seg-
ment (E
22
) and of solvent/polymer segment (E
12
):
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12
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2
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#E
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. (1)
If z is the coordination number of polymer network
and N
1
the number of moles of the solvent and /
2
the
volume fraction of the polymer, the mixing enthalpy is
DMH"(z!2)N
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Solubility parameter d and interaction energies
Hildebrand proposed the following relation for DE
12
for
endothermic ‘‘simple’’ mixtures:
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from which the definitive form of DMH is
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2
)2 (4)
with » the molar mixture volume, /
1
and /
2
are, respec-
tively, the volume fraction of the solvent and of the poly-
mer.
d
i
is the solubility parameter of the compound defined
as
d
i
"[E
ii
(z!2)/(2»
i
)]1@2 (5)
i, i.e. 1 or 2, means, respectively, the solvent or the polymer.
»
i
is the molar volume of the compound i. For classical
solvents, the parameter can be found in the literature data
[7] and is expressed in (J cm~3)1@2 or in (MPa)1@2.
Relation (4) shows that the miscibility of a polymer in
a solvent is possible if
d
1
"d
2
. (7)
The solubility parameter d
M
of a mixture, for instance
water/ethanol, is determined with the help of the following
relation:
d
M
"/d#/@d@ (8)
with d and d@ the solubility parameters of ethanol and
water and / and /@ their volume fractions, respectively.
(/#/@"1) .
In this study, we are assuming that the protein/
water/ethanol mixture is a simple regular mixture. In fact
the protein is very diluted (0.1%).
Material and methods
Material
Gliadin was obtained from a common wheat flour (variety
Hardy) and purified by INRA de Nantes laboratories, and
then dialysed. Its method of purification is as follows:
Gluten was extracted on a preparative scale from the
wheat flour. It was freeze-dried, ground in a refrigerated
grinder and defatted by two extractions with dichloro-
methane for 2 h at 20 °C (gluten/solvent ratio: 1/10 w/v).
After filtering, the residue was evaporated from the gluten
at 20 °C under reduced pressure. Samples of dried gluten
powder (50 g) were stirred gently in an ethanol/water mix-
ture (70/30 v/v) in a gluten/solvent ratio: 1/10 w/v for 4 h
at 20 °C. The suspension was centrifuged (10 000 g for
20 min). The soluble fraction was dialysed exhaustively,
first against water, and then against 0.05 M acetic acid.
Finally, gliadin was freeze-dried.
Analysis of the extracted gliadin fraction was carried
out by reverse phase-HPLC [9] and polyacrylamide gel
electrophoresis at acid pH [10]. In this way, the amount of
protein in the gliadin freeze-dried extract was calculated to
be around 85% w/w and the proportions of the different
gliadin groups were 55% w/w for a and b-gliadins, 15%
w/w for c-gliadin, and for u-gliadin.
All aqueous solutions were prepared from ultra pure
water (Milli Q Plus-Millipore). The physiological saline
phase was prepared from NaCl provided by Merck.
Pure absolute ethanol at 99.5% was provided by Carlo
Erba.
Pure propylene glycol (PG) or 1,2-propanediol greater
than 98% was provided by Fluka.
Pure ethylene glycol (EG) greater than 99.8% R.P. was
provided by Prolabo.
The surface-active agent which disperses the nanopar-
ticles is SynperonicT PE/F68 provided by ICI.
Ethanol was eliminated by evaporation with
Rotavapor R-114, provided by Bu¨chi, under reduced pres-
sure (Divac 2.4L provided by Leybold).
Nanoparticle separation by ultracentrifugation was
carried out with the help of Sigma 3K30 (Bioblock Scien-
tific). The solutions’ turbidity was determinated by UV-
visible Lambda 5 photometer (Perkin-Elmer). Particle
diameters were estimated by quasi-elastic light scattering
(QELS), with the help of a photogoniodiffusometer and
a RTG correlator (&EMATech) with 12 digital counters.
Preparation of different-solubility-parameter solutions
According to Hildebrand, the solubility parameter of
gliadin can be determined using a panel of solvents or
mixtures of them. The solvent which best solubilizes gliadin
has the same solubility parameter (d
G
) as this protein.
Different mixtures were prepared with solvents such as
ethylene glycol (EG) or propylene glycol (PG) and ultra
pure water. Table 1 displays the solubility parameters of
the solvents used [7].
0.1% gliadin solutions were prepared in solvents mix-
tures where d
M
was chosen between 30.2 and 36.9 MPa1@2.
Preparation of gliadin nanoparticles
by desolvation method
This method is based on the fact that gliadin is not soluble
in a non-solvent medium such as water, in contact of
which the protein precipitates.
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Table 1 Solubility parameters of the solvents used
Solvents Water Ethylene Propylene Ethanol
glycol glycol
d (MPa1@2) 47.8 32.9 30.2 26.5
Fig. 1 Preparation of gliadin nanoparticles by desolvation method
Two solutions prepared separately were mixed. The
method is as follows:
— 0.5% (w/v) Gliadin is solubilized at 25 °C in 20 ml of an
ethanol/water mixture A of required d
M
, prepared and
then filtered on 0.45 km.
— Solution B is made from 40 ml of physiological saline
solution (i.e. 0.9% NaCl aqueous solution), filtered on
0.45 km, and from SynperonicT PE/F68 at 25 °C. The
surface-active agent concentration is 0.5% w/w.
— The solution B is slowly poured with the help of
a funnel, 4 mm in diameter, diving into the solvent phase
A at 25 °C, under magnetic stirring (500 r.p.m) for about
10 min. The stirring and the temperature are maintained
for 5 min after this operation. We call this coacervation
step of the nanoparticles ‘‘nanoprecipitation’’.
— The suspension of nanoparticles is concentrated by
evaporation with a rotavapor in order to eliminate most
of the ethanol.
— Then the nanoparticles are purified by centrifugation for
15 min at 20 000 r.p.m and at 4 °C. The surpernatant is
removed and then the pellets are resuspended in 2 ml of
supernatant by three sessions of 5 min ultrasonic waves.
The different steps of the preparation are described in
Fig. 1.
Cross-linking of gliadin nanoparticles
This stage is reached by adding glutaraldehyde to the
suspension. Freshly prepared particles were cross-linked
with 1.64 mg glutaraldehyde/mg nanoparticles for 2 h at
room temperature. This colloidal system was then purified
twice by centrifugation in physiological saline solution.
Characterization of desolvation method media
and of gliadin nanoparticles
„urbidity
For the determination of its solubility parameter, the solu-
bility of a compound dissolved in media of different d
M
is
usually inspected visually for homogeneity and transpar-
ency of the mixtures. More accurate measurement can be
made by turbidity experiments. The more opaque the
solution, the more attenuated the intensity of the incident
beam. The observed absorption is related to the turbidity
q and to the thickness of the cell l.
The measurement is performed by determining the
difference between a suspension and the pure solvent:
(Abs)
1`2
!(Abs)
1
"l (q
1`2
!q
1
)"lDq (9)
with (Abs)
i
"log(I/I
0
); the subscripts 1 and 2 denote sol-
vent and solute, respectively, in this case gliadin.
Quasielastic light scattering (QE‚S)
Particle-size measurements are carried out using quasi-
elastic light scattering (QELS). By this method, mean par-
ticle diameters and sample polydispersity are determined.
This technique is concerned with the time dependence of
the fluctuations on the intensity of light scattered by a sus-
pension of nanoparticles. The correlator accumulates
the value of the light correlation function in 12 digital
counters. Before an analysis, the sample is warmed up at
25 °C for, at least, a quarter of an hour; each change of one
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Table 2 Visual observations of 0.1% gliadin solutions
d [MPa1@2] Mixture [%] „ [°C] Appearance
30.2 100 PG 14.6 Very cloudy
30.6 96 PG/4 Water 14.6 Cloudy
31.8 91 PG/9 Water 14.6 Very cloudy
32.8 85 PG/15 Water 14.6 Very cloudy
32.9 100 EG 17.2 Cloudy
33.9 79 PG/21Water 14.6 Clear
34.2 91 EG/9 Water 17.2 Very clear
35.0 73 PG/27 Water 14.6 Very clear
35.1 85 EG/15 Water 17.2 Very clear
36.0 79 EG/21 Water 17.2 Clear
36.9 73 EG/27 Water 17.2 Cloudy
Fig. 2 Turbidity of gliadin mixtures
degree centigrade promotes an error of 2% on the size
estimation.
For a system of rigid monodisperse particles, the cor-
relation function is
C(t)"A exp(!2Ct)#B (10)
with A and B constants and t the measurement time. C(t) is
related to the fluctuation relaxation time q by
C"Dq2"1/q (11)
where q is the scattering fluctuation wave vector ampli-
tude. D is the translational diffusion coefficient which
allows the determination of the size of a particle at high
dilution limit through the Stokes—Einstein equation by
extrapolation at zero volume fraction:
D"k„/3ngd (12)
with k the Boltzmann constant, „ the absolute temperature
and g the viscosity of the medium in which the particles of
hydrodynamic diameter d are suspended. Particle size
measurements are performed with diluted solutions close to
the dilution limit. And, for spherical particles, only scatter-
ing at one angle, 90 °, is required. In our case, the gliadin
nanoparticles had been shown spherical by SEM [5].
Experimental results
Determination of gliadin solubility parameter,
d
G
(Hildebrand’s method)
The visual observation of 0.1% gliadin solutions gives the
results shown in Table 2. The solvents used are usually
considered as references for the determination of solubility
parameters.
This first approach leads to the conclusion that the
solutions are clearer between 30.2 and 36.9 Mpa1@2. Then
the gliadine solubility parameter, d
G{
is located at
35$1 MPa1@2.
To improve and quantify this result, a turbidity study
has been performed at 25 °C with similar ethanol/water
mixtures of d
M
from 34.0 to 36.1 Mpa1@2. This couple of
solvents was chosen because it will concern the prepara-
tion of gliadin nanoparticles. Figure 2 shows the obtained
results.
It can be concluded more precisely that d
G
value is
34.5$0.5 MPa1@2 .
Gliadin nanoparticle size by QELS
In a first step, the nanoparticles not reticulated were
studied.
This study is based on three different batches of
nanoparticles. Each shown diameter is an average of, at
least, three measurements by QELS.
Evolution of nanoparticles with the process step
Figure 3 shows the nanoparticle diameters plotted versus
the solubility parameters d
M
of the solvent mixtures used
for the desolvation, 24 h after the desolvatation process.
The curves show a minimum size of the diameter when
d
M
corresponds to the gliadin solubility parameter d
G
for
the steps of nanoprecipitation and evaporation by
rotavapor. This minimum size has been observed in three
different sets of experiments. For the centrifugation step,
the behavior is not the same: an inflexion point can be
observed at d
G
on the decreasing plot. As shown by
Table 3, the size is doubled with respect to the nano-
precipitation step at d
G
.
A similar observation is noted, in Fig. 3, between 32.9
and 35.0 Mpa1@2. A possible explanation could be the
aggregation of the particles in both by the action of the
centrifugal force. But, from 36.1 to 37.9 Mpa1@2, diameters
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Fig. 3 Size evolution of gliadin nanoparticles as a function of the
process step, 24 h after desolvation. The error bars represent the
polydispersity of the size distribution
Table 3 Minimum size of gliadin particles 24 h after desolvation
Process stage Nanopreci- Rotavapor Centrifugation
pitation
Diameter (nm) 157.4 146.2 296.4
Fig. 4 Evolution of nanoparticle size after precipitation as a function
of d
M
and time
Fig. 5 Evolution of nanoparticle size after precipitation and after
evaporation by rotavapor as a function of d
M
and of the time. The
symbols are the same as in Fig. 4
Fig. 6 Evolution of nanoparticle size after precipitation, solvent
evaporation and centrifugation as a function of d
M
and time. The
symbols are the same as in Fig. 4
decrease and the polydispersity values increase between 20
and 35%. This different behavior is not easy to explain.
None of the parameters or experimental conditions were
changed during the experiments.
Nanoparticle size as a function of d and time
Figure 4 shows the evolution of the nanoparticle size from
24 h after their nanoprecipitation to 39 days after (d#39).
During the step of nanoprecipitation, the nanoparticles
were subjected neither to evaporation, nor to centrifu-
gation. This plot and Fig. 5 show that, after 28 days
(d#28), the graphs are not complete. In these plots, sev-
eral points are missing since d#28. In fact flocculation is
achieved and the colloidal concentration is too small to be
measured by QELS.
Figure 5 shows the evolution of nanoparticle size from
24 h after their evaporation until 39 days after (d#39).
These particles were not subjected to centrifugation.
Figures 4 and 5 show a similar shape of the curves for
nanoprecipitation and solvent evaporation stages with
a minimum diameter obtained in the vicinity of d
G
. As for
the general shape of the graphs, time does not seem to have
a great influence on the minimum size. Nevertheless, for
a given d
M
different from d
G
, the mean diameter of the
nanoparticles changes with time.
The centrifugation (Fig. 6) has three effects: it affects
the size of particles after the nanoprecipitation, and in-
fluences the temporal size of the suspension, and increases
the polydispersity of size distributions. However, in the
area of solubility parameters around d
G
, the evolution of
the nanoparticle size is less important. Then a greater
stability of size at d
G
can be deduced.
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Fig. 7 Size evolution of gliadin nanoparticles (62EtOH/38H
2
O) in
time after nanoprecipitation and rotavapor
Fig. 8 Time evolution of gliadin nanoparticles cross-linked or not
after centrifugation
Nanoparticle size as a function of time
The former studies show a minimum and rather ‘‘stable’’
size at d
G
. A comparison of the evolution of the nanopar-
ticles diameter prepared at d
G
after nanoprecipitation and
after solvent evaporation follows.
Figure 7 displays a similarity in the relationship be-
tween the size evolution and time. Nevertheless, after the
rotavapor stage, which eliminates most of ethanol, the size
becomes more important than after nanoprecipitation.
This is probably correlated to the higher concentration of
nanoparticles, which are brought closer to each other and
tend to aggregate. It can be also observed that the differ-
ence between the two curves fades away in time. After 40
days, the size is approximately the same as that 24 h after
the preparation of nanoparticles.
Compared evolution of the size of cross-linked
and non-cross-linked particles in time
To prevent any size variations in time, a set of nanopar-
ticles was cross-linked after the process of centrifugation
and re-suspended in physiological saline.
Two interesting observations can be made from Fig. 8:
the size of the non-cross-linked particles oscillates with
time and their mean size increases also with time.
Contrarily to what might be expected [5], the size of
the cross-linked nanoparticles reduces with time and the
solution flocculates. The glutaraldehyde is known to react
with the NH
2
groups of the protein. From this, it may be
assumed that the charge of such groups in aqueous solu-
tion is neutralized by glutaraldehyde and, consequently,
on one side, the protein is more confined, then the size
decreases. On the other side, the suspension flocculates by
lack of electrostatic repulsions between nanoparticles, be-
cause all NH`
3
groups were changed into NH
2
ones.
Conclusion
This study shows that the method of the formation of
gliadin nanoparticles by the solubility parameters allows
the control of their size. Indeed, when the gliadin is
solubilized in its good solvent, whose solubility parameter
is as that of the protein, the smallest size of the particles is
obtained whatever the conditions of protein extraction
and purification. This size varies with the different stages
of the process, the most disturbing of which being centrifu-
gation. Time, and chemical cross-linking affect the evolu-
tion of particle size.
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Gliadin nanoparticles: formation,
all-trans-retinoic acid entrapment and release,
size optimization
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Abstract : Gliadin nanoparticles were prepared by a desolvatation method. They showed good stability
during several weeks in PBS or aqueous medium. Assayed as carriers for all-trans-retinoic acid (RA),
they have a quite good entrapment efficiency : about 75% of added drug at (mg gliadin)—1 and a60 lg~
payload of (mg gliadin)—1 nanoparticles. A rapid release of 20% of the drug after 15 min in sink76.4 lg~
conditions and a diþ usion process in a second step are observed.
According to the nature of vegetal proteins, the size control of the nanoparticles may be reached by
varying the nature of the solvent, the pH and the ionic strength. Because gliadin is poorly solubilized
in aqueous solutions, the ürst method was chosen. In order to quantify more precisely the solvent
eþ ect, the size diameter was optimized through a solubility parameter study. The smallest size was
reached for protein solubility solvent equal to that of gliadin. Size diþ erences were observed with
respect to the process steps; the diameter obtained after nanoprecipitation ýuctuates with time.
1999 Society of Chemical Industry(
Keywords: gliadin nanoparticles ; all-trans-retinoic acid; encapsulation; size optimization; solubility parameter
INTRODUCTION
At the beginning of the twentieth century, Ehrlich1
ürst conceived ‘magic bullets’ to treat patients. In his
opinion, drugs could be introduced into the body
and released next to the site responsible for the
disease. The last few decades have witnessed con-
certed eþorts to enhance the drug eþectiveness
by improving their selectivity, which, with a few
exceptions, is generally poor.2 For instance, in
cancer chemotherapy cytostatic agents also damage
normal, rapidly dividing cells.
A possible approach to enhance drug eþectiveness
consists in the use of site-speciüc drug delivery,
which would not only increase the amount of drug
reaching the site but also simultaneously decrease the
amount being distributed to other parts of the body,
thus reducing unwanted side-eþects.1 Site-speciüc or
targeted delivery, therefore, would also enable a
reduction in the necessary dose to be administered.
By decreasing the side-eþects, it would also increase
the therapeutic index of the drug.3,4 In this context,
a large number of drug delivery systems or drug car-
riers have been conceived and developed. Among
these systems, colloidal drug delivery systems ie lipo-
somes and nanoparticles, and microparticles hold
great promise for reaching the goal of site-speciüc
delivery or drug targeting.
Liposomes are vesicular colloidal drug delivery
systems. They consist of one or more concentric
spheres of lipid bilayer(s) surrounding aqueous
compartment(s).5 These bilayers are usually formed
by amphiphilic lipids, ie phosphatidylcholine or
dipalmitoyl phosphatidylcholine, and cholesterol
which is used to alter the membrane permeability.6
Microparticles can be deüned as polymeric entities
falling in the range 1–250lm (ideally less than
125lm in diameter). At present, there is no univer-
sally accepted size range that particles must have in
order to be classiüed as microparticles. However,
many workers classify particles smaller than 1lm as
nanoparticles and particles larger than 1000lm as
macroparticles.7 Similarly, nanoparticles are solid
colloidal polymeric particles ranging in size from 10
to 1000nm. Both nano- and microparticles are made
of artiücial or natural material.8 The role of these
polymers in the preparation methods of carriers
* Corres pondence to : Groupe Polyme`res –Ce cile Duclairoir,
Interfaces , LCMT UMR 6507, ISMRa, 6 boulevard du Mare chal
Juin, 14050 Caen Cedex, France
Contract/grant s pons or : Re s eau Mate riaux Polyme`res , Plas turgie
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exceeds that of inert excipients. The components
have an inýuence, not only on the biodegradation
kinetics but also on the drug loading, compatibility
with tissues and in vivo drug stability.9
In addition to the properties of the carrier
material, bioacceptability is also inýuenced by the
particle size. A reduction of the particle size enables
intravenous injection. The diameter of the smallest
blood capillaries is 4lm; consequently, solid par-
ticles have to have a smaller diameter, in order to be
able to traverse all capillaries.4 Furthermore, small
colloidal carriers have a tendency to accumulate in
areas of inýammation in the body and in certain
tumours.10 Moreover, it has been demonstrated that
a reduction in particle size of polymeric particles
minimizes possible irritant reactions at the injection
site.4
Finally, it is also interesting to note that for topical
and oral applications it can be interesting to design
small colloidal carriers. In principle, a decrease of
the size allows an increase of the speciüc surface and,
therefore, an increase of the possibilities of inter-
action with the skin and/or the mucosa. Therefore, a
longer residence time of the drug delivery system
could be expected from a decrease of its size.
The aim of this work was to form particles from a
vegetal protein, gliadin (a fraction of wheat gluten),
by a method of desolvating macromolecules.11,12
This method of precipitation has several names in
the literature, including nanoprecipitation,12h14
coacervation,15 solvent displacement16 or drowning-
out.17 These submicronic carriers could entrap dif-
ferent drugs (hydrophilic, hydrophobic and
amphiphilic). All-trans-retinoic acid was chosen for
its application in skin treatments.11 This acid, slight-
ly ionized in water, behaves like a lipophilic drug
when it is introduced in an aqueous medium.
However, if the pH of the medium is increased, this
acid becomes better dissociated and may behave as a
slightly polar molecule.
MATERIALS AND METHODS
Materials
Pure propylene glycol or 1,2-propanediol was pur-
chased from Fluka, Switzerland. Synperonic}
PE/F68 was graciously donated by ICI, UK. This
surface-active agent is a tribloc copolymer polyethyl-
ene oxide–propylene oxide–polyethylene oxide. All-
trans-retinoic acid (RA) or tretinoin M(C20H20O2 ,
300.4), glutaraldehyde and trypsin type I from
bovine pancreas were purchased from Sigma Chemi-
cal Co, USA. The physiological saline phase was
prepared with NaCl provided by Merck, Germany
and ultrapure water (Milli Q Plus, Millipore), as for
all aqueous preparations. Other organic solvents
(acetone, ethanol, etc) and chemical products used to
prepare the phosphate buþer (PBS) were purchased
from Prolabo, France.
Ethanol evaporation was realized by a rotavapor
R-114, provided by Bu chi, Switzerland under
reduced pressure. Nanoparticle separation was
carried out by centrifugation with a Sigma 3K30
(Bioblock Scientiüc, France). UV–visible spectros-
copy was carried out with a UV–visible Lambda 5
photometer (Perkin Elmer, USA). The particle
diameters were measured by Quasi-Elastic Light
Scattering (QELS), also known as photon correlation
spectrometry (PCS) using two pieces of apparatus : a
N4MD submicron analyser (Coultronics) was used
for the characterization of gliadin nanoparticles, and
a photogoniodiþusometer and an RTG correlator
(SEMATech, France) with 12 digital counters were
used for size optimization. The determination of
loading and releasing capacities of gliadin nanoparti-
cles made use of an original HPLC assembly
described in detail later.
Gliadin nanoparticles
Gliadin extraction and puriücation
Gliadin was obtained from a common wheat ýour
(variety Hardy), puriüed at the Nantes Laboratories
of INRA and then dialysed. Its method of puriü-
cation is the following.
Gluten was extracted on a preparative scale from
wheat ýour. It was freeze-dried, ground in a
refrigerated grinder and defatted by two extractions
with dichloromethane for 2h at 20¡C (gluten/solvent
ratio 1/10w/v). After ültering, the residue was
evaporated from the gluten at 20¡C under reduced
pressure. Samples of dried gluten powder (50g) were
stirred gently in an ethanol/water mixture (70/30v/v)
in a gluten/solvent ratio of 1/10w/v for 4h at 20¡C.
The suspension was centrifuged (10000g for
20min). The soluble fraction was dialysed exhaus-
tively, ürstly against water, and then against 0.05M
acetic acid. Finally, gliadin was freeze-dried.
Analysis of the extracted gliadin fraction was
carried out by reverse phase-HPLC18 and polyacry-
lamide gel electrophoresis at acid pH.19 In this way,
the amount of protein in the gliadin freeze-dried
extract was calculated to be around 85% w/w and the
proportions of the diþerent gliadin groups were
55% w/w for a- and b-gliadins, 15% w/w for c-
gliadin, and 15% w/w for u-gliadin.
Preparation of gliadin nanoparticles by desolvatation
This method is based on the insolubility of gliadin in
a non-solvent medium such as water, in contact with
which the protein precipitates. The diþerent steps of
preparation are described in Fig 1. Two solutions
prepared separately were mixed: Solution A contain-
ing 0.5% w/v gliadin solubilized at 25¡C in 20ml of
an ethanol/water mixture, was prepared and then ül-
tered through a 0.45lm membrane. Solution B was
made from 40ml of physiological saline solution (i.e.
0.9% NaCl aqueous solution), ültered through a
0.45lm membrane, and from PE/F68Synperonic}
at 25¡C. The surface-active agent concentration was
0.5% w/w.
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Figure 1. Formulation of gliadin nanoparticles by a
macromolecule des olvatation.
The solvent phase A was then slowly poured with
the help of a funnel, 4mm in diameter, placed into
the solution B at 25¡C, under magnetic stirring
(500rev min~1) for 2min. Stirring and temperature
were maintained for 5min after this operation. This
coacervation of the nanoparticles is named here as
nanoprecipitation. The nanoparticle suspension was
concentrated by evaporation with a rotavaporator in
order to eliminate most of the ethanol. Then the
nanoparticles were puriüed by centrifugation for
15min at 20000rev min~1 at 4¡C. The supernatant
was removed and the pellets resuspended in 2ml of
supernatant by ultrasonication for three sessions of
5min.
Eventually, some batches were cross-linked with
1.64mg glutaraldehyde per mg nanoparticles for 2h
at room temperature. This colloidal system was then
puriüed twice by centrifugation in physiological
saline solution.
Finally, RA-loaded gliadin nanoparticles were pre-
pared by adding the drug in the organic phase before
nanoprecipitation. In addition, the nanoparticle
preparation procedure was performed in the dark in
order to avoid RA degradation.
Evaluation of nanoparticle size by QELS
Particle-size measurements are carried out using
quasi-elastic light scattering (QELS). The correlator
accumulates the value of the light correlation func-
tion in 12 digital counters. Before an analysis, the
sample is warmed to 25¡C during at least 15min:
each change of 1¡C promotes an error of 2% on the
size estimation. Particle diameters are deduced from
the Stokes–Einstein relation:
D \ kT/3ngd (1)
where k is the Boltzmann constant, T the absolute
temperature and g the viscosity of the medium in
which the particles of hydrodynamic diameter d are
suspended. Particle size measurements are per-
formed with diluted solutions close to the dilution
limit. For spherical particles, only scattering at one
angle (90¡) is required. In this study, the gliadin
nanoparticles had been shown to be spherical by
scanning electron microscopy.11
Evaluation of transformed gliadin
The amount of gliadin transformed into nanoparti-
cles was determinated as follows : 5ml of suspension
was centrifuged (20000rev min~1 for 15min) and
the residue was dissolved with ethanol/water (7/3v/
v) mixture at room temperature for 10min. The
samples were assayed by UV–visible spectrophotom-
etry at 280nm. In preliminary experiments, absorb-
ance at 280nm had been shown to depend only on
the concentration of the protein and to be linear up
to 2mg gliadin/ml.11
RA entrapment
RA HPLC analysis
A liquid chromatography (Beckman Instruments)
equipped with a 20ll sample loop injector was used.
RA was analysed by using a modiücation of an iso-
cratic procedure previously reported.20 Samples
were chromatographed using a 15cm ] 4.6mm i.d.
stainless-steel column packed with octadecyl silane
C18 (Ultrasphere ODS, 5lm, Beckman) and a ýow
rate of 1.8ml min~1. The mobile phase, ültered
through a 0.45lm ülter and degassed before use,
consisted of methanol and water containing 10mM
ammonium acetate (75/25v/v). The column effluent
was monitored using a UV detector set at 350nm.
RA stock solutions in methanol were refrigerated and
kept in the dark.
Calibration curves were constructed from a meth-
anolic RA stock solution over the range 0.5–60lg/
ml. The curves were linear and passed through the
origin (r2\ 0.998, n \ 6). The repeatability
(variation coefficient) was determinated to be 0.45%
for the RA concentration 60lg ml~1. Finally, the
detection limit was calculated to be 0.2lg ml~1.
RA loading
RA-loaded gliadin nanoparticles (1–2mg) were dis-
solved in 10ml of a methanol/water mixture (7/3v/v)
at room temperature in the dark. The samples were
then assayed for drug content by UV–visible spec-
troscopy at 350nm. Although gliadin molecules did
not interfere, empty nanoparticles were treated in the
same way and used as references for these determi-
nations. Moreover the supernatants obtained from
the two washing steps were analysed by the HPLC
method described above. This technique allowed the
determination of the amount of non-associated RA
with gliadin nanoparticles. The drug loading
(payload) and the entrapment efficiency were calcu-
lated as follows :
Payload (%)\ 100C1
gliadin nanoparticle yield (mg)
(2)
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Table 1 Solubility parameters of the
s olvents us ed
Solvent d (MPa1@2)
Water 47.8
Ethylene glycol 32.9
Propylene glycol 30.2
Ethanol 26.5
Entrapment efüciency (%)\ 100C1
(C1] C2)
(3)
where is the amount of RA loaded in the nano-C1
particles (determined from spectroscopy
experiments), and is the amount of free RA (dataC2
from HPLC).
In vitro RA release
About 15mg of gliadin nanoparticles (containing
0.85mg of RA) were suspended in 100ml of PBS at
pH 7.4. To prevent drug loss due to photo-
degradation during the dissolution study, the experi-
mental assembly was protected from the light. The
medium was maintained at 37¡C and stirred at
200rev min~1. Samples of 1ml were collected at suc-
cessive time intervals, and centrifuged for 15min at
20000rev min~1. These samples were immediately
analysed by HPLC using the procedure described
above, for their RA content (each measurement was
made in triplicate). Finally, in order to avoid possible
thermal RA degradation during the experiments, the
in vitro drug release tests were performed for only
3h.
Solubility parameters
Theory
Hildebrand21 deüned the solubility parameter d, cor-
related to the mixing enthalpy for endothermic
simple mixtures. In that case, the miscibility of a
polymer in a solvent is possible if
d1\ d2 (4)
with 1 and 2 meaning solvent and polymer. For clas-
sical solvents, the parameter can be found in the
literature22 and is expressed in (J · cm~3)1@2 or in
(MPa)1@2.
The solubility parameter of a mixture (fordM
instance, water/ethanol) is determined with the help
of the following relation:
dM\ /d] /@d@ (5)
where d and d@ are the solubility parameters of
ethanol and water, and / and /@ are their volume
fractions (/] /@\ 1).
This approach is better adapted to non-polar mol-
ecules because their mixing enthalpy values are
slightly endothermic. Because gliadin is one of the
non polar proteins, the preceeding relation can be
applied conveniently.
In this study, the protein/water/ethanol mixture is
assumed to be a simple regular mixture. In fact the
protein is very dilute (0.1%).
Preparation of diþ erent solubility parameter solutions
According to Hildebrand,21 the solubility parameter
of gliadin can be determined using a panel of sol-
vents or mixtures of them. Logically, the solvent
which best solubilizes gliadin has the same solubility
parameter as this protein.(d
G
)
Diþerent mixtures were prepared with solvents
such as ethylene glycol (EG) or propylene glycol
(PG) and ultra pure water. Table 1 displays the solu-
bility parameters of the solvents used.22 0.1% gliadin
solutions were prepared in solvent mixtures where dM
ranged between 30.2 and 36.9MPa1@2.
Turbidity
For the determination of its solubility parameter, the
solubility of a compound dissolved in media of dif-
ferent values could be estimated visually from thedM
homogeneity and transparency of the mixtures. More
accurate estimates can be made by turbidity mea-
surements : the more opaque the solution, the more
attenuated the intensity of the incident beam. The
observed absorption is related to the turbidity q and
to the thickness of the cell l. The measurement is
performed by determining the diþerence between a
suspension and the pure solvent ; then
(Abs)1`2 [ (Abs)1\ 1(q1`2_q1)
\ 1Dq (6)
where and subscripts 1 and 2(Abs)i\ log(I/I0),
denote solvent and solute, respectively, in this case
gliadin.
RESULTS AND DISCUSSION
The term gliadin deünes a group of proteins
extracted from gluten by 70% ethanol.19 These pro-
teins are polymorphic and can be classiüed on the
basis of their electrophoretic mobility in the follow-
ing four fractions : a-gliadin molecular mass about
25–35kDa; b-gliadin, 30–35kDa; c-gliadin 35–
40kDa; u-gliadin, 55–70kDa.19 Other character-
istics of these proteins are, (i) their low solubility in
aqueous solution; (ii) the presence of inter-
polypeptide S–S bonds and hydrophobic interactions
which induce protein chains to assume a folded
shape;23 (iii) a high proline content and a very low
proportion of charged amino acids.19
The method used to prepare gliadin nanoparticles
in this study is based on the desolvatation of macro-
molecules by adding a solvent phase of the protein to
a non-solvent phase (Fig 1).
Gliadin was dissolved in diþerent organic media.11
The solutions were poured into a physiological saline
phase, followed by the further process steps. The
330 Polym Int 48 :327–333 (1999)
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nanoparticle diameters depend on the organic
medium. In fact, the smallest particles were produc-
ed with the ethanolic mixture (7/3v/v); their size was
about 500nm.11 The non-solvent phase was always
an aqueous solution containing NaCl 0.9% w/v (in
order to increase the yield of gliadin nanoparticles)
and Synperonic PE/F 68 which inhibited particle
aggregation. It is interesting to note that both water
and ethanol are considered to be safe for the prep-
aration of drugs. Moreover, gliadin nanoparticles
prepared in this way were stable, and further treat-
ment by heat or chemical crosslinking was not neces-
sary to stabilize them. However, some batches have
been hardened, because it is known that the stability
and drug release characteristics can be modulated by
crosslinkage.14
RA-loaded gliadin nanoparticles
All-trans retinoic acid (RA) appears to be involved in
the proliferation and diþerentiation of epithelial
tissues. These properties make it an attractive agent
for the treatment of skin disorders, such as acne, pso-
riasis, hyperkeratosis, ichthyosis and epithelial
tumours.24 However, several drawbacks and undesir-
able eþects have been reported for the currently
available dosage forms (eg teratogenicity).24 One
possibility to overcome these difficulties and attempt
to increase the therapeutic efficacy, consists of the
use of drug delivery systems possessing the capacity
to control drug release. For this purpose micro-
emulsions,25 topical liposomes26 and gliadin
nanoparticles11 have been proposed.
The drug content was measured by spectropho-
tometry after dissolving RA-loaded gliadin nanopar-
ticles in an ethanol/water mixture (7 : 3). These data
correspond to parameter in eqns (2) and (3).C1
Similarly, the amount of non-entrapped RA, which
corresponds to in eqn (3), was calculated afterC2
HPLC analysis of the supernatants obtained from
the washing steps. From these results, the payload
was calculated and plotted against the ratio between
the amounts of drug and gliadin used for the prep-
aration of RA-loaded gliadin nanoparticles (Fig 2). It
is clear that the drug content associated with nano-
particles (payload) increases with the concentration
of drug ; however, at ratios greater than 90lg mg~1
the stability of RA delivery systems was impaired.
In contrast, the efficiency of RA entrapment
(calculated from eqn 3) was greater than 85% of the
added drug for ratios lower than 60lg mg~1. Above
this ratio, a signiücant amount of drug remained free
(about 25% for a ratio of 90lg mg~1) which was
responsible for the partial loss of physicochemical
stability.
RA release from gliadin nanoparticles
Gliadin nanoparticle formulations were tested for in
vitro release for 3h at 37¡C in the absence of light.
The in vitro release proüles give an indication of the
capacity of the delivery system for the controlled
Figure 2. Influence of the RA/Initial protein ratio on the payload
of RA as s ociated with gliadin nanoparticles .
release of drugs or active molecules. Figure 3 shows
the plot of the data expressed as the cumulative
amounts of RA released from the gliadin nanoparti-
cles as a function of time. RA was released into a
two-step mechanism, characterized by an initial
rapid release followed by a continuous diþusion
process (Fig 3). The ürst release was found to be
about 20% of the loaded drug and can be related
either to the release of the drug entrapped in the per-
ipheral domains of the nanoparticle matrix27 or to a
simple desorption of superücial RA, whilst the
second slower period was linear with respect to time
and appeared to be a diþusion phenomenon.28 Fur-
thermore, in this second step, about 20% of the drug
was released by diþusion in 3h.
Size optimization of gliadin nanoparticles : influence
of the solubility parameter of the protein solvent
phase
The preceeding results show clearly that the gliadin
nanoparticles are able to entrap and to release a lipo-
philic drug such as RA. The size is also a determi-
nant parameter in the optimization of their efficacy
and their bioacceptability.5 Indeed the smaller the
nanoparticles, the better their penetration into small
capillary blood vessels.
Precipitation and coacervation can be considered
part of the general area of solubility parameter and
phase equilibria.29 A correlation between the solu-
bility parameter and the particle diameter should
lead to optimization of their size. This correlation
was studied with gliadin in various solvents. In order
to simplify the experiments, the nanoparticles were
not crosslinked and RA and PBS were absent.
Determination of gliadin solubility parameter dG
(Hildebrand’s parameter)
The solubility parameter of gliadin was mea-dG ,
sured at 25¡C in ethanol/water mixtures of solubility
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Figure 3. In vitro releas e of RA from gliadin nanoparticles
(expres s ed as cumulative releas e). Gliadin nanoparticles were
prepared from a drug/protein ratio of 60 lgmgÉ1.
parameter in the range 33.9–36MPa1@2. In Fig 4,dM ,
minimum turbidity is observed at 34.5^ 0.5MPa1@2,
which corresponds to the clearest solution. It can
therefore be accurately concluded that the value isdG
34.5^ 0.5MPa1@2.
Change of nanoparticle size with the process step
This study is based on three diþerent batches of
nanoparticles. Each diameter is a mean value of at
least three measurements by QELS. At the end of
the nanoprecipitation, evaporation and centrifugation
steps, the solutions in which the nanoparticles are
suspended, contain, respectively, 20%, nearly 0%
and 0% ethanol.
Figure 5 shows the variation of nanoparticle size
24h after desolvatation of one batch of gliadin. The
nanoparticle diameters are plotted versus the solu-
bility parameters of the initial solvent mixturesdM
used for nanoprecipitation. The curves show a
minimum diameter of 150nm when correspondsdM
to the gliadin solubility parameter for the steps ofdG
nanoprecipitation and evaporation by a rotavapor.
This behaviour is not observed for the centrifugation
Figure 4. Turbidity of gliadin mixtures .
Figure 5. Size change of gliadin nanoparticles as a function of
the proces s s tep 24 h after des olvatation. The polydis pers ity of
the s ize dis tribution is repres ented by error bars .
step. Compared to the nanoprecipitation and evapo-
ration steps, the nanoparticles size is doubled at dG .
The nanoparticle size is also doubled between
32.9and 35.0MPa1@2. A possible explanation could
be the aggregation of the particles by pairing through
the action of the centrifugal force. However, from
36.1 to 37.9MPa1@2, the diameters decrease and the
polydispersity values increase to between 20 and
35%. This diþerent behaviour is not easy to explain :
none of the parameters or experimental conditions
were changed during the experiments.
The size of the nanoparticles obtained was fol-
lowed for 39 days. After 28 days for the nanoprecipi-
tation and evaporation steps, some batches
ýocculated, but the nanoparticles obtained with
solvent media close to remained in suspension.dG
The minimum diameter obtained is in the vicinity of
The centrifugation study (not shown here24) hasdG .
two eþects : it aþects the size of the particles after
nanoprecipitation, and inýuences the temporal shape
of the suspension.
Nanoparticle size at as a function of timedG
A comparison of the change of the diameter of non-
crosslinked nanoparticles prepared at after nanop-dG
recipitation and solvent evaporation follows. Figure
6. shows a similarity in the relationship between the
Figure 6. Size change of gliadin nanoparticles with time after
nanoprecipation and evaporation s teps . The polydis pers ity of the
s ize dis tribution is repres ented by error bars .
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diameter size and time. Nevertheless, after the rota-
vapor stage, which eliminates most ethanol, size
becomes more important than after nanoprecipita-
tion. This is probably correlated to the higher con-
centration of nanoparticles, which are brought closer
to each other and tend to aggregate. It can also be
observed that the diþerence between the two curves
decreases with time. After 40 days, the size is
approximatively the same as the 24h after the prep-
aration of the nanoparticles. The oscillations are
probably related to degradation processes of the
nanoparticles, which might be worth examining in
future experiments.
CONCLUSIONS
Gliadin nanoparticles can be obtained by using only
environmentally acceptable solvents such as ethanol
and water. Their size, which is one of the determi-
nant characteristics for medical purposes can be opti-
mized by investigating the solubility parameter d of
the protein solvent phase: the closer d is to the
protein solubility parameter, the smaller the size of
the nanoparticles. Furthermore, these delivery
systems were found to be good carriers for slightly
polar molecules such as RA. In this context, the limit
payload for RA was üxed at 76.4lg drug per mg
nanoparticle, which corresponds to an entrapment
efficiency of about 75% of added RA. RA was rel-
eased in a biphasic way, characterized by an initial
rapid release period (20% of the entrapped drug) fol-
lowed by a continuous and slower release character-
ized by a diþusion process. The nanoparticle size
varies with time, but the mean diameter is almost the
same 40 days after precipitation, which gives a good
indication of their stability.
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¬-Tocopherol, or vitamin E (VE), is widely used as a strong antioxidant in
many medical and cosmetic applications, but is rapidly degraded, because of its
light, heat and oxygen sensitivity. Thus, all of its formulation has to avoid
contact with light, heat or air. Drug loaded carriers are an attractive
opportunity, especially if they are made for bioacceptable macromolecules
such as vegetal proteins. For instance, gliadins, extracted from wheat gluten,
generate nanoparticles by a desolvatation method and may interact with
epidermal keratin for therapeutic or cosmetic formulations. Their lipophilic
drug loading capacities have been investigated. The VE loaded gliadin
nanoparticles have been characterized by their size, by their zeta potential, by
their VE payload, and by their entrapment e ciency. When VE loaded, the
gliadin particle size is 900nm and their charge is close to zero. They are
suitable VE drug carriers with an optimum encapsulation rate 100 VE mg/
gliadin mg with an e ciency of more than 77%. The release behaviour of VE
loaded nanoparticles may be interpreted as a `burst e  ect’, followed by a
di usion process through an homogeneous sphere.
Keywords: Vitamin E, gliadins, nanoparticles, desolvation method, release.
Introduction
¬-Tocopherol (vitamin E) (VE) is known to act as a strong antioxidant or
nitrosamine blocker to prevent the build up of cellular peroxides (Idson 1992,
Marty and Wepierre 1994). The exposure to free oxygen species induces a rise in
lipid peroxidation which may cause injury at di erent sites of the body. For
instance, the action of free radicals produced by a variety of environmental stresses
(among them sun exposure) may promote cataratogenesis (Trevithick et al. 1992),
cardiovascular disease due to the toxicity of lipid peroxides towards endothelial
cells of the blood vessels (Kaneko et al. 1991), or skin damage such as premature
skin ageing (Epstein 1983), skin fragility, and even skin cancers (melanoma or
others) (Sober 1987) related to a decrease in cellular immunity of the skin. VE
appears to be one of the strongest free radical scavengers by its action as a chain
breaking antioxidant in membranes (Tappel 1962), preventing acute or chronic
j. microencapsulation, 2002, vol. 19, no. 1, 53±60
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damage (Kligman and Kligman 1986). When applied on the skin, this drug has
been found to be active in reducing cell membrane phospholipid peroxidation
(Burton and Ingold 1986). Besides these biological activities, VE also exerts
cosmetic functions; notably, it helps delay the progression of ageing (Wester and
Maibach 1997) and possesses a skin moisturizing power (Mayer et al. 1993) and
emolliency (Marty 1998, Tamburic et al. 1999). VE is naturally present in the skin
and can ensure a natural protection against UV light damage (Fuchs et al. 1989).
Its absorbance spectrum is maximum at 295 nm and extends into the solar
spectrum: VE itself may absorb solar UV light and become itself a free radical,
the tocopheroxyl radical (Kagan et al. 1992). It is well known that reductive
antioxidants such as vitamin C can promote the recycling of VE (Kagan et al.
1992), but this mechanism depletes other antioxidants enhancing light-induced
oxidative damages (Kagan et al. 1992). The consequent observation is that VE may
act in two opposite manners : as a peroxyl radical scavenger and as an endogenous
photosensitizer. Nevertheless, in spite of these unwanted drawbacks, VE had been
proved e  ective against malignancies and is widely used as a potent free radical
scavenger.
However, VE is degraded by oxygen and must be carefully protected from
light, heat and prolonged contact with air for dosage forms. To overcome these
inconveniences liposome dosage forms were formulated (Kagan et al. 1992, Koga
and Terao 1996). Another interesting system for controlled drug release could be
nanoparticulate carriers from bioacceptable macromolecules. It is for this reason
that vegetal protein fractions have been chosen from wheat gluten, i.e. gliadins. In
pervious works (Ezpeleta et al. 1996), it has been shown the value of using such
vegetal materials, particularly because they can incorporate a wide variety of
lipophilic substances. Moreover, gliadins possess the ability to interact with
epidermal keratin due to their richness in proline (Tegila and Secchi 1994).
Materials and methods
Materials
¬-Tocopherol (VE) was obtained from Sigma Chemical Co (St Louis, Mo,
USA). Synperonic1 PEF 68 was furnished by ICI Surfactant (Cleveland, UK).
All the aqueous solutions were prepared with ultrapure water (Milli Q Plus,
Millipore, Molsheim, France). Solvents and other chemicals were of analytical
grade and obtained from Prolabo (Paris, France).
Gliadin extraction and puri®cation
Gliadins were extracted from a common wheat ¯our (Hardi variety) LarreÂ et al.
1991). Brie¯y, gluten was freeze dried, ground in a refrigerated grinder and
defatted by two extractions with dichloromethane (gluten/solvent ratio : 1/10)
for 2 h at 20 °C. After ®ltration and residual solvent evaporation under reduced
pressure, samples of dried powder were stored in an ethanol/water mixture (70/30
V/V) for 4 h at 20 °C. The soluble fractions were then dialysed against distilled
water and ®nally freeze dried.
54 C. Duclairoir et al.
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Preparation of VE loaded gliadin nanoparticles
The gliadin nanoparticles were prepared by a desolvation method described
elsewhere (Duclairoir et al. 1999). The nanoparticle procedure was performed
under a ¯ow of nitrogen in the dark, in order to avoid VE degradation. Proteins
were solubilized in an ethanol/water mixture (62/38 v/v) at 25 °C, and the resulting
solution ®ltered through a 0.1 mm pore-sized membrane. Various amounts of VE
in ethanolic solutions were added to the gliadin solution. Nanoparticle formation
occurred when 20mL of this solution was poured into a 0.9% w/v NaCl/water
solution containing Synperonic1PE/F 68 (0.5% v/v) as a stabilizer at 25 °C with
stirring (500 rpm). The organic solvent was evaporated under reduced pressure,
and the resulting suspension was centrifuged (20 000 rpm, 15 min). The super-
natant was removed and, after three washes in ultra pure water, the loaded pellets
were freeze dried and stored at 4 °C in the dark.
Physicochemical characterization of the nanoparticles
The yield of gliadin transformed into particles was analysed by measuring the
gliadin amount in the supernatant after the ®rst centrifugation. The samples were
analysed in a Perkin-Elmer Lambda 8 spectrophotometer at 25 °C at 278 nm.
The size was characterized by a Malvern Mastersizer (Malvern, Worcester-
shire, UK) and by scanning electron microscopy (Jeol, T330A, Japan).
The surface properties of gliadin nanoparticles, loaded and non-loaded, were
analysed by determining their zeta potential in a unimillimolar KNO3 solution at
room temperature. The nanoparticles were observed in very dilute conditions by a
Sephy Zetaphorimeter III (Sephy, Limours, France).
VE loading
About 1 mg of gliadin nanoparticles containing di  erent amounts of VE mg/
gliadin g was digested in 10mL of the ethanol/water mixture (62/38 v/v) at 25 °C in
the dark. The drug content C1 was assayed by High Performance Liquid
Chromatography-Reverse Phase (HPLC-RP) at room temperature using a photo-
diode array detector (Waters 600, Millenium32 software, Waters, Milford, USA) at
295 nm and a 250 3mm Nucleosil1 100-5, packed with C18 column (Macherey
Nagel, DuÈ ren, Germany).
Non-encapsulated VE remaining in the supernatant after the ®rst centrifuga-
tion C2 was measured by HPLC. From these data, the drug loading (payload) was
calculated as the ratio of amount of entrapped drug in nanoparticles (mg) C1/
gliadin nanoparticles yield (mg), i.e.:
Payload…%† ˆ C1…mg†
gliadin nanoparticles yield
100 …1†
and the entrapment e ciency was calculated as the ratio between the VE amount
in particles and the initial drug content …C1 ‡ C2†, i.e.:
Entrapment efficiency ˆ C1‰amount of VE in nanoparticles (mg)Š…C1 ‡ C2† ‰initial drug content (mg)Š 100 …2†
¬-Tocopherol loaded gliadin nano particles 55
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In vitro drug release
About 1 mg of gliadin nanoparticles containing 102.7 VE mg/gliadin mg were
suspended in 10mL of decane under stirring, under nitrogen and in the dark, in
order to prevent drug loss. The medium was then maintained at 25 °C in a
homemade release cell, represented in ®gure 1.
This original cell is a double shell leading to e cient thermostating and an
access allowing easy collecting of aliquots (100 mL) free of nanoparticles by
®ltration by a 0.1 mm pore sized membrane. After each sample collection at
successive time intervals, an equal amount of decane was introduced into the
medium. Thus, during the whole release, the nanoparticle concentration remained
unchanged. The amount of released drug was evaluated by HPLC, as previously
described.
Results
Gliadin nanoparticle characterization
Gliadins, wheat gluten proteins, precipitate into nanoparticles by the desolva-
tion method known as `nanoprecipitation’ (Fessi et al. 1986, Stainmesse et al. 1995,
Alonso 1996), coacervation, solvent displacement or drawing-out phenomenon
(Mersmann 1994). At least 90% of gliadins were transformed into nanoparticles.
These particles, loaded or non-loaded, are spherical, as shown in ®gure 2 by
scanning electron microscopy. The mean diameter of VE nanoparticles is 900 nm
by laser granulometry. The zeta potential of loaded and non-loaded nanoparticles
is essentially zero.
56 C. Duclairoir et al.
Figure 1. Homemade release cell.
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VE encapsulation study
Payload and entrapment e ciency are dependent on the drug/initial protein
ratio. The payload encapsulated (drug/initial drug amount) increases from 0 to
40% and the e ciency of encapsulation (drug/initial drug content) decreases from
65 to 100%. Figure 3 represents the payload and the e ciency versus the ratio VE/
gliadins amount. The best compromise of these two parameters is obtained for 972
VE mg/gliadin mg, with an e ciency of 79.2%. (®gure 3).
VE in vitro release study
Gliadin nanoparticles were tested for in vitro release for 100 h at 25 °C under
nitrogen in the dark. During the experimental period, no VE or particle degrada-
tion was observed. Figure 4 shows the plot of the amount of VE released from the
carrier as a function of time. It can be observed that VE is released in a bistep way,
characterized by an initial rapid release (under 1 h) which can be attributed to the
release of the encapsulated or adsorbed drug in the super®cial external zone of the
spheres.
The second releasing period shows a dependency on time and is related to the
drug di usivity inside the matrix system, the surface area and, of course, the drug
content.
During the ®rst period, both VE and surfactant (Synperonic
1
PE/F68) are
released in the medium because of their weak a nity for the gliadins. As soon as
the nanoparticles are suspended in decane, both VE and Synperonic
1
PE/F68 are
¬-Tocopherol loaded gliadin nano particles 57
Figure 2. Freeze dried VE loaded gliadin nanoparticles by SEM.
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released. The surfactant concentration may be high in the vicinity of nanoparticles,
and micelles may form. These micelles are able then to subsidize a part of the
released VE, playing the role of drug-reservoirs. This should explain the fall in VE
concentration observed.
During the second part, both VE and surfactant continue to be released into the
medium.
In order to explain this release pro®le, some analytical models have been
applied (Washington 1996). The particles are spherical and, assuming that the
58 C. Duclairoir et al.
Figure 3. Payload and entrapment e ciency of VE in gliadin nanoparticles.
Figure 4. VE release in decane from 102.7 VE mg/protein mg loaded nanoparticles at 25°C.
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drug is uniformly distributed inside the carrier and that these latter remained
undegraded during the experimental period, then if Mt is the amount of released
drug at t time, and …1 Mt=M0† the released amount, the following relation can be
written:
Mt
M0
ˆ 1 6
º2
X¬
nˆ1
1
n2
exp… n2º2½ †
· ¸
…3†
where ½ is given by the relation:
½ ˆDt
R2
…4†
with D the di usion coe cient of the drug in the particle and R the particle radius.
This relation can be simpli®ed for the ®rst release period:
Mt
M0
ˆ 6

½
º
r
…5†
For the second period, this relation becomes, for longer release times:
Mt
M0
ˆ 6

½
º
r
3½ …6†
The release has been ®tted to this model for the ®rst release period and for
longer times. The values of the correlation coe cient, r2, are 0.73 and 0.90.
Obviously, the model for the ®rst release does not describe the experimental data.
This underestimates the fast release of adsorbed drug on the particle surface and in
the region close to it, usually called the `burst e  ect’.
In conclusion, by the desolvation method, gliadin nanoparticles are obtained
with a mean diameter of 900 nm and essentially uncharged. These gliadin
nanoparticles are suitable vitamin E drug release carriers, with an optimum
payload of 972 drug mg/protein mg with an entrapment e ciency of at least 77%
of vitamin E. Their in vitro release consists of two periods: a `burst e  ect’ and a
slower di  usion process.
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Polymer Nanoparticle Characterization
in Aqueous Suspensions
Ce´cile Duclairoir and Evelyne Nakache
Equipe Polyme`res-Interfaces, ISMRa, Caen Cedex,
France
This article evaluates several techniques for measuring nanoparticle size
in suspension. The direct techniques measure the nanoparticle size by
electron microscopy. However, with this technique, the particles must be
observed dry, except in the case of environmental microscopy, and their
distribution is calculated by performing image analysis. Other indirect
methods, based on measurements of intensity fluctuations allow size
measurement but these methods are dependent on sample preparation
(concentration, polydispersity, etc.). Two types of materials are char-
acterized and discussed herein: model polystyrene latex particles used for
size standardization in several devices and polydisperse wheat protein
nanoparticles prepared in our laboratory. Our results show that no size
characterization method is totally universal and absolute. Coupling at
least two different methods allows for more rigorous size characteriza-
tion.
Keywords: Size characterization techniques; Nanoparticles; Suspen-
sion; Polydispersity; Multimodal
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Nowadays, polymer colloids are of great interest in many fields: drug
vectorization, agrochemistry, varnishes, paints, inks, and so on. Their
industrial use is related to their efficiency, which is a function of several
parameters: their particle size, surface properties, loading capacity, and
release capacity. In pharmaceutical applications, for instance, sub-
micronic vectors such as drug loaded polymer nanoparticles have to
reach the extremity of the smallest blood capillaries, whose diameter is
about 4 mm. Their small sizes are therefore obviously of great importance.
Numerous techniques have been used to characterize colloids, but their
applications may be limited by theoretical considerations or by experi-
mental limitations. The purpose of this article is, first, to review some size
characterization techniques used to characterize nano- or microparticles.
Some techniques (light scattering, laser granulometry, electron micro-
scopy) will be described extensively. This presentation will also discuss, in
a less systematic way, the applications of the Coulter counter, ultrasonic
or confocal microscopy, and sedimentation techniques. Second, we will
illustrate some of these techniques by analyzing data on very dilute sus-
pension of standard latexes and plant protein nanoparticles[1], studied in
our laboratory. Both theoretical background and practical applications
will be discussed here. Usually nanoparticles are formed from synthetic
polymers, but they may also be formed from animal proteins. The
nanoparticles studied herein are biocompatible, biodegradable, and,
contrarily to animal proteins, they are free from prions.
The sample polydispersity is also a very important parameter, but it
can be hard to estimate. We will discuss here how to overcome this
difficulty.
REVIEW OF NANOPARTICLES SIZE
CHARACTERIZATION TECHNIQUES
IN AQUEOUS SUSPENSIONS
Methods for measuring nanoparticle size may be divided into two
categories: nondestructive methods and destructive methods. These
methods may also be categorized according to practical advantages and
disadvantages, such as limitations on size range, etc.
Nondestructive Methods
The nondestructive techniques allow the study of particles in an
aqueous medium, which may or may not be diluted. For easy size
characterization, the sample must be either monomodal (a unique size
distribution) or multimodal (several size classes) with a limited poly-
dispersity (narrow size distribution).
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Light Scattering
Light scattering (LS) requires the use of highly diluted samples in
order to avoid multiple scattering. The particles in suspension are sub-
jected to Brownian motion and scatter[2] the monochromatic incident
light (wavelength l) in the diffusion volume shown in Figure 1[3]. In order
to avoid particle interactions, the sample has to be highly diluted with the
continuous phase of the suspension. In such an ideal case without any
particle interactions, the intensity fluctuations are collected by a photo-
detector. The data may be treated in two ways:
 Data averaged over a period of time: so-called dynamic light scattering
(SLS)
 Time dependent acquisition: so-called dynamic light scattering (DLS)
and then fitted by theoretical models
When a size determination is carried out by LS, it can be difficult to
choose the best algorithm to use for the interpretation of the data. These
algorithms will be discussed in the sample studies section. Nowadays, any
LS apparatus gives a size evaluation, but care must taken to assure
proper data interpretation. Rayleigh[4], considering time-averaged scat-
tering of isolated spherical scatterers, treated the simplest case. Rayleigh
scattering only applies to particles smaller than l=20[5]. When particles
are larger than about l=20, the method commonly called SLS gives the
radius of gyration, the molecular weight and the second virial coefficient
FIGURE 1 Light scattering device (courtesy of Oxford University Press[3]).
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of the polymer. By a more complex approach, Rayleigh–Gans–Debye
theory[6, 7], investigates particles in interaction in a diluted medium. Sizes
up to l=2 can be measured. The usual incident light is a red or green laser
(l is less than 640 nm), so the biggest observed size is about 300 nm[5].
DLS is a broadly applied size characterization technique, also known
as photon correlation spectroscopy (PCS) or quasi-elastic light scattering
(QELS). By this technique, the intensity fluctuations are fitted, with the
help of a correlator, by an autocorrelation function G1 as a function of
time (Eq. 1).
G1ðtÞ ¼ exp Dq2t
  ð1Þ
with D the translational diffusion coefficient, n solvent refractive index,
and l the wavelength of the incident beam. The wave vector q is given by
q ¼ 4pn
l
sin
y
2
 
ð2Þ
with y the observation scattering angle and n the refractive index of the
medium. Different algorithms or theoretical models can be used for data
treatment and by Stokes law and Einstein’s equation of Brownian
motion, they can yield the diffusion coefficient D and, consequently, the
hydrodynamic radius Rh (radius of sphere having the same diffusion
coefficient as the polymer) as given in Equation 3.
Rh ¼ kT
6pZD
ð3Þ
with k the Boltzman constant, T the absolute temperature, and Z the
sample viscosity. No calibration is needed, and the measured value is
absolute. For spherical particles smaller than l=2, a single measurement
at 90 is sufficient, although for polydisperse materials angular depen-
dence on the measured D values may be observed.
In the two LS methods, plots of the particle diameter versus the size
distribution are generated as shown later in the sample studies. These two
approaches do not take into account the angular dependency of the
intensity fluctuations, even if they are accumulated at different angles
between 30 and 150. For larger particles, which are bigger than l,
the intensity fluctuations depend dramatically on the observation angle.
The Mie theory[8], based on refractive index fluctuations, covers up this
angular dependence and gives the closest size classes to the real size
distribution. The two LS approaches diverge from each other for particle
size greater than 350 nm (i.e., l=2) and the differences increase dramati-
cally. For instance, for a same relative scattering intensity at 90, the
displacement could reach more than 100 nm for submicronic particles.
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The Mie theory allows the observation of particles of, at least, a few
micrometers.
The DLS drawbacks are as follows:
 Several angle acquisitions are necessary, except for spherical particles.
In that case, acquisition at a single angle of 90 is enough.
 The preparative conditions must avoid any pollutant such as oil on the
glassware or ambient dust during experiments and even before. The
glassware has to be cleaned carefully with sulfochromide or surfactant
mixtures and solvents have to be filtered.
 The sample has to be very diluted, which may provoke a dilution
shock. A slightly blue coloration appears for very diluted suspensions
of particles smaller than the light wavelength.
 Numerous algorithms are necessary to interpret light fluctuations and
to discriminate their various meanings.
 The proportions of the different size classes are related to peak areas,
and, due to theoretical assumptions, they could diverge from reality.
Laser Granulometry
Laser granulometry is based on light diffraction by a beam whose l is
smaller than the particle size. The particle refractive index must be dif-
ferent from that of the aqueous medium. A concentric annular detector
at small angles collects the diffracted light. The difference between the
refractive indexes of the particles and the medium leads to the particle
size. The study of the intensity fluctuations allows measurements of the
size distribution, XðdÞ, as given by Eq. (4) with the help of Mie theory[8].
XðdÞ ¼ N
X1
n¼1
½ð2nþ 1Þ=ðnðnþ 1ÞÞ
fanpnðcos yÞ þ bntnðcos yÞg
 ð1Þnþ1 ð4Þ
where pn and tn are related to Legendre polynomials as given in Eqs. (5a)
and (5b)
pnðcos yÞ ¼ Pð1Þn ðcos yÞ=sin y ð5aÞ
and
tnðcos yÞ ¼ d
dy
ðPð1Þn ðcos yÞÞ ð5bÞ
and an and bn are dependent on the particle size, d, and on the relative
refractive index of the particles to their medium, m, as shown in Eqs. (6a)
and (6b).
an ¼ fCnðaÞCnðbÞ mCnðbÞCnðaÞg=fznðaÞznðbÞ mznðbÞznðaÞg ð6aÞ
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bn ¼ fmCnðaÞCnðbÞ CnðbÞCnðaÞg=fmznðaÞznðbÞ  znðbÞznðaÞg ð6bÞ
with a ¼ 2pd=l and b ¼ ma and C Ricatti–Bessel functions and z Hankel
functions.
A lens with a focal length of 45 mm situated between the incident beam
and the sample cell, as shown on Figure 2, allows the observation of
particles between 0.1 and 80 mm and a lens with a focal length of 100 mm
positioned after the sample cell and before the detector, as represented in
Figure 3, characterizes sizes from 0.5 to 170 mm. Thus different optical
systems allow the measurement of different size ranges.
Laser granulometry requires some caution during sample preparation:
 Elimination of dust (glassware cleaning, filtered solvents, etc.)
 Use of the ideal sample concentration, which is often a balance
between a limited sample quantity and systematic dilution. This
dilution may disturb particle stability. Usually, prior to the measure,
a concentration test is done by the estimation of an obscuration factor
of the suspension.
 Prevention of possible gas bubbles during the stirring or ultrasonica-
tion of the sample
FIGURE 2 Laser granulometry device: 45mm lens focal (courtesy of Malvern
Instrument Limited).
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The resulting plot is similar to the plot generated in DLS: size
distribution vs. volume-average diameters.
Coulter Counter
Largely used by the paint and pharmaceutical industries, this method
is an electronic size measuring technique. It is based on the Coulter
principle[9] of allowing the dispersion to flow through a narrow aperture,
where particles cause a change in the conductivity of the medium (see
Figure 4). This conductivity variation, R, is a function of particle dia-
meter, d, and its volume, V, as shown in Eq. (7).
R ¼
reV
A2
1 rerp
 
1 1 rerp
 
d
A
ð7Þ
with A the aperture section, re the electrolyte resistivity, rp particle
resistivity. This method is not very sensitive to submicron sized particles.
This instrument was one of the first particle size instruments on the
market and it is simple and quick to use.
FIGURE 3 Laser granulometry device: 100mm focal lens (courtesy of Malvern
Instrument Limited).
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The drawbacks are encountered in the following:
 The sample preparation must be without pollutant (i.e., oil on the
glassware or ambient dust).
 The difference in the conductivity between particles and the medium
has to be significant. The ideal case consists of a conducting medium
with a nonconducting particle.
Ultrasonic Spectroscopy
Since the beginning of the 1990s, vesicle and polymer particle dia-
meters have been measured by ultrasonic velocity[10]. In the emulsion
domain, this technique is very common and facilitates size investigation
from 10 nm to 1,000 mm. For high frequencies (i.e., study of large
particles), the ultrasound can be destructive, so this method should be
used with caution. This is especially the case for fragile objects such as
vesicles or emulsions.
FIGURE 4 Scheme of Coulter counter apparatus (courtesy of Micromeritics).
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The main advantage of this technique is its application to concentrated
particle suspensions. Caution has to be observed in preparing samples
without gas bubbles, which may disturb ultrasonic wave displacement.
Confocal Microscopy
Confocal fluorescent microscopy[11] involves the study of labeled core
particles. It can be easily achieved with the help of fluorescent markers
for polymerized particles. In confocal microscopy, all objects out of focus
are suppressed from image formation. The minimum measured size is
200 nm. Three-dimensional representations can be built up from two-
dimensional image analyses.
By such microscopy, very small quantities, even of polydisperse sam-
ples, can be observed. This technique also generates very high quality
reflected images in brightfield. The disadvantages are necessary fluor-
escent core and matching solvent in order to reduce light scattering.
Environmental Microscopy
This most recent technique is based on scanning electronic micro-
scopy, but the aqueous environment of the particles is preserved (no need
to dry sample). Performing measurements involves exposing a drop of the
solution sample to an electron beam with a pressure gradient in the
specimen chamber, as shown in Figure 5[12]. This allows a sufficient
sample hydration instead of the high vacuum required in traditional
electronical microscopies. Following irradiation, the sample emits sec-
ondary electrons collected by a detector, as shown in Figure 6. Their
topography is observed in the sample micrograph. Recent work has
shown that by minimizing the electron beam path through the vapor and
by working at the lowest acceptable pressure, remote electron scattering
and artifact X-ray production can be reduced to an acceptable level[13].
This technique is suitable for characterizing polydisperse sample.
Sedimentation
The theory and practice of free sedimentation are ruled by the well-
known Stokes law. Free sedimentation means that a particle sediments
in a manner independent of the neighboring particles[5]. The heavier the
particle is, the shorter the sedimentation time is.
Traditional sedimentation. Gravity-induced sedimentation is too slow
with submicronic objects. In fact, Brownian motion for such particles is
very important and disturbs the sedimentation kinetics. As a con-
sequence, centrifugation and ultracentrifugation are employed.
Centrifugation and ultracentrifugation. These methods separate parti-
cles into size classes by sedimentation resulting from the earth’s gravity
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and centrifugal acceleration. An optical system is generally used to detect
the displacement of the sedimentation front. The centrifugal speed is
less than 10,000 rpm for centrifugation. The minimum particle size is
250 nm[9]. With ultracentrifugation, for inorganic particles, the accessible
size can be as small as a few nanometers[14].
FIGURE 5 Environmental scanning, electronical microscopy apparatus (cour-
tesy of Elsevier Science Editors[12]).
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The drawbacks are as follows:
 Nonspherical particles require a more complex treatment.
 Hard particles are required because of strength of the centrifugal field,
which may deform soft particles.
 Finding an adequate optical system, particularly in the case of turbid
suspensions.
 Several dilutions may be necessary in order to avoid particle inter-
actions. Optimal concentration up to 1% (v=v) is usually obtained[9].
1. Destructive Methods
With destructive methods the particles are removed from the aqueous
environment.
Electron Microscopy
Electron microscopy[15] is a common name for several techniques
where the sample is submitted to an electron beam of modulated power.
In the observation chamber the pressure conditions are strictly con-
trolled, and most measurements are performed under vacuum. A scan-
ning electron microscopy (SEM) micrograph is a topography of the
intensity of the secondary electrons. For transmission electron micro-
scopy (TEM), the intensity of the transmitted electrons is collected
(see Figure 6). The size range and resolution of these techniques are
FIGURE 6 Sample submitting to an electronic beam.
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dependent on the beam power. For example, 20 kV is enough to observe
submicronic particles with a resolution of 50 nm.The sample preparation
is specific to each technique. By these methods, an image of the particles
themselves is obtained. A mean size characterization requires an image
analysis, which must be more elaborate if the sample is polydisperse. In
the latter case, the mean diameter is normally calculated as a number-
averaged diameter. One has to be aware that the electron beam can fuse
particles, such as polymer gels.
Scanning Electron Microscopy (SEM)
The ‘‘dried’’ sample is submitted to an electron beam and the topo-
graphy of secondary electron intensity leads to particle size evaluation.
The smallest observed particles are about 200 nm. The preparation
method of the ‘‘dried’’ sample leads to the distinction between classical
and cryofracture methods.
In the classical case, the aqueous sample is placed on a sample-support
and evaporated under vacuum before covering it with colloidal metal. In
cryofracture SEC, the aqueous sample is frozen by immersion in liquid
nitrogen prior to fracturing. It is then submitting to a gentle cleaning of
the fracture plane surface. The ice quality is of great importance; it has to
be amorphous to form the best replica of the surface.
Platinum, then carbon are deposited in order to obtain a rigid and
SEM observable replica.
Cryofracture TEM
Several preparation methods may be employed depending on the
nature of the sample.
 Small drops of the sample are projected onto a cryogenically cooled
metal surface and mechanically fractured afterward. A replica is formed
by metal vapor deposition and then submitted to the electron beam.
 A thin layer of the sample is frozen and then submitted to the electron
beam. The transmitted electrons are collected to evaluate their intensity
topography. The sample is frozen so rapidly that amorphous and
transparent ice is formed.
Scanning Tunneling Microscopy (STM) and Atomic Force
Microscopy (AFM)
The ‘‘hydrated’’ and slightly conductive sample, where the solvent is
not completely evaporated, can be studied with the help of a sharp metal
tip bound to a piezoelectric crystal.
For STM[15], the sample surface has to be conducting or metallized. A
voltage increase of the piezocrystal moves the tip to a distance where a
tunneling current is detected. For AFM[15], the tip scans over the surface
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and its deflections are detected by a laser system on its backside. The size
resolution is less than one nanometer. The main disadvantage is that the
tip cannot scan convex topology. In this case, tapping (push and pull
STM) may be used, which allows measurements of diameters.
Let us now give some examples of experimental measurements in order
to illustrate some of these techniques and how to choose the appropriate
one.
STUDY OF AN IDEAL SAMPLE: LATEXES
The first example is a standard sample of calibrated polystyrene
nanoparticles, provided by Interfacial Dynamics Corp. (Portland, Ore-
gon, USA). The number-average diameter was given as 310 ( 10) nm
(based upon TEM). This ideal suspension was characterized by three
techniques: DLS, laser granulometry, and SEM.
DLS Study
The complete DLS study was performed on a SEMATech photo-
goniometer (Nice, France) with the help of a Malvern 7032CN correlator
(Malvern, Worcestershire, UK). The Malvern software PCS 1.32 was
used to analyze the data. As stated earlier, the sample preparation has to
be done with caution (no dust, contaminants, or multiple scattering).
For each sample, at least five acquisitions of ten sub-runs were made.
The software for each subacquisition checks off the measurement quality
for each mathematical treatment (monomodal-cumulants, Contin
described later). The intensity ratio suspension=solvent has to be more
than ten. In our case, it is fifty times larger.
The correlator gives results that are highly dependent on the chosen
algorithm (i.e., a mathematical model) and the different theoretical
approaches: monomodal-cumulants, Contin, non-negatively constrained
least squared (NNLS), inverse Laplace transformation (ILT), and so on.
Several such methods are described in the literature, especially in an
exhaustive review by Stepanek[16]. Here, monomodal-cumulants and
Contin treatments are presented, since they are the most used routine
algorithms.
Each algorithm induces some assumptions about the sample compo-
sition and its polydispersity. The monomodal algorithm assumes nothing
about the distribution. It consists in fitting a polynomial to the log
of the normalized correlation function. Contin mode, developed by
the Provencher team[17], analyses the correlation through an inverse
transformation. Its consists in adding a constraint—the regulariser—to
an ordinary least-squares criteria for achieving the best fit. This mode is
convenient for several populations. An automatic mode exists, which is a
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combination of monomodal and Contin mode with a priority to the
monomodal.
In Table I various averaged diameters obtained by different analysis
are compiled.
Three average diameters can be obtained:
 Intensity-average, dI, (also called z-average diameter) calculated by
dI ¼
P
i
nid
7
iP
i
nid
6
i
ð8Þ
with ni the relative particle proportion in the corresponding class size di
 Volume-average, dv, (also called weight-average) is obtained by
assuming that the particles are spherical and multiplying the relative
contribution of each size class di by the volume corresponding to a
sphere in that size class
dv ¼
P
i
nid
4
iP
i
nid
3
i
ð9Þ
 Number-average, dn obtained with the help of
dn ¼
P
i
nidiP
i
ni
ð10Þ
In the case of particle diameters larger than l, a part of the light is
adsorbed and the intensity average diameter estimation is a function of
the particle refractive index which has to be known precisely. Then, the
other average representations are calculated by the chosen method (Eqs.
8–10). Thus, if the refractive index is not properly defined, these average-
diameters can be erroneous.
The intensity value is more appropriate for reporting results from a
DLS analysis based on intensity fluctuations, but the mean number
TABLE I Latex Mean Diameters by Monomodal Algorithm
and Relative Proportion
Analysis Intensity Volume Number
Mean (nm) 307.8 350 316.1
Width 109 146 175
% 100 100 100
Polymer Nanoparticle Characterization 297
D
ow
nl
oa
de
d 
by
 [D
icl
e U
niv
ers
ity
] a
t 1
4:3
8 1
6 N
ov
em
be
r 2
01
4 
P5
diameter also has to be considered, because it can be more easily com-
pared to microscopic results.
Monomodal-Cumulants Model
Here the chosen model is the monomodal one. In Figure 7a, the plot of
the autocorrelation function Gl versus sample time, t, is represented.
Function Gl quantifies the similarity between two acquisitions on a same
small suspension volume taken at two different moments separated by t,
the sample time.
When two acquisitions are identical, G1ðtÞ ¼ 1, the most information
about the suspension is obtained. In the opposite case, when G1ðtÞ equals
zero, i.e., when two acquisitions are totally different, no information
about the system can be extracted.
FIGURE 7a QELS G1 autocorrelation function of latexes in a function of the
sample time t fitted by monomodal algorithm (at least five acquisitions of ten sub-
runs, suspension=solvent intensity ratio>50).
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The first t for which G1(t) equals zero, is called the relaxaton time, tr.
In other words, the shorter the sample time t is, the bigger the ratio tr=t is,
and the better the statistics (number of accumulations) are.
In Figure 7a, the experimental data are represented by crosses and
fitted by the monomodal model curve. The fit is good for most of the
data, and only the data corresponding to the smallest G1 values are not
correctly fitted. The relaxation time, tr, equals 20ms, which can be
considered as a covenient value.
In Figure 7b, the size class distribution in intensity is shown versus the
particle diameters analyzed. Only one peak appears centered about
310 nm. It is a Gaussian curve.
Table I shows that the mean intensity value is very close to the one
measured by TEM, given by Interfacial Dynamics Corp. However, the
measured polydispersity is around 15%. Polydispersity is often an
FIGURE7b QELS intensity-average size distribution of latexes obtained bymono-
modal algorithm (at least five acquisitions of ten sub-runs, suspension=solvent
intensity ratio>50).
Polymer Nanoparticle Characterization 299
D
ow
nl
oa
de
d 
by
 [D
icl
e U
niv
ers
ity
] a
t 1
4:3
8 1
6 N
ov
em
be
r 2
01
4 
P5
important parameter for nanoparticles. The mean volume and mean
number averages are obtained by calculaton. One can note that the mean
number value is very close to the mean intensity one.
Contin Model
The same data may be analyzed via use of the Contin algorithm. Gl
versus sample time and size distribution versus intensity diameters are
represented, respectively, in Figures 8a and 8b. Here, the relaxation time,
tr, is about 30ms, which is longer than with monomodal cumulant model.
As explained below, the shorter the sample time is, the better the statistics
are. Thus, the Contin model does not seem to be the most convenient
model.
The distribution peak form is not as close as the monomodal treat-
ment to a Gaussian distribution. It proves that the Contin analysis, in
this case of a nearly monodisperse sample, is not the more convenient
algorithm. The intensity mean diameter, shown in Table II, is not as close
to the given standard value 310 nm as the monomodal value. The other
mean values are out of range, especially because of their width, which is
as large as the diameter itself.
In conclusion, in the DLS study of nearly monodisperse samples, the
use of the monomodal algorithm is recommended.
Laser Granulometry Study
The use of laser granulometry requires some caution during sample
preparation as mentioned earlier. Similarly to DLS, laser granulometry
results are represented as the size distribution versus volume-average
diameters. Each sample is diluted with the help of the continuum medium
in order to achieve the ideal experimental condition with an adequate
obscuration coefficient (about 0.3). Then acquisitions are made until five
consecutive runs give similar results, in order to achieve good repeat-
ability.
In Figure 9, the size distribution was observed with the 45 mm focal
lens and, in Figure 10, the same observation was carried out with the
100 mm focal lens. With the former, only one population appears centered
on 300 nm and, for the latter, four different size classes are observed, with
three of them being obviously artifacts. The optical system, in relation to
the size range observed, is of great importance if meaningful results are
to be obtained.
Table III gives the results of the 45 mm focal measurements. Among
the various averaged diameters compiled, which are obtained by different
calculations, the two most important are the volume and number
representations. The number diameter will be taken into account in the
following, since it can be easily compared to microscopy results.
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STUDY OF PLANT PROTEIN NANOPARTICLES
The suspension used was a plant protein nanoparticle system described
earlier[1]. It was obtained by a coacervation method. The desolvatation of
macromolecules was caused by addition of a solvent phase, an ethanolic
aqueous solution of the protein, to a nonsolvent phase. The chosen
protein is gliadins, extracted from wheat flour. Several techniques were
applied, DLS (cumulants and Contin), laser granulometry, and SEM, in
order to determinate the most representative distribution for the sample.
DLS Study
The same preparation caution is taken for the DLS sample as
described earlier (no pollutants and no multiple scattering). For each
sample, at least five acquisitions of ten sub-runs are made. The software
FIGURE 8a QELS G1 autocorrelation function of latexes in a function of the
sample time t fitted by Contin algorithm (at least five acquisitions of ten sub-runs,
suspension=solvent intensity ratio>50).
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for each subacquisition checks off the measurement quality for each
mathematical treatment (monomodal-cumulants, Contin described later).
The intensity ratio suspension=solvent is fifty.
Monomodal-Cumulants Model
The relaxation time, tr, of the G1 fit, Figure 11a, is large (longer than
100 ms). The application of monomodal model here seems to be poor.
FIGURE 8b QELS intensity-average size distribution of latexes obtained by
Contin algorithm (at least five acquisitions of ten sub-runs, suspension=solvent
intensity ratio>50).
TABLE II Latex Mean Diameters by Contin Algorithm
Analysis Intensity Volume Number
Mean (nm) 297 391 354
Width 131.4 341.9 351.2
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The intensity size distribution, Figure 11b, presents one peak, but the
number distribution, Figure 11c, presents several. Table IV does not give
narrow values of the mean diameter. This heterogeneity of results shows
that the monomodel assumption is not appropriate for this particular
case.
Contin Model
With the Contin analysis, Figure 12a, tr of Gl is less than 25 ms. The
results are better than those from the monomodal-cumulant model. A
single peak is seen in the size distribution curve, Figure 12b. Its form is
nearly Gaussian and it is centered around 800 nm. The mean intensity
value is around 800 nm, but the width is important. The two other ana-
lyses, in volume and in number, given in Table V, are out of sense and are
probably due to calculation artifacts. In fact DLS analysis points out a
quite polydisperse population with a mean size greater than l (i.e., about
800 nm).
To conclude, DLS analysis shows several distributions, with one of
them composed of particles larger than l.
FIGURE 9 Volume-average size distribution of latexes obtained by laser
granulometry with the 45 mm focal length (obscuration coefficient around 0.3,
five consecutive acquisitions given similar results).
Polymer Nanoparticle Characterization 303
D
ow
nl
oa
de
d 
by
 [D
icl
e U
niv
ers
ity
] a
t 1
4:3
8 1
6 N
ov
em
be
r 2
01
4 
P5
Laser Granulometry Study
From the plant protein nanoparticles suspension, a laser granulometry
sample without any pollutants or gas bubbles was prepared. The size
distribution plot, Figure 13, shows two size classes: one around 500 nm
and another at 6 mm. It is now clear why light scattering was not usable.
The latter class represents less than 10% of the sample population. The
mean volume diameter is 1 mm while 50% of the particle size are less than
550 nm. These results are coherent, but very different. Let us now con-
sider an SEM image of the particles.
FIGURE 10 Volume-average size distribution of latexes by laser granulometry
with the 100 mm focal length (obscuration coefficient around 0.3, five consecutive
acquisitions given similar results).
TABLE III Latex Mean Diameters by Laser Granulometry
Analysis Intensity Volume
Mean (nm) 340 290
Width 28 21
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SEM
The sample preparation was evaporated in a vacuum chamber, and
then the deposition of a colloidal metal was performed. This layer con-
ducts on the sample surface the electron beam and generates the sec-
ondary electrons forming the SEM image. Should the beam fuse the
particles of gel or of soft polymers, cryo-SEM could be used.
Several micrographs (at least 10) of the same sample are taken.
Figure 14 is representative of all of them and shows spherical particles.
The diameter of most of them is less than 700 nm in a ‘‘dry’’ state. A few
of them are bigger than 2 mm such as the one next to the 1 mm bar. This
image confirms the previous results: the Contin DLS diameter of 800 nm,
which has been found in the aqueous medium, and the laser granulo-
metry two size classes whose diameters are upper than 1 mm. It would be
interesting now to perform an image analysis in order to confirm the four
peaks seen by Contin analysis.
FIGURE 11a QELS G1 autocorrelation function of plant protein nanoparticles
fitted by monomodal algorithm (at least five acquisitions of ten sub-runs,
suspension=solvent intensity ratio> 50).
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This example shows that a characterization of nanoparticles size, for
such a non-ideal sample, is not evident. The sample polydispersity leads
to many difficulties. To resolve them, a solution could be to separate the
different size classes, and then to characterize them. Different solutions
may also be used, as reviewed in the following section.
POTENTIAL SOLUTIONS TO PROBLEMS ASSOCIATED
WITH POLYDISPERSITY
Sedimentation
Generally speaking, sedimentation gives access to information over a
wide size range, from a few nanometers up to several micrometers. This is
FIGURE 11b QELS intensity-average size distribution of plant protein nano-
particles obtained by monomodal algorithm (at least five acquisitions of ten sub-
runs, suspension=solvent intensity ratio>50).
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especially true with the ultracentrifugation for nanosized objects. With an
appropriated optical system, the size analysis is made easier with the help
of time used as a separator. A unique size class passes in front of the
optical system at any point in time. In fact, monodisperse and uncharged
hard spherical particles are quickly size characterized in very diluted
suspension if the sedimentation occurs rapidly enough.
These techniques are based on the free and unhindered sedimentation
of particles. The potential complicating factors for such a characteriza-
tion are polydispersity—i.e., size distribution mixture, attractive and
charged particles, non-ideal shapes, temperature, dilution shock, vessel
FIGURE 11c QELS number-average size distribution of plant protein nanopar-
ticles obtained by monomodal algorithm (at least five acquisitions of ten sub-
runs, suspension=solvent intensity ratio>50).
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TABLE IV Plant Protein Nanoparticle Mean Diameters by Monomodal
Algorithm and Relative Proportion
Analysis Intensity Volume Number
Mean (nm) 1107.3 752.5 1023.7 1313.2 446.5 738.5 1035.6 1327.7
Width 523.9 120.5 134.5 205 96.8 156 234.5 102.4
% 100 12.4 39.2 47.8 7.3 30.6 44.4 17.7
FIGURE 12a QELS G1 autocorrelation function of plant protein nanoparticles
fitted by Contin algorithm (at least five acquisitions of ten sub-runs, suspension=
solvent intensity ratio>50).
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geometry, and softness of the particles surface. Nowadays some of these
difficulties are partially covered up. Philipse[18] has written an interesting
review about this point.
FIGURE 12b QELS intensity-average size distribution of plant protein nano-
particles obtained by Contin algorithm (at least five acquisitions of ten sub-runs,
suspension=solvent intensity ratio >50).
TABLE V Plant Protein Nanoparticles Mean Diameters by Contin
Algorithm and their Relative Proportion
Analysis Intensity Volume Number
Mean (nm) 7.8 745.8 1.9 1.3
Width 16.2 1219 0.7 0
% 16.9 83.1 100 100
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Another approach, for a very diluted complex sample, is to couple
DLS with SLS. This method is known as multiangle dynamic light
scattering.
Multiangle Dynamic Light Scattering[19,20]
At different angles, the fluctuation intensities data are cumulated and,
then, integrated in two ways: averaged over a period of time (SLS) and
time dependent (DLS). The two results are correlated: the dynamical data
are evaluated by the Mie scattering function and then related to the
statistical intensity values. The obtained results are more reliable than the
ones generated only by DLS or SLS. Several classes are now resolved and
characterized even if they are close together.
FIGURE 13 Volume-average size distribution of plant protein nanoparticles
obtained by laser granulometry with the 45 mm focal length (obscuration
coefficient around 0.3, five consecutive acquisitions given similar results).
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Another point of view is, first, to separate the size distribution frac-
tions and, then, to analyse them. The separation could occur by one of
the flow field fractionation (FFF) family techniques.
Flow Field Fractionation Techniques
FFF methods[21] are direct and non-invasive methods. The different
fractions of the polydisperse sample are first separated, and then their
mean diameters are evaluated. The separation occurs by differential
retention related to a physicochemical parameter difference in a stream
liquid flowing through a thin channel (50–300 mm). The separated com-
ponents are eluted one by one into a detector, often a MALS detector
(multi-angle light scattering). The size range spreads from a few nm to
100 mm with the help of the Rayleigh–Debye–Gans and Lorentz–Mie
combination algorithms.
Sedimentation Flow Field Fractionation
The discriminating parameter involved in the sedimentation FFF is
the specific gravity difference between the particles and the aqueous
FIGURE 14 Plant protein nanoparticles SEM image.
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phase. A circular channel spins around a centrifuge axis and the species
are separated by the radially induced acceleration. For each peak, the
retention time is related to the particle size through MALS measure-
ments, and these results could be complemented by other microscopic
characterizations.
Sedimentation FFF is not convenient for smaller sized particles
(< 30 nm), whose sedimentation process is too slow. In such case, FFF is
convenient. The separation in this latter technique is driven by a ‘‘cross-
flow’’ field obtained by a second stream at a right angle to the main one.
Environmental Microscopy
Environmental microscopy, as shown earlier, avoids the inconvenience
and possible artifacts of ‘‘dried’’ sample. The sample hydration is con-
trolled by varying the vapor pressure in the chamber while maintaining
the temperature constant[13]. The thermal conductivity of the sample can
be critical. In addition the water can condense or evaporate. Before the
pump-down sequence, the chamber has to be saturated to minimize the
sample water evaporation. This microscopy method needs no prior
sample preparation[18]. The image is a picture of nanoparticles; this
method is less invasive than SEM and the diameters are reliable. With the
use of an image analysis, the size distribution curve is easily obtained.
Such a method affords direct particle observation in their own medium
without any dilution.
CONCLUSION
The different examples presented show that size characterization is not
such an easy analysis especially with a complex sample composed of
several size populations.
Nanosized objects are observable by many techniques. Most of them
are adversely affected by concentrated conditions, polydisperse distri-
butions, and irregular particle shapes. Multiangle dynamic light scatter-
ing can be very helpful in overcoming the last two disadvantages.
The concentration dependency is avoided by eluting and by separating
each size class before identifying them. For instance, multiangle dynamic
light scattering is fruitfully coupled with sedimentation FFF. In this case,
the particles are observed by indirect ways, for example light intensity
fluctuations.
Particles are directly seen by methods such as electronic microscopy.
The major disadvantage of these techniques is that the particles are not
characterized in solution but in a ‘‘dried’’ state, environmental micro-
scopy being an exception. This method is a less invasive technique and
gives results that are most representative of the real sample size
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distribution if it is coupled with an image analysis. Its development seems
to be very promising in the next decades, but currently it is rarely applied.
Finally, to prevent making excessive assumptions, the preferred
solution is to couple several size characterization techniques. It is pre-
ferred that at least one in situ technique be combined with electronic
microscopy.
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Abstract
Biopolymers represent an interesting alternative to synthetic polymers in order to be used as structured carriers for
controlled release and encapsulation applications. In particular, the ability of these carriers to entrap both hydrophilic
and hydrophobic drugs may be very promising for many applications. In addition, the absence of chemical
compounds and organic solvents used to produce biopolymeric matrices could be very interesting for some industrial
applications. Simple or complex coacervation methods involving proteins or protein and polysaccharide mixtures
were used to create new matrices dedicated to controlled release applications. Controlled release experiments with
model compounds were conducted in order to evaluate the performance of such matrices. An alternative and
promising research field deals with particles obtained from hydrogel systems. Totally transparent solid matrices
resulting from the dehydration of new protein gels were formed and swelling capacities of these matrices were studied.
© 2002 Elsevier Science B.V. All rights reserved.
Keywords: Coacervation; Encapsulation; Hydrogels; Swelling; Proteins; Arabic gum
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In the last decades, micro and nanosized col-
loidal carriers have received a growing scientific
and industrial interest (Thies, 1996). These vectors
may be capsules (with liquid core surrounded by a
solid shell), particles (polymeric matrices), vesicles
or liposomes, multiple or single emulsions and
found a wide range of applications. They may be
loaded by living cells, enzymes, flavour oils, phar-
maceuticals, vitamins, adhesives, agrochemicals,
catalysts and offer considerable advantages at use.
Liquids can be handled as solids, odour or taste
can be effectively masked in a food product,
sensitive substances can be protected from delete-
rious effects of the surrounding environment,
toxic materials can be safely handled, and drug
delivery can be controlled and targeted
(Robinson, 1997).
* Corresponding author. Tel.: +33-2-40-67-50-52; fax: +
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E-mail address: drenard@nantes.inra.fr (D. Renard).
0378-5173/02/$ - see front matter © 2002 Elsevier Science B.V. All rights reserved.
PII: S0378 -5173 (02 )00143 -6
P6
D. Renard et al. / International Journal of Pharmaceutics 242 (2002) 163–166164
In the forementioned laboratories, we started
with a new strategy based on phase separation in
order to prepare natural particles. Simple or com-
plex coacervation methods involving proteins or
protein and polysaccharide mixtures (Schmitt et
al., 1998) were used to create new matrices dedi-
cated to controlled release applications. The col-
loidal carriers produced were in the micrometer or
nanometer size range depending on the substrates
or the methods used.
Wheat proteins, gliadins, were implicated in
simple coacervation to produce nanospheres.
Nanoparticles were obtained by desolvation of the
protein using physiological salt solution as non-
solvent. Synperonic PE F68 was used to stabilize
the nanoparticles suspension (Duclairoir et al.,
1998). Gliadins nanospheres typical size was
around 900 nm (Duclairoir et al., 1998). Particles
size and polydispersity increased with the increase
of the solvent/non-solvent ratio and with the ag-
gregated state of the proteins. Controlled release
experiments with model compounds were con-
ducted in order to evaluate the performance of
such matrices. Vitamin E-loaded nanoparticles (1
mg) were digested in 10 ml of an ethanol/water
mixture (62/38 v/v) at room temperature in the
dark. The vitamin E concentration encapsulated
in nanoparticles (C1) and the residual concentra-
tion in the supernatant (C2) were then assayed by
HPLC at 290 nm. Empty nanoparticles were
treated in the same way and used as references for
these determinations. The drug loading (rate) and
the entrapment efficiency were calculated accord-
ing to the equations:
Rate (%)=
C1
mgliadins
Efficiency (%)=
C1
C1+C2
In vitro drug release kinetic was also performed
in non-sink conditions using decane as solvent (to
prevent drug loss from nanoparticles dissolution)
and a laboratory designed release cell. About 10
mg of gliadins nanoparticles (containing 824 g/g
gliadins) were resuspended in 10 ml of decane.
Aliquots were collected at successive time inter-
vals and replaced by the same quantity of solvent
in order to get a constant volume in the release
cell. The samples were analysed by HPLC as
described above for encapsulation experiments.
Fig. 1. Vitamin E (VE) encapsulation rate () and efficiency
() by gliadins nanospheres as a function of VE/gliadins ratio.
Encapsulation of vitamin E (VE) into gliadins
nanospheres revealed that the rate and efficiency
decreased with the decrease of the VE/gliadins
ratio (Fig. 1). For a VE/gliadins ratio of 1, an
encapsulation rate of 824 g/mg gliadins and an
efficiency of 77% were obtained. The VE release
kinetic from loaded particles was displayed Fig. 2.
The experimental points were fitted with the fol-
lowing equations:
VE
initial VE
=6


(short time)
VE
initial VE
=6


−3 (intermediate time)
Fig. 2. Vitamin E (VE) release kinetic by gliadins nanospheres
as a function of time (h). See text for equations used in the
fitting procedure: () released VE (%); (— ) fit (short time);
(----) fit (intermediate time).
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Fig. 3. (Left side) Phase contrast optical micrograph of 1 wt.% -lactoglobulin/Arabic gum mixtures at pH 4.2 ratio 1:1. Scale bar
represents 20 m. (right side) Confocal scanning laser micrograph of a coacervate obtained with a 1 wt.% -lactoglobulin/Arabic
gum mixture at pH 4.2 ratio 1:1. Scale bar represents 5 m.
with =Dt/r2, D being the diffusion coefficient of
the entrapped vitamin E and r, the radius of the
nanoparticles.
The kinetic profile was thus interpreted by a
burst effect coupled with a drug diffusion process
through the particle modelled as a homogeneous
sphere. The drug diffusion coefficient was consid-
erably reduced when entrapped in the carrier:
DVE=1.1 10−20 m2/s compare to DVE=10−9
m2/s in solution. The encapsulation of different
drugs into nanospheres showed that carriers had
more affinity for hydrophobic drugs and that the
-potential of the particles was directly related to
the nature of the drug (Duclairoir, 2000).
In the case of complex coacervation, the -lac-
toglobulin/Arabic gum couple was tested. The
mechanism of formation and the structural prop-
erties of coacervates were first highlighted in order
to better control the stability of these systems.
Coacervation process was established at pH 4.2 in
water where the two biopolymers interact electro-
statically (Schmitt et al., 2000). The structure of
the coacervates was explored using both phase
contrast and confocal scanning laser micro-
scopies. -lactoglobulin/Arabic gum spherical
vesicular coacervates revealed by microscopy were
the hallmark of these dispersions (Fig. 3). Large
‘foam-like’ coacervates induced by partial coales-
cence of single coacervates were visible especially
at the 2:1 protein to polysaccharide ratio (Schmitt
et al., 2001). Increasing dispersions stability was
reached by increasing protein to polysaccharide
ratio or by decreasing total biopolymer concentra-
tion. Another alternative to increase the stability
is to produce composite dispersions containing
both protein aggregates embedded in protein–
polysaccharide coacervates and free coacervates
(Schmitt et al., 2000). These systems could thus be
used as multifunctional reservoirs for applications
in microencapsulation.
An alternative and promising research field
deals with particles obtained from hydrogel sys-
tems. The hydrogels may be sensitive to environ-
mental stimuli such as pH, ionic strength,
electric/magnetic fields, light and temperature de-
pending on the substrate used. Totally transpar-
ent solid matrices resulting from the dehydration
of new protein gels, revealed variable swelling
capacities that depend on the solvent used and
physical chemical conditions. The protein hy-
drogels were formed at pH 8 in 50% ethanol
solutions (Renard et al., 2000). Swelling kinetics
of cylindrical gels in both hydrated (m04.5 mg)
and dehydrated (m01.5 mg) forms were fol-
lowed in different solvent conditions. The swelling
kinetics of -lactoglobulin hydrogels showed that
the increase of mass was the highest in water for
both hydrated and dehydrated gels (Fig. 4). The
capacity of swelling (or not) depended on the
solvent conditions and would allow a controlled
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Fig. 4. Swelling kinetics of -lactoglobulin hydrogels both in
dehydrated and hydrated forms for different solvent condi-
tions: () ethanol; () water/ethanol 50/50 (v/v); () water;
() 0.1M NaCl; () water/ethanol 50/50 (v/v) (hydrated gel);
() water (hydrated gel).
Fig. 5. Optical micrograph of -lactoglobulin beads obtained
by a gelation/emulsification method. Scale bar represents 500
m.
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release of both hydrophilic and hydrophobic
drugs.
A new dispersion/gelation method was devel-
oped to produce micro-beads having potential
applications in the encapsulation field. Basically,
the dispersion of a -lactoglobulin pre-gel in an
apolar phase produced gelled droplets. These
droplets were then washed and dehydrated under
vacuum in order to produce particles of 500 m
mean diameter (Fig. 5). Such protein matrices
were totally transparent and could be used to
encapsulate large molecules or microorganisms.
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Abstract
In this paper, biopolymer nanoparticles are studied, which unlike many synthetic carriers used for controlled release, are
biocompatible and biodegradable systems. Gliadins nanoparticles are obtained by a desolvatation method, also known as
drawning-out precipitation. These particles have been shown to be interesting as drug release systems for all-trans-retinoic
acid. The aim of this paper was to study the influence of the polarity of different drugs on nanoparticle characteristics such as
size and drug loading efficiency. Three drugs of three different polarities were studied: the hydrophobic Vitamin E (VE), the
slightly polar mixture of linalool and of linalyl acetate (LLA) and the cationic amphiphilic benzalkonium chloride (BZC). This
comparative work shows that the amount of the entrapped VE and LLA is higher than that of the cationic BZC, confirming
a strong interaction between gliadins and apolar compounds, due to the apolarity of the proteins. This interaction results in a
low diffusion coefficient and a partition coefficient in favour of gliadins, resulting in a low permeability coefficient. The drug
release kinetics of two substances, LLA and BZC, are observed, in showing a burst effect, then a diffusion process, which can
be modelled assuming that the particles are homogeneous spheres.
© 2002 Elsevier Science B.V. All rights reserved.
Keywords: Nanoparticles; Gliadins; Vitamin E; Linalool; Linalyl acetate; Benzalkonium chloride
1. Introduction
Drug delivery systems are interesting formula-
tions to prevent numerous drawbacks related to the
drug itself, for example by decreasing its degradation
rate. In such a dosage form, the drug is gradually
released unlike all conventional formulations. Sev-
eral carriers have been studied in the last decades,
among them, liposomes, vesicles, films, sponges,
∗ Corresponding author. Tel.: +33-1-46612713;
fax: +33-1-46612713.
E-mail address: oreccam@wanadoo.fr (A.-M. Orecchioni).
simple or complex emulsions, and particles. These
last named delivery systems are found as spheres or
capsules for core/shell particles. Particles are classi-
fied as microparticles for micron-sized systems and as
nanoparticles for sub-micronic systems (Thies, 1996).
Most of them are derived from synthetic polymers
and some from biopolymers (Nakache et al., 2000).
Recently, gliadins, extracted from wheat gluten,
have been used to elaborate nanoparticles (Ezpelleta
et al., 1996; Duclairoir et al., 1999). As biopoly-
mers, gliadins do not present the common drawbacks
of synthetic materials, related to the presence of
monomer or initiator residues (Chasin and Langer,
0378-5173/02/$ – see front matter © 2002 Elsevier Science B.V. All rights reserved.
doi:10.1016/S0378-5173(02)00701-9
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1990). Their biocompatibility is assumed and, as
plant proteins, they are recognized as prion-free un-
like animal proteins. Besides gliadins are hydropho-
bic and slightly polar (Bigelow, 1967; Popineau and
Denery-Papin, 1995). Consequently, they are able to
interact with skin keratin (Teglia and Secchi, 1994).
Thus, gliadin systems seem to have promise in the
development of topical formulations. Moreover, pre-
vious work has shown that the preparation of gliadin
particles can be easily performed by simple coacer-
vation method (Ezpelleta et al., 1996). The obtained
gliadins systems are spherical and submicron-sized,
thus are nanoparticles. They proved to be inter-
esting delivery systems for all-trans-retinoic acid
(RA).
In this study, three drugs of different polarity have
been entrapped in such gliadins nanoparticles. There
are the hydrophobic Vitamin E (VE), the slightly po-
lar linalool/linalyl acetate mixture (LLA), and the am-
phiphilic and cationic benzalkonium chloride (BZC),
with dielectric constants (ε) respectively of 4, 8 and
45 (Maryott and Smith, 1951).
-Tocopherol (Vitamin E) is known as a strong an-
tioxidant or nitrosamine blocker to prevent built up of
cellular peroxides (Idson, 1992; Marty and Wepierre,
1994). For instance, free radicals may promote skin
damages such as premature skin aging (Epstein,
1983), skin fragility and even skin cancers such as
melanoma (Sober, 1987) related to a decrease in cel-
lular immunity of the skin. VE is known to delay the
progression of aging (Wester and Maibach, 1997), to
have skin moisturising properties (Mayer et al., 1993)
and emolliency properties (Tamburic et al., 1999;
Marty, 1998). However, VE is degraded by oxygen
and must be carefully protected from light, heat and
contact with air when it is used in formulations and
dosage forms. To overcome these drawbacks, lipo-
some dosage forms were formulated (Kagan et al.,
1992; Koga and Terao, 1996). Nanoparticulate carri-
ers from bioacceptable macromolecules, particularly
gliadins, are also interesting system for controlled
drug release. They are able to interact with epidermal
keratin due to their being rich in proline (Teglia and
Secchi, 1994).
Linalool and linalyl acetate are the major compo-
nents of aromatic lavender essential oils, frequently
used in aromatherapy. Moreover, linalool and lina-
lyl acetate give antibacterial and antifungal proper-
ties (Lis-Balchin and Hart, 1999) to the formulations.
In dermatologic formulations, for instance, their use
may irritate the patient’s skin. Gliadins encapsulation
could be a fruitful method for LLA formulation. The
coupling of gliadins proline, which allows a powerful
attraction to the skin keratin, and of the gradual and
controlled LLA release, potentially avoids all the po-
tential drawbacks of the drug and even improves LLA
disposition.
BZC is a cationic surfactant often used as antisep-
tic, bactericide (Patterson, 1956), spermicide (Aubeny
et al., 2000) or virucide (Wainberg et al., 1990).
Some original formulations of this drug, better known
as Zeriphian®, are on the market. There are cap-
sules (Wainberg et al., 1990) and vaginal Protectaid®
sponges (Psychoyos et al., 1993). But the medication
can promote some allergies followed by mucous le-
sions (Dhillon et al., 1982). Thus, a dosage form such
as gliadins nanoparticles could be a good alternative
and could avoid lesions promoted by the irritant BZC
and, even, could improve the therapeutic dosage by
delaying the delivery.
This paper reports on the characterization, entrap-
ment and release studies on the novel drug delivery
systems.
2. Materials and methods
2.1. Materials
Gliadins were extracted and purified by Y. Popineau
(LBTP, INRA, Nantes, France). -Tocopherol (VE)
and benzalkonium chloride (BZC) were obtained from
Sigma (St. Louis, MO, United States). The aromatic
extract (LLA) was provided by Euracli (France).
Synperonic® PE F68 was furnished by ICI surfac-
tant (Cleveland, United Kingdom). All the aqueous
solutions were prepared with ultrapure water (Milli
Q Plus, Millipore, Molsheim, France). Ethanol and
sodium chloride were of analytical grade and obtained
from Prolabo (Paris, France).
For VE estimation, methanol (HPLC grade) was ob-
tained from Carlo Erba Reagenti (Val de Reuil, France)
and decane (spectroscopic grade) from Acros Organ-
ics (Geel, Belgium).
LLA quantification was performed using linalool
from Touzart and Matignon (Paris, France) and
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pentane (spectroscopic grade +99%) from Acros
Organics (Geel, Belgium).
BZC content was estimated using chloroform (syn-
thetic grade 99.9%) from SDS (Peypin, France), sul-
phuric acid (analytical grade 96%) from Carlo Erba
Reagenti (Val de Reuil, France), sodium hydroxide
0.1N standard solution from Distrilab (Caen, France),
sodium dodecylsulfate or sodium laurylsulfate (SDS,
analytical grade 99%) from Sigma (St. Louis, United
States), benzethonium chloride 0.00398N standard
solution from Prolabo (Paris, France), Patent blue
VF or blue disulfine VN 150 from Acros Organ-
ics (Geel, Belgium), phenolphthalein from Prolabo
(Paris, France), and dimidium bromide from Acros
Organics (Geel, Belgium).
2.2. Gliadins extraction and purification
Gliadins were extracted from a common wheat flour
(Hardi variety) (Larré et al., 1991). Briefly, gluten
was freeze dried, ground in a refrigerated grinder
and defatted by two extractions with dichloromethane
(gluten/solvent ratio: 1/10) for 2 h at 20 ◦C. After fil-
tration and residual solvent evaporation under reduced
pressure, samples of dried powder were stored in an
ethanol/water mixture (70/30, v/v) for 4 h at 20 ◦C.
The soluble fractions were then dialysed against dis-
tilled water and finally freeze dried.
For this study, the gliadins extract consists of four
fractions: -, -, - and -gliadins. The fractions
are classified due to their hydrophobicity and to their
mean molar mass. This extract has been characterized
by high performance liquid chromatography-reverse
phase (HPLC-RP). It contains 53.7% of /-gliadins,
39.9% of -gliadins and 6.4% of -gliadins.
2.3. Drug quantification
The choice of the three drugs (VE, LLA and BZC)
was made according to their polarity difference. In
consequence, their solubility behaviour differs for a
given solvent.
VE could be easily characterized by its specific
absorption at 295 nm by UV-spectrophotometry. VE
quantification is assayed by HPLC-RP at room tem-
perature using a photodiodes array detector (Waters
600, Millenium 32 software, Waters, Milford, United
States) at 295 nm, and a 250 mm × 3 mm Nucleosil®
100-5, packed with C18 column (Macherey Nagel,
Düren, Germany).
The medium containing LLA is not compatible
with a gas phase chromatography (GPC) analysis
used to quantify the perfume. First of all, the LLA is
extracted from the sample by pentane. LLA solution
and pentane are mixed in equal proportion. The LLA
transfer is known taking into account its partition co-
efficient between the two solvents. To determine this
partition coefficient, a known LLA quantity is dis-
solved in aqueous and ethanolic media. This medium
is mixed with an equivalent volume of pentane. Then
the LLA concentration is quantified in pentane. After
collection of the aqueous phase, it is blended with the
same volume of pure pentane. The LLA quantifica-
tion is assayed in pentane. It is repeated until there
are no remaining LLA traces in the pentane. The
LLA partition coefficient between water and pentane
was calculated as a function of extraction number,
the initial LLA concentration in the aqueous phase
and the experimental LLA concentrations in pen-
tane. When the extraction is completed, 5l of the
extracted solution is analysed by GPC (Varian 3300
GC-FID, United States) equipped with a flame ioni-
sation detector and an apolar DB 5 column (Scientific
Glass Engineering, Australia). The LLA content is
measured by the quantification of linalyl acetate and
linalool, which are respectively 35.7 and 39.7%.
The T73-258 and T73-320 AFNOR specifications
have been adapted to perform the BZC titration. In
fact, this quaternary ammonium is a cationic sur-
factant. Its titration consists of neutralisation by an
anionic surfactant, the sodium laurylsulfate (SDS) in
a biphasic water/chloroform system in the presence
of colour indicators mixture (ethanolic solution of
dimidium bromide 0.8% w/v and Patent Blue VF
0.4% w/v). During the neutralisation, a colour indi-
cator salt is formed and confers pink colour to the
organic phase. After complete BZC neutralisation, a
BZC excess transfers the indicator salt from the or-
ganic phase to the aqueous one, which becomes blue
and the organic fades up.
2.4. Preparation of drug loaded gliadins
nanoparticles
The gliadins nanoparticles were prepared by a de-
solvatation method described elsewhere (Ezpelleta
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et al., 1996; Duclairoir et al., 1999). In the case of VE,
to prevent its degradation, the nanoparticle procedure
has to be performed in the dark, under a nitrogen flow.
Proteins were dissolved in an ethanol/water mixture
(62/38, v/v) at 25 ◦C; the resulting solution was fil-
tered through a 0.1m pore sized membrane. Various
amounts of drug dissolved in ethanolic solutions were
then added to the previous gliadins solution. The
nanoparticle formation occurred when 20 ml of this
solution were poured into a 0.9% w/v NaCl/water
solution containing Synperonic® PE/F 68 (0.5%, v/v)
as a stabiliser, at 25 ◦C, under stirring (500 rpm). The
organic solvent was evaporated under reduced pres-
sure, and the resulting suspension was centrifuged
(20 000 rpm or 34 900 × g, 15 min). The supernatant
was removed and, after three washes in ultra pure
water, the loaded pellets were freeze dried and stored
at 4 ◦C in the dark.
2.5. Physicochemical characterization
The size of the nanoparticles was characterized by
scanning electron microscopy (Jeol, T330A, Japan).
The surface properties of the nanoparticles, loaded
and non-loaded, were analysed by determining their
zeta potential in a unimillimolar KNO3 solution at
room temperature. The nanoparticles were observed
in very diluted conditions by a Sephy Zetaphorimeter
III (Sephy, Limours, France).
The thermogram of nanoparticles, loaded and
non-loaded, were obtained using differential scan-
ning calorimetry (DSC) using a Perkin-Elmer DSC7
apparatus (Uberlingen, Germany) between −50 and
250 ◦C. The temperature gradient was 40 ◦C min−1.
2.6. Drug loading
In order to measure the drug loading, around 1 mg
of gliadins nanoparticles containing different amounts
of drug was digested in 10 ml of the ethanol/water
mixture (62/38, v/v) at 25 ◦C. The drug content C1
was tested by the adequate analysis method according
to the drug (Section 2.3). For VE, the experiments
were performed in the dark under a nitrogen flow, as
explained in Section 2.3.
The non-encapsulated drug remaining in the su-
pernatant after the first centrifugation C2 was also
estimated.
With these two data, the drug loading (payload)
was calculated as the entrapped drug in nanoparti-
cles/gliadins nanoparticles yield ratio
Payload (%) = C1 (mg)
gliadins nanoparticles
yield (mg)
× 100 (1)
and the entrapment efficiency was calculated as the
drug amount in particles/initial drug content ratio
Entrapment efficacy (%)
= C1 [amount of drug in nanoparticles (mg)]
(C1 + C2) [initial drug content (mg)] × 100
(2)
For comparison of the different entrapped drugs, the
dimensionless entrapment efficiency is adequate. But
to simplify the comparison between drugs, an opti-
mal drug concentration has been defined as the best
compromise between the payload and the entrape-
ment efficiency. This optimal drug concentration is
the drug/gliadins ratio obtained at the intersection
of payload and entrapment efficiency curves versus
drug/gliadins ratio.
2.7. In vitro drug release
About 1 mg of gliadins nanoparticles containing X
drug mg gliadins mg−1 were resuspended in a release
medium under stirring.
In the case of VE, the release profile was performed
three times by resuspending 10.1 mg of 824.0 VE
g gliadins mg−1 nanoparticles in 10 ml of decane.
This solvent has been chosen because of its VE affin-
ity, like most organic solvents. The solubility param-
eter of gliadins and of decane are respectively 34.5
(Duclairoir et al., 1998) and 19.0 MPa1/2 (Barton,
1991). Considering such a difference of solubility
parameters, the decane is not able to solubilize the
gliadins nanoparticles and even to modify their sur-
face. The release study was performed under nitrogen
and in the dark in order to prevent VE loss.
For the BZC release, 741.5 mg of 550.3 BZCg
gliadins mg−1 nanoparticles were resuspended in
70 ml of ultrapure water at 25 ◦C. This release study
has been replicated twice. The choice of water has
been motivated by its inability to dissolve the gliadins
nanoparticles and its ability to solulize BZC.
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For each, the medium was then maintained in
a release cell at 25 ± 0.2 ◦C. This original cell is
constituted by a double shell leading to an efficient
thermostating and by an access allowing easy collect-
ing of aliquots exempted of nanoparticles by filtration
through a 0.1m pore sized membrane. Aliquots of
100 and 700l have been collected respectively for
VE during 120 h and for BZC during 150 h. After
each sample collection at successive time intervals, t,
an equal amount of thermostated release medium was
introduced into the system. Thus, during the whole
release, the nanoparticles concentration remained
unchanged. The released drug amount, Mt , was eval-
uated, for each sample, by the adequate analysis tech-
nique as regards to the drug. Then the in vitro release
is found using the plot of Mt /M0 versus the time t with
M0 the effective drug loaded amount in the nanopar-
ticles, expressed as “X drug mg gliadins mg−1”.
3. Results and discussion
3.1. Gliadins nanoparticles characterization
Gliadins, wheat gluten proteins, precipitate into
nanoparticles by the desolvatation method known as
“nanoprecipitation” (Stainmesse et al., 1995; Alonso,
1996), or coacervation, solvent displacement or
drawning-out phenomenon (Mersmann, 1994).
These loaded and unloaded gliadins particles are
spherical, as shown by scanning electron microscopy.
3.1.1. Size characterization
The mean volume–average diameters of loaded and
unloaded nanoparticles are compiled in Table 1.
Table 1
Size characterization, zeta potential, glass transition temperature, entrapment efficiency and optimal drug concentration obtained for drug
loaded nanoparticles according to the dielectric constant of the drug
Particles Unloaded VE loaded LLA loaded BZC loaded
ε – 4 8 45
Mean diameter ±10% (nm) 900 900 930 950
Zeta potential (mV) −1 −1 −1 to −4 20–40 varying with
BZC concentration
Tg 145 134 130 110
Entrapment efficiency (%) – 79.2 82.4 52.3
Optimal drug concentration (g gliadins mg−1) – 972.0 980.0 550.3
To decrease the experimental error on the mean
value and to approach the real mean diameter, several
micrographs of different places of the sample have
to be analysed. The experimental error on the mean
volume–average diameter is around 10%.
Although the experimental error due to the char-
acterization method is more important than the
difference between the diameters themselves, the
number-average diameters obtained by SEM seem to
increase with the drug polarity (ε, their dielectric con-
stant) (Maryott and Smith, 1951), as shown Table 1.
The more polar the drug, the larger the mean diameter
is of loaded particles.
3.1.2. Zeta potential study
In Table 1, are mentioned the zeta potential of
loaded particles and the drug polarity represented by
its dielectric constant, ε, compiled in the literature.
As anticipated, the unloaded nanoparticles are almost
uncharged, as are the gliadins themselves.
The VE loaded nanoparticles have a similar ζ . It
is explained considering the quite low VE dielectric
constant (ε = 4). In the case of LLA, which is slightly
polar (ε = 8), the charge is near zero (the error with
such a technique is estimated around 3 mV).
The zeta potential of BZC loaded nanoparticles dif-
fers according to the drug amount in the particles. BZC
is an ionized cationic surfactant (ε = 45). This differ-
ence could be explained by the presence of a fraction
of the drug present at the particle surface, although
the zeta potential does not increase as a function of
the increasing loaded BZC concentration, as shown on
Fig. 1.
In fact, after zeta potential change, a step value is
reached around 25 mV. Such behaviour can be related
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Fig. 1. Zeta potential of BZC loaded nanoparticles versus the drug entrapped concentration.
to the increased amount of charge number in the dif-
fuse double layer inducing a shielding effect of the
superficial charge decreasing the zeta potential value
(Hunter, 1981).
3.1.3. DSC study
3.1.3.1. Unloaded nanoparticles. Gliadins and the
surfactant (Synperonic® PE F68), as well unloaded
gliadins nanoparticles were studied.
Gliadins, lead to a large glass transition temperature,
Tg, around 165 ◦C. The surfactant thermogram shows
a fusion peak at 52 ◦C. Then gliadins are blended
with surfactant, a unique glass transition appears at
144 ◦C. The disappearance of the surfactant melting
peak could be explained by its low amount or by per-
fect compatibility of the surfactant in the particle ma-
trix. In any case, its presence is attested by decreasing
glass transition temperature and can even be evaluated
around 20%.
3.1.3.2. Loaded nanoparticles. Under the same
conditions, thermogram of drug loaded nanoparticles
show an unique transition corresponding to a glass
transition. The corresponding Tg values are compiled
in Table 1.
The thermogram of the drugs show no glass transi-
tion, but boiling peaks at 210 ◦C for VE, at 200 and
220 ◦C for LLA and at 36 ◦C for BZC. None of these
peaks appear on the thermograms of drug loaded par-
ticles. For VE or LLA loaded particles, the obtained
Tg are close and their difference is less than the ex-
perimental error of 10 ◦C usually attributed to DSC
measurements. For BZC loaded nanoparticles, the Tg
seems to decrease in the presence of drug. The BZC
boiling point is lower than gliadins Tg and could ex-
plained this phenomenon. These results lead to the
conclusion that the drug should be, at least, dispersed
quite homogeneously inside the particle.
3.2. Drug entrapment study
Payload and entrapment efficiency are dependent on
the drug/initial protein ratio.
3.2.1. VE entrapment
Fig. 2 represents the payload and the efficiency ver-
sus the VE/gliadins ratio. The encapsulated/initial VE
payload increases from 0 to 82% and the encapsu-
lated/initial VE efficiency decreases from 100 to 77%.
The optimal VE concentration is obtained for 972.0
VE g gliadins mg−1, with at least, an efficiency of
79.2%.
3.2.2. LLA entrapment
The partition coefficient of LLA between gliadins
solvent and pentane is 0.630 and allows us to eval-
uate C1, the effective LLA concentration contained
in nanoparticles. After centrifugation, C2, the remain-
ing LLA concentration in the supernatant, is evalu-
ated with the help of the partition coefficient of LLA
between the supernatant and pentane estimated to be
0.204.
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Fig. 2. Payload () and entrapment efficiency () of VE loaded gliadins nanoparticles (experiment number n = 3).
On Fig. 3, the LLA payload and the LLA entrap-
ment efficiency by gliadins nanoparticles are shown.
The former increases from 0 to 94%, as the latter
reduces from 100 to 76%.
The optimal LLA concentration corresponds to
980.0 LLA g gliadins mg−1 with an efficiency of
82.4%.
3.2.3. BZC entrapment
BZC payload and BZC entrapment efficiency are
plotted in Fig. 4. The efficiency decreases from 83 to
56% and the payload increases from 0 to 53%.
Fig. 3. Payload () and entrapment efficiency () of LLA loaded gliadins nanoparticles (n = 3).
The optimal BZC concentration is achieved for
550.3 BZC g gliadins mg−1 with an efficiency of
52.3%.
3.2.4. Comparison of entrapment capacity of
gliadins nanoparticles
Table 1 shows the optimal drug concentration in
nanoparticles and the corresponding efficiency for
each drug. The close VE and LLA polarities result
in similar optimum drug concentrations, including
experimental error. Comparing the results of VE and
BZC, molecules with a similar molar mass, indicate
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Fig. 4. Payload () and entrapment efficiency () of BZC in gliadins nanoparticles (n = 3).
that the gliadins nanoparticles have more affinity for
VE than for BZC, whose polarity is higher. VE is as
apolar as the gliadins. Consequently, for any apolar
substance, it could be assumed that gliadins nanopar-
ticles would be able to entrap it with good results.
It can be noticed that BZC entrapment efficiency
is reasonable, probably because of the hydrophobic
chain of this amphiphilic molecule. These results con-
firm the low polarity of gliadins, whose ε is probably
less than 8. Few results are described in literature
concerning plant based nanoparticles and fewer about
gliadins nanoparticles. The only interesting paper
(Ezpelleta et al., 1996) is related to an entrapment
study of all-trans-retinoic acid/gliadins. In this work,
the highest ratio is just lower than 10%, the ratio used
in our study is higher than 10%, but the corresponding
entrapment efficiency are in concordance.
3.3. Drug in vitro release study
The release of two drugs, VE and BZC, has been
studied. In fact, LLA should be studied under a con-
trolled atmosphere and not in a liquid medium. Such
differences between media used here does not allow
an easy comparison to the other drugs.
3.3.1. VE in vitro release study
Gliadins nanoparticle preparations were tested for
in vitro release in decane for about 120 h at 25 ◦C
under nitrogen in the dark. During all the experimental
period, no VE or no particle degradation was observed.
The size and the morphology of nanoparticles have
been measured before and after the release by SEM.
Fig. 5 shows that VE is released in two steps, char-
acterized by an initial rapid release (under 1 h) which
could be attributed to the adsorbed drug in the super-
ficial zone of the spheres. This phenomenon is like a
burst effect. The second releasing period shows a de-
pendency on time and seems to be related to the drug
diffusivity inside the matrix systems.
After roughly 3 h, at the break point between the
two domains: burst effect and delayed release, the VE
amount decreases in the release medium.
This disappearance might be explained by the fol-
lowing hypothesis. During the first period, both VE
and surfactant (Synperonic® PE/F68) are released in
the medium. This surfactant forms micelles at very
low concentrations in decane (lower than 1 mg l−1).
Its amount in nanoparticles is evaluated around 20%.
Thus, in the vicinity of the particles, its concentration
could be sufficient to form micelles. These micelles
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Fig. 5. VE release in decane from 824.0 VE g protein mg−1 loaded nanoparticles at 25 ◦C fitted by short time model (—) and by medium
time model (– – –) (n = 3).
are then able to encapsulate a part of the released VE,
playing the role of drug-reservoirs. As VE is entrapped
in the surfactant micelles, this should explain the ob-
served fall in VE concentration in the release medium.
During the second period, both VE and surfactant con-
tinue to be released in the medium.
In order to explain this release profile, an analytical
model was applied. As shown by SEM, the particles
are spherical. Assuming that the drug is uniformly
distributed inside the delivery system, and that these
remain stable during all the experimental period, it is
known that (Washington, 1996)
Mt
M0
= 1− 6
π2
α∑
n=1
[
1
n2
exp(−n2π2τ)
]
(4)
where Mt is the amount of released drug at t time, and
(1− (Mt/M0)) the released amount and t is given by
τ = Dt
R2
(5)
with D the drug diffusion coefficient through the
particle and R the particle radius.
This relation is simplified for the first releasing
period, i.e. the first few percent decays
Mt
M0
= 6
√
τ
π
(6)
For the second period, the medium release time, this
relation becomes
Mt
M0
= 6
√
τ
π
− 3τ (7)
For longer times, a simplification of Eq. (4) is
Mt
M0
= 1− 6
π2
exp(−π2τ) (8)
Sometimes, the release can be extensively described
only by the short and long time model as shown by
Guy et al. (1982).
The release has been fitted by this model for the
first released drug and by the one for medium times,
i.e. Eqs. (6) and (7). r2, the correlation coefficient, is
respectively 0.7321 and 0.9010. Obviously, the model
of the first stage does not describe the experimen-
tal data. The difference could probably be explained
by an underestimation of the burst effect by this dif-
fusion model, and even, by experimental errors (less
than 1%), but the hypothesis of drug-reservoir micelles
could be an interesting complementary explanation.
For the second period, when the model for medium
times is taken into account, the fit is close to the
data. Then, the VE diffusion coefficient, D, through
the gliadins nanoparticles can be determined; D/R2
is 2.00 × 10−4 s−1. As the average particle radius
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Fig. 6. BZC release in ultra pure water from 550.3 VE g protein mg−1 loaded nanoparticles at 25 ◦C fitted by short time model (—) and
by long time model (– – –) (n = 3).
is 0.45m, the VE diffusion coefficient through the
gliadins nanoparticles is estimated around 4.1±0.1×
10−5 m2 h−1, i.e. 6.0± 0.3× 10−20 m2 s−1.
3.3.2. BZC in vitro release study
The in vitro release was performed at 25 ◦C during
more than 150 h in ultra pure water. The BZC release
profile is represented in Fig. 6.
In less than 30 min, a rapid release occurs until 11%
of the total released amount. This first period can again
be attributed to the drug desorption from the particle
surface. Then the drug diffuses very slowly inside the
nanoparticles; in fact, in more than 150 h, only a fur-
ther 2% of the drug is released after the initial rapid
release.
Once again, BZC kinetics is fitted by the model of a
diffusion process in a homogenous sphere. SEM con-
firms that nanoparticles size remains constant before
and after the drug release. After fitting, the data by
Eqs. (6) and (8), i.e. short and long time models, r2
values are respectively 0.5367 and 0.9669. Again, the
data are not fitted properly by the short time model.
As for VE release, the diffusion process in a homoge-
nous sphere underestimates the “burst effect”. It can
be noticed that there is no BZC decrease, as for VE.
It is not surprising, because no micelle formation can
occur at such concentrations of the PE F68 surfactant
in ultra pure water. Indeed in these conditions, the crit-
ical micellar concentration is 70 g l−1.
The evaluation of BZC diffusion coefficient, D, is
based on the long time model, for which D/R2 equals
1.01 × 10−4 s−1. As the mean particle diameter is
0.475m, the BZC diffusion coefficient through the
gliadins nanoparticles is evaluated around 2.3±0.1×
10−5 m2 h−1, i.e. 6.0± 0.3× 10−21 m2 s−1.
3.3.3. Comparison of release studies
In organic phases, diffusion coefficients are usually
about 10−9 m2 s−1. Here the coefficients are clearly
much lower (1.12× 10−20 m2 s−1 for VE and 6.36×
10−21 m2 s−1 for BZC). Thus, these results confirm
that the drug is retained by the nanoparticle matrix
Table 2.
The diffusion coefficient obtained using the homo-
geneous sphere model is different according to VE
and BZC. This could be related to the different drug
affinity for gliadins.
After 30 h, about 30% of encapsulated VE are re-
leased; on the other hand, after the same time, only
11% are released for BZC. This remark is verified
more accurately after 120 h. Indeed, the release media
are different for both drugs. However, the drug release
process is related to the particle permeability, P, of
each specific drug. In fact, this is a function of the drug
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Table 2
Drug released percentage as a function of the release period and
the drug diffusion coefficient through the loaded nanoparticles
observed and compiled according to the drug
PA Time (h) Released
drug (%)
Diffusion coefficient
(m2 s−1)
VE 1 13.2 1.12 × 10−20
30 30.6
120 70.1
BZC 1 11.1 6.36 × 10−21
30 11.7
120 12.3
diffusion coefficient, Ddrug, across the particle and of
the drug partition coefficient, Kdrug, between the par-
ticle and the release medium as shown in Eq. (9).
P = Kdrug ×Ddrug
d
(9)
with d the distance covered by the drug through the
nanoparticle, i.e. in this case, the particles radius. For
both drugs, the nanoparticles radii are equivalent, thus
d is similar and cannot explain the factor of two be-
tween the diffusion coefficients.
The only modified parameter between the two cases
is Kdrug. The most appropriate explanation may be
that Kdrugfor the (VE/gliadins nanoparticles/decane)
system is lower than for the (BZC/gliadins nanoparti-
cles/water) system.
In the literature, the all-trans-retinoic acid (RA)
release has been observed from gliadins nanoparti-
cles (Ezpelleta et al., 1996), in 100 ml of PBS at pH
7.4 with 15 mg of gliadins nanoparticles containing
60 RAg gliadins mg−1. A similar two steps profile
is observed. The first 20% is released by a burst ef-
fect. After the third hour, a slower release takes place.
Ezpelleta et al. (1996) had supposed that the phe-
nomenon is ruled by a diffusion process. After 3 h, a
similar amount of vitamins (RA and VE) is released by
gliadins nanoparticles: around 20% for RA and 25%
for VE, even if the conditions of temperature and of
drug/release medium are not identical.
4. Conclusion
In conclusion, by a desolvatation method, drug
loaded gliadins nanoparticles are obtained with a
mean radius about 450–475 nm. Three drugs of dif-
ferent polarity: hydrophobic Vitamin E, slightly polar
aromatic mixture and amphiphilic cationic benzalko-
nium chloride were entrapped in the nanoparticles.
The closer the drug and gliadins polarity, the better
the drug entrapment. The release from loaded par-
ticles, of Vitamin E and of benzalkonium chloride,
has been studied and interpreted as a burst effect
completed by a drug diffusion process through the
particle modelled as a homogenous sphere. The dif-
fusion coefficients of the two drugs measured during
the release are of several decades much smaller than
in pure liquids. This confirms the strong entrapment
of the drug in the nanoparticles.
These results show that the gliadins nanoparticles
are suitable controlled released systems for hydropho-
bic and amphiphilic drugs.
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Nanosized colloidal carriers can ensure a controlled and targeted therapeutic substances delivery.
The original contribution of this work was to use biopolymers of vegetable source, which are an inter-
esting alternative to synthetic polymers. The aim of this study was to prepare submicronic particles
from wheat proteins: Gliadins extracted from gluten. The carrier preparation was based on the desol-
vatation of the macromolecules by a couple solvent/non-solvent of the proteins. In a ﬁrst step, it was
of interest to elucidate the gliadin macromolecular conformation in order to understand the mecha-
nism of nanoparticle formation. The experimental work was based on SANS experiments. Because
the size of the colloidal particle suspension is an important parameter to monitor, the modelization
of the particle growth was thoroughly studied. Furthermore, it was observed that the determination
of the solubility parameters of the proteins allowed optimization of the size of the particles. From
those previous experimental results it can be concluded that there is a correlation between the
protein conformation in the solvent and the size of the nanoparticles (NP).
Keywords: Nanoparticles (NP), Protein Conformation, Gliadin, Solubility Parameter, Nucleation,
NP Growth, SANS Experiments.
1. INTRODUCTION
Since a few decades, nanoparticles (NP), objects of sub-
micronic size, have focused interest in the medical or
pharmaceutical ﬁeld, particularly those which consist of
biopolymers such as lipids, polysaccharides, or proteins.
These colloidal systems are very promising for their
ability to encapsulate drugs in order to protect them
from degradation by environmental stress (light, oxygen,
heat,…). Moreover, drug loading of such carriers may
insure a controlled release of the therapeutic substance
towards speciﬁc target in the organism, increase its effec-
tiveness, decrease its losses as well as its possible harmful
side effects.1–4 Furthermore, such nanoparticulate systems
offer many potentialities in various domains other than
medicine or pharmacy: food industry, cosmetology, deter-
gency, oil industry,…56
NP can be formed from variety of materials including
synthetic polymers7 and biopolymers (i.e., natural com-
pounds) such as proteins, lipids, and carbohydrates.8–12
Natural macromolecules from vegetable sources appear
to be a very promising alternative to synthetic polymers
∗Author to whom correspondence should be addressed.
owing to their safety, especially those used as a food
source. The selection of a suitable structure material has
a very important inﬂuence on its potential medical use.
It needs to be non toxic, non antigenic, and able to be
degraded in vivo. Comparing plant and animal proteins, it
appears that vegetable proteins may be more available and
cheaper than animal proteins.
In general, vegetable protein NP display a number of
interesting advantages. Among them, these carriers are
biocompatible, biodegradable, metabolizable, and prions
free. Moreover, they can be prepared under mild condi-
tions, without the use of toxic organic solvents or materi-
als, and they can incorporate a wide variety of drugs in a
relatively non-speciﬁc fashion.13–17
Taking into account all these advantages of plant pro-
teins, this particular contribution will focus particularly on
the use of storage proteins from wheat gluten (gliadins)
when used as structural material to prepare nanoparticles,
and their possible applications in pharmacy and medicine.
Wheat gluten is a protein carbohydrate complex, the
proteins of which are the major component. In gluten two
main fractions are present: Gliadins, (a group of proteins)
made of single chain polypeptides (average molecular
J. Nanosci. Nanotechnol. 2006, Vol. 6, No. 9/10 1533-4880/2006/6/3171/008 doi:10.1166/jnn.2006.455 3171
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weight 25–100 kDa) linked by intramolecular disulphide
bonds, soluble in neutral 70% ethanol, and glutenins,
alcohol-insoluble fraction, consisting of gliadin-like sub-
units stabilized by intermolecular disulphide bonds in large
aggregates (molecular weight greater than 106 kDa).18
Gliadins are polymorphic and can be separated and clas-
siﬁed on the basis of their electrophoretic mobility at
acid pH values in four fractions:  (molecular mass
25–35 kDa),  (30–35 kDa),  (35–40 kDa), and  (55–
70 kDa).19–22 All fractions have remarkably low solubility
in aqueous solution, except at extreme pH. This low
water solubility has been attributed to the presence of
interpolypeptide disulphide bonds and to the cooperative
hydrophobic interactions.
In the present investigation, the preparation method of
gliadin NP was studied. In a ﬁrst step, the principles of
gliadin extraction were reported. Then their solubilization
was studied by applying the solubility parameter approach.
In a third step, the gliadin macromolecular conformation
was investigated by Small Angle Neutron Scattering
(SANS) experiments. Finally, the NP growth was mod-
elized. This theoretical and experimental work could allow
us to determine the relation between the solubilization
parameters involved in the formation of gliadin NP and
the size of NP.
2. MATERIAL AND METHODS
2.1. Materials
Gliadins were extracted and puriﬁed and provided grace-
fully by Dr. Y. Popineau of the Laboratory…Biochimie
et Technologie des protéines de l’ INRA de Nantes
(France)….23
2.1.1. Gliadin Extraction
For this study, 2 batches of gliadins were used: An extract
from corn ﬂour of Renan variety (gliadin G2), the other
of Hardy variety (gliadin G3). Each of these batches are a
mixture of the four fractions (vide supra). For the sake of
simplicity, we will consider that each mixture is a single
protein: Gliadin G2 or gliadin G3.
For gliadin G2 the ﬂour was delipidated in order to elim-
inate soluble and amphiphilic proteins. This favor gliadin
extraction with a very low glutenins fraction.24–26 Brieﬂy
gluten was obtained after extraction of 1 g of wheat
ﬂour of Renan variety in a sodium phosphate 0.05 M
pH 7.8 buffer, then in a NaCl 0.1 M and triton X 114
(20 g/L) solution.2526 These different steps allow to obtain
gluten without glutenins. Then gliadin G2 extraction was
performed with 70/30 ethanol/water mixture (v/v). The
soluble fraction is dialysed ﬁrst against water, then against
acetic acid 0.05 M. Finally gliadin obtained is lyophilized.
For gliadin G3, gluten was extracted on a preparative
scale.21 It was freeze dried, ground in a refrigerated grinder
and defated by two extractions with dichloromethane for
2 h at 20 C (gluten/solvent ratio: 1/10). After ﬁltration,
residual solvent was evaporated from the gluten at 20 C
under reduced pressure. Samples of dried gluten pow-
der were stirred gently in an ethanol/water mixture 70/30
(v/v (gluten/solvent ratio: 1/10) for 4 hours at 20 C. The
suspension was centrifuged (10000× g, for 20 mn). The
soluble fraction, consisting of gliadin was dialysed exhaus-
tively ﬁrst against water, and then against 0.05 M acetic
acid. Finally, gliadin G3 was freeze dried.
The difference between gliadin G2 and gliadin G3
resides in the lack of glutenins in the constitution of
gliadin G2.
2.1.2. Other Materials
Ultrapure water was prepared with a Milli Q Plus appara-
tus (Millipore, Molsheim, France). Sodium chloride NaCl
was of analytical grade (Merck, Darmstadt, Germany).
Pure absolute ethanol at 99.5% was provided by Carlo
Erba Reagenti (Val-de-Reuil, France). Synperonic PE
F68 was furnished by ICI Surfactant (Cleveland, U.K.).
For SANS experiments: Deuterated water D2O-
99.90%D and deuterated ethanol C2D6O-99.00% with
HDO+D2O < 0.3% were provided by Euristop (Gif-sur-
Yvette, France).
2.2. Methods
2.2.1. Gliadin G2 and G3 Solubilization
According to the nature of vegetable proteins, the size con-
trol of the NP may be reached by varying the nature of
the solvent. In order to understand the solvent effect, the
size diameter was examined through a solubility parameter
study.2728
Hildebrand28 deﬁned the solubility parameter  corre-
lated to the mixing enthalpy for endothermic simple mix-
tures. In the case of a polymer/solvent mixture, it was
assumed that the miscibility of the polymer in the solvent
is possible if 1= 2 with 1 and 2 representing respectively
the solvent and the polymer. For classical solvents, 1 can
be found in the literature29 and is expressed in (Mpa1/2).
The solubility parameter M of a mixture (for instance
water/ethanol) is determined by the relation M = 
+

′′ where  and ′ are the solubility parameters of
ethanol and water and 
 and 
′ their volume fraction
(
+
′ = 1). Different mixtures were prepared with ultra
pure water and ethanol which solubility parameters were
respectively 47.8 and 26.5 (Mpa1/2). 0.1% gliadin solu-
tions were prepared in EtOH/H2O mixtures of different M
ranged between 39.1 to 32.9 (Mpa1/2). The determination
of the solubility parameters of gliadin, was inspected for
homogeneity and transparency by turbidity measurements.
2.2.2. Determination of Gliadin Structure by SANS
SANS experiments allow observation at scales smaller
than light wavelength, i.e., smaller than a few ten of
3172 J. Nanosci. Nanotechnol. 6, 3171–3178, 2006
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nanometers. Macroscopic characteristics of a protein can
be determined such as the shape and the molar mass of the
molecule.
The experiments were performed in the Laboratory LLB
of the Research Center of CEA (Saclay, France). The appa-
ratus used was “G2-3 Small Angle Neutron Scattering
Facility PAXY,” a SANS spectrometer for high resolution
(in q space) studies. The instrument is installed at the end
of the cold neutron guide G2. Incoming polychromatic
neutrons are monochromatized by a mechanical velocity
selector from which the spectral range extends between 3
and 20 Å with a resolution of approximatively 10%. The
wave length may vary from 0.4 to 2 nm. The sample holder
is equipped with a double goniometer and two independent
rotating tables. The BF3 multidetector can be positioned at
any distance between 1 and 7 m from the sample in its vac-
uum tube. The collimation of the incident beam is carried
out using diaphragms disposed at 2.5 and 5 m along the
7 m vacuum tube. The scattering angle range (2) extends
from 0 to 60 for distance sample detector <3.5 m. The
data treatments can be done by using available home pro-
grams on PC.
The neutronic diffusion corresponds to the structure
observation through a disc of radius 2/q. q is the diffu-
sion vector, it is deﬁned by the following equation
Q = 4 sin2/ (1)
 is the diffusion angle while the wave length of the inci-
dent beam is .
According to the diffusion vector q observed, the shape
and the molar mass of the molecule can be determined.
Compared to small molecules, proteins exhibited
enhanced ﬂexibility and multiple conformations.30 The
gliadin conformation promoted large discussions. Some
authors3132 showed that in a 70/30 v/v EtOH/H2O mixture
gliadins are prolate ellipsoids. Other authors by Small
Angle X-rays Scattering (SAXS) studies33 showed that the
modelization of the gliadin conformation was represented
by a cylinder. SANS experiments should allow to elucidate
the proper conformation of the protein.
In the Guinier domain,34 the diffusion is due to the
whole structure characterized by the giration radius Rg of
the macromolecules, theorically deﬁned as the mean
square root of the square of the distance of the chain length
from the gravity center.
Rg is calculated from the slope of the curve
lnIq= f q2), with Iq the diffused intensity. Rc, the
radius of the section of the macromolecule, and its length
L are calculated from the slope of the curve ln(qI =
f q2).
According to the presumed shape of the macromolecule,
Rg and Rc allow to reach the characteristical parameters
of the macromolecule geometry:
— for a prolate ellipsoid of major axis a and minor axis b,
Rg = a2/5+b2/10 and Rc = b
√
2 (2)
— for a cylinder of length L and radius R,
R2g = L2/12+R2/2 and Rc = R
√
2 (3)
2.2.3. Preparation of Protein Nanoparticles
Several methods have been reported in the literature for
the preparation of nanoparticles from protein raw mate-
rials. Coacervation or controlled desolvatation methods
have been developed using solvent or electrolyte as the
coacervation agent or by adjusting the pH or the ionic
strength.141535–37 In the coacervation methods promoted
by solvents, the ﬁrst step consists in dispersing the macro-
molecules in an adequate solvent (good solvent, GS), then
adding the mixture to a second solvent which is a non
solvent (NS) of the macromolecules. A required condition
is that the solvent and the non solvent phases are misci-
ble. Recent publications,3839 which were interested in the
precipitation of synthetic polymers, pointed out that the
“Ouzo effect,” i.e. a spontaneous emulsiﬁcation process,
is at the origin of the phenomenon. It enables one to cre-
ate a dispersion of small droplets in a surrounding liquid
phase without the use of surfactants, clouding the precip-
itation medium. According to this observation, the Ouzo
effect could be used for preparing a variety of aqueous
dispersions including NP.
The coacervation process is applied to a macromolecular
solution to reduce the solubility in the system to such
a degree that appropriate phase separation of the macro-
molecule takes place, that is the formation of a
macromolecule-rich phase. The desolvatation leads to
macromolecule precipitation or to coacervate formation.
The phase separation is induced by a phenomenon of the
polymer supersaturation (solvent evaporation, variation in
temperature, pH, addition of non-solvent of the polymer,
addition of ionic reactants,…). It is assumed40 that, before
phase separation is observed, a conformational change
in the macromolecule occurs. The addition of a desol-
vating agent (NS) shrinks the macromolecule coil which
becomes smaller and smaller until the phase separation
from the solvent occurs. It is possible to monitor the phe-
nomenon by turbidity measurement. A desolvatation agent
decreases the turbidity because of the decrease in macro-
molecular size. To prepare small particles, it is important
to maintain the system just outside the coacervation region.
The addition of the coacervation agent should stop as
soon as the Tyndall effect bounded to the macromolecules
aggregation turns the system turbid.13 It was interesting to
point out that these observations are in contradiction with
the Ouzo effect suggested by Vitale et al. and Ganachaud
et al.3839 The Tyndall effect observed in the case of gliadin
NP occured at the end of the nanoprecipitation instead of
promoting the precipitation.
For the preparation of gliadin nanoparticles, gliadin G3
was chosen. The desolvatation method for gliadin NP
preparation was previously described by Ezpeleta et al.13
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Brieﬂy, 0.5% w/v of gliadin were solubilized in 20 ml of
an ethanol/water phase. After ﬁltration through a 0.45 m
membrane, the ethanolic solution was poured into a
40 ml of a constantly magnetically stirred physiological
saline solution (0.9% w/v NaCl) containing 0.5% w/v
Synperonic PE/F68 as stabilizer. The ethanolic solvent
was then eliminated by evaporation under reduced pres-
sure with a Rotavapor R114 (Büchi, Switzerland). Gliadin
NP thus prepared were puriﬁed by centrifugation, Sigma
3K30 centrifuge (Bioblock Scientiﬁc, Illkirch, France)
equipped with a 12159 rotor. The NP were resuspended
in 2 ml of supernatant by ultrasoniﬁcation for 3 sessions
of 5 minutes. NP were freeze dried and stored at 4 C in
the dark.
In order to determine the size of the NP, samples
were taken at constant intervals of time from the mix-
ture protein/GS/NS. The diameters were analysed by
SEM using a JSM T330A (JEOL, Japan) instrument.
To decrease the experimental error on the mean value and
to approach the real mean diameter, at least 5 micrographs
were taken from different places of each sample. Thus
about 250 NP were measured, and the experimental error
was about 10%.
The particle size was also determined by Quasi-elastic
Light Scattering (QELS), with the help of a Malvern
instrument (France) equipped with an ALV 5000 correlator
having 256 digital counters.
3. THEORETICAL BACKGROUND
When the protein in its GS is introduced in the NS two
kinds of precipitate can occur: Either small crystals,41 or an
amorphous precipitate promoted by Van der Waals forces
between macromolecules.
Works of La Mer42 and Mersmann43 will be taken in
account as models. They pointed out two consecutive
and competitive steps which are nucleation and crystal
growth.
3.1. Supersaturation and Precipitation Process
The energy concerned in a precipitation process (for
instance by adding a non-solvent) is the chemical potential
variation
= kT lnC/C∗ (4)
with C the solute concentration in the GS and C* the
saturation concentration in the NS, i.e., the maximum dis-
solution concentration of the macromolecule. If C > C*
when the solute precipitates, the solution is called super-
saturated.
If  is the ratio C/C∗, Eq. (5) becomes
ln= /kT (5)
Figure 1 represents the diagram of solubility of a poly-
mer according to the concentration of the precipitating
Fig. 1. Macromolecule concentration variation according to precipitat-
ing agent concentration.
solvent.41 Four zones coexist. The curve of solubility S
represents the limit of solubility (or saturation) of the
solute in solution, i.e.  is equal to 1. For concentrations
in molecule lower than C*, the solute is soluble in solution
(stable zone). Above S, supersaturation is reached (> 1).
According to the  value, three kinds of behavior can be
observed:
—   1, the solute excess precipitates instantaneously
and gives an amorphous precipitate
—  is weaker but still greater than 1, the solute crys-
tallises in the nucleation zone. Near the precipitating
zone crystallization generates very small and numerous
microcrystals.
— Finally for t metastable zone,  is about equal to 1,
the nucleation process cannot occur. However the nuclei
yet formed are growing, generating eventually new germs
by shocking one to the others or against a wall (heteroge-
neous nucleation).
Different authors suggest that a second nucleation step
occurs, called a secondary or heterogeneous nucleation.
3.2. Nucleation and Particle Growth Process
Nucleation was deﬁned by La Mer42 as “the process
generating from a metastable mother phase the initial
fragments—nuclei or germs—of a new more stable phase
which will evolve thereafter and spontaneously towards the
stable entities of more important size.”
According to Galkin,44 classical models established by
La Mer and Mersmann were a good approximation of
what happens in fact. Indeed several authors4546 consid-
ered that classical nucleation theories account perfectly for
crystallisation or precipitation of amorphous objects. They
suggested that, in spite of the complexity of the struc-
ture of the proteins and their behavior in solution, there
are important similarities between the mechanisms and the
kinetics of precipitation of proteins and those of inorganic
salts.
However, for proteins the nucleation step is very lim-
ited in time. For a high saturation, the nucleation rate is
important even instantaneous.47–50
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3.3. Particle Growth Process
The growth process of a colloidal particle was studied
by Sugimoto.51 According to this author, for a colloidal
particle, the ﬁrst step of growth begins by diffusion of
a solute molecule towards the surface of the solution.
It is followed by the integration of this molecule to the
surface.
Assuming that R is the particle radius,  the thick-
ness layer, and x the distance from the particle center,
the molecular diffusion ﬂux J passing through the spher-
ical surface of radius x in the diffusion layer is given by
Fick’s law.
If C1 is the solute concentration at the solution/surface
interface, the diffusion ﬂux is given by relation (6)
J = 4DRR+C−C1/ (6)
D is the diffusion coefﬁcient
J is related, on the other hand, to dR/dt
J = 4R2/Vm ·dR/dt (7)
Vm is the macromolecule molar volume
The diffusion process is followed by the integration pro-
cess of a molecule in the surface
J = 4 R2kC1−C∗ (8)
k is the integration constant. The integration process is
assumed to be a ﬁrst order process.
From the two previous equations, it can be deduced
C1−C∗/C−C1=D1+R //kR (9)
According to the literature, two approaches seemed to be
the more appropriate to explain protein precipitation.4148
3.3.1. Growth Controlled by the Diffusion Process
If growth is controlled by the diffusion process, the dif-
fusion coefﬁcient D could be expressed by the relation
D kR, which leads to C1= C∗. It can be shown that:
dR/dt =DVm1/R+1/C−C∗ (10)
It can be noticed that dR/dt decreases when R increases,
which means that the variation of R with time becomes
smaller as the particle grows, if (C−C∗) can be regarded
as constant. The growth curve of a NP, R= f t, tends to
be asymptotic.
3.3.2. Growth Controlled by the Integration Reaction
If D kR, then C = C1 and the growth is limited by the
integration reaction at the surface. In this case,
dR/dt = kVmC−C∗ (11)
This equation shows that if the concentration gradient is
constant, R is a linear function of time, provided that
(C−C*) can be regarded as constant.
4. RESULTS AND DISCUSSION
4.1. Gliadin G2 and G3 Solubilization
As previously described, it is assumed that the solvent
which best solubilizes a gliadin has the same solubility
parameter as this protein.28
When varying the ratio ethanol/water (EtOH/H2O) from
50/50 to 70/30 v/v, the solubility parameter varied from
39.1 to 32.9 (Mpa1/2). We observed that the clearest solu-
tion was obtained for a solubility parameter of: 34(5±0(5
(Mpa1/2) for G3 corresponding to an ethanol/water ratio of
62/38 (v/v), and 38(5±0(5 (Mpa1/2 for G2, corresponding
to an ethanol/water ratio of 52/48 (v/v).
These values signiﬁed that G2 was the most soluble in
an ethanolic/water mixture 52/48 (v/v), while the best mix-
ture was 62/38 (v/v) for G3. It can be assumed that gliadins
were in an expanded conformation in these solvents. To
control this hypothesis, the conformation of gliadins was
investigated by SANS.
4.2. Determination of Gliadin Structure by SANS
Because of the lack of contrast between water and ethanol,
the experiments were performed with deuterated solvents:
D2O and EtOD.
G2 was chosen because of its relative purity, compared
to G3, particularly because it contains a very few amount
of glutenins.
Different experiments involving gliadin in different mix-
tures EtOD/D2O v/v were performed.
4.2.1. Modelization of the Experimental Results
Figure 2a and Figure 2b showed the variation of ln(I) ver-
sus q2 and ln(qI) versus q2. The slope analysis and the
value of I at q equals zero allow the determination of
the characteristical parameters of prolate ellipsoid or of
cylinder. With these characteristical parameters, the theo-
retical I /I0= f q curves could be calculated and plot-
ted. These graphs are then superposed on the experimental
values I /I0, in order to determine if the protein confor-
mation is a prolate ellipsoid or a cylinder.
When this modelization was applied to our experimen-
tal results, the mean square variation could not allow to
distinguish between the two shapes.
In order to distinguish them, Lc, the contour length,
independent of Rc and Rg , deﬁned by
Lc =  · I0/Ic0 with Ic0= F ∗ I0
was calculated. F was the normalization factor. Table I
displayed the parameters of the two conformations. By
comparing Lc with on the one hand , the cylinder length L,
and on the other hand, the major ellipsoid axis 2a for
different mixtures, one could not distinguish between the
two shapes. We chose the cylinder shape because its
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(a)
(b)
Fig. 2. (a) Guinier representation of diffused intensity lnI versus q2.
(b) Representation of lnqI = f q2) for gliadin G2.
treatment is simpler. Table I presented in its last col-
umn the parameters obtained after modelization. They con-
ﬁrmed the experimental values of d and L. They are close
to the experimental dimensions of the rods of Gliadin
and Gliadin in solution obtained by Thompson.31
4.2.2. Correlation Between the Solubility Parameter of
the Good Solvent and the Gliadin Conformation
The values of L and d obtained from the different exper-
iments showed that the largest conformation was obtained
for the mixture 62/38: The value of L is maximum
(25 nm), as the value of d is 3.5 nm.
From other experiments we observed that, in deuterated
solvents the solubility parameter of G2 was changed: The
best solvent mixture was obtained for 62/38 EtOD/D2O
v/v, which corresponded to G = 34(5±0(5 (MPa1/2).
Table I. Gliadin G2 characterization by SANS.
Cylinder
EtOD/D2O Rg (nm) Rc (nm) d (nm) L (nm) Lc (nm) parameters after
(v/v) C (g ·L−1) (±2%) (±3%) cylinder cylinder 2a (nm) (±5%) modelization (nm)
52/48 3(5 4(38 1(18 3(32 14(6 19(45 18(85 d = 3(6; L= 16
52/48 5(5 4(41 1(4 3(96 14(5 19(5 16(4 d = 4(0; L= 15(5
55/45 17(1 6(17 0(85∗ 2(4∗ 21(2 27(5 26(7 d = 3(5; L= 23
62/38 18(3 6(97 1(24 3(5 23(8 21(9 26(8 d = 3(5; L= 25
70/30 12(9 5(76 0(81∗ 2(29∗ 19(75 25(7 23(7 d = 3(0; L= 21
∗Imprecision (lack of data at large q).
When considering the two previous observations, we
could conclude that the greatest conformation of gliadin
G2 was obtained when the solubility parameter of the sol-
vent was the same as the gliadin’s one G = 34(5± 0(5
(MPa1/2).
A similar study was performed for gliadin G3, and sim-
ilar results were obtained: considering the cylinder model,
the greatest conformation of gliadin G3 (L= 18 nm, d =
2(6 nm) is obtained when the solubility parameter of the
solvent is the same as the gliadin’s one.
4.3. Experimental Nanoparticle Formation and
Process of Nucleation
Figure 3a showed NP obtained by SEM and Figure 3b the
distribution curve obtained by QELS. They are observed
two hours after their preparation.
The initial gliadin concentration in GS (62/38
H2O/EtOH v/v) was 4.25 g/L. The saturation concentra-
tion of gliadin in NS (H2O+NaCl 0.9%+Synperonic)
was 0.869 g/L. This value could seem rather high because
gliadin is not soluble in salted water but the little amount
of surfactant PE F68 favours the dissolution of gliadin.
The value of (C−C*), which characterized the satura-
tion, was then 3.381 g/L. As =C/C∗ 1, the conditions
were fulﬁlled an amorphous protein precipitation, as seen
before.
Observing the NP with a polarizing microscope, it could
be concluded that no sign of crystallization occured
because no birefringence and no color were observed, so
that NP were amorphous.
Figure 4 shows the evolution of G3 gliadin NP sizes
with time. As soon as the non solvent was added in the
medium, particles formed, which is in favour of an instan-
taneous nucleation.47
Moreover two different curves could be observed:
— a linear curve for the minimum particles diameter, par-
allel to the abscissa,
— a linear curve for the mean particles diameter.
This means that the distribution of size is bimodal:
— small particles, about 70 nm in size, which size did
not change with time. It may be assumed that these small
particles could generate nucleation growth.
— larger particles growing with time.
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(a)
(b)
Fig. 3. (a) SEM micrograph of gliadin NP. (b) Distribution curve of
gliadin NP obtained by QELS.
As the evolution of the mean diameter versus time
appeared linear, a growth process by integration reaction
could be assumed, (vide supra Eq. (11)). When applying
Eq. (11), the value of constant k can be found: 4.12 m · s−1,
which value is quite fast for a NP growth. As assumed
before, this demonstrated that Galkin’s approach seemed
valuable for proteins nucleation and particularly for
gliadin.
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Fig. 4. Diameter kinetics during NP elaboration.
Fig. 5. Evolution of gliadin G3 NP with the solubility parameter of the
solvent.
4.4. Inﬂuence of the Solubility Parameter of
the Good Solvent on NP Precipitation
As the solubility parameter plays an important role in the
conformation of the gliadins, it is interesting to look for
the inﬂuence of this parameter on the NP size (Fig. 5).
The gliadin G3 NP were prepared and allowed to grow
during 2 hours, and their size were measured by QELS.
Figure 5 showed that the size falls to a minimum (about
150 nm) when the solubility parameter of the solvent was
the same as the gliadin one, i.e. 34(5±0(5 (MPa1/2).
4.5. Relation Between the Gliadin Macromolecular
Size and the NP Size
In the conclusion of Section 4.2.2, the macromolecular
size of the protein was the greatest when the solubility
parameter of the GS corresponded to the solubility param-
eter of the protein. For this same solubility parameter, in
Section 4.4, the NP size was the smallest.
Thus the proteins solubilization played a capital inﬂu-
ence on the size of NP. Indeed, the more the solubility
parameter of the good solvent was close to that of the pro-
teins, the smaller were the particles. It could be deduced
from this observation that the more expanded was the con-
formation of the macromolecules at the time of precipi-
tation, the more the surface of contact between proteins
and their non-solvent was important, the more the macro-
molecules contracted and formed small particles.
5. CONCLUSION
The study of the formation of the particles indicated that
nucleation was instantaneous and that the distribution size
was bimodal. In addition the growth of the particles was
carried out mainly by integration: The incorporation of a
macromolecule to the ediﬁce, which was the particle, was
the predominant process.
The curve of gliadin NP growth was elucidated: the
evolution of their mean diameter with time was linear.
This signiﬁed that one could stop the growth at a given
size if it could be possible to freeze the system, at a min-
imal particle size or at another required size.
Moreover, the proteins solubilization plays a capital
inﬂuence on the size of NP. Indeed, the more the solubility
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parameter of the good solvent was close to that of
the proteins, the smaller were the particles. It could be
deduced from this observation that the more expanded was
the conformation of the macromolecules at the time of
precipitation, the more the surface of contact between pro-
teins and their bad solvent was important, the more the
macromolecules contracted forming the smaller particles.
Brieﬂy, the smallest particles were obtained from the pro-
tein solution in which the protein was the more expanded.
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Available online 3 May 2009AbstractPseudomonas fluorescens is a highly heterogeneous species and includes both avirulent strains and clinical strains involved in nosocomial
infections. We previously demonstrated that clinical strain MFN1032 has hemolytic activity involving phospholipase C (PlcC) and biosurfactants
(BSs), similar to that of the opportunistic pathogen Pseudomonas aeruginosa. When incubated under specific conditions, MFN1032 forms
translucent phenotypic variant colonies defective in hemolysis, but not necessarily in PlcC. We analyzed eight variants of the original strain
MFN1032 and found that they clustered into two groups. Mutations of genes encoding the two-component regulatory system GacS/GacA are
responsible for phenotypic variation in the first group of variants. These group 1 variants did not produce secondary metabolites and had
impaired biofilm formation. The second group was composed of hyperflagellated cells with enhanced biofilm capacity: they did not produce BSs
and were thus unable to swarm. Artificial reduction of the intracellular level of c-di-GMP restored the ability to form biofilm to levels shown by
the wild type, but production of BSs was still repressed. Phenotypic variation might increase the virulence potential of this strain.
 2009 Elsevier Masson SAS. All rights reserved.
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Environmental adaptability of microorganisms results from
genetic diversity and natural selection. Bacteria also have
complex regulatory networks enabling them to colonize
a variety of environments [1].
This adaptive behavior can be correlated with phenotypic
variation, which is mainly, but not necessarily, influenced by
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P9diversification is phase variation, which is usually a reversible,
high-frequency phenotype switching corresponding to differ-
ential expression of one or several genes. Phase variation
generates subpopulations within a clonal population. The
switch between the various states is generally a stochastic
event which can be modulated by external factors [14].
Reversion is a requirement to be considered as phase variation,
but it cannot be observed under laboratory conditions [32].
Several studies have described mechanisms involved in phase
variation, and although observations of phase variation are
increasing, few mechanisms have been reported. These can be
divided into genetic rearrangements (DNA inversion or
duplication, transposition, homologous recombination, slip-
ped-strand mispairing) or epigenetic modification/regulation
[11].
InPseudomonas sp., phenotypic variation has been described
for rhizospheric bacteria and the opportunistic pathogen
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typic variation in crop-protective bacteria Pseudomonas was
shown to affect mainly the production of exo-enzymes,
secondarymetabolites and colonization properties [2,26,28,31].
Most of the strains displayed increased motility, generally
associated with a longer length of flagellum. These phenotypic
variations are correlated with the accumulation of spontaneous
mutations in the gacS or gacA genes [29]. These genes encode
the GacA/GacS two-component regulatory system which
regulates secondary metabolism, exo-enzyme production and
biofilm formation, among other functions. Random spontaneous
mutations of the gacA and/or gacS genes seem to result from
a dysfunction in the MutS mismatch repair system, which is
negatively regulated by the general stresseresponse regulator
RpoS, itself under the control of the Gac system [30]. These
mutations seem to be mediated by site-specific recombinases,
although the molecular mechanism has not yet been established
[6,19]. The site-specific recombinase is probably responsible for
phase variation, and gacmutants could be selected a posteriori.
Phenotypic variations, mainly biofilm-related, frequently occur
in the pathogen P. aeruginosa as a result of environmental
pressure [16]. Small colony variants (SCVs) have also been
isolated from the lungs of cystic fibrosis (CF) patients and this
phenotype has been associated with the ability of P. aeruginosa
to persist in the lungs and cause chronic infection [34]. Contrary
to rhizobacteria, spontaneous gacmutations are not assumed to
be involved. By sensing environmental factors, a complex
regulatory network controls phenotypic variation (and perhaps
the switch between acute infections and chronic persistence) [8].
The GacS/LadS/RetS pathway may play a key role by finely
controlling the level of RsmZ and subsequent free RsmA, which
plays a critical role in P. aeruginosa virulence [21]. SCV
emergence is enhanced in gacS PA14 biofilm (which could
also correspond to a low level of rsmZ ), but functional GacS is
necessary for the reversion process [4].
A biofilm-related phenotype also seems to be related to the
intracellular level of the second messenger c-di-GMP [12].
Although c-di-GMP regulation of biofilm has been reported in
diverse bacteria, the mechanism responsible for the switch is
not yet understood.
We report the first phenotypic characterization of variants
from a clinical Pseudomonas fluorescens strain, MFN1032,
isolated from a patient suffering from pulmonary tract that we
had reported previously [3]. This strain displayed phenotypic
variation when incubated at 37 C. Our objectives were to
determine whether these variants enhanced the virulence of
this opportunistic pathogen and to identify the mechanism(s)
involved.
2. Materials and methods2.1. Bacterial strains and culture conditionsStrain MFN1032 was isolated from a patient suffering from
pulmonary tract infection and identified as P. fluorescens biovar
I [3]. The bacteria were cultured in Luria Bertani medium (LB)
or King B (KB) medium and incubated at various temperaturesP9between 17 and 37 C in a gyratory shaker at 180 rpm. When
necessary, 15 mg/mL gentamicin and 40 mg/mL IPTG were
added.2.2. Measurement of phase variation frequenciesAliquots of 20 mL of KB were each inoculated with one
colony from KB agar plate and the cultures grown for three
days, with shaking, at 28 C or 37 C. The optical density of
the cultures was measured and they were diluted such that
when plating on KB medium, an average of 300 colonies per
plate were obtained. For estimations of frequency, at least
1500 colonies were counted. The frequency of switching was
obtained by dividing the number of switches by the number of
generations.2.3. Extracellular activitiesLecithinase and protease activities were recorded after 48 h
incubation at 28 C on eggyolk and milk agar plates, respec-
tively. Agar plates supplemented with 2% sheep red blood
cells (SRBCs) were used to screen for b-hemolytic activity (b-
HA) after 24e48 h growth at 28 C. The plates were examined
for enzyme activities on substrates. Opaque zones showed
lecithinase activity, whilst protease and hemolytic activities
produced clear zones.2.4. Biosurfactant (BS) analysisReverse-phase liquid chromatography coupled with mass
spectrometric detection was used to identify BSs. The method
was adapted from Morin [20]. When required, a drop-collapse-
test was also performed as previously described [25].2.5. Motility assays, static biofilm assay
and quantificationMotility and microarray biofilm assays were performed as
described previously [25].2.6. Electron microscopyVisualization of flagella was performed as described
previously [25].2.7. Scanning confocal laser microscopy analyses
of biofilmBiofilms were formed on glass microscope slides immersed
in 30 mL of LB medium in 9 cm diameter Petri dishes. Cells
were labelled with 2.5 mM of Syto 61 Red fluorochrome
(Molecular Probes) for 5 min at room temperature and cellu-
lose polymers were stained blue using the calcofluor white
fluorochrome (Sigma) (0.3 mg/mL). Slides were washed twice
in phosphate-buffered saline and biofilms were observed using
a Leica DM6000B confocal microscope (Leica Microsystems,
Heidelberg, Germany), with the immersion 63X objective.
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using Leica Confocal Software.2.8. Genetic complementationThe plasmids pMP6562 (carrying the gacS gene), pMP5565
(carrying the gacA gene), pMP6603 (carrying both gacS and
gacA genes) and the parental plasmid pME6010 were generous
gifts fromB. Lugtemberg of Leiden University [29]. pSV35 and
pSV35RetSþ were generous gifts from S. Lory of Boston
University and pJN2133 (expressing PA2133, a PDE enzyme
fromP. aeruginosa 1) [15] fromC.Harwood of theUniversity of
Washington. Each plasmid was transferred to MFN1032 and
variants using the technique of Enderle et al. [7].3. Results3.1. Phenotypic variation occurs during growth
of MFN1032 on specific rich mediaMFN1032 was isolated from a patient suffering from
a pulmonary tract infection. The original isolate formed thick
opaque colonies (most colonies in Fig. 1A). Phenotypic vari-
ation was observed when cultures were grown on KB medium
or egg yolk agar (medium used to screen for lecithinase
activity) (Fig. 1A and B, respectively). After three days of
growth in liquid KB medium, flat and translucent colonies
were found (Fig. 1A). However, a typical P. fluorescens
laboratory strain, MF37, originally isolated from milk, dis-
played no phenotypic variation, even after several days of
growth in liquid King B medium.
The mean frequency of MFN1032 variation was 4 105
switches per generation at 28 C and 4 103 at 37 C.
Phenotypes of the variants were stable and were retained in
subsequent cultures. No reversion to the wild type phenotype
was observed under these conditions. As the frequency of
variants was higher at 37 C, we investigated virulence byFig. 1. Phenotypic variation in strain MFN1032 after growth on King B (A)
P9testing for potential virulence factors and colonization
capacity.3.2. MFN1032 variants display different
extracellular activitiesP. fluorescens phenotypic variation mainly affects extra-
cellular enzymes and secondary metabolites. The extracellular
activities of the variants were investigated and compared with
MFN1032. The wild type MFN1032 produced protease and
lecithinase activities. Lecithinase activity was mainly due to
the production of PlcC, an enzyme involved in secreted HA
(sHA) of MFN1032 [24]. These factors are involved in
MFN1032 virulence, so they were screened for in eight
translucent colony variants which were isolated from KB
medium and then plated on appropriate media (i.e. egg yolk
agar for lecithinase activity, milk agar for protease activity and
SRBC agar for HA). Four of the variants expressed none of
these extracellular activities (group 1) and four were only
deficient for HA (group 2) (Table 1).3.3. Phenotypic variants differ in motility, BS release
and biofilm formationPhenotypic variation is often associated with modification
of motility and adhesion properties, two factors involved in
virulence and colonization. To test motility on solid substrates,
swimming and swarming were determined by growth on 0.3%
and 0.6% agar LB plates, respectively. Diameters of colonies
of MFN1032 and variants were measured after 16 h, 24 h and
40 h incubation at 28 C (the optimal growth temperature of
MFN1032). No significant difference in swimming motility
was observed between the variants and MFN1032 (Fig. 2A).
Concerning swarming ability, after 16 h of growth on 0.6%
agar LB plates, MFN1032 had completely invaded the dish,
whereas no motility was observed for group 1 and group 2
variants (Fig. 2B). Generally, swarming motility (in P. fluo-
rescens and others) is a multicellular behavior resulting fromor egg yolk agar plates (B). Colony variants are indicated by an arrow.
Table 1
Extracellular activities of strain MFN1032 and variants.
Activities Lecithinase Protease Hemolysis
Strains/variants
MFN1032 þ þ þ
Group 1   
Group 2 þ þ 
Lecithinase, protease and hemolytic activities were determined on egg yolk,
milk or 2% SRBCs agar plates, respectively.
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supernatants by HPLCeMS showed that MFN1032 was able
to produce at least three distinct (cyclolipopeptides) CLPs
when cultured in LB medium at 28 C. Mass spectroscopic
analysis revealed the presence of two viscosinamide-like
compounds (with distinct retention time in HPLC) and an
unidentified CLP, presumed to be a massetolide and named
‘‘a’’. No CLPs were found in group 1 or group 2 variant
supernatants (Table 2).
Since the cells displayed swimming motility, loss of
swarming ability could not be due to the absence of flagella.
Electronic microscopy observation confirmed that MFN1032
had a single polar flagellum (Fig. 2C, photo B). Broken
flagella, with a size equivalent to the MFN1032 flagellum,
were observed surrounding group 1 cells (Fig. 2C, photos C
and D), whereas most of group 2 displayed a hyperflagellated
phenotype (most bacteria had four polar flagella) (photos E
and F). We also observed that group 2 cells formed aggregatesFig. 2. Swimming (A) and swarming (B) motility of MFN1032, group 1 and group
with 0.3% or 0.6% agar. (C) TEM observations of MFN1032 and variants. Bacte
phosphotungstic acid (0.5%).
P9on the drip, while most MFN1032 cells were mainly isolated
(photos E and A, respectively).
These properties (autoaggregative behavior and hyper-
flagellated cells) are generally correlated with a biofilm-
related phenotype. It has also been reported that swarming
motility and biofilm are often inversely regulated [33]. We
therefore used confocal laser microscopy to study biofilm
formation of MFN1032 and the variants. Group 2 formed more
biofilm than MFN1032 after 24 h of growth at 37 C, whereas
group 1 biofilm was sparse (Fig. 3A and C). Fluorescent
coloration with the cellulose-specific dye calcofluor [27]
showed that the cellulose exopolysaccharide (EPS) produced
by group 2 was higher and that by group 1 was lower than that
by MFN1032 (Fig. 3B and C).3.4. Mutations in gac genes are responsible for changes
in group 1 variantsGroup 1 and group 2 variants were transformed by electro-
poration with plasmids carrying the gacS gene (pMP6562), the
gacA gene (pMP5565), both (pMP6603) or neither (pME6010, as
a control). The gacS gene restored thewild type phenotype to three
group 1 variants and the gacA gene to the other (Fig. 4A). Most of
the group 1 tested displayed a mutation in the gacS gene, as
observed for most Pseudomonas rhizobacteria [29]. Gac mutants
have better growth kinetics, and consequently have been described
as enhancers of population fitness. We therefore determined the2 variants. Swimming and swarming mobility were determined at 28 C on LB
ria in exponential growth phase were visualized after negative staining with
Table 2
Analysis of BS production by HPLCeMS.
CLPs identified Viscosinamide-like 1 Viscosinamide-like 2 Massetolide
‘‘a’’
Mass (in Da) 1125,8 1125,8 1111,8
Strains/variants
MFN1032 þ þ þ
Group 1   
Group 2   
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and 37 C. Group 1 variants grew slightly faster at 28 C
(GGroup1,28C¼ 49.5 1 min; GWT,28C¼ 54 9 min) and much
faster at 37 C (GGroup1,37C¼ 55.2 1 min; GWT,37C¼
73.3 3 min).3.5. Effect of RetS and PDE on group 2 variantsNo pMP6562, pMP5565 or pMP6603 complemented
group 2 variants. The phenotype for group 2 was thus not due
to defects in the gacS or gacA genes. We therefore searched
for retS, since a mutation in the retS gene in P. aeruginosa
gives a phenotype similar to that of group 2 variants [9] and
retS orthologs are recovered from P. fluorescens genomes
(PFL_0664 and Pfl01_0661 from Pf5 and Pf01 respectively).
The retS gene from P. aeruginosa (on pSV35RetSþ) was
introduced in group 2 variants (parental plasmid pSV35 was
used as a control) and biofilm formation was measured in
a microarray assay. The amount of biofilm was significantly
greater for group 2/pSV35 than for MFN1032/pSV35,
consistent with confocal microscopy findings (above). Biofilm
production was lower in both group 2 and the wild type
transformed by retS than by the control (Fig. 4B). These
findings indicate that the P. aeruginosa retS gene is expressed
in MFN1032 and that it negatively controls biofilm formation.
Group 2/pSV35RetSþ did not show HA on SRBC agar and
produced no BSs (Fig. 4C and D); thus, complementation by
retS was not sufficient to fully restore the wild type phenotype.Fig. 3. Confocal laser microscopy analyses of biofilms from MFN1032 and its va
stained with Syto 61 Red. EPSs were stained blue with calcofluor white fluorochrom
Thickness of biofilm according to the (x, z) axis (the same scale is used for the 3 m
software interface: top: 3D modelling of EPS production; middle: 3D representat
Comparison of thickness of biofilm (black square) and EPS production (white squ
P9Strong phenotypic variation was observed in both group 2- and
MFN1032 retS-overexpressing strains, but not in MFN1032/
pSV35 when incubated under the same conditions. These
unexpected results were reproducible in various clones and
experiments (Fig. 4C).
The effects of introducing retS into group 2 are probably
due to a shunt of a parallel pathway, possibly that involving c-
di-GMP. Indeed, biofilm phenotypes may correlate with the
intracellular level of the second messenger c-di-GMP. C-di-
GMP levels are finely regulated in a spatial and temporal
manner by two kinds of enzymes: diguanylate cyclases
(DGCs) carrying a GGDEF domain and responsible for c-di-
GMP synthesis, and phosphodiesterases (PDEs) carrying an
EAL domain and involved in c-di-GMP degradation. The
intracellular level of this second messenger was artificially
decreased in group 2 and MFN1032 by expressing a PDE
enzyme from P. aeruginosa (PA3133 encoded by plasmid
pJN2133) [15]. Biofilm formation by the transformed cells
was then assayed. Both groups 2/pJN2133 and MFN1032/
pJN2133 produced less biofilm than their controls (Fig. 4B).
The group 2 variant transformed with the gene encoding
PA2133 produced more biofilm than that transformed with the
retS gene (35 3% versus 7 7% relative biofilm formation).
The opposite was true for MFN1032 (0% with pJN2133 versus
12 3% with pSV35RetSþ), implicating different pathways in
variants and wild type. Consistent with this possibility, group
2/pJN2133 displayed a relatively stable phenotype on SRBC
agar (Fig. 4C). Nevertheless, group 2/pJN2133 variants still
displayed a hemolysis- and BS-negative phenotype, suggest-
ing that these factors are regulated independently of biofilm or
that restoration of these activities requires other conditions.
Expression of PDE in MFN1032 resulted in complete loss of
biofilm formation capacity, BS production and hemolysis (as
revealed by the drop-collapse-test from MFN1032/pJN2133
colony and culture on SRBC) (Fig. 4C and D). Expression of
each PDE and retS in MFN1032 enhanced the phenotypic
variation of the strain (Fig. 4C). These results suggest that
phenotypic variation is caused by unidentified genes whichriants after 24 h growth in LB medium at 37 C. Before scanning, cells were
e. Values are means of data of five images from each of two experiments. (A)
icrographics). (B) 3D modelling of biofilms and EPS production using Leica
ion of biofilm; bottom: superposition of EPS and biofilm 3D modelling. (C)
are) of group 1 and group 2 variants with MFN1032 as a control.
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Fig. 4. (A) gacS complementation of a group 1 variant. Restoration of wild type phenotype in a group 1 variant (after transformation with plasmid pM6562 carrying
the gacS gene), is tested by checking lecithinase and HA on egg yolk and SRBC agar plates, respectively. Phenotypes are compared with the same variant carrying
the empty vector. (B) Effect of RetS or PA2133 (PDE) on the capacity of MFN1032 or group 2 variants to form biofilm in a static microarray assay. The quantity of
biofilm was determined by measuring the OD595nm after 24 h of growth at 37
C in LB. The results are means of at least three independent experiments.
(C) Phenotypic variation on SRBC agar plates. (D) HA and production of BSs from MFN1032 and group 2 variants expressing retS (pSV35RetSþ) or PA2133
(pJN2133) genes. SRBC phenotypes are visualized after 48e72 h of growth at 37 C and colonies checked for BS production by the drop-collapse-test. Plasmid
pSV35 (GmR) was used as a control.
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the nature of group 2 variants has not been fully clarified.
4. Discussion
Phenotypic variation is frequent in Pseudomonas and can
affect competitive root colonization by rhizobacteria or
persistence of the opportunistic pathogen P. aeruginosa. This
study is the first to demonstrate that phenotypic variation can
occur in a clinical strain of P. fluorescens. Strain MFN1032
displayed phenotypic variation under specific medium condi-
tions (King B and egg yolk agar media) and temperature. The
variation frequency was enhanced (4 103 per generation)
when bacteria were incubated at 37 C (human physiological
temperature). The phenotype of all variants emerging from
MFN1032 under these conditions was a translucent colony.
We studied eight variants and found that four of them
(group 1) were unable to produce secondary metabolites. As
previously observed for rhizospheric P. fluorescens strains (for
review, see Van den Broek et al.), a gac complementation in
trans of these variants restored the original phenotype. Group
1, however, was no more motile than MFN1032, whereasP9most, if not all, gac mutants of rhizobacteria P. fluorescens
were more motile. A laboratory-adapted strain, MF37, was
impaired in phenotypic variation, suggesting that this
phenomenon is finely controlled. Specific characteristics may
have evolved as a result of strain adaptation to particular
niches.
Phenotypic variation in group 2 variants mainly involved
their attachment properties. The greater capacity of these
variants to form biofilms at solideliquid interfaces was
a consequence of cellulose exopolymer overproduction and
increased flagella number. The second messenger c-di-GMP is
central to regulation of surface colonization and aggregative
behavior in prokaryotes [23]. In P. fluorescens, this molecule
has been reported to regulate the wrinkly spreader phenotype
of SBW25 by controlling production of acetylated cellulose
exopolysaccharides at a post-transcriptional level [10]. This
regulation was of the WspR regulatory protein, a GGDEF
protein with DGC activity. WspR is the final gene product and
primary output component of the chemotaxis-like Wsp
pathway, and is activated by a currently unknown signal pro-
cessed by the rest of the Wsp complex [17]. The intracellular
concentration of c-di-GMP in P. aeruginosa is controlled by
343G. Rossignol et al. / Research in Microbiology 160 (2009) 337e344a Wsp system (thought to function in a similar way to that in
P. fluorescens) and the SadB/SadC/BifA pathway. In PA14,
this system is believed to inversely regulate biofilm formation
and swarming motility by controlling EPS production and
flagellar functions [33]. We showed that PDE PA2133 over-
expression restored the wild type biofilm phenotype in group 2
variants. This suggested that the biofilm was a result of an
intracellular increase in the c-di-GMP level which increased
cellulose EPS production. These observations agree with
previously reported data [10]. In P. aeruginosa PAK, EPS
production is also controlled by the independent parallel
GacS/LadS/RetS pathway which controls the level of the
non-coding small RNA RsmZ. GacS and LadS act in an
opposite manner from RetS on EPS, by enhancing transcrip-
tion of rsmZ, which in turn sequesters the post-transcriptional
repressor RsmA [9]. RetS functionality has not yet been
reported in P. fluorescens, but the GacS/Rsm pathway has
been described in detail for P. fluorescens CHA0 [13]. The use
of the P. aeruginosa retS gene in MFN1032 and its variants
shows that: (1) P. aeruginosa retS is functionally similar to its
ortholog in P. fluorescens, (2) RetS negatively controls biofilm
formation and (3) overexpression of the retS gene is sufficient
to compensate for a biofilm-related phenotype presumed to be
a consequence of perturbation of intracellular c-di-GMP. This
type of phenotype compensation has already been reported in
P. aeruginosa PAK. Goodman et al. showed that PA4332
encoding a GDDEF domain protein with putative DGC
activity was able to restore the wild type phenotype of the
PAK retS mutant strain [9].
Biofilm formation and swarming motility appear to be
inversely regulated in MFN1032; it is possible that loss of
swarming was correlated with loss of BS production. However,
swarming behaviormay be related to factors other thanBS (such
as flagella or cell surface tension) although BS is essential to the
swarming process [22]. Bruijn et al. recently demonstrated that
CLP massetolide A produced by P. fluorescens SS01 is also
essential for biofilm formation. However, they postulated that
the role of CLPs in biofilm formation may be entirely different,
depending on the structure and hydrophobicity of the CLP
produced and the cell surface of the producing strain [5]. We
demonstrated that a strain with impaired BS release (group 2
variants) did not lose its capacity to formbiofilms. Thuswe think
that the CLPs produced byMFN1032 are not involved in biofilm
formation. The regulation of CLPs in MFN1032 appeared to be
very complex.As the gacmutants did not produce BS, theGacS/
GacA system probably controls BS production, as reported in
the literature. It seems, however, that this regulation is not via the
RsmZ pathway, since retS overexpression (which also influ-
ences the RsmZ level) in MFN1032 had no effect on BS
production. Gac regulation may occur at a transcriptional level,
or at least by a different pathway. PDE overexpression in
MFN1032 suppressed BS production; therefore, both higher (in
group 2) and lower (in MFN1032/pJN2133) than wild type
levels of c-di-GMP lead to a BS-negative phenotype.
Compensation of this perturbation (in group 2/pJN2133 for
example) was not sufficient to restore the BS wild type pheno-
type. In P. aeruginosa PA14, overexpression or mutation of theP9PA4332 gene encoding a putative DGC also led to the same
phenotype (enhanced cytotoxicity and biofilm formation). It has
been suggested that the c-di-GMP level is finely controlled
temporally and/or a spatially [24]. Note that feed forward loop
regulation could explain how a single molecule can have
contradictory effects in terms of concentration and kinetics [18].
In conclusion, MFN1032 phenotypic variation is mainly due
to two different processes. First, spontaneous gacmutations lead
to variants with competitive growth advantages (as observed for
rhizospheric bacteria). Although these variants are completely
defective in production of extracellular product, they might
increase the competitiveness of the clinical strain. A second class
of variants displayed a hyperbiofilm phenotype which probably
facilitates persistence in the host during infection. The process
responsible for the emergence of these variants has not been fully
elucidated. Our findings, however, suggest a change in the
intracellular level of c-di-GMP. The genes causing phenotypic
variation and which are responsible for the c-di-GMP decrease
have yet to be identified.
The absence of BS secretion and/or production is
a common feature of all variants. Thus BS production in
MFN1032 appeared to be subtly controlled. We are currently
investigating a putative genetic network controlling BS
production in MFN1032.
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Abstract: To decontaminate dredged harbor sediments by bioremediation or 
electromigration processes, adding biosurfactants could enhance the bioavailability or 
mobility of contaminants in an aqueous phase. Pure amphisin from Pseudomonas fluorescens 
DSS73 displays increased effectiveness in releasing polycyclic aromatic hydrocarbons 
(PAHs) strongly adsorbed to sediments when compared to a synthetic anionic surfactant. 
Amphisin production by the bacteria in the natural environment was also considered. 
DSS73’s growth is weakened by three model PAHs above saturation, but amphisin is still 
produced. Estuarine water feeding the dredged material disposal site of a Norman harbor 
(France) allows both P. fluorescens DSS73 growth and amphisin production. 
Keywords: biosurfactant; solubility enhancement; polycyclic aromatic hydrocarbons; 
bioremediation; dredged sediments 
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1. Introduction 
Recently, increasing interest has been given to biosurfactants, as these metabolites are produced by a 
wide variety of microorganisms [1–8]. Their amphiphilic structure leads them to accumulate at the 
interfaces, thus they are able to increase solubility and diffusion of insoluble compounds in water. 
Compared to their synthetic counterparts, biosurfactants are known for their biodegradability, their 
reduced toxicity, and their environmental ―friendliness‖ [9]. Moreover, their efficiency is often higher 
than conventional surfactants: a similar surface tension reduction is obtained by a smaller biosurfactant 
quantity [3]. Their efficiency has been also proven in extreme conditions (temperature, ionic strength, 
pH) [10–12]. 
Such properties allow the biosurfactants to be potential candidates in many industrial applications, 
especially in the food, cosmetics, agricultural chemicals, biomedical materials or in health care 
and cleaning industries, etc. They have also been tested in environmental applications [3,7,8,13,14].  
Indeed more and more environmental regulations favor these bioproducts compared to synthetic 
surface-active compounds [15]. 
Essentially, biosurfactants are classified either as low or high-molecular-mass. Whereas  
high-molecular-mass biosurfactants consist in particulate and polymeric amphiphiles, the low 
molecular-mass biosurfactants deal with three major types: 
 glycolipids or lipopolysaccharides: rhamnolipids, trehalolopids [16], sophorolipids [17,18]; 
 lipoproteins-lipopeptides: acyclic [19] and cyclic ones (cyclolipopeptides) [20,21]; 
 and hydroxylated crosslinked fatty acids (mycolic acids) or phospholipids [3]. 
Among them, rhamnolipids, produced by Pseudomonas aeruginosa, are intensively described in 
literature and their applications also [3,14,16,22,23]. However, our interest was retained by 
cyclolipopeptides (thereafter mentionned as CLPs), because of the variety of microorganisms, which 
produce them, mainly Bacillus and Pseudomonas bacteria [4,7,21,24] and their abundant variability of 
structures [21,24]. They are composed of several amino-acids linked to a molecule of hydroxyalkyl 
acid [25]. The first discovered was surfactin [26–29]. CLPs are especially attractive for industrial 
applications as they present good surface tension reduction with low critical micellar concentrations 
(CMC, need of minimum CLPs quantity to be efficient) and versatile bioactive properties. Thus, CLPs 
attract attention of food and biomedical industries [30,31].  
Concerning environmental remediation of any organic or inorganic contaminants [14,32], 
biosurfactants present a great potential in oil or metal recovery, increasing bioavailability of low 
solubility compounds [7,19,33,34]. Most of the more persistent organic compounds, such as polycyclic 
aromatic hydrocarbons (PAHs) or polychlorinated biphenyls (PCBs), are toxic and carcinogenic [35]. 
Among all the PAHs, 16 individual PAH compounds, consisting of two to six fused aromatic rings, 
have been classified as priority pollutants by the United States Environmental Protection Agency [36] 
due to their chronic toxic effects. Various environmental matrices, such as air, water, vegetation, soil 
and sediments act as environmental sinks for PAHs. Indeed, high concentrations of PAHs in benthic 
and aquatic organisms, but also in sediments, have already been reported [37,38].  
In the case of river or harbor sediment contamination, dredging seems to be the beginning of a 
solution for pollution remediation [39]. In France, materials dredged annually in the harbors and the 
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channels represent about 50 × 10
6
 m
3
, of that 24 × 10
6
 m
3
 concentrate most of organic and inorganic 
contamination. Regulations have become more strict in Europe in the last decade. To protect the 
marine environment against ecological risks of dredging and capping, contaminated sludge can no 
longer be dumped at sea. The alternative is to store it in confinement sites, which are currently reaching 
capacity in Europe. Different options are now being explored in order to eliminate, or at least to 
weaken, the present contamination in sediments, to valorize them thereafter as filling or building 
materials, etc. The pretreatment processes primarily consist in a granulometric separation of the coarse 
fractions from the fine particles, where pollution is concentrated. After pretreatment, polluted fine 
slurries may be stored in confinement sites or submitted to processes elaborated for polluted grounds. 
The offered remediation strategies are mainly classified in four types: chemical, physical, or  
physical-chemical together, and biological [40]. Briefly, chemical treatments are largely based on 
oxidation with various oxidants. The physical-chemical processes are mainly extraction and washing. 
Washing treatments are less aggressive than physical treatments (e.g., incineration, thermal 
desorption, etc.) and thus less disturbing for the ground [41]. An alternative technique would also be an 
electrokinetic remediation (EK), which presents less important energy cost and is particularly adapted 
for fine sediments. A weak electric current, applied via electrodes inserted horizontally or vertically 
into the matrix to be treated, induces the mobility of the ionized species in the interstitial liquid phase 
towards the two electrodes permitting to reduce the contaminants level inside the sediments [42,43]. 
Finally, several bioremediation approaches are also proposed: first of all to diminish the risk 
associated to the remediation processes to human health, secondly to minimize the costs, and thirdly to 
be less invasive for the environment [44]. Bioremediation consists in soil detoxification by using either 
micro-organisms or biomass to biodegrade or absorb the pollutants. The principal processes are 
generally biostimulation, bioattenuation or bioaugmentation [45]. An extended definition of 
bioremediation would be soil or sediment amendment with additives from biological origins, 
(e.g., biosurfactant which contribute to the decontamination process).  
To achieve better PAH removal efficiencies (extraction and/or degradation) and to pass through 
limitations of individual remediation techniques, physical, chemical and biological treatments can be 
combined [40]. For instance, the combination of an electrokinetic process and bioremediation  
(EK-bioremediation) enhances the transport of bacteria and nutrients for a more effective  
biodegradation [46,47]. Adding solubilizing agents, such as surfactants or cyclodextrines, also 
increases PAH removal [40,47], and in this case, even biosurfactants can be used [39,48]. Ju and 
Elektorowicz demonstrated that the rhamnolipids coupled with an electrokinetic process increased the 
solubility into the aqueous phase of phenanthrene contaminating the soil [48].  
Consequently, we suggest here to work on contaminated harbor dredged sediments and to use 
biosurfactant-enhanced PAH solubilization with the aim of coupling it later with a physical-chemical 
process, such as EK. In natural conditions, i.e., at the aqueous/solid interface, the biosurfactant has to 
be characterized by a low surface tension to improve PAHs solubility, and this is exactly the case of 
CLPs. Thus, in a first step, the present study focuses on the feasability of using the anionic CLP, 
i.e., amphisin, which is produced by Pseudomonas fluorescens DSS73, for a PAH solubilization 
purpose from polluted sediments. Hence, after a PAH’s sorption study on the coarse and finest particles 
of a model sediment, the efficiency of amphisin will be evaluated on the desorption of a PAH mixture 
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from kaolin. As regards to the in situ process, a convenient approach consists in direct addition of 
amphisin in sediments. An alternative solution would be amendment of the bacteria in the polluted 
sediments where they will grow and produce their biosurfactant. In that case, unlike classical 
bioaugmentation, bacterial addition to sediments will not lead to the pollutant biodegradation but 
solely to the biosurfactant production. Thus, in a second step, the feasability of P. fluorescens DSS73 
amendment will be evaluated. Therefore, the effect of three model PAHs, taken separately, will be 
studied on P. fluorescens DSS73 physiology, in erlenmeyer flasks and in low oxygen growth 
conditions. Then to mimic in situ conditions, the effect of estuarine water will be also investigated. 
Thereafter, the biosurfactant production in laboratory conditions or in real estuarine water will 
be verified. 
2. Results and Discussion 
2.1. Purity of Produced Amphisin by Pseudomonas fluorescens DSS73 
In order to verify the production of biosurfactant by P. fluorescens DSS73 grown on DMA, at 8 °C, 
the surface tension of the rinsing solution was evaluated at 32.1 ± 0.9 mN∙m−1. Compared to the 
surface tension of the standard (i.e., 71.7 ± 0.3 mN∙m−1), this value, which is lower than 40 mN∙m−1, 
indicates the presence of a biosurfactant [49]. After purification and lyophilization, the purity of the 
biosurfactant, described earlier as amphisin [20,50] was analyzed by HPLC-UV. On the chromatogram 
presented in Figure 1, a single peak appeared, revealing an ultra-majority production of amphisin by 
P. fluorescens DSS73 and not a mixture of different CLPs. 
Figure 1. HPLC-UV chromatogram (λ = 210 nm) of the freeze dried biosurfactant 
produced by P. fluorescens DSS73, the amphisin and its structure. 
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2.2. PAHs Adsorption at Water/Sediments Interface and Their Mobilization by Amphisin  
2.2.1. PAHs Adsorption on Dredged Sediments Modeled by Sand, Silt and Kaolin 
We worked on a model sediment which was reconstituted to mimic the existing sediments from a 
disposal site managed by a Norman harbor (France). Indeed such a material is able to adsorb 
particulary high PAHs concentrations due to its high proportion of fine particles (see Experimental 
section). Thus, we chose to study the behavior of 15 PAHs (among the 16 U.S. EPA priority PAHs 
generally found in the environment) at various water/solid interfaces, to understand which of the 
sediment constituents is the more retentive.  
Figure 2. Adsorption isotherms of different PAHs at water/sand, water/silt and 
water/kaolin interfaces at 25 °C. (A) phenanthrene; (B) pyrene; (C) indeno[1,2,3,cd]pyrene. 
(A)
 a 
 
 b 
 
 c 
 
 
(B)
 a 
 
 b 
 
 c 
 
 
(C)
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 b 
 
 c 
  
 
Only the adsorption of some of the PAHs is plotted in Figure 2 (for more clarity),  
i.e., phenanthrene, which represents a low weight PAH (Figure 2A), pyrene, which represents an 
intermediary PAH (Figure 2B) and indeno[1,2,3,cd]pyrene, which represents a high weight PAH 
(Figure 2C). The adsorption isotherms show the interfacial exchanges between water and sand, silt or 
kaolin, the main components of the harbor sediment. Two main trends are observed through these 
isotherms. Firstly, PAHs do not adsorb in the same way on the surface of the different sediment 
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constituents. PAH adsorption on sand is markedly weaker than on kaolin, and silt presents an 
intermediate. Indeed, all PAH adsorption isotherms reach a saturation level for sand at approximately 
0.2 mg∙L−1 (1.8 µg of each PAH per gram of dry sand). This saturated value is higher on the silt 
(between 0.4 mg∙L−1 and approximately 0.9 mg∙L−1 according to tested PAH, i.e., between 3.6 and 
8.1 µg∙g−1). The saturation level is not reached on the kaolin surface in the studied concentration range. 
These results demonstrated that PAHs concentrate more on the finest particles, where the proportions 
exceed 9 µg∙g−1 of dry kaolin. Secondly, PAH adsorption is related to its structure, i.e., the number of 
aromatic ring (three or four ring PAHs, respectively, in Figure 2 (A,B), or six ring PAHs in Figure 2C). 
Adsorption isotherms from fine kaolin particles are almost parallel to the y-axis for the very heavy 
PAHs (from benz[a]anthracene to indeno[1,2,3,cd]pyrene), meaning that they are so strongly adsorbed 
on the clay that we can really speak about ―sequestration‖ of PAHs by this major constituent of the 
sediment.  
Tests were also carried out on the presence of sodium chloride (10 g∙L−1), since the water present in 
the sediment pond, closed to the harbor ecosystem, is briny. The presence of salt had rather little effect 
on PAHs adsorption on sediments (data not shown): only light PAHs were slightly less adsorbed on 
fine particles, because they were a little more soluble in the aqueous phase, with a higher ionic strengh.  
Finally, PAHs adsorption was performed on the reconstituted sediment matrix (mixture of sand, silt 
and kaolin). Organic matter (OM) was introduced at 1 or 5% w/w. In such conditions, PAHs 
(especially the heaviest ones) were more strongly adsorbed, and this phenomenon was inceased when 
the OM concentration rose (data not shown).  
Having shown how the adsorption mechanism works, our goal was now to manage to desorb, i.e., to 
transfer into the aqueous solution, a part of the strongly adsorbed PAHs on sediment particles, with the 
aim of their removal by an EK-bioremediation process. Indeed, the mobilization of sequestred PAHs 
by an anionic micellar system could make it possible not only to enhance the PAH solubilization in 
water, but also to enhance the migration towards the anodic compartment of an electromigration pilot. 
Our purpose was also to evaluate the desorption phenomenon in conditions close to real ones, observed 
in sediment disposal sites: the concentration of studied PAHs were lower than those usually found in 
literature [51,52], and the tested PAHs were chosen to cover different PAH characteristics 
(hydrophobicity, more or less complex structure). 
2.2.2. PAHs Solubility Enhancement with the Help of Amphisin 
Based on previous results, kaolin seems to be the most powerful PAHs adsorbent through sediment 
components, so amphisin efficiency was first evaluated on kaolin. The mixture of 15 PAHs was used to 
pollute our model sediment. In this part of the study, for more clarity, we report only phenanthrene, 
representing low weight PAHs (Figure 3A), and indeno[1,2,3,cd]pyrene, representing heavier 
PAHs (Figure 3B). 
Contaminant solubilization is enhanced by any surfactant, synthetic [39] or biological [53], through 
micellar solubilization. Hydrophobic PAHs are entrapped inside the micelle, whose core is more 
hydrophobic than the matrix bulk, and PAHs solubility is greatly enhanced. As reported by Lai [54], 
the PAHs removal efficiency increased with a biosurfactant concentration increase, but it is not 
significantly related to the contact time. 
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Figure 3. Adsorption isotherms of different PAHs at water/kaolin interface in the presence 
of SDS (8 × 10
−2
 mol∙L−1) or amphisin (7.2 × 10−4 mol∙L−1) and in their absence at 25 °C. 
(A) phenanthrene; (B) indeno[1,2,3,cd]pyrene. 
(A)a 
 
b 
 
 
(B)
a 
 
b 
 
 
First, the added amphisin concentration, i.e., 0.1 g∙L−1 into the system, may be slightly above its 
CMC, which should be closer to other CLPs, for example 0.054 g∙L−1 for viscosin [55]. Unfortunately, 
at this concentration, no clear PAHs mobilization was obtained for any PAHs, light or heavy. In fact, a 
small amphisin quantity should be adsorbed on the solid/liquid interface, increasing the effective CMC 
related to this model medium, which is higher than the CMC in water. 
After adding more amphisin (1 g∙L−1, i.e., 7.2 × 10−4 mol∙L−1), an important decrease in the slope of 
the adsorption isotherms was observed as shown in Figure 3. At such a concentration, amphisin kept a 
greater amount of PAHs in the aqueous phase. This PAH mobilization was observed for light PAHs, 
such as phenanthrene (Figure 3A), and for the heavier (and more adsorbed) ones, such as 
indeno[1,2,3,cd]pyrene (Figure 3B). At first sight, PAHs solubilizing enhancement from fine kaolin 
particles was managed with quite a great quantity of amphisin. To compare with a conventional 
synthetic surfactant, namely sodium dodecylsulfate (SDS), 10
−2
 mol∙L−1 (2.88 g∙L−1) of SDS was added 
to evaluate the efficiency of the solubilizing enhancement. As for amphisin, this chosen SDS quantity was 
close to its CMC (8 × 10
−3
 mol∙L−1) and did not significantly allow PAH mobilization in an aqueous 
phase. Yet, with a concentration ―ten-fold‖ over its CMC (23.07 g∙L−1), SDS enhanced the PAH’s 
solubilization in an aqueous phase in equivalent proportions to the amphisin for heavier PAHs 
(Figure 3B). In summary, amphisin, an anionic CLP, presents great potential to mobilize PAHs in 
aqueous phase, even the most adsorbed ones on the kaolin surface, and its efficiency is noteworthy with 
20-times less (in mass concentration) or 110-times less (in molar concentration) that of the anionic 
synthetic SDS.  
Next we tested if the strain is able to grow and still to produce amphisin in the presence of 
pollutants and in the real interstitial aqueous medium of the dredged sediments. 
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2.3. Effect of Three Model PAHs on Pseudomonas fluorescens DSS73 Growth Kinetics  
2.3.1. Growth in Erlenmeyer Flasks 
Pyrene, fluoranthene or phenanthrene was introduced, as model PAHs, before inoculation of Davis 
Minimal Broth (DMB) by P. fluorescens DSS73 to follow its growth in erlenmeyer flasks.  
As PAH concentrations in the dredged sediments are generally under their solubility limit, two 
concentrations were tested: one just below the solubility limit and one slightly above. 
Figure 4. Effect of PAH concentration on maximal specific growth rate of P. fluorescens 
DSS73 in DMB. (§: PAH concentration higher than its solubility limit). (A) pyrene; 
(B) fluoranthene; (C) phenanthrene. All experiments were done in triplicate. 
(A) 
 
(B) 
 
(C) 
 
 
As shown in Figure 4, for all the tested PAHs concentrations, P. fluorescens DSS73 was able to 
grow. At concentrations lower than PAHs saturation, the maximum specific growth rates, µmax, were in 
the same range with or without PAH, thus the presence of pollutants did not significantly modify 
bacterial development. However, when the growth medium was saturated by PAHs, the bacterial 
growth was more disturbed: µmax decreased drastically for each of the three PAHs.  
Culturing in erlenmeyer flasks favors bacterial growth in regard to those existing growth conditions 
in dredged sediment disposal sites, where the oxygenation of the matrix is weaker. So growth tests 
were also performed in oxygen-limited conditions. 
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Figure 5. Effect of different PAH concentrations on the growth kinetics of P. fluorescens 
DSS73 in DMB in oxygen-limited conditions. (§: PAH concentration higher than its 
solubility limit). (A) pyrene; (B) fluoranthene; (C) phenanthrene. All experiments were 
done in triplicate.  
(A)  
 
(B) 
 
(C) 
 
 
2.3.2. Growth in Oxygen-Limited Conditions 
To better mimic in situ parameters, a similar study was made with a microplate reader. With this 
apparatus, same growth rates were obtained with regard to erlenmeyer cultures, when 100 L of culture 
were used in 400 L microplate wells (data not shown). Cultures performed with 200 L exhibited 
reduced growth that can be attributed to a lack of oxygen. Thus, the maximal growth rate was 0.53 h
−1
 
for growth in erlenmeyer flasks versus 0.33 h
−1
 for growth in the microplate.  
As represented in Figure 5, P. fluorescens DSS73 growth was stunted with increasing PAH 
concentration. The higher the PAH concentration was, the longer the lag phase. For some growth 
kinetics, an important experimental error was observed especially at high PAH concentrations. This 
was related to the high variability of the lag phase observed on the three replicates. In Figure 6, the 
previous results were summarized and normalized: µmax was reported versus PAH concentration 
normalized by PAH solubility. It appeared that when the PAH concentration was lower than its 
solubility (e.g., concentration over solubility ratio lower than 1), µmax was not significantly affected by 
PAHs (p = 0.977 and p = 0.305 for pyrene and fluoranthene, respectively, with a t-test) except for 
phenanthrene (p = 0.007). When the PAH concentration was higher than the solubility limit, the 
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maximal specific growth rate was drastically reduced with regard to a medium without contaminant. 
Similar trends were observed in both conditions with or without oxygen limitation.  
Pyrene presented a greater inhibitory effect on P. fluorescens DSS73 growth than the two other 
PAHs. Its structure is made of four juxtaposed aromatic cycles, whereas three cycles exist for the two 
others. Increasing the number of aromatic cycles may lead to a greater negative impact on 
P. fluorescens DSS73 growth. 
To conclude, P. fluorescens DSS73 is able to grow in the presence of PAHs in laboratory conditions. 
Figure 6. Influence of the concentration/solubility ratio of each PAH on the maximal 
specific growth rate (μmax) of P. fluorescens DSS73 in DMB in oxygen limited conditions. 
All experiments were done in triplicate. 
 
2.3.3. Growth Experiments in Estuarine Water 
To approach a more in situ condition, the growth study in limited oxygenation was repeated, this 
time, with estuarine water feeding the dredged material disposal site of a Norman harbor as growth 
medium. Several growth experiments were performed with sterilized or crude estuarine water, with or 
without nutrient addition. In Figure 7, the growth kinetics were plotted in the case of estuarine water 
without added nutrients (Figure 7A) and supplemented with nutrients (Figure 7B). The addition of 
nutrients modified the profile of the growth curve. Indeed, P. fluorescens DSS73 growth curves, in 
Figure 7B, showed two phases with two different μmax (about 0.2 h
−1
, then 0.1 h
−1
) separated by a lag 
phase of 2 h. An explanation of this diauxy phenomenon may be that P. fluorescens DSS73 first 
metabolized the added nutrients, which acted as a growth stimulant, and then used the estuarine water 
as the second source nutrients.  
With or without sterilization, growth curves showed the same trends during exponential phase, with 
similar growth rate values. Then, the sterilization did not improve growth, as would be expected. 
Indeed, it seems that the indigenous flora of estuarine water did not inhibit P. fluorescens DSS73 
growth. Final maximum optical density (ODmax) at the end of the stationary phase was higher in crude 
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estuarine water than in sterilized water, in the case of nutrient addition. An explanation could be that P. 
fluorescens DSS73 may inhibit other microorganisms and even metabolize their residue. Moreover, the 
ODmax values reached in crude estuarine water were equal to 0.4 without addition of nutrient and 0.7 
for the supplemented growth, which leads to the conclusion that adding nutrient improves 
biomass production. 
Figure 7. Growth kinetics of P. fluorescens DSS73 (A) in sterilized or natural estuarine 
water; (B) in sterilized or unsterilized water supplemented with nutrients, compared to DMB. 
(A) 
 
(B) 
 
To conclude, P. fluorescens DSS73 is able to grow in estuarine water and addition of nutrients 
favors the growth. 
2.4. Evaluation of Amphisin Production 
2.4.1. Amphisin Production in the Presence of PAHs 
Table 1. Surface tensions and associated standard deviations of P. fluorescens DSS73’s 
growth in the presence of PAHs, above their solubility limit. All experiments were 
performed in triplicate. 
Tested PAH Surface Tension (mN∙m−1) 
Name Concentration (mg∙L−1) Before Growth After Growth 
Pyrene 0.5 52.2 ± 0.3 48.5 ± 9.1 
Fluoranthene 1.0 55.0 ± 0.1 43.9 ± 7.1 
Phenanthrene 5.0 55.9 ± 0.1 55.6 ± 5.2 
After demonstrating the potential for P. fluorescens DSS73 to grow in the presence of PAHs, we 
could also show that the strain is still able to produce biosurfactants. Table 1 compiled the surface 
tension measured before inoculation and after bacterial growth in erlenmeyer flasks for each of the 
three PAHs, in higher concentration than their solubility limit. For pyrene and fluoranthene, the surface 
tension decreased slightly, but for phenanthrene no modification was noted. The difference of surface 
tension did not reach 20 mN∙m−1 [52] after bacterial growth, which could suggest that no biosurfactant 
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was produced. However, it was interesting to note the enormous relative standard deviation associated 
to the mean values of surface tension after growth (between 9.4% and 18.8%), so interfacial exchanges 
were effectively modified. It may be correlated to the PAH’s entrapment into amphisin micelles; 
amphisin mobilized at interface DMB/PAH could not help to decrease the surface tension relative to 
DMB/air interface. Although it was not clearly established, amphisin could be produced in PAH’s 
presence. 
2.4.2. Amphisin Production by Pseudomonas fluorescens DSS73 Growing in Estuarine Water 
As already shown, P. fluorescens DSS73 growth may occur in estuarine water, and it was still able 
to produce amphisin (Table 2).  
Table 2. Surface tension and associated standard deviations of P. fluorescens DSS73’s 
growth in estuarine water with or without nutrients. All experiments were performed in 
triplicate. 
Tested Medium 
Surface Tension (mN∙m−1) Amphisin 
Production Before Growth After Growth 
DMB 69.3 ± 0.9 30.4 ± 0.5 + 
Estuarine water without nutrient 
60.9 ± 0.5 
32.8 ± 0.2 + 
Estuarine water with nutrients 29.8 ± 0.6 + 
In all cases, after bacterial growth in estuarine water, the surface tension was less than 40 mN∙m−1, 
criterion required to detect biosurfactant production according to Carillo [49]; moreover the growth in 
estuarine water resulted in a decrease of surface tension of more than 30 mN∙m−1. Without any doubt, 
amphisin is produced by DSS73 in estuarine water, with or without nutrient addition. 
3. Experimental Section  
3.1. Microorganism 
P. fluorescens DSS73 is a strain from sugar beet rhizospheric environment and was graciously 
provided by Dr. O. Nybroe (Royal Veterinary & Agricultural University-Thorvaldsensvej, Denmark). 
3.2. Growth Medium 
The bacteria were grown in Davis Minimal Broth (DMB: 30 mmol∙L−1 K2HPO4, 14 mmol∙L
−1
 
KHPO4, 0.4 mmol∙L
−1
 MgSO4, 7.6 mmol∙L
−1
 (NH4)2SO4, 120 mmol∙L
−1
 glucose, and 1 mL of trace 
element solution per liter (pH 7.3). The trace element solution contained per liter of pure water 20 mg 
of CoCl2∙6H2O, 30 mg of H3BO3, 10 mg of ZnSO4∙7H2O, 1 mg of CuCl2∙2H2O, 2 mg of NiCl2∙6H2O, 
3 mg of NaMoO4∙2H2O, 10 mg of FeSO4∙7H2O, and 2.6 mg of MnSO4∙H2O. The glucose and trace 
elements were sterilized separately by filtration (Steriltop, Millipore, France) and aseptically added to 
the rest of the medium. Growth on solid medium was performed on DMA (Davis Minimal Agar) with 
the same composition as DMB supplemented with agar (15 g∙L−1). 
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Cultures were also carried out in estuarine water that was collected in sterile bottles, in an estuarine 
canal feeding the dredged material disposal site (Normandy, France). Then the estuarine water was 
stored at 4 °C and used for the cultures in the following 24 h. The pH of the water was adjusted to 7. 
Bacterial growth was tested in unsterilized or sterilized (by filtration) estuarine water. Cultures were 
done using unsterilized or sterilized estuarine water as aqueous base with DMB components. The 
addition of nutrients resulted in ion precipitation. The precipitate was eliminated by centrifugation 
(7000 g, 10 min). 
3.3. Biosurfactant Recovery 
To test for biosurfactant production, the bacterial colonies were grown on Davis minimal agar. 
DMA culture plates were inoculated with 40 µL of stocked suspension. After incubation for at least a 
week at 8 °C, bacterial colonies were scraped off, transferred to 15 mL of sterile mineral water and 
dispersed by agitation. This mineral spring water was used as its low level in mineral charge ensures a 
good repeatability and high values for tensiometry. After centrifugation (30 min, 4 °C, 18,000 g), the 
surface tension of the supernatant could be determined by the direct method of the pendant drop using 
a G40 goniometer (Krüss, France). 
The biosurfactant purification was performed by liquid-liquid extraction: 100 mL of aqueous 
supernatant completed with 4 × 10
−3
 mol∙L−1 of trifluoroacetic acid (TFA), was mixed and agitated one 
hour with 150 mL of ethyl acetate, and then transferred into a separatory funnel. A second extraction of 
the aqueous phase was carried out each time. After collection of all organic phases, they were 
evaporated at 40 °C and 250 mbar with the rotary evaporator, to obtain approximately 10 mL of 
extract. In order to eliminate free water, this extract was then freeze-dried (semi-pilot freeze-drier 
SMH15, Usifroid, Maurepas, France), the sublimation took at least 2 days. The solid lyophilized 
sample was then solubilized in acetonitrile and was analyzed in liquid chromatography (HPLC) with 
UV detection (at 210 nm): The purified amphisin was separated on a hydrophobic C18 bonded column 
(Beckman, Fullerton, USA) (4.6 mm × 250 mm, particles of 5 µm), using as a mobile phase a solvent 
mixture composed of: 25% water containing 0.1% TFA and 75% acetonitrile, at 1 mL∙min−1. 
3.4. Model Sediment for PAH Adsorption 
A sediment is first characterized through its granulometry, its mineral composition, its water and 
organic matter (OM) content. The granulometric classification, used for sediments in geology (French 
standard NF P18-560), differentiates largest blocks, rollers, stones or gravels, of diameters greater than 
2 mm, sands (diameter ranging between 20 µm and 2 mm), silts (2 to 20 µm) and clay sludges or muds 
(diameters less than 2 µm). The reconstituted studied sediment contained 5% sand, with a particle 
diameter between 125 and 315 µm (Sika, Hostun, France), 75% silt from the Normandy shelves, with a 
diameter between 4 and 100 µm (CETE, Rouen, France) and 20% kaolinite clay, with a diameter being 
less than 80 µm, including 54% of particles less than 2 µm (Imerys, Poigny, France). 
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3.5. PAH Quantification at the Water/Sediment Interface 
The PAH adsorption at the water/sediment interface was carried out in reactors containing 10 g of 
model sediment for 90 mL of aqueous phase (ratio 10/90 in weight or 111 g of dry sediment per liter), 
maintained at a constant temperature (25 °C) in a thermostated bath (Fisher Bioblock Scientific, 
IIlkirsh, France) and under agitation (300 rpm). In many experiments, sodium chloride could be added 
into water at a concentration of 10 g L
−1
. In other experiments, organic matter could be mixed with the 
model sediment, in variable proportions (1 to 5% w/w). This organic matter was obtained from the 
decomposition of a vegetable material (VEOLIA-France): it was then dried 48 h at 50 °C, crushed and 
sieved to obtain particle diameters less than 355 µm. PAH introduction in reactors was done from a 
known concentration (Co) of a stock solution of 16 PAHs (100 mg∙L
−1
) in water. When thermodynamic 
equilibrium was reached (2 h for kaolin alone, 12 h for sand alone, 4 h for the model sediment), the 
solid phase was eliminated by centrifugation (40 min, 11,200 rpm). Then an enrichment protocol by 
SPE (solid phase extraction) was done to concentrate the traces of non-adsorbed PAH still present in 
the aqueous phase at the end of the equilibrium step (Ceq). Indeed, direct PAH analysis and 
quantification by HPLC would have been impossible without SPE enrichment because non-adsorbed 
PAHs were found under the limits of detection of the fluorimetric detector. It must be added that even 
after centrifugation, ultra-fine clay particles remained in suspension in liquid phase; so SPE cartridges 
Strata X (Phenomenex), containing 60 mg of polymeric solid phase, had to be coupled with Phenex 
0.45 µm filters, made of inert Teflon (Phenomenex), to eliminate colloid particles. Moreover, to 
improve PAH extraction yields, which had to be higher than 80%, it was necessary to homogenize the 
aqueous supernatant by adding 20% acetone in volume (HPLC grade, Fisher Scientific) before starting 
its percolation through the SPE cartridge. This step also made it possible to avoid the PAH sorption on 
the flask’s glass walls, leading to high PAH losses, a particularly critical phenomenon when traces of 
PAH have to be analyzed quantitatively. SPE cartridges were first conditioned with methylene 
chloride, methanol and a mixture of acetone/water (20/80 v/v) (all solvents were of analytical grade, 
from Fisher Scientific France). Then, after percolation of the aqueous supernatant through the SPE 
cartridge associated to a filter, extracts were eluted with 5 mL of methylene chloride (HPLC grade, 
Fisher Scientific).  
Methylene chloride was evaporated under nitrogen flow (after adding 60 µL of dimethylsulfoxide) 
for solvent change; then the sample was solubilized again in 4 mL of acetonitrile (HPLC grade, Fisher 
Scientific). 10 µL of this sample was injected on a PP Envirosep C18 bonded column (Phenomenex; 
150 mm × 4.6 mm, particles of 5 µm), with a flow rate of 1 mL∙min−1 controlled by two Beckman 
Coulter Gold 126 pumps.  
Table 3 shows the solvent gradient conditions during chromatographic elution as well as the 
programmed excitation and emission wavelengths of the fluorimetric detector Prostar 363 (Varian, 
Palo Alto, USA). After HPLC analysis, each of the 16 PAHs could be individually quantified. Their 
aqueous concentration could be evaluated (as Ceq at equilibrium in water) and consequently, knowing 
their initial introduced concentration (Co), Cads could be calculated by a simple subtraction as the 
concentration adsorbed on sediment. Adsorption isotherms at 25 °C were then established in varying 
Co and in plotting Cads = f(Ceq). 
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Table 3. HPLC elution gradient for the analysis of the 15 priority PAHs (defined by U.S. 
EPA) plus benzo[e]pyrene, and conditions for the fluorimetric detection. 
Time (min) Elution Gradient ex (nm) em (nm) Detected PAHs 
0 Acetonitrile/water 55/45% 220 330 Naphthalene (1) 
5 Acetonitrile/water 55/45% 
Linear gradient 
for 20 min 
7 220 315 Acenaphthene (2) 
Fluorene (3) 
10 250 370 Phenanthrene (4) 
Anthracene (5) 
13.4 235 420 Fluoranthene (6) 
Pyrene (7) 
17  267 385 Benz[a]anthracene (8) 
Pyrene (9) 
21.7 260 420 Benzo[e]pyrene (10) 
Benzo[b]fluoranthene (11) 
Benzo[k]fluoranthene (12) 
Benzo[a]pyrene (13) 
25 Acetonitrile/water 100/0% 
 
27.4 290 410 Dibenzo[a,h]anthracene (14) 
Benzo[g,h,i]perylene (15) 
29.8 245 500 Indeno[1,2,3-cd]pyrene (16) 
35 Acetonitrile/water 55/45% 220 330  
3.6. Solubility Enhancement of PAHs by Amphisin and SDS 
The mixture of 16 PAHs was introduced into reactors containing kaolin, as further described. After 
mixing them for one hour at 25 °C, the purified and lyophilized biosurfactant was then introduced into 
the system at two different concentrations: 0.1 g∙L−1 and 1 g∙L−1. After three hours of equilibrium, the 
mixture was centrifuged and the non-adsorbed PAH were quantified as described elsewhere. Other 
similar experiments were done with a synthetic surfactant, the sodium dodecyl sulfate SDS (provided 
by Sigma-Aldrich), introduced in a similar way at 2.88 g∙L−1 or 23.07 g∙L−1 in the aqueous phase. 
3.7. Bacterial Growth Conditions 
3.7.1. Growth in Erlenmeyer Flasks with PAHs 
Seed culture was carried out in 10 mL of DMB overnight at 28 °C on a rotary shaker (180 rpm). In a 
500 mL erlenmeyer flask, 50 mL of DMB supplemented with PAH from stock solution in acetone, was 
inoculated with an aliquot of seed culture in order to obtain an initial OD of 0.05. The tested PAH 
concentrations were 0.1 and 0.5 mg∙L−1 for pyrene, 0.2 and 1 mg∙L−1 for fluoranthene and 5 mg∙L−1 for 
phenanthrene. The culture conditions were identical as for the seed culture. Bacterial density was 
determined by measuring optical density at 580 nm (Spectronic 601 spectrophotometer). For each PAH 
concentration, triplicate flasks were employed. 
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3.7.2. Growth in Oxygen-Limited Conditions 
Cultures were made in polystyrene microtitration plates. 180 L of DMB was deposited in each 
400 L well and inoculated by 20 L of seed culture in DMB incubated at 28 °C. To study the effect of 
PAH on bacterial growth, PAH was added to the mixture in the wells, from PAH stock solutions in 
acetone, to obtain final concentrations of 0.125, 0.5, 1.25, 2.5, 3.75 mg∙L−1 for pyrene, of 0.25, 1, 2.5, 
5, 7.5 mg∙L−1 for fluoranthene, and of 1.25, 5, 12.5, 25, 37.5 mg∙L−1 for phenanthrene. To evaluate the 
influence of estuarine water on growth kinetics, DMB was replaced by estuarine water. 
For each condition, P. fluorescens DSS73 growth was followed continuously in triplicate in a 
thermoregulated spectrometer (Xenius, Safas, Monaco) at 28 °C under rotary revolution (180 rpm). 
3.8. Tensiometry 
The surface tension was tested on culture supernatants after centrifugation (30 min, 4 °C, 18,000 g) 
from 50 mL of liquid cultures. The home-made surface tensiometer worked on the principle of the 
Wilhelmy plate method. All surface tensions were measured in triplicate. The measurement validity 
was standardized with mineral spring water of weak mineral charge (71.7 ± 0.3 mN∙m−1).  
4. Conclusions 
Biosurfactant produced by Pseudomonas fluorescens DSS73 seems very promising with regard to 
mobilization in an aqueous phase of strongly adsorbed PAHs on the finest sediment particles. It was 
almost as efficient as conventional synthetic surfactants, such as SDS, for solubilizing the heaviest and 
most strongly adsorbed PAHs. However, mobilization by amphisin needs much lower quantities than 
those required with the synthetic surfactant. Future research needs to investigate if amphisin is also 
efficient in solubilizing PAHs even when another retentive material, i.e., organic matter, enters the 
composition of the sediment; afterwards, we will also have to prove that the ionic amphisin, after its 
increased solubilizing effect, will be able to enhance PAH mobility through the sediment via an 
electromigration process. Indeed, EK remediation is a promising in situ method for grounds or 
sediments of low permeability, and is adapted to numerous pollutant types. 
This study also proved that the strain was able to produce the cyclolipopeptide in hostile growth 
conditions corresponding to real environment, i.e., in estuarine water feeding a dredged material 
disposal site. P. fluorescens DSS73 was also able to produce amphisin, in the presence of a relatively 
high PAH contamination, and even with low oxygen growth conditions. These very promising results 
suggest that bioaugmentation of the biosurfactant producer, P. fluorescens DSS73, could be 
conceivable in situ. As amphisin is biodegradable (which is an advantage for the environment), single 
amendement is not sufficient when long periods are necessary to perform pollution attenuation, which 
is certainly the case when EK remediation is performed in situ, on a large scale. Moreover,  
EK-bioremediation of PAHs via anionic micelles needs certainly a continuous addition of the 
biosurfactant, because aggregates migrate towards the anodic compartment and are consequently 
impoverished inside the sediment during the treatment. Thus, it would be a real advantage to continue 
the mobilization and migration process with biosurfactant production in situ. 
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Caenorhabditis elegans: a model to monitor
bacterial air quality
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Abstract
Background: Low environmental air quality is a significant cause of mortality and morbidity and this question is
now emerging as a main concern of governmental authorities. Airborne pollution results from the combination of
chemicals, fine particles, and micro-organisms quantitatively or qualitatively dangerous for health or for the
environment. Increasing regulations and limitations for outdoor air quality have been decreed in regards to
chemicals and particles contrary to micro-organisms. Indeed, pertinent and reliable tests to evaluate this biohazard
are scarce. In this work, our purpose was to evaluate the Caenorhaditis elegans killing test, a model considered as
an equivalent to the mouse acute toxicity test in pharmaceutical industry, in order to monitor air bacterial quality.
Findings: The present study investigates the bacterial population in dust clouds generated during crop ship
loading in harbor installations (Rouen harbor, Normandy, France). With a biocollector, airborne bacteria were
impacted onto the surface of agar medium. After incubation, a replicate of the colonies on a fresh agar medium
was done using a velvet. All the replicated colonies were pooled creating the “Total Air Sample”. Meanwhile, all the
colonies on the original plate were isolated. Among which, five representative bacterial strains were chosen. The
virulence of these representatives was compared to that of the “Total Air Sample” using the Caenorhaditis elegans
killing test. The survival kinetic of nematodes fed with the “Total Air Sample” is consistent with the kinetics
obtained using the five different representatives strains.
Conclusions: Bacterial air quality can now be monitored in a one shot test using the Caenorhaditis elegans killing
test.
Background
The deep impact on health from chemical pollutants [1]
is now a main concern of governmental policies in most
countries. As well as airborne nanoparticles and chemi-
cals [2], airborne bacterial and fungal contaminants are
also of major importance in human health [3,4]. These
micro-organisms may lead to typical respiratory tract
infections but also to delayed sensitization (allergic)
reactions somehow considered as the “epidemy of the
21st century“ [5]. Some of these micro-organisms simply
originate from the environment but human activities are
also important sources of aerial biological contaminants
[6]. It would be particularly interesting to develop a
microbial air quality alert system equivalent to that for
chemical pollutants. Microbial air quality is commonly
evaluated by measuring the global concentration in the
air of bacteria and fungi by culture-dependant or bio-
molecular methods [7]. High microbial concentrations
in the air are generally associated to potential danger.
The search for endotoxins has been developed [8]. The
composition of microbial communities is often assessed
by molecular methods [8,9] and pathogen species have
been also detected by PCR with specific probes [10].
Studying airborne bacterial and fungal communities in
land [4,9], urban [11-13], and occupational [14] environ-
ments now allows an almost complete description of
environmental air micro-organisms biodiversity. How-
ever, the identification of microbial species and strain is
not sufficient to extrapolate at the sanitary risk level, as
many different parameters may affect virulence. Indeed,
both contact mediated and toxin dependent virulence
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are regulated by environmental conditions including
temperature [15], bacteriophages [16] and of course
microbial communication factors [17]. Sometimes bac-
terial strains are generally considered safe and devoid of
pathogenic potential and, however, induce clinical infec-
tions [18,19]. Determining the real risk associated to air-
borne micro-organisms first requires collecting a
maximum amount of micro-organisms in conditions
which avoid the stress or even the destruction of the
most sensitive micro-organisms which are usually the
most metabolically active [20]. The identification of the
composition of this population should be realized in a
second step but the essential point is to evaluate the
virulence of the complex community. This requires a
cheaper and more rapid test than classical animal assays
but also less sensitive than in vitro cytotoxicity tests. In
the present study, the chosen model was the Caenor-
habditis elegans worm. It is a versatile metazoan model
previously used to assess of the virulence of many
human pathogens [21,22], and especially to study pri-
mary respiratory chain dysfunction in humans [23].
Spontaneous predation and ingestion of bacteria pro-
voke nematode death by contact dependent bacterial
virulence and by the bacterial secretion of toxins
[21,22]. Thus, in the present study, we investigated the
risk linked to airborne bacteria in the dust cloud gener-
ated during crop ship loading in harbor installations
located in close proximity of residential areas. After col-
lection of the total microbial population, bacteria were
identified by traditional phenotypic and molecular tech-
niques. The virulence of some individual representatives
chosen among the collected bacteria was compared
using the nematode C. elegans. to that of the pooled
replicated bacterial population defined as “Total Air
Sample”.
Methods
Aerial bacteria collection
Bacteria were collected in January 2009 at the dockside
of Rouen harbour (Normandy, France) during loading
from crop silo onto ship from stocking silo. All opera-
tions were done in the morning. Samples were obtained
by aspiration of 30, 60, 90, or 190 L (under a flow rate
100 L.min-1) in the dust cloud of particles generated by
crop transfer using an AirTest Omega Biocollector
(LCB, France). In this device, air is drawn in through a
0.5 mm grid to remove macroscopic particles and the
air flow is directed towards the impact medium where
micro-organisms are trapped. In order to limit the stress
on bacteria, a semi-solid impact medium, Tryptipcase
Soy Agar (TSA), was made with Tryptic Soy Broth
(TSB) diluted 1:5 containing agar (10 g.L-1 ) and ampho-
tericin B (25 mg.L-1) as a fungicide.
After collection, impacted TSA plates, presented in
Figure 1, were incubated at 30°C for 72 h to reveal the
colonies of cultivable bacteria. Agar plates showing well
separated and countable colonies were selected and
before other manipulation, a velvet copy of these plates
was done. This velvet was laid on a new TSA plate
which afterwards was incubated at 30°C for 72 h. All
the formed colonies were transferred to and grown in
the same culture in 1:5 diluted TSB and then frozen at -
80°C with a final glycerol concentration of 30%. This
mixture of strains collected from the air impaction was
designed as “Total Air Sample”. Subsequently, from the
original impacted TSA plate, individual colonies were
removed and isolated as pure cultures on TSA for
further analysis and storage at - 80°C as previously
described.
Bacterial characterization and identification
Each isolated bacterial strain was initially characterized
by morphological observation (colony aspect, cell shape,
motility, endospore), Gram staining and biochemical
tests (oxidase, catalase and oxidative metabolism). These
observations allowed different bacterial groups to be
defined. In each group including potential pathogens,
one representative strain was chosen and submitted to
further characterization on API tests galleries. API kits
were operated according to the manufacturer’s instruc-
tions (BioMérieux, France). For Gram-positive bacteria,
API 50CH was used for the identification of Bacillus,
API ID STAPH 32 for identification of germs of the
genus Staphylococcus or Microccocus and API Coryne
for Gram-positive catalase-positive non-sporing rods.
For Gram-negative bacteria, API 20E was used for the
identification of Enterobacteriaceae and API 20NE for
non fermenting rods. Species identification of represen-
tative strains was confirmed by 16S RNA sequencing.
For amplification of the complete 16S RNA gene, uni-
versal primers UNI_OL (5¢-AGAGTGTA GCGGTGAA
ATGCG-3¢,) and UNI_OR (5¢-ACGGGCGGTGTGTA-
CAA-3¢,) were used as suggested by Sauer et al. [24].
Amplicons were then purified through migration on
agarose gel and sequenced directly by using the amplifi-
cation primers UNI_OL and UNI_OR (Qiagen, Ger-
many). Afterwards 16S RNA fragments (+/- 750 pb)
were analyzed (Qiagen, Germany) and homologies with
sequences of other eubacteria were determined by
searching the NCBI (http://www.ncbi. nlm.nih.gov/
sutils/genom_table.cgi) and RDP (http://rdp.cme.msu.
edu/seqmatch/seqmatch_intro.jsp) data banks using
BLAST software. An isolate was positively identified
when the full-length 16S RNA gene yielded a >98.3%
sequence similarity with the closest bacterial species
registered in the data banks.
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Evaluation of bacterial virulence using the Caenorhabditis
elegans killing tests
The virulence of the airborne bacterial population, i.e.
the “Total Air Samples”, was compared to that of indivi-
dual representatives of bacterial strains collected in the
air using the slow killing tests on the nematode Caenor-
habditis elegans, accordingly Figure 1.
Experiments were conducted using the wild-type Bris-
tol strain N2 of C. elegans provided by the Caenorhabdi-
tis Genetics Center (Minneapolis, MN, USA). Worms
were maintained under standard culturing conditions at
22°C on nematode growth medium (NGM) containing 3
g NaCl, 2.5 g peptone, 17 g agar, 5 mg cholesterol, 1
mL 1 M CaCl2, 1 mL 1 M MgSO4, 25 mL 1 M
KH2PO4, H2O for 1 L of medium. This medium was
plated on Petri dishes and Escherichia coli OP50 as
added as a normal food source [21]. For virulence tests,
synchronized worms of the same development level
were obtained by bleaching an adult population using
sodium hypochlorite/sodium hydroxide solution [25].
The resulting eggs were incubated at 22°C on E. coli
OP50 lawns until the worms reached the L4 life stage
(48 h). The stage of development was confirmed by
microscopic observation.
For bacterial virulence assays, “Total Air Samples” or
individual air strain aliquots standardized by dilution (at
OD580 = 1) were prepared by spreading 100 μL on 35
mm Petri dishes containing NGM supplemented with
0.05 mg.mL-1 5-fluoro-2’-deoxyuridine (FUDR), a eukar-
yote DNA synthesis inhibitor preventing C. elegans egg
offspring during the experiments. Plates were incubated
overnight at 29°C and then transferred at room tem-
perature for 4 h. In each Petri dish a mean of 20 L4 syn-
chronized worms, harvested in M9 solution (3 g
KH2PO4, 6 g NaHPO4, 5 g NaCl, 1 mL 1 M MgSO4,
H2O in 1 L) were layered. Plates were incubated at 22°C
and worm survival was scored every 24 h throughout a
22 days period using an Axiovert S100 optical micro-
scope (Zeiss, Oberkochen, Germany) equipped with a
Nikon digital Camera DXM 1200F (Nikon Instruments,
Melville, NY, USA). A worm was considered dead when
it remained static without grinder movements for 20 s.
Results are expressed as percentage of worms surviving
every day and were calculated as the mean of 3 indepen-
dent assays in which each point was the average of 3
replicates. Nematode survival was calculated using the
Kaplan-Meier method, and survival differences were
tested for significance using the log-rank test (GraphPad
Prism version 4.0; GraphPad Software, San Diego, Cali-
fornia, USA).
Results and Discussion
Identification of airborne bacteria in the dust cloud
generated by crop transfer
Plates obtained with 30 L air presented a sufficient
number of colonies which remained well separated. In
cultures obtained with higher air volumes, bacterial
colonies were too numerous for correct isolation.
As seen Figure 1, velvet replicates of impacted TSA
plates were realized to obtain the “Total Air Sample”. A
total of 323 bacterial strains were isolated. The corre-
sponding calculated bacterial concentration in the air
was about 1.1 × 104 CFU.m-3 as shown in Table 1. This
bacterial concentration in the dust cloud generated by
crop loading was slightly higher than obtained in urban
air, which ranged from 5.5 × 102 to 2.5 × 103 CFU.m-3
[7,11]. The large quantity of dusts and particles, which
represents the principal support of bacteria in the air
[26] can explain this result. It is also interesting to note
that the values of bacterial load measured at the centre
of the dust cloud are markedly lower than previously
measured [27]. This difference should be attributed to
the application of more recent procedures aimed at
reducing particle emission during ship loading (for
instance covered conveyor belts).
Morphological characters, Gram staining and bio-
chemical tests were carried out for the 323 bacterial
strains. These orientation tests allowed to distribute the
bacterial population in 8 groups, i.e. Gram-negative oxi-
dase-negative strictly aerobic rods such as Acinetobacter,
Pseudomonas... (Group 1), Gram-negative oxidase-posi-
tive facultatively anaerobic rods such as Aeromonas...
Figure 1 Plotted experimental strategy from collected airborne bacteria to the evaluation of their virulence.
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(Group 2), Gram-negative oxydase-negative facultatively
anaerobic rods mainly Enterobacteriaceae (Group 3),
Gram-negative oxidase-positive strictly aerobic rods like
Pseudomonas...(Group 4), Gram-positive sporing rods
such as Bacillus...(Group 5), Gram-positive catalase-
positive nonsporing rods such as Arthrobacter... (Group
6), Gram-positive catalase-positive strictly aerobic cocci
such as Micrococcus... (Group 7), Gram-positive cata-
lase-positive facultatively anaerobic cocci such as Sta-
phylococcus... (Group 8). No Gram-positive catalase-
negative were found. Gram-negative rods accounted for
the greatest part of the bacterial population (72.4%) with
the following distribution: 39.9% for Group 3, 17.6% for
Group 1, 10.8% for Group 4 and 4.0% for Group 2.
Concerning Gram-positive bacteria, the predominant
group corresponded to Group 6 (11.1%) followed by
Group 5 (5.3%), Group 7 (3.7%), and Group 8 (2.8%).
The bacterial composition, characterized by a predomi-
nance of Gram-negative bacilli, appeared unchanged
compared to a similar study [27]. This observation is
logical with regards to the nature of the material at the
origin of the particles (crops). The main bacterial group,
i.e. Enterobacteriaceae, Group 3, (39.9%), corresponds to
bacterial species frequently associated with plants, and
behave as epiphyte, endophyte or even pathogens [28].
These bacteria colonize crops during field growth, sur-
vive and even proliferate during storage and then are
present in the dust cloud [29]. The second group of
bacteria in quantity is Group 1, represented by P. syrin-
gae, a germ present in the phyllosphere and generally
adapted to growth at low temperature [30]. Catalase-
positive non sporulated Gram-positive rods, Group 6,
representing 11.1% of bacteria in the dust cloud, should
correspond to bacteria of the genus Corynebacteria,
Rhodococcus or Arthrobacter also usually present in the
ground and already detected in urban air [11] and dur-
ing crop manipulations [29].
The aim of this study was to monitor the bacterial air
quality, and the study was focused on the groups includ-
ing potential pathogens: Group 1, 3-5, and 8. From each
of these groups, a representative strain was randomly
chosen among the isolated strains. They were submitted
to API gallery identification and 16S RNA sequencing.
As shown in Table 2, all the orientation results were
confirmed by those of the identification. Indeed, P. syr-
ingae is an oxidase-negative Pseudomonas, then it was
pooled with Acinetobacter. Brevundimonas is related to
the genus Pseudomonas. The correlation between the
API gallery identification and 16S RNA is quite good at
the genus level.
The discrepancies between identification results, espe-
cially at the species level, could be explained by the
incomplete covering of clinical API galleries for the
identification of environmental bacteria. This impreci-
sion could also result from the 16S RNA strategy of
identification, especially when it is applied over a large
diversity of environmental bacteria whose compilation is
not complete in data bases such as NCBI/PUBMED.
Comparison of population and bacterial virulence using
the Caenorhabditis elegans killing test
This study deals with the impact of bacteria present in
outdoor air on human health. A robust and practical
experimental model was therefore needed in relation to
respiratory diseases resulting from bacterial infection.
The nematode C elegans model is known to model
Table 1 Airborne bacterial composition in the dust cloud
resulting from crop transfer
Sample Next to crops ship loading winter
2009
Collected volume 30L
Incubation conditions 30°C on 1:5 diluted TSA plate
UFC/air m3 10767
Group 1 17.6%
Gram-negative rods Group 2 72.4% 4.0%
Group 3 39.9%
Group 4 10.8%
Gram-positive rods Group 5 16.4% 5.3%
Group 6 11.1%
Gram-positive cocci Group 7 6.5% 3.7%
Group 8 2.8%
unexploitable strains 4.6%
Eight groups were represented: Gram-negative oxidase-negative strictly
aerobic rods such as Acinetobacter, Pseudomonas... (Group 1), Gram-negative
oxidase-positive facultatively anaerobic rods such as Aeromonas... (Group 2),
Gram-negative oxydase-negative facultatively anaerobic rods mainly
Enterobacteriaceae (Group 3), Gram-negative oxidase-positive strictly aerobic
rods like Pseudomonas...(Group 4), Gram-positive sporing rods such as
Bacillus...(Group 5), Gram-positive catalase-positive nonsporing rods such as
Arthrobacter... (Group 6), Gram-positive catalase-positive strictly aerobic cocci
such as Micrococcus... (Group 7), Gram-positive catalase-positive facultatively
anaerobic cocci such as Staphylococcus... (Group 8).
Table 2 Identification by API galleries and 16S RNA
sequencing of the five representatives: P. syringae, S.
marcescens, Brevundimonas, B. cereus, and S. aureus
API Test 16S RNA identification
Group
1
Pseudomonas luteola
(G)
Pseudomonas syringae
Group
3
Serratia liquefaciens
(VG)
Serratia marcescens
Group
4
Brevundimonas
vesicularis
Brevundimonas sp.
Group
5
Bacillus cereus (Exc) Bacillus thuringiensis, B. cereus, or B.
anthracis
Group
8
Staphylococcus sciuru
(Exc)
Staphylococcus aureus
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mammalian bacterial pathogenesis [21] and especially in
human respiratory dysfunction [23].
The practical experimental advantages of this free-liv-
ing worm are its ability to feed solely on bacteria, its
short life cycle, and its easy cultivation in large number
[31]. The survival kinetics of C. elegans in the presence
of each bacterial representative (P. syringae, Serratia
marcescens, Brevundimonas, B. cereus, and S. aureus)
was studied for a maximum of 22 days (Figure 2). Even
in the presence of their normal food source (Escherichia
coli OP50) worms progressively die of age, all died after
17 days of culture. It is important to remember that the
DNA synthesis inhibitor (FUDR) present in the medium
prevents C. elegans egg offspring and population
renewal. The survival of worms in the presence of these
bacteria was compared to the one measured using the
opportunistic pathogen P. aeruginosa PAO1, frequently
responsible for respiratory tract infections [32]. Worms
died rapidly in the presence of P. aeruginosa PAO1 (10
days) and none of the environmental strains collected in
the air had equivalent virulence. In fact, all the survival
kinetics were highly significantly different of those
obtained in the presence of P. aeruginosa PAO1 (P <
0.0001 log-rank test). P. syringae, S. marcescens, and B.
cereus presented against C. elegans increased or similar
virulence compared to E. Coli OP50.
Surprisingly, two strains: Brevundimonas sp., and S.
aureus appeared less virulent than E. Coli OP50 (P <
0.0001 log-rank test). Even if S. aureus is accepted as
usually pathogen and Brevundimonas considered as an
opportunistic pathogen, we have to keep in mind that
the bacterial virulence depends on the strains and is clo-
sely related to the bacterial adaptation to its microenvir-
onment. But from the random selection of the
representatives, no strain is known as strictly human
pathogen. Also, according C. elegans test, no sanitary
threat appeared because all representative strains were
less virulent than the standard opportunistic pathogen
P. aeruginosa PAO1. As isolation of all the bacterial
spots on the impacted plate is rather fastidious work
and complex populations should have virulence which
differs from individual strains. Another approach is to
test the virulence of the “global” impacted bacterial
population against C. elegans, as shown in Figure 1.
This was done with the bacterial mix, defined as “Total
Air Sample”. As with the representatives, virulence
against nematodes was studied for the “Total Air Sam-
ple”, corresponding to the bacterial population collected
during crop loading on ships (plotted in Figure 2). The
kinetics of the survival of worms with “Total Air Sam-
ples” was surrounded by most of the representative
plots and was significantly different from that of P. aeru-
ginosa PAO1 (P < 0.0001 log-rank test). Moreover,
within the first 11 days of the study, the percentage of
death of the worm population was greater using “Total
Air Samples” than the avirulent standard E. coli OP50.
This difference vanished afterwards and in both cases all
worms were dead between 17 and 19 days.
The comparison of the lethal effects of the “Total Air
Sample” with each environmental representative was
clearly illustrated at Day 9 (Figure 3). This time corre-
sponds to the last day of nematodes survival in the pre-
sence of P. aeruginosa PAO1. The survival of C. elegans
exposed to P. syringae (50.00%), Pantoae spp (55.26%),
and B. cereus (52.11%) was in the same range as for
Pseudomonas syringae
Serratia marcescens
Brevundimonas sp
Bacillus cereus
Staphylococcus aureus
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Figure 2 Kinetics of survival of C. elegans exposed to bacteria.
Kaplan-Meier survival plots of worms fed with the opportunistic
pathogen Pseudomonas aeruginosa PAO1, bacterial strains isolated
from air: Pseudomonas syringae (Group 1 : Acinetobacter...), Pantoae
sp (Group 3: Enterobacteriaceae...), Brevundimonas sp (Group 4
Pseudomonas...), Bacillus cereus (Group 4: Bacillus...), and
Staphylococcus aureus ( Group 8: Staphylococcus...) and the non-
virulent strain Escherichia coli OP50, and “Total Air Sample”.
Experiments were done in triplicate.
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Figure 3 Comparison of the survival of worms exposed to
bacteria at Day 9. Experiments were done in triplicate.
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worms fed with “Total Air Sample” (47.73%). Neverthe-
less, as noted at Day 9, S. aureus and Brevundimonas
favored the survival of nematodes with 79.55% and
91.66% of survival percentage respectively, compared to
47.73% for “Total Air Sample”. Thus, nematode survival
in the presence of the “Total Air Sample” seems perti-
nent to represent all bacteria synergies and individual
virulence. The “Total Air Sample” can be considered
without great sanitary risk for all healthy and non
immuno-depressed people, as each representative strain.
Thence, any environmental sample with the help of a
biocollector makes the assessment of the bacterial sani-
tary risk possible. After incubation of the softed
impacted TSA plates, the total and cultivable bacterial
population collected can directly feed the C. elegans
nematode model, whose latest death shows the good
quality and bacterial safety of the sample environment.
Conclusion
This study establishes that the outdoor air quality can
be evaluated with the help of C. elegans nematodes
alternative model for bacterial virulence aspects, even
with high concentrations of airborne bacteria. Without
the fastidious microbiological labor (isolation and bac-
terial identification), air quality can be monitored easily
with a one-shot virulence test of the collected bacterial
population obtained from a TSA plate impacted by out-
door air.
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Introduction
Pseudomonas aeruginosa tis an ubiquitous germ known as an 
important opportunistic pathogen of humans, causing a variety of 
infections among which chronic lung infections in cystic fibrosis 
patients [1-3]. Pseudomonas members are also described for their 
striking ability to adapt to various ecological niches [4]. This versatility 
requires a particularly well developed ability to adapt to changes of 
environmental conditions, to which proteins of the outer membrane 
may contribute, due to their partial exposition at the cell surface. 
Among them, OprF is one of the very few general porins [5], allowing 
non-specific diffusion of ionic species and of small polar nutrients [6]. 
OprF is also a major structural protein, anchoring the outer membrane 
to the peptidoglycan layer [7,8]. It is necessary for adaptation to various 
environments since it allows growth in low-osmolarity conditions [8], 
is over-produced in high salinity condition [9] and in ASM medium, 
which mimics the lung environment during cystic fibrosis [10]. It allows 
also the bacteria to respond to temperature variations by modulating 
the outer membrane permeability through a change in channel size 
[11]. OprF has been furthermore involved in adhesion to eukaryotic 
cells [12], and in biofilm formation under anaerobic conditions [13] 
enabling microcolonies formation [10]. Finally, we have recently shown 
that OprF is required for full virulence expression [14]. 
P. aeruginosa displays three types of motility: swimming in liquid or 
at low agar concentrations, twitching on solid surfaces, and swarming 
on semisolid media. Swimming and twitching result from the polar 
flagellum of P. aeruginosa and type IV pili, respectively, whereas 
swarming depends on both appendages and of rhamnolipids [15-17]. 
Rhamnolipids are biosurfactants composed of mono- or di-rhamnose 
linked to the lipid components 3-(3-hydroxyalkanoyloxy) alkanoic 
acids (HAAs) [18,19]. These glycolipids play a central role in swarming 
motility by acting as surface-modifying agents [20]. They can enhance 
cell surface hydrophobicity, by inducing LPS release from the outer 
membrane [21] and by adsorbing onto the cell surface [22,23], which 
can in turn modify the bacterium-substratum interactions. They affect 
biofilm formation through microcolonies formation, motility [24], 
maintaining fluid channels between mushroom-like structures [25], and 
mediating cell detachment from biofilms [26]. Recently, rhamnolipids 
have been furthermore suggested to act as protective agents of P. 
aeruginosa against polymorphonuclear leukocytes, functioning as a 
biofilm shield in vivo [27,28]. 
Since bacterial motility plays a key role in the bacterial adaptation 
to environments, especially in surfaces colonization, we further 
investigated the function of OprF in P. aeruginosa motility. In this 
study, we show that an oprF knock out leads to impaired swarming, but 
not swimming or twitching motilities, at least partly through a deep 
alteration in rhamnolipid production.
Materials and Methods
Bacterial strains and growth conditions
The strains were P. aeruginosa H103 (PAO1 prototroph), its oprF 
mutant H636 obtained by homologous recombination with an oprF 
fragment containing a streptomycin cassette [29], and H636O, which 
corresponds to H636 complemented by plasmid pRW5 (encoding 
carbenicillin resistance) consisting in the functional oprF gene from P. 
aeruginosa H103 cloned into pUCP19 [14,30]. Cultures were inoculated 
at an initial OD600 of 0.07, and bacteria were grown at 37°C on a rotary 
shaker (180 rpm) in Luria Bertani (LB) broth. In complement, 500 µg 
streptomycin mL-1 only or with 300µg carbenicillin mL-1 were added in 
H636 and H636O cultures, respectively. 
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Summary
The OprF porin is the major outer membrane protein of bacteria belonging to the Pseudomonas genus, and is 
partially exposed on the cellular surface. A study based on the comparison between P. aeruginosa H103 and its oprF-
deficient mutant led to the finding that the absence of OprF abolished swarming but not swimming and twitching 
motilities. These phenotypes were explained at least in part by the inability of the oprF mutant to produce biosurfactant 
rhamnolipids. The levels of mRNAs encoding the rhamnolipid biosynthetic enzymes RhlA and RhlB were strongly 
decreased in the absence of OprF, indicating that rhamnolipid production was impaired at the transcriptional level. We 
suggest that the presence of OprF in the outer membrane of P. aeruginosa is required for environments colonization, 
making thus OprF a serious target for limiting P. aeruginosa spreading in case of cystic fibrosis. 
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Motility assays 
These assays were essentially performed as described by Rashid 
& Kornberg [31]. Briefly, LB plates containing 0.3 % agar were point 
inoculated with a toothpick and incubated for 24 hours at 37°C. 
Swimming was quantified by measuring the circular turbid zone. The 
swarming assay was identical, except that LB plates contained 0.5 % 
agar and were incubated for 48 h. For twitching assays, cells were stab 
inoculated to the bottom of the Petri dish through a thin (~ 3 mm) LB 
agar layer (1 % agar). After incubation at 37°C for 48 h, the agar was 
removed, the Petri dish was washed with a stream of tap water, and the 
cells attached to the polystyrene surface were stained with crystal violet 
(1 % w/v) solution. Each assay was made at least in triplicate.
Phage PO4 sensitivity assay
10 μL of lysates that contain 102 plates forming units (PFU) 
of phages was mixed with 107 colonies forming units (CFU) of P. 
aeruginosa cells grown to OD600 of 0.7 and resuspended in 100μL of 
LB. After 10 min of incubation, 3mL of top agar was added, and the 
mixture was plated. Numeration of plaques was made after 16 to 24 h 
of incubation at 37°C.
Rhamnolipid quantification
 The drop-collapse test was performed as previously described 
[32]. Rhamnolipids were further extracted and analyzed by liquid 
chromatography coupled to mass spectrometry (LC/MS) as previously 
described [33].
Quantitative RT-PCR
 Extraction of RNAs, synthesis of cDNAs and real time PCR were 
achieved as previously described [9] using primers described in Table 1. 
PCR reactions were performed in triplicate and the standard deviations 
were lower than 0.15 CT. The relative quantification of the mRNAs of 
interest was obtained by the comparative CT (2-∆∆CT) method [34], using 
16S rRNA as endogenous control [35]. ∆CT values were calculated by 
subtracting the 16S rRNA CT value from the CT value of an mRNA 
of interest from the same sample. ∆CT values were then obtained by 
calculating the difference between: i) the ∆CT value of a given mRNA 
resulting from P. aeruginosa H636 cells grown to a specific stage, and ii) 
Gene sequences (5’-3’) References
rhlA F: GATCGAGCTGGACGACAAGTCR: GCTGATGGTTGCTGGCTTTC
[33]
[33]
rhlB F: GAACAGGCAGACCACGCCR: CGCATCTTCACCCAATGGAT
[33]
[33]
rhlC F: ACCGGATAGACATGGGCGTR: GATCGCTGTGCGGTGAGTT
[33]
[33]
pilA F: ATTGCCATTCCCCAGTATCAGAR: CGAAGCACCTTCCGAACG
This study
This study
fliC F: CTCGGAAAACGCTACCAACGR: GCGAAGTCGGTGTCCTTGAT
This study
This study
estA F: GGTTGGCCATGCCTTCCTR: ACGTCATTCCGTTGAACATCC
This study
This study
16S F: CAGGATTAGATACCCTGGTAGTCCACR: GACTTAACCCAACATCTCACGACAC
[35]
[35]
Table 1: Primers used in quantitative RT-PCR experiments.
 
H103                 H636           H636O              H2O
Figure 1: Drop-collapse test performed by adding 10 mL of culture 
supernatants of the indicated strains (48h) to water drops (20 mL) on glass 
slides.
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Figure 2: Expression levels of the indicated genes in the oprF mutant 
H636, relatively to P. aeruginosa H103. mRNAs were assayed by quanti-
tative RT-PCR performed on RNA extracted from H636 and H103 strains. 
Values above and below 1 show a higher and a lower mRNA level in H636 
than in H103, respectively. PCR reactions were performed in triplicate and 
the standard deviations were lower than 0.15 CT. The experiments were 
performed twice with independent bacterial cultures.
A
B
C
H103                   H636               H636O
Figure 3: Swarming (A), swimming (B) and twitching (B) motilities of P. 
aeruginosa strains H103 (wild type), H636 (oprF mutant), and H636O 
(complemented oprF mutant). 
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the ∆CT value of the same mRNA from P. aeruginosa H103 (wild type) 
cells grown to the same stage. Relative mRNA level values are equal to 
2-∆∆CT: values above and below 1 show a higher and a lower mRNA level 
in the oprF mutant H636 than in the wild type strain, respectively (eg a 
value of 0.5 indicates that the mRNA level was divided by 2 in H636).
Results
Three strains were compared in this study: the P. aeruginosa H103 
wild type strain, its oprF mutant H636, and the oprF-complemented 
mutant strain H636O. The three growth curves obtained in LB medium 
at 37°C with shaking were similar, with a doubling time of 45 min [14]. 
Swarming is altered in the oprF mutant 
The oprF mutant was unable to swarm, and the complementation of 
H636 with the oprF gene restores partially the swarming ability (Figure 
1A). Swimming and twitching were slightly but not significantly altered 
(Figure 1B & Figure 1C), suggesting that both flagella and type IV pili 
were functional. To further dissect the swarming motility deficiency 
phenotype, quantitative RT-PCR experiments were performed to 
assay the transcription level of fliC and pilA genes, encoding the main 
flagellum and type IV pilus subunits, respectively. Figure 2 showed 
that their expression were not significantly down-regulated in the oprF 
mutant compared to H103 strain. The functionality of type IV pili was 
furthermore assayed by infecting the strains with the PO4 phage, which 
uses type IV pili as receptors [36]. The three strains were similarly 
sensitive to phage PO4 (the number of lysis plates being similar), 
indicating that type IV pili were present and functional in the H636 
oprF mutant.
OprF is required for rhamnolipid production
Since swarming is depending on type IV pili, flagella and 
rhamnolipids [17], we next searched for the ability of the oprF mutant 
to produce these major biosurfactants. To achieve this rapidly, we first 
used the drop collapse test as previously described [32]. As shown 
on Figure 3, the drop spreading out in case of H103 and H636O 
suggested that biosurfactants were present. This was not the case for 
H636, suggesting a lack or a reduction in the biosurfactants amount. 
In supernatants of stationary phase cultures of the wild type strain, 
ten different ionic species, corresponding up to twelve rhamnolipids 
species, were identified by LC/MS (Table 2). Extra-cellular rhamnolipid 
production by the oprF mutant was nearly abolished: only three ionic 
species (m/z 675, 677, and 705) were detected in H636 supernatants, 
but in 25 to 50-fold lower amounts than in H103 supernatants (Table 
2). Furthermore, the non detection of the ionic species m/z 649 in H636 
supernatants indicated that Rha-Rha-C10-C10 production dropped 
more than 500 fold in the absence of OprF. We observed similar results 
when assaying rhamnolipids from supernatants of 48 and 72 h cultures 
(data not shown), thereby ascertaining that production of extra-cellular 
rhamnolipids by the oprF mutant is dramatically impaired, and not only 
delayed. The complementation of the mutation restored an efficient 
extra-cellular production of all rhamnolipid species, since their amounts 
were only 1.1 to 2.6-fold lower than in H103 supernatants (Table 2).
rhlAB expression is altered in the absence of OprF 
To investigate whether the production of extra-cellular 
rhamnolipids by the oprF mutant is impaired at the biosynthesis or 
at the secretion level, we assayed rhamnolipids from bacterial pellets. 
A defect in rhamnolipid secretion was expected to lead to higher 
rhamnolipid accumulation in H636 OprF-negative cells than in H103 
cells. This was however not the case (Table 2, intra cellular amounts), 
suggesting that the main defect occurred at the biosynthesis level. 
Mono-rhamnolipid biosynthesis specifically requires the successive 
actions of the enzymes RhlA and RhlB, encoded by the operon rhlAB 
[37,38]. Di-rhamnolipids are synthesized from mono-rhamnolipids by 
a third enzyme, the rhamnosyltransferase 2 RhlC [39]. Rhamnolipid 
production furthermore requires the autotransporter esterase EstA, 
the role of which remains unknown [40]. We therefore examined 
by quantitative RT-PCR whether the expression of these genes was 
affected in the oprF mutant. Whereas rhlC and estA mRNA levels were 
not significantly reduced in H636 mutant compared to H103 wild-
type strain, the rhlA and rhlB mRNA levels were respectively 4.6 and 
9-fold lower than in H103 (Figure 2). The down-regulation of the rhlAB 
operon seems strong enough to explain the rhamnolipid biosynthesis 
defect of the oprF mutant. 
Discussion
OprF is the major outer membrane protein, partially exposed to the 
cell surface. Our study enabled us to find evidences for the involvement 
of OprF in swarming, but not in swimming and twitching motilities. 
Transcription of fliC and pilA genes are not affected, and the sensitivity 
to phage PO4 indicates that the retraction function required for phage 
infection is maintained on the oprF mutant cell surface [16]. Taken 
together, these results suggest that flagella and type IV pili are expressed 
and functional in the oprF mutant. Since rhamnolipids are known to 
play a central role in swarming through their surfactant properties 
[20,41,42], we then focused on their production. Consistently, we found 
Rhamnolipid Ionic species* (m/z)
Extra cellular amount†
(104 Area /OD600)
Intra cellular amount‡
(104 Area /OD600)
H103 H636 H636O H103 H636 H636O
Rha-C10-C10 503 12.3 ± 1.1 ND 11.3 ± 1.9 ND ND ND
Rha-C10-C12:1 529 3.9 ± 0.2 ND 2.2 ± 0.3 ND ND ND
Rha-C12-C10
Rha-Rha-C8-C10 531 2.9 ± 0.1 ND 2 ± 0.2 ND ND ND
Rha-Rha-C10-C8 621 32.5 ± 7.4 ND 24.9 ± 5.2 ND ND ND
Rha-Rha-C8-C12:1 647 3.1 ± 0.7 ND 1.9 ± 0.1 ND ND ND
Rha-Rha-C10-C10 649 502.4 ± 14.5 ND 321.7 ± 55.4 13.2 ± 6.3 5.1 ± 2.2 41.5 ± 12.8
Rha-Rha-C10-C12:1 675 138.1 ± 18.1 3.3 ± 0.3 113.8 ± 13.7 5.5 ± 2.2 1.5 ± 0.7 16.1 ± 5.5
Rha-Rha-C10-C12,
Rha-Rha-C12-C10 677 662.9 ± 3.6 13.2 ± 1.5 257.5 ± 16.6 15.4 ± 6.3 5.6 ± 2.8 56.9 ± 19.4
Rha-Rha-C12-C12:1 703 15.6 ± 3.3 ND 12.7 ± 1.2 0.9 ± 0.5 0.8 ± 0.1 3.7 ± 1.4
Rha-Rha-C12-C12 705 42.9 ± 25.2 1.7 ± 0.2 18.7 ± 1.5 2.9± 0.2 1.7 ± 0.1 5.3 ± 1.7
Total amount of rhamnolipids 1416.7 ± 74.2 18.2 ± 2 766.8 ± 1.5 37.9 ± 15.5 14.7 ± 5.9 123.5 ± 40.8
Table 2: Rhamnolipid amounts produced by P. aeruginosa H103, H636 and H636O grown to stationary phase in LB medium. ND: values not detected. Threshold: <0.8 x 
104 Area/OD600. *Ionic species leading to LC/MS peaks.† Rhamnolipids assayed from culture supernatants. ‡ Rhamnolipids assayed from cell pellets. †,‡ The LC/MS peak 
surface areas were divided by the OD600 values of the cultures. Each value is the average of three independent experiments.
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that the rhamnolipid production is nearly abolished in the oprF mutant, 
which likely explains the swarming motility defect. Rhamnolipid 
biosynthetic genes were shown to be essential (rhlA) or important 
(rhlB) for P. aeruginosa swarming [15,20,24,37]. The roles of HAAs 
(3-3-hydroxyalkanoyloxy alkanoic acids), mono-rhamnolipids and 
di-rhamnolipids, synthesized by RhlA, RhlB and RhlC, respectively, 
were dissected: di-rhamnolipids and HAAs serve as attractant and 
repellents, respectively, while mono-rhamnolipids act as wetting agents 
[42]. The impairment in rhamnolipid production of the oprF mutant 
could therefore explain its inability to swarm. However, restoration of 
the swarming phenotype was incomplete in the complemented mutant 
whereas rhamnolipid production reached near wild type levels. This 
indicated that the lack of rhamnolipid might not be the only cause of 
the swarming defect in the oprF mutant. Alternatively, swarming might 
require a rhamnolipid overproduction, which might not be achieved 
properly in the complemented oprF mutant. 
In the oprF mutant, rhamnolipids did not accumulate intra-
cellularly at higher levels than in the wild type strain, indicating that 
the production is impaired at the biosynthesis level rather than at the 
secretion level. This impairment can be at least in part explained by 
lower levels of rhlAB mRNAs, suggesting an involvement of OprF in 
the rhlAB expression, which is already known to depend on a complex 
regulatory network [43]. Transcription of the rhlAB operon is under 
the direct control of the RhlR-RhlI quorum sensing (QS) system 
and of its cognate autoinducer molecule, N-butyryl-L-homoserine 
lactone (C4-HSL) [44-47] which is itself regulated by the LasR-LasI 
system, encoding the N-(3-oxododecanoyl)-L-homoserine lactone 
auto inducer, (3OC12-HSL) [48,49], and the MvfR-PQS (Pseudomonas 
Quinolone Signal) /HHQ (4-hydroxy-2-heptylquinoline) system [48]. 
We showed recently that QS molecule production was altered in the 
H636 oprF mutant since the amounts of 3OC12-HSL and C4-HSL were 
reduced or delayed, respectively, while that of HHQ was increased [14]. 
It is thus possible that these alterations in QS molecule production 
contribute to the observed decrease in rhlAB transcription. 
It is unclear whether OprF plays a direct and/or indirect role in the 
observed phenotypes. The importance of OprF in stabilizing the outer 
membrane and maintaining the integrity of the cell wall of P. aeruginosa 
has been previously described [7,8,14,29]. A possibility is that the 
lack of OprF can change the cell surface and the composition of the 
outer membrane. Based on these considerations, the alteration of the 
QS and rhamnolipid production could be due to major modifications 
of the cell wall. The alternative possibility that the absence of OprF 
impairs the observed phenotypes by other means than outer membrane 
disorganization cannot be disregarded, considering the major role of 
OprF in binding interferon g and activation of the QS network [50]. 
OprF has been indeed suggested as an environmental outer membrane 
sensor, perceiving variations of its micro environment, and transmitting 
or transducing an unknown signal leading to QS activation [14,51]. 
Whatever the mechanisms involved linking OprF and rhamnolipid 
production, it is clear that the presence of OprF in the outer membrane 
of P. aeruginosa is required for environments colonization, making thus 
OprF a serious target for limiting P. aeruginosa spreading in case of 
cystic fibrosis. 
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Introduction
Surfactants are amphipathic molecules, which are particularly 
well adapted to distribution at interfaces between solids, liquids or 
even vapour [1]. These properties were at the origin of their multiple 
industrial applications in petroleum production, environmental 
control, food transformation, agriculture, pharmaceuticals and 
cosmetics [2,3]. 
Surfactants can be obtained by chemical synthesis but a great 
variety of microorganisms are also able to produce such molecules 
designated in this case as biosurfactants. The chemical nature and 
surface-active properties of biosurfactants are highly variable. 
Although the competitive advantage of biosurfactant production for 
microorganisms still remains unanswered, there is now ample evidence 
that these molecules are essential for survival, host-interactions 
and growth in many bacterial species [4,5]. These molecules should 
increase the bioavailability of hydrophobic water-insoluble substrates 
and improve heavy metal binding. Through this process, biosurfactants 
are involved in bacterial pathogenesis and quorum sensing [6-7]. As 
environmental bacteria need to adapt rapidly to variations of their 
growth conditions [8], the production of biosurfactant is important in 
these species. This is particularly the case in the Pseudomonas genus, 
which is one of the most ubiquitous bacterial groups. In the present 
study, we focused on nine environmental Pseudomonas strains isolated 
from plants and the rhizosphere. All these bacteria have been shown to 
produce cyclolipopeptides (CLPs) as biosurfactants [7-15]. In literature, 
CLPs are described as being involved in attachment at the surfaces, 
inert or green, in motility, and in pathogenicity [7-8]. This last point is 
essential since it appears now that for clinical strain isolates virulence 
depends on CLP production [7,16-18]. Biosurfactant synthesis is well 
documented in Pseudomonas [7-8], but it is remarkable that, until now, 
the influences of the growth temperature of Pseudomonas fluorescens 
on biosurfactant production and physico-chemical properties have 
not been investigated in detail. The production of exoproducts in these 
species is also a temperature dependent process. 17°C is known as the 
optimal growth temperature for many exoproducts synthesized by 
psychrotrophic Pseudomonas [19-22]. As amphiphilic exo-products, 
biosurfactants appear to play a role whenever a microbe encounters 
an interface, inert or living one. The results of these adaptation 
mechanisms could be adhesion, biofilm formation, quorum sensing 
and any response to environmental change [6]. All the knowledge on 
biosurfactant production in Pseudomonas should therefore be carefully 
reanalyzed taking into consideration this thermal parameter. In the 
present study, we investigated the influence of growth temperature 
on biosurfactant production at two key temperatures, 8°C and 17°C. 
The lower one corresponds to the temperature frequently used in 
cold storage conditions while the higher one represents the optimal 
growth temperature for many exoproducts. After sorted out genetically 
the studied Pseudomonas fluorescens strains, the decrease of surface 
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Summary
The present study deals with the influence of growth temperature on biosurfactant production and the adhesion 
process in the psychrotrophic species Pseudomonas fluorescens. We studied a strain panel composed of nine wild 
cyclolipopeptide (CLPs) producers and by two biosurfactant mutants. Where cyclolipopeptide production was charac-
terized at either 8°C or 17°C, cyclolipopeptide production was highlighted by hemolytic and tensiometric methods. Their 
ionic charge was evaluated by a double diffusion test and their identification was made as amphisin- or viscosin- or 
viscosinamide-like biosurfactants by Reverse Phase- High Performance Liquid Chromatography- Mass Spectroscopy. 
This categorization was corroborated by the 16S rRNA phylogenetic study. In Pseudomonas fluorescens, the number 
and relative quantity of cyclolipopeptide produced and bacterial adhesion differed with the growth temperature. Seven 
new cyclolipopeptides were characterized, of which three belong to the viscosinamide family. Biosurfactant secretion 
is intensive at 17°C and the highest adhesion is obtained at a lower temperature (8°C). Cyclolipopeptides appeared to 
antagonize the adhesion process. Strain hydrophobicity was wholly independent of growth temperature and could not 
be correlated with the initial attachment of bacteria, which was thermoregulated. Our study demonstrates that bacterial 
adhesion is controlled by the growth temperature but not by cyclolipopeptides or cell hydrophobicity.
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tension is verified and reveals biosurfactant production. Their ionic 
characterization and the hemolytic bacterial behaviour are compared 
to the RP-HPLC/MS identification and then afford the proposal of a 
rapid CLP identification. The biosurfactant production could modify 
the bacterial surfacial properties and, thence, its adaptative potential 
in their microenvironment. Biosurfactant production are discussed in 
regard to the consequence of the growth temperature on the adhesive 
behaviour of P. fluorescens.
Materials and Methods
Bacterial strains
P. fluorescens PfA7B is a pathogenic strain of broccoli isolated 
from inflorescence. P. fluorescens Pf1vis- is a Tn5 kmr viscosin mutant 
of PfA7B [13]. These two strains were provided by Dr G. Braun 
(Agriculture & Agri-Food, Canada). P. fluorescens DSS73, a strain 
from sugar beet rhizospheric environment, and its kmr amsY::tn5 
amphisin mutant, P. fluorescens DSS73-15C2 [23], were also graciously 
provided by Dr O. Nybroe (Royal Veterinary & Agricultural University 
– Thorvaldsensvej, Denmark). Other strains of P. fluorescens, namely 
CTS22, CTS38, CTS50, CTS70, CTS117, CTS193 [11] and DR54 [10] 
were gifts from Dr T.H. Nielsen (Royal Veterinary & Agricultural 
University, Denmark). They had been isolated from Danish fallow or 
sugar beet fields. Both Danish fields have sandy and loamy soils.
Growth conditions and biosurfactant collection 
The bacterial cultures were grown at 8°C and 17°C in Davis 
minimal media (DMM: 30 mmol.L-1 K2HPO4, 14 mmol.L-1 KHPO4, 0.4 
mmol.L-1 MgSO4, 7.6 mmol.L-1 (NH4)2SO4, 120 mmol.L-1 glucose, and 
1 mL of trace element solution per litre (pH 7.3). The trace element 
solution per litre contained 20 mg of CoCl2.6H2O, 30 mg of H3BO3, 10 
mg of ZnSO4.7H2O, 1 mg of CuCl2.2H2O, 2 mg of NiCl2.6H2O, 3 mg 
of NaMoO4.2H2O, 10 mg of FeSO4.7H2O, and 2.6 mg of MnSO4.H2O). 
15g.L-1 agar was added to obtain a solid medium DMA. The glucose 
and trace elements were sterilized separately by filtration (Steriltop, 
Millipore, France) and aseptically added to the rest of the medium. 
Plates were inoculated with 40μL of a stock strain suspension. To 
collect the potential biosurfactant production, the bacterial colonies 
were carefully scraped off after 4 days incubation at either 8°C or 17°C 
and resuspended in 15mL natural mineral water. This suspension 
was centrifuged 18000g at 4°C for 30 min. The rinsing solution 
corresponded to the obtained supernatant.
Phylogenetic study
The 16S rRNA sequences of the biosurfactant producing strains 
were sequenced in double stranded by Cogenics Genome Express 
(Meylan, France). The sequences were deposited in the Genbank 
database under Accession Numbers indicated in Figure 1 and Table 1.
The 16S rRNA sequences of the Pseudomonas type strains used for 
phylogenetic analyses were retrieved from the Ribosomal Database 
Project (http://rdp.cme.msu.edu/index.jsp). The 16S rRNA sequences 
of the P. fluorescens SBW25 and Pf0-1 strains were retrieved from 
the Pseudomonas Genome Database (http://v2.Pseudomonas.com). 
All the sequences were aligned using Clustal X version 1.81 with 
default parameters [26]. The alignment was truncated to the same size 
corresponding to the shortest sequence (positions 119 to 1368 in the E. 
coli numbering system). All ambiguous positions and positions with 
gaps were removed. A neighbour-joining tree was inferred using the 
Kimura-two-parameter correction with MEGA v3.0 [27]. A maximum 
likelihood analysis was performed using fastDNAml based on the 
HKY model with PhyloWin v2.0 [28]. The degree of statistical support 
for the branches was determined with 1000 bootstrap replicates for 
the neighbour-joining analysis or 100 bootstrap replicates for the 
maximum likelihood analyses.
Hemolysis activity test
Hemolysis has been described as a potential indirect method to 
demonstrate surfactant production [29]. In this test, each bacterial 
strain was streaked onto a 2% sheep red blood cell plate and incubated 
for 48h at 8°C or 17°C. The plates were visually inspected for zones of 
clearing around the colonies, indicative of biosurfactant production. 
Surface tension measurement
Surface tension measurement of a rinsing solution of bacteria 
cultured on solid agar medium is a direct method for determining global 
biosurfactant production. In this study, the rinsing solution, obtained 
as described in paragraph Growth conditions and biosurfactant 
collection, was filtered through 0.22µm filters (Steritop, Millipore, 
France) and the fluid containing the biosurfactants was collected. The 
surface tension of the filtered solution was determined by the direct 
method of the pendant drop using a G40 goniometer (Krüss, France). 
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Figure 1: Phylogenetic relationships among 16S ribosomal RNA genes from 
the panel strain and 28 Pseudomonas type strains. 
The nine biosurfactant-producing strains, the two biosurfactant negative mu-
tants, SBW25 and Pf0-1 strains are in bold print. The unrooted dendrogram 
was carried out using the Neighbour-Joining algorithm. Numbers on tree 
branches report bootstrap results from Neighbour-Joining (above branch) 
and Maximum Likelihood (below branch) analyses for those branches having 
≥50% support. A and B are two distinct phylogenic groups in P.fluorescens 
r-cluster.
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This method is based on the principle that the drop morphology at the 
apex, where it is totally independent of any contact, is correlated to 
the surface tension of the studied liquid. The surface tension can be 
calculated as the difference of pressure between the inside of the liquid 
and its environment divided by the sum of the inverse of the radius of 
the curvature of the drop.
Determining the ionic charge of biosurfactants
The ionic charge of biosurfactants was determined using the agar 
double diffusion technique adapted from Meylheuc [24]. Briefly, in 
these studies two regularly spaced rows of wells (10 mm diameter) were 
made in a low hardness agar Petri dish (1% agar). Wells in the lower 
row were filled with the rinsing solution. Each well in the upper row 
was filled with a pure compound of known ionic charge. The reference 
anionic substance selected was sodium dodecylsulphate (SDS) 20 
mmol.L-1. The cationic compound was cetyltrimethylammonium 
bromide (CTAB) 20 mmol.L-1. Appearance of a precipitation line 
between the wells, indicative of the ionic character of the biosurfactant, 
was monitored for at least one week, at room temperature.
RP-HPLC / MS analysis of biosurfactants
The biosurfactants were analyzed by reverse-phase high 
Strains Access Number
Hemolysis activities onto 2% sheep red 
blood cell plate and incubated for 48 h Surface tension+/-STD mN/m Ionic charge of the rinsing solution
Growth at 8°C Growth at 17°C Growth at 8°C Growth at 17°C Growth at 8°C Growth at 17°C
PfA7B
GQ334362
β ++  β ++ 27.0+/-0.0 26.7+/-0.0 anionic anionic
Pf1 vis- - - 71.2+/-0.1 60.9+/-0.7 non ionic non ionic
CTS38 GQ334368  β +  β + 63.8+/-1.2 31.1+/-0.3 anionic anionic
CTS50 GQ334367  β ++  β + 27.5+/-0.1 27.2+/-0.1 anionic anionic
CTS117 GQ334368  β ++  β ++ 35.9+/-0.7 29.6+/-1.1 anionic anionic
DR54 GQ334370  β +  β + 38.2+/-0.9 34.6+/-1.4 non ionic non ionic
DSS73
GQ334363
α + α + 32.1+/-0.9 33.2+/-0.1 anionic anionic
DSS73-15C2 - - 69.8 +/-0.9 70.8+/-0.3 non ionic non ionic
CTS22 GQ334364 α + α + 57.1+/-2.3 33.2+/-0.2 anionic anionic
CTS70 GQ334365 α + α + 31.4+/-0.1 30.1+/-0.0 anionic anionic
CTS193 GQ334369 α + α + 37.6+/-1.4 35.2+/-0.1 anionic anionic
Table 1: Registration number of sequenced 16S rRNA fragments and surfactant production evaluated by hemolytic phenotype, surface tension and ionic charge of the 
bacterial rinsing solution for the 11 strains.
Hemolysis on plate at 8°C and 17°C was realized as described in materials and methods. a corresponds to opaque lysis areas and b to transparent lysis areas. - : absence 
of clearing zone; + : lysis area≤1mm; ++: lysis area > 1mm. Surface tension of bacterial rinsing was determined as indicated in materials and methods at either 8°C or 17°C 
after four days (triplicate). The ionic charge determination was made with the rinsing solution of bacteria grown at either 8°C or 17°C as described in materials and methods.
Strains
Number of HPLC peaks Molar mass (g.mol-1) Retention time (min)
Growth at 8°C Growth at 17°C Growth at 8°C Growth at 17°C
PfA7B 2 2
1111.7 24.0+/-0.7 24.2+/-0.0
1125.7 28.5+/-0.9 28.7+/-0.0
Pf1 vis- 0 0 ND ND ND
DSS73 1 1 1394.8 16.0+/-0.6 16.0+/-0.6
DSS73-15C2 0 0 ND ND ND
CTS22 1 1 1353.8 16.2+/-0.6 16.0+/-0.5
CTS38 2 4
1111.6 ND 22.2+/-0.5
1125.7 25.1 +/-0.6 26.2+/-0.7
1151.6 ND 34.8+/-0.4
1153.7 36.9+/-0.5 38.0+/-0.0
CTS50 3 5
1111.6 22.1+/-0.8 22.0+/-0.5
1125.6 26.2+/-1.5 26.5+/-0.4
1139.6 31.0+/-1.0 31.0+/-1.0
1165.4 ND 38.0+/-0,9
1167.6 ND 41.1+/-1.1
CTS70 2 2
1394.8 15.7 +/- 0.3 15.7+/-0.3
1408.5 16.8 +/-0.5 16.8+/-0.5
CTS117 2 2
1111.7 21.2+/-0.6 21.1+/-1.0
1125.7 24.9+/-0.9 24.5+/-0.8
CTS193 1 1 1408.9 13.8+/-0.8 13.8+/-0.4
DR54 6 6
1110.7 45.5 +/-0.7 45.4+/-0.6
1124.7 46.9+/-0.4 46.9+/-0.4
1110.7 47.3+/-0.5 47.3+/-0.4
1124.7 48.7+/-0.4 48.8+/-0.4
1150.5 53.7+/-0.5 53.7+/-0.3
1152.6 57.0 +/- 0.5 56.9+/-0.3
Table 2: Biosurfactant characterization by HPLC for the nine wild strains grown at 8°C and 17°C
HPLC was done for biosurfactants produced by the wild strains as described in materials and methods. ND means not detected. The experiments were done in triplicate.
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performance liquid chromatography (RP-HPLC) coupled to mass 
spectrometry (MS) using a method adapted from Morin [25]. Before 
analysis the rinsing solutions were diluted at 50% in a water/acetonitrile/
ammonium acetate mixture 10:90:4. An Agilent Technologies Series 
1100 vacuum degasser, LC pump and autosampler (Hewlett Packard, 
Germany) were used. 20µL of the sample were injected into an 
analytical C18 reverse-phase column (Hypersil ODS, 2.1 x 200 mm, 
5 µm). The samples were first submitted for 4 min to an isocratic 
separation protocol using a water-acetonitrile-ammonium acetate 
mixture (65:35:4, Solution A), followed by a linear gradient from 0 to 
27.3% in 5 min of Solution B consisting of a water-acetonitrile mixture 
(50:50, v/v). The percentage of Solution B was kept constant for 11 
min to allow separation of biosurfactants in isocratic conditions. The 
column was then rinsed by a gradient of Solution B ranging from 27.3 
% to 100% for 35 min. The flow (0.4mL.min-1) was split (1/10) using 
a micro-splitter valve (Upchurch Scientific, USA) turned towards the 
detector. The separated compounds were detected by positive-ion 
electrospray ionization and ion trap mass spectrometry using a Bruker 
Esquire-LC ESI-MS/MS (Bruker Daltonic, Germany). The relative 
proportions of CLPs produced at 8°C and 17°C was estimated by peak 
area divided by the smallest observed area. This was applied for each 
chromatogram from the different strains of P. fluorescens.
The absence of rhamnolipids was verified by parallel HPLC analysis 
as described by Morin [41]. 
Adhesion assays
Adhesion assays were adapted from the biofilm formation 
assay described by O’Toole [30]. The adhesion test corresponded 
to an incubation period not exceeding one generation time. Thus 
only the adhesion inherent in the bacterial contact on the inert 
surface was taken into account without any disruption to the growth 
phenomenon. In triplicate, for each strain, three independent DMM 
culture were adjusted to an OD580nm of 0.4. An aliquot of 100μL of 
each suspension was layered in triplicate in polystyrene micro titration 
plate. To determine of the adhesive ability, bacteria were incubated in 
static condition for 24h at 8°C and 4h at 17°C. The negative control 
consisted in sterile DMM. After removal of the bacterial solution 
and careful rinsing (x3 in 150µL sterile water) bacteria bound to the 
wells were stained by incubation for 30 min with 0.1% crystal violet. 
After rinsing three times with 150µL sterile water, remaining adherent 
bacteria were lysed by adding 100µL SDS (1% in sterile water). The 
adherent bacterial population was estimated by direct measurement 
of absorbance at 595 nm using a microtitration plate reader (Model 
680XR, Biorad). To compare of the results, data were normalized as 
percentage of adhesion ability using as a reference the strain giving 
the median value in the whole study (i.e. PfA7B grown at 8°C). Results 
were normalized as percentage of the median value corresponding to 
the adhesive capability of PfA7B at 8°C. The Mann-Withney test was 
used to evaluate statistical significance between values.
Evaluation of bacterial surface hydrophobicity
The hydrophobicity of strains was evaluated by the microbial 
adhesion to solvent (MATS) test. It consisted in evaluating the affinity 
of the cells to apolar solvents (hexadecane). For the experiments, 
bacterial cells were carefully scraped off after 4 days at either 8°C 
or 17°C and resuspended in saline solution, then were harvested by 
centrifugation at 7000 g for 10 min and resuspended to Abs580 nm=0.4 
(Abs1) in saline solution. Three rinsing, then centrifugation steps, 
were done to eliminate any residual CLP before evaluating the cell 
affinity for hexadecane. This bacterial suspension was mixed with a 
solvent at 1:6 (0.4 :2.4 v/v) by vigorous agitation for 1 min in order 
to form an emulsion. This mixture was then left for at least 15 min 
Group molar mass (g/mol) CLP lipidic tail AA1 AA2 AA3 AA4 AA5 AA6 AA6 AA8 AA9 AA10 AA11
1110.7 Pseudodesmin B C10H19O3 L-Leu D-Gln D-allo-Thr D-Val D-Leu D-Ser L-Leu D-Ser L-Val
Massetolide E C10H19O2 L-Leu D-Glu D-allo-Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Val
1111.7 Massetolide I C10H19O3 x-Leu x-Glu x-Thr x-Abu x-Leu x-Ser x-Leu x-Ser x-Ile
Massetolide J C10H19O4 x-Nva x-Glu x-Thr x-Val x-Leu x-Ser x-Leu x-Ser x-Ile
1124.7 Pseudodesmin A C10H19O2 L-Leu D-Gln D-allo-Thr D-Val D-Leu D-Ser L-Leu D-Ser L-Ile
Viscosinamide C10H19O2 L-Leu D-Gln D-allo-Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Ile
Viscosin C10H19O2 L-Leu D-Glu D-allo-Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Ile
Massetolide F vC10H19O3 L-Leu D-Glu D-allo-Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Leu
1125.7 Massetolide L C10H19O4 L-Leu D-Glu D-allo-Thr D-Ile D-Leu D-Ser L-Leu D-Ser L-Val
Massetolide K C10H19O5
x-cyclopro-
pAla x-Glu x-Thr x-Ile x-Leu x-Ser x-Leu x-Ser x-Val
Viscosin-like CLP WLIP C10H19O6 L-Leu D-Glu D-allo-Thr D-Val D-Leu D-Ser L-Leu D-Ser L-Leu
Massetolide A C10H19O7 L-Leu D-Glu D-allo-Thr D-allo-Ile L-Leu D-Ser L-Leu D-Ser L-Ile
1139.7 Massetolide D C10H19O8 L-Leu D-Glu D-allo-Thr D-allo-Ile L-Leu D-Ser L-Leu D-Ser L-Leu
Massetolide G C10H19O9 L-Leu D-Glu D-allo-Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Ile
Pseudophomin A C10H19O10 L-Leu D-Glu D-allo-Thr D-Ile D-Leu D-Ser L-Leu D-Ser L-Ile
1153.8 Massetolide B C11H21O2 L-Leu D-Glu D-allo-Thr D-allo-Ile L-Leu D-Ser L-Leu D-Ser L-Ile
Massetolide H C12H23O2 L-Leu D-Glu D-allo-Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Ile
1167.6 Massetolide C C12H23O2 L-Leu D-Glu D-allo-Thr D-allo-Ile L-Leu D-Ser L-Leu D-Ser L-Ile
Pseudophomin B C12H23O3 L-Leu D-Glu D-allo-Thr D-allo-Ile D-Leu D-Ser L-Leu D-Ser L-Ile
1353.8 Lokisin C10H19O2 D-Leu D-Asp D-allo-Thr D-Leu D-Leu D-Ser L-Leu D-Ser L-Leu L-Ile L-Asp
Amphisin-like CLP 1394.8 Amphisin C10H19O2 D-Leu D-Asp D-allo-Thr D-Leu D-Leu D-Ser L-Leu D-Gln L-Leu L-Ile L-Asp
1408.8 Tensin C10H19O2 D-Leu D-Asp D-allo-Thr D-Leu D-Leu D-Ser L-Leu D-Gln L-Leu L-Ile L-Glu
Hordersin C10H19O3 x-Leu x-Asp x-Thr x-Leu x-Leu x-Ser x-Leu x-Gln x-Leu x-Ile x-Glu
Table 3: Already published CLP structures, adapted from literature [7-8,11,33-35]. A An means amino-acid number n.
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until the separation of the two phases. The aqueous phase absorbance 
was measured (Abs2) and the percentage of adhesion was expressed as: 
%affinity = (1-Abs2/Abs1) x100.
Results
Phylogenetic classification of the different strains of P. 
fluorescens 
The Accession Numbers of the sequenced 16S rRNA genes obtained 
from the 9 selected environmental strains of P. fluorescens and the two 
mutants, namely PfA7B, Pf1vis-, DSS73, DSS73-15C2, CTS22, CTS38, 
CTS50, CTS70, CTS117, CTS193 and DR54, was compiled in Table 1. 
A phylogenetic analysis was carried out with the 16S rRNA genes of 
our 11 studied strains, the sequences of the Pseudomonas (sensu stricto) 
type strains close to our sequences and the sequences of the SBW25 and 
Pf0-1 strains. According to the study of Bodilis [31], it was possible on 
Figure 1 to distinguish three clusters termed aeruginosa, putida and 
fluorescens r-clusters. The 11 strains appeared distributed in 2 distinct 
groups in the fluorescens r-cluster. Six strains, PfA7B, its viscosin 
mutant Pf1vis-, CTS38, CTS50, CTS117 and DR54 were associated with 
the reference strain of P. fluorescens SBW25 in a first group, Group A. 
The second one, Group B was clearly separated from the others. It was 
represented by the strains DSS73, its amphisin mutant DSS73-15C2, 
CTS193, CTS70 and CTS22.
Hemolytic activity of the different strains of P. fluorescens 
The 11 selected strains of P. fluorescens were tested for their 
hemolytic activity (Table 1). Blood agar lysis was observed with all 
strains after 4 days of incubation at either 8°C or 17°C except with 
the viscosin and amphisin mutants Pf1vis- and DSS73-15C2. Two 
types of clearing zones, characterized by opaque or transparent lysis 
areas corresponding to α- and β- hemolytic activity, respectively, were 
observed. Hemolytic activity results to pores formation on red blood 
cell. α-hemolytic activity reveals incomplete lysis, β-hemolysis resulting 
from complete lysis [18]. It was then possible to classify the strains into 
three phenotypes: non-hemolytic strains ( Pf1vis- and DSS73-15C2), 
α-hemolytic strains (DSS73, CTS22, CTS70 and CTS193) and β- 
hemolytic strains (PfA7B, CTS38, CTS50, CTS117 and DR54). 
Effect of the temperature on the surface tension of the 
rinsing solution from the culture of the different strains of 
P. fluorescens
We measured the effect of temperature on the surface tension 
of the rinsing solution from the culture of the different strains of P. 
fluorescens. The surface tension value of poorly mineralized water is 
71.7mN.m-1 and, as described by Carrillo [32], the limit tension value 
indicative of the presence of biosurfactant in solution is 40 mN.m-1. For 
the 11 strains of P. fluorescens presently studied, the surface tension 
of their rinsing solution was compiled in Table 1. When bacteria were 
grown at 8°C, seven wild bacterial strains, i.e, PfA7B, DSS73, CTS50, 
CTS70, CTS117, CTS193 and DR54, should be considered as surface-
active producers since the surface tension of their rinsing solution was 
below 40 mN.m-1. As logically expected, the two mutants Pf1vis- and 
DSS73-15C2 appeared negative for biosurfactant production. The two 
strains, CTS22 and CTS38, were also negative when grown at 8°C, but 
when the culture conditions were modified to a higher temperature 
(17°C), the production of biosurfactant was apparently stimulating. 
Except the mutants Pf1vis- and DSS73-15C2 that remained negative, 
all the wild strains of P. fluorescens produced a rinsing solution which 
showed surface tension under 40 mN.m-1.
Effect of the temperature on the ionic charge of the rinsing 
solution from the culture of the different strains of P. 
fluorescens
For the 11 strains of P. fluorescens presently studied, the ionic 
charge of their rinsing solution was presented in Table 1. Eight wild 
strains, i.e. PfA7B, DSS73, CTS22, CTS38, CTS50, CTS70, CTS117 and 
CTS193, produced an anionic rinsing solution, while DR54 and the two 
mutants had a non ionic rinsing solution at 8°C and 17°C.
Effect of the temperature on biosurfactant production by the 
different strains of P. fluorescens 
Rinsing solutions from the 11 strains of P. fluorescens cultured 
at either 8°C or 17°C were analyzed by HPLC. The chromatogram 
analysis gave three exploitable data: number of peaks and, for each 
peak, its molar mass and its retention time. All data were compiled 
in Table 2. For all of the nine wild strains, the chromatogram revealed 
at least one peak for each strain, unlike non-biosurfactant producer 
mutants, Pf1vis- and DSS73-15C2. These peaks could be indicative 
of the biosurfactant presence. After growth at 8°C, the detected 
compounds produced by the wild strains, with similar molar mass and 
retention time, were found as after incubation at 17°C, except for two 
wild strains, CTS38 and CTS50. They respectively produced two and 
three exoproducts at 8°C instead of four and five after growth at 17°C. 
The molar mass of these putative biosurfactants ranged from 1110.7 
to 1408.5 g.mol-1, as expected for cyclolipopeptides (CLPs), such as 
viscosin-like, and amphisin-like CLPs. To help in their identification 
(and according to our current knowledge), we compiled in Table 3 
previously published CLPs with similar molar mass. These observed 
values are related to two CLP families cited above. Table 4 listed, by 
strain and for each related HPLC peak, its abundance in the rinsing 
solution obtained at either 8°C or 17°C. 
In the rinsing solution obtained at either 8°C or 17°C from PfA7B, 
two CLPs were detected corresponding to a major peak with a molar 
mass of 1125.7g.mol-1 and 1111.7g.mol-1. The presence of Gln as amino 
acid in position 2, determined by mass spectroscopie (MS) –m/z: 
843.2 and 714.4-, and the anionic charge of the molecule allowed us 
to identify the major peak as viscosin. The second peak was tentatively 
identified as massetolide E owing to the existence of CLP isoforms that 
can skew a precise identification of this molecule.
Strain DSS73 produced a more hydrophilic biosurfactant of 
1394.8g.mol-1 with amphisin-like characteristics. Determining the 
anionic charge of this compound and MS spectrum confirmed its 
identification as amphisin. 
Strain CTS22 was also found to produce a biosurfactant that was 
rapidly characterized as lokisin (1394.8g.mol-1) by its hydrophobicity, 
mass and anionic charge. In fact, the Asp and Gln residue conferred an 
anionic charge to amphisin.
As observed with PfA7B, strain CTS38, grown at 8°C, was found 
to produce two biosurfactant molecules related to the viscosin family. 
The same molecules are identified at 17°C, plus two new ones, whose 
structure appeared rather similar. MS analysis of the molecule eluting 
at 25.1 ± 0.6 min did not make it possible to distinguish between 
possible viscosin diastereoisomers or very close isomers of a same 
mass differing by only one amino-acid inversion between Leu or Ile. 
This molecule should correspond either to massetolide F or to a new 
molecule designated 1 with a primary structure of C10H19O2-Leu/
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Ile-Glu-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Leu/Ile). The second CLP 
generated at 8°C by CTS38 was identified as massetolide H. This 
molar mass corresponded to two CLPs: massetolide B or massetolide 
H, differing in their lipophilic tail (Table 3). The two MS peaks –m/z: 
714.5 and 843.4- showed up as massetolide H. CTS38 only produced 
two CLPs at 8°C, yet 4 different biosurfactants were found at 17°C. In 
addition to the two previously identified molecules as massetolide F or 
1 and massetolide H, a peak corresponding to 2 also detected at 8°C 
in strains CTS50 and CTS117, was identified in the rinsing solution of 
CTS38 grown at 17°C. Three CLPs were known with an identical molar 
mass and they were identified as massetolide E, I and J. Each time only 
one amino acid differs from viscosin’s amino-acid sequence (Table 
3). The MS common intense peaks: 829.5, 700.5 and 518.3 eliminated 
the possibility of massetolide I and J. In addition, massetolide E was 
already attributed to PfA7B as a co-exoproduct. The structure of 
2 may be presumed similar to 1 structure, with the replacement of 
amino acid 9 Val to Ile/Leu. Moreover, another new CLP named 6 was 
investigated. The structure study assumed the change in amino-acid 
1, Leu, by its cyclic analogue, cyclopropylalanine. The MS peak, m/z 
728.4, confirmed the lactone ring described for massetolide H. The 
putative structure of 6 could be proposed as C12H2302-cyclopropAla-
Glu-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Leu/Ile).
The analysis of biosurfactants generated by strain CTS50 was more 
complex since it was found to produce three forms of CLPs. The first 
one eluted at 22.1 ± 0.8 min, for a growth temperature of 8°C, and did 
not correspond to previously identified CLPs. The proposed structure 
of this molecule designated as 2 is C10H19O2-Leu/Ile-Glu-(Thr-Val-
Leu/Ile-Ser-Leu/Ile-Ser-Val). Moreover, the second peak eluted at 
26.2 ± 1.5 min corresponded to a CLP whose characteristics were very 
similar to the molecule produced by strain CTS38 and designated 
as 1 or massetolide F. The last compound, with a more hydrophobic 
character had a molar mass of 1139.6g.mol-1 corresponding potentially 
to massetolide A, D or G or to pseudophomin A as indicated in Table 
Strains Molar mass (g.mol-1) CLP Putative structure HPLC normalized peak aera
Growth at 8°C Growth at 17°C
PfA7B 1111.7 Massetolide E* - 199 535
1125.7 Viscosin - 1100 2569
DSS73 1394.8 Amphisin - 141 2
CTS22 1353.8 Lokisin - 1 72
1111.6 2 or Massetolide E  For 2 C10H19O2-Leu/Ile-Glu-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Val) 0 26
CTS38 1125.7 1 or Massetolide F For 1 C10H19O2-Leu/Ile-Glu-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Leu/Ile) 24 303
1151.6 6 For 6 C12H23O2-cycloproAla-Glu-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Leu/Ile) 0 33
1153.7 Massetolide H - 17 288
1111.6 2 or Massetolide E  For 2 C10H19O2-Leu/Ile-Glu-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Val) 12 37
1125.6 1 or Massetolide F For 1 C10H19O2-Leu/Ile-Glu-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Leu/Ile) 149 214
CTS50 1139.6
Massetolide A or Mas-
setolide G or Pseudopho-
min A
- 750 556
1165.4 7 at least the lactone ring (Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Leu/Ile) 0 5
1167.6 Massetolide C or Pseudo-phomin B - 0 4
CTS70 1394.8 Amphisin - 2 21
1408.5 Tensin - 43 111
CTS117 1111.7 2 or Massetolide E  For 2 C10H19O2-Leu/Ile-Glu-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Val) 18 57
1125.7  1 or Massetolide F For 1 C10H19O2-Leu/Ile-Glu-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Leu/Ile) 21 614
CTS193 1408.9 Hodersin - 1 2
1110.7 3 or Pseudodesmin B For 3 C10H19O2-Leu/Ile-Gln-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Val) 276 184
1124.7 3 or Pseudodesmin B and Viscosinamide - 11 49
1110.7 - 14 41
1124.7 Viscosinamide - 1255 2244
DR54 1150.5 4 For 4 C12H23O2-cycloproAla-Gln-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Leu/Ile) 8 25
1152.6 5 For 5 C12H23O2-Leu/Ile-Gln-(Thr-Val-Leu/Ile-Ser-Leu/Ile-Ser-Leu/Ile) 14 48
* tentatively
Table 4: CLP identification and quantification at 8°C and 17°C 
HPLC/MS was made for CLPs produced by the wild strains as described in materials and methods. CLP quantification was evaluated with the help of the chromatogram 
area under the peaks divided by the smallest observed area, i.e. CTS 22 and CTS193 grown at 8°C.
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3. The MS spectrum of this molecule -m/z : 728.4 and 857.5- led to a 
3-hydroxy decanoic acid as lipidic tail, incompatible with massetolide 
G. However, it was not possible to discriminate between massetolide A 
and D or pseudophomin A. 
The number of CLPs produced by strain CTS50 went from 3 at 
8°C to 5 at 17°C. The two newly detected molecules were a molecule of 
1167.6 g.mol-1 that should be massetolide C or pseudophomin B and 
a new compound called 7 characterized by a molar mass reduction 
of two units compared to the last product. As proposed for CTS50, 
it could be a change in amino acid 1 of Leu, by its cyclic analogue, 
cyclopropylalanine. MS data confirmed a glutamine residue bound to 
the lactone ring (Thr-Ile-Leu-Ser-Leu-Ser-Ile). -m/z: 714.5 and 843.4-.
Two forms of amphisin-like molecules were detected in the 
rinsing solution of strain CTS70 grown at 8°C. Comparing them with 
published CLPs for this strain in different conditions, these molecules 
were identified as amphisin and tensin.
The analysis of biosurfactants generated by strain CTS117 revealed 
the presence of two CLPs previously also investigated in strain CTS50, 
namely the new 2 and the molecule corresponding either to massetolide 
F or 1.
The biosurfactant secretion profile of strain CTS193 was simpler 
with only one molecule of a characteristic mass of 1408.5g.mol-1 
identified as hodersin of the amphisin family.
Conversely, strain DR54 was at the origin of the more complex 
secretion pattern of biosurfactants with 6 different molecules. For 
growth at 17°C, the proportions and mass of the corresponding 
products were respectively 7.13% (1110.7g.mol-1), 1.91% (1124.7g.
mol-1), 1.59% (1110.7g.mol-1), 86.54% (1124.7g.mol-1), 0.97% (1150.5g.
mol-1) and 1.87% (1152.6g.mol-1). The major peak was clearly identified 
as viscosinamide [10]. The properties of other secondary compounds, 
i.e. hydrophobicity, non-ionic character and presence of a glutamine 
residue, also suggested that they were members of the viscosinamide 
family, subgroup of non-ionic viscosin-like CLPs. With the help of very 
few references on viscosinamide-like CLPs [10,35], the exoproduct of 
1110.7g.mol-1 could be designated like pseudodesmin B, but Sinnaeve 
[35] identifies this CLP at the same time as pseudodesmin A, which 
only differs from viscosinamide with respect to the stereochemistry of 
the Leu at position 5, being D rather than L. Hence an other putative 
biosurfactant, named 3, could be suggested as a diastereoisomer 
of pseudodesmin B. The two others molecules left, whose putative 
structure was deduced from MS analysis, were designated as 4 and 5. 
MS peaks revealed CLPs containing Glu in amino-acid 2 since m/z: 
843.2 and 714.4 instead of 842.5 and 714.4 for Gln, as known for 
viscosin-like CLPs. For the two residual peaks, their elution overlapped 
around 47 min and was indicative of a mixture of viscosinamide and, 3 
or pseudodesmin B, in minor quantity. 
The biosurfactant production from bacteria grown at either 8°C or 
17°C was carried out. For the majority of the strains, including PfA7B, 
DSS73, CTS22, CTS70, CTS117, CTS193 and DR54, growth at 17°C 
was not associated with changes in CLP pattern production (Table 2 
& Table 4). In contrast, two strains, CTS38 and CTS50, showed their 
panel of CLPs markedly increased with the growth temperature. 
Among the 22 different identified CLPs, seven named 1 to 7 are 
described for the first time, their putative structures are compiled in 
Table 4. The compounds 1, 2, 6 and 7 are members of viscosin-like 
CLPs, as the other biosurfactants produced simultaneously by strains 
CTS50 and CTS117. CLPs 3, 4 and 5 own to the viscosinamid-like 
CLPs, as their co-produced biosurfactants by DR54. CLPs 3 and 5 
present a similar hydrophilic peptidic moiety with, respectively, CLPs 
2 and 1 except Glu replaced with Gln. 
Effect of the growth temperature on the adhesion ability of 
the two wild P. fluorescens strains, PfA7B and DSS73
With PfA7B and DSS73 and their biosurfactant producer mutants, 
Pf1vis- and DSS73-15C2, adhesion assays were performed at either 8°C 
or 17°C on DMM on polystyrene microtitration plates. As represented 
in Figure 2, increasing the growth temperature from 8°C to 17°C was 
associated with a very significant decrease of the relative adhesion 
affinity for the both strains. At 8°C and 17°C the wild strains presented 
reduced adhesion compared to their surfactant mutant (ratio of 1.5 for 
viscosin mutant and 2 for amphisin mutant at 8°C). 
Hydrophobicity 
The surfacial hydrophobicity was evaluated for four strains: 
PfA7B, Pf1vis-, DSS73 and DSS73-15C2 by measuring the affinity of 
the cells towards the apolar solvent hexadecane. A strain with 100% 
affinity towards hexadecane is highly hydrophobic and a strain with 
0% hexadecane affinity is highly hydrophilic. Hexadecane affinity at 
8°C was illustrated in Figure 2 by white dots and affinity at 17°C by 
grey ones. PfA7B and Pf1vis- were characterized as highly hydrophilic 
for both growth temperature of 8°C and 17°C, as their affinity to 
hexadecane was evaluated less than 10% and appeared rather equal. 
The growth temperature for DSS73 and for its mutant only slightly 
modulated their hydrophobicity, at 17°C they were highly hydrophobic 
(hexadecane affinity greater than 85%) and at 8°C, they became only 
hydrophobic (hexadecane affinity about 60%).
Discussion
The 11 strains of P. fluorescens were selected for the present study, 
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Figure 2: Influence of growth temperature on adhesion of four strains: PfA7B, 
Pf1vis-, DSS73 and DSS73-15C2 and their surface hydrophobicity after incu-
bation at 8°C and 17°C.
Adhesion corresponds to incubation in static condition for 1 day at 8°C (cross-
line pattern) and 4h at 17°C (plain black). For each strain, three independent 
cultures were realized in triplicate. Results were normalized as percentage of 
the median value corresponding to the adhesion obtained for PfA7B at 8°C. 
Statistical analyses were performed on these results with the help of Mann-
Whitney test. NS means non significant (p≥0.05); X significant (p≤0.05); XX: 
highly significant (p≤0.01); XXX: extremely significant (p≤0.001).
Hydrophobicity corresponds to hexadecane affinity evaluated for bacterial cul-
tures after 4 days of incubation at either 8°C (white dot) or 17°C (grey dot). 
(100%: highly hydrophobic, 0%: highly hydrophilic).
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since they represent typical environmental microorganisms naturally 
submit to significant temperature variations. All these strains are 
included in the “fluorescens r-cluster” defined by Bodilis [31] in the 16S 
rRNA based phylogenic tree. However the dispersion of these strains is 
large. In Figure 1 and as previously reported by de Bruijn [14], Group 
A is close to P. fluorescens SBW25 strain from which the genome is 
sequenced, whereas Group B is located at distance, i.e. near the “putida 
r-cluster”, and appears to be close to P. fluorescens Pf0-1 strain, another 
strain from which the genome is sequenced. This situation clearly 
illustrates the high heterogeneity of the species P. fluorescens. Recent 
taxonomic studies are enabled a separation into distinct species for 
related bacteria previously associated with P. fluorescens, such as P. 
mosselii [36]. Bacteria still included in the species P. fluorescens remain 
very diverse as it can be noted by analysis of siderophores expression 
[37]. Nevertheless, for environmental microorganisms, as for clinical 
strains, the very active process of gene transfer forces us to carefully 
consider the usually accepted taxonomical boundaries [38] and even 
the psychrotrophic character of P. fluorescens could be discussed since 
clinical biovar 1 of the species has been shown to grow and adapt at 
37°C on rich medium [39].
The two groups presently defined in the phylogenic study on 16S 
RNA are consistent with the results from the hemolytic activity study, 
summarized in Table 1. The strains, with β-hemolytic activity are 
found in Group A. Group A is distinct from Group B where strains 
characterized by α-hemolytic activity at either 8°C or 17°C are gathered. 
Measuring surface tension from a bacterial rinsing solution was 
used to investigate biosurfactant production. In water, whose surface 
tension is about 70 mN.m-1, if biosurfactants are present in solution, 
the surface tension falls under 40 mN.m-1 [32]. Except for the two 
mutants Pf1vis- and DSS73-15C2 and strains CTS22 and CTS38 grown 
at 8°C, all other wild strains are positive for biosurfactant production 
with a surface tension of the rinsing solution between 26.7 and 35.2 
mN.m-1. The absence of biosurfactant in the rinsing solution of Pf1vis- 
and DSS73-15C2 grown at either 8°C or 17°C suggests that viscosin 
or amphisin blockage, as reported by Braun [13] and by Koch [23], is 
not compensated by the release of any other amphiphilic molecules. 
The case of the strains CTS22 and CTS38 is different since they show 
low but detectable α or b hemolysis activity at either 8°C and 17°C and 
have been previously demonstrated as amphisin- and viscosin-like 
producers, respectively [12]. However, surface tension measurement 
remains a global technique for the detection of biosurfactant production 
and even for very active molecules a sufficient amount is necessary to reach 
the limit value of 40 mN.m-1 [32].
To summarize this macroscopic biosurfactant production, the 11 
strains are sorted into three classes. The non-biosurfactant producers 
are Pf1vis- and DSS73-15C2 mutants. The second group consists 
of the α-hemolytic strains able to produce anionic biosurfactants: 
DSS73, CTS22, CTS70 and CTS193. The third category results from 
the β-hemolytic strains secreting anionic or non-ionic biosurfactants: 
PfA7B, CTS38, CTS50, CTS117 and DR54. 
To screen rapidly a potential CLPs production by a P. fluorescens 
strain, two tests can be performed: hemolytic activity and ionic nature 
of the corresponding rinsing solution or culture supernatant. An 
α-hemolytic phenotype, with anionic rinsing solution, can be assumed 
to be amphisin-like CLPs producer. An anionic rinsing solution 
coupled with a β-hemolytic phenomenon is obtained for viscosin-
like CLPs producer. Viscosinamid-like producer corresponds to a 
β-hemolysis with a non-ionic rinsing solution.
The CLP identification is consistent with the 16S ARN groups and 
the macroscopic biosurfactant evaluation. In fact Group A, in Figure 
1, consists in all the viscosin- and viscosinamide-like producers. More 
precisely, the β-hemolytic strains secreting anionic biosurfactants are 
in the viscosin-like group. In addition, as a β-hemolytic strain and non-
ionic biosurfactant producer, DR54 is characterized as a viscosinamide-
like producer. The second category results from the α-hemolytic strains 
being able to produce anionic biosurfactants: DSS73, CTS22, CTS70 and 
CTS193. They are related in Group B, shown in Figure 1, and produce 
amphisin-like CLPs. The 16S rRNA phylogenetic tree corresponds with 
biosurfactant pattern. Structurally, the peptidic hydrophilic moiety 
differs amoung the studied CLPs. As shown by shorter retention times 
in RP-HPLC (Table 2), ampsin-like CLPs are more hydrophilic than 
viscosin and viscosinamide-like, whose ionic charge is different. Then 
the hemolysis mechanism could be related to CLP hydrophobicity, 
but not to their ionic charge. Hydrophilic amphisin-like CLPs help 
its producer strain to provoke pores formation and partial lysis of red 
blood cells, while their complete lysis is obtained with P. fluorescens 
producing hydrophobic CLPs (viscosin- or viscosinamide-like).
Over the 22 different CLPs identified in the present study (Table 
4), 19 of these molecules have considerably increased production with 
an increase in the growth temperature of the bacteria. This increase 
reaches 10 and even 72 times for amphisin-like production by strains 
CTS70 and CTS22, but, in the vast majority, the CLP quantity detected 
at 17°C is twice as much as that found at 8°C. A similar temperature 
dependency has been reported for putisolvin, another CLP secreted by 
Pseudomonas sp. MIS38 [40] or P. putida PCL1445 [41] and for other 
different CLPs in Bacillus subtilis ATCC6633 [42]. But three molecules 
are differently regulated by temperature. In strain CTS50, production 
of the compound identified as massetolide A, massetolide G or 
pseudophomin A is reduced by 25.8 % when the bacterium was grown 
at 17°C. A reduction factor of the same range, -33.3%, is measured for 
3 produced in strain DR54. The stronger negative effect of temperature 
is observed in strain DSS73 that shows its production of amphisin 
decrease from a mean normalized value of 141 at 8°C to only 2 at 17°C. 
No general trait about temperature-regulated CLPs production can be 
ground : the biosurfactant production seems be more strain dependant, 
than be ruled neither by the bacterial growth temperature neither 
by the produced CLPs nature. Common environmental pressures 
could explain such behaviour [1], yet in the present study there is no 
correlation between the ecology of the strains and their biosurfactant 
patterns.
As mentioned elsewhere, the role of biosurfactants in bacterial 
adhesion, and even later in biofilm production, remains to be discussed. 
Whereas de Bruijn [14,15] showed that in P. fluorescens SBW25 
viscosin is essential for biofilm formation, as well massetolide A in P. 
fluorescens SS101 other CLPs, putisolvins and arthrofactins, appear 
to exert a negative effect on the biofilm structure in Pseudomonas sp. 
MIS38 [43] and P. putida PCL1445 [44]. 
In the present study, the adhesion of bacteria was evaluated on 
two wild strains: PfA7B and DSS73 and their respective CLP mutants: 
Pf1vis- and DSS73-15C2. Moreover these two wild strains produce 
different CLPs: PfA7B viscosine-like CLPs and DSS73 amphisin. These 
biosurfactants are all anionics and amphisin is largely more hydrophilic 
than the viscosin-like CLPs as shown by the great difference in HPLC 
retention time compiled in Table 2. The two wild strains are more 
adherent at 8°C whereas for PfA7B viscosin is more produce at 17°C 
as described in Figure 2. Moreover, the magnitude of adhesion is lower 
for the wild strains than for their CLP deficient mutants. Thus it could 
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be assumed that the CLP production reduces the bacterial adhesion 
process. As reported by Raaijmakers [7] or Palmer [48] or Simoes 
[49], microbial adhesion to surfaces still remains under discussion. 
A consensus has appeared about the initial attachment, which is 
the crucial step of adhesion, even if so little is still understood about 
it yet. Several factors seem to direct this critical step such as surface 
conditioning, mass transport or surface topography, but none of 
these factors is clearly established as dominating. The amphiphilic 
biosurfactant nature has led them to take part in the conditioning 
step of the adhesion in modulating the physico-chemical properties 
of the bacterial microenvironment during its deposition on an inert 
surface. In our study, whatever their nature, amphisin or viscosin-like, 
CLPs penalize the cell attachment of their own bacterial producers: the 
non producing mutant adheres more than the wild strain as shown in 
Figure 2.
Up to now, no implication of the surfacial cell itself was considered 
in attachment process. The hydrophobicity of the strains shown in 
Figure 2 corresponds to cell affinity without any adsorbed biosurfactant 
at their surface. Hydrophilic strain (PfA7B) and hydrophobic strain 
(DSS73) have similarly adhesion. Even if adherent cells number at 
8°C increases with bacterial hydrophobicity, this parameter seems not 
dominating in adhesion process. Overall the growth temperature does 
not greatly modify the cell hydrophobicity.
The present results demonstrate that environmental strains of P. 
fluorescens can synthesize different forms of CLPs from the viscosin, 
viscosinamide and amphisin family and we propose a method for 
rapid CLP screening. Biosurfactant presence is determined using two 
analyses simultaneously: blood agar lysis and tensiometry. If both are 
positive, the double diffusion test is done. Afterwards the CLP class 
can be deduced from the hemolytic type and from the biosurfactant 
charge determination. Precise analysis of the data indicates that in 
P. fluorescens production of CLPs and the crucial adhesion step are 
both markedly affected by the growth temperature but the two events 
appear to be independently regulated and not correlated. Indeed, most 
of the presently studied environmental P. fluorescens CLPs producers 
secrete biosurfactant(s) with a great variety and in larger quantity at 
the optimal exoproduct secretion temperature, 17°C in our case. These 
CLPs disturb the bacterial adhesion process. This initial adhesion, a 
crucial step of biofilm formation, seems to be not controlled by strain 
hydrophobicity and is increased at growth temperature of 8°C. To 
define more precisely the origin of this behaviour difference in bacterial 
adhesion, some more analysis could be done on extracellular polymeric 
substances (EPS) or on specialized attachment structures, such as 
flagella or pili, also known to influence the crucial adhesion step [49]. 
Moreover, increase of flagella length in absence of biosurfactant has 
been already reported [18].
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Gamma-aminobutyric acid (GABA) is widespread in the environment and can be used by animal
and plants as a communication molecule. Pseudomonas species, in particular fluorescent ones,
synthesize GABA and express GABA-binding proteins. In this study, we investigated the effects
of GABA on the virulence of Pseudomonas aeruginosa. While exposure to GABA (10 mM) did not
modify either the growth kinetics or the motility of the bacterium, its cytotoxicity and virulence were
strongly increased. The Caenorhabditis elegans ‘fast killing test’ model revealed that GABA acts
essentially through an increase in diffusible toxin(s). GABA also modulates the biofilm formation
activity and adhesion properties of PAO1. GABA has no effect on cell surface polarity,
biosurfactant secretion or on the lipopolysaccharide structure. The production of several exo-
enzymes, pyoverdin and exotoxin A is not modified by GABA but we observed an increase in
cyanogenesis which, by itself, could explain the effect of GABA on P. aeruginosa virulence. This
mechanism appears to be regulated by quorum sensing. A proteomic analysis revealed that the
effect of GABA on cyanogenesis is correlated with a reduction of oxygen accessibility and an
over-expression of oxygen-scavenging proteins. GABA also promotes specific changes in the
expression of thermostable and unstable elongation factors Tuf/Ts involved in the interaction of
the bacterium with the host proteins. Taken together, these results suggest that GABA is a
physiological regulator of P. aeruginosa virulence.
INTRODUCTION
Gamma-aminobutyric acid (GABA) is a four-carbon non-
protein amino acid, widespread in the environment (Bouche´
et al., 2003). Since the 1950s, it has been known that GABA is
the major inhibitory neurotransmitter in the nervous system
of vertebrates and invertebrates (Owens & Kriegstein, 2002).
In other living organisms, such as plants, fungi or bacteria,
GABA was considered for a long time to be a stress response
factor and/or a nutrient (Higuchi et al., 1997; Shelp et al.,
1999). The hypothesis that GABA could also be a
communication molecule in these organisms started with
the observation that, in plants, GABA controls the guiding of
the pollen tube into the female gametophyte (Palanivelu et al.,
2003). In plant life, GABA now appears to be a ubiquitous
communication molecule produced as a defence against
nematodes, insects and also bacterial phytopathogens (Shelp
et al., 2006). The role of GABA in communication between
plants and bacteria is in line with the identification of GABA-
binding proteins in different prokaryotes corresponding not
only to transporters such as GabP in Escherichia coli or
Bacillus subtilis (Hu & King, 1998; Brechtel & King, 1998)
and Bra in Agrobacterium tumefaciens (Chevrot et al., 2006)
but also to possible specific receptors (Guthrie & Nicholson-
Guthrie, 1989). In addition, many bacteria, including marine
micro-organisms (Morse et al., 1980), lactic bacteria
(Siragusa et al., 2007), E. coli (Richard & Foster, 2003) and
Pseudomonas (Chou et al., 2008) synthesize GABA, suggest-
ing that, like in eukaryotes, GABA might be a conserved and
ubiquitous communication molecule.
That GABA has an effect on the physiology of Pseudomonas
is supported by several observations. A periplasmic protein
Abbreviations: 3oxoC12-HSL, 3-oxo-C12 acylhomoserine lactone; C4-
HSL, C4 acylhomoserine lactone; GABA, gamma-aminobutyric acid;
LDH, lactate dehydrogenase; LPS, lipopolysaccharide; PQS, pseudomo-
nas quinolone signal.
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showing high affinity for GABA and biochemical char-
acteristics similar to a subunit of the mammalian GABAA
receptor was identified in an environmental strain of P.
fluorescens (Guthrie & Nicholson-Guthrie, 1989; Guthrie
et al., 2000). In P. aeruginosa, GABA is an intermediate
metabolite of organic polycation catabolism and an
inducer of the enzymic pathway controlling the intracel-
lular polyamine levels (Chou et al., 2008). The question of
a possible effect of extracellular GABA on P. aeruginosa is
of medical importance. GABA is present in significant
concentrations in the brain matter but also in the
cerebrospinal fluid (Tunnicliff & Malatynska, 2003) and,
essentially following breaches of the meningeal barrier due
to trauma, surgical acts or, more rarely, by diffusion from
infected contiguous structures (paranasal sinus or inner
ear), P. aeruginosa can invade the central nervous system
causing life-threatening infections such as brain abscesses,
ventriculitis or meningitis (Mesaros et al., 2007). However,
GABA is also present in blood (Petty et al., 1999) where it
has immunomodulatory functions (Jin et al., 2011) and, as
P. aeruginosa is a major cause of bloodstream infections
(van Delden, 2007), the bacterium is exposed to GABA
during bacteraemia or septicaemia. With the emergence of
multidrug-resistant strains, it is essential to identify the
hosts and communication factors capable of modulating
the virulence of P. aeruginosa; these should represent new
strategies for treatment (Fothergill et al., 2012).
In the present study, we investigated the effect of GABA on
P. aeruginosa through a multi-phenotypical study. We show
that GABA stimulates P. aeruginosa virulence through
variation of the production of a quorum-sensing-regulated
factor and modulation of enzymes involved in the oxidative
stress response.
METHODS
Bacterial strains and culture conditions. P. aeruginosa PAO1
was obtained from an international collection (University of
Washington). Except for specific tests, as indicated below, bacteria
were grown in Nutrient Broth (NB, Merck). The effect of GABA was
studied at 0.01 mM to avoid possible direct metabolic and pH effects
and since it is the mean value of the concentrations in the synaptic
cleft of neurons (1.5–3 mM, Mozrzymas et al., 2003), in wounded
vegetal (0.1 mM, Shelp et al., 1999) and in the environment (sea water
concentration ,0.1 mM, Johnson et al., 1991). Motility assays were
essentially performed as described by Rashid & Kornberg (2000).
Briefly, NB plates containing 0.3% agar were point-inoculated with a
toothpick previously soaked in a pellet (10 min, 10 000 g) of bacteria
grown to early stationary phase that had been collected by
centrifugation, and incubated for 24 h at 37 uC. The swarming assay
was identical, except that NB plates contained 0.5% agar.
Bacterial virulence assays. The effect of GABA on bacterial
virulence was studied by using two models, i.e. cultured rat glial cells
to evaluate the cytotoxic activity of the bacteria in nerve cells (Picot et
al., 2001) and the nematode Caenorhabditis elegans, a metazoan
model used to assess the general virulence of human pathogens and
environmental bacteria (Duclairoir Poc et al., 2011). Preliminary
controls showed that exposure of P. aeruginosa PAO1 to GABA (0.01
mM) during the whole growth phase, or at the beginning of the
stationary phase, did not modify the growth kinetics of the bacterium.
For the cytotoxic activity, P. aeruginosa PAO1 grown in NB was
inoculated at OD580 0.2 in 25 ml NB containing GABA (0.01 mM) or no
GABA, and cultured at 37 uC with agitation (180 r.p.m.) to early
stationary phase. Bacteria were harvested by centrifugation in an
Eppendorf centrifuge tube (6000 r.p.m., 4 min, 20 uC), rinsed three
times with NB and resuspended at a cell density of 106 c.f.u. ml21 in glial
cell culture medium without antibiotics and antimycotics. The bacterial
viability and density, and the absence of contamination were controlled
by plating. Glial cells were incubated for 4 h with P. aeruginosa and glial
cell death was monitored using the lactate dehydrogenase (LDH) assay
release as described previously (Picot et al., 2003, 2004) using the
Cytotox 96 Enzymic Assay (Promega). Controls realized using bacteria
alone showed that in our experimental conditions P. aeruginosa PAO1
does not produce molecules that interfere with this assay.
The global virulence of P. aeruginosa PAO1 was studied using the wild-
type N2 strain of C. elegans kindly provided by the Caenorhabditis
Genetics Center (Minneapolis, MN, USA). Worms were grown at
22 uC on E. coli OP50 cultures. Synchronous cultures of worms were
obtained as described previously (Blier et al., 2011). Two types of tests:
‘fast-killing’ and ‘slow-killing’ were used. In the ‘fast-killing’ test,
worms are killed by bacterial diffusible toxins whose secretion is
stimulated by use of a high-osmolarity medium (Aballay & Ausubel,
2002). In the ‘slow-killing’ test, worms are killed after ingestion of the
bacteria (Duclairoir Poc et al., 2011). Pathogen lawns used for C.
elegans survival assays were prepared by spreading 50 ml control or
GABA-treated P. aeruginosa PAO1 (OD580 1) (obtained as previously
described) on 35 mm peptone-glucose-sorbitol (PGS: 1% Bacto-
Peptone; 1% NaCl, 1% glucose, 0.15 M sorbitol, 1.7% Bacto-Agar)
conditioned Petri dishes for ‘fast-killing’ evaluation or on 35 mm
nematode growth medium (NGM: 3 g NaCl, 2.5 g peptone, 17 g agar,
5 mg cholesterol, 1 ml 1 M CaCl2, 1 ml 1 M MgSO4, 25 ml 1 M
KH2PO4, H2O to 1 l) conditioned Petri dishes supplemented with
0.05 mg 5-fluoro-29-deoxyuridine ml21 for ‘slow-killing’ experiments.
The plates were incubated overnight at 37 uC and then placed at room
temperature for 4 h. Twenty L4 synchronized worms were harvested
with M9 solution (3 g KH2PO4, 6 g NaHPO4, 5 g NaCl, 1 ml 1 M
MgSO4, H2O to 1 l), placed on the 35 mm assay Petri dishes and
incubated at 22 uC. Worm survival was scored at 1 h, 24 h and each
subsequent day, using an Axiovert S100 optical microscope (Zeiss)
equipped with a Nikon digital Camera DXM 1200F (Nikon
Instruments). The worms were considered dead when they remained
static without grinder movements for 20 s. The results are expressed as
the percentage of living worms.
Biofilm formation. The biofilm formation activity of P. aeruginosa
PAO1 was studied using a technique adapted from O’Toole & Kolter
(1998). An aliquot of 100 ml of a bacterial culture adjusted to OD580 0.4
was layered in a PVC microtitration plate and incubated for 24 or 48 h.
In the first set of experiments, bacteria were grown in the absence of
GABA but were exposed to the molecule during biofilm formation. In a
second set of experiments, bacteria were grown in the presence of GABA
but GABA was not added to the medium during the biofilm formation.
In a third set of experiments, bacteria were grown with GABA as
previously, but the medium in PVC microtitre plates was supplemented
with GABA to maintain the treatment during the 24–48 h of the biofilm
formation test. After removing the bacterial suspension and rinsing,
bacteria and matrix bound to the wells were stained with crystal violet
(0.1%, 30 min). After rinsing, the dye was recovered by adding 150 ml
SDS (1% in sterile water) and the OD595 of the solution was measured.
For comparison of the results, data were normalized as a percentage of
biofilm density in the absence of treatment. Results were normalized as a
percentage of the median value corresponding to the mature biofilm
formation activity of CTS117 at 8 uC.
A. Dagorn and others
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Cell surface properties. The binding index of P. aeruginosa PAO1
on biological (cell) surfaces was determined using the gentamicin
exclusion test (Mezghani-Abdelmoula et al., 2004).
The binding index of bacteria on glass slides was determined by direct
counting. Glass slides were cleaned with ethanol and TDF4 detergent
(4% in 50 uC water) to remove any trace of lipids. A bacterial
suspension [108 c.f.u. ml21 in sterile water (SPW) NaCl 0.9%] was
layered on each glass slide. Bacteria were allowed to adhere for 2 h at
37 uC. Non-adherent bacteria were removed by rinsing and the
remaining adherent bacteria were stained with acridine orange
(0.01% in sterile water). The slides were observed using an
epifluorescence microscope Zeiss Axiovert 100. The binding index
was determined by counting a minimum of 20 homologous fields.
The surface polarity of P. aeruginosa PAO1 was determined using the
microbial adhesion to solvent (MATS) technique (Bellon-Fontaine
et al., 1996). Bacterial cultures in early stationary phase and treated or
not with GABA were harvested by centrifugation at 10 000 g. Pellets
were rinsed twice with 0.9% NaCl in water and diluted to OD400 0.8.
An aliquot of bacterial suspension (2.4 ml) was mixed with 0.4 ml
hexadecane. The tubes were vigorously hand-shaken and the OD400 of
the aqueous phase was measured after 15 min of decantation. The
percentage of affinity for hexadecane was calculated as follows:
[(ODcontrol2OD test)/OD control]6100.
Lipopolysaccharide (LPS) structure. LPS was purified from P.
aeruginosa PAO1 as described by Darveau & Hancock (1983) and was
analysed by MALDI-TOF MS using an Autoflex III mass spectrometer
(Bruker Daltonik). For analysis, a 0.5 ml aliquot of purified LPS was
spotted onto a steel target plate. An aliquot (0.5 ml) of a solution of a-
cyano-4-hydroxycinnamic acid matrix (10 mg ml21 in acetronitrile/
0.2% TFA, v/v) was added to each spot and these were dried at room
temperature. The mass spectrometer was equipped with a pulsed YAG
200 Hz laser and was run in the positive mode. Instrument
calibration was achieved by using calibration standards (Care,
Bruker Daltonics) spotted on the same target plate. Each spectrum
was established over 200 laser shots.
Biosurfactant production assays. The kinetics of biosurfactant
production were monitored over 48 h by measuring the surface
tension of the rinsing solution (SPW) of colonies of P. aeruginosa
grown on solid NB medium, using the Wilhelmy plate technique
(Hiemenz & Lagowski, 1977). Rhamnolipids were further extracted
from 3 ml culture supernatant of bacteria grown for 24 h, and
analysed by HPLC/MS using an Agilent Technologies 1100 system
(Column YP5C18 Interchim 26200 mm) coupled to a Bruker
Esquire-LC ESI-MS/MS positive-ion electrospray ionization and ion
trap mass spectrometer. The extraction and separation protocols were
adapted from De´ziel et al. (2000).
Secreted diffusible virulence factors assays. Secreted caseinase,
esterase, lecithinase, amylase and haemolytic activities were studies by
cultures on agar supplemented with milk, Tween 80, egg yolk, starch
and Columbia blood, respectively. The elastase activity was measured
in liquid bacterial culture medium using an elastin/Congo red assay.
Filtered supernatant (50 ml) of a bacterial culture grown to early
stationary phase was mixed with 1 ml Tris buffer (0.1 M, pH 7.2,
1 mM CaCl2) containing 20 mg elastin/Congo red (Sigma). The tubes
were incubated at 37 uC with agitation. After 18 h, the tubes were
chilled on ice and the reaction was stopped by adding 0.1 ml 0.12 M
EDTA. Non-soluble elastin/Congo red was removed by centrifu-
gation, and the OD490 was measured.
Pyoverdine production was monitored over 48 h. To promote
pyoverdine production, bacteria were grown on King B or in Bacto
Casamino Acids (CAA) medium. Pyoverdine production was
expressed as the OD400/OD580 ratio of the supernatant after removal
of the bacteria by centrifugation (5 min, 10 000 g).
Exotoxin A was assayed in the culture supernatants of P. aeruginosa
PAO1 grown in NB using an ELISA sandwich method on 96-well
microtitre plates as described by Gaines et al. (2005) and Blier et al.
(2011). Each well was coated with goat anti-exotoxin A antibody
(0.25 mg ml21 in 100 mM Na2HCO3) and treated with BSA to block
non-specific binding sites. A standard curve was made by using serial
dilutions of purified exotoxin A (Sigma-Aldrich). Assays were made
on 100 ml culture medium. After 1 h incubation at room temperature,
the plates were washed and incubated with rabbit–anti-exotoxin A.
The plates were then washed and treated with goat–anti-rabbit IgG
conjugated to horseradish peroxidase (Sigma-Aldrich). The reaction
was visualised by adding a substrate solution (Pierce Biotechnology)
and was stopped after 30 min by adding H2SO4 (2 M). The
absorbance was read at OD450 using an ELISA plate reader (Bio-
Tek Instruments). The values are expressed as the ratio of Exotoxin A
(in pg ml21) versus the bacterial culture density (at 580 nm).
The HCN/CN2 production by P. aeruginosa was determined by using
a polarographic method recently developed in our laboratory (Blier
et al., 2012). Voltametric measures were made using a Metrohm 757
VA Computrace. Analyses were carried out in a three-electrode
configuration using a saturated Ag/AgCl3 reference electrode, a
platinum wire as a counter electrode and a Multi-Mode Mercury
Electrode as a working electrode. All experiments were performed at
room temperature. Bacterial cultures were centrifuged and filtered on
a 0.22 mm filter to remove cell fragments. This medium was then
diluted in 0.2 mol borate electrolyte l21 (pH 10.2). The solution was
purged for 3 min with N2 to remove dissolved oxygen and then for
20 s more between each cyanide addition. A potential scan was
carried out in a negative direction from 20.1 to 20.5 V with a sweep
rate of 10 mV s21. The pulse amplitude was 0.05 V with pulse
duration of 0.04 s. The cyanide peak was measured at 2200 mV in a
differential pulse mode and the cyanide concentration was deter-
mined by adding triplicate successive (n54) amounts of 10 mg
potassium cyanide standard l21.
Total proteome analysis. Cultures of P. aeruginosa PAO1 grown to
early stationary phase were centrifuged (20 min, 12 000 g). Pellets
were washed three times in 50 mM Tris/HCl, pH 8. Cells were
disrupted by three freeze/thaw cycles and sonication. Unbroken cells
were removed by centrifugation. The supernatants were supplemen-
ted with benzonase and MgCl2 and incubated for 30 min at 37 uC.
Proteins were precipitated with cold acetone (v/v) and harvested by
centrifugation at 13 000 g for 10 min at 4 uC, and resuspended in
rehydratation buffer containing 7 M urea, 2 M thiourea, 4% (w/v)
CHAPS (Bio-Rad), 0.5% IPG buffer 3-10 (Bio-Rad), 70 mM DTT
and 5 mM TCEP [Tris(2-carboxyethyl)phosphine hydrochloride] to a
final volume of 300 ml. The protein concentration was controlled
using the Bio-Rad protein assay (Bio-Rad) and BSA as standard.
The protein extract was then separated by 2D gel electrophoresis and
in-gel trypsin digestion. For the first dimension electrophoresis,
protein samples were separated by IEF using pH 4–7 IPG strips
(immobilized linear pH gradients, 17 cm, Bio-Rad) as described by
Barbey et al. (2012). After IEF, the IPG strips were reduced in an
equilibration buffer [6 M urea, 50 mM Trisma base, 2% (w/v) SDS,
20% (v/v) glycerol, a few grains of bromophenol blue and 2% (w/v)
DTT for reduction or 2.5% (w/v) iodoacetamide for alkylation]. The
second dimension SDS-PAGE was realized on 12% polyacrylamide
(37.5 : 1 acrylamide/bisacrylamide, Bio-Rad) gels at 50 mA for 4 h.
Proteins on gels were visualized with Coomassie brillant blue R-250
and gel images were captured using a GS-800 densitometer (Bio-Rad).
Variations in spot intensity and distribution were studied using the
Bio-Rad PDQuest 2D analysis software. In-gel digestion was
performed as previously (Barbey et al., 2012). In-gel trypsin digestion
GABA signalling in Pseudomonas
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products were then analysed using a MALDI-TOF/TOF (Autoflex III,
Bruker Daltonics) in positive/reflector mode. Instrument calibration
was achieved using peptide calibration standards (Care, Bruker
Daltonics). Samples were spotted onto MTP 384 ground steel target,
using freshly prepared matrix solution composed of 2,5-dihydrox-
ybenzoic acid (20 mg ml21) in a solution of 0.1% TFA and 50%
acetonitrile. Peptide mass fingerprints obtained from MS analysis and
MS/MS spectra were used to search the NCBI no redundant database
by using online MASCOT software (http://www.matrixscience.com).
Search parameters were set as follows: taxonomy was set on bacteria;
trypsin was given as the digestion enzyme and a maximum of one
missed cleavage site was allowed; carbamidomethylation of cysteine
and methionine oxidation were selected as fixed and variable
modifications, respectively; mass values were set to monoisotopic.
Searches were performed setting a peptide mass tolerance of
100 p.p.m. and a fragment ion mass tolerance of 0.5 Da. The
statistical analyses of the sequences were determined by the
probability-based Mowse score offered by MASCOT software. A P-
value ,0.05 was considered as significant.
Production of quorum-sensing factors. The kinetics of 3-oxo-C12
acylhomoserine lactone (3oxoC12-HSL) and C4 acylhomoserine
lactone (C4-HSL) production by P. aeruginosa was measured over a
24 h period. At each time point (3, 5, 8, 12 and 24 h of incubation)
an aliquot of 5 ml culture medium was collected and centrifuged
for 10 min at 10 000 g. The supernatant was mixed with an equal
volume of dichloromethane. This solution was shaken manually by
flip-flop, and centrifuged again (10 min, 10 000 g). The aqueous
phase was removed and treated for a second extraction following
the same protocol. The two dichloromethane extracts were pooled
and dehydrated by adding Na2SO4. After removal of Na2SO4
crystals by centrifugation, the solvent was evaporated. The samples
were then treated as described previously (Morin et al., 2003) and
analysed by C18 reversed-phase HPLC/MS analysis using an Agilent
Technologies 1100 system coupled to a Bruker Esquire-LC ESI-MS/
MS positive-ion electrospray ionization and ion-trap mass
spectrometer.
The production of pseudomonas quinolone signal (PQS) was
quantified by TLC and C18 reversed-phase HPLC analysis.
Cultures of control or GABA-treated P. aeruginosa PAO1 grown
for 24 h were centrifuged (5 min, 10 000 g). The supernatant was
collected and acidified to pH 3 by addition of HCl. PQS was
extracted three times with 10 ml acidified ethyl acetate [1 ml acetic
acid (ml ethyl acetate)21]. Water traces were eliminated by adding
anhydrous MgSO4. The filtrate was evaporated under nitrogen and
resuspended in 500 ml methanol. For TLC analysis, samples (10 ml)
and synthetic PQS (60 nM) were spotted onto normal phase silica
60 F254 (Merck) TLC plates, previously soaked in 5% K2HPO4 for
30 min and activated at 90 uC for 1 h. Extracts were separated using
a dichloromethane/methanol (95 : 5, v/v) mobile phase, and
visualized under UV light (365 nm). For HPLC analysis, samples
(20 ml) were injected in a C18-Inertsil ODS3 column (5 mm,
4.66250 mm) and were separated by a parabolic gradient ranging
from 25 to 100% methanol in water/acetic acid (1% v/v, flow rate
0.4 ml min21) using a Shimadzu Prominence System equipped with
a LC-20AD parallel double piston pump and a SPD-20AV UV-
visible detector.
Statistical analysis. For analysis of the slow killing test results,
nematode survival was calculated by using the Kaplan–Meier
method, and survival differences were tested for significance by
using of the log–rank test (GraphPad Prism version 4.0). For other
results, each value reported for the assays is the mean of
measurements from a minimum of three independent preparations.
The Student t-test was used to compare the means within the same
set of experiments.
RESULTS
Effect of GABA on P. aeruginosa virulence
Preliminary controls showed that exposure of P. aeruginosa
PAO1 to GABA (0.01 mM) during the whole growth phase,
or at the beginning of the stationary phase, did not modify
the growth kinetics of the bacterium. When grown in the
presence of GABA, P. aeruginosa displayed a strong increase
of its cytotoxic potential on glial cells (88.6±8.6%,
P,0.001), as revealed by the LDH release assay (Fig. 1a).
Since the rat glial cells might be sensitive to GABA
themselves (Angulo et al., 2008), bacteria were carefully
rinsed to remove any trace of free GABA prior glial cells
infection. In addition, control experiments realized by direct
treatment of glial cells with GABA (0.01 mM) in the absence
of bacteria showed that this molecule had no direct effect on
glial cell viability (data not shown).
The effect of GABA on Pseudomonas virulence was tested in
a second model, the nematode C. elegans, which is
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Fig. 1. Effect of GABA (0.01 mM) on the cytotoxicity and virulence
of P. aeruginosa PAO1. The cytotoxic activity of the bacteria was
evaluated on glial cells (a). The global virulence was evaluated on
C. elegans using the ‘fast killing’ test, where the worms are killed
by bacterial diffusible toxins (b) and using the ‘slow-killing’ test, in
which the worms are killed through contact-mediated interactions
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considered to be an equivalent of the acute mouse toxicity
test (Williams et al., 2000) and has been adapted to
compare the virulence of environmental bacteria
(Duclairoir Poc et al., 2011). In addition, whereas the
‘fast-killing’ test gives information on the contribution of
diffusible virulence factors in the lethal activity of the
bacterium, the ‘slow-killing’ test reveals global variations of
virulence, including those that are due to direct contact
with the bacterial surface (Aballay & Ausubel, 2002). The
two tests confirmed that GABA increases the virulence of P.
aeruginosa: the ‘fast-killing’ test clearly shows that GABA-
treated bacteria provoked a sharp decrease in the number
of surviving worms after 24 and 48 h (246.3±5.2 and –
75.2±4.4%, respectively) (Fig. 1b). While the effect of
GABA was less visible in the ‘slow-killing’ test (Fig. 1c), the
log–rank test analysis of the data demonstrated that GABA
treated P. aeruginosa were also significantly more virulent
(P50.0252; n512).
Effect of GABA on biofilm formation
As the virulence of P. aeruginosa, particularly in the lung, is
generally associated with biofilm formation (Høiby et al.,
2010), the effect of GABA on the biofilm formation activity
was studied in vitro using different protocols to take into
consideration a possible metabolization of GABA during
biofilm formation. Bacteria in NB medium were exposed to
GABA as they were forming a biofilm or were pre-treated
with GABA and were then allowed to form a biofilm in the
absence or presence of GABA. When PAO1 was exposed to
GABA only during the biofilm formation period, no
change was observed. Conversely, when the bacteria were
exposed to GABA during the growth phase, a reduction in
biofilm formation was observed after 24 h (213±3 and
215±4%) and 48 h (210±6 and 218±3%) (Fig. 2).
The reduction observed after 48 h in medium without
GABA was not significant, probably because of the
instability of mature biofilms.
Effect of GABA on the surface properties of P.
aeruginosa
In order to determine more precisely the effect of GABA on
the surface properties of P. aeruginosa, the adhesion
potential and the surface polarity of the bacteria were
investigated. The effect of GABA on bacterial adhesion was
studied on living surfaces (glial cells) and on glass; pre-
treatment of bacteria with GABA was associated with an
increase in the binding index of 136±21 and 138.7±8.6%
on glial cells and glass, respectively. However, since the
global variation of adhesion is limited (it appeared only
really detectable on a homogeneous surface such as glass)
the increase measured on glial cells should not be
significant. As bacterial adhesion depends on the surface
polarity, we measured the affinity of the bacteria to
hexadecane using the MATS test. Considering that the
threshold for the affinity to hexadecane of polar (hydro-
philic) bacteria is 20% (Bellon-Fontaine et al., 1996), in
our experimental conditions P. aeruginosa PAO1 behaved
as a highly polar micro-organism (3.5±0.2% affinity to
hexadecane). The surface properties of P. aeruginosa were
not significantly modified by GABA.
Effect of GABA on contact-dependent virulence
factors production
Since our results showed that GABA modulates P.
aeruginosa virulence by acting both on surface-dependent
and diffusible virulence factors, we decided to investigate
the effect of GABA on the structure of the LPS, the main
constituent of the outer membrane of Gram-negative
bacteria. The LPS extracted from P. aeruginosa PAO1 was
analysed by MALDI-TOF MS. Multiple peaks, essentially of
m/z ratio ,3000, probably generated by fragments of lipid
A (Veron et al., 2007), were detected (Fig. 3a). Secondary
peaks with a higher m/z ratio and considered to be
compounds associated with oligosaccharide cores with
different O-antigen repeating units (Veron et al., 2007)
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Fig. 2. Effect of GABA (0.01 mM) on the
biofilm formation activity of P. aeruginosa
PAO1, measured after 24 or 48 h of incuba-
tion. Bacteria were exposed to GABA only
during the growth phase (pre-treatment), only
during the biofilm formation period (during
biofilm) or continuously during growth and
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film). The biofilm formation activity is expressed
as a percentage of the control value. NS, non-
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were present in lower amounts. The mass spectrum of LPS
extracted from GABA-treated bacteria was remarkably
preserved. As noted in Fig. 3(b), the positions and relative
intensities of all the peaks were the same in LPS extracted
from control and GABA-treated P. aeruginosa, demonstrat-
ing that the LPS structure was not altered in response to
GABA treatment. The surface properties of bacteria can be
also influenced by the production of surfactants which
modulate the surface tension between the bacterium and its
immediate environment. A rapid method to check the
bacterial production of surfactant involves collecting
colonies on solid agar medium, cleaning them with pure
water and measuring their surface tension (Carrillo et al.,
1996).
P. aeruginosa PAO1 colonies showed a surface tension of
39.3±1 mN m21, indicating the presence of surfactants in
solution (the mean surface tension of poorly mineralized
water is 71.7 mN m21; Hiemenz & Lagowski, 1977).
Interestingly, the surface tension of the extract of bacterial
colonies grown in the presence of GABA was unchanged
(39.3±1 mN m21) but when this was measured on diluted
extract, we observed a shift in critical micellar concentra-
tion for control and GABA-treated bacteria, suggesting a
difference in the composition of the biosurfactants (data
not shown). Biosurfactants from control and GABA-treated
P. aeruginosa were then extracted and analysed by HPLC-
ESI-MS/MS. A total of 10 different types of rhamnolipids
were identified (Table 1). The same molecules were found in
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Fig. 3. MALDI-TOF analysis of LPS extracted from control (a) and GABA-treated (b) P. aeruginosa PAO1. Each figure is
representative of three independent analyses.
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the extracts of P. aeruginosa exposed or not to GABA and
their relatives proportions were identical, suggesting that the
variations of surface tension observed in dilutions were due
to other soluble factors such as proteins.
Effect of GABA on P. aeruginosa diffusible
virulence factors
The effect of GABA on the major exoenzymic activities
produced by P. aeruginosa PAO1, i.e. caseinase, esterase,
haemolytic, amylase, lecithinase and elastase activities, was
tested. None of these was altered in bacteria grown in the
presence of GABA (data not shown). We investigated the
effect of GABA on the principal secondary metabolites
produced by P. aeruginosa, starting with pyoverdine, the
production of which depends on iron availability in the
environment and thus of the culture medium composition.
We therefore studied the effect of GABA in two media
known to promote pyoverdine secretion. As shown in Fig.
4(a and b), GABA has no effect on pyoverdine production
in any of the tested media.
Exotoxin A is the most toxic secreted virulence factor of P.
aeruginosa in terms of mass/activity ratio (Wolf & Elsa¨sser-
Beile, 2009). The production of exotoxin A by P. aeruginosa
was studied in NB after 10 and 24 h of treatment with
GABA. Exotoxin A was detected in the medium using a
highly sensitive ELISA. As shown in Fig. 4(c), the secretion
pattern of exotoxin A was unchanged in control and
GABA-treated bacteria.
P. aeruginosa is also known to produce non-peptidic toxins,
such as HCN. We have recently developed an original HCN
polarographic assay whose sensitivity is below 1 mg l21 (Blier
et al., 2012). The mean concentration of HCN in the
medium of control cultures of P. aeruginosa after 24 h
of incubation was 1.024±0.015 mg l21 (Fig. 4d). The
concentration of HCN in the medium of GABA-treated
bacteria was significantly increased (+35%, P,0.05),
reaching 1.383±0.015 mg l21.
Effect of GABA on the protein pattern expression
of P. aeruginosa
The cell-associated proteome was investigated by analysing
pellets of P. aeruginosa PAO1 grown in the absence or
presence of GABA. The 2-D electrophoresis assays on total
protein extracts showed limited differences between the
proteome of control (Fig. 5a) and GABA-treated (Fig. 5b)
bacteria. Two proteins (spots 1 and 2) were downregulated
whereas the expression of five other proteins (spots 3–7)
was clearly increased (Fig. 5c). Each spot was excised,
digested in-gel with trypsin and analysed by MALDI-TOF/
TOF. The seven spots corresponded to P. aeruginosa
proteins identified in the NCBI database (Table 2). Spots 1
and 3 corresponded to the same thermo-unstable elonga-
tion factor (Tuf), as confirmed by TOF/TOF fragmenta-
tion, but the neutral form present in spot 1 was only
detected in control bacteria; after treatment with GABA it
was replaced as an acidic form identified as spot 3. Another
protein, the thermostable elongation factor (Ts), found in
spot 6, appeared to be upregulated in the presence of
GABA. Spot 2, not present in bacteria exposed to GABA,
was identified as an ornithine carbamoyltransferase. The
other spots 4, 5 and 7 corresponded to a peroxidase, and
alkyl hydroperoxide reductase and a putative USP-like
protein, respectively.
Effect of GABA on P. aeruginosa quorum sensing
factors
Since cyanogenesis is regulated by the quorum-sensing
system, we investigated the effect of GABA on 3oxoC12-
HSL, C4-HSL and PQS production by P. aeruginosa. The
kinetics of 3oxoC12- and C4-HSL secretion were studied
over 24 h. In the presence of GABA, the peak of
Table 1. Rhamnolipids identified and quantified by ESI-MS analysis in cultures of P. aeruginosa PAO1 grown in the absence or
presence of 0.01 mM GABA
Data are means±SEM.
Rhamnolipids Intensity105 (arbitrary units)
Control PAO1 GABA-treated PAO1
Rha-Rha-C8–C10/Rha-Rha-C10–C8 4.1±1.4 2.6±0.9
Rha-C10–C8/Rha-C8–C10 0.9±0.2 0.7±0.2
Rha-Rha-C8–C12 : 1 6.2±1.7 4.9±1.2
Rha-Rha-C10–C10 318.1±58 257.2±63.1
Rha-C10–C10 80.1±8.6 88.9±19.8
Rha-Rha-C10–C12 : 1 37.4±9.2 36.0±10.6
Rha-C10–C12 : 1 4.3±1.5 4.9±1.1
Rha-Rha-C12–C10/Rha-Rha-C10–C12 67.1±30.7 62.2±20.5
Rha-Rha-C12–C12 : 1 2.4±1.5 2.0±0.8
Rha-Rha-C12–C12 2.3±1.3 2.1±1.0
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production of 3oxoC12-HSL was higher than in control
studies (Fig. 6a). In addition, this peak was observed 8 h
after the beginning of the experiment, whereas it appeared
after 12 h in control bacteria. The production of C4-HSL
was also stimulated in GABA-treated bacteria but the effect
was of lower amplitude and statistically non-significant
(Fig. 6b). The effect of GABA on PQS production was
studied by using two complementary techniques: TLC, the
classical method employed to detect PQS, and HPLC,
which provides a higher resolution. PQS production was
measured after 24 h to allow sufficient accumulation of the
molecule in the culture medium. Both techniques clearly
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Fig. 5. 2D electrophoresis analysis of the total proteome of control (a) and GABA-treated (b) P. aeruginosa PAO1. Seven spots
were modified after exposure of the bacteria to GABA (c). The proteins corresponding to these spots are presented in Table 2.
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showed that the production of PQS by P. aeruginosa PAO1
was not modified by GABA (Fig. 7).
DISCUSSION
GABA is a non-protein amino acid that is conserved in
bacteria and eukaryotes (see Bouche´ et al., 2003 for a
review). In plants, GABA is secreted as a defence signal
against bacterial phytopathogens (Chevrot et al., 2006). In
the case of P. aeruginosa, we observed that GABA did not
affect the growth and motility of the bacterium but did
increase its cytotoxicity and virulence. The C. elegans
model gave a first indication of the mechanisms involved
in the response of P. aeruginosa to GABA. Indeed, GABA
had a strong effect on bacterial virulence in the ‘fast killing
test’. In this test, the secretion of bacterial diffusible
molecules is stimulated by the use of a high-osmolarity
medium, suggesting that soluble toxins have a principal
role in the increase in virulence. In agreement with this
hypothesis, the virulence of P. aeruginosa in the ‘slow
killing test’ appeared to be only marginally increased.
However, the biofilm formation experiments revealed that
the action of GABA should be more complex. When
bacteria were exposed to GABA only during the biofilm
formation period, GABA had no effect. Only bacteria
pretreated during the growth phase showed a generally
significant reduction in biofilm formation, suggesting that
only the early phases of bacterial adhesion are affected by
GABA.
In order to clarify the mechanism of action of GABA on P.
aeruginosa, we focused in a first step on surface associated
factors. GABA increased bacterial cell adhesion but this
effect was not significant. In contrast, we observed a
significant increase in the adhesion on glass of GABA-
treated Pseudomonas. Glass is a polar surface whereas PVC,
on which the biofilm formation tests were done, is
hydrophobic. This is in agreement with the opposite effects
of GABA on bacterial adhesion on these two surfaces.
However, the MATS technique did not reveal any variation
of surface polarity suggesting that GABA was acting on a
specific adhesin(s). LPS, the principal component of the
outer membrane of Gram-negative bacteria, was
unchanged in GABA-treated bacteria. The surface tension
of P. aeruginosa extracts was consistent with the presence of
biosurfactants, and, since biosurfactants can interfere with
the binding properties and biofilm formation activities of
Pseudomonas (de Bruijn et al., 2007), these molecules were
analysed but, here also, the structure and concentration of
rhamnolipids expressed by PAO1 were not modified in
bacteria exposed to GABA.
The effect of GABA on diffusible toxins and on the
proteome of P. aeruginosa was then investigated. The
cytotoxic activity of P. aeruginosa, measured by LDH
release from eukaryotic cells when the cytoplasmic
membrane is disrupted, can be considered as an equivalent
of haemolysis and it is known that this is essentiallyT
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induced by a type III secretion system (Goure et al., 2004)
or phospholipase C (Ostroff et al., 1989). The tests done on
blood-supplemented agar plates showed no variation in
bacterial haemolytic activity. All other exoenzymic activ-
ities studied also remained unchanged. Pyoverdine is
essential for P. aeruginosa virulence (Meyer et al., 1996)
so the production of this siderophore in GABA-treated
bacteria was monitored but it appeared clearly that
pyoverdine production is not modulated by GABA.
Exotoxin A is the most toxic secreted virulence factor of
P. aeruginosa in terms of mass/activity ratio (Wolf &
Elsa¨sser-Beile, 2009). Its secretion was studied in the same
medium used to test the effect of GABA on P. aeruginosa
virulence (NB). As it is a low-iron-inducible toxin, in our
experimental conditions limited concentrations of exo-
toxin A were detected and its production was not affected
by GABA. The arsenal of P. aeruginosa is not exclusively
composed of peptidic molecules and it is interesting to
note that hydrogen cyanide (HCN) is considered to be the
principal diffusible lethal toxin acting on C. elegans
(Gallagher & Manoil, 2001). In the present study, we used
a polarographic assay of HCN/CN2 based on the redox
properties of cyanide ions recently developed in our
laboratory (Blier et al., 2012). High quantities of HCN
were measured in the growth medium of P. aeruginosa
PAO1 and GABA induced a significant increase of HCN
production. By itself, this increase of HCN (35%) could
explain the virulence of GABA-treated P. aeruginosa but
this is not sufficient to understand the variations of
surfaces properties observed in parallel. The total proteome
of GABA-treated P. aeruginosa was then analysed and
compared with that of control bacteria. The differences of
expression were limited to six proteins. A first novel result
was the observation of two spots (1 and 3) corresponding
to the same protein but showing very different pI values.
This protein, identified as the thermo-unstable elongation
factor Tuf, is a GTP/GDP and ribosome binding protein,
but it is also capable of binding the thermostable
elongation factor Ts (Wittinghofer et al., 1983), detected
as spot 6 and markedly overexpressed in GABA-treated
Pseudomonas. The existence of free or GDP+Pi tightly
bound Tuf could explain the shift in pI of the molecule
between control and GABA-treated bacteria. However, we
cannot exclude that GABA itself could bind Tuf, and
because of its acidic character decrease the pI of the
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protein. This binding should also explain the long-term
effect of GABA. In agreement with this hypothesis, which
deserves further study, it has been shown that the
elongation factor Tuf can be associated with the membrane
of P. aeruginosa and it acts as a binding protein for the
human plasma regulators factor H and plasminogen
(Kunert et al., 2007). The change of Tuf charge could also
explain the specific effects of GABA on P. aeruginosa
surface properties independently of variations in polarity,
LPS or biosurfactant production. The four other proteins
modulated by GABA have in common their role in
oxidative metabolism. Ornithine carbamoyltransferase,
identified as spot 2, is a key enzyme of the arginine
deiminase pathway involved in the anaerobic metabolism
of arginine (Vander Wauven et al., 1984). In GABA-treated
bacteria, the ornithine carbamoyltransferase was markedly
repressed, whereas that of the three other proteins, a
putative peroxidase, an alkyl hydroperoxide reductase and
a USP-like protein, were upregulated. As for other enzymes
of this family, the putative peroxidase over-expressed in the
presence of GABA (spot 4) should be implicated in the
removal of toxic peroxides. The alkyl hydroperoxide
reductase, identified as spot 5, is essential for optimal
resistance of P. aeruginosa to organic hydroperoxides and
has an important protective role against oxidative stress
(Ochsner et al., 2000). The hypothetical USP-like protein
PA3309 is overproduced during pyruvate fermention and
in anaerobic/aerobic stationary phases (Schreiber et al.,
2006). An effect of GABA on the oxidative metabolism of
P. aeruginosa could also explain the increase in HCN
observed in the present study, since cyanogenesis requires a
reduced level of free oxygen (Castric et al., 1981).
In P. aeruginosa, cyanogenesis is regulated by quorum
sensing. The hcnABC genes encoding HCN synthases are
controlled by LasR and RhlR, respectively, which are
involved in the regulation of 3oxoC12-HSL and C4-HSL
synthesis (Schuster & Greenberg, 2006). In agreement with
this, in GABA-treated P. aeruginosawe observed a significant
increase in 3oxoC12-HSL formation and a marginal
variation in the C4-HSL kinetics. Conversely, the produc-
tion of PQS, whose synthesis is also under the control of the
two acylhomoserine lactones (Schuster & Greenberg, 2006),
was not affected by GABA. This is also in agreement with the
absence of any effect of GABA on pyoverdin production,
which, through PqsE, is regulated by PQS (Diggle et al.,
2006). The action of GABA on P. aeruginosa is then
fundamentally different from other Gram-negative bacteria
such as Agrobacterium tumefaciens, where GABA provokes a
decrease in acylhomoserine lactone synthesis and a reduc-
tion in virulence (Chevrot et al., 2006).
To our knowledge, this is the first demonstration that
GABA can regulate P. aeruginosa virulence. We show that a
low concentration of exogenous GABA triggers an increase
in virulence of P. aeruginosa due to a stimulation of
cyanogenesis associated with a reduction in oxygen
accessibility and an overexpression of oxygen-scavenging
proteins. This mechanism is regulated by quorum sensing.
GABA also promotes specific changes in the expression of
thermostable and unstable elongation factors involved in
the interaction of the bacterium with the host proteins. As
GABA is a widespread molecule, these observations should
be taken into consideration in agricultural, veterinary and
medical practices.
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21
Abstract22
23
Polycyclic aromatic hydrocarbons (PAHs) can be preponderant in contaminated sediments 24
and understanding how they are sorbed in the different mineral and organic fractions of the 25
sediment is critical for effective removal strategies. For this purpose, a mixture of seven 26
PAHs was studied at the sediment/water interface and sorption isotherms were obtained. The 27
influence of various factors on the sorption behavior of PAHs was evaluated, such as the 28
nature of minerals, pH, ionic strength and amount of organic matter. Afterwards, the release29
of PAHs from the sediment by surfactants was investigated. The effectiveness of sodium 30
dodecyl sulfate (SDS) was compared to natural biosurfactants, of cyclolipopeptidic type 31
(amphisin and viscosin-like mixture), produced by two Pseudomonas fluorescens strains. The32
desorption of PAHs (from naphthalene to pyrene), from the highly retentive kaolinite fraction,33
could be favored by adding SDS or amphisin, but viscosin-like biosurfactants were only 34
effective for 2-3 ring PAHs desorption (naphthalene to phenanthrene). Moreover, while SDS 35
favors the release of all the target PAHs from a model sediment containing organic matter, the 36
two biosurfactants tested were only effective to desorb the lowest molecular weight PAHs37
(naphthalene to fluorene).38
39
Keywords40
Polycyclic aromatic hydrocarbons; PAHs release; Biosurfactants; Sorption isotherms;41
Water/sediment interface42
43
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1. Introduction43
44
Contaminated bottom sediments in rivers and harbors are a significant problem because of the 45
potential risks generated for aquatic organisms, wildlife, and humans. Among the 46
contaminants that can pose threats to small organisms, polycyclic aromatic hydrocarbons 47
(PAHs) are a group of organic compounds which are persistent, toxic, and are known to be 48
potential carcinogens or mutagens [1]. Sediments act as temporary or long-term sinks for this 49
class of pollutants [2, 3]. The properties of sediments differ significantly from those of soils. 50
Indeed, sediments are heterogeneous materials which are characterized by a high proportion 51
of fine particles compared to soils with also a high proportion of organic matter and water 52
content. For these reasons, decontamination methods similar to those used for soils (such as 53
soil washing) are not suitable to all types of sediments, particularly to fine-grained sediments 54
where pollutants accumulate [4]. Among different alternatives (such as bioremediation [5]), 55
electrokinetic (EK) remediation is promising for low permeability sediments. This technology 56
involves applying a low intensity electric current between two electrodes imbedded in the 57
sediment. This remediation process is limited when pollutants are nonionic and with a low 58
aqueous solubility, which is the case of PAHs [6]. Consequently, to improve decontamination 59
processes such as EK remediation, it is necessary to enhance PAH desorption from fine 60
sediment particles, and also to create a favorable environment to facilitate migration towards 61
the electrode chambers.62
Tensioactive compounds have been shown to enhance the mobilization and solubilization of 63
PAHs from contaminated soils [7, 8]. Surfactants are amphiphilic compounds which enhance 64
the apparent solubility of the lipophilic contaminants through micellar solubilization. 65
Desirable surfactant characteristics include low surface tension, low critical micellar 66
concentration (CMC), but also low adsorption to soil or sediment. Anionic surfactants are less 67
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likely to be adsorbed by soil particles than nonionic or cationic ones [9]. But some 68
degradability is also required to avoid accumulation during the remediation processes. 69
Biosurfactants, which are biologically produced from yeast or bacteria, are potentially more 70
biodegradable and less toxic than synthetic surfactants [10]. Biosurfactants are particularly 71
promising for enhanced remediation of soils contaminated by organic components [11, 12].72
Indeed, it has been shown that biosurfactants act to enhance the process of 73
pseudosolubilization/emulsification thereby increasing the availability of organic compounds 74
to microbial cells in bioremediation processes [13]. Although synthetic surfactants have been 75
more extensively studied for enhanced electrokinetic remediation of PAHs [14, 15], 76
biosurfactants also have an interesting potential to help in EK sediment decontamination [16].77
The aim of this study was to evaluate for the first time the potential of two biosurfactants of 78
cyclolipopeptidic (CLP) type (amphisin and viscosin-like CLPs) to desorb PAHs from 79
artificially contaminated model sediment. Indeed, a majority of studies deals with 80
biosurfactants such as rhamnolipids [17, 18] and lipopeptids are far less studied [19, 20]. The 81
final objective (not reported here) is to enhance the decontamination of sediments by an EK 82
process. This paper describes first batch suspension experiments, conducted to determine the 83
extent to which representative sediment components contribute to PAHs sorption. Sorption 84
isotherms of a mixture of PAHs were obtained simultaneously, at trace levels, thanks to a 85
liquid chromatographic method (HPLC) combined to a trace concentration procedure by solid 86
phase extraction (SPE). Afterwards, three anionic surfactants were tested to enhance the 87
aqueous solubilization of PAHs from kaolinite and from a more complex model sediment 88
containing organic matter. A synthetic surfactant, sodium dodecyl sulfate (SDS), was 89
compared to cyclolipopeptidic biosurfactants produced by two Pseudomonas fluorescens90
strains.91
92
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2. Materials and methods93
94
2.1. Materials and chemicals95
96
2.1.1. Solvents and contaminants97
Acetonitrile, methylene chloride, acetone, hexane (of HPLC grade), trifluoroacetic acid 98
(TFA), dimethylsulfoxide, SDS and sodium chloride were purchased from Fisher Scientific 99
(Illkirsh, France).100
A mixture of 15 PAHs (purchased from Sigma-Aldrich-St Quentin Fallavier, France),101
containing 2- to 6-ring PAHs and considered as priority pollutants by the American 102
Environmental Protection Agency, was prepared in acetonitrile (20 µg mL-1). 103
The model sediment was made in order to mimic the mineralogy of natural sediment collected 104
from a disposal site managed by a Norman harbor (France). It contained 5% silica sand 105
(particle diameter dp=125-315 µm) from Sika (Hostun, France), 75% quartz silt (dp=4-100 106
µm) collected from surface formations covering the chalk plateau in Normandy (Rouen, 107
France) and 20% kaolinite (dp<80 µm, with 54% of particles less than 2 µm) from Imerys 108
(Poigny, France). Organic matter (OM) was added to this model sediment: it was kindly109
provided by Veolia (France). OM was obtained from the decomposition of a vegetable 110
material, which was dried for 48h at 50°C, crushed and sieved to 355 µm.111
112
2.1.2. Production and purification of biosurfactants113
Bacteria P. fluorescens DSS73 and P. fluorescens PfA7B were grown on Davis minimal agar 114
culture plates, as described in a previous paper [21]. After incubation for 14 days at 17°C115
[22], colonies were scrapped off, transferred to sterile water and centrifuged 30 minutes at 116
18000g. The biosurfactant purification was slightly modified compared to a previous work 117
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[21]: 100 mL of the aqueous supernatant (containing 610-3 mol.L-1 TFA) was put in contact 118
and agitated one hour with 80 mL methylene chloride and then transferred into a separatory 119
funnel. Amphisin, produced by P. fluorescens DSS73, was extracted three times from each 120
aqueous fraction while viscosin-like mixture, produced by P. fluorescens PfA7B, was 121
extracted five times. After collection and evaporation of all the organic phases with a rotary 122
evaporator, concentrated extracts were freeze dried [21].123
124
2.2. Analytical procedures125
126
2.2.1. Biosurfactant characterization127
Purified biosurfactants were analyzed by liquid chromatography (Beckman Coulter, Fullerton, 128
USA), on a C18 bonded column from Beckman (4.6 mm i.d., dp=5 µm and 250 mm length), 129
using a mobile phase composed of 40% water (with 0.1% TFA) and 60% acetonitrile, at 1 130
mL.min-1 and with a UV detection at 206 nm. The production of P. fluorescens DSS73 was 131
composed of one majority CLP, named amphisin, consisting in a lypophilic chain and 11 132
amino acids (Table 1). The production of P. fluorescens PfA7B was composed of a mixture 133
made of two majority CLPs (viscosin-like biosurfactants), composed of a lypophilic chain and 134
polar parts containing 9 amino acids (Table 1) [22].135
The critical micellar concentrations (CMC) of purified biosurfactants and surface tension 136
measurements were made on a tensiometer DSA30 (Krüss, Germany).137
138
2.2.2. Sorption isotherms139
140
2.2.2.1. Analysis of PAHs by HPLC-FLD141
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Aqueous samples containing PAHs were analyzed by HPLC using a fluorimetric (FLD) 142
detector Prostar 363 (Varian, Palo Alto, USA). 20 µL of samples were injected into a C18143
Envirosep PP column (150x4.6 mm, dp=5 µm) purchased from Phenomenex (le Pecq, 144
France), with a flow-rate of 1 mL.min-1. The mobile phase program was composed of 145
acetonitrile and water 55/45% (v/v) for 5 minutes, followed by a gradient for 20 minutes to 146
finish by 100% acetonitrile. Optimal fluorescence excitation and emission wavelengths were 147
chosen for each PAH to obtain a sensitive detection, and the limits of detection (LOD) and 148
quantification (LOQ) were evaluated (Table 2).149
150
2.2.2.2. Trace enrichment by SPE151
A trace enrichment procedure by SPE (solid phase extraction) was developed for PAHs 152
remaining in the aqueous phase after sorption experiments. 60 mg SPE cartridges (Strata X, 153
Phenomenex) were used, coupled with PTFE Phenex filters (0.45 µm) (Phenomenex). SPE 154
cartridges were conditioned with 8 mL acetone and 10 mL of a mixture acetone/water 20/80% 155
(v/v). After adding 20% acetone in volume to the aqueous medium containing PAHs, it was 156
passed through the SPE cartridge, which was finally rinsed with 10 mL of pure water. Then 157
the cartridge was dried and PAHs were eluted with 5 mL of methylene chloride. After adding 158
60 µL of dimethylsulfoxide, methylene chloride was evaporated under nitrogen flow and 159
solutes were solubilized again in acetonitrile, before injection in the HPLC system. The 160
complete procedure filtration-SPE-HPLC-FLD was evaluated on 20-100 mL aqueous samples 161
spiked with a PAH test solution at 10 µg.L-1. Mean recoveries of each PAH ranged from 162
82.0±3.9% to 94.2±1.2%, which was satisfactory (Table 2).163
164
2.2.2.3. Batch adsorption experiments165
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The sorption experiments were carried out using a sediment/solution ratio of 1/9 (w/w), which 166
represents a solid mass concentration Csed = 0.111 kg.L-1. Mixtures were placed in a bath at 167
25°C (Fisher Bioblock Scientific, Illkirsh, France), under agitation (250 rpm). PAH addition 168
in bottles was performed at known initial concentration (Co (µg.L-1)) from a stock solution of 15 169
PAHs, mimicking the diversity of PAHs in the natural environment. After incubating the 170
samples for 24h, the bottles were centrifuged and the aqueous supernatant discarded. 171
Concentrations of PAHs remaining at equilibrium in the aqueous phase (Ceq (µg.L-1)) were 172
determined as described previously (section 2.2.2.2), with SPE concentration factors of 173
approximately 20 to 40. The concentration of sorbed PAHs (Cads (µg.L-1)) was obtained from the 174
difference between Co and Ceq. Sorption isotherms at 25°C were then established in varying 175
Co and plotting Cads (µg.kg-1) = f (Ceq), with Cads (µg.kg-1) = Cads (µg.L-1) /Csed (kg.L-1). Cads represents the 176
quantity of PAH sorbed per kg of sediment. The initial solute concentrations Co were selected 177
to yield aqueous concentrations remaining at equilibrium distributed over a wide 178
concentration range. However, the water solubility of high molecular weight PAHs 179
(M>202.26 g.mol-1) was, in many cases, lower than the desired initial concentration. So, in 180
the mass balance, precipitation of high molecular weight PAHs may contribute to the181
immobilization of those PAHs and we cannot consider it as a sorption phenomenon. 182
Consequently, sorption isotherms and desorption by biosurfactants were studied only for the 183
seven more soluble PAHs, from naphthalene to pyrene (M<202.26 g.mol-1) (Table 2).184
The variability of the complete process (sorption-filtration-SPE enrichment-quantification by 185
HPLC-FLD) was evaluated from five experiments and Table 3 shows that sorption 186
experiments were relatively reproducible, even at very low aqueous concentrations.187
188
2.2.2.4. Sorption isotherms modeling189
The linear Henry’s model for sorption isotherms was described by equation (1):190
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Cads= Kd x Ceq (1)191
Where Kd is the distribution (or partition) coefficient between the solid and the liquid phases.192
The equation (2) of the empirical Freundlich model was expressed as:193
(2)194
Where KF is the Freundlich constant and 1/n is the heterogeneity factor. Finally, the 195
monolayer Langmuir isotherm was described by the equation (3):196
(3)197
Where KL is the Langmuir constant and Cmax is the maximum sorption capacity of the sorbent.198
199
3. Results and discussion200
201
3.1. Sorption isotherms of PAHs on artificial sediments202
203
Sediments are composed of particles of sand, clays, silts and of organic matter (OM). 204
According to their classification based on the grain size, stones or gravels are differentiated 205
from the finest particles, such as sands (diameter ranging from 50 to 2000 µm), silts (2-50 206
µm) and clays (diameter less than 2 µm) (French standard NF P18-105). So, these three main 207
mineral components were tested as sorbents for PAHs. As PAHs are hydrophobic organic 208
contaminants, with low aqueous solubility, they were strongly sorbed onto particles. Fig. 1 209
shows the sorption isotherms of three of the seven studied PAHs (as examples). As mentioned 210
in section 2.2.2.3., only low molecular weight PAHs (128.18 g.mol-1 M 202.26 g.mol-1),211
introduced below their water solubility, were considered for sorption isotherms. As can be 212
seen on Fig. 1, sorption of PAHs was governed by their own structure and properties and by 213
the size of sorbent particles. Wang et al. [23] demonstrated that the highest PAH 214
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concentration levels were associated with the largest size fractions of harbor sediments, but 215
this result was linked to a higher association of OM with larger particles. In this reported case, 216
OM was responsible for the strongest sorption rather than the mineral particle size [23]. In our 217
study, it is clear that kaolinite is the strongest sorbent when no OM enters the composition of 218
the material. Indeed, clay has the highest specific surface area with respect to volume ratio of 219
any particle size class. In contrast, sand shows a lower capacity to adsorb all PAHs on its 220
surface.221
Experimental data were fitted using linear regressions according to a model based on Henry’s 222
isotherms, and from linear forms of Langmuir and Freundlich isotherms (section 2.2.2.4). 223
Table 4 presents the optimum isotherms and parameters for the various inorganic constituents 224
in the model sediment. From the results, sorption of the target PAHs fit better with the 225
Freundlich model than with the Langmuir one. However, it must be noted that the linear 226
model was relatively appropriate for the PAHs in the studied concentration range, except for 227
the sand material. Indeed, the saturation of sites was observed for sand and not for silt or 228
kaolinite. Since they have low porosity, silicates do not constitute high adsorption sites for 229
nonionic compounds. As highlighted, we could observe for silt and kaolinite a nearly linear 230
shape at relatively low concentrations of PAHs. At these concentration levels, Henry’s model 231
is generally sufficient to describe sorption phenomena [24]. The sorption of PAHs on silt or 232
kaolinite is predominantly controlled by a partitioning process, with the specific surface area 233
being the major controlling factor. Moreover, the structure of the pollutant is also crucial. 234
Indeed, fluoranthene (three aromatic rings and a five-membered ring) is more strongly 235
adsorbed than phenanthrene (three aromatic rings), which is itself more strongly adsorbed 236
than acenapthene (two aromatic rings and an ethylene bridge) (Fig. 1). We can observe that 237
the heavier the PAH is, the higher the sorbent-PAH partition coefficient Kd is (Table 4). Since 238
sorbents tested here did not contain OM, these results could be explained by dispersive and 239
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dipole-induced dipole interactions between mineral surfaces and PAH molecules, which are 240
stronger when the number of aromatic rings is higher.241
The model sediment was a mixture of sand, silt and clay (section 2.1.1.), which was made to 242
mimic the mineral and particle size distribution of dredged harbor sediments collected from a 243
French disposal site. The best fit for the data, for this model sediment, was also obtained with 244
the Freundlich model (Table 4), which consequently described a sorption process of 245
physisorption type through heterogeneous sites. As can be seen in Fig. 1, the sorption 246
behavior of this model sediment was intermediary between pure silt and pure kaolinite 247
sorption behavior. Table 4 indicates that in the studied concentration range, the linear model 248
fit well also.249
As natural sediments from the French Norman disposal site come from marine channels, they 250
can contain high amounts of salts. Moreover, if we consider electrokinetic remediation as a 251
potential process to decontaminate the dredged sediments, it is important to pay particular 252
attention to the pH of the aqueous medium since this remediation process is considered to be 253
more effective at an acidic pH for co-contaminants such as metals. Consequently, we studied 254
the influence of NaCl and pH on the PAH sorption on the model sediment. Fig. 2 illustrates 255
the sorption isotherms of fluorene and pyrene with or without NaCl, at acidic or neutral pH. It 256
emerged from the results that the value of pH and NaCl concentration did not significantly 257
influence the sorption of the seven target PAHs. This can be explained by the fact that PAHs 258
are nonionic molecules that are much less strongly influenced by pH and ionic strength 259
variations than ionic compounds.260
Many studies have demonstrated that OM plays the most important role in the sorption of 261
PAHs in marine sediments [23]. It is why amorphous OM was added, in controlled 262
proportions, to the mineral fraction of the model sediment. Fig. 3 gives the sorption isotherms 263
of three of the target PAHs with various contents of OM. It is clear that the higher the OM 264
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content is, the higher the sorption is. It can be noted that even a very low content of OM (1%) 265
leads to a strong effect. Partition coefficients could be calculated from the linear model, and 266
the organic carbon normalized sorption coefficient Koc was evaluated thanks to the equation 267
(4), where foc is the organic carbon fraction (Table 5):268
Koc=Kd/foc (4)269
The OM percent was converted to organic carbon (OC) by the well-known relationship 270
(equation 5) [25]:271
(%OM)=1.727(%OC) (5)272
Wang et al [23] found values of log Koc ranging from 4.12 to 6.07 for phenanthrene, from 273
4.62 to 6.56 for fluoranthene, and from 4.68 to 5.5 for pyrene. In our case, log Koc values 274
were 4.28 and 4.33 for phenanthrene, 4.53 and 4.66 for fluoranthene, and 4.56 and 4.70 for 275
pyrene (Table 5). These values were similar to the lowest values reported by Wang et al. 276
Indeed, it must be remembered that OM introduced in our studied system was amorphous and 277
was not completely mature. But natural mature bottom sediments include also a small 278
condensed carbon part (soot, coal…) in which interactions are stronger [26]. Even if this 279
condensed part is not predominant in proportion in carbonaceous matter, it contributes 280
significantly to PAH sorption and can explain the highest values of log Koc in many soils or 281
sediments.282
PAHs are characterized by high numerical values of Koc (Table 5): they strongly sorb on 283
carbonaceous matter and the interactions that occur are not polar. So OM plays a major role in 284
sequestrating PAHs and it is well known that when Koc values are high, sorbed compounds 285
are not easy to release.286
287
3.2. Effect of synthetic and biological surfactants on PAH desorption288
289
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When organic decontamination of sediments must be done using technologies such as EK 290
remediation, the first step of the process consists of promoting an increased desorption of 291
PAHs by reducing interfacial tension between the water and the sediment and by increasing 292
the apparent solubility of the contaminant in the aqueous phase [6, 27]. Synthetic but also 293
biological surfactants have been already tested to desorb PAHs from soils and sediments. Pure 294
kaolinite is often used as a model material to test the PAH removal enhancement by 295
surfactants, because of its particular nature [15, 28, 29]: it contains very low fractions of OM296
and it has a very high specific surface area. Consequently, our first experiments, which aimed 297
at understanding the surfactant enhanced removal of PAHs from the mineral part of the 298
sediment, were carried out with kaolinite and three anionic surfactants. Amphisin, produced 299
by Pseudomonas fluorescens DSS73 and viscosin-like biosurfactants, produced by 300
Pseudomonas fluorescens PfA7B, are cyclolipopeptidic (CLP) biosurfactants (Table 1).301
Amphisin contains two aspartic acids in its polar moiety, whose pKa are 3.9 and massetolide 302
E and viscosin contain a glutamic acid, whose pKa is 4.1. The CMC value of the viscosin-like 303
mixture was 0.05 g.L-1, which was lower than that of amphisin (0.3 g.L-1) (Fig. 4).304
Morevover, amphisin made it possible to lower the surface tension of pure water from 305
68.4±0.9 mN.m-1 to 33.5±0.3 mN.m-1 (n=10 replicates) while surface tension was lowered to 306
24.7±0.1 mN.m-1 (n=10) when using the viscosin-like mixture.307
These biosurfactants were compared to the conventional synthetic SDS. Firstly, SDS and 308
amphisin were tested near their CMC, at 2.5 g.L-1 for SDS (CMC=2.3 g.L-1) and 0.3 g.L-1 for 309
amphisin. These surfactant concentrations did not allow any significant release of the PAHs. 310
Indeed, even if anionic surfactants are less strongly retained on kaolinite than nonionic or 311
cationic ones, due to the repulsive negative surface charges, they are partially sorbed on the 312
mineral surface. Such surfactant losses increase the total surfactant concentration required to 313
form micelles in the aqueous phase. Consequently, we can speak about an effective CMC 314
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(CMCeff) above which PAHs can solubilize in aqueous aggregates, with CMCeff > CMC [30]. 315
It is why the biosurfactants and SDS were tested well above their CMC, in a second step, that 316
is ten times their CMC for SDS and for the mixture of viscosin-like CLPs. Amphisin was 317
tested at 1 g.L-1 because it was more difficult to produce high quantities of this biosurfactant.318
Fig. 5 shows the sorption isotherms on kaolinite of three of the seven PAHs studied, when 319
adding SDS, amphisin or viscosin-like CLPs in the aqueous phase. Adding SDS or amphisin 320
led to a significant decrease of the sorption of all the PAHs on the clayey material. In the case 321
of viscosin-like CLPs, they only contributed to a decrease of the sorption of the 2-3 ring 322
PAHs, but not of pyrene (Fig. 5c). In a majority of cases, the sorption isotherms obtained 323
when adding SDS, amphisin or viscosin-like CLPs fit slightly better with the Langmuir model 324
(and no longer with the Freundlich one). It seems that adding surfactants well above their 325
CMC tended to decrease the heterogeneity of sorption sites on kaolinite for the seven studied326
PAHs. 327
In fact, above its CMC, it has been demonstrated that SDS can form hemimicelles at the 328
kaolinite surface, with an orientation of the hydrophobic moieties in the aqueous phase [9, 329
31]. This phenomenon has also been shown for anionic biosurfactants such as bioemulsans or 330
rhamnolipids [32, 33]. The head-on sorption of biosurfactants or SDS, even if low, can also 331
promote the incorporation of lipophilic PAHs into the hemimicelles (so-called 332
adsolubilization phenomenon). Hence, the PAH retention process can be due to two 333
mechanisms: a partition into hemimicelles formed by the sorbed surfactants and a direct334
adsorption to the heterogeneous surface sites of kaolinite. However, a greater interaction 335
between PAHs and aqueous surfactant micelles, than between PAHs and hemimicelles, occurs 336
at high PAH concentrations, leading to a partition of PAHs in favor of the aqueous medium 337
rather than of the kaolinite surface.338
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This mechanism of partial PAH desorption thanks to their incorporation into aqueous micelles 339
cannot completely explain all the cases when the viscosin-like CLPs are used. We observe340
that the viscosin-like mixture actually helps to enhance the release of 2-3 ring PAHs 341
(naphthalene to anthracene) from the kaolinite (Fig. 5a and 5b are given as examples). Yet, it 342
is not effective for the 4-ring more apolar PAHs, fluoranthene and pyrene (Fig. 5c). We can 343
suppose that the mixture of massetolide E and viscosin is less polar than amphisin, since they 344
possess only one ionic amino acid while amphisin possesses two ionic amino acids in its polar345
moiety. It has been shown that relatively more hydrophilic surfactants were more effective in 346
enhancing PAH desorption from soils containing high clay contents [34].347
Next, we tested if biosurfactants or SDS were able to enhance PAH solubilization when OM 348
was introduced into the more complex model sediment. These experiments were carried out 349
with the sediment made of sand, silt, kaolin, 2.5% OM and with 10 g.L-1 NaCl, to mimic the 350
natural dredged sediment collected from a Norman harbor disposal site. Fig. 6 shows the 351
sorption behavior of three of the seven studied PAHs. It appears from Fig. 6a and 6b that if 352
we consider only PAHs of low molecular weight (from naphthalene to fluorene), amphisin 353
and viscosin-like CLPs have a favorable effect on PAH release from the model sediment. 354
Indeed, based on the linear part of the isotherms, distribution coefficients Kd were calculated355
and, for acenaphthylene (as an example), Kd decreased from 129.8 L.kg-1 to 103.4 L.kg-1 and 356
64.7 L.kg-1 when adding respectively amphisin or viscosin-like CLPs. But their effect on 357
desorption is weaker than that of SDS (Kd was only 11.5 L.kg-1 for acenaphthylene) and 358
weaker in comparison to the effect produced from a pure kaolinite surface. However, unlike 359
SDS, the two biosurfactants were unable to enhance desorption of the higher molecular 360
weight PAHs (from phenanthrene to pyrene) from the sediment particles (Fig. 6c). For 361
example, for phenanthrene, Kd values did not vary significantly, from 304.3 L.kg-1 to 301.7 362
L.kg-1 and 291.9 L.kg-1 when adding respectively amphisin or viscosin-like CLPs. 363
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If we compare the kaolinite/water/SDS and sediment/water/SDS systems, it appears that 364
PAHs are more sorbed on the surface of pure kaolinite than on the model sediment, in the 365
presence of SDS (see Fig. 5a/6b and Fig. 5b/6c). For example, for phenanthrene, Kd value is 366
81.8 L.kg-1 for the kaolinite/water/SDS system and only 12.7 L.kg-1 for the 367
sediment/water/SDS system. On the one hand, it has been shown that SDS is less sorbed on 368
the sandy and silty parts of the sediment than on pure kaolinite [31]. Consequently, SDS369
forms fewer hemimicelles on the model sediment than on pure kaolinite, where PAHs can be 370
adsolubilized. On the other hand, it is likely that the presence of SDS decreases the direct 371
sorption of PAHs to OM. Indeed surfactant apolar tails compete for hydrophobic sorption 372
sites on the OM surface, the ionic head being exposed to the solution in this case [31]. Thus, 373
the phenomenon of adsolubilization of PAHs, in the presence of SDS, is weaker in the case of 374
a complex sediment containing OM than in the case of pure kaolinite. It must also be 375
observed that the incorporation of PAHs into SDS hemimicelles formed at the sediment 376
surface is not really affected by PAHs structures, since Kd values are nearly the same from 377
naphthalene to pyrene (for example, 12.6 L.kg-1 for fluorene and 13.1 L.kg-1 for pyrene).378
Concerning the effect of viscosin-like CLPs, it is clear that even if they were introduced at 379
levels which are ten times their CMC in the sediment/water system (like SDS), they do not 380
contribute to change the sorption of the higher weight PAHs (from phenanthrene to pyrene) 381
(Fig. 6c). And, for all the PAHs (even the lowest), the sorption is always higher on the model 382
sediment than on the pure kaolinite (Fig. 5a/6b). In the example of fluorene, Kd value is 36.4 383
L.kg-1 at the kaolinite/water interface and 81.6 L.kg-1 at the sediment/water interface. It 384
indicates that the favorable desorption effect noted from pure kaolinite is not as large in the 385
case of the complex sediment. All these observations are also valid for the effect of amphisin, 386
which is effective on the release of PAHs from pure kaolinite, but which helps only slightly to 387
desorb low weight PAHs (from naphthalene to fluorene) from the model sediment (Fig. 6a 388
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and 6b). Indeed, in the example of fluorene, the Kd value is only 39.4 L.kg-1 for the 389
kaolinite/water/amphisin system but 127.1 L.kg-1 for the sediment/water/amphisin system.390
In fact, the cyclolipopeptidic biosurfactants tested are less polar than SDS and consequently, 391
their sorption on OM must be greater. Clearly, SDS has one of the highest hydrophilic-392
lipophilic balance value (HLB=40), which means that its hydrophilic part is preponderant in 393
the mass balance. Concerning amphisin and viscosin-like CLPs, their molecular structure and 394
their ability to lower the surface tension of water are near those of viscosin (27 mN.m-1), 395
whose HLB is considered to be near 10. With such approximate values of HLB, it suggests396
that the lipophilic part of our tested CLPs is more predominant than that of SDS [35]. So 397
CLPs certainly compete more with PAHs for hydrophobic sorption sites on OM. But unlike 398
SDS, their polar moiety, exposed to the aqueous phase and composed of amino acids (many 399
of them being non polar), are not repulsive for apolar PAHs, which can be likely adsolubilized 400
on the hemimicelles formed on the OM surface. Finally, the sorbed viscosin-like mixture is 401
probably slightly less attractive for PAHs than amphisin, because it contains only four or five 402
apolar amino acids in the polar heads, while amphisin contains six apolar amino acids, 403
reinforcing adsolubilization of PAHs. It is probably why amphisin contributes less in the 404
release of low weight PAHs, from the sediment to the aqueous phase, than viscosin-like CLPs405
(Fig. 6a and 6b).406
407
4. Conclusions408
409
Batch tests made it possible to understand the sorption behavior of mixtures of PAHs at the 410
sediment surface, varying the nature of minerals, the pH, the ionic strength and the content of 411
organic matter. So it can be concluded that the fractions of kaolinite and OM in sediment play 412
the major role in PAH sorption, especially since the molecular weight of PAH increases. 413
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Three anionic surfactants were tested to enhance PAHs solubilization from the particulate 414
surface to the aqueous phase. The addition of SDS causes an important reduction in the 415
sorption of all PAHs to kaolinite or to the model sediment containing OM, for two reasons. 416
The surfactant competes for sorption sites on the particle surface and adsolubilization of 417
PAHs into hemimicelles is less favorable than incorporation into micelles in the aqueous 418
phase. Two anionic cyclolipopeptidic biosurfactants, produced by Pseudomonas fluorescens419
strains, were also tested. Amphisin presents an interesting potential to enhance the desorption420
of the seven target PAHs from kaolinite to the aqueous phase. We can notice that we need 20 421
times less in mass concentration or 100 times less in molar concentration than SDS to obtain 422
good results. Viscosin-like CLPs (mixture of massetolide E and viscosin) present the same 423
interesting desorption potential from kaolinite than amphisin, but only for 2-3 aromatic ring 424
PAHs (from naphthalene to phenanthrene). Conversely, for the more lipophilic fluoranthene 425
or pyrene, adsolubilization on the kaolinite surface is unfortunately more preponderant than 426
incorporation into aqueous micelles of viscosin-like CLPs.427
Finally, micelles of the two biosurfactants are able to release only low weight PAHs (from 428
naphthalene to fluorene) from the model sediment containing OM. Indeed, the more lipophilic429
PAHs are not only more strongly sorbed onto the hydrophobic particles of OM, but they also 430
incorporate the surface hemimicelles formed by the biosurfactants rather than the aqueous 431
micelles. However, we can anticipate that biosurfactants, altering the distribution of low 432
weight PAHs between particulate and aqueous phases, may favor their removal from 433
sediments by remediation processes which need better solubilization of PAHs in the aqueous 434
interstitial phase (such as EK processes), or which need an increase of their bioavailability for 435
biodegradation processes.436
437
Acknowledgements438
P17
Page 19 of 38
Ac
ce
pte
d M
an
us
cri
pt
19
The authors thank the “Région Haute Normandie” for financial support through Normandy 439
SCALE research network (RESSOLV program). The authors thank Dr. O. Nybroe (Royal 440
Veterinary & Agricultural University-Thorvaldsensvej, Denmark) for the gift of the 441
Pseudomonas fluorescens DSS73, Dr G. Braun (Agriculture & Agri-Food, Canada) for the 442
gift of Pseudomonas fluorescens PfA7B and C. Farmer for her linguistic support.443
444
P17
Page 20 of 38
Ac
ce
pte
d M
an
us
cri
pt
20
444
References445
446
[1] M.K. Song, M. Song, H.S. Choi, Y.J. Kim, Y.K. Park, J.C. Ryu, Identification of 447
molecular signatures predicting the carcinogenicity of polycyclic aromatic hydrocarbons 448
(PAHs), Toxicology Letters 212 (2012) 18-28.449
[2] L. Guzella, C. Roscioli, L. Vigano, M. Saha, S.K. Sarkar, B. Bhattacharya, Evaluation of 450
the concentration of HCH, DDT, HCB, PCB and PAH in the sediments along the lower 451
stretch of Hugli estuary, West Bengal, northeast India, Environment International 31 (2005)452
523-534.453
[3] W.X. Liu, J.L. Chen, X.M. Lin, S. Tao, Distribution and characteristics of organic 454
micropollutants in surface sediments from Bohai Sea, Environmental Pollution 140 (2006) 4-455
8.456
[4] C.N. Mulligan, R.N. Yong, B.F. Gibbs, An evaluation of technologies for the heavy metal 457
remediation of dredged sediments, J. Hazard. Mater. 85 (2001) 145-163.458
[5] S. Semrany, L. Favier, H. Djelal, S. Taha, A. Amrane, Bioaugmentation: Possible solution 459
in the treatment of Bio-Refractory Organic Compounds (Bio-ROCs), Biochem. Eng. J. 69 460
(2012), 75-86.461
[6] M. Pazos, E. Rosales, T. Alcantara, J. Gomez, M.A. Sanroman, Decontamination of soils 462
containing PAHs by electroremediation: A review, J. Hazard. Mater. 177 (2010) 1-11.463
[7] C.N. Mulligan, R.N. Yong, B.F. Gibbs, Surfactant-enhanced remediation of contaminated 464
soil: a review, Engineering Geology 60 (2001) 371-380.465
[8] M.T. Alcantara, J. Gomez, M. Pazos, M.A. Sanroman, PAHs soil decontamination in two 466
steps: Desorption and electrochemical treatment, J. Hazard. Mater. 166 (2009) 462-468.467
P17
Page 21 of 38
Ac
ce
pte
d M
an
us
cri
pt
21
[9] M.J. Sanchez-Martin, M.C. Dorado, C. del Hoyo, M.S. Rodriguez-Cruz, Influence of clay 468
mineral structure and surfactant nature on the adsorption capacity of surfactants by clays. J.469
Hazard. Mater. 150 (2008) 115-123.470
[10] S. Mukherjee, R. Das, R. Sen, Towards commercial production of microbial surfactants,471
Trends Biotechnol. 24 (2006) 509-515.472
[11] A. Franzetti, P. Carreda, C. Ruggeri, P. La Colla, E. Tamburini, M. Papacchini, G. 473
Bestetti, Potential applications of surface active compounds by Gordonia sp. strain BS29 in 474
soil remediation technologies, Chemosphere 75 (2009) 801-807.475
[12] C.N. Mulligan, Recent advances in the environmental applications of biosurfactants,476
Curr. Opin. Colloid Interface Sci. 14 (2009) 372-378.477
[13] S.S. Cameotra, P. Singh, Synthesis of rhamnolipid biosurfactant and mode of hexadecane 478
uptake by Pseudomonas species, Microbial Cell Factories 8 (2009) 16-21.479
[14] R.E. Saichek, K.R. Reddy, Surfactant-enhanced electrokinetic remediation of polycyclic 480
aromatic hydrocarbons in heterogeneous subsurface environments, J. Environ. Eng. Sci. 4481
(2005) 327-339.482
[15] J.W. Yang, Y.J. LeeJ, J.Y. Park, S.J. Kim, J.Y. Lee, Application of APG and Calfax 16L-483
35 on surfactant-enhanced electrokinetic removal of phenanthrene from kaolinite,484
Engineering Geology 77 (2005) 243-251.485
[16] J.H. Chang, Z. Qiang, C.P. Huang, A.V. Ellis, Phenanthrene removal in unsaturated soils 486
treated by electrokinetics with different surfactants: Triton X-100 and rhamnolipid, Colloids 487
Surfaces A 348 (2009) 157-163.488
[17] X. Pei, X. Zhan, L. Zhou, Effect of biosurfactant on the sorption of phenanthrene onto 489
original and H2O2-treated soils, J. Environ. Sci. 21 (2009) 1378-1385.490
P17
Page 22 of 38
Ac
ce
pte
d M
an
us
cri
pt
22
[18] H. Yu, G.H. Huang, C.J. An, J. Wei, Combined effects of DOM extracted from site 491
soil/compost and biosurfactant on the sorption and desorption of PAHs in a soil-water system, 492
J. Hazard. Mater. 190 (2011), 883-890.493
[19] T. Lima, L. Procopio, F. Brandao, A. Carvalho, M. Totola, A. Borges, Simultaneous 494
phenanthrene and cadmium removal from contaminated soil by a ligand/biosurfactant solution 495
Biodegradation 22 (2011) 1007-1015.496
[20] A.K. Singh, S.S. Cameotra, Efficiency of lipopeptide biosurfactants in removal of 497
petroleum hydrocarbons and heavy metals from contaminated soil, Environ. Sci. Pollut. Res.498
Int. (2013) DOI 10.1007/s11356-013-1752-4.499
[21] A. Groboillot, F. Portet-Koltalo, F. Le Derf, M.G.J. Feuilloley, N. Orange, C. Duclairoir-500
Poc, Novel application of cyclolipopeptide amphisin: Feasibility study as additive to 501
remediate Polycyclic Aromatic Hydrocarbon (PAH) contaminated sediments, Int. J. Mol. Sci.502
12 (2011) 1787-1806.503
[22] C. Duclairoir-Poc, T. Meylheuc, S. Ngoya, A. Groboillot, J. Bodilis, L. Taupin, A. 504
Merieau, M.G.J. Feuilloley, N. Orange, Influence of growth temperature on cyclolipopeptides 505
production and on adhesion behaviour in environmental strains of Pseudomonas fluorescens,506
J. Bacteriol. Parasitol. (2011) S1-002. doi:10.4172/2155-9597.S1-002507
[23] X.C. Wang, Y.X. Zhang, R.F. Chen, Distribution and partitioning of Polycyclic Aromatic 508
Hydrocarbons (PAHs) in different size fractions in sediments from Boston Harbor, United 509
States, Marine Pollut. Bull. 42 (2001) 1139-1149.510
[24] A. Mechlinska, M. Gdaniec-Pietryka, L. Wolska, J. Namiesnik, Evolution of models for 511
sorption of PAHs and PCBs on geosorbents, Trends Anal. Chem. 28 (2009) 466-482.512
[25] F.J. Stevenson, Humus Chemistry. Genesis, Composition, Reactions. 2nd Ed., Wiley 513
Interscience, New York, 1994.514
P17
Page 23 of 38
Ac
ce
pte
d M
an
us
cri
pt
23
[26] Y. Ran, K. Sun, X. Ma, G. Wang, P. Grathwohl, E.Y. Zeng, Effect of condensed organic 515
matter on solvent extraction and aqueous leaching of polycyclic aromatic hydrocarbons in 516
soils and sediments, Environmental Pollution 148 (2007) 529-538.517
[27] K.R. Reddy, P.R. Ala, S. Sharma, S.N. Kumar, Enhanced electrokinetic remediation of 518
contaminated manufactured gas plant soil, Engineering Geology 85 (2006) 132-146.519
[28] R.E. Saichek, K.R. Reddy, Effect of pH control at the anode for the electrokinetic 520
removal of phenanthrene from kaolin soil, Chemosphere 51 (2003) 273-287.521
[29] J. Gomez, M.T. Alcantara, M. Pazos, M.A. Sanroman, A two-stage process using 522
electrokinetic remediation and electrochemical degradation for treating benzo[a]pyrene 523
spiked kaolin, Chemosphere 74 (2009) 1516-1521.524
[30] F. Bordas, P. Lafrance, R. Villemur, Conditions for effective removal of pyrene from an 525
artificially contaminated soil using Pseudomonas aeruginosa 57SJ rhamnolipids,526
Environmental Pollution 138 (2005) 69-76.527
[31] M.S. Rodriguez-Cruz, M.J. Sanchez-Martin, M. Sanchez-Camazano, A comparative 528
study of adsorption of an anionic and a non-ionic surfactant by soils based on 529
physicochemical and mineralogical properties of soils, Chemosphere 61 (2005) 56-64.530
[32] W.H. Noordman, M.L. Brusseau, D.B. Janssen, Adsorption of a multicomponent 531
rhamnolipid surfactant to soil, Environ. Sci. Technol. 34 (2000) 832-838.532
[33] M. Garcia-Junco, C. Gomez-Lahoz, J.L. Niqui-Arroyo, J.J. Ortega-Calvo, Biosurfactant-533
and biodegradation-enhanced partitioning of Polycyclic Aromatic Hydrocarbons from 534
nonaqueous-phase liquids, Environ. Sci. Technol. 37 (2003) 2988-2996.535
[34] W. Zhou, L. Zhu, Efficiency of surfactant-enhanced desorption for contaminated soils 536
depending on the component characteristics of soil-surfactant-PAHs system, Environmental 537
Pollution 147 (2007) 66-73.538
P17
Page 24 of 38
Ac
ce
pte
d M
an
us
cri
pt
24
[35] D.A. Vaza, E.J. Gudina, E.J. Alameda, J.A. Teixeira, L.R. Rodrigues, Performance of a 539
biosurfactant produced by a Bacillus subtilis strain isolated from crude oil samples as 540
compared to commercial chemical surfactants, Colloids Surfaces B: Biointerfaces 89 (2012) 541
167-174542
543
P17
Page 25 of 38
Ac
ce
pte
d M
an
us
cri
pt
25
543
Figure captions544
545
Fig. 1: Sorption isotherms of PAHs on sand, silt, kaolinite and model sediment (without OM).  546
a:  acenaphthene   b: phenanthrene   c: fluoranthene547
548
Fig. 2: Sorption isotherms of PAHs on model sediment (without OM), with or without NaCl 549
(10 g.L-1), at controlled pH or not.   a: fluorene   b: pyrene550
551
Fig. 3: Sorption isotherms of PAHs on model sediment (NaCl=10 g.L-1, pH=7.2) with various 552
contents of OM.   a: acenaphtene   b: phenanthrene   c: fluoranthene553
554
Fig. 4: Surface tension measurement of aqueous solutions containing amphisin and viscosin-555
like biosurfactants as a function of their concentration (logarithmic scale).556
557
Fig. 5: Sorption isotherms of PAHs on kaolinite (NaCl = 10 g L-1, pH = 7.2) with or without 558
SDS or biosurfactants (amphisin or viscosin-like mixture).   a: fluorene   b: phenanthrene   c:559
pyrene560
561
Fig. 6: Sorption isotherms of PAHs (NaCl=10 g.L-1, pH=7.2, OM=2.5%) on model sediment 562
with or without SDS or biosurfactants (amphisin or viscosin-like mixture).   a: acenaphthene   563
b: fluorene   c: phenanthrene564
565
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Table 1: Characterization of the cyclolipopeptidic biosurfactants produced by Pseudomonas fluorescens strains [22]566
567
Amino acids of cyclopeptidic headsStrains Molar mass
(g mol-1)
CLP Lipidic tail
AA1 AA2 AA3 AA4 AA5 AA6 AA7 AA8 AA9 AA10 AA11
1111.7 Massetolide E C10H19O2 L-Leu D-
Glu
D-allo-
Thr
D-
Val
L-
Leu
D-
Ser
L-
Leu
D-
Ser
L-
Val
PfA7B
1125.7 Viscosin C10H19O2 L-Leu D-
Glu
D-allo-
Thr
D-
Val
L-
Leu
D-
Ser
L-
Leu
D-
Ser
L-Ile
DSS73 1394.8 Amphisin C10H19O2 L-Leu D-
Asp
D-allo-
Thr
D-
Leu
D-
Leu
D-
Ser
L-
Leu
D-
Ser
L-
Leu
L-Ile L-
Asp
568
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Table 2 : Optimal fluorescence excitation and emission wavelengths, limits of detection 
(LOD) and quantification (LOQ) for target PAHs in HPLC-FLD, and mean recoveries and 
their relative standard deviation (RSD) obtained by SPE (spiked PAHs at Co=10 µg.L-1).
FLD detection parameters SPE performance
substance ex/em
(nm)
LOD a
(µg L-1)
LOQ b
(µg L-1)
Mean recovery 
(%)
RSD (%) 
(n=5)
naphthalene 220/330 0.4 1.3 82.0 3.9
acenaphthene 220/315 0.5 1.7 85.1 3.6
fluorene 220/315 0.3 1.0 85.7 3.6
phenanthrene 250/370 0.4 1.3 94.2 1.2
anthracene 250/370 0.3 1.0 82.0 2.3
fluoranthene 235/420 1.4 4.7 89.7 4.5
pyrene 235/420 1.9 6.3 90.0 1.9
a   calculated as 3 times the background noise.
b   calculated as 10 times the background noise.
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Table 3: Reproducibility (standard deviations SD) of batch adsorption experiments for some 
PAHs sorbed on the model sediment, containing (or not) 2.5% of organic matter (+ or - OM) 
(spiked PAHs at Co=100 µg.L-1).
substance Ceq ± SD (µg L-1)  (n=5) Cads ± SD (µg g-1)  (n=5)
naphthalene (- OM)
naphthalene (+ OM)
20.1 ± 3.3  
7.5 ± 1.9  
0.727 ± 0.029  
0.834 ± 0.017  
phenanthrene (- OM)
phenanthrene (+ OM)
12.3 ± 2.7  
1.3 ± 0.3  
0.791 ± 0.024  
0.899 ± 0.003  
fluoranthene (- OM)
fluoranthene (+ OM)
3.6 ± 0.3
2.8 ± 0.5
0.868 ± 0.004
0.898 ± 0.001
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Table 4 : Best isotherms and parameters of selected PAHs for various mineral components 
and the model sediment (without OM).
Acenaphthene Phenanthrene Fluoranthene
linear Freundlich linear Freundlich linear
Kd r2 KF 1/n r2 Kd r2 KF 1/n r2 Kd r2 KF
sand 26.4 0.569 51.2 0.861 0.920 44.8 0.843 49.2 0.922 0.926 44.2 0.777 37.1
silt 40.7 0.962 54.6 1.183 0.986 54.0 0.978 152.9 1.376 0.964 99.7 0.988 122.2
kaolinite 145.3 0.967 48.9 0.708 0.957 188.3 0.964 30.6 0.553 0.934 390.9 0.977 73.5
model
sediment
52.5 0.954 133.6 1.334 0.963 97.4 0.983 186.9 1.286 0.979 219.0 0.955 628.9
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Table 5: Partition coefficients Kd of PAHs (and r2 values associated to the linear isotherm 
equation) for the model sediment with or without OM, and organic carbon partition 
coefficients Koc
Model 
sediment
Model sediment 
+ 2.5% OM
Model sediment 
+ 5% OM
Kd
(L.kg-1)
r2 Kd
(L.kg-1)
r2 Koc
(L.kg-1)
Kd
(L.kg-1)
r2 Koc
(L.kg-1)
naphthalene 45.2 0.943 68.1 0.911 1577 163.3 0.903 1891
acenaphthene 52.5 0.954 129.8 0.953 8967 341.9 0.958 11809
fluorene 53.8 0.993 141.6 0.940 9782 395.5 0.958 13661
phenanthrene 97.4 0.983 304.3 0.950 21021 555.0 0.935 19170
antracene 177.9 0.969 653.6 0.945 26144 809.8 0.910 27970
fluoranthene 219.0 0.955 652.2 0.943 45151 973.1 0.941 33611
pyrene 222.0 0.997 952.9 0.923 49724 1042.1 0.918 35994
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 The sorption of a mixture of PAHs was studied at the sediment/water interface
 Clay and organic matter fractions were the most influent factors on PAHs sorption
 Desorption of PAHs by cyclolipopeptidic (CLP) biosurfactants was investigated
 Release of 2-4 ring PAHs from kaolinite was favored by adding SDS or amphisin
 Amphisin and viscosin-like were effective to release low weight PAHs from sediments
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Abstract: Different bacterial species and, particularly Pseudomonas fluorescens, can 
produce gamma-aminobutyric acid (GABA) and express GABA-binding proteins. In this 
study, we investigated the effect of GABA on the virulence and biofilm formation activity 
of different strains of P. fluorescens. Exposure of a psychotropic strain of P. fluorescens 
(MF37) to GABA (10−5 M) increased its necrotic-like activity on eukaryotic (glial) cells, 
but reduced its apoptotic effect. Conversely, muscimol and bicuculline, the selective 
agonist and antagonist of eukaryote GABAA receptors, respectively, were ineffective.  
P. fluorescens MF37 did not produce biosurfactants, and its caseinase, esterase, amylase, 
hemolytic activity or pyoverdine productions were unchanged. In contrast, the effect of 
GABA was associated to rearrangements of the lipopolysaccharide (LPS) structure, 
particularly in the lipid A region. The surface hydrophobicity of MF37 was marginally 
modified, and GABA reduced its biofilm formation activity on PVC, but not on glass, 
although the initial adhesion was increased. Five other P. fluorescens strains were studied, 
and only one, MFP05, a strain isolated from human skin, showed structural differences of 
biofilm maturation after exposure to GABA. These results reveal that GABA can regulate 
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the LPS structure and cytotoxicity of P. fluorescens, but that this property is specific to 
some strains. 
Keywords: host-microbial interactions; cytotoxicity; virulence; bacterial adhesion; 
lipopolysaccharide; biofilms; pyoverdine 
 
1. Introduction 
Gamma-aminobutyric acid (GABA) is a non-protein amino acid widespread in the environment [1]. 
Also, many bacteria, such as Pseudomonas aeruginosa [2,3], Pseudomonas fluorescens [4], marine 
Pseudomonas [5,6], lactic bacteria [7] and Escherichia coli [8], can synthesize GABA. Some of these 
bacteria release GABA, suggesting that GABA should act as a communication molecule between 
bacteria and their host or even between bacteria. Indeed, different GABA binding sites or sensors have 
been identified in bacteria. A GabP permease has been isolated in E. coli and Bacillus subtilis [9,10]. 
Corynebacterium glutamicum expresses a specific GABA transporter, also designated as GabP, but 
having low sequence identity with the GabP permease [11]. A selective GABA binding protein, 
Atu4243, was identified more recently in Agrobacterium tumefaciens and in several pathogenic or 
symbiotic Proteobacteria, including Pseudomonas [12]. Last year, we observed that in P. aeruginosa, 
GABA could bind the thermo-unstable ribosomal elongation factor, Tuf, a multiple function protein 
potentially translocated to the bacterial membrane, where it could act as a surface sensor [13]. A 
GABA binding protein (GBP), sharing common biochemical and pharmacological characteristics with 
the mammalian GABAA receptor, was identified 20 years ago in an environmental strain of  
P. fluorescens [14], but this strain was patented and not deposited in international bacterial strains 
libraries. Until now, the recognition of GABA by other strains of P. fluorescens was not investigated, 
and the function of this molecule in P. fluorescens remains unknown. 
In Lactobacillus, Lactococcus lactis and E. coli, GABA is involved in the resistance to acid  
stress [15,16], and in many species, including Shigella flexneri and Listeria monocytogenes, this 
system should be essential for colonization of the gastro-intestinal tract [17]. The physiological role of 
GABA was investigated in detail in A. tumefaciens, where it was shown that this molecule, which is 
released by plants in response to infection, induces the expression of a lactonase that cleaves  
N-3-oxo-octanoyl-L-homoserine lactone (3-oxo-C8-HSL), leading to a reduction of tumor  
formation [18]. GABA is also an inhibitor of virulence in the phytopathogen Pseudomonas syringae 
pv. tomato, where at high concentrations, it downregulates the expression of hrp genes and increases 
the resistance of the plant to infection [19]. Conversely, in the human opportunistic pathogen,  
P. aeruginosa, GABA reduces biofilm formation activity, but increases the production of hydrogen 
cyanide and its virulence [13]. It was then particularly interesting to investigate the effect of GABA on 
P. fluorescens, which is frequently found in the rhizosphere, where it can enhance the resistance of 
plants against bacterial pathogens, including P. syringae pv. tomato [20], but is also found in the 
clinical environment, where some strains adapted to the human physiological temperature behave 
clearly as opportunistic pathogens [21]. 
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In the present study, we investigated the effect of GABA on the growth kinetic, mobility, cytotoxic 
activity, binding potential on biotic and abiotic surfaces, biofilm formation activity, surface polarity, 
biosurfactant production, lipopolysaccharide (LPS) structure, exoenzymes secretion and pyoverdine 
production by environmental and clinical strains of P. fluorescens. 
2. Results 
2.1. Effect of GABA on the Cytotoxic Activity, Adhesion Potential, Biofilm Formation Activity and 
Surface Properties of Pseudomonas fluorescens 
Before the tests, bacteria were exposed to GABA 10−5 M during the whole growth phase and rinsed 
to remove any trace of free GABA. The concentration of 10−5 M was selected to avoid any possible 
metabolic or pH effect and because it is the mean value of the concentrations in the synaptic cleft of 
neurons (1.5–3 mM [22]), in wounded vegetal (10−4 M [23]) and in the environment (sea water 
concentration <10−7 M [24]). Administration of GABA did not modify the growth kinetic or the 
swimming and swarming mobility of the psychrotrophic strain of P. fluorescens MF37 (data not 
shown). The cytotoxic activity of P. fluorescens MF37 was studied using a model of cultured rat glial  
cells [25], and the cell viability was determined by measurement of the release of lactate 
dehydrogenase (LDH) and nitrite ions in the culture medium. In comparison to the cells exposed to 
control bacteria, when glial cells were exposed to P. fluorescens MF37 treated with GABA (10−5 M), 
we observed a significant increase of LDH release (+71.5% ± 5.4%, p < 0.001) (Figure 1A) and a decrease 
of the nitrite ion concentration (−53.3% ± 2.9%, p < 0.001) (Figure 1B). Bacteria exposed to GABA 
10−6 M also showed an increase of cytotoxicity, but this effect was not significant. Muscimol (10−5 M), 
a selective agonist of eukaryote GABAA receptors, and bicuculline (10−5 M), an antagonist of these 
receptors, were without effect on P. fluorescens MF37 cytotoxicity. Because glial cells can also detect 
GABA [26], control studies were realized by direct treatment of glial cells with GABA (10−5 M), and 
we observed that GABA had no effect on glial cell viability. As previously demonstrated [25,27], in 
our experimental conditions, P. fluorescens MF37 did not release detectable amounts of LDH and NO.  
As adhesion is a key step in the expression of bacterial virulence, we investigated the adhesion 
potential of GABA treated P. fluorescens MF37 on cultured glial cells and glass. The binding index of 
GABA treated bacteria on primary cultures of rat glial cells was unchanged, but we observed a 
significant increase of adhesion (+55% ± 12%, p < 0.01) on glass surfaces (Figure 2). The effect of 
GABA on P. fluorescens MF37 biofilm formation was studied using the crystal violet technique and 
confocal microscopy. When P. fluorescens MF37 was pre-treated only during the exponential growth 
phase, the crystal violet technique revealed a limited, but significant reduction of biofilm formation on 
polyvinyl chloride (PVC) microtitration plates (−7% ± 2%, p < 0.05) after 48 h incubation, whereas 
there was no difference after 24 h (Figure 3). Conversely, when the bacteria were pre-treated during 
the exponential growth phase and the biofilm formation period, we observed a significant reduction of 
the biofilm after 24 h (−18% ± 4%, p < 0.05), but this effect was not maintained at 48 h. A unique 
treatment with GABA during the biofilm formation period was without effect. When the biofilm 
formation activity of P. fluorescens MF37 was studied on glass slides by confocal microscopy, we did 
not observe any change in the morphology or thickness of 5, 24 and 48 h-old biofilms. Other strains of  
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P. fluorescens originating either from agricultural soil (Pf0-1), plant leaves (SBW25), human skin 
(MFP05) or from the pulmonary tract and considered as an opportunistic pathogen (MFN1032) were 
studied in the same conditions. Only the biofilm formed by MFP05 was affected by GABA (Figure 4). 
There was no difference between the biofilms formed by control and GABA-treated bacteria after 5 h 
incubation. In contrast, the 24 h-old biofilm of GABA-treated MFP05 showed an irregular bacterial 
cluster and appeared more mature, its aspect being identical to a 30 h-old biofilm. This effect  
was transient, and after 48 h, the aspect of control and GABA-treated P. fluorescens MFP05 biofilms 
was the same. 
Figure 1. Effect of GABA, the GABAA receptor agonist muscimol and the GABAA 
receptor antagonist bicuculline (10−5 M) on the cytotoxicity of P. fluorescens MF37 on 
eukaryotic (glial) cells. The necrotic activity of the bacterium was determined by assay of 
lactate dehydrogenase (LDH) in the culture medium. (A) The apoptotic activity was 
evaluated by the assay of nitrite; (B) in which nitrites are produced upon activation of  
NO-synthase in the target cell. Dotted lines indicate the production of LDH and nitrites in 
the medium of control eukaryotic cells not exposed to the bacterium (: p < 0.001). 
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Figure 2. Effect of GABA (10−5 M) on the adhesion properties of P. fluorescens MF37 to 
eukaryotic cells or glass. Adhesion is expressed as the percentage of the control value 
(dotted line) (NS: non-significant; : p < 0.01). 
 
Figure 3. Effect of GABA (10−5 M) on the biofilm formation activity of P. fluorescens 
MF37 in 96-well PVC microtitration plates. The biofilm formation activity of bacteria was 
measured after 24 or 48 h of incubation. Bacteria were exposed to GABA only during the 
growth phase (pretreatment), only during the biofilm formation period (during biofilm) or 
continuously during growth and biofilm formation (pretreated + during biofilm). The 
biofilm formation activity is expressed as the percentage of the control value (dotted line).  
(NS: non-significant; : p < 0.05). 
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Figure 4. Effect of GABA (10−5 M) on the biofilm formation activity of P. fluorescens 
MFP05 on glass slides. 2D, 3D and 3D/z figures resulting from confocal laser scanning 
observations were realized after 24 and 48 h of biofilm formation. 
 
As these results suggested an evolution of the surface properties of P. fluorescens, we investigated, 
by the microbial adhesion to solvent (MATS) technique, the surface hydrophilic character of the 
microorganism. The affinity of P. fluorescens MF37 to hexadecane was significantly increased after 
treatment by GABA (0.6% ± 0.2% for control, 3% ± 0.7% for GABA-treated bacteria, p < 0.05) 
(Figure 5A), but the affinity of MF37 to hexadecane remained below 20%, which is considered the 
threshold value for highly hydrophilic bacteria [28]. Then, it appears that the global polarity of this 
strain was unchanged. Complementary studies showed that the surface tension from the rinsing 
medium of P. fluorescens MF37 colonies was also the same before or after GABA treatment  
(55.7% ± 0.4 and 55.8 ± 2.2 mN/m, respectively) (Figure 5B), indicating that in both conditions,  
P. fluorescens MF37 was not producing biosurfactant susceptible to modulation of bacterial adhesion.  
2.2. Effect of GABA on Secreted Diffusible Factors and Lipopolysaccharide Structure 
In order to identify the origin of the effect of GABA on P. fluorescens MF37 cytotoxicity, we 
investigated the effect of GABA on the caseinase, esterase, amylase, elastase and hemolytic secreted 
activities of the bacterium, but no difference was observed between control and GABA-treated bacteria 
(data not shown). Then, we investigated the effect of GABA on the production of pyoverdine, a 
siderophore essential for the colonizing activity of Pseudomonas and for virulence in plants and 
animals [29]. Using King B medium, a time-dependent increase of pyoverdine production was 
observed with both control and GABA-treated bacteria (Figure 6A). After 24, 32 and 48 h of 
incubation, the OD400/OD580 ratio used to monitor pyoverdine production was higher in GABA-treated 
bacteria, but the difference with control bacteria was not significant. For that reason, the same 
experiment was repeated using Bacto Casamino Acids (CAA) medium, another pyoverdine-inducing 
medium. An increase of pyoverdine was observed from 6 to 48 h of incubation, but it appeared clearly 
that GABA was not modulating pyoverdine production (Figure 6B). 
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Figure 5. Effect of GABA (10−5 M) on the global surface polarity (A) and biosurfactant 
production (B) of P. fluorescens MF37. The surface polarity was determined by 
measurement of the affinity of bacteria to hexadecane. The biosurfactant production was 
estimated by measurement of the surface tension of rinsing solutions of bacterial colonies 
grown on solid agar medium. (NS: non-significant; : p < 0.05). 
 
Figure 6. Effect of GABA (10−5 M) on pyoverdine production by P. fluorescens MF37. 
The pyoverdine production was measured in King B (A) and Bacto Casamino Acids 
(CAA) (B) medium. The production of pyoverdine is expressed as the ratio of pyoverdine 
adsorption (OD400) on the OD580 nm of the bacterial culture. 
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The lipopolysaccharide (LPS) is one of the major virulence factors and the principal endotoxin of 
Pseudomonas. LPS extracted from P. fluorescens MF37 exposed or not to GABA was studied by 
MALDI-TOF mass spectrometry. We observed that the mass spectra of LPS extracted from control 
bacteria (Figure 7A) showed limited, but significant and repeatable, differences in comparison with the 
mass spectra of GABA-treated bacteria (Figure 7B). The modified peaks were found essentially in the 
region of low m/z fragments, considered as corresponding to lipid A fragments [30]. Three peaks of a 
higher m/z ratio, presumably associated with fragments of the oligosaccharide core [30], were also 
particularly decreased in GABA-treated bacteria, suggesting that GABA induced a large 
rearrangement of the LPS structure.  
Figure 7. MALDI-TOF analysis of the lipopolysaccharide (LPS) extracted from control 
(A) and GABA-treated (B) P. fluorescens MF37. Each figure is a representative example 
of three different analysis. Arrows indicate peaks particularly modified between control 
and GABA-treated bacteria.  
A
In
te
ns
. [
a.
u.
]
B
In
te
ns
. [
a.
u.
]
m/z
X10 6
2000 4000 6000 8000
m/z
X10 6
2000 4000 6000 8000
0.00
0.5
1.00
1.5
0.00
0.5
1.00
1.5
 
P18
Int. J. Mol. Sci. 2013, 14 12194 
 
 
3. Discussion  
GABA is present from eukaryotes to bacteria and should have a pivotal role in inter-kingdom 
communication [31,32]. We have recently described that GABA stimulates the virulence of the 
opportunistic pathogen, P. aeruginosa [13]. The existence of GABA binding proteins or sensors in 
other Pseudomonas and, particularly, in P. fluorescens has been known for a long time [14], but the 
physiological effect of GABA in this species was not investigated until now. 
As shown with P. aeruginosa PAO1, GABA (10−5 M) had no effect on the growth kinetic and 
mobility of P. fluorescens MF37, but markedly affected the cytotoxic activity of this bacterium. LDH 
is a stable eukaryotic enzyme considered as a marker of necrosis or non-specific cell death, whereas 
nitrite ions can be employed as markers of apoptosis, since they are generated by the spontaneous 
conversion of nitric oxide (NO) during eukaryotic cells apoptosis [25,33]. Whereas the release of LDH 
from glial cells exposed to GABA-treated bacteria was increased, the concentration of NO was 
significantly decreased. These results are only contradictory in appearance, since the time course of 
necrosis is more rapid than required for induction of apoptosis [34], and a rapid induction of necrosis 
can prevent the activation of apoptosis [35]. It is also interesting to note that the absence of response of 
P. fluorescens MF37 to muscimol and bicuculline suggests that in this strain, the GABA sensor is not 
related to the muscimol-sensitive GBP protein identified by Guthrie et al. [36] in an environmental 
strain of P. fluorescens. The virulence of P. fluorescens is highly variable and appears strain- and 
environment-dependent. A psychrotrophic strain, such as P. fluorescens MF37, has a marked cytotoxic 
activity on animal cells [25], and some clinical strains have an infectious potential in the same range as 
P. aeruginosa [21]. Conversely, in plants, P. fluorescens is essentially, if not always, considered as a 
protecting agent [20,37]. Also, GABA appears to have opposite effects on bacterial virulence in plants 
and animal models. Indeed, as in P. aeruginosa [13], GABA acts as promoter of P. fluorescens 
cytotoxicity on rat glial cells, whereas in a phytopathogen, such as A. tumefaciens, GABA reduces the 
virulence [18]. This should be correlated to the different functions of GABA in plants, where it is a 
main contributor of the defense system [38], and in animals, where its protective role is apparently 
marginal [39]. Alternatively, these differences should reflect opposite adaptation processes between  
α- and γ-Proteobacteria, such as Agrobacterium and Pseudomonas.  
Bacteria have two lifestyles, i.e., planktonic and in biofilms. In biofilms, bacteria are protected 
against the action of antibiotics and host immune system molecules [40]. We tested the effect of 
GABA on P. fluorescens adhesion and biofilm formation activity on living cells, PVC (hydrophobic) 
and glass (hydrophilic) surfaces. GABA did not modify the initial binding index of P. fluorescens 
MF37 on living glial cells, but increased its adhesion on glass. On PVC, we observed a significant 
reduction of the biofilm formation activity only after 48 h, when the bacteria were pretreated with 
GABA during their growth phase, and after 24 h (but not after 48 h), when the bacteria were pretreated 
both during the growth phase and the biofilm formation period. These results suggest that only bacteria 
in the early growth phase are sensible to GABA either, because they express a sensor differently or, as 
in biofilm, GABA is unable to affect their physiology. We also tested the effect of GABA on the 
biofilm formation activity of bacteria on glass to observe the biofilm structure. This study was 
performed on P. fluorescens MF37, but also in other strains from environmental (Pf0-1, SBW25), clinical 
(MFN1032) or human skin (MFP05) origin. GABA did not affect the structure and the thickness of the 
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biofilms, except in the case of MFP05, where GABA induced an apparent increase of the biofilm 
maturation speed. GABA is synthesized and released in skin [41], and the response of MFP05 to 
GABA should represent an adaptation response to host signals. It is interesting to note that human skin  
P. fluorescens are special. Indeed, whereas these bacteria are found in abundance on skin regions in 
metagenomic studies [42], they are rarely cultivable [43], suggesting that they require specific growth 
conditions. In agreement with our results, this points out the high heterogeneity of P. fluorescens and 
their dependence in regards to the microenvironment. 
As bacterial adhesion is governed by the surface properties, we investigated the effect of GABA on 
the hydrophobicity, biosurfactant production and LPS structure of P. fluorescens MF37. The surface 
hydrophobicity of the bacteria was estimated by the MATS technique. The affinity of P. fluorescens 
MF37 to hexadecane is under 20% ; then, according to Bellon-Fontaine et al. [28], this strain was 
hydrophilic in our experimental conditions. GABA significantly increased the affinity of P. fluorescens 
MF37 to hexadecane, but the general hydrophilic character of the bacterium was preserved. It is 
known that biosurfactants synthesized by P. fluorescens are implicated in surface adhesion and biofilm 
formation [44]. The possible effect of GABA on biosurfactants production was studied by direct 
measurement of the surface tension of the rinsing medium of bacterial colonies. In control medium, 
this value was over 40 mN/m, indicating that P. fluorescens MF37 was not producing biosurfactants, 
and this surface tension was unchanged after GABA treatment. As in parallel, GABA did not interfere 
with the swimming or swarming potential of P. fluorescens MF37; this suggests that the structure and 
activity of flagella and pili were not modified. This is not excluding that GABA could interfere with 
other adhesins, but, if any, this effect should be marginal.  
P. fluorescens releases different diffusible enzymatic activities, but none was modified by GABA. 
Similarly, pyoverdine, which can trigger cytotoxicity [45], was also unaffected. In order to identify the 
factor responsible for the evolution of the cytotoxicity and surface properties of GABA-treated  
P. fluorescens MF37, we investigated the effect of GABA on the LPS structure. LPS is the major 
endotoxin of Pseudomonas, and it is known to play a key role in bacterial adhesion [46,47]. MALDI-TOF 
mass spectra of LPS extracted from control and GABA-treated P. fluorescens MF37 showed limited, 
but repeatable differences. These differences were essentially observed in low m/z LPS sub-fragments 
that should be generated by cleavage of lipid A. Interestingly, in P. aeruginosa, structural changes in 
this region have been associated with an increase in necrotic activity [30]. As observed in the case of 
growth temperature variations [27] or exposure to natriuretic peptides [35], the virulence of P. fluorescens 
MF37 appears modulated by a rearrangement of the LPS structure. It should be noted that NO has, by 
itself, a high cytotoxicity on glial cells [48], but its production by cells exposed to GABA-treated 
bacteria was reduced, suggesting that its contribution to glial cell death is marginal. Then, although  
P. fluorescens MF37 and P. aeruginosa PAO1 respond to GABA by an increase in cytotoxicity, the 
mechanisms appear to be very different. In P. aeruginosa, the effect of GABA is due to an  
over-production of a diffusible virulence factor (HCN) [13], whereas in P. fluorescens, it is essentially, 
if not only, dependent on the LPS structure and, then, contact-dependent.  
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4. Experimental Section  
4.1. Bacterial Strains and Culture Conditions 
P. fluorescens MF37 is a natural rifampicin-resistant mutant of the strain MF0 from raw milk [49]. 
This strain is a model of psychrotrophic Pseudomonas widely used in our laboratory. P. fluorescens 
MFN1032 is a clinical strain adapted to grow at 37 °C collected from a pulmonary tract infection [21]. 
It is considered to be a nosocomial bacterium. P. fluorescens MFP05 was collected from human skin, 
where this species is considered as a member of the transient bacterial microflora. P. fluorescens 
SBW25 and Pf0-1 are environmental bacteria. The SBW25 strain was isolated from plant leaves, 
whereas the Pf0-1 strain was isolated from agricultural soil [50]. For pre-treatment, bacteria were 
transferred to 25 mL of nutrient broth (NB, Merck, Darmstadt, Germany) containing or not containing 
GABA (10−5 M) and were cultured at 28 °C, until the beginning of the stationary phase. The density of 
the bacterial suspension was determined by absorption at 580 nm (ThermoSpectronics, Cambridge, UK). 
4.2. Swimming and Swarming Mobility Tests 
Cultures of P. fluorescens MF37 in NB in the early stationary phase were collected and centrifuged 
(10 min, 6000 rpm). For the swimming mobility test, plates containing 0.3% agar were inoculated on 
the surface using a needle previously soaked with the centrifugation pellet. The plates were incubated 
at 28 °C until the development of a migration halo. The diameter of the halo was measured between  
4 and 48 h after inoculation. The values of mobility were determined over a minimum of 3 
independent measures. For the swarming mobility test, the same protocol was used, except that NB 
medium was supplemented with 0.5% agar. 
4.3. Cytotoxic Activity Tests 
The effect of GABA, muscimol and bicuculline on the cytotoxic activity of P. fluorescens MF37 
was investigated on primary cultures of rat glial cells using biochemical indicators of apoptosis and 
necrosis, as previously described [25,27]. Rat glial cells, obtained from newborn (24–48 h) rat brain, 
were grown in DMEM/Ham’s medium (2/1) supplemented with 10% fetal calf serum, 2 mM 
glutamine, 0.001% insulin, 5 mM HEPES, 0.3% glucose and 1% antibiotic-antimycotic solution 
(Biowhittaker, Emerainville, France). The cells were layered at a concentration of 105 cells/well on  
24 well-plates coated with poly-L-lysine (50 µg.mL−1) and kept at 37 °C in a 5% CO2 humidified 
atmosphere. Glial cells were allowed to grow for 12–16 days before use. For the tests, bacteria were 
pretreated with GABA overnight (18 h) at 28 °C. Before the tests, bacteria in the stationary phase were 
harvested by centrifugation (6000 rpm, 5 min) and rinsed 3 times to remove any trace of free GABA. 
Bacteria were then re-suspended at a density of 106 CFU.mL−1 in glial cell culture medium without 
antibiotics and antimycotics and incubated with glial cells during 24 h. The concentration of LDH was 
determined using the Cytotox 96 Enzymatic Assay (Promega, Charbonnieres, France). Nitrite ions 
(NO2−) resulting from the spontaneous conversion of nitric oxide (NO) in the incubation medium were 
measured using the Griess colorimetric reaction.  
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4.4. Evaluation of the Bacterial Biofilm Formation Activity by the Crystal Violet Technique 
The biofilm formation activity of P. fluorescens MF37 was studied using the crystal violet 
technique adapted from O’Toole and Kolter [51]. Cultures of P. fluorescens MF37 grown in NB and in 
the early stationary phase were centrifuged for 10 min at 6000 rpm and rinsed with sterile water NaCl 
0.9% (SPW). Then, an aliquot of 100 μL of a bacterial culture adjusted to an OD580 = 0.4 was layered 
in a polystyrene microtitration plate (96 wells) and incubated for 24 or 48 h. In a first series of 
experiments, bacteria were grown in the absence of GABA, but were exposed to the molecule during 
the biofilm formation. In a second series of experiments, bacteria were grown in the presence of 
GABA, but GABA was not added to the medium during the biofilm formation step. In a third series of 
experiments, bacteria were grown with GABA, as previously, but the medium in PVC microtitration 
plates was supplemented with GABA to maintain the treatment during the 24 to 48 h of biofilm 
formation. At the end of the incubation time (24 h or 48 h) at 28 °C, the OD595 was measured. After 
removal of the bacterial suspension and rinsing with SPW, bacteria and matrix bound to the wells were 
stained with 150 µL of crystal violet (0.1%, 30 min). After rinsing, the dye was recovered by adding 
150 µL of SDS (1% in sterile water, 15 min), and the OD595 nm of the solution was measured. Data 
were normalized as a percentage of biofilm density in the absence of treatment. The percentage of 
biofilm formation was evaluated by the following equation: 
% of biofilm formation = (OD595 after crystal violet staining/OD595 before crystal violet staining) × 100 (1)
4.5. GFP Transformation  
P. fluorescens MF37, SBW25, MFN1032, Pf0-1 and MFP05 were transformed with the pSMC2.1 
plasmid [52]. The plasmid was extracted from an E. coli strain containing the green fluorescent protein 
(GFP) gene and a kanamycin resistance cassette. Briefly, 1.5 mL aliquots of bacterial cultures realized 
in LB medium at 28 °C and reaching an OD580 between 1 and 2 were centrifuged for 1 min at  
13,000 rpm. The pellet was washed 3 times with 300 µL of sucrose (300 mM) and re-suspended in  
100 µL of sucrose (300 mM). For the Pf0-1 strain, the pellet was washed and re-suspended using cold 
distilled water. Competent cells were mixed with 5 µL of pSMC2.1 plasmid and electroporated at  
1800 V. After electroporation, bacteria were incubated in 1 mL of LB medium for 1 h at 28 °C under 
180 rpm agitation. A small volume of the culture (100 µL) was layered on LB agar supplemented with 
kanamycin (200 µg/mL). After 24 h of incubation, transformed bacteria were observed by confocal 
microscopy (LSM 710, Zeiss, Oberkochen, Germany) to verify the integration of the plasmid and the 
production of a green fluorescent signal. 
4.6. Confocal Microscope Study of the Bacterial Biofilm Formation Activity on Glass Surfaces 
A pre-culture and cultures of the GFP transformed strains of P. fluorescens were realized in NB 
medium, supplemented with kanamycin (200 µg/mL) for MFN1032, MF37 and SBW25. The plasmid 
was stable in the strains MFP05 and Pf0-1, and the antibiotic pressure was not necessary. After 24 h of 
incubation with or without GABA (10−5 M), bacteria were centrifuged at 7000× g for 10 min at room 
temperature. The pellets were washed one time with SPW and adjusted at OD580 = 1 in a final volume 
of 25 mL. Glass slides, washed beforehand with ethanol, were placed in Petri dishes, covered with the 
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bacterial suspension and incubated at 28 °C in static condition. After 2 h, glass slides were washed two 
times with SPW. One slide was heath fixed to control the adhesion capacity of the bacteria, and the 
others were covered with 25 mL of NB and incubated at 28 °C. After 5, 24 and 48 h of incubation, one 
glass slide was washed two times with SPW, dried, fixed and observed with a confocal microscope 
(LSM 710, Zeiss) using an ×63 immersion objective. Images were processed using Zen software 
(Zeiss, 2009); a median filter was applied, images were segmented and fluorescence was quantified. 
4.7. Evaluation of Bacterial Surface Properties 
The binding index of bacteria on biological (cell) surfaces was determined using the gentamicin 
exclusion test [33]. Glial cells were exposed to bacteria (106 CFU·mL−1) in culture medium without 
antibiotics and antimycotics for 4 h. At the end of the incubation period, cultures were rinsed 3 times 
with fresh medium to remove unattached bacteria. A part of the wells was immediately treated with 
500 µL of Triton X100 in SPW (0.1% v/v) for 15 min at 37 °C. After plating and incubation for  
2 days at 28 °C, the total number of bacteria present at the surface and in the cells was determined. 
Other wells were exposed to gentamicin (300 µg·mL−1) for 1 h at 37 °C, rinsed 3 times and then 
treated with Triton X100 (0.1%) for 15 min. Extracellular bacteria were killed by gentamicin, and the 
colonies obtained after culture correspond to bacteria exclusively present in the intracellular 
compartment. The number of adherent bacteria was calculated as the difference between the total 
number and the intracellular bacteria.  
The binding index of bacteria on glass slides was determined by direct counting. Before use, glass 
slides were cleaned by immersion in ethanol (70% in water), rinsed in sterile water and treated with 
TFD4 detergent (4% in 50 °C water) for 1 h to remove any traces of lipids. Then, glass slides were 
rinsed in sterile water and dried under laminar air flow. A bacterial suspension (108 CFU·mL−1 in 
SPW) was layered on each glass slide. Bacteria were allowed to adhere for 2 h at 28 °C. Non-adherent 
bacteria were removed by rinsing with SPW, and the remaining adherent bacteria were immediately 
stained with acridine orange (0.01% in SPW) for 20 min. After rinsing in SPW and drying, the  
slides were observed using an epifluorescence microscope Zeiss Axiovert 100 equipped with a  
Nikon DXM1200F color camera. The binding index was determined by counting a minimum of  
20 homologous fields.  
The surface polarity of bacteria was determined using the microbial adhesion to solvent (MATS) 
technique [28]. Bacterial cultures treated or not with GABA (10−5 M) were harvested by centrifugation 
for 10 min at 10,000× g. Pellets were rinsed 2 times with SPW and diluted to OD400 = 0.8. An aliquot 
of bacterial suspension (2.4 mL) was mixed with 0.4 mL of hexadecane in glass tubes. The tubes were 
vigorously hand-shaken for 10 s, vortexed for 45 s and hand-shaken again for 10 s. After 15 min, the 
OD400 of the aqueous phase was measured. The percentage of affinity for hexadecane was calculated 
by the relation: [(OD control − OD test)/OD control] × 100. 
In this relation, OD control corresponds to the OD400 of bacterial suspension without hexadecane, 
and OD test corresponds to the OD400 of bacterial suspension with hexadecane. 
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4.8. Surface Tension and Biosurfactant Production in Bacterial Culture Medium 
The biosurfactant production was monitored indirectly by measuring the surface tension of the 
rinsing solution (SPW) of colonies of P. fluorescens grown during 48 h on solid NB medium, using the 
Wilhelmy plate technique [53]. 
4.9. Study of the Lipopolysaccharide Structure  
The lipopolysaccharide (LPS) was purified from P. fluorescens MF37, as described by Darveau and 
Hancock [54]. Bacteria in the early stationary phase were harvested by centrifugation (6000× g,  
10 min, 4 °C). Each pellet was re-suspended in 10 mM Tris-buffer 10 mM containing 2 mM MgCl2,  
200 µg mL−1 pancreatic DNase and 50 µg·mL−1 pancreatic RNase and was submitted to sonication  
(4 burst of 30 s, probe density 70). The suspension was then incubated for 2 h at 37 °C. Then, 0.5 M 
tetrasodium-EDTA, 100 µL of Tween 20 and 10 mM Tris-hydrochloride were added. The samples 
were centrifuged (10,000× g, 30 min, 20 °C) to remove the peptidoglycan. The supernatants were 
incubated overnight with 200 µg/mL of protease, at 37 °C, with constant shaking. Two volumes of 
0.375 M MgCl2 in 96% ethanol were added. The samples were then centrifuged (12,000× g, 15 min,  
4 °C), and the pellets were sonicated in a solution of Tween 20, 0.5 M tetrasodium-EDTA and 10 mM 
MgCl2. The pH of the solutions was lowered to 7 to prevent lipid saponification. The solutions were 
incubated for 30 min at 85 °C, to ensure that outer membrane proteins were denatured, and the pH of 
the solutions was increased to 9.5. Protease was then added, and the samples were incubated overnight 
at 37 °C. Two volumes of 0.375 M MgCl2 in 96% ethanol were added, and the samples were 
centrifuged (12,000× g, 15 min, 4 °C). The pellets were re-suspended in 10 mM Tris-HCl, sonicated 
and centrifuged twice to remove insoluble Mg2+-EDTA crystals. The supernatants were then 
centrifuged (62,000× g, 2 h, 15 °C). The pellets containing the LPS were re-suspended in distilled 
water. The LPS extracts were analyzed by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight 
mass spectrometer (MALDI-TOF) using an Autoflex III TOF/TOF 200 MALDI mass spectrometer 
(Bruker Daltonics Wissembourg, France). For analysis, a 1 µL aliquot of purified LPS was spotted 
onto a steel target plate and air dried. A volume of 1 µL of a solution of α-cyano-4-hydroxycinnamic 
acid matrix (14 mg/mL in acetonitrile/2.5% trifluoroacetic acid, v/v) was added on each spot and dried 
at room temperature. The mass spectrometer was equipped with a pulsed YAG 200 Hz laser and was 
run in the positive mode. Instrument calibration was achieved by using calibration standards (Care, 
Bruker Daltonics, Wissembourg, France) spotted on the same target plate. Each spectrum was 
established over 200 laser shots. 
4.10. Detection of Diffusible Virulence Factors 
Little is known about diffusible virulence factors produced by P. fluorescens. In the present study, 
we focused on the production of exoenzymes and pyoverdine. 
Secreted caseinase, esterase, amylase and hemolytic activities were studied from cultures on milk, 
Tween 80, starch and Columbia blood supplemented agar medium, respectively. For these tests, the 
medium was inoculated on the surface using a needle previously soaked with the centrifugation pellet 
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and were incubated at 28 °C until the development of a halo revealing the bacterial enzymatic activity. 
The diameter of the halos was measured 24 h and 48 h after incubation.  
The elastase activity was measured in liquid bacterial culture medium using an elastin/Congo red 
assay. Filtered supernatant (50 µL) was mixed with 1 mL of Tris buffer (0.1 M Tris-HCl pH 7.2, 1 mM 
CaCl2) containing 20 mg of elastin/Congo red (Sigma, St Quentin Fallavier, France). The tubes were 
incubated at 28 °C with agitation. After 18 h, the tubes were chilled on ice, and the reaction was stopped 
by adding 0.1 mL EDTA 0.12 M. Non-soluble elastin/Congo red was removed by centrifugation, and 
the OD490 was measured. 
Pyoverdine production was monitored from 6 to 48 h of bacterial culture. To promote pyoverdine 
production, bacteria were grown on King B medium (for 1 L: 10 g glycerol; 20 g polypeptone; 1.5 g 
K2HPO4; 6 mM MgSO4, 7 H2O; pH 7) or in Bacto Casamino Acids (CAA) medium (for 1 L: 5 g of 
casamino acid; 0.9 g of K2HPO4; 2 mM MgSO4, 7H2O; pH 7.4). Pyoverdine production was expressed 
as the ratio OD400/OD580 of the supernatant after removal of the bacteria by centrifugation  
(5 min, 10,000× g). 
4.11. Statistical Analysis 
For all the results, each value reported for the assays is the mean of measurements from a minimum 
of three independent preparations. The Student t-test was used to compare the means within the same 
set of experiments. 
5. Conclusions 
In this present study, we demonstrate that GABA increases the cytotoxicity of P. fluorescens MF37 
through modifications of the LPS structure. Furthermore, we observed that GABA can affect the 
biofilm formation activity and the surface polarity of the bacterium. These properties are not shared by 
all P. fluorescens strains, suggesting that GABA-sensitive strains adapted in response to specific 
environmental conditions. The mechanisms of virulence modulated by GABA in P. fluorescens  
and in P. aeruginosa are totally different, suggesting the existence of different detection and  
regulatory mechanisms. 
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Abstract
Background: Skin is the largest human neuroendocrine organ and hosts the second most numerous microbial population
but the interaction of skin neuropeptides with the microflora has never been investigated. We studied the effect of
Substance P (SP), a peptide released by nerve endings in the skin on bacterial virulence.
Methodology/Principal Findings: Bacillus cereus, a member of the skin transient microflora, was used as a model. Exposure
to SP strongly stimulated the cytotoxicity of B. cereus (+55363% with SP 1026 M) and this effect was rapid (,5 min).
Infection of keratinocytes with SP treated B. cereus led to a rise in caspase1 and morphological alterations of the actin
cytoskeleton. Secretome analysis revealed that SP stimulated the release of collagenase and superoxide dismutase.
Moreover, we also noted a shift in the surface polarity of the bacteria linked to a peel-off of the S-layer and the release of S-
layer proteins. Meanwhile, the biofilm formation activity of B. cereus was increased. The Thermo unstable ribosomal
Elongation factor (Ef-Tu) was identified as the SP binding site in B. cereus. Other Gram positive skin bacteria, namely
Staphylococcus aureus and Staphylococcus epidermidis also reacted to SP by an increase of virulence. Thermal water from
Uriage-les-Bains and an artificial polysaccharide (TefloseH) were capable to antagonize the effect of SP on bacterial
virulence.
Conclusions/Significance: SP is released in sweat during stress and is known to be involved in the pathogenesis of
numerous skin diseases through neurogenic inflammation. Our study suggests that a direct effect of SP on the skin
microbiote should be another mechanism.
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Introduction
Skin is the largest neuroendocrine organ of the human body [1]
and it hosts the second most numerous microbial population [2].
There is increasingly strong evidence that bacterial virulence is
partly regulated by host hormones and neurotransmitters [3,4]. By
sweat or direct contact with the dermis or the epidermis [5], skin
micro-organisms are in contact with host communication factors.
It is therefore paradoxical to note that, until now, the interaction
of skin neuropeptides with the bacterial microflora was not taken
into consideration.
Substance P (SP), the main neuropeptide identified in skin nerve
endings, is essentially located in primary afferent C-fibers and is
released in the skin [6]. This undecapeptide of the tachykinin
family has multiple bioactivities other than neurotransmission [7],
such as capillary vasodilatation, fibroblast and keratinocyte
proliferation or mast cell degranulation [1]. It is considered a
major mediator of neurogenic inflammation [8] and itch [9].
Cutaneous neuropeptides, and particularly SP, contribute to the
pathogenesis of numerous skin diseases, like psoriasis [10], atopic
dermatitis [11,12], immediate and delayed hypersensitivity [13],
acne [14] or rosacea [15]. These diseases have multifactorial
origins and we suggest that SP could also act through interaction
with the skin microflora. Indeed, SP has both direct and indirect
antimicrobial activities by acting as a weak cationic antimicrobial
peptide [16] and by stimulating the release of cathelicidins and
defensins [17]. Different skin neuropeptides have antibacterial
activities [3] but, as SP, these activities are generally observed at
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high non-physiologic concentrations (.1024 M). At low doses,
peptides, including anti-microbial ones, can affect the bacterial
physiology independently of any modification in their growth rate
[18]. For instance, at sub-micromolar concentrations some
neuropeptides, such as dynorphin [19] or natriuretic peptides
[20,21] have been shown to stimulate bacterial virulence.
In the present study, we investigated for the first time the action
of SP on skin bacterial virulence using a human skin strain of
Bacillus cereus. The mechanism of SP action on Bacillus cereus and its
binding site were identified. We revealed that SP is acting on other
Gram positive bacteria, namely Staphylococcus aureus and Staphylo-
coccus epidermidis, suggesting that SP should act as a regulator of
bacterial virulence in some of the principal skin associated
bacteria. We also observed that this effect of SP on bacterial
virulence can be antagonized by thermal water and an artificial
polysaccharide.
Materials and Methods
Bacterial Strains, Growth Media and Culture Conditions
Bacillus cereus (MFP01), Staphylococcus aureus (MFP03) and
Staphylococcus epidermidis (MFP04) originate from our library and
were isolated previously from the skin of human donors in the
framework of an industrial collaborative program. These bacteria,
collected under control of the CRO Bio-EC (Longjumeau, France)
in agreement with French and EU Ethic guidelines (ARS
Biomedical Research Agreement Nu2012-12-010, Bioethic Agree-
ment DC-2008-542), have been identified using APIH strips, 16S
ribosomal RNA gene sequencing and whole proteome analysis by
MALDI mass spectrometry and Biotyper analysis (Bruker
Daltonics). For confocal microscopy, these bacteria were trans-
formed by insertion of the pTeTON-GFP plasmid [22]. Bacteria
were grown at 37uC in Luria-Bertani (LB). For pre-treatment, they
were diluted at a ratio of 1:40 in fresh broth and the peptides were
added at the beginning of the log growth phase. Before use
bacteria were rinsed to remove traces of the tested molecule.
Substance P (SP) and the reversed sequence peptide (SPrev) were
obtained from Polypeptide, Strasbourg, France. In all the studies,
controls were carried out using SPrev.
Infection Studies
The interaction of bacteria with keratinocytes was studied using
HaCaT cells (Cell Line Services, Eppelheim, Germany). Cells
grown at 37uC in 5% CO2 atmosphere in Dulbecco’s modified
Eagle’s medium (DMEM, Lonza) were starved of antibiotics 24 h
before infection assays. Cells were used between passages 41 and
65. The cytotoxic potential of bacteria was determined by
measurement of lactate dehydrogenase (LDH) using the Cytotox
96 assay (Promega, Charbonnieres, France). The bacterial
activation of caspase-1 was measured using a commercial kit
(BioVision RP, Milpitas, California). For cytological studies B.
cereus was treated with SPrev or SP and monolayers of HaCat cells
were exposed to the bacteria at a multiplicity of infection (MOI) of
10:1. After incubation, keratinocytes were washed to remove
unattached bacteria. Cells were then fixed for 10 min in 4%
paraformaldehyde in water and permeabilized for 4 min in 0.2%
Triton-X 100 in phosphate buffered saline (PBS). Actin was
stained with anti-actin rabbit monoclonal antibody (Millipore,
Molsheim, France) and revealed using goat anti-rabbit Alexa 633-
labelled antibody (Molecular Probes, Saint-Aubin, France).
Preparations were observed using a LSM 710 confocal laser-
scanning microscope (Zeiss).
Identification of SP Stimulated B. Cereus Virulence Factors
For cereulide assay, B. cereus treated with SPrev or SP (1026 M)
were extracted with pentane. The solvent was evaporated and the
residue was analyzed by HPLC-MS as described by Ha¨ggblom
et al. [23]. Since cereulide is not commercially available, the
calibration was made using valinomycin (Sigma, St Quentin-
Fallavier, France). For the study of B cereus exoproteins,
supernatants from bacterial cultures were obtained by centrifuga-
tion at 70006 g for 10 min. After filtration on 0.22 mm disposable
filter units, proteins were precipitated overnight on ice by addition
of 10% trichloroacetic acid (TCA, v/v). Proteins were harvested at
130006 g for 20 min at 4uC, washed three times in cold acetone
and dried for 1 h at room temperature. Extracted proteins were
then dissolved in rehydratation buffer [24] in a final volume of
350 mL. The protein concentration was determined on an aliquot
by Bradford assay. Proteins were separated on 12% w/v
polyacrylamide 1D gel SDS-PAGE and on 2D gels using pH 4
to 7 non-linear IEF strips and 12% w/v polyacrylamide gel [24].
The second dimension separation was run at 50 mA/gel for 4 h.
Gel images were captured using a GS-800 densitometer (Bio-Rad)
and analyzed using the Bio-rad PDQuest 2D analysis software.
Bands or spots of interest were dissected, submitted to in-gel
trypsin digestion [24], and analysed by MALDI-TOF using an
AutoFlex III mass spectrometer (Bruker Daltonics) and a
FlexControl software Version 3.3. The spectrometer was used in
a positive/reflector mode using peptide calibration standards
(Bruker Daltonics) as references. Samples were spotted onto MTP
384 ground steel targets using freshly prepared matrix solution
composed of 2,5-dihydroxybenzoic acid (20 mg.mL21 in trifluor-
oacetic acid and acetonitrile). Each spectrum was established over
an average of 500–1000 laser shots and 2,5-dihydroxybenzoic acid
as matrix. The MS peak list was submitted for fingerprinting using
Biotools (Version 3.2). The NCBI data base was searched using
MASCOT (http://www.matrixscience.com/cgi/nph-mascot.exe).
Transmission Electronic Microscopy Observations
Control and SP-treated B. cereus were studied by Transmission
Electronic Microscopy (TEM) using a Tecnai 12, FEI Company
microscope. Bacteria fixed in 2% glutaraldehyde and postfixed
with 1% osmium tetroxide were embedded in 2% agarose low
melting point. After solidification, samples were cut into 2 mm3
slices, dehydrated, embedded in Spurr and polymerized for 24 h
at 60uC. Ultrathin sections were obtained using a Leica EM UC6
ultramicrotome. The sections were contrasted with 0.5% uranyl
acetate and lead citrate (10 min). The microscope was set at
60 kV. Images were processed by the PRIMACEN Platform
(http://primacen.crihan.fr).
B. Cereus Surface Hydrophobicity and Biofilm Formation
Studies
The polarity of control and SP treated B. cereus was studied using
the MATS technique [25] and two solvent couples: chloroform/
hexadecane and ethyl acetate/n-decane. The effect of SP on B.
cereus biofilms was investigated using a LSM 710 CLSM (Zeiss).
GFP-transformed bacteria grown for 13 h in the presence of SP or
SPrev were poured in dishes containing sterile glass slides. After
2 h a slide was heat fixed to observe the initial adhesion. The other
slides were covered by LB medium containing SP or SPrev and
incubated for 5 or 24 h without agitation. In order to control their
structure, the biofilms were scanned every micrometer in depth at
3 random positions. Three-dimensional (3D) images and ortho
cuts (3D/z) were reconstructed using ZenH 2009 software (Zeiss).
The biofilm thickness was quantified using the same software.
Effect of Substance P on Skin Bacterial Virulence
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Identification of the B. Cereus SP Binding Site
For identification of the B. cereus SP binding site, proteins
from mid-log growth phase bacteria were extracted as previously
described [27]. Briefly, bacteria were harvested by centrifugation
and washed with ice-cold PBS. The pellet was resuspended in
non-denaturing lysis buffer (Tris 50 mM pH 8, EDTA 40 mM,
NaCl 137 mM, glycerol 10%, Triton X-100 1%, Phenylmethyl-
sulfonylfluoride 1 mM) supplemented with complete protease
inhibitor cocktail (Complete Protease Inhibitor cocktail tabs,
Boehringer). After sonication, cell fragments were removed by
centrifugation and the supernatant was ultracentrifugated at
148,0006 g, 50 min, 4uC. The pellet was then resuspended in a
second ice cold lysis buffer (Tris 50 mM pH8, MgCl2 10 mM,
Triton X-100 2%, Phenylmethylsulfonylfluoride 1 mM, Protease
Inhibitor cocktail). The SP binding site was investigated by an
immunoprecipitation technique adapted from Mijouin et al. [26].
SP antibody-associated beads were made by incubating G
protein-coupled agarose beads (Millipore) and SP monoclonal
antibody (Abcam, Paris, France) overnight. Meanwhile, 1.5 mg
of B. cereus membrane protein extract was incubated with SP
(1026M) for 1 h at 20uC. To reduce the non-specific binding,
50 mg of rabbit polyclonal serum was added. Unlabelled agarose
beads were added to fix non specific complexes. The sample was
incubated 30 min at 4uC and the beads were removed by
centrifugation (140006 g, 10 min). The supernatant, containing
the SP bond ligand, was then incubated with the SP antibody-
associated beads for 1 h at room temperature under slow orbital
agitation. Beads were then washed by successive low speed
centrifugation cycles in non-denaturing lysis buffer. The ligand
was separated from the beads and denaturated by adding
loading buffer (Tris 200 mM pH 6.8, glycerol 45%, SDS 6%, b-
mercaptoethanol 6%, bromophenol blue 0.03%) and boiling for
5 min. Before loading on 12% w/v polyacrylamide gel SDS-
PAGE, the beads were eliminated by centrifugation. Proteins
were visualized by colloidal coomassie brilliant blue G250
staining (Sigma). Three independent experiments were conduct-
ed. The electrophoretic band of interest was dissected, submitted
to in-gel digestion and analyzed by MALDI-TOF as previously
described.
Inhibition of the SP Virulence Stimulating Activity
Bacteria were diluted to a ratio of 1:40 in fresh broth and
exposed at the beginning of the log growth phase to SP or SPrev
(1026M) and Uriage Thermal Water (UTW) 30% v/v or
TefloseH (TF) 0.1% w/v or SRrev (1026M). After 1 h, the
micro-organisms were harvested by centrifugation, washed and
the cytotoxic potential of the bacteria was determined at an
MOI of 10:1 by measurement of LDH release. Controls showed
that at the concentrations of TF and UTW used had no effect
on the growth kinetics of the bacteria or on the survival of
keratinocytes.
Statistical Analysis
Cytotoxicity (LDH), caspase 1 and MATS experiments were
conducted independently at least three times at different days. The
results are expressed as Means 6 SEM and statistical differences
were determined using the Student’s t-test. Significant differences
were noted as w, ww and www for p-values ,0.05, ,0.01 and
,0.001, respectively. For each biofilm, the thickness was
calculated from a minimum of 20 measures in different fields
using the ZenH 2009 software (Zeiss). The mean biofilm thickness
was quantified over three different experiments and the Student t-
test was used to compare the means. SDS-PAGE electrophoresis,
bidimensional electrophoresis, MALDI-TOF and immunoprecip-
itation figures are representative of three independent experi-
ments.
Results
Substance P is Stimulating the Virulence of Bacillus
Cereus
The study was realized on Bacillus cereus MFP01, a strain
identified on the skin of normal human volunteers. Preliminary
controls showed that exposure of B. cereus to SP (1026 M) during
the whole growth phase or at the beginning of the stationary
phase, did not modify the growth kinetics of the bacterium. SP was
also without effect of the swimming and swarming activities. The
peptide was not tested at higher concentrations as it is known to
have possible antibacterial activities [16]. When B. cereus was
grown in the presence of SP, the bacterium showed a strong
increase in its cytotoxic potential on keratinocytes, as revealed by
the LDH release assay (Fig. 1A). The threshold of SP activity was
between 1029 and 1028 M. At a concentration of 1026M, the
cytotoxic activity of B. cereus reached 55363% (P,0.001) of the
control. Since keratinocytes might be sensitive to SP [28], bacteria
were carefully rinsed to remove any trace of free SP prior cell
infection. In addition, control experiments realised by direct
treatment of keratinocytes with SP (1026 M) showed that, in our
experimental conditions, SP had no direct lethal effect on
keratinocytes and did not modify the cytotoxic effect of SP treated
bacteria. The specificity of the effect of SP on B. cereus was also
controlled by using the SP reversed sequence peptide (SPrev).
Even at the highest concentration used (1026 M), SPrev was
without any effect on B. cereus cytotoxicity. Then SPrev was used as
a control for SP during the whole study. The response of B cereus to
SP was particularly rapid. A 5 min treatment of the bacterium
during the mid log growth phase was sufficient to reach 90.5% of
the maximal response (Fig. 1B). There was no difference of
cytotoxic activity between bacteria exposed to SP for 10 min and
1 h. The cytotoxic activity of the bacteria was not modified after
1 h of treatment.
In order to characterize more precisely the effect of SP on B.
cereus virulence we measured the production of caspase-1 by
keratinocytes after infection with bacteria pretreated for 1 h
with SPrev (control) or SP 1026 M. As shown in Fig. 2A, after
30 min of infection, the production of caspase-1 by keratino-
cytes exposed to SP treated Bacilli rose significantly (+174651%,
P,0.05). Caspase-1 is an enzyme involved in pyroptosis and cell
necrosis which is activated during the inflammasome induction
[29]. An assay of other caspases and/or cytokines should be
necessary to determine the precise inflammatory pathway
induced by B. cereus. As this process is generally associated
with alterations of the cellular morphology, we observed
HaCaT keratinocytes exposed to SPrev and SP treated B.
cereus. After a 30 min infection with control bacteria the
histological structure of keratinocytes remained unchanged,
whereas the structure of HaCaT cells exposed to SP-treated
B. cereus was dramatically altered (Fig. 2B). In particular, we
observed a complete disorganization of the actin cytoskeleton
and the formation of intra-cytoplasmic vesicles. After 1 h
infection with SP treated bacteria the HaCaT cell monolayer
was completely disorganized. It is interesting to note that
keratinocytes exposed to control bacteria for a longer period
(5 h) finally presented the same aspect, suggesting that SP not
only increased but also accelerated the production of virulence
factors.
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Substance P Induces the Release of Superoxide
Dismutase and Collagenase by Bacillus Cereus and a peel-
off of its S-layer
The effect of SP appeared mediated through the production of
diffusible virulence factors since bacterial cultures and filtered
growth medium were equally cytotoxic. As the effect of SP was
rapid, we first investigated a possible increase in the production of
cereulide, the emetic toxin of B. cereus known for its very short
kinetic of action [30]. HPLC-MS analysis showed that B. cereus
MFP01 actually produced cereulide (106 ng/g wet weight of
bacteria) but this production was unchanged after SP treatment.
Then, exoproteins produced by B. cereus were studied. Image
analysis of 1-D gels showed variations in 3 major bands between
the control and SP treated bacteria, two in the mid-log phase
culture secretome and a different one in the late stationary phase
(Fig. 3). The first protein over-expressed by 1 h SP-treated B. cereus
was identified by MALDI-TOF as a 24 kDa manganese depen-
dent superoxide dismutase (SOD) (NCBI number ZP_00239265).
The second protein was as the 66 kDa collagenase ColT (NCBI
number ZP_04321651). These proteins were not over-expressed
by late stationary phase bacteria but we noted an increase of a
87 kDa band corresponding to the S-layer crystal protein (NCBI
number YP_002337034.1). These results were confirmed by 2-D
electrophoresis. However, Bacillus cereus is known to express
different types of related S-layer proteins [31] and the PDQuest
2D analysis revealed that in fact two closely related 87 kDa
proteins, the S-layer crystal protein (YP_002337034.1) but also the
S-Layer protein Sap (HM626283.1), were over produced by B.
cereus after a 13 h treatment with SP (Fig. 4). Conversely 10
proteins, essentially energetic and intermediate metabolism
enzymes, were down regulated by SP (Table 1).
Bacteria were then examined by TEM. Control B. cereus showed
a continuous pseudo crystalline surface (Fig. 5A). In contrast, the
S-layer of bacteria treated with SP (1026 M) for 13 h appeared
interrupted and separated from the membrane by a gap (Fig. 5B).
Long amorphous membrane-like structures were observed in the
vicinity of the bacterial surface suggesting an important desqua-
mation of the S-layer (Fig. 5C,D). These modifications were
associated with a shift in the surface polarity of B cereus.
Considering that the threshold for the affinity to hexadecane of
polar (hydrophilic) bacteria determined by the MATS technique is
20% [25], in our experimental conditions control B. cereus behaved
as a highly polar micro-organism (562% and 862% affinity to
hexadecane and decane, respectively) (Fig. 6). SP treated bacteria
showed a significant increase in affinity to hexadecane (+1062%)
and to decane (+961%). In agreement with these observations
indicating an increase of surface hydrophobicity of SP-treated B.
Figure 1. Effect of Substance P on the cytotoxic activity of Bacillus cereus. (A) Dose response curve of the effect of Substance P (SP) and of
the reversed sequence peptide (SPrev). (B) Time course response of the bacteria to SP and SPrev (1026 M). (www=p,0.001).
doi:10.1371/journal.pone.0078773.g001
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cereus, the affinity of the bacteria to a polar solvent such as ethyl
acetate was reduced. Moreover, a comparison of the affinity to the
different solvent couples revealed that SP induced a shift in Lewis
acid/base character of the bacterial surface. Indeed, in control
bacteria the difference in the percentage of affinity between
hexadecane and chloroform was about 20% while it decreased to
5% in the couple ethyl acetate/decane. In SP-treated B. cereus,
these values were 19 and 14% respectively, showing that the
bacterial surface evolved from a highly polar and strict Lewis basic
character, to a mid polar and Lewis acido-basic character.
Substance P Increases the Biofilm Formation Activity of
Bacillus Cereus
Surface properties of Bacillus have a great influence on their
biofilm formation activity [31]. The effect of SP on B. cereus biofilm
formation was studied by confocal microscopy using GFP-
transformed bacteria. First, we verified that the growth kinetic of
GFP-pTeTON plasmid transformed bacteria was not modified in
the absence or presence of SP or SPrev. After a 2 h treatment with
SP (1026 M), the mean surface coverage of the bacteria was
unchanged except in specific points where the bacterial mat
tended to form blisters (Fig. 7A). The density of the biofilm was
also unchanged after 5 h exposition to SP. Yet its thickness was
increased on reconstructed 3D and transversal (3D/z) images. As
calculated using ZenH software, after 5 h exposition to SP, the
thickness of the biofilm rose from a mean value of 10.5 mm to
17.1 mm with SP treated bacteria (Fig. 7B). This effect was
maintained, but to a lower degree, in 24 h old biofilms.
Substance P is Binding on the Bacillus Cereus Thermo
Unstable Ribosomal Elongation Factor Ef-Tu
We investigated the presence of a SP binding site in the
membrane of B. cereus considering the properties of SP (ionic
charge and peptidic structure) and the very short delay required
for the effect of SP on bacteria (,5 min) which suggested an
interaction of SP with a surface sensor. A single band,
corresponding to a 43 kDa protein, was found as the possible
membrane ligand of SP in B. cereus (Fig. 8). No trace of non-specific
or secondary binding protein was observed. We only noted a
partial binding of SPrev on the same 43 kDa protein suggesting
that SPrev can bind to the same site with a lower affinity.
Nevertheless, SPrev is an inverted peptide and not a scramble, and
some epitopes can be preserved. The SP binding site was identified
by MALDI-TOF with a MASCOT score of 98 and a coverage
Figure 2. Effect of Substance P treated Bacillus cereus on caspase 1 induction and on the morphology of HaCaT cells. (A) Cells exposed
to SP treated bacteria showed an increase of caspase 1 production (w= p,0.05). (B) After a 30 min infection with control bacteria the morphology of
HaCaT cells remained unchanged but when the cells were exposed to SP treated B. cereus we observed a complete disorganization of the actin
cytoskeleton ( ) and the formation of multiple cytoplasmic vacuoles (R). Bar = 20 mm.
doi:10.1371/journal.pone.0078773.g002
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percentage of 59% (15 matched fragments) as the Thermo
unstable ribosomal Elongation factor (Ef-Tu) (NCBI number
NP_830009, 42912 Da, pI = 4.93).
Substance P also acts on Staphylococcus Aureus and
Staphylococcus Epidermidis Virulence but its Effect can be
Antagonized
B. cereus is responsible for severe cutaneous infections [32] but
Staphylocci are considered as the principal Gram positive skin
bacteria [2]. The effect of SP on the virulence of B. cereus was then
compared to that of the peptide on human skin strains of S. aureus
and S. epidermidis. As B. cereus, S. aureus and S. epidermidis responded
to a 1 h exposure to SP (1026 M) by a significant increase in their
cytotoxicity on HaCaT cells (+242.1617.2% and +198.5617%,
respectively) (Fig. 9) suggesting that SP should have similar effects
over different species of Gram positive bacteria. We also observed
that a polysaccharide rich in rhamnose and obtained by
fermentation, TefloseH (TF) or a thermal water from Uriage-les-
Bains (UTW) were able to antagonize the effect of SP on the three
Gram positive bacteria (281.6 and 181% reduction in the activity
of SP on B. cereus for UTW and TF respectively, and total
inhibition in the case of S. aureus and S. epidermidis).
Discussion
The skin microbiote is divided in two groups, the resident and
the transient microflora. Bacteria of the normal resident micro-
flora establish a quasi-symbiotic relation with the host [33]. In fact,
the variations of skin bacterial population or virulence essentially
concern the transient microflora that includes mostly opportunistic
pathogens. Bacillus cereus is a member of this sub-population. In
addition to food-born diseases, this bacterium is now recognized as
responsible for primary cutaneous infections [32]. This species
expresses a large arsenal of virulence factors, including hemolysins,
phospholisases, an emetic toxin and pore forming enterotoxins
[34] and was selected because of its high infectious potential that
made easier the observation of cytotoxicity differences.
The stimulation of B. cereus cytotoxicity by SP was high (5.5 fold
for SP 1026 M) and rapid (5 min). The controls allowed us to
exclude an artefact due to a direct action of SP on keratinocytes.
As the reversed sequence peptide SPrev, which has the same
amino acid composition as SP was without effect, we can also
exclude a metabolic action of the peptide. The assay of cereulide
production showed that B. cereus MFP01 synthesizes this toxin and
then containes the ces gene, encoded by a 270 kb plasmide, related
to the PXO1 virulence plasmid of B. anthracis [35,36] but the
expression of this plasmid is apparently not regulated by SP. B.
cereus reacted to SP by an over production of the collagenase ColT.
This should explain the disorganization of the cell monolayer and
is consistent with in-vivo studies showing that the role of collagenase
in B. cereus virulence is essential [37]. The increase of caspase 1
production by keratinocytes exposed to SP-treated bacteria and
the morphological changes of the cells are in agreement with an
induction of cell necrosis and pyroptosis [29]. However, a massive
cell death, as observed with SP treated bacteria, is associated with
the release of high amounts of potentially toxic oxidizing
compounds. The production of SOD by SP treated B. cereus
should be a defence reaction against this threat. This response of
B. cereus to SP was not observed when the bacteria were exposed to
SP over a long (13 h) period. In this case, we only noted an
increase of the release of S-layer proteins. This result was
correlated to the observation of a massive peeling-off of the S-
layer of B. cereus and to a drop in surface polarity. These events can
be interpreted as a general defence reaction of the bacterium
against SP. Indeed, although SP did not affect the growth of B.
cereus, this molecule has structural and functional homologies with
antimicrobial peptides and, as recently shown, the bacterial S-
layer should act as a barrier against cationic antimicrobial peptides
Figure 3. SDS page analysis of secreted Bacillus cereus
proteins after 1 or 13 h treatment with Substance P (SP) or
Substance P reverse (SPrev) (1026 M). Bacteria exposed for 1 h to
SP showed an increase in the production of the collagenase (ColT) and
of superoxide dismutase (SOD). Bacteria treated for 13 h with SP
presented in contrast an increase in the S-layer crystal protein (SL).
Results are representative of three independent experiments.
doi:10.1371/journal.pone.0078773.g003
Figure 4. Bidimensional electrophoresis analysis of secreted
proteins by Bacillus cereus after a 13 h exposure to Substance P
reverse (Control) or Substance P (SP) (1026 M). (A) Twelve spots
were modified after exposure of the bacteria to SP. (B) Two proteins (1
and 2) were over produced whereas the expression of 10 others was
down regulated. Identified proteins are presented in Table 1. Results are
representative of three independent experiments.
doi:10.1371/journal.pone.0078773.g004
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[38]. However, in the present study the concentration of SP was 3
logs below that of the more active antimicrobial peptide (LL-37)
[38] and the bacterium reacted not only by releasing S-layer
monomers, but by an almost complete desquamation of the S-
layer. The B. cereus S-layer ultra structure has not been investigated
in detail. Assuming that as in other species, in one B. cereus cell the
S-layer contains an average of 40,000 monomers [39], we
calculated that at a concentration of 1028 M (over the threshold
of SP effect) less that 1 SP molecule was available to interact with
10 S-layer proteins. Then, SP acts probably indirectly on the
stabilization of the polymeric form of the S-layer. The loss of the S-
layer induced by SP in B. cereus was associated with a decrease in
the global surface polarity of the bacterium. As described in
Bacillus anthracis, cell surface polarity plays a leading role in the
adherence to mammalian cells [40] but, to the contrary of our
observations, the cytotoxicity of hydrophobic strains is generally
lower [41]. The correlation between surface hydrophobicity and
virulence in B cereus is highly strain dependant [42] but it is also
Figure 5. TEM observation of control (SPrev) and Substance P (SP) treated Bacillus cereus. Whereas control bacteria presented a
continuous intact surface (A), bacteria exposed to SP showed a detachment of the S-layer (R) (B). Long amorphous structures were observed in the
vicinity of bacterial, suggesting a desquamation of the S-layer (C, D).
doi:10.1371/journal.pone.0078773.g005
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known that the surface of B. cereus in biofilms is more polar and
hydrophilic than the surface of the planktonic bacteria [43].
However, emetic strains such as B. cereus MFP01 only produce a
transient biofilm which tends to disorganize after 24 h. As we
observed, since the bacterium remained globally hydrophilic, the
surface variations are limited [31].
Figure 6. Effect of Substance P reverse (SPrev) and Substance P
(1026 M) on the affinity of Bacillus cereus to solvents of different
polarities. chloroform (CH), hexadecane (HD), decane (De) and ethyl
acetate (EA) (w= P,0.05, ww= P,0.01, www= P,0.001). Each value
represents the mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0078773.g006
Figure 7. Effect of Substance P reverse (SPrev) and Substance P (SP) (1026 M) on the biofilm formation activity of Bacillus cereus. The
biofilm formation was observed after 2, 5 and 24 h. (A) Two dimensions (2D) and reconstructed three-dimensions (3D) and ortho cuts (3D/z) images
showed that the density of the biofilm was essentially unchanged. (B) In contrast, the thickness of the biofilm was significantly increased after 5 and
24 h inclubation with SP (NS= non significant; ww= p,0.01; www= p,0.001).
doi:10.1371/journal.pone.0078773.g007
Figure 8. SDS page analysis of Bacillus cereus Substance P (SP)
binding proteins separated by immunoprecipitation using SP
antibody-associated beads. SP was found able to bind on a 43 kDa
protein that was identified by MALDI-TOF/TOF as the Thermo Unstable
ribosomal Elongation factor Ef-Tu (arrow: 43 kDa). SPrev was also
capable of binding to this protein but with a reduced effectiveness.
Results are representative of three independent experiments.
doi:10.1371/journal.pone.0078773.g008
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The kinetic of SP on B. cereus requires a rapid detection of the
peptide; therefore we hypothesized the presence of a surface
binding site. Indeed, although untreated B. cereus MFP01 showed
an intact S-layer protection wall, the S-layer presents multiple
pores allowing the secretion of proteins [44]. Additionally, the size
of these pores is sufficient to enable the passage of small exogenous
peptides similar to SP [38]. We identified a 43 kDa protein, the
Thermo unstable ribosomal Elongation factor Ef-Tu, as a specific
SP binding site in B. cereus. Ef-Tu is present in large excess in
bacteria [45]. In addition to its original function at the ribosomal
level, it is known that in case of bacterial stress this protein is
translocated to the bacterial surface [46] and in B. anthracis Ef-Tu
was identified as a plasminogen receptor [47]. As there is no
sequence homology between SP and plasminogen, Ef-Tu appears
as a multifunctional sensor of host signals in Bacilli. Because
neither SP nor plasminogen are deemed capable of crossing the
membrane, Ef-Tu should be associated with a transduction system
to trigger the bacterial response. In this regard, it is interesting to
note that, in the membrane of B. subtilis Ef-Tu is colocalized and
should interact with the actin-like protein MreB [48]. The
bacterial cytoskeleton does not only show structural homology
with its eukaryotic counterpart, but has also similar functions [49],
and MreB should play a same role as actin in SP signal
transduction in bacteria.
The capacity of detecting SP is shared by other Gram
positive bacteria since we observed that S. aureus and S.
epidermidis also reacted to SP by a marked increase in
cytotoxicity. Furthermore, the specificity of SP action on
Staphylococci was the same as in B. cereus with an absence of
response to SPrev. Bacilli and Staphylococci are not closely related
species, thus we can expect that other Gram positive bacteria
should also react to SP. The bacterial diversity in neuropathic
diabetic foot ulcer, which is essential in the evolution of the
disease, appears dependent of host factors [50]. The decrease of
SP expression observed in diabetic foot ulcer [51] should
contribute to limit bacterial virulence and consequently host
immune reaction, leading to the typically observed low-level
chronic infection state. Alternatively, whereas the mean basal
concentration of SP in sweat is picomolar [52], local concen-
trations at the vicinity of the producing cells or nerve terminals
should be much higher. The skin concentration of SP is
increased in case of atopic dermatitis [53]. Moreover, a 50 fold
increase of SP is observed in sweat during depressive disorders
[52] and in the case of skin breaches, as measured after surgery,
the level of SP in skin exudates can be 8 to 10 nanomolar [54].
The present results should be confirmed using primary adult
cells as HaCaT cells are immortalized human keratinocytes, but
the threshold of SP effect on B. cereus is consistent with the
physiological concentrations of SP suggesting that this peptide
should actually act in skin as a regulator of the virulence of
gram-positive bacteria.
Thermal waters have been known since antiquity to reduce or
cure chronic skin inflammation. This is the case of the thermal
water from Uriage-les-Bains (UTW). As it is isotonic, this water
has no effect on the viability of keratinocytes but when the bacteria
were exposed to SP in the presence of 30% UTW, the effect of SP
on the virulence of the three bacterial species was reduced or even
totally abolished. The mechanism involved was not studied but
this water contains a high concentration of anions, particularly
chloride (3500 mg/L) and sulfate (2862 mg/L). Then, since SP is
a cationic peptide we cannot exclude that it was chelated by these
ions and then unable to act on the bacteria. Another compound,
TefloseH (TF), a polysaccharide containing rhamnose, glucose and
glucuronic acid (BioEurope, Solabia Group) showed similar
antagonist effects on SP when it was administered with the
peptide. This compound claims to have an anti-adhesive effect on
bacteria but because of its charge, it could also act by trapping and
sequestering the peptide.
In summary, we showed that SP was able to increase the
virulence of bacteria that are commonly present on the skin. The
role of SP on skin infections is still controversial. Our study
evidenced that the effects of this neuropeptide are not only due to
SP effects on inflammation or immunity but could also relate to
direct effects on bacteria, by enhancing their virulence. Moreover,
the role of bacteria in the pathogenesis of psoriasis, acne or atopic
dermatitis is known [33] and our results suggest that the
exacerbation of these diseases by SP is not only due to a
modulation of inflammation and immunity or to a direct effect of
SP on keratinocytes and sebocytes: SP could also exacerbate these
diseases by enhancing the virulence of some bacteria then breaking
skin defences.
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Introduction  
For environmental policies, air quality is 
generally related to the presence of 
chemicals and particulate matter and its 
pollution is correlated with uncontroversial 
health impact. According to a survey in 
European intensive care units, 68% of sepsis    
are lung infections and Pseudomonadaceae 
are the second most common organisms 
(14%), but the only ones that induce rising 
mortality rates (Vincent et al., 2006).  
Gram-negative Pseudomonadaceae bacteria 
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The presence of human pathogens in the environment is a key concern, therefore 
the air needs to be evaluated as a potential source of bio-contamination. This study 
dealt with the characterization of fluorescent pseudomonads strains isolated from 
air in order to evaluate their factors of virulence. 19 strains were identified by API® 
strips, by MALDI-Biotyper and by 16S rDNA gene sequencing. Their growth at 
30°C and 37°C, biosurfactant and biofilm production, motility and production of 
exoproducts were tested. A Pseudomonas fluorescens clinical strain was used as 
reference. By comparison with the virulence factors of this climical strain, most of 
these strains isolated from air did not produced highly virulent factors. However a 
bacterial couple : P. fluorescens MFAF76a and P. putida MFAF88, was selected 
thanks to their observed characteristics linked to virulence quite similar with traits 
of the clinical reference. The cytotoxicity of their culture supernatant was 
investigated toward human epithelial pulmonary cells. Results revealed that these 
airborne fluorescent Pseudomonas strains secreted exoproducts, such as enzymes, 
surfactants and siderophores, highly virulent against the studied pneumocytes.  
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present a great adaptive ability related to 
their large genome (Stover et al., 2000). P. 
aeruginosa is well known as prevalent 
pathogen in acute and chronic infections 
(Clifton & Peckham, 2010; Fernstrom & 
Goldblatt, 2013), although other fluorescent 
Pseudomonas species are ubiquitous. In fact, 
Pseudomonas are widespread Gram-
negative bacteria present in various 
ecological niches: soil, water (Rajmohan et 
al., 2002), care units (Vincent et al., 2006), 
humans (Chapalain et al., 2008; 
Donnarumma et al., 2010) and air (AFSSET, 
2010; Morin et al., 2013).   
Moreover, some strains, isolated from a 
clinical environment, are able to grow at or 
above 37°C (Chapalain et al., 2008). P. 
fluorescens MFN1032, a clinical strain, was 
recently isolated from a patient with a lung 
infection (Chapalain et al., 2008) and 
induces cytotoxic responses (Rossignol et 
al., 2008; Madi et al., 2010; Sperandio et al., 
2010; Sperandio et al., 2012). The 
pathogenicity of Pseudomonas bacteria is 
correlated with their enzymatic secretion 
(Gessner & Mortensen, 1990 ; Rossignol et 
al., 2008 ; Strateva & Mitov, 2011).  
The purpose here was, after identification, to 
assess the potential for virulence of 19 
airborne fluorescent pseudomonads strains, 
selected from Gram-negative oxidase-
negative strictly aerobic rods collected 
during a previous study (AFSSET, 2010; 
Duclairoir Poc et al., 2011a ; Morin et al., 
2013). For each of them, physiological 
characterization and determination of 
virulence factors were confronted. Two 
airborne bacteria appeared to have great 
similarities with the clinical standard, P. 
fluorescens MFN1032.   
To compare the cytotoxicity of their secreted 
factors, A-549 human pulmonary type II-
like epithelial cell line was implemented in 
order to assess their potential virulence 
toward human by airways. Those cells play 
a critical role in coordinating both innate 
defence and inflammatory responses 
(Hawdon et al., 2010) and make it suitable 
to study virulence in conditions fairly close 
to in vivo.   
Materials and Methods  
19 airborne fluorescent Pseudomonas 
strains  
In a previous study (AFSSET, 2010; Morin 
et al., 2013), more than 3000 bacteria were 
collected in air samples between June 2008 
and September 2009 in 3 areas : in peri-
suburban Evreux (Normandy, France), in the 
suburbs of Rouen (Normandy, France) and 
in dust clouds generated during crop ship 
loading in Rouen harbor installations 
(Normandy, France). About 3000 bacterial 
isolates were stored and then frozen at -
80°C. Morphological characters, Gram 
staining and biochemical tests used to 
separate this bacterial population into 8 
groups, which included a Gram-negative 
oxidase-positive strictly aerobic rods group 
containing Pseudomonas spp.  
This group appeared among the most 
predominantly collected groups of airborne 
Gram-negative bacteria on harbor 
installations. Proportionally to their relative 
sample representation, 19 fluorescent 
Pseudomonas strains were randomly 
selected.   
Clinical standard strain, MFN1032  
P. fluorescens MFN1032 is a clinical strain 
isolated after a lung infection, related to 
biovar I of P. fluorescens species (Chapalain 
et al., 2008).    
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Identification of the 19 airborne strains 
API® identification  
The 19 representative strains were submitted 
to metabolic characterization using API® 
20NE strips. API® kits were operated 
according to the manufacturer s instructions 
(BioMérieux, France).   
Mass spectrometric MALDI-Biotyper 
bacterial identification  
These isolates were submitted to bacterial 
identification by MALDI mass spectrometry 
(MS) based on the total proteome screening 
analyzed using an algorithmic method to 
identify bacterium. The bacterial proteomes 
were obtained using an Autoflex III Matrix-
Assisted Laser Desorption/Ionization-Time-
Of-Flight mass spectrometer (MALDI-TOF) 
(Bruker, Germany) coupled to the MALDI-
Biotyper 3.0 algorithmic system for 
microbial identification (Hillion et al., 
2013). Before MS analysis, the bacterial 
material was spotted onto a MALDI target 
plate and overlaid by matrix (10g.L 1 -
cyano-4-hydroxycinnamic acid in 50% 
acetonitrile, 2.5% trifluoroacetic acid 
provided by Sigma-Aldrich, France).   
The software generated scores evaluating 
the probability of correct identification of 
the microorganism. The species 
identification is considered acceptable for 
score values over 2.0 and, between 1.7 and 
2.0, the genus identification is assumed 
confident. (Hillion et al., 2013)  
16S rDNA gene sequencing and 
identification  
The same isolates were identified by 16S 
ribosomal DNA gene sequencing. For 
amplification of the complete 16S RNA 
gene, universal primers UNI_OL 
(AGAGTGTA GCGGTGAAATGCG) and 
UNI_OR (ACGGGCGGTGTGTACAA) 
were used as already described (Duclairoir 
Poc et al., 2011a). The nucleotide sequences 
were registred on GenBank, NCBI 
(http://www.ncbi.nlm.nih.gov/genbank/sub
mit/) and were compiled in Table 1.  
Partial 16S rRNA gene sequences were 
aligned with reference sequences using 
BLAST data bank (http://blast.ncbi. 
nlm.nih.gov/Blast.cgi?PROGRAM=blastn&
PAGE_TYPE=BlastSearch&LINK_LOC=bl
asthome).  
The minimum similarity among all members 
of the Pseudomonas genus is assumed at 
77% (Balet et al., 2010). Over 95% of 
similarity, the species is considered surely 
identified.   
Physiological characterization of airborne 
bacteria: Growth conditions   
The bacteria were cultured in Luria Bertani 
medium (LB) (AES Chemunex, France) 
under shaking (180 rpm) at 30°C, close to 
optimum growth temperatures of 
Pseudomonas fluorescens species, i.e. 28°C 
(Merieau et al., 1993), and at 37°C, i.e. 
human body temperature. The bacterial 
density was determined by measuring 
optical density (OD) at 580 nm (Helios , 
Thermo Spectronic,USA ) during at least 
120h. Thanks to these growth kinetiks 
curves, the maximum growth rate, max, was 
calculated for each strain.  
Determination of virulence factors of 
airborne bacteria  
Bacterial enzymatic characterization   
Several methods were used to screen 
enzymatic activities. Each test was done at 
30°C and 37°C.  
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Proteolytic activity was determined on 
Trypticase soy agar (TSA) (AES Chemunex, 
France) with skimmed milk 20%. Esterase 
was detected by growth on TSA (AES 
Chemunex, France) containing Tween 80 
1% colored with Phenol red (1%).  
Lecithinase and lipoproteolytic activities 
were analyzed by growth on TSA (AES 
Chemunex, France) with egg yolk 50% 
(VWR, Germany). Bacteria hydrolyse 
lecithin contrasting medium next to the 
inoculated streak. On the contrary a lighter 
colored zone shows lipoproteolytic activity. 
In the secreted hemolysis test, bacterial 
strains were streaked onto a 2% sheep red 
blood cell plates, whose were visually 
inspected the zones of clearing around the 
colonies. The pyoverdine production was 
observed by growth on King B Agar plates 
(AES Chemunex, France). After 48h 
incubation, the plates were observed with 
Ultra-Violet light at 365nm (VL-6LM, 
Vilber Lourmat, France), as the produced 
pyoverdine induces fluorescence.  
Biosurfactant production  
Surface tension measurement of a rinsing 
solution of bacteria cultured on solid agar 
medium is a direct method for determining 
global biosurfactant production, in ideal 
conditions for biosurfactant production and 
was done as previously described 
(Duclairoir Poc et al., 2011b).  
Bacterial motility  
Motility characters were observed through 
the evaluation of swim, swarm, twitch 
deplacements after 40h at 30°C and 37°C. 
These motilities were obtained thanks to 
specific agar concentrations: 0.3% for the 
swim deplacement, 0.5% for the swarm and 
1% for the twitch. Initially, the plates were 
inoculated with overnight culture in LB at 
30°C and 37°C (Rossignol et al., 2008). 
Adhesion assays on abiotic surface  
The bacterial adhesion was evaluated in 
triplicate in polystyrene microtitration plate 
at 30°C and 37°C incubated in LB during 
24h and 48h. The adherent bacterial 
population was estimated by direct 
measurement (quantification) of absorbance 
at 595 nm after 0.1% crystal violet 
coloration and after cell lysis by sodium 
dodecylsulfate 1% (Duclairoir Poc et al., 
2011b).  
Evaluation of supernatant virulence using 
the A549 pneumocyte model  
The cytotoxicity of P. fluorescens 
MFN1032, MFAF76a and MFAF88 culture 
supernatants, in LB at 30°C and 37°C, was 
evaluated toward A-549 human pulmonary 
type II-like epithelial cell line as described 
elsewhere (Pimenta et al., 2006).  
The percentage (%) of total lysis was 
calculated as follows: 
%LDH = 100 X (ODsample - OD0%) / (OD100% 
- OD0%)  
A percentage as lower than 20% could be 
assumed linked to an avirulent strain. Four 
other classes were defined : 20-40%: weak 
virulence, 40-60%: virulence, 60-80%: 
highly virulent and greater than 80%: 
extremely virulent.  
Results and Discussion  
Identification of airborne fluorescent 
pseudomonads : preponderance of   
Pseudomonas fluorescens cluster  
The Pseudomonas genus is splitted into 
three well-supported clusters in the 16S 
rRNA phylogeny named aeruginosa, putida 
and fluorescens r-clusters (Bodilis et al., 
2012). Different approaches : API/ MALDI 
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Biotyper/ 16S rRNA gene sequencing, 
were done to identify the 19 airborne 
selected strains. According to the 
classification stated by Bodilis (Bodilis et 
al., 2012), a putative identification was 
proposed for each strain based on the more 
reliable identification by 16S rRNA 
sequencing (homology>95%) and /or by 
MALDI-Biotyper (score>2). The three 
strains : MFAE20, MFAB75 and MFAK14, 
were stated as Pseudomonas spp., their 
genus was surely identified, but their species 
could not confidently assumed. The majority 
of the 19 airborne strains are identified as 
Pseudomonas fluorescens.   
The preponderance of Pseudomonas 
fluorescens species among the airborne 
Gram-negative bacteria was no surprise, due 
to their ubiquitous character created by their 
large genome (Stover et al., 2000). Morever 
P. fluorescens is observed as the most 
common Pseudomonas species (at least 
42%) in outdoor air, as already reported by 
Nevalainen (Nevalainen et al., 1990).   
Although the pathogenicity of P. aeruginosa 
is largely described and cause several human 
diseases, specially in lung infections (Clifton 
& Peckham, 2010), the literature on other 
fluorescent Pseudomonas is poorly 
documented in airways transmitting route, 
even if such bacteria are able to induce 
pulmonary pathologies such as P. 
fluorescens strains (Chapalain et al., 2008).   
This study aimed to contribute on a better 
knowledge of the impact of fluorescent 
pseudomonads on the safety of the air, that 
we breathe. To evaluate the potential of 
virulence on this panel of 19 airborne 
strains, two contamination situations were 
explored. Firstly, conventional airway 
infections at 37°C, corresponded to an 
internal infection such as pulmonary, and, at 
30°C, temperature of an external infection 
such as burned dermal injuries (Church et 
al., 2006) or as contamination of medical 
devices (Gershman et al., 2008).  
Physiology of the 19 airborne bacteria : 
overall able to growth at 37°C  
The growth rate for each of 19 airborne 
Pseudomonas strains, compiled in Table 1, 
was evaluated in LB medium at 30 and 
37°C. Most of them were able to grow at 
37°C, except MFAH4a and MFAD21c. 
Twelve other strains had an higher grow rate 
at 30°C, similar to the optimal growth 
temperature for P. fluorescens species, 28°C 
(Merieau et al., 1993). The first 5 strains, 
namely, MFAF76a, MFAF49a, MFAF88, 
MFAO2 and MFAF80b, presented an 
equivalent or increasing growth rate 
between 30 and 37°C. In addition to 
survival, they were able to multiply at 
human physiological temperature, which 
could facilitate the infectious processes.  
Characterization of bacterial 
extracellular virulence factors  : all the 
airborne strains produce several factors 
of virulence  
MFN1032 was introduced in the panel to 
have a standard of virulence with a clinical 
origin that assures its pathogenic potential 
(Chapalain et al., 2008, Rossignol et al., 
2008; Rossignol et al., 2009; Madi et al., 
2010; Sperandio et al., 2010; Sperandio et 
al., 2012) and then makes a possible 
comparison of studied airborne 
Pseudomonas spp.   
The 19 airborne Pseudomonas strains 
showed different patterns of secretion, as 
tabulated in Table 2. All strains synthesized 
lipoproteolytic enzymes and, except for 
MFAE48, induced clearing zones on sheep 
red blood cell plates revealing secreted 
hemolysis a minima incomplete for at least 
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one growth temperature. According to 
conventional microbiological nomenclature, 
the secreted hemolysis could be categorized 
as complete ( ), incomplete ( ) or no 
hemolysis (Luo et al., 2001). In any case, 
hemolytic phenomenon could result from 
synergy between activity of several 
hydrolysases, such as proteases, lecithinases, 
lipoproteases, and biosurfactants (Rossignol 
et al., 2008; Zhang et al., 2009). The 
hemolysis was complete for MFAF49a, 
MFAF80b and MFAD21c at 30°C and for 
MFAO2, MFAO39, MFAB75 and MFAH4a 
at 37°C.  
Some virulence factors could be, on the one 
hand, strain-dependant: no protease and no 
lecithinase for MFAF49a, MFAF80b and for 
several strains less adapted at 37°C, no 
esterase for MFAF88 and MFAO39, no 
pyoverdine production for MFAF80b, 
MFAE88, MFAE20 and MFAH106a. On 
the another hand, some virulent exoproducts 
were strain- and temperature-dependant in 
the case of MFAF88 and the most of the 
strains were more adapted at 30°C than at 
37°C.  
Surprisingly, both strains, MFAH4a and 
MFAD21c, were not able to grow at 37°C in 
broth, but presented virulence factors at 
37°C. To stimulate enzymatic secretion, 
bacterial growth was done on agar medium, 
promoting sessile lifestyle (i.e. in a surface 
adherent community). Such conditions 
seemed to facilitate the growth of MFAH4a 
and MFAD21c, contrary to more planktonic 
and less protective cell growth in broth. An 
other common character for this couple was 
their secretion of biosurfactant, as for 
MFN1032, MFAF88, MFAO2, MFAA66a, 
and MFAK14. This surfactive production 
was established through a surface tension 
lowered above 45mN/m (Carillo et al., 
1996). Biosurfactants favor bacterial 
displacement, but may be affecting 
adhesion, even colonisation of the host 
(37°C) or of a medical device or even burn 
injuries (30°C) (Van Hamme et al., 2006).  
To conclude, only MFAF76a, MFAO2 and  
MFAO40 exhibit activity for all the tested 
enzymes like the clinical strain P. 
fluorescens MFN1032, but, among them, 
only MFAO2 produces biosurfactant as 
MFN1032.  
Bacterial motility : some strains swim, all 
swarm and none twitch  
Infection deals in part with bacterial motility 
to allow their colonisation in the host.  
The 3 motile types : twitch, swim and 
swarm, were tested at 30 and 37°C.   
No twitching, but swarming motility was 
noted for any strain at either temperature, as 
shown in Table 3. The swarming motility is 
a collective microbial motility resulting 
from, at least, one functional flagella, often 
completed by biosurfactant production 
(Kearns, 2010).   
Although all strains were able to swim at 
30°C, only 6 of them maintained the 
swimming mode at 37°C. This displacement 
allows bacteria to individually move 
towards the host with the help of functional 
flagella.   
The flagella dependant motilities, i.e. swim 
and swarm, are involved in the development 
of biofilms (O Toole & Kolter, 1998). For 
instance, functional flagella are needed for 
swarming mobility, which is related to the 
surface movement in the case of bacterial 
groups. This mobility is favored by 
biosurfactive production or by 
lipopolysaccharides, outer membrane 
components, for some Gram-negative 
bacteria (Kearns, 2010).  
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Bacterial adhesion on abiotic surface: 
different behaviours  
As noted in Table 3, thicker biofilms were 
observed at 30°C than at 37°C. For 
MFAF76a, MFAF88, MFAE48 and 
MFAE8b, their biofilm were observed at 
24h and 48h at either temperature. When the 
biofilm evolved between 24h and 48h, most 
of the time it increased, the mature structure 
was not yet reached, the biofilm seemed still 
under edification. However, for both 
temperatures, MFN1032 had a lowest ability 
to form biofilm at 48h than at 24h, this 
phenomenon was already reported about P. 
fluorescens biosurfactant production 
(Duclairoir Poc et al., 2011b). This biofilm 
reduction was noted at 30°C for MFAF88, 
MFAF80b and MFAO29 and at 37°C for 
MFAH4a.  
Concerning contamination, the bacterial 
presence on biofilm is stabilized in the host 
or on a surface, and even protects from 
hostile microenvironment behind its shelf-
shielding extracellular polymeric substances. 
Nevertheless, a biofilm could reduce over 
the time and persists slimmer; the lacking 
cells could be assumed in dispersing and 
colonising elsewhere in host (McDougald et 
al., 2012).  
Selection of two airborne strains: 
P.fluorescens MFAF76A and P. putida 
MFAF88  
In P. aeruginosa infections, tissue damage is 
due to the production of several extracellular 
and cell-associated virulence factors 
(Strateva & Mitov, 2011), similar 
exoproducts are produced by all 
Pseudomonas species and also known as 
factors of virulence.   
Through the obtained results, two airborne 
strains, MFA76a and MFAF88, are of 
particular interest: they are able to grow at 
37°C and possibly better than at 30°C. They 
swim and swarm, thanks to their flagella and 
completed for MFAF88 by its biosurfactant 
production, as shown in Table 2. They 
present some virulent factors and form 
biofilm at either temperature. P. fluorescens 
MFA76a is very close to MFN1032 except 
for biosurfactant production and P. putida 
MFAF88 had an enzymatic pattern very 
different from MFN1032, but produced 
biosurfactant, as MFN1032.  
Virulence of culture supernatant of 
MFN1032, MFAF76a, MFAF88 toward 
A-549 pneumocytes : strain-dependant 
virulence   
Exoproducts such as lipases and proteases 
produced by P. fluorescens are known for 
their virulence (Rossignol et al., 2008; 
Zhang et al., 2009). Thus testing the growth 
supernatant could have a promising 
outcome. The need of an adequate cytotoxic 
model was crucial at this point and had to be 
ideally close to in vivo contamination by 
airway or pulmonary infection mode. The 
evaluation of virulence toward 
pneumocytes, such as cellular line A549 was 
assayed. The cytotoxic mechanism involved 
only the action of exoproducts, such as 
enzymes, siderophores or biosurfactants. All 
the supernatants, resulting from bacterial 
growth at 30°C and 37°C, induced lysis of 
the pulmonary cells by contact for 12h. 
Supernatant of MFAF88 induced a strong 
virulent response, in similar range (around 
80%) at 30°C and 37°C. Furthermore, 
surpernatants of MFN1032 and MFAF76a 
had significantly changed their virulence 
towards epithelial cells for both growth 
temperatures. MFN1032 was extremely 
virulent at 30°C and MFAF76a at 37°C and 
their virulence was less severe, i.e. only 
highly virulent, at 37°C for MFN1032, and 
at 30°C for MFAF76a, respectively.  
P20
Int.J.Curr.Microbiol.App.Sci (2014) 3(8) 708-722   
715
 
Table.1 Characterization of the 19 airborne fluorescent Pseudomonas spp. strains  
Strain 
Sampling 
localisation & 
season 
API® 20NE 
identification 
MALDI Biotyper: 
total proteomic 
comparison (score) 
Identity percentage of 
16S ribosomial RNA 
sequence <GenBank 
accession numbers> 
Putative 
identification 
max at 
30°C 
(h-1) 
max at 
37°C 
(h-1) 
MFAF76a Rouen Harbor, Summer P. fluorescens (excellent) P. koreensis (2.122) 
P. koreensis strain AGB-1 
(96%) <KJ470785> fluorescens r-cluster 1 1.08 
MFAF49a Rouen Harbor, Summer P. fluorescens (excellent) P. abietaniphila (2.094)
P. lundensis (85%) 
<KJ470784> fluorescens r-cluster 0.79 1.05 
MFAF88 Rouen Harbor, Summer 
Bulkholderia 
pseudomallei (very good)
Pseudomonas spp. 
(1.982) 
P. putida strain CG29 
(99%) <KJ470787> putida r-cluster 0.47 1.01 
MFAO2 Rouen Harbor,Winter P. fluorescens (excellent) P. koreensis (2.001) 
Pseudomonas sp. strain E1 
(86%) <KJ470791> fluorescens r-cluster 0.93 0.88 
MFAF80b Rouen Harbor, Summer P. fluorescens (excellent) P. abietaniphila (2.152)
P. abietaniphila strain 
HMGU118 (99%) 
<KJ470786> 
fluorescens r-cluster 0.71 0.77 
MFAE88 Rouen Harbor, Summer 
P. oryzihabitans (very 
good) 
Pseudomonas spp. 
(1.866) 
P. rhizosphaerae strain 
BKB1(95%) <KJ470782> fluorescens r-cluster 0.83 0.38 
MFAO39 Rouen Harbor,Winter P. fluorescens (excellent) 
Pseudomonas spp. 
(1.962) 
P. putida strain bD1 
(100%) <KJ470793> putida r-cluster 0.84 0.35 
MFAA66a Surburban Rouen, Summer P. oryzihabitans (good) P. congelans (2.164) 
P. syringae pv. Syringae 
strain XJLX-2-2  (99%) 
<KJ470777> 
fluorescens r-cluster 0.68 0.32 
MFAO40 Rouen Harbor,Winter P. fluorescens (excellent) P. koreensis (2.149) 
P. fluorescens strain 
TCA33 (99%) 
<KJ470794> 
fluorescens r-cluster 0.85 0.3 
MFAE20 Rouen Harbor, Summer 
P. oryzihabitans (very 
good) 
Pseudomonas spp. 
(1.917) 
P. graminis strain 8B2 
(84%) <KJ470780> Pseudomonas spp. 0.64 0.26 
MFAE48 Rouen Harbor, Summer 
P. oryzihabitans (very 
good) P. graminis (2.403) 
P. graminis strain 
R5SpM3P2C1 (99%) 
<KJ470781> 
fluorescens r-cluster 0.59 0.22 
MFAB75 Surburban Rouen, Summer
P. oryzihabitans (very 
good) 
Pseudomonas spp. 
(1.728) 
P. plecoglossicida strain 
ETLB-3 (78%) 
<KJ470778> 
Pseudomonas spp. 0.8 0.22 
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MFAE8b Rouen Harbor, Summer P. fluorescens (excellent) 
Pseudomonas spp. 
(1.856) 
P. rhizosphaerae strain -
Y12 (79%) <KJ470783> fluorescens r-cluster 0.82 0.21 
MFAO48 Rouen Harbor,Winter 
P. oryzihabitans (very 
good) P. savastanoi (2.098) 
P. syringae CC1557 
(99%) <KJ470795> fluorescens r-cluster 0.6 0.19 
MFAK14 Surburban Rouen, Winter P. fluorescens (good) 
Pseudomonas 
spp.(1.923) 
P. putida strain SCR2 
(78%) <KJ470790> Pseudomonas spp. 0.62 0.17 
MFAO29 Rouen Harbor,Winter P. fluorescens (good) P. chlororaphis (2.006)
P. thivervalensis strain 
BD2-26 (99%) 
<KJ470792> 
fluorescens r-cluster 0.6 0.15 
MFAH106a Rouen Harbor, Summer 
P. oryzihabitans 
(excellent) 
Pseudomonas spp. 
(1.821) 
P. rhizosphaerae strain 
R2-255 (99%) 
<KJ470788> 
fluorescens r-cluster 0.64 0.14 
MFAH4a Rouen Harbor, Summer P. fluorescens (excellent) P. poae (2.255) 
P. fluorescens strain RK2 
(83%) <KJ470789> fluorescens r-cluster 0.79 
No 
growth 
MFAD21c 
Residential 
Evreux, 
Summer 
P. fluorescens (very 
good) P. poae (2.147) 
P. fluorescens strain RK2 
(86%) <KJ470779> fluorescens r-cluster 0.78 
No 
growth    
Score >1.700 : probable genus    
  
Score >2.000 : probable species, 
secure genus    
Air sample localisation and season; bacterial identification by API®20NE strips, by MALDI-Biotyper and by16S rDNA gene sequencing after 
matching with NCBI data bank 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome); and maximum specific 
growth rate ( max) at 30 and 37°C in LB medium, 180rpm, classified by decreasing max at 37°C.      
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Table.2 Extracellular virulence factors, at 30°C and 37°C, and biosurfactant production for  
MFN1032 (clinical strain) and for each airborne strain 
The observed characters were proteolytic, esterase lecithinase, lipoproteinase and hemolytic activities, after 5 days, or pyoverdine 
production, after 2 days. The biosurfactant production was observed on Davis Minimum medium after 5 days. Experiments done in 
three independant assays.  
Activity Proteolytic Esterase Lecithinase Lipoproteolytic Secreted hemolytic Pyoverdin production Biosurfactant 
Incubation 
temperature (°C) 30 37 30 37 30 37 30 37 30 37 30 37 production 
MFN1032 ++ ++ ++ ++ ++ ++ + + 
 
++ ++ + 
MFAF76a ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ - 
MFAF49a - - ++ ++ - - ++ + ++ ++ - 
MFAF88 - + - - - ++ + ++ ++ + + 
MFAO2 ++ ++ ++ ++ ++ ++ ++ + ++ ++ + 
MFAF80b - - ++ ++ - - ++ ++ - - - 
MFAE88 - - - ++ - - ++ ++ - - - - 
MFAO39 - + - - ++ - + ++ ++ - - 
MFAA66a + + + - - - + ++ ++ ++ + 
MFAO40 ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ - 
MFAE20 ++ - ++ ++ - - ++ ++ - - - 
MFAB75 - - + - - - + ++ ++ ++ - 
MFAE48 - V ++ V - V ++ V - - - + - 
MFAE8b - - ++ ++ - - ++ + ++ - - 
MFAO48 - - ++ ++ - V ++ V - ++ - - 
MFAK14 - + ++ - - - + ++ + - + 
MFAO29 + V ++ V - V ++ V ++ - - 
MFAH106a ++ ++ ++ ++ - + ++ ++ - - - - 
MFAH4a ++ ++ ++ ++ - - + + ++ ++ + 
MFAD21c ++ ++ ++ ++ - - ++ ++ ++ ++ + 
++: important activity : partial hemolysis
+: light activity : complete hemolysis
V: weak and variable
-: no activity 
P20
Int.J.Curr.Microbiol.App.Sci (2014) 3(8) 708-722   
718
 
Table.3 Motility and biofilm ability, at 30°C and 37°C, for MFN1032 (clinical strain) and for each airborne strain. 
The observed motility characters were swim, swarm, twitch, after 40h. The biofilm formation was observed after 24h and 48h  
Activity Swim Swarm Twitch Biofilm formation 
after 24h 
Biofilm formation 
after 48h 
Incubation 
temperature (°C) 30 37 30 37 30 37 30 37 30 37 
MFN1032 ++ ++ + + - - ++ + + - 
MFAF76a ++ ++ + + - - ++ + ++ + 
MFAF49a + - + + - - - - + + 
MFAF88 ++ ++ + + - - ++ + + + 
MFAO2 ++ + + + - - + - + - 
MFAF80b + - + + - - ++ - + - 
MFAE88 + - + + - - + - + - 
MFAO39 + - + + - - ++ - ++ - 
MFAA66a + - + + - - - - - - 
MFAO40 + - + + - - ++ - ++ - 
MFAE20 + - + + - - + - + + 
MFAB75 + - + + - - - - + - 
MFAE48 + - + + - - + + + + 
MFAE8b ++ + + + - - ++ + ++ + 
MFAO48 + - + + - - - - - - 
MFAK14 + + + + - - - - - - 
MFAO29 + - + + - - + - - - 
MFAH106a + - + + - - + - + - 
MFAH4a V - + + - - - + + - 
MFAD21c V - + + - - - - - - 
++: deplacement upper than 30mm ++: OD595 higher than 0.200 
+: deplacement upper than 10mm +: OD595 higher than 0.050 
=: deplacement lower than 10mm -: OD595 lower than 0.050 
V: weak and variable   
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Figure.1 Virulence towards A549 pneumocytes exposed to culture supernatants  
obtained at 30°C and 37°C  
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The virulent pattern is strain- and 
temperature-dependant. In fact, P. putida 
MFAF88 shows a constant virulence, its 
secretion varies nevertheless with 
temperature. Virulence could then be 
attributed to the common production at 30 
and 37°C, i.e. lipoproteases, siderophores, 
and may be completed by biosurfactants, 
even if their quantities could be secreted 
quite variably at the two temperatures.   
This variability in intensity of secretion 
could also explain the decrease in virulence 
for MFN1032. As shown in Table 2, all the 
enzymes and pyoverdine were expressed at 
30°C as well as at 37°C, but no evidence 
was given about quantity. Rossignol and 
cowokers rightly note, at 37°C, a weaker 
production of phospholipase C, than at 28°C 
(Rossignol et al., 2008). This enzyme is 
known as a major factor of virulence.  
Like MFN1032, the same families of 
exoproducts are secreted by P. fluorescens 
MFAF76a at both temperatures. However a 
slightly significative increase in virulence is 
noted at 37°C and again might be due in the 
exoproducts secretion modulation in 
concentration or in nature.  
In any case, airborne P. fluorescens 
MFAF76a and P. putida MFAF88 may 
induce by their secretion, especially at 37°C, 
cytotoxic responses from A549 airway 
epithelial cells. Thus the biohazard, that they 
create as biocontamination, must be 
identified and not ignored. Moreover the 
virulence of these airborne strains and of the 
clinical standard, P. fluorescens MFN1032 
operates on different ways from each other. 
To better understand these virulent 
mechanisms, an exoproteomic study would 
create insight.  
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Available online 2 December 2014AbstractLipids are major functional components of bacterial cells that play fundamental roles in bacterial metabolism and the barrier function be-
tween cells and the environment. In an effort to investigate the bacterial lipidome, we adopted a protocol using MALDI-TOF MS imaging
coupled to HPTLC to screen a large number of phospholipid classes in a short span of time.
With this method, phospholipids of airborne Pseudomonas fluorescens MFAF76a were visualized and identified in sample extracts (mea-
surement accuracy below 0.1 Da, phospholipid identification by means of four characteristic fragment peaks). Via this technique, the P. fluo-
rescens lipidome was shown to comprise three major lipid classes: phosphatidylethanolamine, phosphatidylglycerol and phosphatidylcholine.
The protocol described herein is simple, rapid and effective for screening of bacterial phospholipid classes. The remarkable presence of a
eukaryotic phospholipid, phosphatidylcholine, was observed in P. fluorescens MFAF76a. This lipid is known to play a role in bacteriaehost
interactions and had not been known to be found in P. fluorescens cells.
© 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
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The emergence of molecular biology techniques at the end
of the 20th century was at the origin of complete renewal of
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P21essentially on gene and protein expression. However, there is a
growing interest in the analysis and identification of bacterial
lipids [1]. Accordingly, in addition to terms such as “prote-
omics”, “genomics”, and “metabolomics”, the term “lip-
idomics” was introduced in microbiology [2].
Lipids are major compounds of bacterial cells and share a
large variety of biological functions. Among these molecules,
phospholipids, the major constituents of the cell membrane,
play a fundamental role in metabolism, maintenance of
membrane integrity, nutrient transport and signal transduction
[3]. Bacterial phospholipids (PLs) are constituted by different
long-chain (C14eC20) fatty acids linked by ester bonds to the
major phosphatidyl moiety. Phosphatidic acid (PA),reserved.
2 T. Kondakova et al. / Research in Microbiology 166 (2015) 1e8phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylglycerol (PG), phosphatidylinositol (PI), phos-
phatidylserine (PS) and cardiolipin (CL) represent the main
classes of PLs [4].
Screening of PLs is usually performed using a variety of
mass spectrometric techniques. For structural analysis fast-
atom bombardment in combination with tandem mass spec-
trometry, electrospray ionization and matrix-assisted laser
desorption ionization (MALDI) have been employed [5e7].
Electrospray ionization MS applied in negative ion mode and
combined with liquid chromatography enables separating most
of the different classes of phospholipids and identifying these
molecules on the basis of the length of fatty acyl chains and
unsaturated bond numbers or positions [8]. Although seldom
used to provide detailed information for particular molecular
species, MALDI is also potentially an excellent analytical
method for rapid screening of lipids in biological matrices
[9,10]. The use of MALDI MS for PLs analysis helps to
overcome numerous problems related to the complexity and
diversity of the extracts, as often encountered in bacterial
material, and appears to be the most convenient method for
complete screening in bacterial lipid extracts [2,11].
In the present report, we describe an analytical method
coupling HPTLC to MALDI TOF for bacterial lipid analysis,
fragmentation and identification. This method was used to
identify PLs expressed in an airborne strain of Pseudomonas
fluorescens MFAF76a, of particular interest. The adaptation
potential of this environmental strain, elsewhere characterized
[12], could reside at least by part in the composition of its
outer and/or cytoplasmic membrane; thus, its lipidome was
established by HPTLC-MALDI TOF imaging.
2. Materials and methods2.1. Bacterial strain and growth conditionsP. fluorescens MFAF76a is an airborne strain isolated from
a sample of air in dust clouds generated during crop ship
loading in Rouen harbor installations (Normandy, France)
[12]. This strain was grown at 28 C under gentle agitation
(180 rpm) in Luria-Bertani medium (AES, France). Aliquots
of cells from 3 independent cultures were collected at the end
of the exponential phase (OD 0.7). Cells were harvested by
centrifugation at 4 C (13,000 g) for 15 min. After removal of
supernatant, cells were washed with sterile saline solution and
centrifuged at 4 C (13,000 g) for 10 min. Three successive
washes were done. Aliquots of cells were resuspended in
deionized water and lyophilized using a Freeze Dryer Heto
PowerDry PL9000-50/HSC500 (Thermo Fisher Scientific,
Saint-Herblain, France).2.2. Reagents and chemicalsPL standards, 2,5-dihydroxybenzoic acid (DHB) and sol-
vents (chloroform (CHCl3), methanol (CH3OH), ethanol
(CH3eCH2OH), triethylamine (N(CH2eCH3)3), acetone
(CH3eCOeCH3) and acetonitrile (CH3eCN)) were obtainedP2from SigmaeAldrich (Saint-Quentin-Fallavier, France). Stock
solutions of PL standards were prepared in CHCl3 or in
mixture of CHCl3/CH3OH (2/1, v/v). All chemicals were of
the highest commercially available purity and used without
any further purification.
HPTLC silica gel 60 plates F254 (75  50 mm, on
aluminum backs) were obtained from Merck (Darmstadt,
Germany). TLC chambers (80  120 mm) were purchased
from Fisher Scientific SAS (Illkirch, France).2.3. Bacterial lipid extractionLipids were extracted according to the method of Bligh and
Dyer [13]. In summary, 5.5 mL of CHCl3/CH3OH/H2O (2/2/
1.8, v/v/v) were added to about 1 g of lyophilized bacteria.
Samples were mixed for 2 min and centrifuged for 10 min at
3000 g. The chloroform phase containing PLs was then
collected and stored at 20 C under N2 atmosphere.2.4. High performance thin-layer chromatography
(HPTLC)PLs were first separated by HPTLC using a method adapted
from Fuchs et al. [10]. HPTLC plates allowing electric current
conduction were washed with CHCl3/CH3eCH2OH/H2O/
N(CH2eCH3)3 (35/35/7/35, v/v/v/v) and activated at 110
C
under a vacuum for 2 h. Lipid extracts (100 mL) were
deposited on HPTLC plates in triplicate and separated using
CHCl3/CH3eCH2OH/H2O/N(CH2eCH3)3 (35/35/7/35, v/v/v/
v) as a running separation solution.
Individual lipid spots were visualized by UV fluorescence
at 365 nm after spraying of a primulin dye solution (0.05% in
CH3eCOeCH3/H2O, 8/2, v/v). Retention factors (Rf) were
calculated using the Sweday JustTLC software (v. 4.0.3, Lund,
Sweden).2.5. HPTLC-MALDI couplingDHB was selected as the MALDI matrix, since it allows
positive ion spectra of lipids and does not interfere with silica
of HPTLC plates. Its peaks can be used as calibration
standards.
HPTLC plates were dip-coated using a solution of DHB
(200 g/L in C2H3N/0.1% trifluoro-acetic acid, 90/10, v/v) [7]
and immediately dried under a dust-free atmosphere. This
operation was repeated a second time, leading to a mean of
DHB of 5 mg/cm2. HPTLC plates were then fixed on a TLC
MALDI target provided by Bruker Daltonics (Bremen,
Germany).2.6. MALDI TOF analysisMALDI TOF mass spectra were acquired using an Autoflex
III mass spectrometer equipped with a laser OptibeamTM Nd/
YAG (355 nm) with 200-Hz tripled-frequency (Bruker Dal-
tonics, Bremen, Germany). The excitation voltage was
19.5 kV and the reflector voltage was 21.0 kV. Laser strength1
3T. Kondakova et al. / Research in Microbiology 166 (2015) 1e8was kept about 30% above threshold for a good signal-to-noise
ratio. Substantial strength is needed to desorb lipids from silica
[14]. All MS spectra were obtained in reflector positive ion
mode using TLC MALDI software (v. 1.1.7.0) provided by
Bruker Daltonics (Bremen, Germany). 200 single laser shoots
were averaged for each point. The distance between two points
was then determined as 1 mm. When obtained via this tech-
nique, 2D mass spectra enable rapid analysis of each lipid
spot. Post-source decay (PSD) spectra were acquired on a
Bruker Autoflex mass spectrometer (Bruker Daltonics), as
previously described [15]. Briefly, precursor ions were isolated
using a time ion selector. The fragment ions were refocused
onto the detector by stepping the voltage applied to the
reflectron in appropriate increments. This was done automat-
ically using the “FAST” (“fragment analysis and structural
TOF”) subroutine of FlexAnalysis software.
Calibration was performed in two steps. External cali-
bration was performed using the DHB matrix and Peptide
Calibration Standard II (ref 822570, Bruker Daltonics, Bre-
men, Germany) covering a mean mass range between 200
and 3500 Da. The external calibration of the apparatus was
performed daily in FlexControl software. Supplementary
internal calibration was made using sphingomyelin (1 mg/
mL) mixed with the matrix solution before dipping.
Peaks generated by these standards were used to calibrate
TLC MALDI software. This double calibration method
improved measurement accuracy to below 0.1 Da for lipid
identification. Lipids were identified using the LIPID MAPS
database.2.7. HPTLC-MALDI TOF imagingMass spectrometry imaging (MSI) of each spot was per-
formed using FlexImaging software (v. 2.1., Bruker Daltonics,Fig. 1. Scheme illustrating the general HPTLC-MA
P21Bremen, Germany). A polygon measurement region was
defined starting from the lipid migration line. The number of
laser shots per pixel was set at 200 and the distance between
two adjacent pixels was 200 mm, with multiple additions of
single position acquisition run (every 40 shots). Following MS
and MS/MS identification, the lipid line migration was
reconstructed according to lipid-identified areas. Individual
lipid spots were labeled by a specific color code according to
m/z.
3. Results3.1. HPTLC MALDI-TOF MS analysis of lipid standardsA lipid standard mixture was analyzed in order to check
identification against MS and MS/MS lipid databases (www.
lipidmaps.org) and to identify specific fragmentation mecha-
nisms. The general protocol employed for standards and
subsequently bacterial lipid extracts is presented in Fig. 1.
Typical HPTLC-MALDI TOF MSI of lipid standard
mixture is presented in Fig. 2. The reconstructed lipid standard
line migration is presented on the left side of Fig. 2. The Rf of
lipid spots were calculated in JustTLC software using
primulin-dyed HPTLC plates (data not shown). MS spectra of
each lipid, identified on the basis of their Rf and encoded in
artificial colors, are on the right side of Fig. 2. Lipid identi-
fication was completed by MS, PDS and MSI analysis directly
on the HPTLC plate using TLC MALDI and FlexImaging
software.3.2. HPTLC-MALDI-TOF MSI analysis of bacterial PLsMSI analysis of P. fluorescens MFAF76a lipids is presented
in Fig. 3. As visible on its left side, 3 spots were separatedLDI TOF MSI method of PL class analysis.
Fig. 2. HPTLC-MALDI TOF MS analysis of lipid standard mixture. Lipid mixture (100 mL) was deposited in triplicate on the HPTLC plate and developed with
CHCl3/CH3eCH2OH/H2O/N(CH2eCH3)3 (35/35/7/35, v/v/v/v) as a solvent system. Lipid standards were purchased from SigmaeAldrich and used in CHCl3 or in
mixture of CHCl3/CH3OH (2/1, v/v). The DHB matrix was used as a 200 g/L solution in CH3eCN/0.1% trifluoro-acetic acid, 90/10, v/v. After matrix application,
MALDI TOF MS, PSD and MSI analyses are performed. All spectra were acquired on an Autoflex III MS equipped with a laser OptibeamTM Nd/YAG (355 nm,
200-Hz tripled-frequency) (Bruker Daltonics, Bremen, Germany). MSI analysis of lipid spots is presented on the left side of the figure. Following MS and PSD
identification, the lipid line migration was reconstructed according to lipid-identified areas. Individual lipid spots were labeled with a specific color code according
to m/z. Sphingomyelin (SM) e ( ); PC e ( ); lysophosphatidylethanolamine (LPE) e ( ); PI e ( ); PE e ( ); PG e ( ) and triglycerides (TAG) e ( ); *matrix
peaks; **unidentified peaks. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
4 T. Kondakova et al. / Research in Microbiology 166 (2015) 1e8with Rf 0.24 ± 0.01; 0.43 ± 0.02 and 0.62 ± 0.03. On the right
side of Fig. 3, the 2D representation shows the lipid line
migration versus MS peak intensity (increasing m/z). The
different lipid spots had specific regions of m/z localization. To
eliminate most of the matrix peaks, only m/z from 500 to 2000
were studied.
Based on the response factors, the following PLs were
identified: PC (Rf ¼ 0.24 ± 0.01), PE (Rf ¼ 0.43 ± 0.02) and
PG (Rf ¼ 0.62 ± 0.03) (Fig. 4). Detailed MS and PDS
spectra are presented on the right side of Fig. 4. PDSP2spectra of selected peaks are superposed on the lipid MS
spectrum.
2,5-dihydroxybenzoic acid (DHB), selected as matrix, en-
ables cleavage of phosphate-glycerol bond and induces loss of
the hydrophilic head group, i.e. [M-HG þ H]þ, characteristic
of each lipid class [1]. This loss is caused by a positive charge
localized on the phosphate group [16].
The spot with Rf ¼ 0.62 ± 0.03 was identified as PG. Two
most intense peaks, at m/z 743.5 and 765.5, showed one PG
species singly and doubly sodiated, respectively [PG(16:0/1
Fig. 3. HPTLC MALDI TOF MS analysis of bacterial PLs. MSI analyses were performed in triplicate using FlexImaging software (v. 2.1., Bruker Daltonics,
Bremen, Germany). On the left side of the figure, MSI analysis shows P. fluorescens lipid distribution. On the right side, 2D MS representation obtained via TLC
MALDI software is shown. The 2D MS image presents the P. fluorescens lipid line migration versus MS peak intensity (increasing m/z between m/z ¼ 500e1300).
PLs and retention factor (Rf): PC-0.24 ± 0.01 ( ); PE-0.43 ± 0.02 ( ); PG-0.62 ± 0.03 ( ). The analyses were performed for three independent bacterial lipid
extracts.
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peak at m/z 791.6 was related to another doubly sodiated PG
molecule [PG(16:0/18:1)þ2NaeH]þ. The PDS fragment at m/
z 195.1 was characteristic of PG and corresponded to the
sodiated head group [HG þ Na]þ (Fig. 4/A/1 & 2). The peaks
at m/z 550.5 and 572.5, corresponding respectively to pro-
tonated and monosodiated species, illustrate loss of the head
group of PG (Fig. 4/A/1). The peaks at m/z 576.5 and 598.5
indicate loss of protonated and sodiated polar head groups of
PG species [PG(16:0/18:1)-HG þ H]þ and [PG(16:0/18:1)-
HG þ Na]þ (Fig. 4/A/2, Table 1). The alkyl chain length was
confirmed by GC MS analysis of PL fatty acids (see supple-
mentary data Table S1).
The spot with an Rf value of 0.43 ± 0.02 led us to
assume the presence of PE, a typical constituent of the
Pseudomonas lipidome [17e19]. Two pairs of MS peaks (m/z
712.5 and 734.5; 738.5 and 760.5), separated by 22 Da, sug-
gested the presence of two PE molecules (Fig. 4/B). This lipid
class is characterized by a specific PDS fragments peak at m/
z ¼ 123.4 corresponding to the dehydrated PE head group
[HG-H20]
þ (Fig. 4/B/3 & 4); and m/z ¼ 164 to the sodiated
head group: [HG þ Na]þ (Fig. 4/B/3 & 4). The peaks at m/
z ¼ 669.5 and 695.5 corresponded to loss of ethanolamine
[PE(16:0/16:1)-C2H5N þ Na]þ and [PE(16:0/18:1)-
C2H5N þ Na]þ, respectively. For PE(16:0/16:1), two frag-
ments at m/z ¼ 550.5 and 572.5, showed loss of the protonatedP21and sodiated ethanolamine head groups, [PE(16:0/16:1)-
HG þ H]þ and [PE(16:0/16:1)-HG þ Na]þ (Fig. 4/B/3). Peaks
at m/z ¼ 576.5 and 598.5 were characteristic of the loss of
protonated and sodiated head groups of PE(16:0/18:1) (Fig. 4/
B/4). Remarkably, the same fragments were found for PG,
indicating the same length of alkyl chains in PE and PG
molecules (Table 1).
The spot with Rf ¼ 0.24 ± 0.01 was unexpectedly identified
as PC. Two MS peaks (m/z ¼ 732.6 and 754.5) of one
PC(16:0/16:0) species differentiated with 22 Da were found
(Fig. 4/C). Fragments at m/z ¼ 184.1 and m/z ¼ 147.0 were
characteristic of PC and corresponded to loss of the polar head
group with specific rearrangements [HG þ H]þ and [HG-
(CH3)3 þ Na]þ (Fig. 4/5) [20]. The peaks at m/z ¼ 548.5 and
570.5, Fig. 4/5, were attributed to the loss of the sodiated and
protonated polar head groups, [PC(16:0/16:0)-HG þ H]þ and
[PC(16:0/16:0)-HG þ Na]þ, respectively. The predominant
fragment at m/z ¼ 697.6 showed the loss of ammonia from the
polar head group [PC(16:0/16:0)-NH4OH þ H]þ. The results
of this study are summarized in Table 1.
4. Discussion
It is noteworthy that, up until now, the HPTLC-MALDI
TOF MSI method was only used for PL analysis in eukary-
otic cell lipidomes and human tissue and body fluid [21]. We
Fig. 4. HPTLC-MALDI TOF MS and PDS analysis of bacterial PLs. MS analysis of Rf 0.24 ± 0.01-PC; Rf 0.43 ± 0.02-PE and Rf 0.62 ± 0.03-PG realized in TLC
MALDI software. Lipid peaks were detected in positive MALDI mode on an HPTLC plate. PSD spectra with identification of PL fragments are superimposed.
Lipid identification was performed on the basis of MS, PSD and MSI analyses using the LIPID MAPS database, MS and PSD spectra of lipid standards obtained
previously. The alkyl chain length was confirmed by GC MS analysis of PL fatty acids (supplementary data, Table S1). The analyses were performed for three
independent bacterial lipid extracts. *DHB peaks; **unidentified peaks; HG: head group.
6 T. Kondakova et al. / Research in Microbiology 166 (2015) 1e8propose herein the first adaptation of this method to the study
of the bacterial lipidome. Thus, total lipids of airborne P.
fluorescens MFAF76a were extracted and separated on
HPTLC plates to resolve individual PL spots. This HPTLC
technique was coupled to MALDI TOF MS. A complete study
of detected spots by MS, PDS and MSI was carried out,
enabling PL identification in the lipidome of P. fluorescens
MFAF76a. The HPTLC-MALDI TOF MSI method of PL
analysis appears perfectly adapted to the analysis of bacterial
lipids, as demonstrated in the present study.
This method has many key advantages: 1) due to access to a
MALDI TOF spectrometer, it is inexpensive, since HPTLC
plates only need to have an electric conductor metal back, butP2are inserted into the spectrometer using a reusable TLC
MALDI adapter; 2) HPTLC-MALDI TOF MS is a rather rapid
method; TLC MALDI software enable screening of one
sample in 5 min; 3) coupling between MALDI MS and
HPTLC for separating individual lipids increases the sensi-
tivity of the method compared to other existing techniques; 4)
MS imaging, designed for MS analysis of tissue, is a good
method for mapping individual lipid species distribution in
HPTLC plates.
However, the method continues to have its drawbacks. It
suffers from a lack of sensitivity; the required quantity of
extracted lipid remains high. A volume of 100 mL of bacterial
lipid extract (containing a mean of 40 mg lipids) was necessary1
Table 1
PL composition of P. fluorescens MFAF76a.
Retention
factor
Lipid
class
Peak position (m/z) and
adducts
Species Molar
mass (Da)
0.24 ± 0.01 PC 732.6 [PC þ H]þ PC (16:0/16:0) 731.5
754.5 [PC þ Na]þ
0.43 ± 0.02 PE 712.5 [PE þ Na]þ PE (16:0/16:1) 689.5
734.5 [PEþ2NaeH]þ
738.5 [PE þ Na]þ PE (16:0/18:1) 715.5
760.5 [PEþ2NaeH]þ
0.62 ± 0.03 PG 743.5 [PG þ Na]þ PG (16:0/16:1) 720.5
765.5 [PGþ2NaeH]þ
791.6 [PGþ2NaeH]þ PG (16:0/18:1) 746.5
7T. Kondakova et al. / Research in Microbiology 166 (2015) 1e8for one migration line; this implies starting extraction from a
large volume of bacterial culture (generally 100 mL).
Moreover, difficulties in PSD fragmentation and identifi-
cation of PL alkyl chains remain an issue. Since analysis was
performed with DHB as the MALDI matrix, the spectrometer
was run in a positive mode and non-polar alkyl chain
fragments have low intensity. Other experiences with
other MALDI matrices, such as 9-aminoacridine or trihydro
xyacetophenone in negative MALDI mode, showed weak in-
tensity of individual lipids (data not shown). This makes PDS
fragmentation of lipid peaks too insensitive and complicates
lipid identification.
The HPTLC-MALDI TOF MSI method led to original re-
sults on the lipidome of P. fluorescens. In bacteria, most lipids
are located in the cell wall. For Gram-negative bacteria like P.
fluorescens, this cell wall consists of an association of a
multiplicity of individual proteins with a somewhat limited
series of major lipid species, with the main constituents of PL
essentially considered to be PE, PG, CL and minor lysoPLs,
like lysoPE and lysoPG [17,18,22,22e25]. The absence of CL
in our results can be explained by the extraction method
employed. As shown by Lopalco et al. [14], after lipidic
extraction, CL is found with denatured proteins in the aqueous
phase and thus not in the chloroform phase that was presently
analyzed [26]. In any case, the presence of PE and PG was
confirmed by our method, and these two lipid classes are
considered as major components of the Pseudomonas lip-
idome [17,27]. Conversely, the detection of PC is quite un-
usual in a bacterial cell [9,10]. This lipid is the major
constituent of the membrane bilayer in eukaryotes [28], but it
is rarely found in prokaryotes, and only 10% of bacterial
species are known to synthesize PC [29]. This PL is found
only in the lipidome of very specific bacteria, particularly
eukaryotes, symbiotic or pathogenic. Even in an opportunistic
pathogen such as P. aeruginosa, PC is only detected in small
amounts (less 4% of total lipids), but its role appears essential
in virulence expression [30,31]. Thus, PC could facilitate the
assembly or localization of specific proteins to P. fluorescens.
Further proteomics studies should help to better understand the
role of PC in this bacterial lipidome.
In conclusion, the HPTLC-MALDI TOF MSI technique ap-
pears to be a rapid and inexpensive method for the study of the
bacterial lipidome. Mass spectrometric analysis can be realized
directly after lipid separation on HPTLC plates. This method,P21adapted from eukaryotic lipid analysis, should efficiently com-
plete proteomic tools for investigating bacterial adaptation to host
and stress. In the present study, HPTLC-MALDI TOF MSI
enabled revealing expression of different forms of PE and PG in
the lipidome of an airborne P. fluorescens strain. Moreover, it
shows the presence of PC, suggesting potential for adaptation to
interactions with eukaryotic hosts.
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Dredged harbor sediment co-contaminated by heavy metals and polycyclic aromatic hydrocarbons
(PAHs) was subjected to enhanced electrokinetic treatments, using a mixture of a chelating agent (citric
acid CA) and a surfactant as additives in the processing ﬂuids. We tested various operating conditions (at
1 V cm1): different CA concentrations, applying a periodic voltage gradient, pre-conditioning the sedi-
ment with the additives, and replacing the synthetic surfactant Tween 20 (TW20) by biosurfactants.
Increasing the CA concentration was favorable for both metal and PAH removal. Applying a periodic volt-
age gradient associated to a low concentration of CA and TW20 provided the best results for Zn, Cd and Pb
removal and also for removal of the 16 priority PAHs. Promising results were obtained with solutions
containing rhamnolipids (0.028%) and a viscosin-like biosurfactant produced by Pseudomonas ﬂuorescens
Pfa7B (0.025%), associated to a periodic voltage gradient. Although the rhamnolipid and the viscosin-like
compounds involved a higher electrical current than TW20, metals were less removed from the sediment.
The electroosmotic ﬂow was lower when we used biosurfactants, hence a less effective effect on PAH
removal.
 2015 Elsevier Ltd. All rights reserved.1. Introduction
Management of dredged sediment is of great concern for main-
taining harbor activities (Benamar and Baraud, 2011). In France,
chemical guidance values are provided to assess the chemical
2 M.T. Ammami et al. / Chemosphere 125 (2015) 1–8hazard following the disposal of dredged sediment into environ-
mental waters, as recommended by the OSPAR convention direc-
tives or French regulations such as GEODE guidelines (14/06/
2000). Thus the restricted disposal of dredged sediment into the
marine environment has led managers to treat it ashore. However,
storage on disposal sites is not a sustainable solution because of
the risk of contaminants transferring to the environment. Reuse
of dredged sediment in construction materials in civil engineering
or habitat restoration can be proposed (Yozzo et al., 2004; Wang
et al., 2012), but such sediment management requires treatments
to reduce their contamination level.
In contaminated dredged sediment, inorganic metals (Peng
et al., 2009) and persistent organic pollutants such as polycyclic
aromatic hydrocarbons (PAHs) (Sprovieri et al., 2007) are of great
concern regarding their toxicological hazard: they bioaccumulate
in food chains, and induce higher mortality rates, growth reduction
or disturbance of reproductive processes in marine organisms
(Roberts, 2012). Powerful techniques must be developed in order
to remove them from sediment, such as thermal desorption, sedi-
ment washing or ﬂushing, solvent extraction, bioremediation
(Jones et al., 2001; Libralato et al., 2008; Beolchini et al., 2009).
However these technologies fail when low permeable soil or sedi-
ment is encountered.
Electrokinetic (EK) remediation is a technology that has
received attention as a practical in-situ and ex-situ remediation
technique for low permeable clay-rich soil or ﬁne-grained sedi-
ment. Brieﬂy, when a low voltage gradient is applied to the sedi-
ment via embedded electrodes, charged pollutants electromigrate
towards the electrode of the opposite charge (Ryu et al., 2011).
The electric ﬁeld induces an electro-osmotic ﬂow, and solubilized
neutral pollutants can be also transported with the pore ﬂuid
(Cameselle and Reddy, 2012). Successful laboratory-scale EK tests
have been reported for sediments or soils contaminated by metals
or PAHs (Giannis et al., 2009; Pazos et al., 2010). Simultaneous EK
removal of both metals and PAHs has been investigated lately
(Maturi and Reddy, 2008; Colacicco et al., 2010; Ammami et al.,
2013).
Enhanced EK technology is highly dependent on the type of pro-
cessing solution used. The main reaction, inherent to the EK pro-
cess, is water electrolysis. It generates H+ at the anode side and
OH at the cathode side, and thus causes metals to precipitate near
the cathode (Nogueira et al., 2007). Therefore acids are suitable
candidates near the cathode as they enhance their solubilization
and transport to the cathode. Adding complexing agents can also
convert soil-bound metals into soluble complexes and enhance
their removal (Gidarakos and Giannis, 2006). Concerning PAHs,
enhancing agents that allow their better desorption from sediment
particles and solubilization in the pore ﬂuid can be used to achieve
satisfactory results. Various surfactants, cyclodextrins or cosol-
vents have been tested (Park et al., 2007; Maturi et al., 2009;
Hahladakis et al., 2013).
Mechanisms of EK PAH removal by synthetic surfactants have
been investigated, but little research has been carried out using
biosurfactants (Alcantara et al., 2009; Chang et al., 2009; Gonzini
et al., 2010). Biosurfactants are biological surface active agents pro-
duced by certain yeasts or bacteria. They were used to clean soils
polluted by organics, especially rhamnolipids produced by Pseudo-
monas aeruginosa (Bordas et al., 2005; Lai et al., 2009). Other clas-
ses of biosurfactants, such as lipopeptides or bioemulsans have
also been tested for applications in soil or sediment remediation
(Mulligan et al., 1999; Dahrazma and Mulligan, 2007; Juwarkar
et al., 2007; Franzetti et al., 2009).
We conducted bench-scale electrokinetic tests to understand
the effect of different operating parameters on the removal, in
one stage, of mixed contaminants from dredged sediment, i.e. ﬁve
metals (Cd, Cr, Cu, Pb, Zn) and the 16 priority PAHs deﬁned by theP2US-EPA. We tested the amount of chelating agent (citric acid), the
nature of the surfactant (synthetic Tween 20 or biological surfac-
tants: rhamnolipids and, for the ﬁrst time, a cyclolipopeptide)
and sediment pre-conditioning. Moreover, little is known about
the beneﬁts of the application of a periodic electric potential on
the EK surfactant-enhanced removal of PAHs (Saichek and Reddy,
2005). So we also assessed the combination of enhancing agents,
never tested together before, with the application of a periodic
voltage gradient.
2. Materials and methods
2.1. Materials
2.1.1. Chemicals
Acetonitrile, methylene chloride, toluene and acetone were pro-
vided by VWR (Fontenay sous Bois, France). Nitric acid (65%), hydro-
chloric acid (37%), citric acid (CA) and Tween 20 (TW20) were
obtained from Fisher Scientiﬁc (Illkirch, France). A standardmixture
of 16 priority PAHs, perdeuterated phenanthrene, cadmium nitrate,
chromium nitrate, copper sulfate, zinc nitrate and lead nitrate were
provided by Sigma–Aldrich (St Quentin-Fallavier, France).
2.1.2. Sediment sampling
The dredged sediment was collected from the disposal site of a
French harbor in Normandy, localized near important urban cen-
ters and industrialized areas. Its properties are presented in Table 1.
pH was measured according to the NF ISO 10390 standard,
electrical conductivity according to the NF ISO 11265 standard
and moisture content was obtained in accordance with the French
NF P 94-050 standard. Organic matter content was measured in
accordance with the NF EN 12879 standard. Particle size distribu-
tion was determined using a laser particle-sizing device (Malvern
Instruments, Malvern, UK).
2.1.3. Biosurfactants
The rhamnolipid biosurfactant (90% purity) was obtained from
AGAE Technologies (Corvallis, USA). The other biosurfactant was
our own production: Pseudomonas ﬂuorescens PfA7B strain
was ground on culture plates and its biosurfactant production was
recovered after 14 d of incubation, as described in a previous paper
(Groboillot et al., 2011). Thebiosurfactant, amixtureof twoviscosin-
like cyclolipopeptides (viscosin andmassetolide E),waspuriﬁedand
characterized, as already described (Portet-Koltalo et al., 2013). The
critical micellar concentrations (CMCs) of the biosurfactants were
determined by surface tension measurements using the pendant
drop method (Tensiometer DSA30, Krüss, Germany).
2.2. Electrokinetic tests
The experimental EK setup is described in a previous paper
(Ammami et al., 2013). Brieﬂy, the natural sediment was packed
into a Teﬂon PTFE chamber. Graphite electrode plates were placed
in each electrode compartment, separated from the sediment by
porous glass papers. Two pumps ﬁlled the electrode reservoirs
with the aqueous processing ﬂuids (10 mL h1). A voltage gradient
(1 V cm1) was applied continuously or periodically (5-d-on/2-d-
off cycles) and the electrical current was periodically measured.
At the end of each treatment, the sediment was extracted and
cut into four slices for analysis.
Experiments 1 to 3 consisted in increasing CA concentrations
while keeping the TW20 concentration constant (Table 2). Experi-
ments 4 and 5 consisted in the same operating conditions as exper-
iment 1, but experiment 4 was conducted under a periodic electric
potential and experiment 5 with pre-conditioned sediment. In this
latter case, the sediment was previously air-dried for a week and
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Table 1
Properties of the dredged sediment and its metal and PAHs contaminants, compared to N1, N2 levels of GEODE guidelines.
Sediment properties Contaminants
Heavy metalsa,b (mg kg1) PAHs a,c (mg kg1)
Particle size distribution and diameters Clay 6.3% dp < 2 lm Cd 4.98 ± 0.12 > 2.4 (N2) Naph 0.109 ± 0.011 < 0.160 (N1)
Silt 86.2% dp = 2–63 lm Cr 94.71 ± 3.65 > 90 (N1) Acy 0.055 ± 0.003 > 0.040 (N1)
Sand 7.5% dp = 63–2000 lm Cu 56.29 ± 1.72 > 45 (N1) Ace 0.056 ± 0.004 > 0.015 (N1)
Organic matter content 2.6% Pb 64.67 ± 1.86 < 100 (N1) Fluo 0.062 ± 0.009 > 0.020 (N1)
pH 8.4 ± 0.1 Zn 405.99 ± 12.69 > 276 (N1) Phen 0.236 ± 0.021  0.240 (N1)
Electrical conductivity 1.82 ± 0.2 mS cm1 Ant 0.241 ± 0.013 > 0.085 (N1)
Moisture content 93% Flt 0.470 ± 0.020 < 0.600 (N1)
Pyr 0.443 ± 0.012 < 0.500 (N1)
B(a)ant 0.296 ± 0.017 > 0.260 (N1)
Chry 0.376 ± 0.020  0.380 (N1)
B(b)ﬂt 0.390 ± 0.025  0.400 (N1)
B(k)ﬂt 0.252 ± 0.033 < 0.200 (N1)
B(a)pyr 0.313 ± 0.021 < 0.430 (N1)
I(123cd)pyr 0.337 ± 0.030 < 1.700 (N1)
Db(ah)ant 0.065 ± 0.006 > 0.060 (N1)
B(ghi)per 0.343 ± 0.029 < 1.700 (N1)
a mg kg1 dry mass, mean values obtained from 5 replicates.
b French ofﬁcial journal order of 6 August 2006.
c French ofﬁcial journal order of 8 February 2013.
Table 2
Conditions for EK remediation experiments, mean anodic and cathodic electroosmotic ﬂows and ﬁnal energy consumption (great changes in conditions appear in bold).
Exp. Anolytes and catholytes Duration (d) Voltage gradient/mode Energy consumption (W h) Mean anodic/cathodic EO ﬂows (mL h1)b
1 TW20 (4.94 g L1) + CA (0.1 M) 21 1 V cm1/DC 18.7 0.097/0.075
2 TW20 (4.94 g L1) + CA (0.5 M) 22 1 V cm1/DC 95.1 +0.152/+0.560
3 TW20 (4.94 g L1) + CA (1 M) 22 1 V cm1/DC 109 +0.183/+1.192
4 TW20 (4.94 g L1) + CA (0.1 M) 24 1 V cm1/periodic 51.1 0.120/+0.179
5a TW20 (4.94 g L1) + CA (0.1 M) 50 1 V cm1/DC 97.7 0.296/+0.561
6 Rhamnolipid (0.275 g L1) + CA (0.1 M) 24 1 V cm1/periodic 89.5 0.004/+0.088
7 Vicosin-like (0.250 g L1) + CA (0.1 M) 24 1 V cm1/periodic 108.4 0.152/+0.267
a Initial water content was 45% for experiment 5, unlike all the other EK tests for which water content was 93%.
b EOF is by convention positive from anode to cathode.
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hydrated with 45% moisture, using an aqueous solution containing
TW20 (4  103 M) and CA (0.1 M) and the mixture was equili-
brated for 24 h before starting the EK treatment. Experiments 6
and 7 were performed using CA and biosurfactants as enhancing
agents, respectively rhamnolipids and a cyclolipopeptidic mixture.
Energy consumption was obtained by multiplying the mean
electric current intensity (when steady state was reached), the
applied voltage and the processing time (Table 2).2.3. Analytical methods
2.3.1. Metal extraction and analysis
Three aliquots of treated sediment were collected from each
sliced section and dried 48 h at 35 C, ground, and each 0.5-g
sub-sample was digested in PTFE tubes using 10 mL of nitric
acid:hydrochloric acid 3:1 (v:v). The tubes were subjected to
microwave irradiation at 170 C (1200W output) for 10 min
(MarsX, CEM Corporation, Matthews, USA). The mineralized sol-
utes were completed to 100 mL with water and ﬁltered through
PTFE ﬁlters (0.2 lm). Metal concentrations (Cd, Cr, Cu, Pb, Zn) were
analyzed in triplicate using an ICP-AES (ICAP 6300, ThermoFisher
Scientiﬁc, Waltham, USA). Metals in the aqueous efﬂuents were
also analyzed by ICP-AES after ﬁltration. The linearity of the detec-
tor response was between 0.01–10 mg L1. Detection and quantiﬁ-
cation thresholds, calculated respectively as 3 and 10 times the
standard deviation of the blank sample noise, were respectively
0.001/0.005 mg L1 for Cd, 0.005/0.020 mg L1 for Pb, 0.018/
0.060 mg L1 for Zn, 0.003/0.010 mg L1 for Cr and 0.002/P220.080 mg L1 for Cu. Metal quantiﬁcation was obtained with rela-
tive standard deviations in the 2.4–3.9% range.2.3.2. PAH extraction and analysis
Three aliquots of sediment were taken from each sliced section
and were dried one night at 35 C, crushed, and each 5-g sub-sam-
ple was extracted by microwave-assisted extraction (MarsX) with
40 mL of toluene:acetone 1:1 (v:v) at 140 C for 30 min (1200W
output). The extracts were ﬁltered through PTFE ﬁlters (0.2 lm)
and evaporated under vacuum to 1.5 mL. An internal standard (per-
deuterated phenanthrene) was added, and then 1 lL was injected
(splitless mode, 285 C) into a gas chromatographer (6850 series,
Agilent, Santa Clara, USA), equipped with a mass spectrometer
detector (5975C series). Separation was performed using a
50 m 0.25 mm i.d. DB5-MS capillary column (0.25 lm ﬁlm thick-
ness) from J&W Scientiﬁc (Folsom, CA, USA), with helium as a carrier
gas (1.4 mLmin1). The oven temperature was programmed at 55 C
for 1.2 min, increased to 180 C (40 Cmin1) and then to 300 C
(4.5 Cmin1). The detector operated at 70 eV. Quantiﬁcation was
based on selected ion monitoring for better sensitivity. The linearity
of the detector response was between 0.05–5 mg L1. Detection and
quantiﬁcation thresholds were respectively in the range 1.5–
5 lg L1 and 5–16.5 lg L1. PAH quantiﬁcation was obtained from
relative standard deviations in the 2.7–14.1% range.3. Results and discussion
Previous studies demonstrated that using an acidic chelatant
(CA) and a nonionic surfactant (TW20) as ﬂushing reagents was
4 M.T. Ammami et al. / Chemosphere 125 (2015) 1–8efﬁcient to obtain signiﬁcant removal of metals (Zn, Cd, Cu, Pb) and
of ﬁve PAHs from a spiked sediment mimicking the properties of
our harbor sediment (Ammami et al., 2013). Consequently, we
tested the CA/TW20 mixture on the natural sediment. CA and sur-
factants were simultaneously tested, such as in the work of
Alcantara et al. (2012), and not sequentially, such as in the work
of Reddy et al. (2009) or Hahladakis et al. (2014). Considering that
electroosmotic ﬂow could be reversed in some cases (Genc et al.,
2009), we chose to introduce the ﬂushing reagents at the two elec-
trode cells.
Table 1 shows that the harbor sediment was contaminated by
metals and PAHs. GEODE guidelines recommend that sediment
should not be disposed of in the marine environment if contami-
nant concentrations exceed the N2 level: in that case the sediment
is considered to have a strong impact on the environment. If con-
taminant concentrations are below the N1 level, dumping at sea
is authorized without a toxicology impact study. If the concentra-
tion is between the N1 and N2 thresholds, the sediment is consid-
ered contaminated and its eco-toxicity impact has to be analyzed.
Table 1 shows that a major part of the pollutants was between the
N1 and N2 levels and that Cd was above the N2 level: for these pol-
lutants, assessing EK remediation conditions that could lower the
contamination levels down to below the N1 level was the main
objective.
As one of our upcoming objectives is to apply the EK process in
situ, it seemed essential to use enhancing agents with low impact
on the environment. Such is the case for CA; moreover, CA is selec-
tive comparatively to other chelatants (Gidarakos and Giannis,b
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Fig. 1. Evolution of electric current with elapsed time (a) EK remedi
P22006). We also tested environment-friendly biosurfactants to
replace TW20: commercial rhamnolipids, that have been already
tested for EK remediation (Gonzini et al., 2010), and a cyclolipo-
peptide that has never been tested, but previous studies demon-
strated that it could favor desorption of low molecular weight
PAHs from sediment (Portet-Koltalo et al., 2013).
Cationic surfactants are not chosen as enhancing agents
because they highly sorb onto negative sediment particles (Kaya
and Yukselen, 2005). Nonionic surfactants are less sorbed and they
have a low CMC; to ensure that micelles of the nonionic TW20
could form in the pore ﬂuid, we tested it at 50 times its CMC
(0.5%), which is not high compared to other studies (Colacicco
et al., 2010; Alcantara et al., 2012). Concerning anionic surfactants,
their strong point is that they poorly sorb onto sediment particles.
So we added the anionic biosurfactants at only 5 times their CMC,
evaluated at 50 mg L1 for the viscosin-like and rhamnolipid bio-
surfactants (Table 2).
3.1. Variation of the electric current and sediment parameters
Fig. 1 shows the electric current (EC) variation for the seven
tests. Fig. 1a shows that EC initially increases to a maximum value
within the ﬁrst hours of treatment, and then it drops and stabilizes
(Colacicco et al., 2010). The initial high values are due to the solu-
bilization of salt precipitates which increases the EC (Mitchell,
1993). But over time, ions are depleted as they electromigrate
and current intensity decreases to stabilized current values
(Maturi and Reddy, 2006).00 600 700 800 900 1000
e (h)
exp 3 exp 5
00 600 700 800 900 1000
e (h)
exp 6 exp 7
ation tests 1, 2, 3 and 5 and (b) EK remediation tests 4, 6 and 7.
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other things) more solubilized charged metal complexes were
formed. In experiment 5, moisture content was only 45%, versus
93% for the other experiments. In the ﬁrst hours of EK treatment,
lowering the moisture content led to a lower EC than in experi-
ment 1, as there were fewer available H+ ions from water electrol-
ysis. It was also probably less easy for the ionic species to migrate
through the less dispersed pore network (Reddy et al., 2002),
which can explain the more gradual decrease of current in exper-
iment 5 and a longer stabilization time. However, EC remained
higher in experiment 5 compared to experiment 1. This behavior
may be attributed to the amount of available ionic species (other
than H+), which were better mobilized in pore ﬂuid during the
pre-conditioning step of the sediment.
Fig. 1b shows that current intensity was more ﬂuctuating when
a periodic voltage was applied. This periodicity generated an EC
that followed an up-and-down pattern. When the voltage was
not applied, it allowed time for the mass transfer of charged sol-
utes from the soil to the aqueous medium, causing a higher current
when the voltage was applied again (Maturi et al., 2009). Replacing
TW20 by rhamnolipid or viscosin-like biosurfactants revealed that
mean EC values were signiﬁcantly higher (5.5 mA, 13.1 mA and
16.2 mA, respectively). The higher current obtained when we
added biosurfactants may be due to their higher dielectric con-
stant: TW20 is an uncharged surfactant, whereas rhamnolipids
are in their anionic form at pH values above their pKa (4.3–5.5),
and the mixture composed of massetolide E/viscosin contains glu-
tamic acids that are in their anionic form when pH values are
above their pKa (4.1).
As regards the sediment pH at the end of each test (Fig. 2), it
underwent an overall but low acidiﬁcation process compared to
the initial pH value. The carbonates in the natural sediment
increased its buffering capacity and impeded the progress of the
acidic front from the anode towards the cathode (Ouhadi et al.,
2010). Fig. 2 shows that sediment acidiﬁcation obviously increased
when the CA concentration was increased. Additionally, pre-condi-
tioning the sediment with CA and applying a longer EK treatment
duration allowed for a better acidiﬁcation. Lastly, applying a peri-
odic voltage gradient seemed to hamper the acidic front migration.
We also calculated mean anodic and cathodic electroosmotic
ﬂows (EOFs), which are summarized in Table 2 (Supplementary
Fig. SM-1 shows the evolution of EOF at the cathode and the anode
sides during some EK treatments). An EOF is produced when excess
ions in the diffuse double-layer migrate towards the opposite2
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Fig. 2. Distribution of pH within sed
P22charged electrode and transfer the momentum to the surrounding
pore water and to the dissolved ions or neutral species. This ﬂow
depends on the zeta-potential of the sediment particles, which is
negative when the pH is above the zero point of charge of the par-
ticles: then, the positively charged diffuse double-layer migrates to
the cathode (Kaya and Yukselen, 2005). At the end of our tests, the
pH of the sediment did not become too acidic, even near the anode
(Fig. 2), so overall EOFs occurred preferentially towards the cath-
ode. Mean overall EOFs were calculated by difference between
the cathodic and the anodic EOFs, which were positive by conven-
tion towards the cathode and that ranked as follows: experiment
n1 (0.023 mL h1) < n6 (0.092 mL h1) < n4 (0.299 mL h1) < n2
(0.409 mL h1) < n7 (0.419 mL h1) < n5 (0.857 mL h1) < n3
(1.010 mL h1).
Increasing the CA concentration in the purging ﬂuid induced a
higher overall EOF. This is a known effect of CA (Nogueira et al.,
2007). So acidiﬁcation of the sediment with a high CA content
was favorable for sustaining a high EOF. Moreover, the use of a
periodic voltage gradient (experiment 4) generated a signiﬁcantly
higher overall EOF compared to experiment 1; a higher EOF was
also sustained in experiment 5 compared to experiment 1,
although a lower moisture content is in principle detrimental to
the EOF (Reddy et al., 2002). A longer contact time between sedi-
ment particles and CA (when voltage was not applied or during
the preconditioning step) favors its sorption onto particles, which
modiﬁes the zeta-potential, leading to a more negative charged
surface and so to a better EOF (Cameselle and Reddy, 2012).
Introducing rhamnolipid in the purging ﬂuid was not really
beneﬁcial for the overall EOF compared to TW20, unlike viscosin-
like biosurfactant. The velocity of EOF is proportional to the dielec-
tric constant of the ﬂuid and to the zeta potential, but inversely
proportional to the viscosity of the purging solution. The higher
dielectric constant of the ﬂuid obtained when using rhamnolipids
was probably counteracted by a higher viscosity.
Regarding energy consumption (Table 2), experiment 1 was the
less expensive EK test. But experiment 4, which consisted in apply-
ing a periodic voltage gradient, should also be singled out for its
low energy consumption.
3.2. Metal removal
Table 3 indicates the metal percentages removed in the seven
tests. Compared to the previous results obtained on model sedi-
ment, all the metals were harder to remove from the dredged.5 0.75 1
istance from anode
xp 5 exp 4 exp 6 exp 7
iment after EK treatments 1–7.
Table 3
Metal and PAH removals (%) after each EK treatment.
Exp. 1 Exp. 2 Exp. 3 Exp. 4 Exp. 5 Exp. 6 Exp. 7
Metals
Cd 12.8 35.6 38.6 34.9 7.4 33.5 33.0
Cr 1.3 6.1 8.5 8.5 1.6 0.1 0.1
Cu 1.6 2.8 8.7 5.6 5.0 2.0 9.2
Pb 12.9 25.5 33.4 28.8 2.2 10.6 13.1
Zn 43.0 49.4 51.6 50.2 53.0 20.2 17.2
PAHs
Naph 38.4 39.0 53.3 44.5 47.2 25.6 34.8
Ace 30.4 27.9 47.8 42.2 25.3 0.0 7.7
Acy 67.5 67.3 74.3 73.1 76.0 60.5 63.9
Fluo 35.7 34.2 48.3 32.9 49.9 25.7 38.7
Phen 20.4 24.2 41.5 32.9 40.8 11.8 13.2
Ant 31.9 31.8 53.4 40.8 46.1 2.1 11.2
Flt 32.5 37.3 51.3 45.8 51.4 21.4 33.7
Pyr 30.8 35.7 50.3 44.6 52.0 19.2 29.2
B[a]ant 31.7 40.8 54.4 48.5 56.5 25.5 31.3
Chry 54.6 58.0 67.8 63.0 63.4 51.5 53.7
B[b]ﬂt 9.1 15.5 32.9 24.3 37.7 0.0 0.6
B[k]ﬂt 48.0 58.1 66.2 62.8 71.0 41.0 50.0
B[a]pyr 22.6 39.8 50.2 44.0 56.0 14.5 18.9
I[1.2.3-cd]pyr 43.0 59.0 61.1 57.4 71.6 34.6 41.4
Db[ah]ant 26.0 50.5 51.9 50.1 61.3 15.8 32.3
B[ghi]per 42.8 70.9 65.0 63.3 72.2 45.7 50.1
Total PAH removal 35.3 43.1 54.4 48.1 54.9 24.7 31.9
6 M.T. Ammami et al. / Chemosphere 125 (2015) 1–8sediment in the same operating conditions (Ammami et al., 2013).
As mentioned, the buffering capacity of the natural sediment coun-
teracts the acidiﬁcation of the sediment and prevents metal solubi-
lization and electromigration.
In most cases, at the end of the experiments, Zn and Cd were
found preferentially in the cathode compartment whereas Cr, Cu
and Pb were found preferentially in the anode compartment. Zn
was generally the easiest to remove whereas Cr and Cu were the
hardest to remove. Zn tends to precipitate as a hydroxide only at
pH > 7 whereas Cr, Cu and Pb precipitate at pH values above 4–5.
So Zn was easier to remove from the sediment in its cationic form
at pH > 6. At this pH, Cr and Cu remained immobilized in the sed-
iment and apparently did not form high amounts of soluble com-
plexes with CA. Concerning Pb, which precipitates at the pH
conditions of our sediment, its removal can be attributed to the
formation of chelates with CA that preferentially migrate to the
anode compartment. Regarding Cd, it only forms hydroxides at
pH > 8. But its migration as a free cation was very low. Moreover,
the stability of Cd complexes with citrate is low, so its migration
to the anode was low too (Gidarakos and Giannis, 2006). In fact,
Cd is most likely bound to organic matter (OM) than the other met-
als and is difﬁcult to mobilize. However, increasing CA concentra-
tions tended to enhance Cd removal, as CA contributes to
dissolving large amounts of humic substances at pH > 6 and can
thus favor Cd desorption (Yang et al., 2001). So increasing CA con-
centrations was beneﬁcial for all metals, but the least impacted
was Zn, which preferentially migrates as a free cation.
Even though metals were found preferentially in the anode or
cathode compartments, the ﬁnal distributions inside the sediment
did not differ markedly between metals for a given test (see Sup-
plementary Fig. SM-2). In experiments 1, 4, 5 and 6, all metal
amounts tended to decrease slightly from the anode to the cath-
ode. In experiments 2 and 3, metals tended to concentrate in the
second quarter of the sediment from the anode and to be better
removed near the electrodes, more particularly near the anode.
Regarding experiment 7, metal amounts tended to decrease from
the cathode to the anode.
In general, increasing CA concentrations helped to better
remove all the metals, and the effect was improved nearby the
anode. Applying a periodic voltage gradient enhanced theP2decontamination of the overall sediment column: the highest
pulsed current intensity was really favorable for metal removal.
Reducing the moisture content and pre-conditioning the sediment
was not favorable for metal removal (except for the more mobile
Zn), although current intensity was higher.
Finally, swapping TW20 for biosurfactants was not beneﬁcial
for metal removal, although mean current intensity was higher.
In the pH conditions of the sediment, the two biosurfactants are
in their anionic form and they can theoretically help transport met-
als as counter-ions (Mulligan, 2009). But they electromigrate pref-
erentially towards the anode, which counteracts EOF. Juwarkar
et al. (2007) demonstrated that Cd was easy to remove by using
processing solutions containing rhamnolipids, but their good
removal rates were obtained with solutions containing 0.1% bio-
surfactant; this is much higher than the concentrations we used
(0.025% and 0.028% for the viscosin-like and rhamnolipid com-
pounds, respectively). In another case, it was necessary to use a
0.25% solution of a cyclolipopeptidic surfactant to ﬂush Zn and
Cu (Mulligan et al., 1999). So the limited effect of biosurfactants
on metal removal in our tests was also probably due to their afﬁn-
ity for the sediment particles and to their too low concentration in
the pore ﬂuid (Ochoa-Loza et al., 2007).
3.3. PAH removal
Supplementary Fig. SM-3 shows a general decrease of all the
PAHs in the sediment after EK treatments, even for the high molec-
ular weight (HMW) PAHs, which are the most strongly sorbed to
the OM and clayey fractions of the sediment (Portet-Koltalo
et al., 2013). PAHs desorption and solubilization were possible
owing to the presence of the surfactants in the purging solution,
which can form micellar aggregates at concentrations higher than
their CMC and solubilize PAHs in their hydrophobic core. But cit-
rate ions can also play a role by increasing PAH desorption through
a considerable release of OM into the solution (Yang et al., 2001).
The EOF is a major factor to consider for the transport of neutral
compounds such as PAHs, alone or incorporated into nonionic sur-
factants. The overall EOF towards the cathode increased when
TW20 was mixed with increasing concentrations of CA. Table 3
shows that total PAH removal also increased from 35.3% to
2
M.T. Ammami et al. / Chemosphere 125 (2015) 1–8 754.4%. In the same way, applying a periodic voltage gradient or
equilibrating the sediment with the additives prior to EK treatment
led to a better EOF, and better PAH removal along with it (Table 3).
PAH desorption and solubilization are rate-limited processes; dur-
ing the ‘‘down’’ voltage interval, re-equilibration at the solid–liquid
interface occurs and more PAHs can be solubilized into micellar
aggregates. For the same reasons, the equilibration time before
EK experiment 5 started was beneﬁcial for PAH removal. In this
case, the beneﬁt was more substantial for HMW PAHs (Table 3),
which are more strongly bound to OM and certainly need an addi-
tional reaction time to desorb and solubilize into micelles.
PAH removal was correlated with the increase of the overall
EOF towards the cathode, with a linear regression coefﬁcient
R2 = 0.844 (for CA/TW20 mixtures). Supplementary Fig. SM-4a
shows actually the tendency of PAHs to be depleted near the catho-
dic section. But when CA concentration is increased in the purging
ﬂuid, depletion in the second quarter section near the anode
becomes pronounced: part of the PAHs incorporated into micelles
may therefore have moved through the EOF towards the cathode,
but a non-negligible part of the PAHs also electro-migrated toward
the anode through their incorporation into humic substances che-
lated to CA (Yang et al., 2001).
Using biosurfactants instead of TW20 yielded poorer PAH
removal results (Table 3). The cyclolipopeptide was mostly in its
anionic form, so the migration of micelles via the EOF was probably
non-signiﬁcant. PAH removal near the anode compartment via
electromigration of anionic micelles or via incorporation into che-
lated dissolved humic substances was quite efﬁcient, but as noth-
ing happened near the cathode, results were poorer compared to
experiment 4 (Table 3).
The case of experiment 6 is different: PAHs were concentrated
in the section near the anode (Supplementary Fig. SM-4b). Unlike
the cyclolipopeptide, rhamnolipids allowed for PAH decontamina-
tion in the section near the cathode, but not at all near the anode.
Compared to experiment 4, total removals were consequently
poorer. By contrast, Chang et al. (2009) showed that EOF and phen-
anthrene removal were better when a nonionic surfactant was
replaced by a rhamnolipid introduced at ten times its CMC. We
can suppose that the more acidic pH of their treated sediment
(pH  4) was favorable to the formation of the protonated neutral
form of the rhamnolipid. In that case, the rhamnolipid may be
more prone to transport PAHs in the same direction as the EOF,
leading to a better removal.
Table 3 shows that many structurally close PAHs with similar
chemical properties have very different elimination levels. For
example, acenaphthylene was consistently far less removed than
acenaphthene, or benzo[k]ﬂuoranthene was consistently much
more removed than benzo[b]ﬂuoranthene. PAHs can be more or
less easily degraded by oxidation in electrochemical treatments.
Moreover, the anodic oxidation of PAH mixtures occurs heteroge-
neously on each PAH (Alcantara et al., 2009). So part of PAH
removal can be attributed not only to migration processes but also
to their oxidative degradation, which is more or less effective.4. Conclusions
The experiments involving the highest amount of CA, or per-
formed with a lower amount of CA but applying a periodic voltage
gradient, were the most powerful to remove metals, particularly
Zn, Cd and Pb. Energy and additive consumption were lower with
the periodic voltage gradient, and Zn, Pb and Cr were removed to
levels below N1. However, Cd remained at a level above N2 and
Cu at a level above N1. Our natural sediment contained high
amounts of carbonates, with a high buffering capacity; thereforeP22in the case of Cd and Cu, associating higher amounts of CA, a peri-
odic voltage gradient and a longer treatment seems necessary.
As regards PAHs, adding a nonionic surfactant but also CA had a
positive effect on their removal, as well as applying a periodic volt-
age gradient. Once again, considering energy and additive con-
sumption, experiment 4 was the most favorable. All PAH levels
decreased in the sediment, and only ﬂuorene and anthracene
remained at levels above N1. Introducing TW20 at a higher concen-
tration and extending the treatment duration can be a solution to
obtain better results. For in-situ treatments, pre-conditioning large
amounts of sediment with additives, though favorable for PAH
removal, seems too expensive.
To go further, non-invasive treatments that preserve the biolog-
ical characteristics of the sediment (Gonzini et al., 2010) and make
it possible to reuse it after remediation can be achieved by using
biosurfactants. Promising results could be obtained using not only
rhamnolipids but also a cyclolipopeptidic biosurfactant, associated
to the application of a periodic voltage gradient. But these biosur-
factants should be tested at higher concentrations to favor the for-
mation of micelles in the pore ﬂuid over their sorption onto
sediment particles.
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Covalent  immobilization  of biomolecules  on the surface  of  cyclic  oleﬁn  copolymer  (COC)  is still a  tough
challenge.  We  developed  a robust  method  for COC  surface  grafting  through  reaction  with  aryldiazonium.
Chemical  diazonium  reduction  generated  an  aryl radical  and the formation  of a grafted  ﬁlm  layer  on  the
organic  surface.  We  also  demonstrated  that  the chemical  reduction  of diazonium  salt  was not  sufﬁcient
to  form  a ﬁlm  on  the  COC  surface.  UV illumination  had to  be  combined  with  chemical  reduction  to  graft
an  aryl  layer  onto  the  COC surface.  We  optimized  organic  ﬁlm  deposition  by using  different  chemicaliazonium salt
yclic  oleﬁn copolymer
OC
rafting
urface  treatment
nterface
reducers,  different  reaction  times  and reagent  proportions.  We  characterized  surface  modiﬁcations  by
ﬂuorescence  microscopy  and  contact  angle  measurements,  infrared  spectroscopy,  X-ray  photoemission
spectroscopy  and  Raman  spectroscopy,  and  assessed  the topography  of  the  aryl  ﬁlm  by  atomic  force
microscopy.  This original  strategy  allowed  us  to evidence  various  organic  functions  to  graft  biomolecules
onto  COC  surfaces  with  a fast  and efﬁcient  technique.
©  2014  Elsevier  B.V.  All  rights  reserved.. Introduction
Easy methods for modifying thermoplastic surfaces with spe-
iﬁc chemicals and functionalities have been attracting scientists’
ttention for years. Rigid thermoplastics are increasingly used
o develop biodevices (microarray chips, biosensors, cell culture
evices microﬂuidic chips, etc.) [1,2]. Cyclic oleﬁn copolymer (COC)
as promising properties such as good transparency, high chemical
esistance, low cost, high stiffness [3,4]. Despite these advantages,
Abbreviations: NBD, 4-nitrobenzenediazonium tetraﬂuoroborate;
BD,  4-bromobenzenediazonium tetraﬂuoroborate;
EBD, 4-(2bromoethyl)benzenediazonium tetraﬂuoroborate;
BD,  4-(carboxymethyl)benzenediazonium tetraﬂuoroborate;
BD,  4-mercaptobenzenediazonium tetraﬂuoroborate; COC, cyclic oleﬁn
opolymer; PMMA,  polymethylmethacrylate; PET, poly(ethyleneterephtalate);
I  water, deionized water.
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ulien.vieillard@univ-rouen.fr (J. Vieillard), benjamin.berton@univ-rouen.fr
B.  Berton), sandrine.morin@univ-rouen.fr (S. Morin-Grognet),
ecile.duclairoir@univ-rouen.fr (C. Duclairoir-Poc), franck.lederf@univ-rouen.fr
F. Le Derf).
ttp://dx.doi.org/10.1016/j.apsusc.2014.12.060
169-4332/© 2014 Elsevier B.V. All rights reserved.
P23COC has a chemically inert and hydrophobic surface that renders
biomolecule analysis tricky. COC has been used in microﬂuidic
channels without any modiﬁcation for speciﬁc analyses [5–7].
But biomolecules (proteins, DNA, etc.) or hydrophobic impurities
adsorbed onto the hydrophobic polymer usually affect the char-
acteristics of the device (variable electroosmotic ﬂow, unwanted
ﬂuorescence background, extra peak dispersion, etc.). Controlling
surface functionalization is therefore crucial. Different approaches
aimed at modifying COC surfaces have been described in the lit-
erature. A chemical method to brominate COC using a palladium
catalyst has been reported [8]. This approach is interesting because
the bromide group can be converted into a different group (OH,
COOH, etc.) by changing the nucleophilic agent and thus yield
numerous original COC polymers. However, this method modiﬁes
the whole polymer structure and thereby its physical and chemical
properties, so this could result in unwanted effects. To pattern COC
devices with DNA, COC surfaces were coated with silane layers to
generate SiO2-COC microarrays [3]. COC modiﬁcation by dynamic
or static coating has also been tried. Dynamic coating involves
dissolving additives in a buffer solution to obtain a coating layer
that physically adsorbs onto the surface. Thanks to this method,
hydroxyethylcellulose, hydroxypropylcellulose and ethylene gly-
col solutions were physisorbed onto COC surfaces [4,9]. Although
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ynamic coating is a simple and reliable method, it requires
ontinuous regeneration, so that its applications in the ﬁeld of sur-
ace preparation are limited. COC surfaces have also been coated
ith different static polymer adlayers such as triblock copoly-
er, dimethylacrylamide copolymer and antibiofouling copolymer
10–13]. Such polymers are amphiphilic, with a hydrophobic inter-
ace in contact with COC on one side and a hydrophilic interface
n contact with the aqueous solution on the other side. COCs have
lso been modiﬁed using covalently grafted polymers to create a
obust coating with tunable chemistry. To obtain covalent coat-
ng, COCs have to be previously activated. Two main strategies
ave been described, based on gas plasma irradiation or on UV
hotoactivation. Ozone oxidation has also been successfully tested
o generate polar groups such as hydroxyls, esters or carboxylic
cids on COC surfaces [14,15]. In radiofrequency plasma treatment,
ifferent gasses have been tested (oxygen, nitrogen, argon, and
xygenated argon plasma), in a wide range of electrical powers
25–200 W)  for various lengths of time (0–300 s). In all cases, gas
adiofrequency plasmas were effective for improving COC surface
ettability. However, some limitations were noted. For instance,
lasma irradiation increased the surface roughness of the material,
he plasma-treated sample had to be stored in air-tight condi-
ions for its wettability to be maintained, and treatment length
ad to be controlled carefully to avoid “over-treatment” result-
ng in wettability losses [1,16,17]. So far, plasma activation of COC
as been limited to surface characterization to improve the bond-
ng process between COC and other materials [1,16,18]. Except an
xperiment assessing platelet adhesion onto a COC surface, plasma
rradiation has not been tested for biomolecule analysis [17]. UV
llumination has been tested successfully to activate COC surfaces in
rder to graft DNA or acrylic monomers onto them [19,20]. Another
pproach tested the reaction of a COC surface with UV-sensitive
olecules such as an anthraquinone photolinker [21], benzophe-
one [22], benzoin methyl ether [23], and aryl azide [24]. Apart
rom these approaches, UV illumination was tested to photograft
olymers onto a COC surface. That way, microﬂuidic channels hol-
owed in COC were patterned by N-vinylpyrrolidone, acrylic and
ethacrylate ﬁlms [24–28]. As a large amount of methacrylate
onomers is available, COC surfaces progressively gained new
unctionalities including low protein adsorption, adjustable elec-
roosmotic ﬂow or immobilization of reactive groups ready to use
ith biomolecules. Some polymeric monoliths were photo-grafted
n COC microﬂuidic channels to develop original analytical tools
23,29]. Different ways (phenanthroline, amine, reactive silane or
lkyne azide chemistry) are suitable for grafting process [30–32].
ryldiazonium salts have been successfully grafted on many mate-
ials such as carbon, metal, semi-conductor and polymers [33,34].
he grafted aryl layers have proved efﬁcient in sensing devices
edicated to metal ion [30,35], protein [36–38] and DNA detec-
ion [37]. Aryldiazonium salts are easy to prepare, and a wide
ange of reactive functional groups can be synthetized from ani-
ine derivates or nitro precursors. Surface modiﬁcation by reaction
ith aryldiazonium salt requires generating an aryl radical that
onds to the surface. This aryl radical is spontaneously obtained by
lectrochemical reduction or by chemical reduction (iron powder,
ypophosphorous acid, sodium iodide, and ascorbic acid) but also
y UV assistance, under ultrasonic frequency, thermolysis, solvoly-
is or microwave treatment [33,34,38]. Aryldiazonium salt is added
s an isolated salt or generated directly in situ during the grafting
rocess. Depending on the experiment, aryldiazonium is dissolved
n an aprotic medium with a supporting electrolyte or in an aque-
us medium [34]. Although some polymer surfaces are difﬁcult to
odify, Teﬂon® is modiﬁed with aryldiazonium salt to obtain a
olyacrylic acid ﬁlm on its surface. In this case, iron powder is added
s a chemical reducer to generate the aryl radical [39]. This wet
hemical treatment called Graftfast process is employed to modify
P23ience 329 (2015) 337–346
polyvinylidene  ﬂuoride membranes, poly(ethylene terephthalate),
acrylonitrile–butadiene–styrene polymers and polyvinylchloride
(PVC) polymers [39–42]. Chehimi et al. also observed that the
aryl radical generated from aryldiazonium salt could be covalently
grafted onto a polymeric surface such as poly(methyl)methacrylate
[43].
The  present work focuses on grafting different aryl ﬁlms on COC
surfaces. We  tested different reducing agents prepared in aqueous
media to obtain a covalent diazonium bonding on COC surfaces. We
also assessed COC surface modiﬁcations by means of water angle
contact, IR and Raman spectroscopy and X-ray photoelectron spec-
troscopy (XPS). We  thus demonstrated that the properties of COC
surfaces can be modulated using aryldiazonium chemistry.
2.  Materials and methods
2.1.  Materials and reagents
Cyclic  oleﬁn copolymer plates (MCS-TOPAS-03 and MCS-COP-
04 Zeonor) were purchased from Microﬂuidic Chip Shop, Jena,
Germany, in 1-mm thick microscopy slide format that we cut
into 1 cm × 2 cm plates. The plates were rinsed with acetone in
an ultrasonic bath for 20 min  and dried before use. Hypophospho-
rous acid, sodium nitrite and all the chemicals were obtained from
Sigma–Aldrich, Saint Quentin Fallavier (France).
2.2. Synthesis of diazonium salts
4-Nitrobenzenediazonium tetraﬂuoroborate and 4-
bromobenzenediazonium tetraﬂuoroborate were used in their
original form. R-ArN2+BF4− (R = –CH2COOH, –CH2CH2Br, -OH, -SH)
were synthesized from the corresponding anilines by diazotization
as described by Khosroo and Rostami [44]. Brieﬂy, the corre-
sponding para-aniline was dissolved in HBF4. The mixture was
cooled to 0 ◦C in an ice water bath. Then sodium nitrite aqueous
solution was  slowly added. After 20 min, the mixture was cooled
to −20 ◦C to precipitate aryldiazonium salts. Then, the slurry was
ﬁltered by suction, washed with cold tetraﬂuoroboric acid and
cold diethylether. Aryldiazonium tetraﬂuoroborate salts were kept
at −20 ◦C. Their 1H and 13C NMR  spectra (300 MHz, Bruker) are
presented in Figs. A and B. In agreement with the literature, the
intense band at 2290 cm−1 corresponding to the –N N stretch
of the diazonium group was  observed by IR spectroscopy [37].
For comparison purposes, aryldiazonium salts were also prepared
in situ from the corresponding aniline prepared in aqueous HCl
0.5 M by reaction with 3 molar equivalents of sodium nitrite.
Then, the COC plate was  immersed and 9 molar equivalents of
chemical reducer were added. The chemical reactor was incubated
in a UV curing system equipped with a UV metal halide lamp
(225 mW cm−2, Dymax, Wiesbaden) for 1 h. After grafting, COC
plates were sonicated with acetone for 10 min.
2.3. Characterization
2.3.1. Infrared spectroscopy (ATR-FTIR)
ATR-FTIR spectra were recorded with a Tensor 27 (Bruker) spec-
trometer with a ZnSe ATR crystal. For each spectrum, 20 scans were
accumulated with a resolution of 4 cm−1. Background spectra were
recorded on air before each analysis.
2.3.2. Fluorescence microscopy
An inverted microscope (Axio Observer A1, Zeiss) equipped
with a high pressure mercury lamp and a femtowatt photo-
toreceiver (model 2151, New Focus) were used for ﬂuorescence
measurements.
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.3.3. UV–visible absorption
The  optical transparency of diazonium treated COC surface was
valuated by UV–visible spectrophotometry (Shimadzu UV1650).
he substrate of COC was mounted directly on the measurement
etup perpendicularly to the optical pathway. Absorption spectra
ere monitored from 800 nm to 200 nm.
.3.4. Raman ﬂuorescence spectroscopy
All the Raman spectra were obtained with a Horiba Jobin Yvon
AbRam HR system. A 632.8 nm HeNe laser and a confocal optical
icroscope were used for analysis. All the spectra were acquired
ith 50× magniﬁcation and recorded for 1 min  with a spatial res-
lution of 2 cm−1.
.3.5. X-ray photoelectron spectroscopy (XPS)
X-ray photoelectron spectra were recorded on a Vacuum Gener-
tor ESCALAB 210 spectrometer using a non-monochromatic Al K
-ray source (150 W).  Pass energy was set at 160 eV for the survey
nd 40 eV for the core level of N1s, C1s, O1s and Br3p. The spectra
ere calibrated against C1s set at 285 eV.
.3.6.  Contact angle analysis
COC surface wettability was determined by measuring the con-
act angles of deionized (DI) water using an automatic goniometer
G40, Krüss, Germany). After a 5-s equilibration, two 5 L water
roplets were observed. The triplicate experiments were run at
oom temperature at 2 positions on the substrate.
.3.7. Atomic force microscopy (AFM)
The surface 2D and 3D topography were imaged by using a
ICOSPM (Molecular Imaging) in contact mode. AFM measure-
ents were performed with silicon nitride cantilevers having a
pring constant of 0.3 N/m at a ﬁxed scan rate of 1 line/s with a res-
lution of 512 pixel × 512 pixel. AFM images were analyzed with
he SPIP Software (Scanning Probe Image Processor) to determine
he arithmetical mean roughness (Ra) at a scale of 20 m × 20 m
reas. Samples were inspected by AFM before and after chemical
odiﬁcation.
. Results and discussion
.1.  Description of surface functionalization strategy
Chehimi et al. [43] recently demonstrated that polymeric mate-
ials such as polymethylmethacrylate (PMMA) can be modiﬁed by
hemical reduction of diazonium salt in the presence of a chemical
educer in acidic solution. So far this strategy has not been described
n the literature to modify COC surfaces. So we tested a similar
pproach to modify TOPAS cyclic oleﬁn copolymer (COC). Commer-
ial 4-nitrobenzenediazonium (NBD) was mixed with a reducing
gent in HCl for 1 h. During the reaction, the color of the solu-
ion changed, indicating sub-product (Ar–N N–Ar) formation, and
 few gas bubbles were generated, corresponding to nitrogen elimi-
ation. At the end of the reaction, a nitrobenzene ﬁlm was  observed
n the COC surface. The ATR-FTIR spectra of our COC surfaces are
resented in Fig. 1.
The  IR spectrum of pristine COC displayed alkyl vibration at
000 cm−1 (Fig. 1, blue curve). When the COC surface was  incu-
ated with 4-nitrobenzenediazonium salt and a reducing agent, the
haracteristic ring vibration at 1599 cm−1, and the NO2 vibrations
t 1522 and 1347 cm−1 appeared (Fig. 1, pink curve). To test the
trength of the molecular bonding between the ﬁrst layer of the ﬁlm
nd the COC surface, we cleaned COC samples with an organic sol-
ent in an ultrasonic bath for 10 min. As described in Fig. 1A (green
urve), the IR signatures at 1599, 1522 and 1347 cm−1 were com-
letely removed from the spectrum, demonstrating that, the ﬁlm
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was just physisorbed on the COC surface. Different approaches are
presented in the literature to activate COC surfaces before molec-
ular grafting [15,16]. Surface oxidation with ozone and UV light
generated polar groups on COC surfaces [15,45]. This approach was
investigated using a UV illuminator equipped with a metal halide
lamp. The main part of the spectrum of this lamp was  distributed
in the UVA wavelength region where COC presented good trans-
parency. The spectral distribution of the lamp is presented in Fig.
C. We  monitored the inﬂuence of UV illumination on COC wettabil-
ity using contact angle measurements (Fig. D). Pristine COC  was
hydrophobic, with a 94◦ contact angle of water droplets. When
COC was  illuminated by UVA light, hydrophobicity of the mate-
rial decreased with time. After 1 h of illumination, the contact
angle was 77◦, and it was down to 20◦ after 6 h of irradiation,
which corresponds to hydrophilic behavior. The rate of modiﬁ-
cation of the contact angle was  higher during the ﬁrst hour, so
we kept this reaction time to illuminate the COC surface before
diazonium reaction. After illumination, the surface was incubated
with aryldiazonium salt and hypophosphorous acid (H3PO2) for
1 h. A nitrophenyl ﬁlm was observed, with nitrophenyl IR signature
on the COC surface (data not shown). Nevertheless, as previously,
the ﬁlm was completely removed after 10 min  of ultrasonic treat-
ment.
Aryl radical may be formed by illumination of diazonium salt
[46–48]. So, the grafting process of nitrobenzene diazonium salt has
been tested on COC without any chemical reducer. Unfortunately,
no modiﬁcation of COC surface was  observed by ATR-FTIR analysis
(data not shown). So, light illumination was not sufﬁcient to graft
diazonium salt in our case.
Finally,  we  assessed another approach where the aryldiazonium
salt, the COC sheet, the reducing agent and HCl are prepared in a
reactor and immediately incubated under UVA light for 1 h. Thus
we obtained a thick layer on the COC surface. IR signatures of nitro
stretching and ring vibration before and after ultrasonic cleaning
are presented in Fig. 1B (pink and green curves, respectively). Inter-
estingly, we  observed no band in the 2200–2300 cm−1 region for
the stretching of the characteristic N2+ bond. COC material is chem-
ically resistant to classical solvents (DMSO, acetonitrile, acetone,
and ethanol), so we  have evaluated the chemical resistance of the
grafted layer using organic, basic and acidic solvents. After 5 min
of rinsing with various solvent, the aryl layers are not modiﬁed.
By this method, we validated that COC was covalently modiﬁed by
diazonium salt reduction.
To  investigate the optimal conditions for surface grafting,
we tested 4-nitrobenzenediazonium surface grafting under var-
ious conditions such as different diazonium salt concentrations,
reducing agent concentrations, diazonium salt/reducing agent
ratios, chemical reducers, reaction times and temperatures. We
ﬁrst assessed the inﬂuence of the reaction time by ATR-FTIR.
Fig. 2 focuses on the spectra obtained from 15 min to 180 min
reaction times in the presence of a reducing agent and 4-
nitrobenzenediazonium salt.
Illuminating the COC surfaces without any diazonium salt for
15 min  to 3 h induced no modiﬁcation (data not shown). After
15 min  of reaction, we observed ring vibration at 1600 cm−1 and
NO2 vibrations at 1525 cm−1 and 1350 cm−1. The intensity of these
peaks increased with grafting time. These results imply that nitro-
phenyl ﬁlms were correctly formed on COC  with a multilayer
pattern. The 1350 cm−1 peak reached a highest intensity after 1 h
(Fig. 2, green curve). Conversely, the ring vibration is highest after
180 min  (Fig. 2, purple curve). It could be inferred that after 3 h, the
NO2 group is hidden in the multilayer. Ultrasonic waves could also
generate cracks on the surface [49] that disorganize and destroy the
upper layer of nitrophenyl ﬁlm. We  conﬁrmed this conclusion by
measuring the intensity of the 1600 cm−1 band, which was higher
before ultrasonic treatment (Fig. 1B).
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tig. 1. IR spectra of COC surface (A) in absence or in presence (B) of UVA irradiatio
alt  for 60 min  (pink curve), and COC grafted with NBD then cleaned with ultraso
egend, the reader is referred to the web version of the article.)
Secondly, we  tested different proportions of reducing agent and
ryldiazonium salt with a reaction time of 1 h (Fig. 3). Hypophos-
horous acid, ascorbic acid, iron ﬁlings, and sodium iodide are well
nown chemical reducers of diazonium salt [33]. We  tested all
our reducers to graft NBD salt on COC surfaces. The results are
hown in Fig. 3A, H3PO2 was the only suitable reducer for grafting
BD on a COC surface in our conditions. A concentration of 0.1 M
ig. 2. Inﬂuence of reaction time on nitrophenyl ﬁlm formation on COC surface. Focus be
rafted with NBD for (purple curve) 15 min, (red curve) 30 min, (green curve) 60 min, an
he  reader is referred to the web  version of this article.)
P23lysis of pristine COC (blue curve) of COC grafted by nitrobenzenediazonium (NBD)
atment (green curve). (For interpretation of the references to color in this ﬁgure
aryldiazonium  salt with 10 molar equivalents of reducing agent
seemed to be necessary and sufﬁcient for polyphenyl ﬁlm forma-
tion (Fig. 3B). Thus, peak intensities at 1600 and 1521 cm−1 were
similar with 10 or 50 molar equivalents of reducing agent. These
results are in accordance with Chehimi et al. [43], who showed
that an excess of reducing agent was required for aryldiazonium
grafting.
tween 1650 and 1200 cm−1 of the IR spectra of (black curve) pristine COC, and COC
d (yellow curve) 180 min. (For interpretation of the references to color in the text,
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rig. 3. Focus between 1200 and 1600 cm−1 of the IR spectra of COC surface incu-
ated  with NBD for 1 h in presence of (A) various chemical reducers, and (B) various
mount of molar equivalent of reducing agent.
Thirdly, we assessed the inﬂuence of the reaction temperature,
s aryl radicals are temperature sensitive. During light illumination,
he temperature in the illuminator increased from room tempera-
ure to 60 ◦C in 15 min  (Fig. E). To control the temperature during
iazonium reaction, the reactor was insulated with ice or liquid
ater (at 20 ◦C). The temperature of the solution increased slowly
nd the highest temperature measured in the chemical reactor was
ig. 4. IR spectra of COC surface grafted by NBD without any temperature control (blue cur
eaction initiated at 20 ◦C (red curve). (For interpretation of the references to color in this
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no more than 47 ◦C after 1 h. The IR spectra obtained in the presence
of a thermal insulator are presented in Fig. 4.
The characteristic band of the nitrophenyl ﬁlm was  higher when
the temperature remained under control. These results conﬁrm the
observations of Abiman et al. [50], who tested diazonium reac-
tion on carbon nanotubes. The topography of the ﬁlm was different
when the reaction started in melting ice or in liquid water at 20 ◦C.
At 0 ◦C, ﬁlm deposition was  more heterogeneous than at room
temperature. It is also important to note that the glass transition
temperature (Tg) of COC is 70 ◦C. Thus, by controlling the reaction
temperature, one can avoid it getting too close to the Tg and thus
limiting possible deep modiﬁcations of the COC polymer. To sum
up, we  obtained the best conditions for diazonium grafting on COC
when 0.1 M aryldiazonium was mixed with 10 molar equivalents
of H3PO2 in a temperature-controlled acidic medium under UV
illumination for 1 h.
In literature, COCs are presented under various names (Topas,
Zeonor) corresponding to various suppliers and chemical composi-
tions. To assess the performance of our technique, we  also grafted
a Zeonor device with NBD in our best conditions. As presented in
Fig. 5, we grafted a nitrophenyl layer ﬁlm on a Topas as well as on a
Zeonor device. Interestingly, IR signals were more intensive on the
Zeonor than on the Topas surface, meaning that the layers were
thicker on the Zeonor sample.
There  are currently just a few commercially available diazonium
salts, but aryldiazonium salts could be isolated or synthesized
in situ from aniline derivates. That way, various organic func-
tions could be grafted onto the COC surface. To demonstrate the
polyvalence of the diazonium reaction, we  synthesized different
aryldiazonium salts and grafted them onto COC  surfaces. The IR
spectra of COCs grafted with 4-(carboxymethyl)benzenediazonium
(CBD), 4-bromobenzenediazonium (BBD), or 4-(2-
bromoethyl)benzenediazonium (BEBD) are presented in Fig.
F. We observed the poly-aryl-like layer through a Br absorption
band at 735 cm−1, ring vibration at 1600 cm−1 (Fig. F.3) and a
carbonyl (C O) stretching band at 1715 cm−1 (Fig. F.2). In the
previous experiment, aryldiazonium salts had been isolated before
grafting. Berthelot et al. [37], also assessed another, faster and
easier method using in situ chemical reduction. We compared the
phenyl ﬁlm obtained from isolated and in situ reduced CBD (Fig.
G). Ring vibration at 1600 cm−1 and a carbonyl band at 1715 cm−1
were present in the IR spectra, demonstrating the covalent bonding
ve), with temperature reaction initiated at 0 ◦C (green curve), and with temperature
 ﬁgure legend, the reader is referred to the web version of the article.)
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f the carboxymethylphenyl layer. Interestingly, both methods (in
itu and from isolated diazonium salts) produced IR spectra with
imilar intensities for carbonyl and phenyl vibrations.
.2. Surface chemical composition
To  conﬁrm the attachment of the diazonium ﬁlm, we grafted
OC surfaces with NBD and BEBD, and then examined them by
PS. We  ﬁrst characterized pristine COC. The XPS spectrum dis-
layed 3 peaks at 536.2 eV, 285 eV and 286.4 eV, assignable to O1s,
1s and C2s, respectively. The 285 eV peak was characteristic of sat-
rated hydrocarbon. The 286.4 eV peak was assignable to a carbon
tom singly bonded to an oxygen atom (i.e. C-OH or C–O–C) [16].
he oxygen detected at 536.2 eV probably resulted from oxygen
dsorbed onto the surface or from the oxidization step during the
anufacturing process of Topas COC polymer [15].
The  XPS spectra recorded from the NBD-treated COC surfaces
isplayed 4 peaks at 533 eV, 406 eV, 400 eV and 285 eV. As pre-
iously, the 533 eV peak corresponded to O1s attributed to the
arbonyl group. The peaks at 400 and 406 eV corresponded to N1s
Fig. 6). Mévellec et al. [39] also observed an XPS proﬁle with two
eparated peaks for N1s with NBD grafted onto a gold surface. The
06 eV peak corresponded to the nitro group while the 400 eV
ig. 6. N1s and Br3p XPS survey spectra of COC surface after chemical functionaliza-
ion  with NBD and BEBD respectively.
P23 both chemically modiﬁed by NBD for 60 min. (For interpretation of the references
peak was attributable to a mixture of amino groups (NH2) and azo
bridges (N N) [39,51,52].
The  Br3p XPS spectra of a BEBD-coated COC displayed two  large
peaks at 184 eV and one small peak at 190 eV assigned to alkyl
bromide [53,54]. As previously, a 285 eV peak corresponded to C1s
(aliphatic carbon) and 528–533 eV peaks corresponded to lattice
oxygen and carbonyl groups, respectively (Fig. 6). So, the XPS results
suggested that the COC surface was  chemically modiﬁed after dia-
zonium grafting.
3.3. Contact angle analysis of COC surface
The chemical composition of the COC surface changed according
to the diazonium layer grafted on it, with resulting modiﬁcations
of the surface properties such as wettability or light absorption. To
assess the wettability of the treated material, we measured con-
tact angles on untreated COC surfaces, light-activated surfaces and
diazonium-grafted surfaces. The effects of diazonium grafting on
COC surface wettability are summarized in Fig. 7.
The  surface of pristine COC was expectedly hydrophobic, with a
contact angle of 93.9◦ in DI water. NBD and BEBD grafting altered
COC surface wettability, with a higher contact angle (106◦ and 85◦,
respectively) than the light-treated COC surface (77◦). Conversely,
CBD or MBD  grafting modiﬁed COC wettability by decreasing water
contact angle values (56–60◦) unlike BBD grafting did not further
modify wettability (73◦) as shown in Fig. 7.
Fig. 7. Effect of various diazonium ﬁlm layer on wettability of COC surface. Wett-
ability was analyzed by water droplet contact angle measurements.
F. Brisset et al. / Applied Surface Science 329 (2015) 337–346 343
 CBD 
3
s
p
a
i
o
t
w
3
v
u
v
2
o
r
v
ﬁ
t
a
A
c
rFig. 8. 3D AFM images of COC native surface (A), NBD grafted COC (B) and
.4. Surface topographies
To  better understand surface wettability, we  investigated
urface topographies at the nanoscale. We  imaged the surface mor-
hologies of different grafted COCs by AFM (Fig. 8). Native COC had
 smoother surface than grafted surfaces, and grafted layers exhib-
ted a needle-like structure. COC slides displayed a few scratches
riginating from sample handling.
Using peak-to-valley analysis of the scratches, we  estimated
he thickness of the aryl layer. Pristine COC was  103 nm thick
hile NBD-, CBD- and BBD-treated COC surfaces were 350 nm,
49 nm,  630 nm thick, respectively. These results conﬁrmed the
isual aspect of the COC samples. The mean roughness value of the
ntreated COC surface was about 7.7 nm while mean roughness
alues of the NBD- and CBD- and BBD-treated samples reached 21,
2 and 25.5 nm,  respectively, for 1 h reaction time. So, the nature
f the aryldiazonium salt had no inﬂuence on roughness. Surface
oughness increased from 7.7 nm (ground value) to 28 nm (ﬁnal
alue) when aryl grafting time was brought to 120 min, yet, the
nal value was almost reached after 60 min. 30 min  of reduction
ime is enough to graft COC surface. The aryl layer is more uniform
nd less thick after 30 min  of reduction than after 60 min  (Fig. 8D).
fter a reaction time of 30 min, the mean rugosity was 12 nm in
omparison to 28 nm after 1 h. These results match well with the
esults obtained by IR spectroscopy.
P23grafted COC (C), NBD grafted COC after 30 min of chemical reduction (D).
3.5.  Optical properties of COC surface treated by diazonium salts
Due  to its optical properties (good transparency, low auto-
ﬂuorescence, and low absorption), COC is used to develop
polymeric biodevices [15]. However, several authors point out that
UV treatment modiﬁes the optical properties of COC. That is why
we assessed grafted COC by UV–visible spectrophotometry, epi-
ﬂuorescence microscopy and Raman spectroscopy. The UV–visible
absorption spectra of pristine and grafted COCs are presented in
Fig. H. The nitrophenyl ﬁlm grafted on a COC surface generated
a stronger absorption signal than pristine COC. This increase was
directly related to ﬁlm thickness. Thus, after a 1-h reaction time,
surface absorbance at 400 nm was  0.05 A.U. for pristine COC vs.
0.32 A.U. for nitrobenzene grafted COC (Fig. H). For grafting opti-
mization, it was  interesting to work with nitrobenzene grafted
COC, but for biosensor development it is important to work with
transparent and low absorbance material. The absorbance of the
carboxymethylbenzene grafted layer on COC is only 0.09 A.U. at
400 nm which is comparable to pristine COC (Fig. J).
Using UV light to activate COC surfaces can also generate auto-
ﬂuorescence of the material [45]. So we  carried out ﬂuorescence
measurements to check if grafted diazonium COC was compatible
with ﬂuorescence detection. We  made our ﬂuorescence measure-
ments using an inverted microscope equipped with a mercury
lamp and a photodetector. We  monitored ﬂuorescence at 565 nm
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Tig. 9. Fluorescence intensity analysis of COC before and after chemical function-
lization  by various diazonium salts. Fluorescence measurement on oxidized COC
as presented as a control.
hroughout the COC polymer layer. The results are presented in
ig. 9.
Fluorescence increased with illumination time, conﬁrming
hat UV light induced COC auto-ﬂuorescence. However, in our
ase, the resulting auto-ﬂuorescence was only 0.13 A.U. after 1 h
f UV illumination as compared to 0.10 A.U. for pristine COC
Fig. 9). With BEBD-grafted COC surfaces, the ﬂuorescence signal
ncreased to 0.87 A.U. BEBD diazonium salt was not ﬂuorescent
y itself. Therefore there was a complementary effect between
OC auto-ﬂuorescence and the polyphenylene ﬁlm. To improve the
nderstanding of this phenomenon, we grafted different aryldiazo-
ium salts onto COC surfaces for 1 h and monitored the resulting
uorescence signals (Fig. 9). MBD  and BBD generated an intense ﬂu-
rescence signal ranging between 2.0 and 4 A.U. Conversely, NBD
nd CBD generated a weak ﬂuorescence signal ranging between
.22 and 0.46 A.U. after 1 h of reaction time. For biosensing appli-
ation, it is crucial that COC modiﬁed with carboxymethylphenyl
ayers keep low autoﬂuorescence. Then, carboxylated terminated
ayer will be coupled with amine derivates using EDC/NHS immo-
ilization procedure.
To  establish a relationship between ﬂuorescence measurements
nd chemical surface properties, we analyzed COC surfaces by
aman spectroscopy. We  tested pristine COC and light irradiated-
OC as controls (Fig. I). We  observed a few bands corresponding
o C–H vibration (2800–3000 cm−1), aliphatic C–C vibration
2800–3000 cm−1) and alicyclic C–C vibration (1300–600 cm−1) on
oth surfaces. No modiﬁcation of the Raman spectra was induced by
ight oxidization. After diazonium grafting onto the COC surface, the
aman ﬂuorescent background shifted from 200 A.U. to 6000 A.U.
Fig. I). Except for this background modiﬁcation, we observed a few
haracteristic bands at 1592 cm−1 corresponding to aromatic C C
ibration [55] and an additional single peak at 650 cm−1 possibly
ndicating vibration of the carbon–bromide bond [56].
Taking  in account all our observations, we demonstrate that
t is possible to covalently modify COC surfaces with diazonium
alt. Different mechanisms have been suggested to describe the
nteraction between diazonium and COC surfaces [38]. In our case,
he diazonium ﬁlm was strongly bonded on the COC surface and
e observed no IR band corresponding to the diazonium function,
hether by IR or XPS analysis. Therefore we can infer that the dia-
onium ﬁlm was not adsorbed onto the surface. Using radical traps,
hehimi et al. [43] demonstrated that diazonium reaction with
olymers required radical formation. Diazonium reaction with COC
as temperature-sensitive, probably due to the thermal sensitiv-
ty of the aryl radical. Unlike PMMA  or PVC [43,46], the reactivity of
he aryl radical was not sufﬁcient for grafting onto a COC surface.
esides, there was no diazonium grafting on COC when its sur-
ace was oxidized by light irradiation before the grafting process.
hus, light illumination was required for grafting but not sufﬁcient.
emperature was an important parameter to be controlled, but
P23ience 329 (2015) 337–346
not enough to obtain diazonium grafting because no grafting was
obtained without light irradiation. Light illumination, controlled
temperature and H3PO2 had to be combined to obtain satisfactory
diazonium grafting.
In  our opinion, the growth of the diazonium layer was  indepen-
dent of the surface properties as in the mechanism developed by
Chehimi et al. on PMMA  [43]. First, the aryl radical was  formed,
attacked the COC surface to create a bond between the aromatic
ring and COC and obtain the ﬁrst layer of the ﬁlm. Then, diazo-
nium multilayers were assembled. The growth of the diazonium
layer was not homogenous, depending on where the ﬁrst bond was
created on the surface. Thus, we  locally observed a few graft-free
holes on the surface. It is not quite clear how the radical bonded
the surface. Stachowiack et al. suggested that aryl radicals from
benzophenone could bond the COC surface by hydrogen ablation
when irradiated by UV wavelength [22]. Another mechanism of
COC bonding could be to directly link C–H bonds on the COC sur-
face as described for diazonium attacking carbon-based material
[52]. Due to the high number of ethyl groups in COC and light
requirement, COC probably needs both mechanisms to bond the
ﬁrst diazonium layer.
4.  Conclusion
In this paper, we  investigate the surface modiﬁcation of cyclic
oleﬁn copolymer by aryldiazonium. Taking advantage of the reac-
tivity of the diazonium radical, we performed a covalent grafting
on COC in acidic solution in the presence of a chemical reducer.
We tested the inﬂuence of temperature, reagent concentration and
light irradiation time to provide optimal conditions for the cova-
lent functionalization of the COC surface. We established the best
reaction conditions as follows: One hour under UV irradiation with
hypophosphorous acid and diazonium solution. Thus a thick layer
of diazonium was  grafted onto the surface. To show the versatil-
ity of the process, we  immobilized diazoniums bearing different
organic functions on the COC surface. We  assessed each modiﬁed
surface by IR and XPS spectroscopy, contact angle measurements,
ﬂuorescence microscopy and AFM. The aryldiazonium grafting was
strong enough to withstand ultrasonic treatment, meaning that
the aryldiazoniums were covalently grafted onto the COC surface.
According to the diazonium we used, we modiﬁed wettability, ﬂu-
orescence emission, roughness and the chemical reactivity of the
COC material which is normally inert.
Compared to other treatments, the modiﬁcation of the surface
properties was stable for a few weeks. We observed a correla-
tion between ﬂuorescence intensity of the modiﬁed surface and
diazonium layer thickness. This point is still under investigation.
To our knowledge, this is the ﬁrst time aryldiazonium has been
used to functionalize a COC surface. Using aryldiazonium salt
can bring beneﬁts such as versatile chemical groups for post-
functionalization, low cost and a fast process. This work give the
opportunity to develop biosensor using carboxylated terminated
COC surfaces to attach covalently peptide, protein or NH2 termi-
nated DNA. Our results are encouraging and should open onto new
ﬁelds of applications for COC surfaces. For instance, aryldiazonium
could be used to immobilize biomolecules randomly or with an
orientated shape to develop analytical biochips.
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A B S T R A C T
The genus Pseudomonas is one of the most heterogeneous groups of eubacteria, presents in all major
natural environments and in wide range of associations with plants and animals. The wide distribution of
these bacteria is due to the use of speciﬁc mechanisms to adapt to environmental modiﬁcations.
Generally, bacterial adaptation is only considered under the aspect of genes and protein expression, but
lipids also play a pivotal role in bacterial functioning and homeostasis. This review resumes the
mechanisms and regulations of pseudomonal glycerophospholipid synthesis, and the roles of
glycerophospholipids in bacterial metabolism and homeostasis. Recently discovered speciﬁc pathways
of P. aeruginosa lipid synthesis indicate the lineage dependent mechanisms of fatty acids homeostasis.
Pseudomonas glycerophospholipids ensure structure functions and play important roles in bacterial
adaptation to environmental modiﬁcations. The lipidome of Pseudomonas contains a typical eukaryotic
glycerophospholipid – phosphatidylcholine –, which is involved in bacteria–host interactions. The ability
of Pseudomonas to exploit eukaryotic lipids shows speciﬁc and original strategies developed by these
microorganisms to succeed in their infectious process. All compiled data provide the demonstration of
the importance of studying the Pseudomonas lipidome to inhibit the infectious potential of these highly
versatile germs.
ã 2015 Elsevier Ireland Ltd. All rights reserved.
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The genus Pseudomonas is one of the most heterogeneous
groups of eubacteria. These bacteria are found in all natural
environments (Ringen and Drake, 1952), like water (Mena and
Gerba, 2009), soil (Couillerot et al., 2009; Kiely et al., 2006) and air
(Duclairoir Poc et al., 2014; Morris et al., 2007) and also in
association with plants and animals. Some Pseudomonas species
are of medical importance and count among the principal human
opportunistic pathogens (Driscoll et al., 2007). The concept of
Pseudomonas diversity originates from the biochemical studies of
Stanier et al. 1966, who performed a comparative study on the
growth characteristics of 267 strains on 146 different organic
compounds and a wide range of physiological tests. Since their
initial designation at the end of the nineteenth century and their
taxonomic redeﬁnition by Palleroni, many species have been
classiﬁed in other genus (Palleroni, 2010) and, nowadays, the genus
Pseudomonas is divided in two major lineages represented by
typical species, namely Pseudomonas aeruginosa and Pseudomonas
ﬂuorescens (Mulet et al., 2010; Palleroni, 2010). The P. aeruginosa
lineage is the most homogeneous and consists predominantly of
the P. aeruginosa species. The P. ﬂuorescens lineage is much more
diverse and is by itself separated in 3 major groups: P. ﬂuorescens,
Pseudomonas putida and Pseudomonas syringae (Mulet et al., 2010).
The members of P. aeruginosa lineage are generally found in
riparian soil associated with decaying plants (Jones et al., 2013;
Ringen and Drake, 1952; Vasil and Ochsner, 1999). However, P.
aeruginosa group includes important opportunistic pathogens,
particularly involved in nosocomial infections in immunocompro-
mised hosts and in cystic ﬁbrosis (Driscoll et al., 2007). P.
aeruginosa infections are always difﬁcult to treat due to the
natural resistance of this bacterium (Obritsch et al., 2005).
Consequently, a therapy with two or three antimicrobial agents
is typically used (Lodise et al., 2007; Szaff et al., 1983; Valerius
et al., 1991). Thus, the utilization of antibiotics uncommonly used
in clinical practice, such as polymyxins like colistin, is recom-
mended (Gunderson et al., 2003; Sabuda et al., 2008). Bacteria of
the P. ﬂuorescens lineage are found preferentially in soil and in
association with plants (Bodilis et al., 2006; Loper et al., 2012).
Members of the P. putida group show an adaptation to various
ecological niches and are characterized by their adaptation to grow
in soils and sediments contaminated with high concentrations of
heavy metals and organic contaminants (Hachicho et al., 2014;
Heipieper et al.,1996; Ramos et al.,1997; Wu et al., 2011). Members
of the P. syringae group are plant pathogens. P. syringae is well
known for its capacity to grow epiphytically on diverse plants and
for its ice-nucleation activity (Joardar et al., 2005; Kozloff et al.,
1984; McCann et al., 2013). Recently, strains of P. syringae, virulent
on diverse species of crop plants, were isolated from epilithic
bioﬁlms of rivers (Morris et al., 2007) and clouds at several
kilometers altitude (Amato et al., 2007) outside the zones of
agricultural production (Morris et al., 2008). Bacteria of the P.
ﬂuorescens group commonly found in soil (Bodilis et al., 2006) and
water (Janek et al., 2010) are also able to develop in air (Duclairoir
Poc et al., 2014; Kondakova et al., 2014). Some of P. ﬂuorescensP2group members, adapted to the human temperature are members
of the skin microbiota or behave as opportunistic pathogens
(Chapalain et al., 2008).
The wide distribution of Pseudomonas suggests a remarkable
degree of physiological and genetic adaptability. Physiologically,
bacterial adaptability to ecological niches and environmental
modiﬁcations depends essentially on the structure and organiza-
tion of their envelope. Most protective membrane functions, as
osmotic or heat shock response, are traditionally attributed to
proteins that are immersed in the lipid bilayer (Allan et al., 1988;
Gotoh et al., 1989), but the lipids are not only a matrix to
accommodate proteins but play a major role in bacterial
functioning (Boughton and Pollock, 1953; Lindgren et al., 1977).
As in the case of proteins, bacteria have the capacity to adjust their
membrane lipid composition in response to environmental
modiﬁcations (Cullen et al., 1971; Fang et al., 2000; Parsons and
Rock, 2013; Pepi et al., 2008; Ramos et al., 1997). This is especially
true in Gram-negative bacteria, like Pseudomonas, because of their
double envelope with outer and inner membranes. Although a
considerable diversity of lipid structures exists in the bacterial
world, most predominant lipids in Pseudomonas membranes are
glycerophospholipids (GPs). GPs are deﬁned as acylated derivatives
of sn-glycerol-3-phosphate composed of two fatty acid chains, a
glycerol unit and a phosphate group linked to a polar head group
(Zhang and Rock, 2008). The variety of chemical structures and
functions of GPs is due to the polar head group (HG) and fatty acid
(FA) composition. GP polar HGs determine the membrane
properties and associated functions, such as the barrier function
to prevent the entry of noxious compounds and the passive and
active inﬂux of nutrient molecules (Sutterlin et al., 2014; Heath
et al., 2002a,b). They inﬂuence membrane-related processes such
as protein export and DNA replication (Nikaido, 2003). Adjust-
ments in FA composition are related to the formation of trans-
unsaturated or cyclopropylated FAs. Formation of unsaturated or
cyclopropylated FAs by Pseudomonas occurs in response to osmotic
stress, solvent exposition and temperature adaptation, and are
interpreted as a mechanism that modiﬁes the permeability of the
GP bilayer to minimize energy expenditure and optimize growth
(Heipieper et al., 1996; Pepi et al., 2008). The recent identiﬁcation
of lipid signaling molecules and the involvement of GPs in bacteria/
eukaryotes interactions (Sato and Frank, 2014; Vromman and
Subtil, 2014) demonstrate the key role of lipids apart from cell wall.
GP synthesis, composition and functions in bacterial cells were
determined early in bacterial lipid metabolism and homeostasis
studies realized particularly on the Escherichia coli lipidome
(Guchhait et al., 1974; Heath and Rock, 1995; Larson et al., 1984;
Parsons and Rock, 2013; Wang and Cronan, 2004). However, the
high ability of Pseudomonas to adapt to various ecological
conditions could suppose the involvement of other speciﬁc
mechanisms of GP homeostasis. This review is aimed at organizing
the wealth of information on GP metabolism and homeostasis in
Pseudomonas. These data provide important insights into the
mechanism and the regulation of bacterial GP synthesis, role of GPs
in bacterial metabolism and homeostasis as well as in host–
bacteria interactions.4
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2.1. Fatty acid biosynthesis
Fatty acid synthesis (FAS) in Pseudomonas spp. is conducted by
the type II FA synthetic pathway. FAS II is found in bacteria, plants
and eukaryotic parasites. This mechanism is divided in individual
steps wherein each component is encoded by a separate gene that
produces a unique protein, catalyzing a single step in the pathway
(Heath et al., 2002a,b). Proteins in this pathway are located in the
cytosol, and each has been puriﬁed and biochemically character-
ized (White et al., 2005). In FAS II enzymes, the active sites are
usually not located on the protein surface but within a deep cavity.
These active sites are connected to the protein surface through
narrow tunnel. The enzymatic activity and substrate speciﬁcity are
dependent on the size and the shape of the tunnels and active site
chemistry (Biedermannova et al., 2012; White et al., 2005).Fig. 1. Proposed pathway of fatty acid synthesis in Pseudomonas spp.
(A) Initiation module: the acetyl-CoA carboxylase (ACC) generates malonyl-CoA via the
protein (ACP) by malonyl-CoA:ACP acyltransferase (FabD). The initiation of the new acyl
b-ketoacyl-ACP synthase III (FabY, PA 5174 for P. aeruginosa – green color – and potent
(B) Elongation module: the NADPH-dependent b-ketoacyl-ACP reductase (FabG) reduces
ACP dehydrases (FabA and FabZ). Then, enoyl-ACP reductases (FabI for all Pseudomonas 
initiated by b-ketoacyl-ACP synthase I and II (FabB and FabF).
(C) Incorporation of exogenous fatty acids: after diffusion across the outer membrane thro
CoA. Further metabolism depends on acyl-CoA ester chain length. Long chains C16/C18-Co
acylglycerol-phosphate acyltransferases PlsB/PlsC. Medium C10 to C14 acyl-CoA esters are
enzyme and condensed with malonyl-ACP to form the b-keto-decanoyl-ACP.
(D) Transfer to the membrane: C16/C18 fatty acids chains are transferred to the membrane
glycerol-3-phosphate to form lysophosphatidic acid (LPA). Alternatively, PlsX transfers t
which is acylated in sn-1-position by the integral plasma-membrane protein PlsY to form
(PA). OM: outer membrane; IM: inner membrane.
P242.1.1. Acyl carrier protein
The major player of FA biosynthesis in bacterial cells is the acyl
carrier protein (ACP). It is a small protein (about 9 kDa) containing
the prosthetic group 40-phosphopantetheine (White et al., 2005;
Zhang and Rock, 2008). The ACP is produced by acpP gene as the
apoprotein. ACP is one of the most abundant proteins in the cell
and is converted to its active form by ACP-synthase (AcpS). AcpS
transfers the 40-phosphopantetheine prosthetic group from CoA to
apo-ACP (White et al., 2005). The 40-phosphopantetheine pros-
thetic group of ACP injects the substrate into tunnels for catalysis.
ACP interacts speciﬁcally and transiently with all of the enzymes of
FAS. The negative residues of ACP (its prosthetic group sulfhydryl)
interact with a patch of positive surﬁcial residues of the FAS
enzymes (Heath et al., 2002a,b). The ACP of P. aeruginosa was
successively puriﬁed and characterized by Kutchma and coworkers
(Kutchma et al., 1999). In addition to GP synthesis, ACP plays an
essential role in synthesis of rhamnolipids, and in a broad range of
other biosynthetic reactions of acyl transfer (nonribosomal peptide
and depsipeptide biosynthesis). ACP is a precursor of oligosac-
charides and proteins transacylation (Kutchma et al., 1999; White carboxylation of acetyl-CoA. The malonyl group is transferred to the acyl carrier
 chain formation is performed by condensation of malonyl-ACP with acetyl-CoA by
ial FabH enzymes for Pseudomonas strains).
 obtained previously ketoester, and a water molecule is removed by b-hydroxyacyl-
spp. and FabV for P. aeruginosa) complete the cycle. The new cycle of elongation is
ugh FadL protein, FA is retained by FadD enzymes catalyzed esteriﬁcation of FA with
A esters can be incorporated directly into de novo GPs by the glycerol-phosphate and
 degraded in the b-oxidation cycle. C8-CoA esters are intercepted by FabH1 (PA3286)
 by acyltransferases. The PlsB enzyme catalyzes the acylation of the sn-1-position of
he acyl group to inorganic phosphate to form reactive acylphosphate intermediate,
 LPA. Next, PlsC transfers a FA to the sn-2-position of LPA to form phosphatidic acid
30 T. Kondakova et al. / Chemistry and Physics of Lipids 190 (2015) 27–42et al., 2005). Acyl-ACP is an acyl donor for synthesis of N-acyl
homoserine lactones (AHLs) of the quorum sensing mechanism
(Gould et al., 2004).
2.1.2. Initiation of fatty acid biosynthesis
2.1.2.1. Acetyl-CoA carboxylase and FabD acyltransferase. The
acetyl-CoA-carboxylase (ACC) performs the ﬁrst step of FAS in
Pseudomonas. The malonyl-coenzyme A (malonyl-CoA) is
generated through the carboxylation of acetyl-CoA (Fig. 1A)
(Parsons and Rock, 2013). The ACC is a four-subunit complex
consisting in a biotin carboxylase (AccC), a biotin carboxyl carrier
protein (AccB), and two carboxyltransferases (AccAD) (Table 1)
(Guchhait et al., 1974). This enzyme complex governs the quantity
of produced FA to maintain a normal lipid/protein ratio. The
organization of genes encoding the component enzyme activities
of ACC varies in different organisms. In E. coli, the accAD and theTable 1
Genes, enzymes and functions in fatty acid and glycerophospholipid synthesis.
Gene Enzyme activity Functions 
acpP Acyl carrier protein (ACP) Production of ACP 
accC Acetyl-CoA carboxylase biotin
carboxylase subunit (AccC)
ATP-dependent transfer of C
to AccB
accB Acetyl-CoA carboxylase biotin carboxyl
carrier protein subunit (AccB)
Transfer of the carboxy-biot
enzyme composed of AccA
accA Acetyl-CoA carboxylase carboxyl
transferase (a-subunit) (AccA)
Transfer of the CO2 from ca
accD Acetyl-CoA carboxylase, carboxyl
transferase (b-subunit) (AccD)
Transfer of the CO2 from ca
fabD Malonyl-CoA:ACP transacylase (FabD) Transfer of malonyl-CoA to
PA3333 (fabH2) b-Ketoacyl ACP synthase III (FabH2) Unknown functions 
PA3286 b-Ketoacyl ACP synthase III (FabH1) Channeling of 8-carbon acy
PA5174 b-Ketoacyl ACP synthase (FabY) Condensation of malonyl-A
fabB b-Ketoacyl-ACP synthase I (FabB) Complementation of acyl-A
ACP
Essential enzyme for unsat
ACP
fabF b-Ketoacyl-ACP synthase II (FabF) Complementation of acyl-A
ACP Temperature-dependen
fabG 3-Ketoacyl-ACP- reductase (FabG) Reduction of ketoester to o
fabA b-Hydroxydecanoyl-ACP dehydrase
(FabA)
Dehydration of hydroxyacy
Isomerization of trans-2 to 
fabZ (3R)-Hydroxymyristoyl-ACP
dehydratase (FabZ)
Dehydration of hydroxyacy
fabI NADH-dependent enoyl-ACP reductase
(FabI)
Formation of saturated fatt
fabV NADH-dependent enoyl-ACP reductase
(FabV)
Formation of saturated fatt
desA D-9 fatty acid desaturase (DesA) Introduction of double bond
phospholipids
desB Acyl-CoA D-9-desaturase (DesB) Introduction of a double bo
at the 9-position
plsB Glycerol-3-phosphate acyltransferase
(PlsB)
Acylation of the 1-position
LPA
plsC 1-Acyl-sn-glycerol-3-phosphate
acyltransferase (PlsC)
Formation of PA
plsY Glycerol-3-phosphate acyltransferase
(PlsY)
Acylation of the 1-position
LPA
plsX Glycerol-3-phosphate acyltransferase
(PlsX)
Transfer of acyl group to in
acylphosphate intermediate
pssA Phosphatidylserine synthase (PssA) Condensation of CDP-diacy
psd Phosphatidylserine decarboxylase
(Psd)
Decarboxylation of PS, form
pgsA CDP-diacylglycerol-glycerol-3-
phosphate 3-phosphatidyltransferase
(PgsA)
Condensation of CDP-dyacy
formation of PGP
pgpA Phosphatidylglycerophosphatase A
(PgpA)
Dephophorylation of PGP, f
cls Cardiolipin synthetase (Cls) Condensation of two PG m
pcs Phosphatidylcholine synthase (Pcs) Condensation of choline wi
P2accBC genes are cotranscribed (Kondo et al., 1991; Li and Cronan,
1992). In P. aeruginosa, accBC genes are organized in one operon,
and accA and accD are found in different regions of chromosome
(Best and Knauf, 1993). Upon synthesis, the malonyl-CoA is
transferred to ACP by a malonyl-CoA:ACP transacylase (FabD)
(Fig. 1A, Table 1). The gene coordinating the production of FabD
protein belongs to the fab gene cluster of P. aeruginosa (Kutchma
et al., 1999).
2.1.2.2. Role of FabH and FabY in determining fatty acids structure in
Pseudomonas. The following step of FAS is the initiation of new
acyl chain formation by condensation of malonyl-ACP with a short-
chain acyl-CoA (Fig. 1A). Usually, in g-proteobacteria, this reaction
is catalyzed by FabH enzyme. The known sequences of FabH vary
according to the bacterial species, but are characterized by a
conserved Cys-His-Asn catalytic triad and utilization of a ping-
pong mechanism (Davies et al., 2000; Qiu et al., 1999; White et al.,References
(White et al., 2005; Kutchma et al., 1999;
Best and Knauf, 1993)O2 from bicarbonate to biotin attached
in intermediate to the transcarboxylase
 and AccD subunits
rboxybiotin to acetyl-CoA
rboxybiotin to acetyl-CoA
 the ACP (White et al., 2005; Kutchma et al., 1999)
(Davies et al., 2000; Yuan et al., 2012a;
Yuan et al., 2012b; Six et al., 2014; Zhang
and Rock, 2012)
l-CoA intermediates
CP with a short-chain acyl-CoA
CP by two-carbon unit from malonyl-
urated FAS, elongating cis-3-decenoyl-
(Garwin et al., 1980; Hoang and
Schweizer, 1997)
CP by two-carbon unit from malonyl-
t production of cis-unsaturated FA
btain the hydroxyacyl-ACP (Fisher et al., 2000; Price et al., 2001; Ren
et al., 2000)
l-ACP to trans-2-ACP
cis-3-decenoyl ACP
(Hoang and Schweizer, 1997; Mohan
et al., 1994)
l-ACP to trans-2-ACP
y acid chains (Hoang and Schweizer, 1999)
y acid chains (Zhu et al., 2010; Massengo-Tiassé and
Cronan, 2008)
 into acyl chains previously attached to (Zhu et al., 2006; Subramanian et al.,
2010)
nd into saturated acyl-CoA speciﬁcally
 of glycerol-3-phosphate, formation of (Röttig and Steinbüchel, 2013; Lu et al.,
2007; Cronan and Bell, 1974; Yoshimura
et al., 2007)
 of glyceril-3-phosphate, formation of
organic phosphate to form reactive
lglycerol with serine, formation of PS (Shi et al., 1993; Mileykovskaya and
Dowhan, 1997)ation of PE
lglycerol with glycerol phosphate, (Heath et al., 2002a,b; Kikuchi et al.,
2000; Suzuki et al., 2002)
ormation of PG
olecules, formation of CL (Heath et al., 2002a,b; Bernal et al., 2007)
th CDP-diacylglycerol, formation of PC (Geiger et al., 2013; Wilderman et al.,
2002)
4
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intermediary metabolism (Parsons and Rock, 2013). Only
thioesters with less than four carbons are able to pass FabH
active site tunnel in E. coli (White et al., 2005). The FabH enzyme
has many similarities with FabB and FabF condensation enzymes of
elongation module, which add a two-carbon unit from malonyl-
ACP to growing acyl-ACP (see part Elongation module) (Parsons and
Rock, 2013). The most important difference between these three
enzymes is the conﬁguration of the active site: Cys-His-His triade
for FabB/FabF, and Cys-His-Asn for FabH (Davies et al., 2000). fabH
is an essential gene for bacterial FA synthesis, thus it is a target for
antibacterial development (Castillo and Pérez, 2008; Davies et al.,
2000; Lai and Cronan, 2003; Zhang and Cronan, 1998). Most
bacteria have a single FabH enzyme. However, in P. aeruginosa the
FAS initiation is carried out by another enzyme PA5174, named
FabY. This condensing enzyme performs a task usually attributed to
FabH but uses a Cys-His-His active site of FabB/FabF enzymes (Yuan
et al., 2012b). The fabY mutant is still viable indicating a possible
alternative secondary mechanism of FAS in P. aeruginosa (Yuan
et al., 2012a). It exhibits a growth defect and a decreased
production of quorum sensing signaling molecules,
rhamnolipids and siderophores (Yuan et al., 2012b). The fabY
mutant is susceptible to a number of antibiotics, including certain
b-lactams (Six et al., 2014). The study of one of E. coli FabH ortholog
in P. aeruginosa (FabH1-PA3286) showed that this enzyme plays a
unique role in channeling of C8 acyl-CoA intermediates arising
from FA ß-oxidation (Fig. 1C green color, Table 1). Yuan and
colleagues proposed that P. aeruginosa can incorporate exogenous
FAs with C8 via PA3286 catalysis. In this pathway exogenous FAs,
intercepted by Fad enzymes, are condensed with malonyl-ACP
using PA3286 to make the FAS intermediate ß-keto-decanoyl-ACP
(Figure 1/C) (Yuan et al., 2012a). This case of direct utilization of
long-chain acyl-CoA has been demonstrated also for E. coli (Black
et al., 2000), Mycobacterium tuberculosis during the synthesis of
mycolic acids (Choi et al., 2000) or Rhodococcus opacus (Holder
et al., 2011). Structural characterization of PA3286 is needed to
shed more light upon how this enzyme catalyzes the reactions
with long acyl chains.
The initiation of FAS in P. ﬂuorescens lineage is poorly
documented. We have found the open reading frames (ORF)
coding FAS enzymes in genomes of ﬁve Pseudomonas type strainsFig. 2. Phylogenic analysis of FabB/FabF, FabH and FabY proteins among Pseudomonas 
A phylogenic tree, based on protein sequences translated from open reading frames foun
domain clusters were found in databases and analyzed using the neighbor-joining meth
Company, Denmark). The branches of the tree are labeled by the strain name and referenc
of tree. To scale the tree, branch lengths are calculated corresponding to the number of am
indicated in bleu squares. The FabB of E. coli K-12 substr. W3110 is used for rooting th
P24(P. aeruginosa PAO1, P. ﬂuorescens Pf0-1, P. putida KT2440, P. fulva
12-X, and P. syringae pv. theae). Fig. 2 shows a phylogenic
distribution of protein translated from these ORFs. We observed
that FabB and FabF have two FAS domain protein clusters well
conserved among P. aeruginosa and P. ﬂuorescens lineages. These
enzymes are representatives from all ﬁve analyzed Pseudomonas
strains, consistent with their role in FAS elongation. The FabY
enzyme is not conserved suggesting strain speciﬁc role(s) outside
primary FAS metabolism. The distribution of FabY in Pseudomonas
is conﬁned to P. aeruginosa PAO1 and Pseudomonas fulva 12-X
(member of the P. putida group). Conversely, no fabY ortholog was
detected in P. putida, P. ﬂuorescens, and P. syringae. This indicates
that this alternative metabolism observed for P. aeruginosa should
be also active in speciﬁc members of the P. putida group such as P.
fulva. However, supplementary studies are necessary to support
this thesis. It is likely that FAS domain proteins should be also
involved (Yuan et al., 2012b). Indeed, we found annotated
sequences to fabH in all studied Pseudomonas strains. FabH
proteins present two major and divergent clusters. The
FabH1 enzyme was studied in P. aerugnosa (FabH1-PA3286) and
was discussed above (Fig. 1). fabH1 orthologous gene sequences
were found in all studied Pseudomonas strains. This could indicate
the ability of these Pseudomonas strains to intercept long C8 acyl-
CoA chains. Surprisingly, three strains (P. putida KT2440, P.
ﬂuorescens Pf0-1, P. aeruginosa PAO1) have more than one fabH
annotated sequence (FabH2, Fig. 2). The role of FabH2 is unknown
in the absence of biochemical studies of this enzyme (Zhang and
Rock, 2012). Therefore, we can suppose this enzyme is involved in
alternative metabolic pathway(s).
2.1.3. Elongation module
The iterative cycle of acyl chain elongation is divided in four
steps catalyzed by six enzymes. In the ﬁrst step, ß-ketoacyl-ACP
synthase I and II (FabB and FabF) complement the growing of acyl-
ACP by two-carbon unit to form malonyl-ACP (Fig. 1B). The
resulting ketoester is reduced by a NADPH-dependent ß-ketoacyl-
ACP reductase (FabG), and a water molecule is then removed by a
ß-hydroxyacyl-ACP dehydrases (FabA and FabZ) (Fig. 1B). The last
step is catalyzed by enoyl-ACP reductases (FabI/FabV) to form a
saturated acyl-ACP, which in turn serves as a substrate for anothertype strains.
d in selected Pseudomonas genomes was established. Sequences coding FAS proteins
od. Analyses were conducted by using CLC Sequence Viewer 7 (CLC bio, a QIAGEN
e in NCBI database. The percent value of the bootstrap support is present in all nodes
ino acid substitutions per site. The four main clusters (FabB, FabF, FabH and FabY) are
e tree.
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(Fig. 1B) (Heath et al., 2002a,b).
Chemical structures of FabB and FabF enzymes are very similar
(Huang et al., 1998; Olsen et al., 1999). However, FabF is responsible
for temperature-dependent production of cis-unsaturated FA
(Table 1) (Garwin et al., 1980). At low temperatures, FabF promotes
the production of D11-18:1, whereas at higher temperatures, FabF
is inactivated and the formation of D11-18:1 is reduced (Garwin
et al., 1980; Zhang and Rock, 2008). FabB is an essential enzyme for
unsaturated FAS (Hoang and Schweizer, 1997; Wang and Cronan,
2004) (see part Introduction of the double bond), which has theFig. 3. Proposed mechanism of formation of unsaturated fatty acids in Pseudomonas st
(A) FabAB pathway of double bond introduction in Pseudomonas: At the 10-carbon stage 
of ß-hydroxyacyl-ACP to trans-2-enoyl-ACP and the isomerization of trans-2-enoyl-ACP t
form a saturated FA chain (C16/C18:0-ACP). The cis-3-enoyl-ACP is elongated by the FabB e
GPs thought the action of acyltransferases (PlsX, PlsY, PlsB and PlsC). Production of the
(B) DesCB/DesA pathways of double bond introduction: Exogenous FAs enter the cell and
(FadD). DesA is a GP acyl-desaturase that introduces a double bond in the D9-position
synthesis and exogenous saturated FAs. DesB is an acyl-CoA desaturase that introduces a d
involved in electron transport supporting FA desaturation reactions. Regulation of the
regulation patways.
P2catalytic property of elongating cis-3-decenoyl-ACP, whereas FabF
does not (Table 1) (Hoang and Schweizer, 1997).
The next reduction of ketoester is catalyzed by a short-chain
dehydrogenase/reductase family member FabG (Fig. 1B, Table 1). It
is an essential protein for bacteria and plants (Fisher et al., 2000;
Price et al., 2001; Ren et al., 2000).
The third step of dehydration is catalyzed by the FabA or FabZ
ß-hydroxyacyl-ACP dehydratases (Fig.1B). Although FabA and FabZ
are two isoforms, FabZ catalyzes the dehydration of hydroxyacyl-
ACP to trans-2-ACP (Table 1). In addition to dehydration, FabA also
carries out the isomerization of trans-2 to cis-3-decenoyl-ACPrains.
of elongation module, the bifunctional FabA enzyme performs both the dehydration
o cis-3-enoyl-ACP. Then the enoyl-ACP reductase (FabI) reduces the trans-isomer to
nzyme to form an unsaturated FA chain (C16/C18:1-ACP), which is incorporated into
 FabA protein is under the control of the DesT transcriptional repressor.
 are converted to their acyl-CoA derivatives by the long-chain-fatty-acid-CoA ligase
 into formed GPs. The GP substrates for DesA are produced from both de novo FA
ouble bond in the D9-position. DesC is a predicted oxidoreductase which is probably
 DesBC system is insured by DesT. OM: outer membrane; IM: inner membrane,
4
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have very similar sequence characteristics, but they differ in active
site residues, an Asp in FabA and a Glu in FabZ (Kimber et al., 2004;
Mohan et al., 1994). The coupled transcription of the two genes
coordinates the production of the two proteins (FabA and FabB)
that are essential for unsaturated fatty acid biosynthesis (Hoang
and Schweizer, 1997).
Usually, the fourth and ﬁnal step in FAS is catalyzed by a NADH-
dependent enoyl-ACP reductase FabI (Fig. 1B, Table 1). The active
site of this enzyme has a Tyr-Lys catalytic diad (Roujeinikova et al.,
1999; White et al., 2005). The FabI mechanism involves the transfer
of a hydride to the C3 of the C2¼C3 bond and the development of an
enolate anion on the C1 carbonyl oxygen, which accepts a proton
from a Tyr hydroxyl moiety. The obtained enol then undergoes
tautomerization to yield the thioester (Rafferty et al., 1995). FabI is
exclusively bacterial enzyme. The reduction of enoyl-ACP deriv-
atives is thought to coordinate FA and GP biosynthesis and to
regulate the degree of FA unsaturation (Hoang and Schweizer,
1999). The regulation of the ratio of unsaturated/saturated FAs is
an essential mechanism of Pseudomonas adaptation to environ-
mental modiﬁcations (Heath and Rock, 1995; Heipieper and
Fischer, 2010; Ramos et al., 1997). FabI is the target of a group of
antibacterial compounds, and is a typical triclosan-sensitive enoyl-
ACP reductase (Chuanchuen et al., 2003; Heath and Rock, 1995).
Triclosan is a very widely used biocide, which speciﬁcally inhibits
enoyl-ACP-reductase activity. FabI is present in all Pseudomonas
species (Zhu et al., 2010). Remarkably, P. aeruginosa possesses an
another enoyl-ACP reductase isozyme FabV (Figure 1/B, green color,
Table 1) (Zhu et al., 2010). It is considerably larger than typical
short-chain dehydrogenase/reductase family members. The Tyr
and the Lys active site residues of FabV are separated by eight
amino acids instead of six in FabI (Massengo-Tiassé and Cronan,
2008).
In P. aeruginosa the genes encoding several enzymes of
elongation cycle (fabF-acpP-fabG-fabD) are clustered (called the
fab cluster) (Hoang and Schweizer, 1999; Kutchma et al., 1999). The
genes coordinating the production of the FabH, FabY and FabZ
proteins, are absent in this cluster.
2.1.4. Introduction of the double bond
Bacterial membranes should conserve the appropriate ﬂuidity
to maintain normal membrane structure and functions under
various environmental changes (Heipieper and Fischer, 2010;
Keweloh and Heipieper, 1996; Rühl et al., 2012). To increase
membrane rigidity, Pseudomonas produce more saturated FAs
whereas when higher ﬂuidity is needed, unsaturated FAs are
synthetized (Mansilla et al., 2004; Pepi et al., 2008; Zhu et al.,
2006). A considerable diversity of mechanisms is used by
Pseudomonas to generate unsaturated FAs. Bacteria of this genus
use the bifunctional FabA enzyme which performs both the
dehydration of ß-hydroxyacyl-ACP to trans-2-enoyl-ACP and the
isomerization of trans-2-enoyl-ACP to cis-3-enoyl-ACP at 10-
carbon stage of elongation module (Fig. 3A, Table 1) (Parsons
and Rock, 2013). Resulting cis-3-enoyl-ACP is then elongated by
FabB enzyme. In E. coli the expression of fabA and fabB genes are
transcriptionally regulated by the FadR activator and the FabR
repressor (Feng and Cronan, 2012). In Pseudomonas the FabAB
pathway is positively and negatively regulated by the DesT protein
(PA4890) (Subramanian et al., 2010). DesT binds to a DNA
palindromic site in the gene promoter. This binding is positively
and negatively regulated by acyl-CoA. The DesT binds to saturated-
and unsaturated-CoA with the same afﬁnity, but the binding to
DNA is enhanced when DesT is bound to an unsaturated acyl-CoA
and released when DesT is bound to a saturated acyl-CoA (Miller
et al., 2010; Zhang et al., 2007).P24In addition to the FabAB dependent mechanism, P. aeruginosa
generates unsaturated FAs by two other pathways (Fig. 3B). The
DesA enzyme, a membrane-associated D9-desaturase, introduces
a double bond in D9-position of fatty acyl chains attached to the
sn-2 position of existing GPs (Fig. 3B, Table 1) (Parsons and Rock,
2013). We have found P. aeruginosa desA orthologs in a majority of
Pseudomonas spp. (www.pseudomonas.com, data not shown). This
suggests the presence of DesA dependent mechanism in most of
Pseudomonas strains. However, the mechanism of DesA regulation
is unknown and necessitates biochemical studies. Zhu et al.
suppose that desA expression is regulated by membrane biophysi-
cal properties (Zhu et al., 2006). DesCB proteins, encoded by the
desCB 2-genes0 operon, are responsible for the introduction of a
double bond speciﬁcally at the D9-position of acyl-CoA produced
from exogenous saturated FAs (Fig. 3B, Table 1) (Subramanian
et al., 2010). DesB is an acyl-CoA D9-desaturase, and the DesC is a
predicted oxydoreductase which is probably involved in the
electron transport that supports FA desaturation reactions cata-
lyzed by DesB (Zhu et al., 2006). The desB mutants are known to be
deﬁcient in the synthesis of proteolytic enzymes, pyocyanin and
rhamnolipids. They show impaired swarming and twitching
motilities and reduced virulence in the Caenorhabditis elegans
infection model. These data demonstrate that DesB is not only a FA
desaturase but also a factor required for full virulence in P.
aeruginosa (Schweizer and Choi, 2011). The DesBC pathway is like
FabAB, regulated by a DesT dependent mechanism. However, the
role of DesT in controlling fabAB expression likely accounts for the
fact that DesT is conserved in both protein sequence and
chromosomal location in all Pseudomonas species examined, yet
only P. aeruginosa has a desCB operon (Subramanian et al., 2010).
The reasons why Pseudomonas strains have three independent
mechanisms of unsaturated FA formation need to be determined.
2.2. Transfer to the membrane
The FAS in Pseudomonas generally ends when the acyl chain has
16 or 18 carbons in length. The FA chain is then transferred into
membrane to form GPs thanks to acyltransferases. Thus, the FA is
transferred from acyl-ACP or acyl-CoA to the sn-1-position of
glycerol-3-phosphate to form the 1-acyl-glycerol-3-phosphate,
also known as lysophosphatidic acid (LPA). Next, the LPA is
acylated in the sn-2-position to form phosphatidic acid (PA)
(Fig. 1D) (Cullinane et al., 2005; Rock et al., 1981; Zhang and Rock,
2008).
The PlsB, an inner-membrane protein, catalyzes the acylation of
the sn-1-position of glycerol-3-phosphate (Fig. 1D, Table 1). This
enzyme can use both acyl donors: acyl-ACP and acyl-CoA (Lu et al.,
2006) and has an eukaryotic ortholog. The second step of PA
formation is always catalyzed by PlsC enzyme (Fig. 1D, Table 1),
ubiquitously distributed in all bacteria (Röttig and Steinbüchel,
2013).
Alternatively, Pseudomonas spp. has a second acylation system
PlsX/PlsY. The PlsX, a peripheral membrane protein, transfers the
acyl group to inorganic phosphate to form a reactive acylphosphate
intermediate (Fig. 1D, Table 1) (Zhang and Rock, 2008). Next, the
PlsY an integral plasma-membrane protein acylates the sn-1-
position of glycerol-3-phosphate and allows the PlsC enzyme to
form the PA (Fig. 1D, Table 1) (Cullinane et al., 2005). Why
Pseudomonas possesses two acylation systems is still an enigma.
PlsY is characterized as a remarkably small (23 kDa) mem-
brane-bound enzyme in comparison to PlsB (93 kDa). It possesses
ﬁve membrane-spanning segments and three cytoplasmic
domains. This enzyme has no eukaryotic homologs (Röttig and
Steinbüchel, 2013). Unlike PlsB, the PlsY unables to directly use
acyl-ACP or acyl-CoA (Lu et al., 2007, 2006). An E. coli, plsB mutant
was produced by Robert Bell's research group (Cronan and Bell,
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which owe their requirement to a Km defect in sn-glycerol 3-
phosphate acyltransferase (Cronan and Bell, 1974; Larson et al.,
1984). Therefore, the plsB mutation was overcomed by addition of
exogenous glycerol-3-phosphate in the medium (Larson et al.,
1984). Yoshimura et al. generated targeted plsX, plsY and plsB gene
deletions (Yoshimura et al., 2007). plsB is an essential gene in E. coli,
whereas single deletion mutants of plsX or plsY have no effect on
bacterial growth. The double plsX/plsY mutant cannot be produced,
indicating the essential role of the PlsX/PlsY complex in GP
biosynthesis. Despite great therapeutic value, the transfer of FA
modules to the membrane GPs remains a puzzle that will require
more research to unravel.Fig. 4. Glycerophospholipid head group diversity.
Phosphatidic acid (PA) is the precursor for GPs synthesis in Pseudomonas. The cytidine dip
in Pseudomonas. It is formed from PA and cytosine triphosphate (CTP) via CdsA catalys
phosphatidylserine (PS) decarboxylation. CDP-DAG is condensed with serine via the P
decarboxylase Psd to yield PE. For phosphatidylglycerol (PG) formation, CDP-DAG is con
(PGP). Then, PGP is dephosphorylated by a PGP phosphatase (PgpA). Cardiolipin (CL) 
Phosphatidylcholine (PC) is formed through the PC synthase (Pcs) pathway when chol
P23. Glycerophospholipid biosynthesis and functions in
Pseudomonas
3.1. Glycerophospholipid head group diversity
An assortment of different polar HGs can be attached to the PA
basic structure in bacteria, creating the optimum surface charge for
membrane (Boeris et al., 2007; Parsons and Rock, 2013). The
membrane charge depends on the ratio between zwitterionic GPs,
e.g. phosphatidylethanolamine (PE), and GPs with acidic HGs, e.g.
phosphatidylglycerol (PG). The balance in electrostatic charge is
required for many integral membrane proteins to adopt the correct
steric conformation in the cell membrane (Parsons and Rock,
2013). Bacteria can modify membrane charge to adapt to stress
factors, like high temperature or solvent stresses (De Carvalho
et al., 2008; De Carvalho, 2012).hosphate-diacylglycerol (CDP-DAG) is a key intermediate in the synthesis of all GPs
is. Phosphatidylethanolamine (PE), a major GP of Pseudomonas, is synthesized by
S synthase PssA catalyze to form PS. Then, PS is decarboxylated thanks to the PS
densed with glycerol phosphate by PgsA, to form phosphatidylglycerol phosphate
is synthesized through condensation of two PG molecules by a CL synthase (Cls).
ine is condensed with CDP-DAG to form the PC.
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Table 2
Glycerophospholipids and their functions.
Glycerophospholipid Chemical formula Functions in bacterial cells References
Phosphatidic acid (PA) 1. Basis in the synthesis of all membrane
phospholipids
2. Negative membrane charge
(Parsons and Rock, 2013;
Zhang and Rock, 2008)
(Sutterlin et al., 2014)
Phosphatidylethanolamine
(PE)
1. Most predominant phospholipid of
Pseudomonas
2. Membrane architecture (lateral pressure
and curvature stress in membranes)
3. Adaptation to organic solvents
contamination and temperature stress
4. Motility and chemotaxis
5. Precursor for lipopolysaccharides synthesis
(Boeris et al., 2007; Gill,
1975; Bhakoo and Herbert,
1980)
(Heath et al., 2002a,b)
(Nikaido, 2003; Rühl et al.,
2012; Gill, 1975; Bhakoo
and Herbert, 1980)
(Shi et al., 1993)
(Raetz et al., 2007)
Phosphatidylserine (PS) 1. Precursor for PE synthesis (Parsons and Rock, 2013)
Phosphatidylglycerol (PG) 1. Major anionic phospholipid of
Pseudomonas
2. Membrane architecture
3. Adaptation to organic solvents and
temperature stress
(Rühl et al., 2012; Suzuki
et al., 2002)
(Zhao et al., 2008)
(Nikaido, 2003; Rühl et al.,
2012; Gill, 1975; Bhakoo
and Herbert, 1980)
Cardiolipin (CL) 1. Formation of dynamic protein–lipid
membrane domains
2. Cell division
3. Resistance to organic compounds and
antibiotics
(Camberg et al., 2007;
Mileykovskaya and
Dowhan, 2009; Romantsov
et al., 2007)
(Mileykovskaya and
Dowhan, 2005; Dowhan
et al., 2004; Mileykovskaya
and Dowhan, 2009)
(Ramos et al., 1997)
(Bernal et al., 2007)
Phosphatidylcholine (PC) 1. Interactions symbiotic/pathogenic
bacteria-eukaryotic hosts
2. Membrane structure formation
3. Resistance to heavy metals
4. Metabolic cycle, biomolecules formation
(Minder et al., 2001;
Sohlenkamp et al., 2003;
Martínez-Morales et al.,
2003)
(Geiger et al., 2013)
(Boeris and Lucchesi, 2012)
(Geiger et al., 2013)
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signiﬁcantly depending on the bacterial strains (Bhakoo and
Herbert,1980; Bobo and Eagon,1968; Boeris et al., 2007; Boeris and
Lucchesi, 2012; Cullen et al., 1971; Tashiro et al., 2011).
Pseudomonas spp. possesses four major GP species. PE and PG
present the two major Pseudomonas spp. GPs, which together
account for about 95%. Integral cellular analysis gives the
composition of about 75% PE and 20% PG. Remainders are
represented by cardiolipin (CL) (Diedrich and Cota-Robles, 1974)
and phosphatidylcholine (PC), recently found in Pseudomonas
strains (Boeris and Lucchesi, 2012; Geiger et al., 2013; Kondakova
et al., 2014). CL is accumulated in Pseudomonas spp. when the cells
enter the stationary growth phase. This lipid can be up to 10% of
total GPs, and is required for prolonged survival of bacteria (Gill,
1975; Heath et al., 2002a,b). PC is the major component of
eukaryotic cells, but it was also detected in the lipidome of P.
aeruginosa, P. ﬂuorescens and P. putida in small quantity (less than
4%) (Wilderman et al., 2002). The schema of Pseudomonas GPs
synthesis is shown in Fig. 4.
3.2. Phosphatidylethanolamine production and functions
PE is a major component of the Pseudomonas lipidome (Table 2)
(Boeris et al., 2007; Fuchs and Schiller, 2008). The bacterial PE is
synthesized exclusively via phosphatidylserine (PS) decarboxyl-
ation (Dowhan, 1997; Gibellini and Smith, 2010). The ﬁrst step
catalyzed by PS synthase (PssA) is the condensation of cytidine
diphosphate-diacylglycerol (CDP-DAG) with serine to form PS.
Then PS yields PE by PS decarboxylase (Psd) (Fig. 4). PS is a minor
GP of Pseudomonas (Bhakoo and Herbert, 1980), since it is quickly
converted to PE (Table 2). It has been demonstrated that the lack of
PE is lethal for bacteria, but this lethality is suppressed by media
supplementation with high concentration of divalent metal
cations. A pss null mutant contains no PS and PE in its lipidome
and has a defect in motility (Shi et al., 1993), in Cpx dependent
signal transduction pathway (Mileykovskaya and Dowhan, 1997)
and in division site selection. This last was attributed to a
concomitant increase in CL content (Mileykovskaya and Dowhan,
2005; Ramos et al., 1997) (see part Cardiolipin synthesis and
functions). A defect in the native folding of lactose permease LacY,
which causes the loss of active membrane transport, is also
observed (Dowhan et al., 2004). Complete inactivation of psd
indicates that this gene is required for motility and chemotaxis
(Ramos and Filloux, 2007; Shi et al., 1993). PE is mostly located in
the inner membrane, and may be transferred from the inner to the
outer membrane by lipid ﬂippases (Sanyal and Menon, 2009). The
PE plays a major role in membrane structure, because it is able to
form reversed non lamellar structures like the hexagonal phase. In
membrane, PE increases lateral pressure and introduces curvature
stress (Birner et al., 2001). Moreover PE is the precursor of many
essential biological molecules including DAG, FAs, PA (Gibellini and
Smith, 2010) and lipopolysaccharides (LPS), major Pseudomonas
virulence factor (Ham et al., 2011; Raetz et al., 2007).
3.3. Phosphatidylglycerol synthesis and functions
The second predominant Pseudomonas GP is phosphatidylgly-
cerol (PG) (Table 2) (Diedrich and Cota-Robles, 1974). Unlike PE, PG
is an anionic lipid at pH 7. The hydroxyl group of PG has the
potential to form intermolecular hydrogen bonds (Zhao et al.,
2008). The PG synthesis is organized in two steps and starts with
CDP-DAG (Fig. 4). First, the CDP-DAG is condensed with glycerol
phosphate by PgsA protein, to form phosphatidylglycerol phos-
phate (PGP). The second step is the PGP dephosphorylation by PGP
phosphatase (PgpA) (Table 1) (Rühl et al., 2012; Heath et al., 2002a,
b). It has long been thought that PG is an essential bacterial GP, butP2Kikuchi et al. (2000) showed that in E. coli, a null pgsA mutant is
viable if the major outer membrane lipoprotein (Lpp) is deﬁcient.
In the null pgsA mutant, the PG production is not detected (less
than 0.01% of total GPs, below the detection limit), although the PA,
an acidic biosynthetic precursor, was accumulated (4%). Nonethe-
less, the null pgsA mutant does not grow at high temperature, in
low-osmolality or minimal media, but it grows almost normally in
rich media (Suzuki et al., 2002). PG is therefore nonessential for
Pseudomonas viability or basic life GP functions, but it plays an
important role in bacterial machinery. Studies of the toxic effects of
organic solvents on bacteria revealed that an adaptive bacterial
mechanism to solvent stress modiﬁes the amount of PG relative to
PE in the cell membrane (Fang et al., 2000; Murzyn et al., 2005).
This alteration in the HG composition is the way of preserving
stability and low membrane permeability (Murzyn et al., 2005).
3.4. Cardiolipin biosynthesis and functions
CL is also called diphosphatidylglycerol because of its unique
dimeric molecular structure in which two phosphatidyl moieties
are linked by a glycerol. This GP is one of the major participants in
the formation of membrane domains in Pseudomonas spp. (Table 2)
(Gill, 1975; Heath et al., 2002a,b). Although CL has two phosphate
groups, it is not fully ionized at pH 7 due to intramolecular
hydrogen bonding between the free hydroxyl residue of the central
glycerol and a protonated phosphate (Kates et al., 1993). CL is
produced in Pseudomonas species by condensation of two PG
molecules (Figure 4) thanks to the CL synthase (Cls) (Table 1)
(Heath et al., 2002a,b). Due to its propensity to form non-bilayer
structures dependent on pH or divalent counter cations, CL is able
to participate in the formation of dynamic protein–lipid mem-
brane domains of higher curvature, for example in bacterial
division sites (Table 1) (Mileykovskaya and Dowhan, 2005). This
explains the co-localization of CL with some proteins, like
osmosensory transporter ProP, or Eps system, found in the polar
regions in bacterial cells (Camberg et al., 2007; Mileykovskaya and
Dowhan, 2009; Romantsov et al., 2007). The long-term solvent
response involves the increasing of CL production in P. putida
(Bernal et al., 2007; Ramos et al., 1997). The cls null mutant has a
more rigid membrane, is more sensitive to toluene stress and to
several antibiotics than the parental strain, suggesting that RND
efﬂux pumps involved in the extrusion of these drugs are not
working efﬁciently without CL production (Bernal et al., 2007).
3.5. Phosphatidylcholine synthesis in Pseudomonas
PC is the major membrane-forming GP in eukaryotic cells (Cole
et al., 2012). However, at least 15% of bacteria have the ability to
synthesize PC (Geiger et al., 2013). For example, PC synthesis is
described in Agrobacterium tumefaciens (Kaneshiro and Law, 1964),
Rhodobacter sphaeroides (Arondel et al., 1993), Sinorhizoum meliloti
(De Rudder et al., 2000), Zymomonas mobilis (Tahara et al., 1994),
Bradyrhizobium japonicum (Minder et al., 2001) and many other
eubacteria. PC is detected in small quantity (less than 4%) in the
lipidome of Pseudomonas spp. (Geiger, 2010). PC and PE have a very
similar chemical structure. Both have a zwitterionic state at pH
7 and possess a dipole moment across their respective head groups
(Sohlenkamp et al., 2003). However, there are signiﬁcant and
important differences in chemistry and properties between the
two GP. PC has a head group and hydrophobic domains of similar
diameter and forms lipid bilayers. PE has a small head group
relative to a large hydrophobic domain and favors the hexagonal II
phase formation (Dowhan and Bogdanov, 2002). Two pathways for
PC biosynthesis exist in bacteria: the glycerophospholipid N-
methylation (Pmt) pathway and the phosphatidylcholine synthase
(Pcs) pathway. In the Pmt pathway, PE is three times methylated to4
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transferases (Wilderman et al., 2002) whereas in the Pcs pathway,
choline condenses directly with CDP-DAG to form PC (Geiger et al.,
2013; Gibellini and Smith, 2010). In P. aeruginosa PAO1, orthologs of
rhodobacterial pmtA (PA0798) and pcs (PA3857) are found (Table 1)
(Wilderman et al., 2002). The pmtA-deﬁcient mutant still
synthesizes PC at wild type level whereas a pcs null mutant forms
no detectable amounts of PC (Wilderman et al., 2002). These data
suggest that the Pcs pathway is predominant in P. aeruginosa PC
synthesis (Fig. 4) (Geiger et al., 2013). The both (pcs and pmt null
mutants) affects the viability of PAO1, demonstrating the impor-
tant role of both genes in P. aeruginosa (Wilderman et al., 2002). It
has been shown, that P. putida is able to synthesize PC via the Pcs
pathway (Boeris and Lucchesi, 2012). Recently, we identiﬁed the PC
production in P. ﬂuorescens strains (Kondakova et al., 2014). We
found orthologs to P. aeruginosa PAO1 pmt and pcs in P. ﬂuorescens
Pf0-1. Tblastx analyses show pmt: Pﬂ01_0427 and pcs:
Pﬂ01_2093 with 28 and 66% of amino acid identity respectively
(www.pseudomonas.com, BLAST analysis, data not shown). PC
plays a role in membrane formation in P. aeruginosa and is involved
in P. putida resistance to heavy metals (Boeris and Lucchesi, 2012)
(Table 2). In addition, pseudomonal PC can function as an
intermediate during the biosynthesis of other biomolecules or
form part of metabolic cycle (Geiger et al., 2013, p. 201).
4. Exploitation of host glycerophospholipids by Pseudomonas
Lipids have been loosely deﬁned as biological substances that
are generally hydrophobic in nature and in many cases soluble in
organic solvents presenting important structural materials in
living organisms (Fahy et al., 2005). The role of lipid is wider than
structural material formation (Ganapathy et al., 2013), and several
studies help us to understand the mysterious reason why nature
synthesizes thousands of different lipids (Kanfer and Kennedy,
1964, 1963). In 1989, for the ﬁrst time Irvine and Berridge showed
that the phosphoinositides are involved in bacterial signaling
system quorum sensing (Berridge and Irvine, 1989). Then, Haucke
and Di Paolo showed the lipid implication in membrane trafﬁc
(Haucke and Di Paolo, 2007).
One example of host lipid exploitation by Pseudomonas is
illustrated in the type 3 secretion system (T3SS). This mechanism,
identiﬁed in human and plant pathogens P. aeruginosa and P.
ﬂuorescens and delivering virulence effector proteins into eukary-
otic cells, appears functionally dependent on lipids (Cornelis,
2002; Mavrodi et al., 2011). At the tip of the T3SS needle, bacterial
proteins are inserted into the host cell membrane to form a
translocon that perturbs the membrane bilayer. P. aeruginosa has
two translocon components, PopB and PopD, capable to bind
directly to two eukaryotic lipids: cholesterol and phosphatidyl-
serine, causing a cholesterol-dependent lyse of membrane
(Schoehn et al., 2003). Approximately, 28% of strains of P.
aeruginosa encode a potent cytotoxin, ExoU (Feltman et al.,
2001), which is a marker of highly virulent P. aeruginosa strains
isolated from patients with ventilator-associated pneumonia (Diaz
and Hauser, 2010; Schulert et al., 2003). The ExoU is a cytotoxic
phospholipase A2 effector protein secreted by the T3SS directly
into host cells (Tyson and Hauser, 2013). Among membrane GPs,
ExoU possesses high afﬁnity for phosphatidylinositol 4,5-bisphos-
phate or PI(4,5)P2, and it is capable to use this phospholipid as a
substrate (Kierbel et al., 2005; Sato and Frank, 2014). Lysing cell
membranes, ExoU contributes to the ability of P. aeruginosa to
disseminate rapidly from lung tissue into the bloodstream (Van der
Meer-Janssen et al., 2010). Then, Pseudomonas strains have a large
capacity to exploit eukaryotic lipids in order to improve their host
interactions. Within the last few years, bacteria–host lipid
interactions became a very promising research area. For earlierP24studies, we highly recommend very comprehensive reviews (Ham
et al., 2011; Van der Meer-Janssen et al., 2010; Vromman and Subtil,
2014).
4.1. Phosphoinositide signaling and Pseudomonas
Many internal organs such as epithelial sheets are composed by
separate apical and basolateral surfaces that are deﬁned by distinct
lipid and protein compositions and are separated by tight junctions
(Gibson and Perrimon, 2003). The apical surface plays a role of
barrier to the environment. The basolateral surface is adapted for
interaction with other cells and for exchange with the blood-
stream.
Phosphoinositides (PIs) are small lipids derived from phospha-
tidylinositol. As key components of eukaryotic cell membranes, PIs
have essential roles in a wide range of cellular processes, such as
membrane dynamics, actin cytoskeleton arrangements and vesicle
trafﬁcking (Michell, 2007). This differential distribution of PIs in
cell is regulated by PI kinases and phosphatases, which intercon-
vert diverse PI species (Ham et al., 2011). Phosphatidylinositol
3,4,5-trisphosphate (PI(3,4,5)P3) is described as stably localized at
the basolateral membrane and is excluded from the apical plasma
membrane (Vanhaesebroeck and Alessi, 2000). This GP is a key
determinant of P. aeruginosa interaction with host cells (Botelho
et al., 2000; Kierbel et al., 2005). Insertion of exogenous PI(3,4,5)P3
into the apical surface results in the rapid transformation of
regions of the apical membrane to one with basolateral
constituents. P. aeruginosa could create a local microenvironment
that facilitates colonization and entry into the cell (Kierbel et al.,
2007). For this, polarized monolayers P. aeruginosa binds near cell–
cell junctions and coopts PI3 kinase generating PI(3,4,5)P3 at the
surface. Membrane protrusions enriched by PI(3,4,5)P3 and actin
accumulate at the apical surface in the site of bacterial binding.
This causes the decreasing susceptibility of the intact epithelium to
P. aeruginosa–mediated invasion or damage (Kierbel et al., 2007).
The PI(3,4,5)P3 pathway of cell invasion by P. aeruginosa depends
on the phospholipase D (PLD) enzymes activity (Jiang et al., 2014).
The PLD enzymes catalyze the hydrolysis of GP phosphodiester
bonds to product PA, and have been identiﬁed as type 6 secretion
system (T6SS) effectors (Russell et al., 2013). Two such effectors in
P. aeruginosa are PldA (PA3487) (Russell et al., 2013) and PldB
(PA5089) (Jiang et al., 2014) targeting bacterial and eukaryotic cells
(Spencer and Brown, 2015). Both proteins have signiﬁcant
homology to eukaryotic PLDs, but not to any prokaryotic PLDs,
suggesting they were acquired horizontally, perhaps from a
eukaryotic organism (Wilderman et al., 2001). PLD proteins of P.
aeruginosa imposed cell death occurs through PA accumulation, via
degradation of the major membrane components: PC for
eukaryotes (Jiang et al., 2014) or bacterial PE (Russell et al., 2013).
4.2. Eukaryotic phosphatidylcholine exploitation
As the major eukaryotic phospholipid, PC is supposed to play an
important role in the interactions between symbiotic and
pathogenic bacteria and their eukaryotic hosts (Martínez-Morales
et al., 2003). But recent ﬁndings showing the PC presence in about
15 % of all bacteria put into question this hypothesis. However,
plant-colonizing P. syringae species detects and exploits choline in
hosts for osmoprotection and nutrition (Chen et al., 2013). P.
aeruginosa in turn produces a number of virulence factors that
facilitate the establishment of lung infections. Mammalian lungs
are naturally coated by indispensable lung surfactant, which is
composed of approximately 80% of PC (Bernhard et al., 2001). This
lipid serves as an important nutrient for P. aeruginosa during cystic
ﬁbrosis lung infection (Sun et al., 2014). P. aeruginosa hemolytic
phospholipase C (PlcH) is a secreted hydrolase that degrades host-
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et al., 2011). In the PC-rich environment of the lungs, the PlcH
degradation products of PC, DAG, and phosphorylcholine play
different roles in the disease process. DAG may induce the
abnormal release of inﬂammatory mediators and increase the host
inﬂammatory response, thereby promoting tissue damage (Johan-
sen et al., 1994; Sage and Vasil, 1997). Phosphorylcholine can be
converted to choline or glycine betaine. These compounds serve as
osmoprotectant agents which shield bacteria against the effects of
hyperosmolar environments (such as the lungs tissues) (Jackson
et al., 2013; Sage and Vasil, 1997). Since P. aeruginosa is able to
utilize choline and glycine betaine as sole sources of carbon;
nitrogen and energy (Lisa et al., 1983). Sun et al., 2014). A null P.
aeruginosa plcH mutant was less able to colonize epithelial cell
monolayers and defective in bioﬁlm formation when grown in lung
(Jackson et al., 2013). In a mouse thermal injury model, plcH
mutant had a 10-fold increase in its LD50, compared to that of its
wild type parent (Ostroff et al., 1989), Using the transparent
zebraﬁsh model, it has been demonstrated, that the PlcH is
selective for endothelial cells, and also could contribute to
apoptosis in lung endothelial cells and further exacerbates chronic
inﬂammation seen in cystic ﬁbrosis patients (Vasil et al., 2009).
However, the role of PC in Pseudomonas spp.—host/symbiont
interactions is still a promised area of future lipidomic researches.
4.3. Pseudomonas lipids as a target for a new antibiotic development
The bacterial FAS II differs signiﬁcantly from the mammalian
and fungal system (FAS I), which uses a large complex multifunc-
tional enzymes (White et al., 2005; Zhu et al., 2010). The
differences between the FAS I and FAS II systems make the FAS
II one of the most attractive biochemical pathways to be used as
targets for new antibacterial agents (Heath et al., 2002a,b, 2001;
Payne et al., 2001; Zhang et al., 2006). Triclosan 1 (5-chloro-2-(2, 4-
dichlorophenoxy)phenol), a broad spectrum antimicrobial agent,
can speciﬁcally inhibit enoyl-acyl carrier protein reductase, FabI, to
block lipid biosynthesis (Castillo and Pérez, 2008; McMurry et al.,
1998). Through subsequent kinetic and structural studies, triclosan
was shown to be a potent inhibitor of FabIs from many organisms,
such as Staphylococcus aureus (Suller and Russell, 2000), and
Haemophilus inﬂuenza (Marcinkeviciene et al., 2001). However, P.
aeruginosa is resistant to triclosan, because this species encodes
triclosan-resistant enoyl-ACP reductase isozymes. As discussed
above, P. aeruginosa contains two enoyl-ACP reductases, FabI and
the triclosan resistant FabV. Upon deletion of the fabV gene, the
mutant strain became extremely sensitive to triclosan (>2,000-fold
more sensitive than the wild-type strain), whereas the mutant
strain lacking FabI remained completely resistant to the biocide
(Zhu et al., 2010).
Over the last few years, P. aeruginosa lipidome became a target
for new antibiotic development. The family of peptidomimetic
antibiotics, based on membranolytic host-defense peptide prote-
grin I perturbs the LPS assembly in the outer membrane (Srinivas
et al., 2010). A new aminoglycoside derivative 30,40,6-tri-2-
naphylmethylene (30,406-tri-2NM neamine) also targets P. aerugi-
nosa LPS (Ouberai et al., 2011). It bound to LPS inducing membrane
permeabilization. The accumulation of this drug within P.
aeruginosa phospholipids causes the membrane destabilization.
Electrostatic phospholipids/antibiotic interactions are probably
critical in the 30,406-tri-2NM neamine efﬁciency. Thus the positive
charge of this compound targets negatively charged phospholipids,
like CL and PG (Ouberai et al., 2011). In any cases, these studies
support the concept of lipid as attractive targets for drug
development.P25. Conclusions and perspectives
The Pseudomonas genus includes ubiquitous bacteria, taming all
ecological niches, which are able to adapt to highly diverse
environmental modiﬁcations. In this review, we explored speciﬁc
Pseudomonas mechanisms for FA and GP synthesis, composition
and homeostasis. Pseudomonas spp. possesses three independent
pathways to add double bonds in FA chains. These mechanisms,
non-existent in many other bacteria, are known to protect
Pseudomonas strains from stress factors. The FabV enzyme allows
P. aeruginosa to resist to the antimicrobial agent triclosan. P.
aeruginosa FabH enzyme was recently described as a component of
the system of incorporation of long chain FAs. The Pseudomonas GP
composition is more complex, than that one of E. coli. Pseudomonas
spp. is able to synthetize the PC. This cell compound could be used
by bacteria in the network of host–pathogen interactions.
Improving our knowledge of GP biosynthesis in Pseudomonas
should be helpful in understanding the physiology of these highly
versatile microorganisms.
The ability of Pseudomonas spp. to exploit eukaryotic lipid is an
emerging area of studies that will take advantage with the rapid
development of high-throughput mass spectrometric, microscopic
and genomic techniques. The establishment of bacterial lipid
proﬁles should lead to the identiﬁcation of the speciﬁc role of
individual lipid species. Moreover the functions of minor bacterial
lipids and the mechanism of lipid production in molecular level
could be enlightened by the coupling of mass spectrometry with
omics tools. The interactions between pseudomonal human or
plant pathogens and their host, the role of individual GPs in these
interactions should be investigated more ﬁnely. Hence, novel
intracellular signaling or trafﬁcking mechanisms could be
revealed. This will certainly support the development of more
speciﬁc drugs against Pseudomonas pathogens.
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DOI 10.1186/s12866-015-0405-9RESEARCH ARTICLE Open AccessA Pseudomonas fluorescens type 6 secretion
system is related to mucoidy, motility and
bacterial competition
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Nicole Orange1 and Annabelle Merieau1*Abstract
Background: Pseudomonas fluorescens strain MFE01 secretes in abundance two Hcp proteins (haemolysin
co-regulated proteins) Hcp1 and Hcp2, characteristic of a functional type 6 secretion system. Phenotypic studies
have shown that MFE01 has antibacterial activity against a wide range of competitor bacteria, including
rhizobacteria and clinically relevant bacteria. Mutagenesis of the hcp2 gene abolishes or reduces, depending on
the target strain, MFE01 antibacterial activity. Hcp1, encoded by hcp1, may also be involved in bacterial competition.
We therefore assessed the contribution of Hcp1 to competition of P. fluorescens MFE01 with other bacteria, by
studying MFE01 mutants in various competitive conditions.
Results: Mutation of hcp1 had pleiotropic effects on the MFE01 phenotype. It affected mucoidy of the strain and its
motility and was associated with the loss of flagella, which were restored by introduction of plasmid expressing
hcp1. The hcp1 mutation had no effect on bacterial competition during incubation in solid medium. MFE01 was
able to sequester another P. fluorescens strain, MFN1032, under swimming conditions. The hcp2 mutant but not the
hcp1 mutant conserved this ability. In competition assays on swarming medium, MFE01 impaired MFN1032
swarming and displayed killing activity. The hcp2 mutant, but not the hcp1 mutant, was able to reduce MFN1032
swarming. The hcp1 and hcp2 mutations each abolished killing activity in these conditions.
Conclusion: Our findings implicate type 6 secretion of Hcp1 in mucoidy and motility of MFE01. Our study is the
first to establish a link between a type 6 secretion system and flagellin and mucoidy. Hcp1 also appears to
contribute to limiting the motility of prey cells to facilitate killing mediated by Hcp2. Inhibition of motility
associated with an Hcp protein has never been described. With this work, we illustrate the importance and
versatility of type 6 secretion systems in bacterial adaptation and fitness.
Keywords: Pseudomonas fluorescens, Type 6 secretion system, Hcp protein, Competitive inhibition, Motility,
Mucoidy, ExopolysaccharidesBackground
Environmental bacteria are in perpetual war against sev-
eral competitors, and thus require weapons to conquer
new territory. The type 6 secretion system (T6SS) of
Gram-negative bacteria is an effector translocation appar-
atus resembling an inverted bacteriophage puncturing
device [1-3]. It is involved in a broad variety of functions,* Correspondence: annabelle.merieau@univ-rouen.fr
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P25including antibacterial activity [4,5] and bacterial commu-
nication [6]. For example, Proteus mirabilis uses the killing
activity of T6SS for self-recognition: this T6SS seems to be
activated when opposing P. mirabilis swarms meet. The
result of its action is a visible boundary called the Dienes
line [7,8].
The T6SS machinery comprises at least 13 proteins,
the core components, and sometimes, additional pro-
teins [9,10]. Some of the core component proteins can
affect systems other than T6SS. Hcp proteins, extracellu-
lar components of this secretion machinery, are released. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Hcp secretion and mucoid phenotype in P. fluorescens
strains. A: Mucoidy was assessed on LB agar at 28°C. +: mucoid, −:
non mucoid. B: Mucoidy at 28°C or 37°C of MFE01. +: mucoid, −:
non mucoid. The images shown are representative of three assays.
C: Concentrated supernatants of cultures in late exponential growth
phase, grown at 28°C or 37°C, were analysed by SDS-PAGE (15%
separation gel) and Coomassie staining. Bands (indicated by arrows)
with an approximate molecular mass of 21 kDa were observed in
MFE01 and MFE07 supernatants at 28°C. Mass spectrometry identified
these major supernatant proteins as Hcp proteins.
Decoin et al. BMC Microbiology  (2015) 15:72 Page 2 of 12into the medium, and therefore may serve as markers of
a functional T6SS apparatus [11]. Silverman and col-
leagues demonstrated that P. aeruginosa Hcp are not
only structural proteins but also play a crucial role as
chaperone and receptor for T6SS effectors. Various Hcp
proteins transport their own effectors and this effector
selection by Hcp seems to be specific [12].
The diversity of T6SS regulation reflects the vast array
of its functions. The P. aeruginosa H1-T6SS gene cluster
exhibits posttranscriptional regulation involving two sen-
sor kinases, RetS and LadS [13-15]. High concentrations
of synthetic c-di-GMP have negative effects on sensor
kinase RetS, leading to P. aeruginosa H1-T6SS being
turned on [16]. It is likely that a similar regulatory path-
way controls the expression of P. protegens Pf-5 and P.
syringae pv. syringae T6SS gene clusters [17,18]. How-
ever, T6SS regulation involves systems that regulate
other genes suggesting regulatory cross-talk between
T6SS and other virulence factors.
Environmental bacteria are often surrounded by an
extracellular matrix, forming a protective capsule called
the glycocalyx [19]. This extracellular matrix is generally
composed of bacterial exopolysaccharides (EPS). EPS are
involved in a variety of functions, including microcolony
formation, protection against bacteriophages and mucoid
phenotypes. The mucoid phenotype of Pseudomonas sp. is
believed to be a global adaptive stress response to adverse
environmental conditions [20,21]. It is characterized by
overproduction of EPS alginate leading to shiny, raised
and opaque colonies. The mucoid phenotype is a major
factor contributing to P. aeruginosa infection in cystic
fibrosis (CF) patients [22,23] but is unstable in vitro [24].
Some P. aeruginosa CF isolates acquire a mucoid pheno-
type through mutation of the anti-sigma factor MucA, a
negative regulatory factor that sequesters AlgU, a positive
regulator of alginate production [22,25]. A proteomic
study by Rao and coworkers found that mucoid P. aeru-
ginosa strains do not express T6SS genes [26]. Unlike P.
aeruginosa, some Vibrio cholerae strains are mucoid and
have an active T6SS [27]. Some environmental P. fluores-
cens strains produce alginate or neutral and amino sugars
which give a mucoid phenotype [28,29]. The P. fluorescens
mucoid phenotype, like that in P. aeruginosa, was re-
ported to be unstable [29]. The mucoid phenotype can
occur following mutation of the negative regulator of the
alginate biosynthetic operon, muc [30]. We previously
characterized the strain MFE01, a mucoid environmental
P. fluorescens isolate. It constitutively secretes two charac-
teristic T6SS proteins at 28°C: Hcp1 and Hcp2. It also ex-
erts antibacterial activity during contact on a solid surface
with competitive bacteria; this activity is associated with
Hcp2 [31]. The aim of this work was to study the role of
Hcp1 and the link between T6SS and the mucoid pheno-
type of MFE01.P25Results and discussion
Some mucoid P. fluorescens strains secrete Hcp abundantly
The phenotypes of four P. fluorescens strains were obser-
ved after growth on LB agar plates at 28°C. Environmen-
tal strains MFE01 [31] and MFE07 (this study) had a
stable shiny aspect, characteristic of mucoid pheno-
types at 28°C. Skin strain MFP05 [32] and clinical strain
MFN1032 [33] did not have a mucoid phenotype at this
temperature (Figure 1A and B).
MucA is a negative regulator of the mucoid phenotype
[22] in Pseudomonas species. We introduced the mucA
gene of the Pseudomonas protegens strain Pf-5 (previously
described as a P. fluorescens strain) [34] into MFE01. The
expression of mucA did not switch-off mucoidy at 28°C,
suggesting that the mucoid phenotype of MFE01 is not
due to a mutation of the mucA gene or is MucA inde-
pendent (Figure 1A). Scanlan and Buckling showed that
the environmental P. fluorescens strain SBW25 has an
MFE01 
MFE01 
hcp2 
MFE01 
hcp1 
MFE01 
hcp1 
+hcp1 
MFE01 
hcp1 
+pPSV35 
- - + + + 
Figure 2 Effects of hcp1 and hcp2 mutations on mucoid
phenotype. Representative images of mucoidy of MFE01, MFE01Δhcp1,
MFE01Δhcp2, MFE01Δhcp1+pPSV35 and MFE01Δhcp1+hcp1 at 28°C on
LB agar (n = 3). +: mucoid, −: non mucoid.
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nisms of this phenotype remain unknown, they do not in-
clude mutations at many of the loci commonly reported
to be involved in mucoid conversion, including mucA and
algU. They also demonstrated that lytic phage exerts a se-
lection pressure by selecting the mucoid phenotype [29].
We prepared supernatants of cultures of mucoid P.
fluorescens strains MFE01 and MFE07 and found that
these strains secreted large amounts of proteins identi-
fied as Hcp by Mass Spectroscopy (MS) (Figure 1C).
The spot for the protein secreted by MFE01 matched
significantly with gi: 398989489 (T6SS effector, Hcp1 fam-
ily from Pseudomonas sp GM24) with a score of 120 for a
score threshold of 84. The spot for the protein secreted
by MFE07 spot matched significantly with gi:77458272
(hypothetical protein Pfl01_2045 from Pseudomonas
fluorescens Pf0-1, Hcp1 family) with a score of 65 for a
score threshold of 54. The non-mucoid P. fluorescens
strains MFP05 and MFN1032 did not secrete detectable
amounts of Hcp proteins into the extracellular medium.
The optimal growth temperature of MFE01 is 28°C but
it can grow at 37°C. Clearly visible at 28°C, the mucoid
phenotype and Hcp secretion were both switched off at
37°C, suggesting a common regulation of these two phe-
notypes (Figure 1B,C).
Unterweger and colleagues observed a correlation be-
tween the mucoid phenotype and Hcp secretion in V.
cholerae smooth strains [27]. Sigma-54 controls T6SS
genes transcription, so they introduced vasH, encoding a
sigma-54 activator protein, into rough (non mucoid) V.
cholera strains impaired in Hcp secretion: the expression
of vasH restored the mucoid phenotype, but not the
Hcp secretion. However, vasH can activate transcription
of genes other than T6SS genes via sigma-54 [35,36]
suggesting that the correlation between mucoidy and
T6SS in V. cholerae may be due to a common regulation
system.
Hcp1 of P. fluorescens MFE01 is involved in mucoid
phenotype
We constructed hcp mutants, and found that the hcp1
mutation (MFE01Δhcp1 strain) lead to the loss of mucoidy
at 28°C whereas the hcp2 mutation (MFE01Δhcp2 strain)
did not affect the mucoid phenotype (Figure 2). The
introduction of a plasmid carrying the hcp1 gene into
MFE01Δhcp1 (MFE01Δhcp1+hcp1 strain) restored the
wild-type phenotype, suggesting a direct link between
hcp1 expression and mucoidy. We analysed and com-
pared the extracellular matrices (ECM) of MFE01 and
MFE01Δhcp1. The mucoid phenotype is a consequence
of exopolysaccharide (EPS) accumulation [37], so we de-
termined ECM sugar composition by Gas–liquid Chro-
matography (GLC). No significant difference between
MFE01 and MFE01Δhcp1 was observed concerning theP25proportion of characteristic sugars of the Pseudomonas
EPS (rhamnose, mannose, galactose and glucose; Figure 3A).
Thus, MFE01Δhcp1 is able to secrete an EPS similar to
that produced by MFE01. Nevertheless, the MFE01 ECM
contained twice as much EPS as the MFE01Δhcp1 ECM
suggesting that the loss of the mucoid phenotype was a
consequence of less EPS accumulation (Figure 3B). In
Pseudomonas aeruginosa, biofilm formation and T6SS ex-
pression are negatively regulated by the sensor RetS and
retS mutants produce a hyperbiofilm phenotype [16]. Bio-
film formation by MFE01 and mutants was then assayed.
The moderate biofilm biovolume was not significantly dif-
ferent between MFE01 and MFE01Δhcp1 or MFE01Δhcp2
mutants (Figure 3C). These findings indicate that mucoid
phenotype and biofilm formation are not co-regulated by
T6SS in MFE01.
ECM protein fractions from supernatants of MFE01,
MFE01Δhcp1 and MFE01Δhcp1+hcp1 were studied by
SDS-PAGE (Figure 4A). Proteins of approximate molecu-
lar mass of 38 kDa were present in ECM extracts from
MFE01 and MFE01Δhcp1+hcp1 but not in MFE01Δhcp1.
MS identified these 38 kDa proteins as flagellin proteins:
they matched significantly with flagellin from Pseudo-
monas moraviensis (gi: 515142380) with a score of 94 for
a score threshold of 86. Thus, the mucoid phenotype ap-
pears to involve the accumulation of both EPS and flagel-
lin in ECM, which are perturbed by hcp1 deletion. This
was unexpected because the literature generally reports an
inverse cross-talk between the mucoid phenotype and
flagellar assembly. For example, the alternative sigma fac-
tor, σ22 (synonym AlgT or AlgU), is a positive regulator of
alginate biosynthesis and a negative regulator of flagellum
biosynthesis [38].
P. fluorescens MFE01 Hcp1 is involved in motility
We examined motility of our various strains to eluci-
date the relation between flagellin accumulation in the
ECM and flagellum functionality. MFE01, MFE01Δhcp1,
MFE01Δhcp2, MFE01Δhcp1+pPSV35 (empty vector con-
trol) and MFE01Δhcp1+hcp1 were assayed for swimming;
0 
10 
20 
30 
40 
50 
60 
Rh
a M
FE
01
 
Rh
a M
FE
01
hc
p1
 
M
an
 M
FE
01
 
M
an
 M
FE
01
hc
p1
 
Ga
l M
FE
01
 
Ga
l M
FE
01
hc
p1
 
Gl
c M
FE
01
 
Gl
c M
FE
01
hc
p1
 
%
 o
f 
E
C
M
 to
ta
l s
ug
ar
s
ns 
ns 
ns 
ns 
0 
0,1 
0,2 
0,3 
0,4 
0,5 
M
FE
01
 
M
FE
01
hc
p1
 
E
PS
 (
nm
.µ
l-1
) 
* 
A B 
B
io
vo
lu
m
e 
(µ
m
3 /
µm
2 )
 
0 
2 
4 
6 
8 
10 
12 
14 
M
FE
01
 
M
FE
01
hc
p1
 
M
FE
01
hc
p2
 
M
FE
01
hc
p1
hc
p2
 
M
FE
01
hc
p1
+h
cp
1 
C 
Figure 3 Analysis of the sugar composition of the extracellular matrix and effect of hcp1 and hcp2 mutations on biofilm biovolume.
A: Relative quantity of major sugars (Rha = Rhamnose, Man =Mannose, Gal = Galactose and Glc = Glucose) determined by gas chromatography in
extracellular matrix (ECM) of MFE01 and MFE01Δhcp1. Values are mean results of four independent experiments, and the error bars represent
standard error of the mean. Strains were compared pairwise by non-parametric Mann–Whitney two-tailed tests. ns: no significant difference.
B: Gas chromatographic determinations of the absolute quantity of exopolysaccharides (EPS) in the extracellular matrix (ECM) of MFE01 and
MFE01Δhcp1. Values are mean results of four independent experiments and the error bars represent standard error of the mean. Strains were
compared pairwise by non-parametric Mann–Whitney two-tailed tests. *p-value <0.05. C: Biovolume of biofilms. The biofilms were grown on glass
surface at 28°C for 48 h under a flow of LB medium. Biovolumes were obtained by COMSTAT analyses. Values are mean results of at least five
independent experiments and the error bars represent standard error of the mean. Statistical analyses were performed using Non-parametric
Mann–Whitney Tests (two tailed). ns means no significant difference in biovolume (p-value >0.05) relative to the MFE01 biofilm biovolume assay.
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was restored by hcp1 introduction in trans. The restor-
ation of wild-type phenotype in MFE01Δhcp1+hcp1 is in-
consistent with a possible polar effect of the hcp1 deletion
(Figure 4B).
The type 3 secretion system is related to the flagellum
[39], but little is known about the relation between T6SS
and the flagellar regulon. The IcmF of Vibrio cholerae, aB 
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(n = 3). Molecular weight markers are indicated. B: Swimming assay on LB i
motile but MFE01Δhcp1 and MFE01Δhcp1+ pPSV35 (empty plasmid used a
P25T6SS protein, is involved in motility [40]. IcmF is an
inner-membrane protein of the T6SS found in numerous
pathogens, and has been implicated in intracellular
multiplication inside host cells [41,42]. In an avian
pathogenic E. coli, icmF mutation impaired motility [43];
the authors indicate that this contrasts with other mu-
tants in T6SS genes, notably clpV and hcp, which had no
motility defects. Their findings suggest that the motilityMFE01 hcp1 
MFE01 hcp1+pPSV35 
MFE01 01 hcp2 
MFE01 hcp1+hcp1 
the extracellular matrix and on motility. A: Protein fractions from
SDS-PAGE and Coomassie staining. Bands with approximate molecular
erature of 28°C and were identified as flagellin proteins by MALDI-TOF
n 0.3% agar at 28°C. MFE01, MFE01Δhcp2 and MFE01Δhcp1+hcp1 were
s control) were non motile (n = 3).
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defect of motility because of a non-functional T6SS.
IcmF was somehow involved in flagellar regulation. The
restoration of the motility of MFE01Δhcp1 by hcp1
introduction in trans implies that the function of T6SS
associated to hcp1 expression is directly involved in mo-
tility in this strain.
The hcp1 mutant of P. fluorescens MFE01 retains virulence
toward competitor bacteria
The Hcp concentration was slightly lower in the super-
natant of MFE01Δhcp1 than that of the wild-type
MFE01 at 28°C (Figure 5A). This is consistent with our
previous observations [31]: most of the Hcp secreted by
MFE01 is produced from the expression of the hcp2
gene. We have also demonstrated that MFE01 has a kill-
ing activity against various Gram-negative bacteria on
solid medium. MFE01Δhcp2 reduced prey cell popula-
tions, but significantly less than MFE01 indicating that
Hcp2 contributes to the killing activity, and that another
factor is also involved. To determine whether Hcp1
could be this other factor, we co-cultured mutant
MFE01Δhcp1 and the prey MFN1032 on a filter on solid
media for 4h at 28°C. There was no significant difference
of the MFN1032 population between the co-culture with
wild-type MFE01 and the co-culture with MFE01Δhcp1
(Figure 5B). Thus, Hcp1 was not the key factor in this
antibacterial activity even if it contributed to killing.100
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Figure 5 Hcp secretion and killing activity of P. fluorescens MFE01 an
MFE01Δhcp1 cultures were analysed by SDS-PAGE and Coomassie staining. B
indicated by the arrow, were observed at a growth temperature of 28°C. MW
assays were performed. Prey cells (MFN1032 carrying pSMC21-gfp) were or w
MFE01Δhcp1Δhcp2 and MFE01Δhcp2; after 4 h at 28°C, MFN1032 cfu were co
* Indicates a significant difference in MFN1032 cfu (p-value <0.05) relative to t
a significant difference in MFN1032 cfu (p-value <0.05) relative to the MFN103
P25Whereas, the MFE01Δhcp2 mutant had significantly less
antibacterial activity than MFE01 and MFE01Δhcp1. The
double mutant, MFE01Δhcp1Δhcp2, was even less bac-
tericidal than MFE01Δhcp2 but nevertheless reduced the
MFN1032 population. Another system independent of
Hcp1 and Hcp2 seems to be involved in killing activity.
P. fluorescens MFE01 inhibits the motility of P. fluorescens
strain MFN1032
The killing activity mediated by T6SS during swarming
in P. mirabilis involves self-recognition (the Dienes ef-
fect), and we therefore studied the behaviour of MFE01
in conditions permitting its motility [7,8]. In swimming
conditions (in 0.3% agar), P. fluorescens MFN1032 was
spotted into the centre of a ring formed by MFE01 or its
mutants (Figure 6A). MFE01, MFE01Δhcp1+hcp1 and
MFE01Δhcp2 inhibited MFN1032 motility, but swim-
ming MFN1032 spread through the MFE01Δhcp1 and,
MFE01Δhcp1+pPSV35 mutants (Figure 6B). The hcp1
mutation thus abolished MFE01 confining MFN1032.
Introduction of the native hcp1 gene in trans restored
the inhibitory activity on MFN1032 swimming. Thus, in
these swimming conditions, hcp1 expression seems re-
quired for P. fluorescens MFE01 to control the swim-
ming of P. fluorescens MFN1032. In these conditions,
MFE01Δhcp1 lacked motility whereas MFE01 was motile
(Figure 4B). The confinement of MFN1032 could be
simply due to the formation of a physical barrier by the 
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Figure 6 Effects of P. fluorescens MFE01 and its mutants on competitive bacteria. A: Schematic drawing of the assay: P. fluorescens
MFN1032 was inoculated into the centre of a ring formed by MFE01 or a mutant on LB medium in 0.3% agar. On this medium MFN1032 and
ME01 can swim. B: Swimming of MFN1032 in competition with MFE01 or mutants. Results after incubation at 28°C, 24 h. The images shown are
representative of three assays. C: Co-cultures were performed on swarming medium (LB in 0.6% agar) at 28°C, 24h. On this medium MFN1032 can
swarm but ME01 cannot. Prey cells (MFN1032) were or were not mixed with P. fluorescens MFE01 or its derivatives at ratio 1:5. The images shown
are representative of three assays. D: Quantitative black histograms represent survival of MFN1032 and white squares the MFN1032 swarm diameter
(n = 4, error bars represent standard error of the mean). * Indicates a significant difference of the MFN1032 cfu (p-value <0.05) relative to the MFN1032/
MFE01 assay. ns: no significant difference.
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not form this barrier.
So we therefore conducted co-cultures overnight on
0.6% LB agar, conditions allowing the swarming of
MFN1032. On these plates, MFE01 and mutants were
unable to swarm because MFE01 lacks surfactantsP25essential for P. fluorescens swarming [44]. MFE01 and
MFE01Δhcp2 clearly inhibited MFN1032 swarming,
whereas MFE01Δhcp1 and MFE01Δhcp1Δhcp2 had much
less effect on MFN1032 swarming (Figure 6C,D). This
indicates that the inhibition of motility observed was
not due to MFE01 or its derivatives forming a physical
Decoin et al. BMC Microbiology  (2015) 15:72 Page 7 of 12barrier. Also, diameter of the MFN1032 swarming was
reduced, albeit to a lesser extent, by the double mutant
MFE01Δhcp1Δhcp2 providing further evidence for an-
other unidentified inhibitory factor. These experiments
are uninformative about whether the decrease in swarming
diameter is due to a killing activity or an immobilization
activity.
We consequently assayed the bactericidal activity of
MFE01 and its mutants by counting MFN1032 cells in
each swarming condition (Figure 6D). The MFN1032
population underwent 5-logs drops after co-culture with
wild-type MFE01. Co-culture with MFE01Δhcp1 and
MFE01Δhcp2 did not significantly decrease the MFN1032
population. We assumed that when co-cultured with
MFE01Δhcp1, MFN1032 cells could swarm and thereby
escape from the killing activity mediated by Hcp2,
which requires close contact. When in co-culture with
MFE01Δhcp2, MFN1032 could not be able to escape
but the killing activity is abolished by hcp2 mutation.
In antibacterial activity assays on solid media (Figure 5B),
the MFN1032 cells were immobilized on a filter, and
therefore unable to escape the killing activity of the hcp1
mutant.
These results suggest that MFE01 needs Hcp1 and
Hcp2 to kill MFN1032 in conditions of motility: Hcp1
could reduce the motility of prey cells and thereby facili-
tate killing by Hcp2.Figure 7 Phenotypes of the MFE01ΔtssC mutant. A: Swimming assay o
motile contrary to MFE01Δhcp1 and MFE01ΔtssC strains (n = 3). B: Represen
28°C, 24 h (n = 3). +: mucoid, −: non mucoid. C: Effects of P. fluorescens MF
were performed on LB medium supplemented with X-Gal (40 μg/ml) at 28
were not mixed with P. fluorescens MFE01 or its derivatives at ratio 1:1. Blue
representative of three assays.
P25Phenotypes assigned to Hcp1 and Hcp2 are associated to
a T6SS
Analysis of MFE01 draft genome is under way. Prelimin-
ary results indicated that this genome contains only one
T6SS cluster exhibiting all core component genes but
hcp genes. The two hcp genes, hcp1 and hcp2, are separ-
ately located outside this cluster and are associated with
vgrG genes. Into this unique T6SS we identified a gene
coding for a putative protein corresponding to a protein
member of EvpB/VC_A108 family (TIGR03355). This
putative protein matched with the WP_016772499.1
sequence (MULTISPECIES: type VI secretion protein
[Pseudomonas], with 99% identity and coverage of
100%). These proteins are described as T6SS needle
sheath proteins TssC and are essential components of
this system. MFE01ΔtssC, a mutant disrupted in this
T6SS core component gene, was non motile in swim-
ming conditions and non-mucoid at 28°C as well as
MFE01Δhcp1 (Figure 7A and B) whereas MFE01Δhcp2
conserved the wild type phenotype (mucoid and motile).
During co-culture on LBG containing X-gal at 28°C
with E.coli containing pUC19 (E.colipUC19), MFE01Δhcp2
and MFE01ΔtssC allowed E.colipUC19 growth (blue spots)
whereas MFE01Δhcp1 and MFE01 inhibited E.colipUC19
growth (white spots) (Figure 7C). ME01ΔtssC pheno-
type seems similar to a patchwork of MFE01Δhcp1
and MFE01Δhcp2 phenotypes. These results provide an LB in 0.3% agar at 28°C during 24 h. MFE01 and MFE01Δhcp2 were
tative images of mucoidy of MFE01 and MFE01ΔtssC on LB agar at
E01 and its mutants on competitive E.coli on solid medium. Co-cultures
°C during 24 h. Prey cells (E.coli DH5αmcr containing pUC19) were or
is due to X-Gal degradation by E.colipUC19. The images shown are
Table 1 Plasmids and strains used in the study
Strains or plasmids Relevant characteristics Reference/
source
P. fluorescens
MFE01 Air isolate, RifR [31]
MFE01Δhcp2 MFE01 with early stop
codon in hcp2
[31]
MFE01Δhcp1 MFE01 with hcp1 disruption This study
MFE01Δhcp1 + hcp1 MFE01Δhcp1 with pPSV35
carrying the wild-type
hcp1 gene
This study
MFE01Δhcp1Δhcp2 MFE01 with hcp1 and hcp2
mutations
This study
MFE01ΔtssC MFE01 with tssC disruption This study
MFN1032 Clinical strain [33]
MFP05 Skin isolate [32]
Pf-5 Plant isolate [34]
MFE07 Air isolate This study
Escherichia coli
DH5αmcr General cloning strain LMSM
collection
S17.1 RP4-2-Tc::Mu, aph::Tn7, recA,
SmR, donor strain for
conjugation
[48]
Vectors
pPSV35 P. aeruginosa oriV, lacIq mob+,
PlacUV5, pUC18 MCS,
expression vector, GmR
[49]
pSMC21-gfp Replicative plasmid, KmR, gfp [46]
pME3087 Suicide plasmid, TcR [47]
pUC19 Replicative plasmid, lacZ, ApR Invitrogen®
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in a T6SS.
Conclusion
In this work, we further illustrate the importance and
versatility of the T6SS in bacterial adaptation and fitness.
We demonstrated cooperation between two different
Hcp proteins in bacterial competition. The observations
indicate that T6SS associated with Hcp1 secretion has
pleiotropic effects on P. fluorescens MFE01: it affects
mucoidy, motility and competitor inhibition in motility
conditions. The relationships between T6SS and flagellin
and between T6SS and mucoidy have not yet been fully
elucidated. Nevertheless, we describe some of the mech-
anisms associated with MFE01 motility and inhibition of
prey cell motility. This suggests that some effectors, that
are used to inhibit competitor motility, could be accu-
mulated in MFE01Δhcp1, in absence of Hcp1, and con-
sequently might inhibit the mutant’s own motility.
Analysis of MFE01 draft genome is under way. Numer-
ous mutants should be constructed to analyse function
of unknown putative genes surrounding these hcp genes
to ensure an informative genomic annotation and to ex-
plain how this T6SS could impact mucoidy and motility.
Methods
Bacterial strains, plasmids and culture conditions
All strains and plasmids used are listed in Table 1. All
bacterial strains were grown in LB medium with shaking
(180 rpm). Pseudomonas fluorescens strains were grown
at 28°C or 37°C and Escherichia coli at 37°C. Media were
supplemented with antibiotics as appropriate: kanamycin
(Km) 50 μg/ml (E. coli) or 200 μg/ml (P. fluorescens);
tetracycline (Tc) 15 μg/ml; gentamicin (Gt) 15 μg/ml
(E. coli), or 50 μg/ml or 100 μg/ml (P. fluorescens in liquid
and solid media, respectively).
Hcp secretion analysis
Hcp secretion was studied by harvesting the superna-
tants by centrifuging the cultures at 5000 × g for 10 mi-
nutes at 20°C and passing them through a Millipore
membrane with 0.22 μm pores. TCA (trichloroacetic
acid, Sigma-Aldrich) was added to the supernatant to a
final concentration of 10% and the mixture was incu-
bated overnight at 4°C. The supernatant was removed by
centrifugation at 13000 × g, for 30 minutes at 4°C. The
protein pellet was washed twice with 5 ml of 20 mM
Tris base (VWR) in cold acetone (Merck) and centri-
fuged at 13000 × g, for 30 minutes at 4°C. The dry pellet
was then resuspended in distilled water. Proteins were
separated by sodium dodecyl sulphate polyacrylamide
gel electrophoresis (SDS-PAGE). Briefly, samples were
mixed with an equal volume of 2 × Laemmli sample bufferP25(with β-mercaptoethanol), boiled for 5 min at 100°C and
then cooled to room temperature before loading.Mucoid phenotype and swimming assays
Strains were plated on LB agar with 0.1 mM IPTG and
incubated for 24 h at 28°C; the colonies were then exam-
ined for the mucoid phenotype. Swimming assays were
performed as previously described [45].Swarming killing assay
The protocol described by Alteri and colleagues [8]
was used with minor modifications. Aliquots of 5 μl
of a mixture of strains at a ratio of 5:1, MFE01 or
mutants: MFN1032 containing plasmid pSMC21-gfp
[46] were spotted onto LB 0.6% agar with 0.1 mM
IPTG. The plates were incubated overnight at 28°C, and
the entire swarm was collected, and serially diluted. Ali-
quots of 10 μl of each dilution were plated on LB agar
supplemented with 200 μg kanamycin and colony forming
units counted.
Table 2 Oligonucleotides used for this study
Primer name Primer sequence (5′-3′)
PFL_1449mucAF ATAATAAGAGCTCATGAGTCGTGAAGCCCTGC
PFL_1449mucAR ATAATAATCTAGATTAGCGGTTTTCCAGGCTTG
Hcp1F ATGGCAACACCAGCGTACATG
Decoin et al. BMC Microbiology  (2015) 15:72 Page 9 of 12Motility inhibition
Overnight cultures were centrifuged at 3000 × g, for 5
minutes at room temperature. The cell pellets were
collected on toothpicks which was used to stab 0.3%
agar LB plates, with 0.1 mM IPTG; the plates were then
incubated at 28°C overnight.Hcp2R TTAAACGACTGGAGCACGCCA
Hcp3F CCTGATCACTGCCGGCGCTT
Hcp4R ACGCCAGTCATCGGAACCCG
muta1tssC CTGAGACTCCAGTAGCCAAG
muta2tssC AAGCTTTCCAGACCGAAGAAATACTTCGTGGGT
CCAGGTGAT
muta3tssC ATCACCTGGACCCACGAAGTATGAAGGCTTCAT
CTCCCTGAC
muta4tssC ATGTCATTGAGATCGGGCAAAntibacterial competition assay
Antibacterial competition assays in solid media were
performed as described by Decoin and coworkers [31].
To ensure pSMC21-gfp stability (presence or absence) in
our conditions, MFN1032 containing pSMC21-gfp was
cultivated in LB medium containing kanamycin until
OD580 nm of 1. Serial dilutions were then plated on LB
plates without Kanamycin during 24 h at 28°C. Colonies
were scrapped and suspended in NaCl 9 g/L and ad-
justed to OD5580 nm of 1. Serial dilutions were plated on
selective (with kanamycin) and non-selective (without
kanamycin) plates and counting. Statistics were done by
pairwise strain comparisons (non-parametric Mann–
Whitney-two tailed Test): no significant difference was
observed between the two conditions (p-value >0.05,
n = 6).
For E.coli growth inhibition, Pseudomonas fluorescens
MFE01 and mutants were cultivated at 28°C in LB
medium with shaking at 180 rpm overnight. Escherichia
coli DH5αmcr transformed with pUC19 (E.colipUC19),
allowing blue detection on medium containing X-Gal,
was cultivated at 37°C in LB with ampicillin (50 μg/ml)
with shaking at 180 rpm overnight. The OD580 nm was
adjusted to 0.5 and the strains were mixed at a 1:1 ratio.
A volume of 20 μl was spotted in LB agar plates supple-
mented with X-Gal (40 μg/ml) and incubated overnight
at 28°C.Disruption of the hcp1 gene in P. fluorescens MFE01
MFE01Δhcp1 was generated by deletions in the 5′
(44 bp) and 3′ extremities (18 bp) of hcp1. 5′ and 3′
truncated hcp1 was generated by PCR with the Hcp3F
and Hcp4R primers (see Table 2). The resulting trun-
cated hcp1 construct was introduced between the
EcoRI and HindIII sites (blunt-ended) of the transfer-
able suicide plasmid pME3087 (6.9 Kb) [47]. The resulting
plasmid, pME3087Δhcp1, was verified by sequencing and
was then transferred into MFE01 by biparental mating:
E. coli S17-1 [48] containing pME3087Δhcp1 and recipi-
ent MFE01 cells were mixed and spotted onto LB agar
plates and incubated overnight at 37°C. The mating
mixture was then suspended in 1 ml of sterile NaCl 9 g/L
and 0.1 ml aliquots were spread on LB agar plates supple-
mented with tetracycline (12 μg/ml), to select for the pres-
ence of the integrated plasmid, and rifampicin (25 μg/ml),
to kill the E. coli S17-1 donor bacteria and to ensure theP25selection of MFE01. The resulting hcp1 mutant (contain-
ing two truncated hcp1 genes) was named MFE01Δhcp1.
Disruption of the hcp2 gene in P. fluorescens MFE01Δhcp1
and disruption of the tssC gene in P. fluorescens MFE01
A markerless hcp2 mutation was introduced into
MFE01Δhcp1 strain by the protocol described by Decoin
and co-workers [31]. The resulting strain was named
MFE01Δhcp1Δhcp2. The same protocol with PCR modifi-
cations was used to introduce a markerless tssC mutation
into MFE01 strain. This tssC deletion was achieved by
PCR with the muta1tssC and muta2tssC primers (<650 bp
product) or the muta3tssC and muta4tssC primers (<650
bp product) (Table 2). The PCR products obtained cor-
responded to the upstream and downstream parts, re-
spectively, of the tssC gene of MFE01, each carrying an
overlapping sequence at the end. PCR parameters were as
follows: annealing temperature, 62°C, extension time, 45 s;
35 cycles. A third PCR was then carried out in which the
overlapping sequences of the two first products were hy-
bridized together allowing the tssC deletion after PCR
with the muta1tssC and muta4tssC primers. The PCR
parameters were as follows: annealing temperature, 62°C;
extension time, 1 m 45 s and 35 cycles. The mutant con-
taining the tssC deletion was verified by DNA sequencing
and named MFE01ΔtssC.
Heterologous expression of mucA in MFE01
The mucA (PFL_1449) sequence was amplified with the
PFL_1449mucAF and PFL_1449mucAR primers (Table 2)
by standard PCR from genomic DNA from P. protegens
Pf-5. The PCR conditions were as follows: an annealing
temperature of 64°C, an extension time of 30 s and 25
cycles. The polymerase used was Phusion® High-Fidelity
DNA polymerase (NEB). The PCR product was digested
with SacI (NEB) and XbaI (NEB) and ligated into
pPSV35 [49] digested with the same enzymes. E. coli was
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plasmid was checked by PCR. Fresh MFE01 colonies
were washed twice in cold sterile distilled water and
transformed with 5 μl of plasmid DNA by electropor-
ation in 1 mm cuvette at 1.8 kV (Savant electroporater).
LB was then added and the mix incubated for 1 h at 28°C
with shaking (180 rpm). The samples were then plated on
LB agar supplemented with gentamicin and with 0.1
mM IPTG.
Insertion of the hcp1 gene into pPSV35 and construction
of strain MFE01Δhcp1+hcp1
The hcp1 gene was amplified from the P. fluorescens
MFE01 genome with the Hcp1F and Hcp2R primers
(Table 2). The PCR conditions were as follows: an an-
nealing temperature of 59°C, an extension time of 30 s
and 25 cycles. The polymerase used was the Phusion®
High-Fidelity DNA polymerase (NEB). The amplified
fragments were inserted into the pPSV35 shuttle vector
at SmaI site by blunt-end ligation, and the resulting
pPSV35-hcp1 was used to transform E. coli DH5αmcr
cells by electroporation. Plasmid DNA was isolated using
the QIAprep Spin Miniprep Kit (Qiagen) and checked
by PCR and asymmetric digestion with BamHI (NEB) to
verify the orientation of the insert. MFE01Δhcp1 was
transformed with pPSV35-hcp1 by electroporation as
described in the section “Heterologous expression of
mucA in MFE01”. The resulting strain was called
MFE01Δhcp1+hcp1.
Preparation and purification of extracellular matrix (ECM)
containing exopolysaccharides (EPS)
Strains were tested for EPS production on LB agar at
28°C. ECM was extracted as described by Dignac and
colleagues with modifications [50]. Biomass was harvested
and suspended in NaCl 9 g/L then sonicated at 37 Watts
for 30 sec on ice and centrifuged (20,000 × g for 30 min).
Clear supernatants were collected and three volumes of
ice-cold ethanol were added; the samples were incubated
for 24 h at 4°C, and EPS were collected by centrifuga-
tion (7000 × g, 30 min). The EPS-containing pellets were
resuspended in water and lyophilised.
Analysis of the monosaccharide composition of EPS by
gas chromatography – flame ionization
Lyophilised EPS were hydrolysed by treatment with 2M
trifluoroacetic acid for 2 hours at 110°C. Monosaccha-
rides were then derivatised: methanol-1M HCl (Supelco)
was added and the samples incubated at 80°C overnight;
then a mix of hexamethyldisiloxan:trimethyldisiloxan:
pyridine (3:1:9, Supelco) was added and the samples in-
cubated at 110°C for 20 minutes. The resulting deriva-
tives were dried then dissolved in 1 ml of cyclohexane
and injected into the 3800 GC system equipped with aP25CP-Sil5-CB column (Agilent Technologies). Elution was
performed with the following gradient of temperature:
120°C to 160°C at a rate of 10°C per minute, 160°C to
220°C at a rate of 1.5°C per minute, 220°C to 280°C at a
rate of 20°C per minute. Quantification was based on
the internal standard and response factor determined
previously for each monosaccharide.Biofilm formation
Pure culture biofilms were grown in continuous-culture
three-channel flow cells (channel dimensions, 1 by 4 by
40 mm). The system was assembled and prepared as fol-
lows: system sterilization during 4 h with bleach at 1.2%
and rinsing with sterile NaCl 9 g/L. Before flow chamber
inoculation, LB medium was injected into the system at
28°C. Overnight cultures were centrifuged at 8 000 × g
during 5 min at room temperature. Pellets were recov-
ered and washed twice with 2 mL of sterilized physio-
logical water. Channels were inoculated with 1 mL of
pure bacterial suspension at DO580nm = 0.1. Bacteria
were allowed to attach to the glass surface (microscope
coverslip, VWR International, Fontenay sous Bois, France)
during 2 h at 28°C under static conditions. Biofilm growth
was then performed under a constant flow of LB medium
with antibiotics at appropriate concentration if necessary
(Wakson Marlow 205S, 2.5 mL/h) for 48 h at 28°C.Confocal laser scanning microscopy (CLSM) and image
analyses
Microscopic observations were performed with a LSM
710 system, Zeiss, Germany by using a 63x oil immersion
objective. Biofilms were observed after a 15 min incuba-
tion with 5 μM Syto 9® green fluorescent nucleic acid stain
(life technologies) (excitation and emission λ, 488 nm and
510 nm, respectively). Biofilm stacks were analysed with
COMSTAT software. The calculated parameter was the
biovolume, which is the volume of bacteria (in μm3) per
μm2 of glass surface. The results were the mean of at least
five independent experiments.Mass spectrometry analysis
Mass spectroscopy (MS) analyses were performed with a
MALDI-TOF AutoflexIII (Brucker) in positive ion mode
as described by Barbey et al. [51]. Statistical analyses
of the sequences involved determining the probability
based on Mowse score with MASCOT software (pep-
tide tolerance = 100 ppm and mass values =MH+). A
p-value of less than 0.05 was considered significant.
The criteria used to accept a protein identification based
on peptide mass fingerprinting (PMF) data included a
score probability greater than a score threshold defined by
MASCOT software.
Decoin et al. BMC Microbiology  (2015) 15:72 Page 11 of 12Statistical analysis
Non-parametric Mann–Whitney Tests (two tailed) with
GraphPad Prism version 6.0 (La Jolla, CA) were used for
statistical analyses. A p-value <0.05 was considered to be
statistically significant.
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Human exposure to nitrogen dioxide (NO2), an air pollutant of increasing interest in
biology, results in several toxic effects to human health and also to the air microbiota.
The aim of this study was to investigate the bacterial response to gaseous NO2. Two
Pseudomonas fluorescens strains, namely the airborne strain MFAF76a and the clinical
strain MFN1032 were exposed to 0.1, 5, or 45 ppm concentrations of NO2, and
their effects on bacteria were evaluated in terms of motility, biofilm formation, antibiotic
resistance, as well as expression of several chosen target genes. While 0.1 and 5 ppm
of NO2did not lead to any detectable modification in the studied phenotypes of the two
bacteria, several alterations were observed when the bacteria were exposed to 45 ppm
of gaseous NO2. We thus chose to focus on this high concentration. NO2-exposed
P. fluorescens strains showed reduced swimming motility, and decreased swarming in
case of the strain MFN1032. Biofilm formed by NO2-treated airborne strain MFAF76a
showed increased maximum thickness compared to non-treated cells, while NO2 had
no apparent effect on the clinical MFN1032 biofilm structure. It is well known that
biofilm and motility are inversely regulated by intracellular c-di-GMP level. The c-di-GMP
level was however not affected in response to NO2 treatment. Finally, NO2-exposed P.
fluorescens strains were found to bemore resistant to ciprofloxacin and chloramphenicol.
Accordingly, the resistance nodulation cell division (RND) MexEF-OprN efflux pump
encoding genes were highly upregulated in the two P. fluorescens strains. Noticeably,
similar phenotypes had been previously observed following a NO treatment. Interestingly,
an hmp-homolog gene in P. fluorescens strains MFAF76a and MFN1032 encodes a
NO dioxygenase that is involved in NO detoxification into nitrites. Its expression was
upregulated in response to NO2, suggesting a possible common pathway between NO
and NO2 detoxification. Taken together, our study provides evidences for the bacterial
response to NO2 toxicity.
Keywords: airborne, Pseudomonas fluorescens, nitrogen dioxide, biofilm, antibiotic sensitivity, motility, air
pollution
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INTRODUCTION
Most world-wide cities have serious air-quality problems, which
have attracted attention in the past decade. One of the most
common source of air pollution is engine emissions, which
include, among other toxic molecules, the nitrogen oxides (NOx;
reviewed in Sher, 1998; Skalska et al., 2010). The general term
NOx includes nitric oxide (NO) and nitrogen dioxide (NO2).
NO in turn is able to damage bacterial cells interacting with
bacterial proteins (McLean et al., 2010; Laver et al., 2013) and
DNA (Tamir et al., 1996; Burney et al., 1999) either directly,
or via formation of reactive nitrogen species (RNS), causing
alterations in bacterial metabolism, among which respiration,
and homeostasis. As a result, bacteria have developed specific
NO detoxification pathways and defense mechanisms (Cruz-
Ramos et al., 2002; Flatley et al., 2005; Spiro, 2007). In order
to counteract the NO-mediated respiratory arrest (Husain et al.,
2008), the detoxification processes are completed in several
bacteria by metabolism reprogramming (Auger et al., 2011;
Auger and Appanna, 2015). NO was furthermore identified as
a signaling molecule, which promotes the biofilm dispersion
in various bacterial strains, including Pseudomonas aeruginosa
(Barraud et al., 2009; Cutruzzola and Frankenberg-Dinkel, 2015)
and P. putida (Liu et al., 2012). This molecule is also known
to modulate bacterial antibiotic sensitivity, protecting bacteria
from a wide range of antibacterial agents (Gusarov et al.,
2009; McCollister et al., 2011; van Sorge et al., 2013), such as
vancomycin and daptomycin (van Sorge et al., 2013). Contrary
to NO, NO2 has a low solubility in water (Augusto et al., 2002).
Thence NO2 in aqueous media concerned a few reports in the
microbiological context. However, in natural environments NO
is unstable and quickly oxidized to form NO2 (Skalska et al.,
2010), considered as a major air pollutant. Its atmospheric level is
ruled by European environmental commission andWorldHealth
Organization (INERIS, 2011; Reduction of pollutant emissions
from light vehicles, 2015; WHO |Ambient (outdoor) air quality
health, 2015). NO2 toxicity to human health is well documented
and is known to increase cardiovascular diseases (Chaloulakou
et al., 2008), or to aggravate respiratory symptoms especially in
children (Pershagen et al., 1995; Chauhan et al., 1998). On the
opposite, the stress promoted by NO2 was poorly evaluated on
bacteria.
It is increasingly evident that the air is a biotic environment,
containing bacteria as one of the major compounds of primary
atmosphere aerosol particles (Burrows et al., 2009b; Després
et al., 2012). Mean airborne bacterial concentrations can
indeed be greater than 1 104 cells m−3 (Bauer et al., 2002;
Burrows et al., 2009a). Although unstable, the air microbiota
is frequently constituted with members of Pseudomonas genus
(Fang et al., 2007; Pearce et al., 2010; Després et al., 2012;
Dybwad et al., 2012; Šantl-Temkiv et al., 2015). Among these
highly versatile elements, the P. fluorescens strains are widely
adaptable and distributed (Bodilis et al., 2004) in all major
natural environments, including water (Bodilis et al., 2004),
soil (Varivarn et al., 2013) and clouds (Ahern et al., 2007).
Several P. fluorescens strains were also found to promote
humans acute infections and were reported in clinical samples
of immuno-compromised patients (Chapalain et al., 2008; Scales
et al., 2014). All these properties make P. fluorescens a goodmodel
for further investigations of airborne bacteria.
We have investigated in previous studies the microbiota
(bacteria, yeasts and fungi) of Rouen harbor terminal (France)
(Morin et al., 2013). Thus, several P. fluorescens strains
were isolated. Among them, the airborne P. fluorescens strain
MFAF76a was characterized as a virulent strain, particularly
its exoproducts against human epithelial pulmonary cells
(Duclairoir Poc et al., 2014). The aim of this study is to investigate
the physiological response of airborne P. fluorescens MFAF76a
to NO2 as a marker of air pollution in terms of motility, biofilm
formation and antibiotic resistance. This response was compared
to that of the clinical strain P. fluorescensMFN1032 isolated from
the sputum of a pneumonia-suffering patient (Chapalain et al.,
2008). The parameters of bacterial NO2 exposure were adapted to
mimic real-life air conditions. Thus, the two strains were exposed
to gaseous NO2 at three concentrations: 0.1 ppm as an annual
guideline value (WHO |Air quality guidelines - global update,
2005) 5 ppm as the threshold causing reversible effects on human
health, and 45 ppm as a high NO2 concentration provoking
irreversible effects (INERIS, 2011).
MATERIAL AND METHODS
Strains and Growth Conditions
Cyan Fluorescent Protein (CFP)-labeled P. fluorescensMFN1032
and MFAF76a were used in this study. The strains and plasmids
are listed in Table S1. The 729-bp cfpopt gene, encoding the
CFP, was extracted from pTetONCFPopt plasmid (Sastalla et al.,
2009) using PstI and Xmal enzymes (NEB, Ipswich, USA). Then
CFP cassette was separated by 1% agarose gel electrophoresis
and purified with QIAquick Gel Extraction Kit (Qiagen, Hilden,
Allemagne). The pPSV35 vector (Rietsch et al., 2005) was
digested using PstI and Xmal and purified using QIAquick PCR
Purification Kit (Qiagen, Hilden, Allemagne). The CFP cassette
was then cloned into the PstI and Xmal sites of the pPSV35
vector. The resulting pCFP vector was introduced into One
Shot R© TOP10 Chemically Competent E. coli (LMSM collection)
by heat shock. After antibiotic selection of the clones (gentamycin
15µg/mL), the transformation was confirmed by confocal laser
scanning microscope (CLSM 710, ZEISS). The obtained plasmid
was then extracted from E. coli using QIAprep Spin Miniprep Kit
(Qiagen, Hilden, Allemagne) and introduced into P. fluorescens
strains by electroporation. The transformants were selected in
LB containing 15µg/mL of gentamycin and fluorescence was
assayed using CLSM.
Bacteria were grown at 28◦C under limited agitation
(180 rpm) in DMB (Davis Medium Broth) minimal medium
with 2.16 g/L glucose as carbon source (Duclairoir-Poc et al.,
2011). Overnight cultures were diluted (A580 = 0.08) in fresh
DMB and grown to the end of exponential phase (A580 =
2, 13 × 108 CFU/mL). Bacterial cultures at the end of
exponential growth phase (about 3 × 107 bacteria per filter)
were transferred on cellulose nitrate membrane filter (0.45µm,
pore size 0.2µm, diameter 47mm, Sartorius Biolab Products,
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Gottingen, Germany) and grown on DMB agar plates at 28◦C
for 4 h to obtain a single layer’s bacterial population. After 4 h
of incubation, the cellulose membranes containing bacteria were
placed on agar one-well dishes (size 127.8 × 85.5mm, Thermo
Scientific Nunc, Roshester, USA), which were directly transferred
into the gas delivery device (Figure 1).
Exposition to Nitrogen Dioxide
In order to mimic the atmospheric conditions, bacterial NO2
exposure was achieved in gas phase for 2 h, according to
Ghaffari et al. (2005). The gas delivery device consisted of
two sterile cylindrical Plexiglas exposure chambers (one for the
NO2 exposure, the second one for the control—exposure to
synthetic air). The exposure chambers were deposed in a drying
oven at 28◦C (Figure 1). The NO2, N2, and O2 obtained from
Air Liquide GMP Europe (Mitry-Mory, France) were mixed
together using digital mass flow regulators (Alicat Scientific, Inc.,
Tucson, USA) in order to get pre-calculated concentrations of
NO2 and maintain the O2/N2 ratio at 2/8 (v/v). The resulting
gas mixture and the synthetic air were routed independently
to each of the exposure chamber at a constant flow rate of 2
L/min, allowing parallel treatment of bacteria originating from
the same bacterial culture. After passing through the exposure
chamber, the NO2 concentrations were monitored by AC32M
nitrogen oxides analyzer (Environnement S.A, Poissy, France)
and safely vented to a chemical hood. Temperature and relative
humidity data were monitored to control reliable steady-state
environmental conditions inside the exposure chambers. Three
concentrations of NO2 (0.1 ppm; 5 ppm and 45 ppm) were used
in this study. After exposure, bacteria were diluted to A580 = 2 in
sterile saline solution and used for the subsequent experiments.
Antibiotic Sensitivity Assays
After NO2 exposure, bacterial sensitivity to ciprofloxacin,
chloramphenicol, tobramycin and kanamycin (Sigma-Aldrich,
St. Quentin Fallavier, France) was assayed. The minimum
inhibitory concentration (MIC) was determined by the broth
microdilution method achieved in DMB. Briefly, NO2-exposed
bacteria were diluted to A580= 0.08 and added to a 96-well
test plate (NuncTM, Roskilde, Denmark) containing different
concentrations of antibiotics in triplicate. The test plates were
incubated at 28◦C for 24 h. Synthetic air- exposed bacteria
were used as control. MIC was defined as the lowest antibiotic
concentration that inhibited bacteria growth as determined by
turbidimetry at A580.
Growth inhibition assays were achieved as previously
described (van Sorge et al., 2013). Exposed bacteria were
diluted in DMB supplemented by the indicated antibiotics in
subinhibitory concentrations (the last antibiotic concentrations
allowing bacterial growth). Bacteria were added to Bioscreen
Honeycomb plates (Oy Growth Curves Ab Ltd., Helsinki,
Finland) in a total volume of 200µL of DMB (A580 = 0.08).
Growth was measured every 15min (A580) for 24 h. The NO2
effect on the bacterial antibiotic sensitivity was calculated as
the percentage of bacterial growth with antibiotics after NO2
exposure on the bacterial growth with antibiotics after exposure
to synthetic air, using the following formula: 100×A580 NO2
exposed bacteria/A580 synthetic air exposed bacteria (%).
Motility Assays
Swimming and swarmingmotility assays were performed on agar
plates using DMB containing 0.2% (wt/vol) and 0.5% (wt/vol)
agar, respectively, as previously described (Déziel et al., 2001).
Briefly, 5µL of NO2 or synthetic air- exposed bacteria were
spotted on the surface of agar plates. The resultant diameters of
swim and swarm zones were measured after 24 h of incubation at
28◦C. Motilities were assayed in three independent experiments
with three replicates for each experimental condition.
Biofilm Monitoring By Confocal Laser
Scanning Microscopy
NO2 or synthetic air- exposed bacteria were diluted in sterile
saline solution to A580= 1 to avoid bacterial multiplication, and
added to glass-bottom dishes (SensoPlateTM, VWR, Fontenay-
sous-Bois, France). After 2 h of incubation at 28◦C, planktonic
bacteria were removed and bacterial adhesion on glass-
bottom dishes was observed using a confocal laser scanning
microscope (CLSM 710, ZEISS) with an immersion objective
63×. After addition of DMB, the samples were incubated at
28◦C for 24 h. Biofilms were rinsed with saline solution and
observed using CLSM. All biofilm assays were performed in
three independent experiments with two replicates for each
experimental condition. The biofilm thickness and related
biomass (bacterial volume,µm3/µm2) were estimated from 6
fields on 3 independent experiments using COMSTAT software
(Heydorn et al., 2000).
Gene Sequences Identification
The non-annotated genome drafts of MFN1032 and MFAF76a
were used to identify the corresponding nucleotide sequences
(data not shown). Homologous sequences search in P. fluorescens
annotated genomes was performed using pseudomonas genome
database (http://pseudomonas.com/). The conserved nucleotide
sequences were identified in P. fluorescens MFN1032 and
MFAF76a using Blast+ (Stand-alone) software (v. 2.2.30, NCBI)
according to Altschul et al. (1997), and are listed in Table S2.
Extraction and Quantification of Bis-(3′,
5′)-Cyclic Dimeric Guanosine
Monophosphate (c-di-GMP)
Extraction and quantification of intracellular c-di-GMP level
were performed in NO2 or synthetic air- exposed bacteria as
previously described (Spangler et al., 2010; Strehmel et al., 2015).
Identification and quantification of c-di-GMP was performed
using three specific mass transitions from molecule ion m/z 691
to the product ions: m/z 152, m/z 135, and m/z 540. The external
calibration was carried out at c-di-GMP concentrations ranging
from 10 ng to 200 ng in 500µL H2O using the internal standard
cXMP (50 ng). The resulting concentrations of c-di-GMP were
normalized against total protein contents of respective cultures,
which was determined by the bicinchoninic acid assay (Smith
et al., 1985). All experiments were performed in three replicates
for each experimental condition.
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FIGURE 1 | Schematic representation of NO2 gas delivery system. Bacterial NO2 exposure was done in gas phase for 2 h. Two exposure chambers (one
for the NO2 exposure, the second one for the control—synthetic air exposure) were used. The gases, including NO2, N2 and O2 were mixed together to obtain
pre-calculated concentrations of NO2 and maintain the O2/N2 ratio at 2/8 (v/v). NO2 concentrations, temperature and relative humidity were controlled.
Quantitative RT-PCR
Total RNA was prepared by the hot acid-phenol method
(Bouffartigues et al., 2012) from NO2-exposed and not bacteria.
Residual DNAs were eliminated by acid phenol treatment. The
absence of DNA was confirmed by showing that PCR reactions
failed without prior cDNA synthesis. RNAs were nonspecifically
converted to single stranded cDNAs using the High Capacity
cDNA Archive Kit (Applied Biosystems). Synthesis of cDNAs
and real time PCR, allowing the quantification of mRNAs of
interest were performed as previously described (Gicquel et al.,
2013) using primers listed in Table S3.
Statistical Analysis
All experiments were carried out several times. To assess the
significance of differences between the obtained data, Mann-
Whitney test or pairwise strain comparisons (t-test) were applied
and quantified the significance as (∗) for p < 0.05, (∗∗) for
p < 0.01 and (∗∗∗) for p < 0.001.
RESULTS AND DISCUSSION
NO2 is one of the most common air pollutants, but its effects
on the air microbiota is poorly studied. In order to assess the
bacterial response to NO2, airborne P. fluorescens MFAF76a and
clinical control MFN1032 strains were exposed to gaseous NO2
(as shown Figure 1) at 0.1, 5, or 45 ppm concentrations, and
their effects on bacteria were evaluated in terms of motility,
biofilm formation, antibiotic resistance, as well as expression
of several chosen target genes. While 0.1 and 5 ppm of NO2
did not lead to any significant modification of the studied
parameters in both the bacteria (data not shown), several
alterations were observed when the bacteria were exposed to
45 ppm of gaseous NO2. We thus chose to focus on this
concentration.
NO2-Mediated Modifications of Bacterial
Biofilm
In order to test the NO2 effect on P. fluorescens biofilm,
both airborne MFAF76a and clinical MFN1032 were exposed
to gaseous NO2 and synthetic air and grown for 4 h in
static conditions. In the control condition, the airborne strain
MFAF76a produced only a poorly structured biofilm with low
biomass and thickness (Figure 2A). To the best of the authors’
knowledge this is the first time that the biofilm of airborne P.
fluorescens strain was investigated. On the opposite, the clinical
strain MFN1032 was able to form a structured mushroom-like
biofilm, with about 2 and 3 fold more biomass and thickness than
the airborne strain MFAF76a, respectively (Figure 2B, control).
These data are consistent with previous studies showing that
clinical strains can strongly adhere and form structured biofilms
(Rossignol et al., 2008; Ma et al., 2009). After NO2 exposition,the
airborne strain MFAF76a produced biofilms with about 3 fold
increase of the maximal thickness, while the biomass was
similar (Figure 2A), when compared to synthetic air treatment.
These data suggest that NO2 led to induce biofilm formation
in this strain. Accordingly, similar NO concentrations were
previously found to promote an increase of biofilm formation
in P. aeruginosa (Barraud et al., 2006), suggesting a common
effect between NO and NO2 treatment. On the other hand, NO2
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FIGURE 2 | NO2 effect on P. fluorescens biofilm and intracellular c-di-GMP level. (A) Airborne MFAF76a and (B) clinical MFN1032 P. fluorescens strains were
exposed in triplicate to 45 ppm of NO2. Biofilm formation was analyzed in static conditions after 24 h development using confocal laser scanning microscope. The
biofilm biomass and the maximum thickness were estimated from 6 fields on 3 independent experiments using COMSTAT software. Intracellular c-di-GMP
concentrations (C) were measured in triplicate by LC-MS/MS for control ( ) and 45 ppm of NO2 treated ( ) MFAF76a and MFN1032. Obtained results are presented
as average values ± SEM. Statistical significance was calculated by the non-parametric Mann-Whitney-Test. n.s., non-significant.
exposure of the clinical strain MFN1032 led to a 1.7 fold increase
in biofilm production in terms of biomass, while the maximal
thickness was unchanged (Figure 2B). Taken together these
data suggest that the NO2-mediated biofilm modifications are
strain-dependent. Since we have shown previously that airborne
MFAF76a expresses a virulence activity toward A549 epithelial
pulmonary cells (Duclairoir Poc et al., 2014), these data suggest
that elevated concentrations of NO2 increases biofilm formation
in potentially virulent airborne strain and may represent a
sanitary risk.
Since biofilm formation is related to increased c-di-GMP
production (Ha and O’Toole, 2015), we next quantified the c-
di-GMP levels after NO2 or synthetic air exposure. As shown
in Figure 2C, both NO2-exposed P. fluorescens strains did
not exhibit statistically significant variations of intracellular
c-di-GMP concentrations. This was quite surprising since
observed in our study NO2 mediated biofilm induction. NO-
mediated reduction of the intracellular c-di-GMP level leading to
dispersion of P. aeruginosa biofilms has been related to increase
phosphodiesterases (PDEs) activity, and as a consequence to
promote the switch between the biofilm and the planktonic ways
of life (Petrova and Sauer, 2012; Roy et al., 2012; Li et al.,
2013; Petrova et al., 2014). In this bacterium, the following
PDEs, including DipA, MucR, NdbA and BdlA, are enzymes
that are involved in c-di-GMP catabolism (Petrova and Sauer,
2012; Roy et al., 2012). The mRNA levels of dipA, mucR, ndbA
and bdlA genes (KT186437, KT186445, KT186444 and KT186436
respectively, Table S2) were quantified by qRT-PCR experiments,
in the two strains, that were both previously exposed to NO2
or synthetic air. For the two strains, NO2 exposure did not
lead to any modification in gene expression (data not shown).
Altogether, these data suggest that (i) NO2 may have an effect
on the structure or on the biomass of the biofilm, in case
of the studied airborne or clinical strains, respectively, (ii)
these phenotypes would not be related to variations of the
intracellular c-di-GMP levels, and (iii) NO and gaseous NO2 may
have a common and concentration-dependent effect on biofilm
formation.
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NO2 Reduced Bacterial Motility
Since biofilm structure and production were not implemented by
c-di-GMP level in our conditions, we next assayed the effects of
NO2 on bacterial motility, since appendices like flagella and type
IV pili are also involved in the first step of biofilm formation, i.e.,
adhesion (Caiazza et al., 2007; Guttenplan and Kearns, 2013).
Swimming concerns motility in a liquid medium, mediated
by production and activity of flagella. As shown on Figure 3A,
gaseous NO2 exposition significantly decreased the swimming
motility of both strains, suggesting an impairment of the
flagellum production and/or activity.
Swarming is a complex motility that has been related to
functional flagella, type IV pili and production of biosurfactants
like cyclolipopeptides (Duclairoir-Poc et al., 2011) for some P.
fluorescens strains, or rhamnolipids for P. aeruginosa strains
(Caiazza et al., 2005). The airborne strain MFAF76a was
unable to swarm in tested experimental conditions. On the
opposite, MFN1032 is a swarmer clinical strain (Rossignol et al.,
2008). As shown in Figure 3B, exposition to NO2 but not to
synthetic air led to fully inhibit the swarming motility of this
strain.
Taken together, our data show that gaseous NO2 treatment
results in a decreased motility in both of the studied strains.
This decrease in motility could be a consequence of a lower
production of the required appendices. Alternatively it could
also be due to lower appendices activity, suggesting that they
could increase the attachment of the bacterium on the glass slide.
This phenotype would then be consistent with the increase in
biofilm maximal thickness in case of the airborne strain, and
biomass in case of the clinical strain. However, to date, the switch
between motility and biofilm had frequently been associated
to variations in the c-di-GMP level (Ha and O’Toole, 2015),
but, herein, the gaseous NO2-mediated differences in terms of
biofilm structure could not be related to any c-di-GMP level
variations.
Effect of NO2 on MexEF-OprN Efflux Pump
Expression and Antibiotic Resistance
To further characterize the effects of gaseous NO2 on bacterial
physiology, we next assayed antibiotic resistance. Since NO, a
member of RNS, was found to induce the expression of mexEF-
oprN genes (Fetar et al., 2011) and modulate bacterial resistance
to fluoroquinolones, chloramphenicol and aminoglycosides
(Gusarov et al., 2009; McCollister et al., 2011; van Sorge et al.,
2013), we investigated the effect of gaseous NO2 on these
phenotypes.
In order to study the effect of NO2 on MexEF-OprN
eﬄux pump, the transcription levels of mexE, mexF and oprN
genes (KT070324, KT070321 and KT070325 for MFAF76a;
KT070323, KT070322 and KT186432 forMFN1032, respectively)
were compared using qRT-PCR in two P. fluorescens strains
exposed or not to 45 ppm of NO2. In airborne and clinical
strains, the mexE mRNA level was increased by almost 14-
and 100-fold respectively; that of mexF almost 3.5- and 47-
fold respectively and that of oprN almost 4.6- and 73-fold
respectively (Figure 4). These data show that NO2 promoted
TABLE 1 | NO2 exposure increases Pseudomonas fluorescens antibiotic
resistance.
Strain NO2 concentration Ciprofloxacin Chloramphenicol
(ppm) MIC (µg/mL) MIC (µg/mL)
MFAF76a 0 6.25 50
45 12.5 >100
MFN1032 0 3.125 150
45 6.25 200
mexEF-oprN expression, potentially causing modifications in P.
fluorescens antibiotic resistance. We next tested the functionality
of this pump. Since the MexEF-OprN RND eﬄux pump is
involved in fluoroquinolone resistance, we next assayed bacterial
sensitivity against ciprofloxacin by evaluating their MICs. As
shown in Table 1, both the P. fluorescens strains were more
resistant to this antibiotic after exposure to NO2 than to
synthetic air. Chloramphenicol is a nitroaromatic antimicrobial
that is a substrate for MexEF-OprN (Köhler et al., 1997; Sobel
et al., 2005). Accordingly, NO2-exposed P. fluorescens strains
MFAF76a and MFN1032 were about 2 fold more resistant
to this antibiotic than synthetic air-treated bacteria (Table 1).
Taken together, these data suggest a possible higher activity
of this eﬄux pump in response to NO2 exposure. We next
followed the growth of the NO2-exposed P. fluorescens strains
in DMB medium containing ciprofloxacin or chloramphenicol
at the higher antibiotic concentration leading to bacterial growth
(Figure 5). Data were standardized with the control, the synthetic
air treated cells growth. While ciprofloxacin had no effect on
NO2-exposed bacteria, chloramphenicol at a concentration of 25
and 100µg/mL for strain MFAF76a and MFN1032, respectively,
led to an increase in growth for the two NO2-exposed
P. fluorescens strains (Figure 5). Remarkably, the statistically
significant increase of bacterial growth was maintained from
2 to 10 h, suggesting a possible NO2 protective effect that
would be conserved for 8 h after exposure. Taken together, our
data show that NO2 induced mexEF-oprN gene expression,
and consequently increased the resistance to ciprofloxacin and
chloramphenicol.
MexEF-OprN-overproducing mutants with enhanced
fluoroquinolone resistance often increase bacterial susceptibility
to aminoglycosides apparently owing to impairment of the
MexXY system (Sobel et al., 2005; Morita et al., 2015). The
effect of NO2 on tobramycin and kanamycin sensitivity was
then assayed by performing MICs. As shown in Table 2, NO2
treatment led to reduce the MICs of the two tested antibiotics,
suggesting that NO2 increases P. fluorescens sensitivity to
aminoglycosides. Tobramycin and kanamycin, at subinhibitory
concentration of 1.55 and 3.1µg/mL respectively, were found to
decrease the growth of NO2-exposed bacteria (Figure 6). This
effect was observed only from 6 to 10 h of growth for MFN1032
and from 6 to 18 h of growth forMFAF76a, highlighting the time-
limited NO2 effect on bacterial antibiotic sensitivity. Altogether,
our data show that NO2 increases P. fluorescens sensitivity to
tobramycin and kanamycin, accordingly its homolog NO is
also found to increase P. aeruginosa sensitivity to tobramycin
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FIGURE 3 | NO2 decreases P. fluorescens motility. Airborne MFAF76a and clinical MFN1032 P. fluorescens strains were exposed in triplicate to 45 ppm of
NO2( ). Swimming (A) and swarming (B) motilities were assayed on DMB-swim/swarm plates after 24 h incubation. The motile bacterial movement was evaluated in
three independent experiments with three replicates. The data were compared with control exposed to synthetic air ( ). Obtained results are presented as average
values ± SEM. Statistical significance was calculated by the non-parametric Mann-Whitney-Test p < 0.05 (*) and < 0.001 (***).
FIGURE 4 | NO2 effect on MexEF-OprN and MexXY efflux pump gene
transcription. The nucleotide sequences of the mexEF-, oprN- and
mexXY-homolog genes were obtained using the non-annotated genome
drafts of airborne MFAF76a ( ) and clinical MFN1032 ( ) P. fluorescens. The
GenBank accession numbers of nucleotide sequences are listed in Table S2.
Quantification of mRNA level was assayed using qRT-PCR on RNAs extracted
from NO2- and synthetic air- exposed P. fluorescens. The PCR reactions were
performed in triplicate and the standard deviations were lower than 0.15 Ct.
Statistical analysis used pairwise strain comparisons (t-test) p < 0.01 (**) and
< 0.001 (***). Dotted line shows the gene expression in synthetic air- exposed
control.
(Barraud et al., 2006). Noticeably, this phenotype is consistent
with previously published data supporting decreasing resistance
to aminoglycosides of MexEF-OprN-overproducing mutant
(Sobel et al., 2005; Morita et al., 2015). Since this phenotype
is often associated with the impairment of the MexXY-OprM
eﬄux pump, we next assayed the effect of NO2 on the expression
of the mexXY genes. As shown in Figure 4, NO2 treatment
had an opposite effect on mexXY gene expression. While NO2
increased the expression of mexXY in the airborne strain
MFAF76a, it drastically reduced production of mexXY mRNA
in the clinical strain MFN1032. While this latter phenotype is
often described in the literature (Sobel et al., 2003) as leading
to increased aminoglycoside susceptibility, the overproduction
of the two RND eﬄux pumps MexEF-OprN and MexXY-OprM
is remarkable and found in very few strains, among which the
multiresistant strain PA7 (Morita et al., 2015). Nevertheless, the
increased expression of mexXY in the airborne strain cannot be
related to the increased susceptibility to aminoglycosides, which
we observed. Taken together, our data indicate that the NO2
effect on bacterial aminoglycoside resistance is complex and
strain-dependent, and the up- or down- production of mexXY
cannot account solely to explain the increased susceptibility to
aminoglycosides of the two studied strains. Another hypothesis
may arise related to the effects of NO2 on membrane properties.
Indeed, the NO2 effect on P. fluorescens membrane was recently
investigated, demonstrating the NO2-mediated modifications
in both the membrane glycerophospholipids composition
(i.e., ratio zwitterionic/anionic glycerophospholipids) and in
the membrane electron-accepting properties (Kondakova,
personal communication). It is thus conceivable that these
membrane modifications would alter bacterial membrane
permeability, facilitating the aminoglycoside entry into the
bacterial cell.
NO2-Mediated Gene Expression in P.
fluorescens
Remarkably, we have shown herein a link between gaseous NO2
and soluble NO treatment. Indeed, NO is found to induce
the expression of mexEF-oprN genes (Fetar et al., 2011) and
modulates bacterial resistance to several antibiotics (Gusarov
et al., 2009; McCollister et al., 2011; van Sorge et al., 2013).
Since NO2 and NO are related chemical toxic compounds, and
since NO detoxification pathways have been deeply investigated,
the NO2 effects on several chosen target genes were tested.
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FIGURE 5 | NO2 protects Pseudomonas fluorescens from
chloramphenicol toxicity. After 2 h exposure to 45 ppm of NO2, growth of
airborne MFAF76a (A) and clinical MFN1032 (B) P. fluorescens with
ciprofloxacin ( ) and chloramphenicol ( ) was assayed. Growth curves were
performed with ciprofloxacin (3.125µg/mL for MFAF76a and 1.156µg/mL for
MFN1032) and chloramphenicol (25 and 100µg/mL respectively), and A580
was recorded at the indicated time points. The control sample was bacteria
exposed to synthetic air, and grown in presence of antibiotics in indicated
concentrations. The data are shown as percentages of growth relative to
synthetic air-exposed control. Pooled data from three independent
experiments in duplicate ± SEM are reported. Statistical significance was
calculated by the non-parametric Mann-Whitney-Test p < 0.05 (*); n.s.,
non-significant. Dotted line shows the control (100%).
The most well-studied pathway for NO detoxification is based
on flavohemoglobin (FlavoHb) (Hmp for E. coli and Fhp for
P. aeruginosa), which acts as an NO dioxygenase to transform
NO to NO−3 (Figure 7A) (Corker and Poole, 2003; Arai et al.,
2005). After exposure to 45 ppm of NO2, the hmp mRNA levels
were increased almost 25- and 23-fold in MFAF76a and in
MFN1032 (respectively KR818822 and KR818823 in Table S2 and
Figure 8), indicating that NO2 induces hmp expression in both
P. fluorescens and suggesting a possible involvement of Hmp in
NO2 detoxification. The NO2 effect on the Hmp synthesis was
observed in other studies, where, to activate the Hmp-dependent
detoxification pathway, NO2 was proposed to be reduced to NO
(Poole et al., 1996). In Pseudomonas spp., NO2 reduction can be
performed by nitrite reductase (NIR) enzymes (Figures 7B,C),
including the well-studied respiratory cytochrome cd1 nitrite
reductase (Figure 7B) of the denitrification pathway (Arai et al.,
2005; Shiro, 2012). According to the genome draft analysis
TABLE 2 | NO2 decreases Pseudomonas fluorescens resistance to
aminoglycosides.
Strain NO2 concentration Kanamycin MIC Tobramycin MIC
(ppm) (µg/mL) (µg/mL)
MFAF76a 0 8.3 6.2
45 6.2 3.1
MFN1032 0 20.0 12.5
45 16.7 8.3
FIGURE 6 | NO2 exposure affects Pseudomonas fluorescens growth
with aminoglycosides. After 2 h exposure to 45 ppm of NO2, growth of
airborne MFAF76a (A) and clinical MFN1032 (B) in presence of tobramycin
(1.55µg/mL; ) and kanamycin (3.1µg/mL; ) was tested. A580 was
recorded at indicated time points. The control sample was bacteria exposed to
synthetic air, and grown in presence of antibiotics in indicated concentrations.
The data are presented as percentages of growth relative to air-exposed
control. Pooled data from three independent experiments in duplicate ± SEM
are reported. Statistical significance was calculated by the non-parametric
Mann-Whitney-Test p < 0.05 (*), < 0.01 (**); n.s. non-significant. Dotted line
shows the control (100%).
(data not shown), both MFAF76a and MFN1032, like the
majority of P. fluorescens strains (Redondo-Nieto et al., 2013), do
not possess denitrifying genes, but harbor the genes encoding for
the assimilatory nitrite reductase NirBD (Figure 7C). The latter is
part of the Nas assimilatory pathway (from nitrate assimilation),
where nitrate is reduced to nitrite, which is then reduced to
ammonia (Jeter et al., 1984; Moreno-Vivián et al., 1999). In order
to test the NO2 effect on the expression of nirBD operon, the
nirB mRNA level (Pfl76a_nirB -KT186428 - and Pfl1032_nirB -
KT070320 -, Table S2) was compared in the NO2-exposed or
non-exposed P. fluorescens strains. In both strains, the mRNA
level of nirB was not modified compared to the control condition
(data not shown), indicating the absence of NO2 effect on the
expression of genes coding for assimilatory NIR. To the best of
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FIGURE 7 | Scheme of Hmp-mediated NO detoxification and NO2
reduction pathways in Pseudomonas spp. (A) Flavohemoglobin (Hmp) is
involved in NO detoxification acting as an NO dioxygenase to transform NO to
NO−3 . The NO2 reduction is performed by nitrite reductase enzymes, including
the respiratory cytochrome cd1 nitrite reductase, NIR (B) and the assimilatory
nitrite reductase NirBD (C). The respiratory NIR is involved in NO−2 reduction to
NO in anaerobic conditions. NirBD takes a part of the nitrate assimilatory
pathway, and reduces nitrite to ammonia.
FIGURE 8 | Transcription of hmp is increased in response to NO2
exposure. The nucleotide sequences of the hmp-homolog gene in P.
fluorescens strains were obtained using the non-annotated genome drafts of
airborne P. fluorescens MFAF76a ( ) and clinical MFN1032 ( ). The GenBank
accession numbers of hmp nucleotide sequences are listed in Table S2.
Quantification of mRNA level was assayed using qRT-PCR on RNAs extracted
from NO−2 and synthetic air-exposed P. fluorescens. The PCR reactions were
performed in triplicate and the standard deviations were lower than 0.15 Ct.
Statistical analysis used pairwise strain comparisons (t-test) p < 0.01 (**).
Dotted line shows the gene expression in air-exposed control.
our knowledge, the involvement of Nas pathway in NO/NO2
detoxification was not demonstrated. Given the presence of
ammonium in DMB medium (Duclairoir-Poc et al., 2011), we
think that the production of supplementary ammonium through
the nitrite reduction is not appropriate. However, in order to
better understand the mechanism of the NO2 detoxification,
the Hmp-, Nir- and Nas-mediated mechanisms should be
investigated in more details.
In this study, the response of airborne P. fluorescensMFAF76a
to gaseous NO2, as a marker of air pollution, was for the first
time investigated and compared to the response of the clinical
P. fluorescens MFN1032 strain. We show that NO2 leads to
increased biofilm formation through a c-di-GMP independent
mechanism, reduced motility, as well as increasing ciprofloxacin,
chloramphenicol resistance and aminoglycosides susceptibility.
The question is now to understand how the NO2 leads to the
observed phenotypes. NO2 has some similarities with it relative
NO. NO2, like NO, induced the expression ofmexEF-oprN genes,
encoding the RND eﬄux pumpMexEF-OprN. Its overexpression
could, among others, be involved in the observed increase of P.
fluorescens resistance to ciprofloxacin and chloramphenicol. NO2
induces also bacterial biofilm formation by strain-dependent
mode, without c-di-GMP production variation. Thus, the
high P. fluorescens adaptability to many environments, and a
possible NO2 propensity to increase some bacterial antibiotic
resistance and biofilm formation may diminish the effectiveness
of antibiotic therapies in highly polluted area. In addition,
we show the NO2-mediated upregulation of the hmp-homolog
gene in P. fluorescens, suggesting a possible common pathway
between NO and NO2 detoxification. Taken together, our data
show that gaseous NO2 can be perceived by airborne bacteria,
leading to physiological modifications that may be relevant
for human health (biofilm formation, antibiotic resistance).
In the context of the worrying increase of atmospheric NO2
concentrations (Bernagaud et al., 2014), these findings are
of ecological relevance, especially because of the high NO2
concentrations, found in the close vicinity of any vehicle.
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A B S T R A C T
Model emulsions were developed with or without commercial titanium dioxide nanoparticles (NP)
carrying various surface treatments in order to get close physicochemical properties whatever the NP
surface polarity (hydrophilic and hydrophobic). Rheology and texturometry highlighted that the
macroscopic properties of the three formulated emulsions were similar. However, characterizations by
optical microscopy, static light scattering and zetametry showed that their microstructures reﬂected the
diversity of the incorporated NP surface properties. In order to use these model emulsions as tools for
biological evaluations of the NP in use, they had to show the lowest initial microbiological charge and,
speciﬁcally for the NP-free emulsion, the lowest bactericidal effect. Hence, formulae were developed
preservative-free and a thermal sterilization step was conducted. Efﬁciency of the sterilization and its
impact on the emulsion integrity were monitored. Results highlighted the effect of the NP surface
properties: only the control emulsion and the emulsion containing hydrophilic NP fulﬁlled both
requirements. To ensure the usability of these model emulsions as tools to evaluate the ‘NP effect’ on
representative bacteria of the skin microﬂora (S. aureus and P. ﬂuorescens), impact on the bacterial
growth was measured on voluntary inoculated formulae.
ã 2016 Elsevier B.V. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Pharmaceutics
journal homepage: www.elsev ier .com/locate / i jpharm1. Introduction
Titanium dioxide (TiO2) NP are commonly used in Cosmetics,
especially as UV ﬁlters in sunscreen emulsions. Their tiny size,
enabling transparency in the visible range, makes it possible to
obtain end products without any residual traces on skin in addition
to a good UV-protection (Serpone et al., 2007). However, if
compared to micrometric oxides, nanometric ones are more
reactive and in particular photo-reactive. Therefore, such nano-
objects receive a ﬁrst coating with silica or alumina as it allows
quenching photo-produced radicals (Serpone et al., 2006); in
addition, a second coating is sometimes added in order to improve
their dispersibility in formula. Whereas European Regulation
(European Parliament, Council of the European Union, 2014)
clearly mentions the obligation to demonstrate the safety of even
coated NP, very few studies took interest on their behavior in use.
Santaella et al. (Santaella et al., 2014) compared the eco-toxicity of* Corresponding author at: University of Le Havre, 25 rue Philippe Lebon, B.P. 540
76058 Le Havre cedex, France.
E-mail address: celine.picard@univ-lehavre.fr (C. Picard).
http://dx.doi.org/10.1016/j.ijpharm.2016.06.014
0378-5173/ã 2016 Elsevier B.V. All rights reserved.
P27NP with degraded coating in aqueous environment (Auffan et al.,
2010) to that of pure TiO2. Other studies dealt with the impact of
zinc oxide NP on bacteria according to their size (Pasquet et al.,
2014). However, aggregation state and physicochemical behavior
of NP in formula have to be taken into account and their safety in
emulsions when they are layered on skin remained a critical
question. Moreover, these questions are closely related to the large
variety of surface treatments commercially available (polar, non-
polar, hydrophilic, hydrophobic . . . ).
To evaluate the only effect of NP in formula, emulsions need to
be developed in order to respect three main criteria:
- Being stable and exhibiting similar microstructure and macro-
scopic properties whatever the coating of the incorporated NP;
- Exhibiting the lowest initial microbiological charge;
- Giving the control emulsion (without NP) the lowest bacteri-
cidal effect.
Therefore emulsions need to be developed without preserva-
tive. Hence, in order to fulﬁll the second criterion, alternative
process, like sterilization procedures, consisting in the elimination
126 L. Rowenczyk et al. / International Journal of Pharmaceutics 510 (2016) 125–134of germs and spores in a product, has to be used. However,
cosmetic form does not allow the use of technics such as ﬁltration
of emulsion systems because it could lead to a demixing
phenomenon (Kocherginsky et al., 2003) or UV or gamma
radiations because of presence of UV ﬁlters in this study.
Sterilization by high temperature seemed the best solution
especially as this kind of methods begins to be used on cosmetic
emulsions (Delaunay and Legendre, 2013) associated to an adapted
packaging (Devlieghere et al., 2015). Nevertheless, high temper-
atures could accelerate aging (Waterman and Adami, 2005) and,
recently Rossano et al. (2014) demonstrated that aging of
emulsions containing hydrophobic NP induced particles aggrega-
tion, adsorption of formula’s compounds and coatings deteriora-
tion. Thus, as it is still relatively unexplored, it is essential to bring
data concerning the effect of coatings and sterilization tempera-
ture on the emulsion properties. Our study focuses on the
characterization of model emulsions in order to ensure the
similarity in terms of microstructure and physicochemical
properties of a control emulsion without nanoparticle and
formulae containing either hydrophilic/hydrophobic NP.
Finally, microbiological evaluations were conducted on two
skin bacteria strains to check the low initial microbiological charge
of the model emulsions and the low bactericidal impact of the
control one.
2. Experimental
2.1. Chemical and reference materials
Water with a resistivity of 18 mV cm used during the emulsion
preparation and zetametry was puriﬁed, ﬁltrated on 0.2 mm and
treated by UV in order to eliminate germs, after described as
ultrapure. Otherwise distilled water with a resistivity of 18 mV cm
was used for other emulsion characterizations. Two different
grades of TiO2NP were kindly given by Kobo and Merck; one
hydrophilic, with a simple silica coating named N1 (EUSOLEX1
TAVO, Merck Chimie SAS, France) and a second, hydrophobic,
composed of alumina (and) triethoxycaprylylsilane named N2 (A10-
TiO2-11S7, Kobo Products, France). Other cosmetic grade ingre-
dients, introduced in Table 1 were chosen to obtain simpliﬁed
sunscreen, oil-in-water emulsions type, and to improve NP
dispersions. Ingredients were used as received. To achieve
emulsions with the lowest bactericide impact, no preservative
was added.
2.2. Emulsion preparation
During preservative-free emulsion preparation, precautions
were taken in order to minimize the risks of microorganisms
contamination: all stainless steel materials were steamed for
45 min at 190 C and glass bottles were rinsed with ethanol prior to
drying (INRS, 2014). For technical reasons it was impossible toTable 1
Content, function and supplier of ingredients used in emulsions.
Phase Content (%w/w) Product INCI Name 
Phase A 2.75 Steareth 2 
1.75 Steareth 21 
2.00 Parafﬁn 
0.20 Beeswax 
20.00 Cetearyl ethylhexanoate 
Phase B 0.10 Acrylates/C10-30 alkyl acrylate cr
Qs Deionised water
0.13 Triethanolamin 
5.00 TiO2 NP 
P2make all operation under laminar ﬂow hood in sterile conditions.
But controls revealed that aerial contaminants in ﬁnal formula-
tions remained under the detection limit.
2.2.1. Emulsion without nanoparticle
Emulsion without NP was adapted from the protocol described
by Rossano et al. (2014). It was developed to obtain similar
emulsions, with or without NP, and to improve the NP dispersion.
The gelling agent was sprinkled in water and hydrated 20 min
without stirring. This mix corresponding to the phase B and the
phase A were separately homogenized at 80 C under mechanical
stirring for 10 min. After water loss compensation, phase A was
added to phase B off the heat and under vigorous stirring
(11000 rpm for 1.5 min), by using a rotor-stator type homogenizer
(Ultra-Turrax, stator diameter 25 mm, rotor diameter 18 mm, IKA).
Then, the mixture was put under stirring (Turbotest, radial ﬂow
turbine of 55 mm diameter, VMI Raynerie) at 750 rpm and
triethanolamin (TEA) was immediately added. After 5 min, the
stirring rate was raised to 1000 rpm. A cold water bath was used
once cooled below 38 C. When the temperature of emulsion was
close to 25 C, pH was adjusted at 6.6–6.8 using HCl 0.4 M. The
mixture was kept under stirring for 5 additional minutes. It was
then put under vacuum to remove air bubbles incorporated during
the previous process.
2.2.2. Nanoparticle dispersions
Because rotor-stator type homogenization was not sufﬁcient to
obtain an acceptable dispersion in emulsion, NP powders were ﬁrst
pre-dispersed in one of the emulsion phases, leading to a NP paste.
Hydrophilic NP and water with a ratio of 1/2 (w/w) were sonicated
10 min (Ultrasonic cleaner, VWR, 45 kHz, 120 W). Hydrophobic NP
and cetearyl ethylhexanoate with a ratio of 2/3 (w/w) were mixed.
Then, this pre-dispersion was grounded on a three-cylinder mill for
three times to reduce the size of agglomerates.
2.2.3. Emulsions with nanoparticles
The protocol remained the same as without NP except that just
after the addition of TEA, NP paste was added under a stirring of
1000 rpm to reach the optimal dispersion in emulsion. The end of
the preparation was the same than without NP.
2.2.4. Sterilization
Each emulsion was poured into several 50 mL glass autoclave-
resistance bottles (VWR). After maturation at 20  2 C for 24 h, a
half of them was sterilized during 20 min at 120 C and 1 bar
relative pressure in an autoclave (Laboster, Subtil-Crepieux,
Chassieu, France). The second part was let at the same tempera-
ture. After heating and when the temperature cooled below 90 C,
the autoclave was opened and the bottles were let at ambient air in
order to accelerate the cooling. Thus, for instance, ST-F-0 was the
autoclaved version of F-0.Function Supplier
Surfactant Croda (UK)
Surfactant Croda (UK)
Emollient Baërlocher (France)
Emollient Baërlocher (France)
Emollient Stéarinerie Dubois
osspolymer Polymer gelling agent Lubrizol (Belgium)
Additive BASF (Germany)
Inorganic UV ﬁlter –
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of the sterility value (SV): SV =
R
10 T tð ÞTrefð Þ=Z :dt
 T(t) is the core temperature in the time interval,
 Tref is the reference temperature,
 Z is the difference of temperature required to accelerate tenfold
the germs destruction reaction.
In the case of a sterilization step, Tref and Z are respectively
equal to 121.1 C and 10 C (Bimbenet et al., 2007). A temperature
probe (DataTrace, CMI) was introduced into a product bottle in
order to obtain the core temperature essential for the SV
calculation.
2.3. Emulsions characterization
Once prepared, emulsions were characterized after a period of
maturation for two days or if so, sterilization.
2.3.1. Microstructural characterization
2.3.1.1. Optical microscopy. Qualitative observations were
performed using an optical microscope (DMLP/DC 300, Leica
Microsystems, Wetzlar, Germany) equipped with a camera and the
IM1000 software (version 1.20 Release 19). In order to visualize
emulsion microstructures, droplets sizes and quality of NP
dispersion, a tip of emulsion plus a water drop were placed
between slide and coverslip. Pictures were obtained at a
magniﬁcation of 200.
2.3.1.2. Particle size measurement. Particles sizes measurements
were performed by using a laser diffractometer SALD 7500 Nano
(405 nm, Shimadzu, Marne-la-Vallée, France) combined with the
measure cell SALD BC 75 consisting in a 7 mL batch and a stirrer
and equipped with the WingSALD II-7500 software (version 3.1). In
order to reach an absorption value of the samples between 1.2 and
1.5 and the best quality of the obtained signal, particle dispersions
had to be diluted and homogenized according to the following
procedures. Approximately 0.1 g of NP pastes was pre-dispersed in
a test tube with 5 mL of distilled water for coating 1 or of cetearyl
ethylhexanoate for coating 2. This pre-dispersion was then
sonicated 5 min (120 W). In the case of emulsion particle sizing
measurement, approximately 0.1 g of emulsion were pre-diluted in
a test tube with 5 mL of distilled water. The mix was vortexed 10 s
at 1000 rpm. Finally, pre-dispersed samples were added by drop
until reaching the expected absorption. All measurements were
performed at least in triplicate on two different batches. D10, D50
and D90 were thereafter expressed in particle volume. By this way,
for instance, D10 represented the threshold value in micrometer
for which 10% of particles had a smaller size.
2.3.1.3. Zetametry. Mean zeta potentials of emulsions were
performed using a Zeta Sizer Nano-Z and folded capillary cells
(Malvern instruments, Malvern, UK). Emulsions were diluted at
0.5% w/w in ultrapure water containing NaCl at 104M
(conductivity of 1.70 mS/cm). Six samples of each emulsion were
adjusted at pH 2, 4, 6, 8,10 and 12, respectively, with using NaOH or
HCl (0.4 or 0.04 M).
Measurements were performed at least three times.
2.3.2. Macroscopic properties
2.3.2.1. Rheology. Rheological properties were achieved with a
controlled-stress rheometer (Discovery HR1, TA instrument,
Guyancourt, France) using an aluminum cone-plate geometryP27(40 mm diameter, cone angle of 1.994 and truncation of 47 mm).
Data analyses were conducted with the software TRIOS1 3.0. Stress
sweep was carried out at 25 C, temperature controlled by Peltier
effect, with an imposed stress gradient from 0.01 to 150 Pa and a
ﬁxed frequency of 1 Hz. This analysis highlighted the linear
viscoelastic region and permitted to obtain the viscoelastic
parameters, independent of the applied stress as listed below:
 tan (d), where d is the phase shift between strain and stress and
is equal to G0 0/G0.
 G0, the elastic modulus (Pa),
 G0 0, the viscous modulus (Pa),
 gc, the critical strain, corresponds to the percentage strain at 90%
of the plateau G0 value.
All measurements were performed at least twice on two
different batches.
2.3.2.2. Texture analyses. Texture analyses were performed by
using a TA.XT Plus (Stable Micro Systems, Cardiff, UK) and the
software Texture Exponent 32 (version 5,0,6,0, 2010). It allows the
characterization of mechanical properties of emulsions. The
protocol was adapted from Gilbert et al. (2013). Effect of the
compression was studied with the P/35 probe (35 mm diameter,
aluminum). 750 mL of emulsion were deposited on the analyzer
base by using a Microman1M250 (Gilson) and compressed by the
probe until a gap of 0.5 mm with a rate of 1 mm/s. Three
parameters were recovered:
 the positive area, corresponding to the work required during the
product compression (kg s),
 the maximum force reached (kg),
 the negative area, corresponding to the work required during the
probe removal (kg s).
Ability to spreading was lead with the friction modulus A/FR. A
polypropylene (PP) sheet was ﬁxed on the analyzer base and the
probe was covered with a HelioplateTM HD 2 (Helioscreen, Creil,
France) consisting of a PMMA plate. Four lines of each 50 mL of
emulsion were deposited using a Microman1 M250 (Gilson,
Villiers-le-Bel, France) in the displacement direction. The probe
was pulled on a distance of 120 mm with a speed of 3 mm/s.
Pictures were taken from spreading traces on the PP sheet. In order
to evaluate the corresponding traces thickness, the lightness
evolution (L* factor in the CIE L*a*b* color model) was measured
every 2 cm, starting to the beginning of the trace (Spectrophotom-
eter CM-5, Konica Minolta, Nieuwegein, Netherlands).
All measurements were performed at least twice on two
different batches.
2.4. Micrbiological assays
2.4.1. Bacteria strain and culture conditions
Pseudomonas ﬂuorescens MFP05 and Staphyloccocus aureus
MFP 03 are normal human skin bacteria strains collected by
swabbing and characterized by metabolic, proteomic and genomic
analysis (Hillion et al., 2013). These strains are stored on cryobeads
at 140 C. Before use, they were sub-cultured over-night in
50 mL of Luria Bertani (LB) broth at 28  2 C for MFP05 or 37  2 C
for MFP03. The cultures were then diluted again in LB broth to
reach the appropriate initial bacterial density corresponding to an
OD 580nm= 0.08. OD values were measured using a spectropho-
tometer (Helios Epsilon, ThermoSpectronics, Cambidge, UK).
Bacteria were used when the cultures reached the end of the
exponential growth phase.
Fig. 1. Particle size distributions given in volume particle of fresh emulsions.
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Mesophilic aerobic bacteria in emulsions were counted and
detected by using the norm NF EN ISO 21149:2006 (AFNOR, 2009).
It includes three culture tests. To base the study on solid grounds,
we chose to correlate two of them. The ﬁrst one, without
enrichment, consists in diluting approximately 1 g of emulsion
in ten times this exact mass in peptone water and then vortexing at
1000 rpm for 20 s. 100 mL of this mix was spread on a TSA Petri dish
and incubated at 30  2 C for four days. The second test, with
enrichment, was the dilution of approximately 1 g (exactly
weighed) of emulsion in ten times the mass in EUGON LT 100
broth. The liquid mix was incubated at least 20 h at 30  2 C under
orbital stirring at 180 rpm. Then the mix was vortexed at 1000 rpm
and 100 mL were spread on a EUGON LT 100 agar Petri plate. They
were then incubated at 30  2 C for four days. Three Petri dishes
were prepared for each condition and emulsion. The number of
mesophilic aerobic bacteria (N) was determined by the equation:
 N = m/(V  d) where,
 m is the mean number of colonies on Petri dishes,
 V is the inoculated volume on a Petri dish (mL),
 D is the dilution of the emulsion (1/10 in this case).
2.4.3. Evolution of willingly inoculated bacteria in model emulsions
Approximately 5 g of each emulsion were diluted to the third in
physiologic water (NaCl 0.9%) or LB broth. Obtained solutions were
inoculated with MFP03 or MFP05 at an initial concentration
between 105 and 106 UFC/mL. The exact bacterial concentration
was controlled by plating 100 mL of solutions and serial dilutions
on TSA Petri Dishes immediately after bacterial inoculation.
Inoculated solutions were incubated at 28  2 C in the case of
MFP05 or 37  2 C for MFP03 under orbital agitation at 180 rpm.
After different period of time (24 h, 48 h and 72 h, respectively),
100 mL of solutions were spread on TSA Petri dishes in order to
monitor bacteria growth evolution. All Petri dishes were incubated
24 h at 28  2 C for MFP05 or 37  2 C for MFP03 before counting.
2.5. Data analyses
Results were expressed as mean  standard deviation (SD).
Statistical analyses of collected data were performed on XLSTAT
software (version 2012.1.01, Addinsoft, France). Single-way analy-
ses of variance (ANOVA) were applied to data series in order to test
signiﬁcance of parameters. When a signiﬁcant difference was
revealed between emulsions (p < 0.05), groups of emulsions were
formed using Tukey multiple comparison test.
3. Results and discussion
3.1. Comparative study of emulsions with or without nanoparticles
Three emulsions were obtained by the lab-scale process
depicted in the Material and Methods section: a control emulsion
without NP (F-0), an emulsion (F-N1) with hydrophilic NP (N1) and
an emulsion (F-N2) with hydrophobic NP (N2).
3.1.1. Microstructural characterization
3.1.1.1. Characterization of nanoparticles dispersions. When
working with NP, emulsions and their mixtures, an important
issue is to characterize size distributions, making sure that the
techniques used, the operating conditions and analyses
parameters ﬁtted well.
Both NP primary sizes given by suppliers were around 10 nm
diameters which correspond to the dimension of the particlesP2measured just after manufacturing. However, at the nanometric
scale, attractive forces are intense and NP in powder are known to
form aggregates-like structures of much larger dimensions (larger
than 1 mm) (Aldous and Kent 2013). Thus, in the present study,
several processes were tested to improve the particles dispersions
in emulsions. The best one was obtained when pre-dispersion was
prepared separately and added after the emulsiﬁcation step. Size
distributions of NP in pre-dispersion were monitored by laser
granulometry as described in Materiel & Methods. Because of the
thinness of the dispersions, determination of the refractive indexes
(RIs) of the particles was required to use the Mie theory. Different
parameters could have an impact on this RI and should be
investigated. At the studied wavelength, calculation models
showed that the crystallinity, the shape and the size did not
impact the RI of TiO2-particles (Auvinen et al., 2013). The coating
could also have an effect on the particles refraction. Thus,
calculations based on the RI of the TiO2 or of the coating were
made and gave the same results in term of size distribution.
Added to ester phase, N2 NP formed larger aggregates, with a
D90 equal to 30 mm. Thanks to its high viscosity, the paste was
reﬁned using a three-cylinder mill. This method decreased the D90
under 4 mm. N1 NP in water were already well-dispersed and had a
D90 already around 11 mm. Due to the low viscosity of the
hydrophilic dispersion, an ultra-sonication treatment was used
and reduced even more the D90 until 1.7 mm. Given in number of
particles, the D50 of N2 was equal to 180 nm and the D50 of N1 to
60 nm. Consequently, N1 met the ofﬁcial deﬁnition of NP (Ofﬁcial
Journal of the European Union, 2011) while N2 was really close.
However, in this study, size distribution was expressed in volume
as it magniﬁes the impact of the biggest aggregates and allows a
better evidencing of the dispersion heterogeneity.
3.1.1.2. Characterization of emulsions. For the same reasons as
above, emulsions size distributions were also given in volume of
colloids. All colloids present in emulsions, TiO2-particles as well as
oil droplets, were detected during measurements. Since these
colloids had various sizes and optical properties, the use of a RI was
not applicable. For this reason, the Fraunhofer’s approximation was
chosen in term of calculation model. This model is generally
applicable for colloids owning size larger than few micrometers;
however Jones (1977) and Seville et al. (1984) demonstrated that
the error made on the measured size is acceptable, when
considering smaller and non-absorbing colloids like in our
situation.
For F-0, even if this monomodal distribution was polydisperse
(Fig. 1), the D90 value, around 7 mm and the D50 value at 2.331 mm
both proved that the blank emulsion was mostly composed of
small droplets. F-N1 size distribution was very similar to the blank
one: only the D10 was signiﬁcantly lower. NP in the emulsion7
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around 0.6 mm. Size distribution obtained for F-N2 highlighted a
large distance between the D10 and the D90 values and depicted a
high polydispersity. Moreover, the D50 was ﬁve time higher than
the mean size value for F-0: F-N2 distribution was thus essentially
formed of a new larger population around 10 mm.
As sampling required for the size distribution measurement
induced a dilution of emulsions and, as a consequence potential
physical modiﬁcations compared to the initial droplets sizes in
bulk, the microstructure of emulsions was also controlled by
optical microscopy. Indeed, the lowest dilution necessary to this
method allowed observations closer to the reality even if limited by
the resolution around 1 mm. Microscopic observations of F-0
(Fig. 2A) conﬁrmed the thinness and the homogeneity of the
emulsion and allowed to identify droplets network, appearing as a
sort of spider web visible on the picture by alternation of dark
areas, build of droplets, and white areas consisting of blank. This
phenomenon depicted a highly ﬂocculated system. It justiﬁed the
sample preparation for the granulometry measurement that
reduce the aggregation phenomena and allowed the measurement
of primary sizes. Optical microscopy also conﬁrmed that only few
aggregates were formed in F-N1 and that the majority of the NP
was well-dispersed once in emulsion (Fig. 2B). The important
droplets network described for F-0 was no longer observed for F-
N1. In this work, the high amount of tiny particles located in the
continuous phase led to the formation of a new network,
consisting of particles and droplets. Moreover TiO2-particles
coated with silica had negative surface charges (Junior and Baldo
2014) that might lead to a repulsion between droplets and
prevented ﬂocculation. The optical micrograph of F-N2 (Fig. 2C)
showed large dark objects, around 10–20 mm, masking droplets
and corresponding to the aggregates characterized by the D90
value. Added to an oil-in-water emulsion, hydrophobic particles
could not be as well dispersed as N1 and formed large vesicles of
cetearyl ethylhexanoate and NP. Here again, F-N2 was less
ﬂocculated than F-0 surely because the initial emulsion was less
concentrated in oil droplets: vesicles contained almost 40% of the
total oil of the emulsion. To conclude, the blank emulsion and theFig. 2. Optical micrograph of; A: F-0, B: F-N1 et C:
Table 2
Characteristic parameters of emulsions.
Viscoelastic parameters 
G0  SD (Pa) G”  SD (Pa) tan delta  SD gc SD (%) 
F-0 622A 80 122CD 13 0.20C 0.01 2.21AB 0.77 
ST-F-0 384B 28 106D 13 0.28A 0.02 2.80A 0.28 
F-N1 648A 60 143BC 11 0.22B 0.01 1.88BC 0.20 
ST-F-N1 675A 138 195A 27 0.29A 0.02 1.55C 0.57 
F-N2 670A 55 159B 11 0.24B 0.00 1.18C 0.09 
Different letters in the same row means signiﬁcant difference between emulsions for t
P27emulsion with hydrophilic NP were very similar in term of size
distributions, while F-N2 containing hydrophobic NP was rougher.
In both case, the presence of NP seemed to avoid the ﬂocculation
phenomenon.
3.1.2. Macroscopic properties
Emulsions are viscoelastic materials that have both solid and
viscous liquid properties. In this study, dynamic oscillatory tests
did through a stress sweep (Table 2) bring out these behaviors. On
the linear viscoelastic region, the G0 of F-0 was much higher than
the G0 0 demonstrating the elastic behavior of the emulsions. This
led to a tan d equal to 0.2; this low value corresponds to a strong
viscoelastic system. Approaching gc, emulsion structure kept up
until a strong decrease of both moduli. The observed G0 0 overshoot
is characteristic of a weak gel (not shown) usually obtained when
any gelling agent is added in emulsion continuous phase.
With a similar G0 value, F-N1 and F-N2 showed the same
predominant elastic behavior as F-0. Even if it was demonstrated
that a less ﬂocculated networks or a higher mean size could lead to
a lower elastic modulus (Tadros 2004; Pal 1996), in this study, the
presence of a solid dispersion offset this fall because it
strengthened the network. However, for both emulsions contain-
ing NP, tan d was signiﬁcantly higher and the G0 0 overshoot was no
more observed. The presence of NP in emulsion gave a system
considered as a weaker gel compared to F-0, sign of a reduction of
the network strength. Critical strains, gc, were reduced showing a
more polydispersed system: ﬁnally, F-N2 appeared less homoge-
nous than F-N1 which was less than F-0.
Texture analyses were performed on emulsions and brought out
the same behaviors for F-0, F-N1 and F-N2 during compression test
(Table 2). Those results highlighted that the consistency of the
three emulsions was the same. Spreading tests performed in order
to mimic the application of sunscreen on skin, also highlighted the
same behaviors of emulsions. The presence of UV ﬁlters only raised
the lightness proﬁle of traces (Fig. 3) but did not modify the
spreading quality. Finally, the slight differences observed during
the microstructural characterizations did not impact the macro-
scopic properties of these emulsions. F-N2. (The scale bar corresponds to 100 mm).
Compression parameters
Positive Area + SD (kg s) Maximum force (kg) Negative Area + SD (kg s)
0.170A 0.023 0.363BC 0.034 0.154A 0.022
0.166A 0.012 0.337C 0.026 0.157A 0.012
0.194A 0,030 0.427B 0.051 0.160A 0.032
0.285B 0.061 0.518A 0.072 0.247B 0.038
0.188A 0.029 0.408B 0.071 0.163A 0.026
his parameter (p < 0.05).
Fig. 3. Evolution percentage of lightness (L*) along spreading traces.
Fig. 5. Particle size distributions given in volume particle of sterilized emulsions.
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In this study, a classical sterilization batch method, imitating
Appertisation, was chosen and consisted in high temperature
sterilization by autoclaving emulsions directly in its storage
packaging (glass bottles). The calculated SV was superior to
22 min whereas the minimum value recommended by the
European Pharmacopoeia (Delaunay and Legendre, 2013) is only
15 min, meaning that the treatment was efﬁcient. By this way,
three new emulsions were obtained ST-F-0, ST-F-N1 and ST-F-N2.
During sterilization, high temperatures decreased the viscosity
procured by the gelling agent. After cooling, ST-F-0 and ST-F-N1
restructured spontaneously and recovered a normal emulsion
aspect without demixing. Sterilized formula containing N2 was no
longer homogenous: a compact block stood in the middle of the
glass bottle and was surrounded by a clearer liquid. After few hoursFig. 4. Optical micrograph of; A: ST-F-0, B: ST-F-N1, C: liquid part of ST-F-N
P2cooling down, the viscosities of both phases equilibrated and the
batch looked more homogenous even if lumps were still
observable.
3.2.1. Microscopic characterization
The blank emulsion, ST-F-0, and the emulsion with hydrophilic
NP, ST-F-N1, had droplet size distributions similar to their non-
sterilized versions: only the D90 signiﬁcantly increased after
thermal treatment. Some larger droplets could be observed on the
micrograph of ST-F-0 (arrows on Fig. 4A) conﬁrming the presence
of a new larger droplets population around 10–100 mm (Fig. 5).
Large objects around 10 mm were present in F-N1 after sterilization
(Figs. 4B and 5) and consisted in both droplets and particles
aggregates.
Observations of ST-F-N2 phases (Figs. 4C and D) showed that
the block part was constituted of around 500 mm long dark objects
probably corresponding to large NP aggregates. The liquid part
contained mostly ﬁne droplets and air bubbles which appeared in
the formula during the sterilization step as a consequence of the
gas dilatation. The sterilized emulsion looked like after an2 and D: solid part of ST-F-N2. (The scale bar corresponds to 100 mm).
7
L. Rowenczyk et al. / International Journal of Pharmaceutics 510 (2016) 125–134 131accelerated aging already described by Rossano et al. (2014). These
observations highlighted the high heterogeneity of ST-F-N2 that
constituted a real barrier to the physicochemical characterizations
of the emulsion and particle size measurements were not
conducted.
Zeta potential (ZP) measurement gave a mean value that took
into account surfaces of both droplets and particles (curves not
shown). At pH 7, corresponding to the pH in emulsions after
maturation, ZP measured for F-0 was around 30 mV. Presence of
NP in F-N1 and F-N2 slightly decreased the ZP intensity at
respectively 23 mV and 17 mV. After heat treatment, the
measured mean zeta potential in emulsions signiﬁcantly ampliﬁed
for F-0 (–43 mV) and F-N1 (–33 mV) indicating that surface
rearrangements occurred and increased electrostatic repulsion
forces, favorable to the emulsion stability. To sum up, the thermal
treatment did not impact the integrity of microstructures of the
blank emulsion and of the emulsion containing hydrophilic NP
while emulsion with hydrophobic NP was no longer homogeneous.
3.2.2. Macroscopic properties
As illustrated on Table 2, the G0 value measured for ST-F-0 was
signiﬁcantly lower than the previous value obtained for F-0, while
the G0 0 value remained the same; thus, the solid behavior of the
emulsion dramatically decreased. Moreover, the tan d increased
indicating that the gel behavior was considerably reduced.
Complementary manipulations on polymer solutions showed that
the G0 value was divided by two whereas the G0 0 remained similar
after the sterilization step. The viscoelastic evolutions of the
emulsion during heat treatment may result from a decrease of the
ﬂocculated network but also from polymer degradation. Compres-
sion tests did not allow differentiating F-0 and ST-F-0 (Table 2):
therefore, apparent texture, like ﬁrmness of the emulsion, was not
impacted by the heat treatment. For ST-F-N1, the G0 value was the
same as its non-sterilized version whereas the G0 0 value was
increased (Table 2). The rise of the tan d reﬂected a reduction of the
viscoelastic behavior of the emulsion. Moreover, gc decreased
indicating a loss of homogeneity, in relation with the rise of the
D90 value.
The maximum force reached during the ST-F-N1 compression
test (Table 2) was signiﬁcantly higher when compared to other
emulsions. This result revealed an high ﬁrmness for the sterilized
emulsion containing hydrophilic NP (Friedman et al., 1963), in line
with the high value of the viscous modulus. As this phenomenon
should be explained by water losses during sterilization inducing a
concentration effect of both droplets and particles, the water
content of emulsions was evaluated by desiccation before and after
the sterilization step but no difference was observed. Then, the
increase in consistency and changes in viscoelastic behaviors of ST-
F-N1 should not be explained only by the slight changes in size
distributions but also by the structural rearrangements as
suggested by surface modiﬁcations evidence by zetametry.
However, the gc remained identical in control and sterilized
emulsions highlighted that their homogeneity was not impacted
by the heat treatment (Table 2). Moreover, spreading tests
highlighted that the important consistency of the ST-F-N1 did
not affect the spreading quality as seen by comparing F-N1 and ST-
F-N1 traces (Fig. 2). Nevertheless, the lightness measurement was
higher along the ST-F-0 trace than along the F-0 trace. Chan-
trapornchai et al. already measured the bulk lightness of low
concentrated emulsions with monitored ﬂocculation. They dem-
onstrated that in these conditions ﬂocculated droplets decreased
the L-value (Chantrapornchai et al., 2001). In this present work, as
ST-F-0 and F-0 had the same granulometry proﬁles, ST-F-0 seemed
less ﬂocculated than the F-0 formula.
Although ST-F-N2 was not homogeneous, its spreading quality
was tested in order to evaluate the impact of lumps in use.P27Experiments conﬁrmed the heterogeneity of this emulsion: at the
beginning of the trace, lightness was similar to that of F-N2 but L*
quickly decreased. Previous studies have shown that the lightness
of an emulsion decreases with the size of droplets (Chantraporn-
chai et al., 1998). Then, the presence of larger droplets in ST-F-N2
than in the other emulsions could explain the low value of
measured lightness. It is also interesting to note that the trace did
not end before the maximum mobile displacement and was not
well-spread (Fig. 6). In fact, the emulsion seemed not to adhere on
the hydrophobic surface of PP sheet but remained on the
hydrophilic PMMA plate. This phenomenon should be regarded
as a ﬁrst sign of phase separation.
In conclusion, ST-F0 and ST-F-N1 showed macroscopic proper-
ties slightly different than their non-sterilized versions. Mainly, the
gel behavior was considerably reduced for both emulsions.
However, these emulsions remained homogeneous and their
qualities in term of consistency and spreading ability were
acceptable. In addition to the presence of lumps in ST-F-N2, the
emulsion was less covering compared to other studied emulsions
and did not match the properties of sun protection cream.
3.3. Assessment of the microbiological properties of model emulsions
3.3.1. Initial microbiological charge: evaluation of aerobic mesophilic
bacteria content
The efﬁciency of the sterilization process was evaluated
following NF EN ISO 21149:2006 (AFNOR, 2009). Culture
without enrichment gave the real number of mesophilic aerobic
bacteria in emulsions. It was around 100 and 170 UFC/g of
product and appears acceptable in regard of the acceptation limit
recommended by the European Pharmacopoeia for the non-
sterile cutaneous products ﬁxed at 200 UFC/g of product
(European Pharmacopoeia 8.0, 2014). Petri dishes spread with
enriched non-sterilized emulsions were covered with bacteria
colonies after incubation. On the contrary, in the case of
sterilized emulsions, Petri dishes were devoid of any bacteria
development thus proving the efﬁciency of the heat treatment.
Hence, these results demonstrated that the initial emulsion
microbiological charge of emulsions was acceptable and could
not be an obstacle to future microbiological assays. For this
purpose, only the non-sterilized versions were thereafter tested
on bacteria strains.
3.3.2. Bactericidal effect of model emulsions
Two normal human skin bacteria strains were used: Pseudo-
monas ﬂuorescens MFP 05, a gram negative ubiquitous bacterium
representing more than 90% of the microbial ﬂora in humid skin
areas (Grice et al., 2008), Staphyloccocus. aureus MFP03, a gram
positive bacterium, usually considered as a member of transient
human skin ﬂora carried by 35–60% of the human population
(Percival et al., 2012).
When the control emulsion was diluted in LB broth (Fig. 7A)
nutrient contribution let P. ﬂuorescens and S. aureus to quickly
develop. The growth of MFP03 (slope of the linear part of the curve)
appeared more rapid than for MFP05 but this difference should
only reﬂect their optimal growth temperature (37 C and 28 C
respectively) and metabolism. In this culture condition, no
bactericidal effect of the control emulsion was observed.
Thus, it appears interesting to evaluate the bactericidal effect of
the presence of NP. The results highlighted that the NP did not
signiﬁcantly affect the growth of both bacteria. Finally, both strains
grew as well in all emulsions, with or without NP. One hypothesis
could be that the high nutrient contribution of LB broth hided the
effect of the nanoparticle presence as well as their coatings.
Therefore, dilution in physiological water was conducted as it only
brings nutrients already present in the emulsion. In this second
Fig. 6. Example of spreading traces, A: for F-N2, B: for ST-F-N2.
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emulsion were also similar and there was no NP effect (Fig. 7B).
The growth kinetic of P. ﬂuorescens MFP05 was reduced with a
plateau, corresponding to the total biomass formed which was
decreased of ten times. P. ﬂuorescens MFP05 is resistant and highly
adaptable to environment variations (Chapalain et al., 2008) as
previously shown, emulsions are not appearing as a favorableFig. 7. Bacteria growth in different diluted emulsions (n = 3); *emu
P2media for bacteria development (Teixeira et al., 2007). This was
conﬁrmed by the behavior of S. aureus MFP03 that was unable to
grow in emulsion diluted in physiological water. This bacterium
could not adapt and metabolize emulsion components. Its
population was undergoing a progressive decay due to the lack
of adapted resources.lsions diluted in physiologic water, **emulsions diluted in LB.
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in the introduction and this test following the bacteria growth in
emulsions highlighted the absence of NP effect.
4. Conclusion
In this study, formulation development was conducted to
provide lab-scale preservative-free sunscreen emulsions that
should contain the same major ingredients and differed only by
the presence and nature of TiO2NP, an inorganic UV-ﬁlter. This
development phase showed that TiO2NP could be difﬁcult to
implement, depending on their coating. While hydrophilic NP,
coated with silica, was easily integrated into the continuous phase
of the emulsion and did not change markedly the physicochemical
characteristics of the emulsion, hydrophobic NP, coated with
alumina (and) triethoxycaprylylsilane induced formation of large
aggregates with the other ingredients during the emulsion
preparation. Process had therefore to be carefully optimized and
controlled in order to succeed in obtaining well dispersed and
smooth emulsion. Emulsions containing NP as well as the control
one had been characterized by microscopic analyses (laser
diffraction granulometry and optical microscopy) and macroscopic
analyses (rheology and texturometry) in order to ensure that they
shared the same physicochemical properties. Even if these
technics highlighted slight differences in terms of microscopic
structures between emulsions, other macroscopic analyses such as
rheology and texturometry did not showed bulk major differences.
This should allow assessing the role of NP in use, regardless the
global physicochemical properties of formulae.
We were able to show that the three emulsions fulﬁlled the
main criteria for the evaluation of the effect of NP in formula on the
microbiota. One interesting point is that non-sterile formula,
developed with speciﬁc cautions taken with the formulation
material and procedure, showed an initial bacterial charge well
below the acceptable limit as deﬁned by the European Pharmaco-
peia 8.0.
Applicability of high temperature sterilization to cosmetic
emulsions and sunscreen emulsions containing inorganic UV-
ﬁlters was as well evaluated. Although this treatment should be
estimated sufﬁcient to induce emulsion demixing, the control
emulsion and the emulsion containing hydrophilic NP passed
through it. For both emulsions, the change in gel behaviors could
not be only explained by the presence of new larger but minor
populations; polymer deterioration and structural rearrangements
may also explain these phenomena. Unfortunately, for emulsions
containing hydrophobic NP, sterilization induced the formation of
two phases; one formed by aggregated NP and larger droplets, and
the other by a liquid phase containing small droplets. Even starting
from an emulsion with an optimized dispersion of hydrophobic NP,
heat treatment induced dramatic changes for both the micro-
structure as well as the macroscopic properties of this emulsion.
The polymeric coating of hydrophobic NP probably makes this kind
of treatment more difﬁcult to adapt and formulation development
remains to be done. As an example, additional emulsiﬁers may be
used to stabilize NP during the sterilization step. Nevertheless the
high temperature sterilization appears applicable to cosmetic
emulsions and sunscreen emulsions containing, or not, inorganic
hydrophilic UV-ﬁlters.
Finally, in order to verify the usability of these model emulsions,
an evaluation of the microbiological effect of NP was performed on
non-sterile formula. It revealed that, when bacteria were voluntary
inoculated in formulae, all emulsions had the same impact on the
growth of two human skin bacteria representative strains, S. aureus
and P. ﬂuorescens.
The model emulsions developed in this article are well suited
for the evaluation of the ‘NP effect’ in formula on microbiota,P27because they hide their other physicochemical aspects whatever
the polarity of the coating.
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Skin-bacteria communication: 
Involvement of the neurohormone 
Calcitonin Gene Related Peptide 
(CGRP) in the regulation of 
Staphylococcus epidermidis 
virulence
Awa R. N’Diaye1, Camille Leclerc1, Takfarinas Kentache2, Julie Hardouin2, 
Cecile Duclairoir Poc1, Yoan Konto-Ghiorghi1, Sylvie Chevalier1, Olivier Lesouhaitier1 & 
Marc G. J. Feuilloley1
Staphylococci can sense Substance P (SP) in skin, but this molecule is generally released by nerve 
terminals along with another neuropeptide, Calcitonin Gene Related Peptide (CGRP). In this study, 
we investigated the effects of αCGRP on Staphylococci. CGRP induced a strong stimulation of 
Staphylococcus epidermidis virulence with a low threshold (<10−12 M) whereas Staphylococcus aureus 
was insensitive to CGRP. We observed that CGRP-treated S. epidermidis induced interleukin 8 release by 
keratinocytes. This effect was associated with an increase in cathelicidin LL37 secretion. S. epidermidis 
displayed no change in virulence factors secretion but showed marked differences in surface properties. 
After exposure to CGRP, the adherence of S. epidermidis to keratinocytes increased, whereas its 
internalization and biofilm formation activity were reduced. These effects were correlated with an 
increase in surface hydrophobicity. The DnaK chaperone was identified as the S. epidermidis CGRP-
binding protein. We further showed that the effects of CGRP were blocked by gadolinium chloride 
(GdCl3), an inhibitor of MscL mechanosensitive channels. In addition, GdCl3 inhibited the membrane 
translocation of EfTu, the Substance P sensor. This work reveals that through interaction with specific 
sensors S. epidermidis integrates different skin signals and consequently adapts its virulence.
Skin is the major neuroendocrine organ of the human body1 and harbors a large and highly diverse microbi-
ota2. Skin bacteria are continuously exposed to host molecules that diffuse through to the upper layers of the 
epidermis and are present in sweat3. Many of these molecules are released by afferent nerve terminals and show 
important local variations in their concentration in response to stress, inflammation or even pain1,4. We have 
previously shown that skin bacteria of different phyla, including gram-positive species such as Bacillus cereus5, 
Staphylococcus aureus5,6 and Staphylococcus epidermidis5,6, and gram-negative bacteria such as Pseudomonas 
fluorescens7 can detect Substance P (SP), the principle skin neuropeptide. This molecule between nano- and 
micro-molar concentrations acts on bacteria and leads to a general increase in virulence. There is now ample 
evidence that bacteria can detect a large range of neurohormones8. In skin nerve terminals, SP is frequently 
co-localized and co-secreted with Calcitonin Gene Related Peptide (CGRP)9 another neuropeptide abundantly 
expressed in the skin10.
CGRP is a 37 amino acids peptide that belongs to the calcitonin superfamily of hormones including cal-
citonin, amylin, and adrenomedullin. Two isoforms of this peptide—α -CGRP (or CGRP I) and β -CGRP (or 
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CGRP II)—are produced from the same gene by alternative splicing, but α -CGRP is the major form expressed in 
sensory skin fibers1. CGRP is one of the most potent vasodilatory neuromediators and it potentiates the effects of 
Substance P on vascular permeability and edema formation in skin1. In addition, CGRP exerts trophic effects on 
endothelial cells and melanocytes. Regarding the effects of this family of peptides on bacteria, a direct antimicro-
bial effect of CGRP has been described toward Escherichia coli and Pseudomonas aeruginosa11 and is explained 
by the structural similarities between CGRP and antimicrobial peptides. However the antimicrobial spectrum 
of CGRP is limited and it has been shown to have no effect on Staphylococcus aureus viability11. The ability of 
bacteria to detect and respond to neuropeptides through specific sensors and mechanisms was recognized only 
at the end of the 20th century and has diffused slowly in the scientific community under the name “Microbial 
Endocrinology”12. Many peptides initially identified for entirely unrelated functions that have secondary antimi-
crobial activity at non-physiological concentrations, such as natriuretic peptides, have been found to be able to 
modulate bacterial adhesion, biofilm formation activity and virulence through specific interaction with sensor 
proteins13. However, to date the physiological effects of CGRP on bacteria and its potential detection by bacterial 
sensory proteins have not been investigated.
In the present report, we studied the effect of α CGRP on S. aureus and S. epidermidis, two of the major bac-
terial species constituting the skin microbiota. Strains isolated from normal human skin were used to avoid the 
bias that are potentially encountered when library reference strains are used. The effect of α CGRP on S. aureus 
and S. epidermidis virulence was investigated in cultured keratinocytes and reconstructed human epidermis to 
more closely simulate normal skin conditions. Although they are of the same genus, these bacteria had completely 
different sensitivities to CGRP. The CGRP sensor was identified in S. epidermidis, and the mechanism of action 
of the peptide was partly elucidated. A schema was then proposed to explain how S. epidermidis can sense and 
integrate different host signals and adapt its virulence in response to a cutaneous environment.
Results
CGRP stimulates the cytotoxicity of Staphylococcus epidermidis on cultured keratinocytes and 
reconstructed human epidermis. Preliminary experiments showed that exposure of S. aureus (MFP03) 
or S. epidermidis (MFP04) to CGRP (10−6 M) over the entire growth phase did not modify the growth kinetics 
of these bacteria. The effect of CGRP on bacterial cytotoxicity was evaluated on HaCaT keratinocytes by meas-
urement of lactate dehydrogenase (LDH), a stable cytosolic enzyme released during cell lysis14. CGRP (10−6 M) 
did not affect the cytotoxicity of S. aureus toward HaCaT cells (Fig. 1A). In contrast, when S. epidermidis was 
previously treated with CGRP (10−6 M), the bacterium showed a strong increase in cytotoxicity (+388 ± 8%, 
p < 0.001). As a control, CGRP (10−6 M) was administered alone and had no effect on HaCaT keratinocytes via-
bility. Because the bacteria were rinsed to remove any traces of free peptide before being layered on keratinocytes, 
Figure 1. Effect of CGRP on the cytotoxic activities of S. aureus and S. epidermidis. (A) Comparative effect 
of CGRP 10−6 M on the cytotoxicity of S. aureus MFP03 (SA) and S. epidermidis MFP04 (SE) toward HaCaT 
keratinocytes. The dotted line indicates the basal cytotoxicity level (100%) in control HaCaT cell cultures. 
(B) Dose response curve of the effect of CGRP on S. epidermidis MFP04 cytotoxicity (NS = not significantly 
different; ★★★p < 0.001). The results are representative of three independent experiments.
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this result can be explained only by a direct action of CGRP on S. epidermidis. Lower concentrations of CGRP 
were tested on S. epidermidis to investigate the dose-response relationship. This study showed that the threshold 
of the CGRP effect on S. epidermidis was remarkably low (< 10−12 M) (Fig. 1B). These results were confirmed by 
using reconstructed human epidermidis (RHE) exposed to control or CGRP-treated S. epidermidis (106 and 107 
CFU) and two different techniques to exclude any artefacts. In the first case, the cytotoxicity of bacteria was meas-
ured through assays of LDH release, as previously described. As observed with HaCaT cells, CGRP (10−6 M) alone 
had no effect on RHE viability. When RHE was exposed to 106 CFU S. epidermidis, the cytotoxicity of CGRP-
treated bacteria increased (+ 173 ± 3%, p < 0.001), whereas that of the control did not (Fig. 2A). Using a ten-fold 
higher inoculate (107 CFU) did not change the cytotoxicity of the control bacteria but induced a higher increase 
in the cytotoxicity of CGRP-treated S. epidermidis (+ 315 ± 7%, p < 0.001). In a second series of experiments, the 
virulence of S. epidermidis on RHE was measured by using MTT assays, which reflect mitochondrial respiratory 
activity and therefore cell viability15. A significant decrease in RHE viability was observed in the presence of 
106 and 107 CFU S. epidermidis previously exposed to CGRP (− 23 ± 2% and − 56 ± 4%, p < 0.001, respectively) 
(Fig. 2B). Because CGRP stimulates the virulence of S. epidermidis, as previously observed using Substance P6 and 
because the two peptides are generally released by the same nerve fibers9, S. epidermidis was exposed simultane-
ously to Substance P and CGRP. Used alone and at the same concentration, the effect of CGRP on S. epidermidis 
cytotoxicity was stronger than that of Substance P (Fig. 3). However, when bacteria were pre-treated with both 
peptides simultaneously (10−6 M each), the cytototoxicity of S. epidermidis was reduced relative to that of CGRP-
treated bacteria (− 50 ± 8%, p < 0.001) and Substance P-treated bacteria (− 32 ± 12%, p < 0.001) (Fig. 3).
CGRP-treated Staphylococcus epidermidis stimulates Interleukin 8 and cathelicidin secretion 
by keratinocytes. Because keratinocytes develop an efficient innate immune response to bacteria through 
activation of pro-inflammatory and antimicrobial peptides16, the production of interleukin 8 (IL8), catheli-
cidin (LL37) and β -defensin 2 (HBD2) by HaCaT cells and RHE was measured after exposure to control or 
CGRP-treated S. epidermidis. The basal level of IL8 secretion by HaCaT keratinocytes was not changed when the 
cells were exposed to CGRP (10−6 M) alone or to control bacteria (Fig. 4A). In contrast, CGRP-treated S. epider-
midis triggered a significant increase in IL8 secretion (+ 24 ± 3%, p < 0.001). Similar results were obtained using 
RHE, although the range of the response was amplified (Fig. 4B). By itself, the cutaneous strain of S. epidermidis 
MFP04 induced a significant increase in IL8 production by RHE (+ 28 ± 5%, p < 0.5), but when the bacteria were 
previously exposed to CGRP, a much more substantial stimulation of IL8 secretion was observed (+ 138 ± 8%, 
Figure 2. Effects of CGRP (10−6 M) on the virulence of S. epidermidis toward RHE. The effect of CGRP on 
the virulence of S. epidermidis MFP04 (SE) was studied on RHE (SkinEthic™ ) by using bacterial cultures at 106 
and 107 CFU/mL and two different techniques: assay of lactate dehydrogenase (LDH) release by dying cells (A) 
and measure of mitochondrial respiratory activity (viability) by MTT assays (B). The dotted lines indicate the 
basal cytotoxicity levels (100%) measured in RHE cultures using the two techniques. (★★★p < 0.001). The results 
are representative of three independent experiments.
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Figure 3. Combined effects of CGRP and Substance P on the cytotoxic activity of S. epidermidis. The 
comparative effects of CGRP and Substance P (SP) alone or in association (10-6 M each) on the cytotoxic activity 
of S. epidermidis (SE) were studied in HaCaT cells. (★★★p < 0.001). The results are representative of three 
independent experiments.
Figure 4. Effects of CGRP (10− 6 M) on S. epidermidis-induced expression of IL8 in cultured HaCaT 
keratinocytes (A) and RHE (B). IL8 was assayed in the culture medium of HaCaT cells and RHE (SkinEthic™ )  
exposed to control or CGRP-treated bacteria. (NS = not significantly different; ★p < 0.05; ★★★p < 0.001). The 
results are representative of three independent experiments.
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p < 0.001). HaCaT cells exposed to untreated bacteria showed a decrease in LL37 secretion (− 28 ± 4%, p < 0.001) 
whereas an insignificant increase in LL37 was observed when they were exposed to CGRP-treated S. epidermidis 
(Fig. 5A). The response of RHE was more acute because control and CGRP-treated S. epidermidis induced a 
stimulation of LL37 (+ 208 ± 12% p < 0.001 and + 343 ± 8% p < 0.001, respectively) (Fig. 5A). However, LL37 
production was significantly higher when the cells were exposed to CGRP-treated bacteria relative to the control 
bacteria (p < 0.001). In parallel, the secretion of HBD2 by both cultured keratinocytes and RHE was significantly 
reduced when they were exposed to control S. epidermidis (− 44 ± 12% and − 67 ± 2%, p < 0.001, respectively). 
The decrease in HBD2 production was more important than when keratinocytes and RHE were exposed to 
CGRP-treated bacteria (− 67 ± 11% and − 79 ± 2% (Fig. 5B)).
The effects of CGRP on Staphylococcus epidermidis cannot be explained by over-expression of 
virulence proteins. To investigate the origin of the increase in S. epidermidis virulence induced by CGRP, proteins 
were extracted from the secretomes of control and CGRP-treated bacteria, analyzed by 2D-gel electrophoresis and 
identified by Matrix-Assisted Laser Desorption Ionization Time-of-Flight mass spectrometry (MALDI-TOF/TOF). 
Image analysis of 3 replicates of 2D gels allowed the detection of nine major proteins over-expressed in the CGRP 
treated S. epidermidis condition compared with the control condition (Fig. 6). Interestingly, among these proteins, 
superoxidase dismutase (Spot 3), alkaline shock protein 23 (Spot 5), DnaK protein (Spot 7) and peroxidoxin (Spot 9) 
are required for bacterial adaptation to stress (Table 1). Other identified proteins, including dihydrolipoyl dehy-
drogenase (Spot 1), inosine-monophosphate dehydrogenase (Spot 2) and citrate synthase (Spot 6), are involved in 
intermediate metabolism. Only one of the proteins over-expressed in CGRP-treated S. epidermidis, immunodom-
inant surface antigen B (IsaB) (Spot 3) and its precursor (Spot 8), is considered to be a virulence factor because of 
its antigenic activity17. In addition, tandem mass spectrometry analysis identified of a core of 170 proteins repro-
ducibly found in the secretome of control and CGRP-treated S. epidermidis MFP04 and confirmed the absence of 
significant variations in the expression of potential cytotoxic proteins (Table S1).
CGRP affects the surface properties of S. epidermidis. Adhesion and internalization of S epidermidis 
were studied using HaCaT cells and a gentamicin protection assay, as previously described18. When bacteria were 
pre-treated with CGRP (10−6 M) a significant increase in S. epidermidis adhesion to the surfaces of keratinocytes was 
Figure 5. Effects of CGRP (10−6 M) on S. epidermidis-induced expression of antimicrobial peptides in 
cultured HaCaT keratinocytes (A) and RHE (B). Cathelicidin LL37 and β -defensin 2 (HBD2) were assayed in 
the medium of HaCaT cells and RHE (SkinEthic™ ) exposed to control or CGRP-treated bacteria. (NS = not 
significantly different; ★★★p < 0.001). The results are representative of three independent experiments.
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observed (+ 29 ± 3%, p < 0.001) (Fig. 7A). This effect was associated with a marked decrease in S. epidermidis inter-
nalization in HaCaT cells (− 65 ± 4%, p < 0.001) (Fig. 7B). The effect of CGRP on biofilm formation by S. epidermidis 
was investigated by confocal laser-scanning microscopy in a flow cell system. When bacteria were pretreated with 
CGRP and introduced into the flow cell system, a marked decrease in biofilm formation was observed (Fig. 8). 
After 24 h, the mean thickness of the biofilm of control bacteria reached 23 ± 1 μ m, whereas it was only of 6 ± 1 μ m 
with CGRP-treated S. epidermidis. The calculated biomass showed a similar significant decrease (− 68 ± 16, 
p < 0.01%). These effects were correlated with a clear evolution of the surface polarity of CGRP-treated bacteria, 
as measured by the MATS technique (Microbial Adhesion To Solvents19). The higher affinity for apolar solvents 
(decane and hexadecane - Fig. 9) indicated that after exposure to CGRP, the surface of the bacterium evolved from 
having a mid-hydrophilic to a low-hydrophobic characteristic. In parallel, the affinity of the bacterium for hexa-
decane and chloroform, related to the Lewis acid characteristic, was marginally increased (+ 6 ± 1 and + 15 ± 4%, 
p < 0.001, respectively) whereas the affinity for decane and ethyl acetate, showing Lewis acid characteristics, was 
markedly enhanced (+ 113 ± 4 and + 115 ± 7%, p < 0.001, respectively). Thus the Lewis acid characteristic of the 
bacterial surface was reinforced.
The DnaK protein acts as a sensor of CGRP in S. epidermidis. Assuming that CGRP is unable to cross 
the bacterial membrane because of its charge and hook shape20 and the binding of CGRP to its sensor protein is 
sufficiently stable, we investigated the CGRP-binding protein in S. epidermidis membrane extracts via an immu-
noprecipitation technique using CGRP antibody-coated beads as previously described5. A unique CGRP bind-
ing protein of an apparent mass of 70 kDa was identified in the proteome of S. epidermidis MFP04 (Fig. 10). In 
agreement with the absence of an effect of CGRP on S. aureus, this protein was absent in the membrane proteome 
in S. aureus MFP03 (Fig. 10). A band corresponding to this protein was subsequently dissected and analyzed by 
tandem mass spectrometry. This protein was identified by mass spectrometry analysis with a score of 140.29 and 
coverage of 64 as the 66.1 kDa chaperone protein of S. epidermidis DnaK.
Export of DnaK through the large conductance mechanosensitive channel MscL is required 
for the effects of CGRP on S. epidermidis. Electrophysiological approaches have demonstrated that in 
the membrane of E. coli, DnaK is exported through the large conductance mechanosensitive channel MscL21. 
MscL also triggers the export of EfTu21, the Substance P sensor protein in S. epidermidis6. MscL is a ubiquitous 
protein and is also expressed by S. epidermidis22. As shown herein, CGRP increases the export of DnaK by S. epi-
dermidis (Spot 7 in Fig. 6 and Table 1). The effect of CGRP on S. epidermidis cytotoxicity was then studied in the 
presence of GdCl3 (10−3 M) a specific inhibitor of the MscL channel23. Exposure of bacteria to GdCl3 resulted in 
a significant reduction of the cytotoxic activity of CGRP-treated bacteria (− 78 ± 15%, p < 0.001) (Fig. 11A). In 
contrast, the effect of the control bacteria remained unchanged, suggesting that in the absence of CGRP, DnaK is 
unable to modulate bacterial cytotoxicity. In parallel, we observed through western blotting that CGRP induces 
a concomitant export of EfTu (Fig. 11B). Moreover, EfTu translocation through the bacterial membrane was 
Figure 6. Bidimensional electrophoresis analysis of secreted S. epidermidis proteins in control conditions 
and after a 2 h treatment with CGRP (10−6 M). Nine spots were identified, corresponding to proteins 
significantly up-regulated after exposure of the bacteria to CGRP. Proteins corresponding to these spots are 
presented in Table 1. The results are representative of three independent experiments.
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completely inhibited by exposure to GdCl3 (10−3 M) (Fig. 11B). This inhibition was observed in either the absence 
or presence of CGRP.
Discussion
Skin is a complex neuroendocrine organ whose physiology results from equilibrium among many local factors. 
In addition to the well-documented release of Substance P, skin sensory nerve terminals generally release CGRP1. 
This neuropeptide is also expressed locally by monocytes and macrophages24, Langerhans cells25 and keratino-
cytes26. CGRP is produced in significant amounts in skin and is now recognized as a pleiotropic signaling mol-
ecule in mammals27. The present work extends this notion, showing that CGRP can also act as a regulator of 
bacterial physiology, modulating the virulence and surface properties of one of the principle skin associated 
bacteria, S. epidermidis.
The stimulatory effect of CGRP on S. epidermidis cytotoxicity is stronger than that observed under identical 
doses of Substance P5. Similarly, the threshold of CGRP activity on S. epidermidis is extremely low, below the 
picomolar level, and well below the mean concentrations of CGRP in blood (± 84 × 10−12 M)28 and skin (between 
5.4 and 0.3 × 10−12 M/g tissue)10. The effect of CGRP on S. epidermidis virulence was confirmed using RHE. RHE 
shows a fully differentiated stratum corneum29, thus indicating that this observation is physiologically relevant. 
The low concentration of CGRP required to induce a bacterial response allows metabolic action of the peptide to 
be excluded. Moreover, the absence of the effect of CGRP on S. aureus indicates that it is highly specific, because 
this species is closely related to S. epidermidis. In contrast, the antagonistic effect of CGRP and Substance P 
towards S. epidermidis suggests the existence of a common step in the response of the bacterium to both peptides. 
This hypothesis was confirmed later in this study.
In agreement with these first results, we observed that CGRP-treated bacteria induce an up-regulation of 
interleukin 8 (IL8) secretion by cultured keratinocytes and RHE. In skin, as in many tissues, this result indicates 
the activation of an inflammatory process30. Because the pro-inflammatory response of keratinocytes is generally 
associated with induction of antimicrobial peptide secretion16, the production of LL37 and HBD2 by HaCaT cells 
and RHE was measured after exposure to CGRP-treated bacteria. An increase in LL37 secretion was observed in 
both models when these cells were exposed to CGRP pre-treated S. epidermidis. S. epidermidis is one of the major 
commensal bacteria of the human skin and is normally well tolerated31. However, the present results demonstrate 
that when the bacterium is exposed to CGRP, the skin tolerance towards it is reduced, and an innate immune 
response is activated. Nevertheless, this response should be incomplete because a parallel decrease in HBD2 
production was observed.
Analysis of the secretome of CGRP-treated bacteria by two techniques, 2D electrophoresis coupled with 
MALDI-TOF/TOF and tandem mass spectrometry, did not reveal significant variations in the production of 
diffusible proteins/enzymes with similarity to known virulence factors. The IsaB protein and its precursor were 
increased, but IsaB is involved in the escape mechanism from the host defense system32 and is not directly respon-
sible for bacterial cytotoxicity. Of course, we cannot exclude the association of several individual proteins among 
the 170 regularly identified in the secretome of S. epidermidis MFP04 (this study); however, even in this list, the 
number of proteins or enzymes potentially capable of acting as virulence factors is very limited. In contrast, 
an increase in several chaperone proteins involved in bacterial adaptation was observed, suggesting that CGRP 
is detected by S. epidermidis as a stress signal. In fact, CGRP appears to modulate the surface properties of S. 
Spot
NCBI accession 
Number Gene Name Putative function
Mascot 
score
Number of 
matched peptides
Coverage 
(%)
Mass (Da) 
& pI
1 WP_002435425.1 Dihydrolipoyl dehydrogenase
Pyridine nucleotide-disulphide 
oxidoreductase fold NAD(P) 
(+ )-binding proteins
107 16 41 49733/4.72
2 WP_002434485.1 Inosine-monophosphate dehydrogenase
The catalytic domain of the inosine-
monophosphate dehydrogenase 
(IMPDH). IMPDH catalyzes the NAD-
dependent oxidation of inosine  
5′ -monophosphate (IMP) to xanthosine 
5′ monophosphate (XMP)
100 21 43 52493/5.35
3 WP_002453341.1 Superoxidase dismutase Inorganic ion transport and metabolism 108 15 71 22697/5.04
4 WP_002435927.1 Immunodominant surface antigen B (isaB)
Immune response during septicemia: 
generally classified as a virulence factor 
(increased expression in vivo during 
human sepsis)
98 10 62 20088/4.84
5 WP_002432778.1 Alkaline shock protein 23 Alkaline pH tolerance 120 18 72 19187/4.91
6 WP_002434679.1 Citrate synthase CoA binding site: oxalate citrate binding site catalytic triad 144 24 55 42519/5.26
7 WP_049427550.1 DnaK Chaperone: functions in stress- induced protein refolding and degradation 242 43 72 66071/4.54
8 WP_002436880.1 Immunodominant antigen B (isaB) precursor IsaB pro-protein 101 8 41 18400/5.54
9 WP_030061284.1 Peroxidoxin Controls cytokine-induced peroxide levels: confers protection to cells 141 13 91 21268/4.5
Table 1.  Proteins over-expressed in the secretome of CGRP-treated S. epidermidis identified by MALDI-
TOF/TOF.
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epidermidis. The bacterium showed increased adherence to keratinocytes. In contrast, its internalization pro-
cess was reduced, thus suggesting that the surface properties of the bacterium hindered its penetration into the 
cytoplasmic compartment of the target cell. S. epidermidis internalization is mediated by the major autolysin/
adhesin AtlE, and the eukaryotic protein Hsp70 was identified as its putative host cell receptor33. However, in the 
present study we observed that CGRP induced an increase in the export of DnaK, a member of the heat shock 
protein 70 (Hsp70) family34. Thus, we can not exclude the possibility that DnaK might interfere with AtlE on the 
S. epidermidis surface, inducing an inhibition of its adhesion potential toward target cells. In Staphylococci, DnaK 
is also involved in biofilm formation35 and thus is a potential target for new antibiofilm molecules36. In agreement 
with the hypothesis of a key role of DnaK in the response of S. epidermidis to CGRP, we observed that the biofilm 
formation activity of the bacterium was reduced after exposure to the peptide. In the present study, the biofilm 
formation was monitored on a glass surface and under dynamic conditions. Glass is a polar surface37, and bacte-
ria must develop sufficient adhesion forces to resist the flow. Thus, our observations suggest that CGRP-treated 
bacteria present a decrease in adherence to polar materials such as glass and thus present a more hydrophobic 
surface. This hypothesis was confirmed through use of the MATS technique, which revealed that after exposure 
to CGRP, the surfaces of the bacteria evolved from having a mid-hydrophilic to a low-hydrophobic characteris-
tic. These results are also coherent with the higher adhesion on the surface of HaCaT cells, thus suggesting that 
CGRP-treated bacteria develop a higher affinity toward membrane phospholipids than do untreated bacteria. 
Although no direct relationship was found among surface polarity, biofilm formation and virulence in clinical 
species of S. epidermidis38, CGRP appears to have has a coherent effect on these parameters, thus leading to 
increased virulence.
A central role of DnaK in the response of S. epidermidis to CGRP was confirmed when this protein was iden-
tified by immunoprecipitation and tandem mass spectrometry as the CGRP binding protein. In Staphylococci, 
DnaK is known for its multiple roles in environment and stress adaption35 but the binding of CGRP to DnaK 
Figure 7. Effects of CGRP (10−6 M) on the binding (A) and invasion activities (B) of S. epidermidis (SE) toward 
HaCaT cells. After 1 h incubation at a MOI of 10:1, the total number of cell-associated bacteria was determined 
by direct counting after plating. Invasive bacteria were also quantified by direct counting after elimination 
of extracellular bacteria by gentamicin. (★★★p < 0.001). The results are representative of three independent 
experiments.
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was initially unexpected. However, alignment of the S. epidermidis DnaK amino acid sequence with eukaryotic 
sequences shows matches at the first rank with protein Q8T885 [www.uniprot.org] which is also designated as 
a CGRP receptor component protein (CGRP-RCP), a subunit of the CGRP receptor of eukaryotes necessary for 
signal transduction39. Moreover, studies in yeast suggest that CGRP-RCP is a multifunctional protein involved 
in transcription40, and in a recent study in S. epidermidis DnaK has been suggested to be exposed at the surface 
of the bacterium and to act as a receptor for endothelial cells33. A STRING10 network analysis [http://string-db.
org/] indicated that S. epidermidis DnaK interacts not only with other chaperone proteins but also with EfTu, the 
moonlighting protein previously identified as the sensor for Substance P in Staphylococci6 (Figure S1). In E. coli, 
DnaK and EfTu are released upon osmotic shock by a translocation mechanism involving the mechanosensitive 
channel MscL21. MscL can be blocked by gadolinium chloride (GdCl3)23, and we observed that pre-exposure 
of S. epidermidis to GdCl3 inhibited the stimulatory effect of CGRP on S. epidermidis cytotoxicity. In addition, 
CGRP increases the release of EfTu, and this effect is antagonized by GdCl3, thus suggesting that the peptide 
induces the opening of MscL and, as shown in E. coli, a simultaneous translocation of DnaK and EfTu21. Of 
course the increase of DnaK in the secretome of CGRP-treated bacteria could potentially result from many other 
events, including increased membrane permeability, cell lysis or reduced extracellular degradation. However, in 
Figure 8. Effect of CGRP (10−6 M) on S. epidermidis biofilm formation under dynamic conditions. Biofilm 
formation by S. epidermidis in the absence or presence of CGRP was studied by confocal laser scanning 
microscopy using a flow-cell system. Two dimensional (2D) images collected at 1 μ m intervals were used 
to reconstruct ortho cuts (3D/z) and three-dimensional (3D) images. Pictures are representative of three 
independent experiments. Scale bars = 20 μ m.
Figure 9. Effects of CGRP (10−6 M) on the relative affinity of S. epidermidis to solvents. Partition between 
water and solvents of different polarities and Lewis acid-base values of control (empty bars) and CGRP-treated 
(dotted bars) S. epidermidis was studied with the MATS technique using chloroform (CH), hexadecane (HD), 
decane (DE) and ethyl acetate (EA). (★★★p < 0.001). The results are representative of three independent 
experiments.
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MscL-deficient strains of E. coli, DnaK is not released, even after osmotic shock21, suggesting that DnaK export 
is almost exclusively controlled by MscL. Because we observed that CGRP did not affect the growth and via-
bility of S. epidermidis and that as a chaperone, DnaK is a stable molecule, the effect of CGRP on DnaK export 
through MscL channels is the main hypothesis explaining the present results. Moreover, this hypothesis provides 
a potential explanation for the antagonistic effects of CGRP and Substance P. Indeed, if DnaK and EfTu are 
exported through the same channel, they would compete for translocation when the bacterium is simultaneously 
exposed to CGRP and Susbtance P. This hypothesis is summarized in Fig. 12. This mechanism may also explain 
the absence of sensitivity of S. aureus to CGRP. Indeed, DnaK is also expressed in S. aureus, but the oligomeric 
structure of MscL is still a matter of debate, and the diameter of this channel differs among bacterial species41. 
EfTu is a 43 kDa protein but DnaK is much larger (66.1 kDa) and it is possible that DnaK is unable to translocate 
through the S. aureus membrane, thus making this species insensitive to CGRP.
Reasons for the preservation or emergence of a CGRP-sensing system in S. epidermidis remain hypotheti-
cal. However, interestingly S. epidermidis not only is a commensal bacterium but also is associated with severe 
Figure 10. SDS page analysis of CGRP-binding proteins in S. aureus and S. epidermidis membrane 
extracts. The CGRP sensor was identified in S. aureus (SA) and S. epidermidis (SE) membrane extracts by 
immunoprecipitation using CGRP antibody-associated beads. CGRP was associated with a 70 kDa apparent 
mass protein that was identified by tandem mass spectrometry as the chaperone protein DnaK. The lactonase 
QSDA was used as a control. The results are representative of three independent experiments.
Figure 11. Effect of pre-treatment by GdCl3 on the cytotoxicity of control and CGRP- treated S. epidermidis 
(A) and on the relative intra- and extra-cellular concentrations of EfTu produced by S. epidermidis in control 
conditions and after exposure to CGRP, GdCl3 or CGRP and GdCl3 (B). Bacteria (SE) exposed or not to GdCl3 
(1 mM) were subsequently grown in the absence or presence CGRP (10−6 M). Their cytotoxic potential was 
measured on HaCaT cells (A). EfTu was analyzed by western blotting in the stroma (intra) and growth medium 
(extra) of S. epidermidis grown in the absence (control) or presence of CGRP (10−6 M), GdCl3 (1 mM) or both 
substances (CGRP and GdCl3) (B). (NS: non significant; ★★★p < 0.001). The results are representative of three 
independent experiments.
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forms of atopic dermatitis42 and is currently regarded as the most frequent cause of nosocomial and medical 
device-associated infections43. CGRP expression is increased during stress and in psoriatic skin and this peptide 
is one of the most potent vasodilatory mediators1. Because, in parallel CGRP reduces neutrophilic accumula-
tion1, as has been described in the lung, where Pseudomonas aeruginosa uses interferon as an infection inducer44, 
S. epidermidis should detect CGRP as a signal of favorable conditions for tissue invasion and shift from commen-
sal to pathogenic behavior.
In conclusion, this study reveals a totally new function of CGRP in the skin as a regulator of S. epidermidis vir-
ulence. Our results also illustrate a new role of DnaK as a moonlighting protein45 acting as a sensor for CGRP in 
S. epidermidis. The translocation mechanism of DnaK through MscL provides an explanation for the antagonistic 
effects of CGRP and Substance P on S. epidermidis and for the absence of the effect of CGRP on S. aureus. These 
results demonstrate that skin bacteria can integrate different signals from cutaneous origin and consequently 
adapt their virulence to the microenvironment.
Methods
Bacterial strains and culture conditions. S. aureus (MFP03) and S. epidermidis (MFP04) were collected 
from the skin of healthy volunteers46. These bacteria were characterized by phenotypic, metabolic, MALDI-
Biotyper proteomic analysis and 16S ribosomal RNA gene sequencing. All bacteria were grown at 37 °C in 
Luria-Bertani (LB) medium under gentle agitation (180 rpm). Bacteria were stored on cryobeads at − 140 °C and 
subjected to two pre-culture phases. For the studies, bacteria collected at the end of the exponential growth phase 
were diluted in fresh broth. The peptides, diluted in sterile physiological water (NaCl 0.9%), or an equivalent 
volume of physiological water in control studies, were added at the beginning of the log growth phase. Before 
the tests, the bacteria were harvested by centrifugation (7,000 × g) and washed with sterile physiological water 
to remove any trace of free peptide. The bacterial density and the absence of contamination were controlled by 
plating. The viability of the bacteria in eukaryotic cell culture medium and under different culture conditions 
was controlled in preliminary studies (data not shown). CGRP and Substance P were obtained from Polypeptides 
(Strasbourg, France). Gadolinium chloride (GdCl3) was obtained from Sigma-Aldrich (Saint-Quentin Fallavier, 
France).
Cytotoxicity studies. The cytotoxicity of bacteria was studied in the human keratinocyte cell line HaCaT 
and in RHE. HaCaT Cells, provided by Cell Line Services (Eppelhein, Germany), were grown at 37 °C under a 
5% CO2 atmosphere, in Dulbecco’s modified Eagle’s medium (DMEM, Lonza, Levallois-Perret, France) supple-
mented with 10% fetal calf serum and 1% antibiotic cocktail (HyClone Thermo Scientific, Illkirch, France). Cells 
were used between passages 41 and 65. One day before use, the HaCaT cells were starved of antibiotic and fetal 
calf serum. The cells were incubated with control or treated bacteria at a multiplicity of infection (MOI) of 10:1.
RHE, obtained from Episkin (Lyon, France) was grown according to the specifications of the provider. Briefly, 
after delivery RHE was immediately incubated at 37 °C, under a 5% CO2 atmosphere, in provider medium and 
Figure 12. Schematic model representing the potential translocation of DnaK and EfTu through the 
membrane of S. epidermidis, thus leading to recognition of CGRP and Substance P. DnaK and CGRP are 
probably translocated in the periplasmic compartment through the MscL channel. CGRP and Substance P 
are binding to DnaK and EfTu, either in the periplasm or after diffusion through the cell wall, thus leading 
to formation of complexes able to promote the bacterial response through a yet-unknown mechanism. 
Competition of DnaK and EfTu for the same transporter may explain the antagonistic effects of CGRP and 
Substance P.
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allowed to stabilize for 48h. One day before use, RHE was transferred to antibiotics-free medium. For infection 
tests, RHE was exposed to control or treated bacteria at a final concentration of 106 or 107 CFU.
The lethal effect of bacteria was determined by assaying LDH which is released by keratinocytes, by using a 
Cytotox 96 assay (Promega, Charbonnières, France) and by measurement of keratinocytes survival with MTT 
assays, thus allowing cellular NAD(P)H-dependent metabolic activity to be determined through evaluation of 
the conversion of a tetrazolium dye (MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) into 
insoluble purple formazan crystals according to the OECD Draft Revised Guideline TG43115.
Antimicrobial peptides and interleukin 8 assays. The potential effect of CGRP on S. epidermidis-induced 
expression of antimicrobial peptides and chemokines was investigated by measurement of IL8, cathelicidin (LL37) 
and β -defensin 2 (HBD2) production by HaCaT cells and RHE after exposure to control or CGRP-treated bacte-
ria. IL8, LL37 and HBD2 were assayed in the culture medium of HaCaT cells and RHE by using human CXCL8/
IL-8 cat. D8000C (R&D system, Lille, France), human cathelicidin cat. CSB-EL004476HU and β -defensin 2 cat. 
CSB-E13201h (Cusabio, Aachen, Germany) ELISA kits according to the manufacturers’ protocols.
Secretome analysis. Supernatants of control or CGRP-treated S. epidermidis were obtained by centrifu-
gation and filtration. Proteins were precipitated by the addition of trichloroacetic acid on ice. These proteins 
were harvested by centrifugation, washed in cold acetone, dried at room temperature and re-dissolved in a rehy-
dratation buffer47. The protein concentration was determined by Bradford assays. Equal amounts of proteins 
(300 μ g) were loaded on each gel (12% w/v polyacrylamide) and separated. For 2D-gel electrophoresis, protein 
samples were first separated by isoelectric focusing (IEF) using pH 3 to 10 nonlinear IEF strips (GE Healthcare, 
Vélizy-Villacoublay, France) as previously described47. The strips were then transferred horizontally onto 12% 
polyacrylamide gels and covered with 0.5% agarose and the second dimension separation was run. Proteins were 
visualized by colloidal Coomassie brilliant blue G250 staining. Gel images were captured using a GS-800 densi-
tometer (Bio-Rad, Schiltigheim, France). Variations in spot intensity and distribution were studied using Bio-Rad 
PDQuest 2D® analysis software. Culture medium proteins were excluded and electrophoretic spots of interest 
were dissected and subjected to in-gel trypsin digestion and analyzed by MALDI-TOF/TOF using an AutoFlex III 
mass spectrometer (Bruker Daltonics, Wissembourg, France). The spectrometer was used in a positive/reflector 
mode. Samples were spotted to MTP 384 ground steel targets (Bruker Daltonics, Wissembourg, France) using a 
freshly prepared matrix solution composed of 2,5-dihydroxybenzoic acid in a solution of trifluoroacetic acid and 
acetonitrile. Each spectrum was established over an average of 500–1000 laser shots. FlexAnalysis software gen-
erated an MS peak list, which was subjected to peptide mass fingerprinting using the integrated software Biotools 
(Version 3.2). The NCBI database was searched using the online MASCOT software and statistical sequence 
analyses were performed using the probability-based Mowse score.
For tandem mass spectrometry analysis, all experiments were performed using a LTQ-Orbitrap Elite coupled 
with an Easy nLC II system (Thermo Scientific, Villebon-sur-Yvette, France). The samples were injected onto an 
enrichment column (C18 PepMap100, Thermo Scientific, Villebon-sur-Yvette, France). Separation was achieved 
with an analytical column needle (NTCC-360/100-5-153, NikkyoTechnos, Tokyo, Japan). The mobile phase con-
sisted of H2O/0.1% FA (buffer A) and ACN/FA 0.1% (buffer B). Tryptic peptides were eluted at a flowrate of 
300 nL/min using a three-step linear gradient: from 2 to 40% B over 25 min. The mass spectrometer was operated 
in positive ion mode with a capillary voltage and a source temperature set at 1.5 kV and 275 °C, respectively. The 
samples were analyzed using the CID (collision induced dissociation) method. The first scan (MS spectra) was 
recorded in the Orbitrap analyzer (R = 60,000) in the mass range m/z 400–1800. The 20 most intense ions were 
then selected for MS2 experiments. Singly charged species were excluded for MS2 analysis. Dynamic exclusion of 
already fragmented precursor ions was applied for 30 s, with a repeat count of 1, a repeat duration of 30 s and an 
exclusion mass width of ± 10 ppm. Fragmentation occurred in the linear ion trap analyzer with collision energy 
of 35. All measurements in the Orbitrap analyzer were performed with on-the-fly internal recalibration (lock 
mass) at m/z 445.12002 (polydimethylcyclosiloxane). Raw data files were processed using Proteome Discoverer 
1.3 software (Thermo Scientific, Villebon-sur-Yvette, France). Peak lists were searched using the MASCOT search 
engine (Matrix Science, Boston, USA) against the database Swiss Prot database searches were performed with 
the following parameters: 1 missed trypsin cleavage site allowed; variable modifications: carbamidomethylation 
of cystein, and oxidation of methionine; mass tolerance on parent and daughter ions: 10 ppm and 0.5 Da respec-
tively. Only proteins represented by more than 1 peptide sequence, by 2 folds and with power > 0.8 were retained. 
Each protein identification was validated by an ANOVA test.
Binding and invasion studies. Binding and invasion studies were performed with HaCaT cells. 
Cultured keratinocytes were infected for 1 h with S. epidermidis (MFP04) at an MOI of 10:1. In the first series 
of experiments, at the end of the incubation period HaCaT cells were washed six times with DMEM to remove 
non-adherent bacteria and then disrupted with 1 mL of 0.9% Triton X100. The total number of cell-associated 
bacteria (intra- and extra-cellular) was then counted by plating serial dilutions on Tryptone Soya Agar medium 
(TSA). Invasive bacteria were quantified by gentamicin protection assays as described by Mezghani-Abdelmoula 
et al.18. In these experiments, at the end of the incubation period HaCaT cells were treated with 100 μ g/mL gen-
tamicin to kill extracellular bacteria. The cells were then washed and lysed as previously described and the num-
ber of invading bacteria released from the cells was counted. Cells surface adherent bacteria were calculated by 
subtracting of the number of invasive bacteria from the total number of cell-associated bacteria. For each assay, 
serial dilutions of the whole bacterial inoculum were plated. The effect of HaCaT cell lysis buffer on the viability 
of S. epidermidis (MFP04) was controlled in preliminary tests.
P28
www.nature.com/scientificreports/
13Scientific RepoRts | 6:35379 | DOI: 10.1038/srep35379
Biofilm formation studies under dynamic conditions. After an overnight pre-culture in LB at 37 °C, 
S. epidermidis MFP04 was inoculated at an OD580 of 0.08 in LB medium and sub-cultured for 2 h. CGRP (10−6 M 
final concentration) was added, and bacteria were grown for an additional 1 h. Bacteria were then washed and 
adjusted to an OD580 of 0.1 in 0.9% NaCl supplemented with CGRP (10−6 M). The bacterial suspensions were then 
used to study biofilm formation under dynamic conditions at 37 °C in a three-channel flow cell as described by 
Bazire et al.48. Briefly, each bacterial suspension was injected into a flow cell channel, and bacteria were allowed to 
adhere to the glass coverslip for 2 h. A flow (2.5 mL/h) of LB medium was then applied for 24 h. At the end of the 
experiments, the biofilms were stained with 5 × 10−6 M Syto 61 red dye or 5 × 10−6 M SytoX (Molecular Probes, 
Thermo Fisher Scientific, Villebon-sur-Yvette, France). Observations were made using a confocal laser scanning 
microscope (LSM 710 confocal laser-scanning microscope; Zeiss, Marly le Roi, France). The biofilm thicknesses 
and corresponding biovolumes were estimated by measuring field samples from at least 3 independent experi-
ments using COMSTAT software (Matworks, Natick, USA)49.
Characterization of bacterial surface polarity. Stationary phase bacteria were harvested (7,000 × g; 
10 minutes) and washed twice in 0.9% NaCl. The polarity of control and CGRP-treated S. epidermidis MFP04 was 
studied using the Microbial Adhesion To Solvent (MATS) technique19 and two solvent couples: chloroform/hex-
adecane and ethyl acetate/n-decane. In total, 2.6 mL of bacterial suspension at OD400 0.8 was mixed for 60 s with 
0.4 mL of each solvent indicated above. The OD of the aqueous phase was measured at 400 nm. The percentage of 
cells in each solvent was calculated using the following equation: (1− A/A0) × 100. Each experiment was repeated 
in triplicate using three independent cultures.
CGRP binding site identification. Mid-log growth phase bacterial cultures were centrifuged at 7,000 × g for 
10 min. The pellets were resuspended in 5 mL of lysostaphin diluted in phosphate buffered saline (PBS) (10−5 g/mL). 
This mix was incubated for 1h at 37 °C with shaking at 180 rpm. Then, the samples were then centrifuged for 
20 min at 7,000 × g and 4 °C. Each pellet was solubilized in 6 mL of non-denaturing lysis buffer (Tris 50 × 10−3 M 
pH 8, EDTA 4 × 10−3 M, NaCl 137 × 10−3 M, glycerol 10%, Triton X100 1%, phenylmethylsulfonyl-fluoride 10−3 M 
and supplemented with protease inhibitors (Boehringer, Paris, France). Four freeze/thaw cycles were applied to 
the suspension at − 80 °C for 20 min/37 °C for 10 min. The bacteria were lysed by sonication using a number of 
short pulses (1 min) with pauses (2 min) on ice to maintain a low temperature. The cell lysates were once again 
centrifuged at 13,000 × g for 10 min at 4 °C to remove unbroken cells. For total protein extracts, the supernatant 
was incubated with benzonase (0.125 × 10−6 L/mL) and MgCl2 (1.625 × 10−6 L/mL) for 1 h at room temperature to 
degrade nucleic acids. The proteins were precipitated with 20% trichloroacetic acid, vortexed for 15 seconds and 
incubated overnight at 4 °C. Samples were then centrifuged at 13,000 × g for 20 min at 4 °C and solubilized in a 
rehydratation buffer (urea 7 M, 15.2% thio-urea, 4% CHAPS, 25 × 10−6 L/mL IPG buffer, 10.79 × 10−3 g/mL DTT 
and 1.43 10−3 g/mL TCEP in water). To extract membrane proteins, the supernatant containing the total proteins 
was ultracentrifuged at 35,000 rpm for 50 min at 4 °C. The pellet containing membrane proteins was solubilized in 
a solution containing 5 × 10−5 M Tris pH 8, 10−5 M MgCl2, 2% Triton X100 and 10−9 M phenylmethylsulfonylflu-
oride and supplemented with protease inhibitors.
The CGRP binding site was extracted by using an immunoprecipitation technique adapted from Mijouin et al.5. 
Briefly, 6 × 10−6 L of G protein-coupled agarose beads (Millipore) and 1.5 10−6 g of CGRP monoclonal anti-
bodies (Abcam, Paris, France) were allowed to associate overnight at 4 °C. Meanwhile, 1.5 × 10−3 g of mem-
brane protein extracts was incubated with CGRP (10−6 M) for 1h at room temperature under slow orbital 
agitation. To reduce the non-specific binding, 5 × 10−5 L of rabbit polyclonal serum was added. Unlabelled 
G protein-coupled agarose beads were added to remove non-specific complexes. The samples were incu-
bated for 30 min at 4 °C under slow orbital agitation. The unlabelled beads were removed by centrifuga-
tion (10,000 × g, 4 °C, 10 min). The supernatant containing the CGRP bound ligand was then mixed with 
the CGRP antibody-associated beads and incubated for 1 h at room temperature under slow orbital agita-
tion. For each sample, the beads were washed two times with 250 × 10−6 L of non-denaturing lysis buffer by 
low-speed centrifugation cycles. Each sample was boiled for 5 min with 5 × 10−5 L of Laemmli 2x buffer 
(Tris 0.2 M pH 6.8, glycerol 45%, sodium dodecyl sulfate (SDS) 6%, β -mercaptoethanol 6% and bro-
mophenol blue 0.03%) to separate the ligand from the beads. Before loading on a 12% SDS polyacryla-
mide gel electrophoresis (PAGE) gel, the beads were removed by centrifugation (14,000 × g, 4 °C, 5 min). 
Proteins were visualized by colloidal Coomassie blue G250 staining (Sigma-Aldrich, Saint Quentin Fallavier, France). 
Three independent experiments were conducted.
After dissection of the band of interest and protein solubilization, the CGRP-binding proteins were identified 
by tandem mass spectrometry as previously described, using an LTQ-Orbitrap Elite coupled with an Easy nLC II 
system (Thermo Scientific, Villebon-sur-Yvette, France).
Western blot analysis of EfTu in intra- and extra-bacterial compartments. Proteins extracted from 
the bacterial stroma and growth medium after fractionation as previously described were separated on a 12% w/v 
polyacrylamide SDS-PAGE gel. After separation, proteins were transferred onto nitrocellulose membranes at 50 mA 
for 1h in Tris base (0.192 M) transfer buffer containing glycine (14.5% g/L w/v) and methanol (20% v/v) using a 
Bio-Rad Mini TransBlot Electrophoretic Transfer Cell system. Membranes were then air-dried and immersed for 2 h 
in blocking buffer (Tris buffer saline (TBS): 5 × 10−5 M, 0.15 M NaCl, 5% whole milk). Membranes were incubated 
with primary antibody raised against bacterial EfTu6 (1:100 in blocking buffer) at room temperature for 2 h while 
shaking. After incubation, the blot was washed three times in 1x TBS supplemented with 0.05% (w/v) Tween 20 for 
30 min and incubated for 1.5 h with shaking with secondary antibody diluted 1/5000 (goat anti-rabbit IgG alkaline 
phosphatase conjugate, Bio-Rad, Schiltigheim, France). ). Electrophoretic bands were detected using an alkaline 
phosphatase conjugate substrate kit (Bio-Rad, Schiltigheim, France).
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Statistical analysis. All results are expressed as means ± standard error (SEM) calculated over a minimum 
of three independent experiments. Significant differences were estimated using Student’s t tests and are noted 
as ★ , ★ ★ and ★ ★ ★ for p-values < 0.05, < 0.01 and < 0.001, respectively. For confocal microscopy studies, the 
biofilm thickness and biomass were calculated from a minimum of 20 measures in different fields.
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Abstract 25 
The impact of two differently coated TiO2-nanoparticles (NPs) was evaluated on two 26 
representative bacteria from the cutaneous microbiota (Staphylococcus aureus and Pseudomonas 27 
fluorescens) in conditions of use. Particles were coated in order to exhibit either hydrophilic or 28 
hydrophobic behavior. A first exposure scenario within some fresh/aged model emulsions was 29 
developed in order to measure both the impact of the NPs presence and their surface nature during 30 
the emulsions conservation. Thanks to this protocol, it was demonstrated that, during aging, the 31 
hydrophobic NPs modified the physicochemical characteristics of the emulsions, such as the pH or the 32 
colloids sizes, and favored the development of potential pathogenic bacteria. A second scenario was 33 
then envisaged, aiming to mimic the exposition of the skin, especially of the cutaneous bacteria, to 34 
NPs. Tested NPs were extracted from emulsions with different aging, and results highlighted the 35 
importance of both the NP coating nature and their history in emulsion. The different NPs impacts on 36 
the bacteria growth were discussed and linked to their surface properties modifications during aging, 37 
as polarity and charges. Finally, through two exposition scenarios, this work highlights the major 38 
impact of the NPs surface properties on bacteria.  39 
1. Introduction 40 
The TiO2-nanoparticles (NPs) are commonly used in cosmetics due to their attractive optical 41 
properties: they protect the skin against the ultraviolet radiations, and as fine particles, they are not 42 
whitening once layered on skin. On the other hand, the TiO2-NPs have a stronger reactivity, and 43 
especially photoreactivity, enhancing the production of reactive oxygen species (ROS) that can induce 44 
cellular damages (Dunford et al., 1997; Kamat et al., 2000; Kawaguchi et al., 1997). For this reason, NP 45 
cosmetic grades are often surface-modified by applying a passivation coating (silica or alumina), in 46 
order to quench the photo-production of radicals (Cao and Zhang, 2011; Serpone et al., 2006). In 47 
addition, in order to raise their affinity with the emulsion, a second coating is sometimes added. 48 
Authors already highlighted coating deteriorations when the NPs are released after using in 49 
aqueous  environment (Auffan et al., 2010; Labille et al., 2010). However, during their formulation and 50 
storage, NPs are already exposed to a variety of aggressions in emulsion which can accelerate their 51 
aging and induce particles aggregation or adsorption of sunscreen compounds (Rossano, 2014). These 52 
modifications could affect the surface properties of the NPs and thus, change their impact on human 53 
skin. Whereas the impact of these kinds of NPs on eukaryotes cells was previously documented 54 
(Rossano, 2014), there is no information concerning their impact on the skin bacteria. However these 55 
microorganisms could be in contact with these NPs through two scenarios.  56 
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- First, it has been demonstrated that for a cosmetic product, the main contamination comes 57 
from the skin microflora of the consumer (Brannan and Dille, 1990). Hence, it appeared 58 
interesting to test the impact of the emulsion containing, or not NPs, on germs of the human 59 
skin microflora. Thus, we could wonder about the effect of the NPs on the microbiological 60 
conservation of the cosmetic emulsions. 61 
- Then, since the cutaneous bacteria represent the first skin barrier, a major consideration 62 
remains the safety of such NPs when layered on this shield. Indeed, some cosmetic ingredients 63 
have already been proved to impact the development of the cutaneous bacteria (Mijouin et 64 
al., 2013; Taylor et al., 2003) and could be involved in skin disorders (Christensen and 65 
Brüggemann, 2014). 66 
For this purpose, three model emulsions containing NPs, or NPs-free (reference), were previously 67 
developed with the same major ingredients to ensure qualities, making possible to conduct 68 
microbiological testing (Rowenczyk et al., 2016). These only differed by the presence and nature of 69 
TiO2-NPs:  70 
 one containing hydrophilic NPs, only passivated by silica,  71 
 a second one containing hydrophobic NPs, coated with alumina and 72 
triethoxycaprylylsilane, 73 
 a last one NPs-free.  74 
The impact of these NPs were studied though two protocols of exposure and related to their surface 75 
nature (surface charge and polarity) and modifications during aging. 76 
2. Material and Methods 77 
2.1. Chemical and reference materials 78 
Ultrapure water with a resistivity of 18 MΩ.cm used during the emulsion preparation and 79 
zetametry was purified, filtrated on 0.2 µm and treated by UV in order to eliminate germs. Otherwise 80 
distilled water with a resistivity of 18 MΩ.cm was used for other emulsion characterizations.  81 
Two different grades of TiO2-nanoparticles were kindly given by Kobo and Merck; one hydrophilic, 82 
with a simple silica coating named N1 (EUSOLEX® TAVO, Merck Chimie SAS, France) and a second, 83 
hydrophobic, composed of alumina (and) triethoxycaprylylsilane named N2 (A10-TiO2-11S7, Kobo 84 
Products, France). The other cosmetic grade ingredients were chosen to obtain oil-in-water sunscreen 85 
emulsions with optimal NP dispersions. To achieve emulsions with the lowest bactericide impact, no 86 
preservative was added.  87 
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Solvents were used as received: diiodomethane (DIM), 99 % purity, from Avocado (La tour du pin, 88 
France), decane, hexadecane, chloroform and ethyl acetate were obtained from Alfa Aesar (Karlsruhe, 89 
Germany). Potassium bromide (KBr), 99 % purity, (Fisher scientific, Illkirch, France) was dried for 24 h 90 
at 100°C before use. 91 
2.2. Emulsion preparation.  92 
The preparation protocol was previously described in Rowenczyk et al. (Rowenczyk et al., 2016). 93 
For the preparation of the preservative-free emulsion, precautions were taken in order to minimize 94 
the risk of contamination by environmental microorganisms. Stainless steel material was steamed for 95 
45 min at 190°C  and glass bottles were rinsed with ethanol prior to drying (INRS, 2014). For technical 96 
reasons it was impossible to make all operation in sterile conditions under laminar flow hood but 97 
controls revealed that, in our experimental conditions, airborne contaminants in final formulations 98 
remained under the detection limit.  99 
2.3. Emulsion aging 100 
Once prepared, the emulsions were maturated for 24h at ambient temperature and then 101 
characterized a first time as fresh emulsions. Then, they were aged through accelerated conditions 102 
which allowed quickly observing physicochemical modifications. Whereas some studies conducted on 103 
aging at 50°C (André et al., 2003), this temperature is high enough to reach the melting points of 104 
ingredients and to change the emulsion physical state. For these reasons, the aging temperature was 105 
fixed in this work at 40°C and the emulsions were characterized every week, after being slowly cooled 106 
down to room temperature. At least, three batches of each emulsion were prepared and characterized. 107 
2.4. NP extraction. 108 
The NPs were extracted from the fresh and aged emulsions by a protocol adapted from Nischwitz 109 
et al. (2012). Between 1 and 2 g of emulsions were weighed in a polypropylene tube and diluted with 110 
around 8 mL of a mix of methanol/pentane (3/1) destined to break the emulsion structure. The mixture 111 
was homogenized by vortexing for 2 min and ultra-sonicating for 5 min (120 W). It was then centrifuged 112 
for 10 min at 8000 g to recover NPs at the bottom of the tube. The supernatant was removed. These 113 
steps were repeated twice to extract the NPs from the emulsion. Then, three simple washings with 114 
methanol followed in order to remove pentane traces. Remaining methanol was evaporated under 115 
vacuum for 1 h and the traces of water were removed by a two-hour long freeze drying step. Extraction 116 
was performed on at least three different batches of each emulsion. By this protocol, different 117 
powders were obtained: 118 
For N1 hydrophilic NPs:  119 
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 N1S: N1 native NP powder which underwent the protocol of extraction, 120 
 N1F: N1 NP extracted from F-N1 fresh emulsion, 121 
 N1A: N1 NP extracted from F-N1 aged emulsion. 122 
For N2 hydrophobic NPs, N2S, N2F and N2A were obtained by the same way. 123 
2.5. Physicochemical characterizations. 124 
2.5.1. Particle size measurement. 125 
The particle size measurements were performed by using a laser diffractometer SALD 7500 126 
Nano (405 nm, Shimadzu, Kyoto, Japan) combined with the measurement cell SALD BC 75 consisting 127 
in a 7 mL batch and a stirrer:  the WingSALD II-7500 software (version 3.1, Kyoto, Japan) was used to 128 
extract the data. Emulsions were diluted and homogenized according to the following procedures until 129 
reaching absorption between 1.2 and 1.5, corresponding to a good signal. Approximately 0.1 g of 130 
emulsion was pre-diluted in a test tube with 5 mL of distilled water and then vortexed for 10 sec at 131 
1000 rpm. Finally, the pre-dispersed samples were added dropwise until reaching the expected 132 
absorption. All measurements were performed at least in triplicate on two different batches. D10, D50 133 
and D90 diameters were thereafter expressed in particle volume, with, for instance, DX representing 134 
the threshold value in micrometer for which X % of the particles had a smaller size. 135 
2.5.2. Zetametry. 136 
The zeta potentials of the NPs, bacteria and emulsion were measured using a Zeta Sizer Nano-Z and 137 
folded capillary cells (Malvern instruments, Malvern, UK). Measurements were performed at least 138 
three times and analyzed with the software Zetasizer (version 7.11, Malvern, UK). 139 
 The hydrophilic NPs and the bacteria in exponential growth phase were dispersed at 0.5 % 140 
w/w in ultrapure water containing NaCl 3x10-2 M  and with a conductivity of 3 mS/cm. Six 141 
samples of each culture were adjusted at pH 2, 4, 6, 8, 10 and 12, respectively, using NaOH 142 
or HCl (0.4 or 0.04M). Before measurement, the dispersions of NPs were ultra-sonicated for 143 
5 min and the suspensions of bacteria were vortexed for 20 sec at 1000 rpm. 144 
 The measurements on hydrophobic NPs followed the same protocol as above excepted that 145 
dispersion was obtained with adding a surfactant (Tween 80 at 4 g/L). 146 
 Prior to measurements, emulsions were diluted at 0.5% w/w in ultrapure water containing 147 
NaCl 10-4 M and with a conductivity of 1.70 µS/cm. Then, six samples of each emulsion were 148 
adjusted at pH 2, 4, 6, 8, 10 and 12, respectively, using NaOH or HCl (0.4 or 0.04 M), and 149 
then vortexed for 20 sec at 1000 rpm just before ZP measurement.  150 
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The curve giving the ZP as a function of pH was obtained by a polynomial fit with the minimal R2. 151 
Then, extrapolations allowed recovering ZP values at the other pH.  152 
2.5.3. Sessile drop method. 153 
Complementary to zetametry, we decided to use sessile drop method to characterize the NP surface. 154 
For that purpose, NPs (10 % w/w) from three different batches were first dispersed in potassium 155 
bromide (KBr). This solid dispersion was then compacted under 6 tons using a high pressure press in 156 
order to obtain homogeneous pellets. Three pellets per emulsion batch were prepared. The sessile-157 
drop method was conducted on these pellets with a Digidrop goniometer (GBX, Dublin, Ireland) and 158 
the software Windrop ++ (1.18.04, GBX, Dublin, Ireland). Static contact angles of ultrapure water (polar 159 
component: 51.0 mN/m and dispersive component: 21.6 mN/m) and diiodomethane (DIM, polar 160 
component: 0 mN/m and dispersive component: 50.8 mN/m) were measured. The polar and dispersive 161 
components of the surface were calculated using the Owens-Wendt theory (Owens and Wendt, 1969) 162 
from the contact angle obtained with both fluids. 163 
2.5.4. Microbial adhesion to solvents test (MATS). 164 
Complementary to zetametry, we decided to use MATS to characterize the bacteria surface. The 165 
adhesion tests were performed by measuring the bacterial repartition between a bacterial suspension 166 
(DO = 0.4) in saline water (NaCl 0.15 M) and a series of solvents with different polarity: chloroform, 167 
hexadecane, decane and ethyl acetate. 1.2 mL of bacterial suspension and 0.2 mL of the solvent were 168 
poured together into a tube and vortexed for 1 min. The mixture was left at rest for 15 min to allow 169 
the phase separation. Then, the optical density (DO) was measured at 400 nm in the aqueous phase. 170 
The percentage of adhesion was calculated using the following equation (Bellon-Fontaine et al., 1996): 171 
 %	ࢇࢊࢎࢋ࢙࢏࢕࢔ = ൬૚ − ࡭
࡭૙
൰× ૚૙૙ (1)  
A0, is the initial DO in the aqueous phase and A, is the DO in the aqueous phase after mixing.  172 
 ઢ૚ = %	ࢇࢊࢎࢋ࢙࢏࢕࢔	ࢎࢋ࢞ࢇࢊࢋࢉࢇ࢔ࢋ− %	ࢇࢊࢎࢋ࢙࢏࢕࢔	ࢉࢎ࢒࢕࢘࢕ࢌ࢕࢘࢓ (2)  
 ઢ૛ = %	ࢇࢊࢎࢋ࢙࢏࢕࢔	ࢊࢋࢉࢇ࢔ࢋ − %	ࢇࢊࢎࢋ࢙࢏࢕࢔	ࢋ࢚ࢎ࢟࢒	ࢇࢉࢋ࢚ࢇ࢚ࢋ (3)  
If Δ1 > 10, the surface of the bacteria is a Lewis base and if Δ2 > 20, it is a Lewis acid.  173 
2.6. Microbiological tests 174 
2.6.1. Bacteria strains and culture conditions 175 
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Pseudomonas fluorescens MFP05 and Staphyloccocus aureus MFP03 were collected by swabbing 176 
on normal human skin and were characterized by metabolic, proteomic and genomic analysis (Hillion 177 
et al., 2013); they were stored on cryobeads at -140°C. Before use, they were sub-cultured over-night 178 
in 10 mL of Luria Bertani (LB) broth at 28 ± 2°C for MFP05 or 37 ± 2°C for MFP03, and then diluted again 179 
in LB broth to reach the appropriate initial bacterial density corresponding to an optical density, 180 
OD580nm = 0.08. OD values were measured using a spectrophotometer (Helios Epsilon, 181 
ThermoSpectronics, Cambidge, UK). Bacteria were used when the cultures reached the exponential 182 
growth phase. 183 
2.6.2. Willingly inoculated bacteria in model emulsions.  184 
Approximately 5 g of each emulsion were diluted to the third in saline water (NaCl 9 g/L) or LB 185 
broth, and then inoculated with MFP03 or MFP05 at an initial concentration between 105 and 106 186 
UFC/mL. The exact bacterial concentration was controlled by plating 100 µL of solutions and serial 187 
dilutions on TSA Petri Dishes immediately after bacterial inoculation. Inoculated solutions were 188 
incubated at 28 ± 2°C in the case of MFP05 or 37 ± 2°C for MFP03 under orbital agitation at 180 rpm. 189 
After 24h, 48h and 72h, 100 µL of solutions were spread on TSA plates in order to monitor bacterial 190 
growth. All Petri dishes were incubated for 24h at 28 ± 2°C for MFP05 or 37 ± 2°C for MFP03 before 191 
counting. 192 
2.6.3. Willingly inoculated bacteria in NP dispersions.  193 
The NPs were dispersed at 5 % w/w in LB broth containing 4 g/L of Tween 80. The obtained 194 
solutions were inoculated with the previous cultures of MFP03 or MFP05 in order to reach an initial 195 
DO of 0.08. The exact bacterial concentration was controlled by plating 100 µL of solutions and serial 196 
dilutions on TSA Petri Dishes immediately after bacterial inoculation. The inoculated solutions were 197 
incubated at 28 ± 2°C in the case of MFP05 or 37 ± 2°C for MFP03 under orbital agitation at 180 rpm. 198 
Every hour until 8 h, 100 µL of solutions were spread on TSA plates in order to monitor bacteria growth 199 
evolution. All Petri dishes were incubated for 24h at 28 ± 2°C for MFP05 or 37 ± 2°C for MFP03 before 200 
counting. 201 
2.7. Data analysis.  202 
Results were expressed as mean ± standard deviation (SD). Statistical analyses of collected data were 203 
performed on XLSTAT software (version 2012.1.01, Addinsoft, France). Single-way analysis of variance 204 
(ANOVA) was applied to data series in order to test significance of parameters. When a significant 205 
difference was revealed between emulsions or NPs according to the Tukey discriminant test, groups 206 
of emulsions/NPs were formed and noted with * for p<0.05, ** for p<0.01 or *** for p<0.001. In the 207 
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results tables, different letters in the same row mean significant difference between emulsions or 208 
nanoparticles for this parameter. 209 
3. Results and discussion 210 
3.1. Effect of emulsion media, with or without NPs, on bacteria contamination: emulsion 211 
conservation 212 
3.1.1. Bacteria growth within fresh model emulsions 213 
This study aims to evaluate the impact of the two NPs surface nature used in sunscreen emulsions, 214 
on two bacteria commonly found on the human skin and thus, potentially introduced in use in the 215 
cosmetic product (Brannan and Dille, 1990). Two major germs of the human microbiota were selected: 216 
Staphylococcus aureus and Pseudomonas fluorescens. S. aureus is a Gram positive bacterium, usually 217 
considered as a member of the transient human skin flora but it is demonstrated to be carried by 35 218 
to 60 % of the human population and to behave as a commensal (Percival et al., 2012). P. fluorescens 219 
is a Gram negative ubiquitous bacterium representing more than 90 % of the microbial flora in humid 220 
skin areas such as the inner elbow (Grice et al., 2008). The latter is also present in abundance in the 221 
environment. 222 
The control emulsion was previously developed without NPs in order to have a very low bactericidal 223 
impact and to only measure the “NP effect” on the bacterial strains (Rowenczyk et al., 2016). The three 224 
model emulsions were formulated to exhibit the lowest initial microbiological charge and the same 225 
physicochemical characteristics (pH, particle size, texture, opacity). Moreover, they are ensured to 226 
have any effect on the results of further microbiological tests. (Hamouda et al., 2001) 227 
The potential of the selected germs to grow in these emulsions was evaluated. Since they were 228 
semi-solid products, a dilution by three was imposed in Luria Bertani broth (LB) before bacteria 229 
inoculation at a concentration of 106 UFC/g emulsion. In these conditions, both germs quickly 230 
developed since the medium brought an important nutrient contribution (Figure 1, A and B). If the 231 
maximal biomass reached by MFP03 appeared to be higher than for MFP05, this difference should only 232 
reflect the difference of optimal growth temperature (37°C and 28°C respectively) as well as 233 
metabolisms of both germs. However, both strains demonstrated a good growth rate within all 234 
emulsions, i.e.in the absence or presence of NPs. Thus, in these culture conditions, no detectable “NP 235 
effect” was observed on the bacterial growth regardless of their surface properties. 236 
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 237 
Figure 1: Growths of S. aureus (MFP03) (A) and P. fluorescens (MFP05) (B) in the fresh emulsions diluted in LB broth 238 
(n=3). 239 
It is hypothesized that the important nutrient contribution brought by the LB broth could hide the 240 
potential impact of the NPs on the bacteria. Hence, in a second series of experiments the LB broth was 241 
replaced by saline water (SW) and the three model emulsions were diluted the third in SW before 242 
inoculation by bacteria (Figure 2, A and B). In this situation, no growth of S. aureus MFP03 was 243 
observed (Figure 2, A). Moreover, the population of S. aureus showed a progressive decrease indicating 244 
that the bacterium was unable to metabolize emulsion components. In contrast, the growth potential 245 
of P. fluorescens MFP05 was preserved when the emulsions were diluted in SW although the final 246 
biomass formed after 72 h was reduced by ten compared to the dilution in LB broth (Figure 2, B). These 247 
result are in agreement with previous works showing that emulsions are not favorable media for 248 
bacterial development (Teixeira et al., 2007), even in the case of a bacterium such as P. fluorescens 249 
which is known for its high adaptation potential (Chapalain et al., 2008).  250 
 251 
Figure 2: Growths of S. aureus (MFP03) (A) and P. fluorescens (MFP05) (B) in the fresh emulsions diluted in saline water 252 
(n=3). 253 
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However, as for LB broth dilution, and whatever the species, the behaviors of the bacteria were 254 
the same in the three fresh model emulsions. Finally, no impact of the presence or nature of the NPs 255 
was highlighted in the fresh emulsions. 256 
3.1.2. Bacteria growth within aged model emulsions 257 
The three previous models emulsions were submitted to an accelerated aging step (40°C during 258 
49 days) to mimic the real conditions during sunscreen lotion conservation and use. Indeed, several 259 
studies have already proved that the surface of the NPs can be modified when they are rejected in 260 
aqueous environment (Auffan et al., 2010; Labille et al., 2010). On the basis of these works, it appeared 261 
interesting to study the surface modifications induced in aged emulsions. Thus, the three emulsions 262 
were tested following the same procedure than for the fresh ones, i.e. in absence or presence of 263 
different coated NPs.  264 
In the case of S. aureus MFP03, no difference of growth kinetic was observed between the three 265 
aged emulsions diluted in rich medium (LB broth) (Figure 3, A). In contrast, the growth of S. aureus in 266 
aged emulsion diluted in poor medium (SW) was totally different when compared to the growth in 267 
fresh ones (Figure 3, B). The number of viable bacteria did not decrease, as observed for the fresh 268 
emulsions, but remained stable for the control emulsion (F0) and for the emulsion containing 269 
hydrophilic NPs (F-N1). A moderate, but significant, increase of the S. aureus population was even 270 
observed for the emulsion containing hydrophobic NPs (F-N2).  271 
 272 
Figure 3: S. aureus growth in the aged emulsions; A: diluted in LB broth; B: diluted in saline water (SW) (n=3). 273 
Conversely, as previously observed, no difference of growth kinetic was observed using P. 274 
fluorescens MFP05 whatever the dilution medium used (LB broth or SW) and independently from the 275 
presence of NPs and from their surface properties (Data not shown). 276 
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3.1.3. Evolution of the physicochemical characteristics of the emulsions during aging 277 
The evolution of the physicochemical characteristics of the three emulsions was monitored over 278 
time during aging. Each emulsion remained macroscopically stable, i.e. no demixing phenomenon was 279 
observed. However some of their microscopic parameters might evolve during aging. 280 
The pH is a key parameter to consider since it was already taken into account during bacterial 281 
growth predictions due to its important impact on charges and ionic interactions (Sutherland et al., 282 
1994). Hence, pH variations during the emulsion aging could explain the differences observed on 283 
bacterial growths. On the one hand, because of the presence of hydrophobic NPs in F-N2, the pH 284 
increased from 6.8 to 7.4 during aging (Table 1). Conversely, the pH of both F0 and F-N1 remained 285 
similar and stable (around 6.9). However, if S. aureus is able to grow over a large range of pH (4.5 - 286 
9.3), it is admitted that its optimal growth is between 7.0 and 7.5. Since the usual bacterial growth is 287 
strongly dependent on the pH of the media, respectively the lower or upper values leading to 288 
important reductions of its development (Bergdoll, 1989). Thus, the pH data are in accordance with 289 
the microbiological results observed for aged emulsion containing hydrophobic NPs. 290 
Table 1: pH, zeta potential (ZP) and mean diameters of emulsions (n=3). ZP values are obtained by extrapolation of the 291 
experimental points. 292 
 pH  SD 
ZP 
(mV) 
Volumic mean 
diameter  SD 
(µm) 
Fresh F0 6.8  0.1 -23 2.33  0.09 
Aged F0 7.0  0.1 -26 2.81  0.25 
Fresh F-N1 6.8  0.1 -30 2.11  0.13 
Aged F-N1 7.0  0.2 -32 1.63  0.28 
Fresh F-N2 6.8  0.1 -16 10.11  0.41 
Aged F-N2 7.4  0.1 -14 13.16  6.44 
 293 
Previous studies also pointed out the surface charges as an important parameter. Indeed, the 294 
electrostatic repulsions could prevent or enhance the bacteria/emulsion interactions (Ly et al., 2006). 295 
The fresh emulsion containing hydrophilic NPs had a more negative ZP (around -30 mV) than the 296 
control one (around -20 mV). On the contrary, the emulsion containing hydrophobic NPs had a less 297 
intense ZP value, about -15 mV. These results highlighted that F-N1 is more efficiently stabilized by 298 
electrostatic repulsions. Hence, although the presence of hydrophobic NPs (N2) clearly changed the ZP 299 
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of the emulsion, no difference between the bacterial growths in the three fresh emulsions was 300 
observed (3.1.1).  301 
 We have shown in Table 1 that the pH of the three emulsions evolved slightly differently during 302 
aging. This variation has to be taken into account for the determination of the surface charges after 303 
aging. As depicted in Table 1, the ZP measurements did not highlight major differences in terms of 304 
mean surface charges between colloids, whether in the fresh or aged emulsions.  305 
 306 
Table 1 also reports the mean diameter of the colloids present in the emulsion, including the oil 307 
droplets and the NPs. Whereas the mean diameters for F0 and F-N1 remained similar after aging, the 308 
one for the aged F-N2 significantly increased, with large variations between tested samples,  showing 309 
a more heterogeneous state for this emulsion due to aging. This result could partly explain the absence 310 
of inhibitory effects of this emulsion on the survival of S. aureus and the growth of the bacterium. This 311 
is consistent with previous results showing that in fine emulsions, the droplets could prevent the 312 
bacterial division by steric hindrance (Hamouda and Baker, 2000). Moreover, the lower steric 313 
hindrance in the aged emulsion enhanced the diffusion of the ingredients in the emulsion continuous 314 
phase. Hence, bacteria could more easily access to nutriments essential for their metabolism.  315 
Hence, these results prove that the presence of hydrophobic NPs could significantly degrade the 316 
physicochemical characteristics of the emulsion F-N2 and as a consequence, reduce the 317 
microbiological conservation of this cosmetic emulsion. 318 
3.2. Direct impact of the NPs extracted from the emulsions on two cutaneous bacteria: skin 319 
exposure 320 
3.2.1. Bacterial growth in LB broth containing nanoparticles 321 
The second main goal of this work was to study the impact of the NPs when they are layered on 322 
the human skin. Once applied onto the skin, the aqueous and oily phases of the sunscreen emulsions 323 
are generally quickly removed (Rhodes and Diffey, 1997) and the NPs are the last component 324 
remaining at the skin surface. For that reason, the NPs were extracted and recovered from the fresh 325 
(N1F and N2F) or aged emulsions (N1A and N2A) after numerous solvent washings. This protocol was 326 
developed to mimic the skin evaporation and the leaching by sweat and sea. Then, the impact of the 327 
extracted NPs was compared to the one of control NPs corresponding to the commercial powder that 328 
underwent the same solvent washing protocol (N1S or N2S). 329 
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The growth kinetics of both bacteria were monitored in LB broth containing 5 % w/w of NPs, 330 
corresponding to the concentration added in the initial emulsions, plus a surfactant required to 331 
disperse the hydrophobic NPs. Preliminary tests allowed choosing Tween 80 (4 g/L) as a non-332 
bactericidal surfactant efficient at a relatively low concentration (Data not shown).  333 
The presence of the hydrophilic or hydrophobic NPs did not impact the total biomass formed by 334 
bacteria (Data not shown) but affected their generation times. Whereas in model emulsions the 335 
hydrophilic NPs did not affect  the growth kinetics of both bacteria, in the present experimental 336 
conditions (i.e. NPs used alone after recovery from emulsions), hydrophilic NPs increased the 337 
generation time of both germs (Figures 4). It is worth mentioning that NPs extracted from aged 338 
emulsions tended to have a greater impact on the bacterial growth kinetic. This result suggests that 339 
this effect does not only result from steric hindrance but also from NP surface modifications occurring 340 
during aging.  341 
  342 
Figure 4: Impact of the hydrophilic N1 NPs on the generation times of;  343 
A: S. aureus (MFP03) and B: P. fluorescens (MFP05) (n=3). 344 
The control NPs (N1S and N2S) increased only slightly the generation time of both bacteria (Figure 345 
5, A and B), thus highlighting the low impact of these NPs. Moreover, the hydrophobic NPs extracted 346 
from the fresh emulsion induced opposite effects on the two strains. Whereas they were without 347 
significant effect on the growth of P. fluorescens MFP05, they significantly increased the generation 348 
time of S. aureus MFP03. In addition, NP extracted from the aged emulsion and the control NPs had a 349 
similar effect on both bacteria. 350 
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  351 
Figure 5: Impact of the hydrophobic N2 NPs on the generation times of;  352 
  A: S. aureus (MFP03) and B: P. fluorescens (MFP05) (n=3). 353 
All together, these results show that the hydrophilic NPs induce an intrinsic similar inhibitory 354 
effect on the growth of S. aureus and P. fluorescens. This effect is minimal for NPs extracted from fresh 355 
emulsion while it is slightly increases for NPs extracted from aged emulsions. Concerning the 356 
hydrophobic NPs, their effect depends on the bacterial strain. Whereas it is generally limited or non-357 
significant on P. fluorescens MFP05, it appears more intense on S. aureus MFP03. Moreover, when the 358 
hydrophobic NPs were extracted from fresh emulsions (N2F), they had a strong impact on S. aureus 359 
which was not observed on P. fluorescens. As for a hypothesis,  the impact of NPs on bacteria could 360 
depend on their surface nature and their aging in emulsion. 361 
3.2.2. Influence of physicochemical properties of NP surface on their bacterial impact 362 
Results above described an “NP effect” on the bacteria growth and more precisely, a “surface 363 
nature and history NP effect”. At this stage, two main hypotheses can be proposed:  364 
 First, the outer coating of the NPs may be degraded. However, in this hypothesis, since the 365 
impact of the aged NPs on the bacteria appeared fairly lowed, it seems that such a 366 
degradation of the passivation coating remains limited. 367 
 Secondly, different ingredients of the emulsion could strongly interact with and adsorb onto 368 
the surface of the NPs. Part of these ingredients may remain adsorbed at the NPs surface in 369 
spite of the extraction protocol. This second hypothesis is consistent with previous work. 370 
(Rossano, 2014) 371 
Hence, the surface properties of the extracted NPs were thereafter studied and compared. 372 
 Surface charges of NPs and bacteria 373 
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The surface charges of both the bacteria and the NPs have to be considered since intense surface 374 
charges may create electrostatic repulsions and thus, prevent interactions between particles (Duffy et 375 
al., 2011). Then, the zeta potential values of NPs (Figure 6, A) and bacteria (Figure 6, B) were measured 376 
in water containing 1.8 g/L NaCl. Moreover, for the hydrophobic NPs, measurements were performed 377 
by adding 4 g/L Tween 80. This non-ionic surfactant was chosen as it does not induce any surface 378 
charge modifications. 379 
 380 
Figure 6: A: Zeta potentials of NPs in water (1.8 g/L NaCl) and B: bacteria. 381 
The results given in the Figure 6 (A) show that the surface charges of the hydrophobic NPs were 382 
slightly negative (around -5 to -10 mV at pH 7). This may be explained by the outer coating made of 383 
silane, partially masking the alumina surface. Zeta Potential (ZP) of alumina is typically negative. 384 
However, since this coating is well-known to be porous (Egerton and Tooley, 2002), the positive 385 
charges of the titanium dioxide could be revealed. Hence, the apparent charge takes into account both 386 
the negative and positive charges and is, consequently, close to the isoelectric value.  387 
In contrast, the hydrophilic NP appeared to be highly negatively charged with a mean value of -45 388 
mV at pH = 7, pH of LB medium (Figure 6, A). This value is consistent with the negative charges of the 389 
silica coating. It is worth mentioning that for both hydrophobic and hydrophilic NPs, native NPs and 390 
NPs from fresh or aged emulsions had almost the same zeta potential.  391 
The surface of P. fluorescens MFP05 was close to the isoelectric value (around 0 mV) whereas the 392 
S. aureus MFP03 one was strongly negative. Moreover, this latter value increased with the pH (Figure 393 
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6, B). These differences actually reflect the surface nature of these bacteria. The surface of Gram 394 
negative bacteria, such as P. fluorescens, consists in a dynamic membrane allowing a rapid adaptation 395 
to the environment, including pH variations (Baysse and O’Gara, 2007). On the contrary, the surface 396 
of Gram positive bacteria, such as S. aureus, is made of a thick wall of peptidoglycan which does not 397 
belong the same dynamism and thus, is more directly impacted by medium charges and pH.   398 
The hydrophilic NPs and S. aureus presented highly negatively surfaces at pH=7 (Figure 6, A and 399 
B). Then, as suggested by Duffy et al. (2011), if the surface charge was the major parameter, 400 
electrostatic repulsions should prevent interactions between hydrophilic NPs and S. aureus. However, 401 
in this work, the inhibitory effect on S. aureus MFP 03 is increased in the presence of the hydrophilic 402 
NPs, the most negatively charged particles. In contrast, the surface of P. fluorescens was poorly 403 
charged and could more easily interact with the hydrophilic NPs surface and even more with the 404 
hydrophobic NPs one.  405 
 Surface free energies of NPs and bacteria 406 
As revealed by the MATS technique, both S. aureus MFP03 and P. fluorescens MFP05 presented 407 
hydrophilic surfaces since their adhesion percentages to alkanes were low (Figure 7, A). Then, we can 408 
hypothesize that both strains, and especially P. fluorescens MFP05, should preferentially interact with 409 
the hydrophilic NPs (N1). Indeed, these germs are more likely able to meet and interact with the 410 
hydrophilic NPs that belong to the same emulsion phase. This explains why they were more impacted 411 
by these NPs as already shown in the present work.  412 
Moreover, both strains exhibited a marked Lewis acido-basic character, shown by the great 413 
difference between the affinities of each solvents couple. However, S. aureus MFP03 appeared to be 414 
less hydrophilic than P. fluorescens MFP05 strain since its adhesion percentages to alkanes was higher. 415 
These results were in accordance with the higher effect of hydrophilic NPs on P. fluorescens MFP05 as 416 
discussed earlier in this paper. 417 
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 418 
Figure 7: A: MATS results for S. aureus (light grey) and P. fluorescens (dark grey);  419 
B: Polar (in light grey) and dispersive (in dark grey) components of the NP pellets  420 
This study was completed by the measurement of the polar and dispersive components of the 421 
NPs in order to qualitatively evaluate the different surface free energies between them (Figure 7, B). 422 
The dispersive component of the hydrophilic NPs was significantly higher when compared to the 423 
hydrophobic NPs one. Moreover, the NPs extracted from fresh emulsions (N1F) appeared to be 424 
significantly less polar than the native ones (N1S) or the NPs extracted from aged emulsions (N1A). 425 
Hence, this proved that the polarity of the hydrophilic NPs really depends on their history in emulsion. 426 
However, the hydrophilic NPs extracted from fresh emulsions (N1F) were the one that less impacted 427 
both bacteria. Then, these results confirm that the polarity of the NPs is a key parameter influencing 428 
their impact on bacteria. 429 
4. General discussion 430 
A first scenario was elaborated to mimic a microbial contamination of sunscreen emulsions 431 
containing NPs or NPs-free. In the absence of usable exogenous metabolites, the three fresh emulsions 432 
appeared as a poorly favorable media, inducing a progressive reduction of S. aureus and partly 433 
inhibiting the growth of a highly adaptable bacterium such as P. fluorescens. Moreover, it was 434 
demonstrated that fresh emulsions containing NPs or NPs-free have the same impact on both Gram 435 
positive and Gram negative bacteria. However, these emulsions could not prevent any potential 436 
contamination if some nutriments are present, as for a rich culture medium. These results highlighted 437 
that the microbial reductions observed in poor media is not due to a strong toxicity of the emulsions 438 
but comes from their structures and properties. According to previous works, the emulsion 439 
granulometry and pH were demonstrated as the major parameters influencing the germs growth 440 
(Bergdoll, 1989; Hamouda and Baker, 2000; Ly et al., 2006).  441 
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After aging, the impact of the three model emulsions on bacteria was different and a “NP effect” 442 
did appear. Even in the absence of exogenous nutriment, the aged emulsion containing hydrophobic 443 
NPs showed a slower but still significant growth of S. aureus. In addition, this effect was observed after 444 
only 24 to 72 h whereas cosmetic compounds need to undergo much longer storage time. It appeared 445 
that emulsions, initially formulated in order to have similar microstructures and macroscopic 446 
properties, evolved differently during aging depending on the presence and nature of NPs. After aging, 447 
whereas both the control emulsion and the one formulated with hydrophilic NPs remained stable and 448 
similar, the pH and the colloids size of the emulsion containing hydrophobic NPs significantly increased. 449 
These results are consistent with a previous study showing that, under high temperature, NPs can 450 
either stabilize or destabilize the emulsion, depending on their coating nature (Rowenczyk et al., 2016). 451 
Hence, the nature of TiO2-NPs employed in the formulation is a key parameter to be considered since 452 
the presence of specific NPs in the emulsion made the cosmetic highly vulnerable to some bacteria 453 
contaminations. Hence, this study revealed that long storage conditions should be a major concern in 454 
regard of the microbiological safety and physicochemical modifications of those products. 455 
In a second scenario mimicking the layered NPs on skin, we investigated the impact of NPs, 456 
extracted from the fresh/aged emulsions, when put directly in contact with cutaneous bacteria. First, 457 
it was demonstrated that the impact of the NPs on the bacteria could be related to their surface nature. 458 
Hence, it seemed that this impact is the results of NPs/bacteria interaction phenomena. Whereas the 459 
surface charge of the particles did not appear as a determinant parameter, the polarity of the NPs 460 
should be in accordance with their impacts on bacteria. Previous works showed that the surface free 461 
energy of the bacterial envelope is an important parameter in bacterial adhesion (An and Friedman, 462 
1998; Sivakumar et al., 2010). More specifically, in this study, S. aureus and P. fluorescens which are 463 
both hydrophilic bacteria were more impacted by the hydrophilic NPs; moreover, the most hydrophilic 464 
one, P. fluorescens, appeared to be also the most impacted by the hydrophilic NPs. This study also 465 
highlighted that the surface properties of the NPs, such as their polarity, evolved during their aging in 466 
emulsion.  For instance, the hydrophilic NPs extracted from a fresh emulsion were significantly less 467 
polar than other hydrophilic NPs and showed the lowest impact on the growth of both bacterial 468 
species.  469 
There is a relation between the polarity of NPs, their interaction and their impact on some 470 
cutaneous bacteria. It appeared that both the nature of the TiO2-NPs coating and their aging have to 471 
be considered regarding the NP toxicity on cutaneous bacteria. Of course, other phenomena still have 472 
to be explored. For instance, it is well-known that even within a same species the results are 473 
heterogeneous between strains. A given bacterial strain can modulate its surface charges and polarity 474 
within a few minutes under the effect of environmental factors (Baumgarten et al., 2012). Moreover, 475 
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it is known that bacterial interactions are also driven by a multitude of adhesins (An and Friedman, 476 
1998).  477 
5. Conclusion 478 
In this study, we evaluated the impact of coated TiO2-NPs on two cutaneous bacteria strains: S. 479 
aureus and P. fluorescens. To our knowledge, it is the first work dealing with the impact on bacteria of 480 
cosmetic grades of TiO2-NPs with different surface natures and where, aging phenomena occurring 481 
during the cosmetic use were taken into consideration. For these purposes, the impact of TiO2-NPs on 482 
bacteria was tested in multiple conditions, i.e. in fresh or aged formula and using native NPs or NPs 483 
extracted from these emulsions. In addition, two innovative exposure protocols were developed 484 
herein, close to the conditions encountered in emulsion or after spreading onto the skin surface. They 485 
allowed studying the impact of the NPs on the microbiological conservation of sunscreens as well as 486 
the safety of the NPs on two representative germs of the skin microbiota.  487 
During the cosmetic storage, the presence of some NPs may significantly modify the emulsions 488 
properties, such as granulometry and pH. These phenomena could alter the microbiological 489 
conservation of the cosmetic towards potential pathogens. Then, once layered on skin, it was 490 
highlighted that the NP impact on bacteria highly depends on their surface characteristics, principally 491 
their polarity. Moreover, this work put emphasis on the role of the NP surface modifications during 492 
aging and highlighted that the latter had to be taken into account during the microbiological 493 
evaluations. The present surface characterizations are a first step but are not enough to fully 494 
understand the different phenomena involved and thus, in order to conclude on the nature of these 495 
modifications. In further works, their chemical nature needs to be elucidated to explain the evolution 496 
of NP properties during aging in emulsion. 497 
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ABSTRACT
Nowadays air pollution is increasing due to anthropogenic activity. Among all air pollutants, nitrogen 
oxides (NOx) such as NO
2
 are predominant. It is well known that those compounds exhibit direct toxic 
effects on human health. However, microorganisms are also exposed to them, but the effect of NOx on 
the virulence of air microbiota is still poorly understood. In this study, we evaluated the impact of NO
2
 
on the adaptability and virulence of an airborne strain of P. fluorescens, MFA76a, by exposition of this 
strain to 45 ppm of NO
2
. The growth kinetics and cultivability were analysed. A decrease of cultivability 
coupled with an increase of the lag phase was observed suggesting a potential toxicity of NO
2
. Since 
NOx particularly target lipids, the membrane permeability was assessed thanks to Live Dead tests and 
confocal microscopy. A significant alteration of membrane permeability was observed. Furthermore, 
more abundant bacterial aggregates were detected compared to the control. Thus, a lipidomic study 
was performed using MALDI-TOF MS Imaging coupled to HPTLC. Interestingly, bacteria exposed to 
NO
2
 were lacking one putative glycerophospholipid molecule. In agreement with a previous study from 
Kondakova et al., these data demonstrate the adaptation potential of P. fluorescens MFAF76a to an air 
pollutant such as NO
2
.
Keywords: air pollution, antibiotic resistance, membrane, adaptation, P. fluorescens, toxicity.
1 INTRODUCTION
Air is a complex environment contaminated by particle matter, nitrogen oxides, ozone and 
hydrocarbons. It is also a biotic environment since microorganisms, mostly bacteria, are 
found  [1]. Even if this environment is unstable, several studies highlight the presence of 
members of Pseudomonas strain in air microbiota [2, 3]. During the past decades, due to the 
increase of anthropogenic activities, the level of atmospheric pollutants is rising and the con-
trol of air quality remains a topic of major interest [4, 5]. Among all air pollutants, nitrogen 
oxides species, including nitrogen oxide (NO) and nitrogen dioxide (NO
2
), are predominant 
[4]. It is well known that these compounds are toxic to human health, leading to cardiovas-
cular and respiratory pathologies (allergy, asthma, bronchitis) [4, 5]. Thus, threshold values 
were set up by World Health Organization (WHO) to prevent the potential risks on human 
health. Regarding the increase of respiratory pathologies, a potential impact of NO
2
 could be 
presumed on air microbiota. NO
2
 induces cells damages, directly by interacting with proteins, 
DNA and lipids or either via formation of reactive nitrogen species interfering with metabo-
lism, respiration functions and thus homeostasis [6–8]. Bacterial stress is generally leading 
to the expression of virulence factors; thus, NO
2
 may have an impact on bacterial virulence, 
which could consequently alter human health. Infection by opportunistic pathogens repre-
sents a big threat for immune-compromised or cystic fibrosis patients as they are more sensi-
tive. Indeed, this pathogens could alter the healthy microbiota and its homeostasis [9–11]. 
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This dysbiosis and the pathogen itself could lead to an acute infection with potential lethal 
outcome [10]. Breathing NO
2
-polluted air could potentiate this mechanism. Since P. fluores-
cens are widespread in the environment [12], including in the air [13], and had already been 
isolated from sputum of patients suffering from pneumonia, it seems particularly interesting 
to focus on this species [14]. An airborne strain P. fluorescens MFAF76a was previously iso-
lated and characterized with virulent traits [13, 14]. Thus, MFAF76a seems to be the perfect 
candidate to test the bacterial response to NO
2
 stress. Its membrane adaptability and viru-
lence response to NO
2
 contamination remain to be resolved. Therefore, several approaches 
were implemented in this study such as physiological tests and lipodomic analysis.
2 MATERIAL AND METHOD
2.1 Bacterial strain and growth condition
In this study, the wild-type P. fluorescens MFAF76a strain was used [13]. Overnight cultures 
in Luria Bertani medium (LB, AES) were grown at 28°C under limited agitation (180 rpm). 
Then cultures were diluted (A
580 
= 0.08) in Davis Medium Broth (DMB), a minimal medium 
with 2.16 g/L glucose as carbon source. The incubation was done at 28°C under agitation 
for 16 h to reach the stationary phase. Bacterial cultures were transferred on cellulose nitrate 
membrane filters (0.45 μm, pore size 0.2 μm, diameter 47 mm, Sartorius Biolab Products) 
and incubated on DMB agar plates at 28°C for 4 h to obtain a monolayer of bacteria. Then 
the membranes covered by bacteria were laid on agar one-well dishes (size 127.8 × 85.5 mm, 
Thermo Scientific Nunc), which were directly transferred into the gas delivery device [15].
2.2 Exposition to nitrogen dioxide
As previously described by Kondakova et al., an exposure system was developed in order 
to mimic the environmental exposition [15]. Briefly bacterial bed was exposed during 2 h at 
28°C with a constant gas stream of 2 L/min, in two separate exposure chambers. A control 
was obtained using synthetic air. The NO
2
-exposed bacteria were laid in contact with a mix-
ture of N
2
/O
2
 8/2 (v/v) complemented with 45 ppm of NO
2
 (Air Liquide GMP Europe). After 
exposure, bacteria were resuspended in sterile saline solution.
2.3 Cultivability and growth kinetics
Cultivability tests were performed by serial dilution in saline solution from the bacterial sus-
pension to reach dilution of 10−7. 100 µL of dilution range 10−4 to 10−7 were spotted onto LB 
agar plates in triplicate for both conditions. After incubation at 28°C for 24 h, viable colony 
forming unit were numerated.
After adjustment of the bacterial concentration to A
580 
= 0.08 in DMB, growth kinetics 
were done for both conditions in triplicate in a 96-well test plate (Nunc™). The bacterial 
population was evaluated every 15 min by turbidimetry at A
580
 during 24 h.
2.4 Lipid identification
2.4.1 Phospholipids
As previously described by Kondakova et al. [16], the lipids were extracted from lyophilized 
bacteria according to the method of Bligh and Dyer [17]. Then phospholipids (PLs) were first 
separated by HPTLC [18]. Retention factors (R
f
) were calculated using the Sweday JustTLC 
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software (v. 4.0.3) after visualizing spots at 365 nm thanks to staining with primuline dye 
spray. A DHB matrix, allowing the positive ion spectra of lipids, was selected [16]. MALDI 
TOF mass spectra were acquired using an Autoflex III (Bruker Daltonics) and all MS spectra 
were obtained in reflector positive ion mode using TLC MALDI software (v. 1.1.7.0). Post-
Source Decay spectra were acquired as previously described using FlexControl software 
(Bruker Daltonics) for each spot related to one specific lipid [16]. Lipids were identified 
using the LIPID MAPS database. Thanks to previous results, the MS Imaging of lipid spots 
was obtained using the FlexImaging software (v. 2.1.; Bruker Daltonics). According to the 
m/z, individual lipidic spots were labelled by a specific colour code.
2.4.2 Fatty acids
The fatty acids (FAs) methyl esters (FAME) were obtained by incubation for 15 min at 95°C 
in a boron trifluoride (BF
3
, 140 g/L) in methanol and extracted by hexane [19]. They were 
separated and analysed by gas chromatography (GC) coupled to flame ionization detection 
using an Agilent Technology, 6890 Network GC System. The apparatus was equipped with 
a CP-Sil 88 capillary column (Chrompack; length, 50 m; inner diameter, 0.25 mm; 0.25 mm 
film). All experiments were performed in triplicate. The degree of FAs saturation was deter-
mined as the ratio between the saturated FAs and the unsaturated FAs [20].
2.5 Microbial adhesion to solvent
The hydrophobicity of P. fluorescens MFAF76a strain was evaluated by the microbial adhe-
sion to solvent (MATS) test [21]. It consisted of assessing the affinity of the cells to two sol-
vent duos composed of a monopolar solvent and an apolar solvent. In each set, both solvents 
have similar surface tension, but the monopolar one was acidic (electron accepting, e.g. chlo-
roform) or basic (electron donor, e.g. ethyl acetate). The apolar solvents were hexadecane and 
decane, respectively. For the experiments, bacterial cells were resuspended in saline solution 
to A
400 
= 0.8 (Abs
1
). This bacterial suspension was mixed with each solvent at 1/6 (v/v) by 
vigorous agitation for 1 min to form an emulsion. After at least 15 min of delay, the separa-
tion of the two phases of the mixture occurred. The aqueous phase absorbance (Abs
2
) was 
measured and the percentage of adhesion was expressed as in eqn (1):
 = − ×
affinity% 1
Abs
Abs
1001
2
 (1)
2.6 Membrane permeability assays
After exposure, 1 mL of bacterial suspension was stained for 15 min with SYTO9 (5.01 nM) 
and propidium iodide (PI, 30 nM) from the Live/Dead BacLight kit (L-7012, Thermofisher). 
Prolong diamond (P36965, Thermofisher) was added as anti-fading agent before observation 
using a confocal laser scanning microscope (CLSM 710, ZEISS). Thence, with an immer-
sion objective × 63, damaged and total bacteria were respectively observed as PI and SYTO9 
positive.
2.7 Statistical analysis
All experiments were carried out at least three times. Significances of differences between 
mean values were assessed using the Mann-Whitney test with significance set at p<0.05 (*), 
<0.01 (**), and <0.001 (***).
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3 RESULTS AND DISCUSSION
To investigate the response of air microbiota on the NO
2
 air pollutant, the bacterial strain 
P. fluorescens MFAF76a was exposed to 45 ppm of NO
2
 for 2 h. After exposure, several 
physiological tests including cultivability and growth kinetics, as well as membrane perme-
ability and lipidomic studies were done. The results were compared with those of a control 
samples, coming from the same bacterial culture exposed similarly to synthetic air. In NO
2
-
treated bacteria, a decrease of one log in cultivability of P. fluorescens MFAF76a strain was 
observed (Fig. 1a). Moreover, the exposure promoted an increase of half an hour of the lag 
phase compared with the control and no significant variation of generation time (Fig. 1b). 
Altogether these results suggested a diminution of the culturable bacterial density after expo-
sure. The A
580
 do not reflect the culturable bacterial concentration. Two hypotheses could be 
proposed to explain such a phenomenon. The exposure to NO
2
 seems to enhance the appari-
tion of viable but non-culturable bacteria and/or the bacterial death. Moreover the treatment 
to NO
2
 could also impact the bacterial physiology since they need to detoxify this compound 
first. Thence all those factors could promote the delay previously discussed. However, the 
generation time was not significantly impacted. This data suggest no great alteration in meta-
bolic pathway implicated in cell division. An exposure at 45 ppm of NO
2
 clearly impacts the 
physiological behaviour of P. fluorescens MFAF76a strain.
Since the membrane is the first barrier protecting bacteria from their environment, a mac-
roscopic study by MATS technique was realized to assess the surface polarity and thence 
potential membrane alteration of exposed bacteria. The bacterial affinity to chloroform and 
hexadecane indicated no significant change in Lewis base character after exposure to NO
2
 
(Fig. 2). This parameter is related to the presence of lone pair usually found in unsaturations 
or around heteroatoms such as constituting proteins or polar head of glycerophospholipids. 
As no drastic modification in hydrophobicity was observed, the proteins should not be impli-
cated. However, a decrease in acidity of Lewis (affinity relative to decane and ethyl acetate) 
from bacteria exposed to NO
2
 was noticed and could suggest fewer electron pair acceptors 
Figure 1: Physiological response of P. fluorescens MFAF76a strain after two hours’  exposure 
at 45 ppm of NO
2
. (a) Bacterial cultivability. (b) Bacterial growth kinetics in DMB, a minimal 
medium. For each exposure condition, three independent experiments were done in three 
replicates.
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outwards the membrane. These alterations reveal slight changes within the bacterial mem-
brane, which could be limited in composition, but more surely in structure. A combination of 
both may also be possible. For instance, alkyl chains may swivel outwards burying electron 
pair acceptors inside membrane.
To better understand the nature of that membrane alteration, lipids extraction and identifica-
tion using HPTLC-MALDI TOF MS were performed after exposure (Fig. 3). Indeed phosphati-
dylglycerol (PG), phosphatidylethanolamin (PE) and phosphatidylcholin (PC) were found in 
both extracts (Figs 3a and 3b). Those results are coherent with previous data [16]. Interestingly, 
a putative glycerophospholipid named ‘unknown glycerophospholipid’ (UGP) was identified in 
this study. This putative PL was only observed in control bacteria exposed to synthetic air and 
was absent in NO
2
-treated cells, indicating its probable sensitivity to NO
2
 and/or membrane 
Figure 2: Microbial adhesion to solvent tests of P. fluorescens MFAF76a strain after exposed 
or not to NO
2
. For each exposure condition, three independent experiments were done in 
three replicates.
Figure 3: Lipidome of P. fluorescens MFAF76a strain after exposure or not to NO2. (a) 
HPTLC MALDI-TOF MS Image of their glycerophospholipids. (b) List of glycerophos-
pholipids identified. PG: Phosphatidylglycerol (yellow spot); PE: Phosphatidylethanolamin 
(purple spot), UGP: Unknown glycerophospholipid (green spot, circle in green), PC: Phos-
phatidylcholin (red spot), R
f
: Retention factor. For each exposure condition, three independ-
ent experiments were done in three replicates.
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adaptation of MFAF76A to this stress, by exclusion of this PL from the cell wall. We noted that 
the long FA chains of this UGP (C
16
, C
17
 and C
18
) were mostly saturated. Such saturated lipids 
favour the membrane fluidity. Thence the absence of UGP in exposed bacteria is suggesting a 
decrease of membrane fluidity. However, after FAME analysis, no significant alteration in the 
degree of FA saturation and cis/trans isomers ratio was detected (Fig. 4). We hypothesized that 
bacteria, in response to the lack of UGP after exposure to NO
2
, reorganizes the membrane to 
compensate this loss, suggesting a potential membrane adaptation to NO
2
 stress.
In order to investigate potential changes of membrane permeability, Live Dead tests using 
SYTO9 (green) and IP (red) labels were performed and analysed using CLSM. Interestingly, 
the red labelling was predominant after exposure to NO
2
 unlike the control (Fig. 5). IP dye 
entered largely in bacterial cells revealing membrane permeabilization. NO
2
 alters polyun-
saturated lipids through production of nitro alkyl radicals in eukaryotic cells but no literature 
deals on NO
2
 effect on bacterial lipids [8].
An increase of cell aggregation was also observed and it is interesting to note that deletion of 
the main outer membrane porin OprF, which induces a parietal stress, is known to promote a 
similar effect in P. aeruginosa H103 [21]. Then the bacterial ‘community behaviour’ was inves-
tigated through biofilm formation using CLSM and a CFP-labelled P. fluorescens MFAF76a 
strain. Exposed bacteria form a thicker biofilm with some heterogeneities certainly due to the 
presence of bacterial amasses unlike the control [15]. This phenomenon was also observed with 
the oprF mutant in P. aeruginosa H103 [22]. Thus, the exposure to NO
2
 may lead to membrane 
modification causing a parietal stress to P. fluorescens MFAF76a. Subsequently, the aggrega-
tion of the bacterial cells could promote the biofilm formation and so the bacterial survival.
Biofilms represent a threat in clinic, as their elimination is more and more challenging. 
Interestingly, a previous study evaluated the impact of NO
2
 on antibiotic resistance using 
ciprofloxacin and chloramphenicol [15]. Such antibiotics are usually prescribed respectively 
for treatment of first and last stage of cystic fibrosis to eradicate Pseudomonas infection 
[23]. For the NO
2
-treated bacteria a two-fold increase in MICs of both antibiotics was noted, 
indicating that in response to NO
2
, P. fluorescens exhibits an increase in resistance against 
Figure 4: Fatty acid methyl esterification of P. fluorescens MFAF76a strain after exposition 
to NO
2
 or synthetic air (control). For each exposure condition, three independent experiments 
were done in three replicates; ns: not significant.
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chloramphenicol and ciprofloxacin [15]. Surprisingly, a sub-inhibitory concentration of chlo-
ramphenicol (25 µg/mL) significantly increased the bacterial growth between 2 and 10 h of 
culture compared to the control. Thence a protective effect of NO
2
 is conserved for 10 h after 
exposure. On the contrary, the growth kinetics of the exposed strain was unchanged in pres-
ence of a sub-inhibitory concentration of ciprofloxacin (3.125 µg/mL) [15]. Various stresses 
can lead to the modulation of bacterial resistance to antibiotics [24, 25]. Astonishingly, new 
therapeutic strategies are focusing nowadays on the use of gaseous nitrogen oxide as a pre-
treatment to decrease the antibiotic resistance encountered in cystic fibrosis patients [26].
In correlation with previous data, a transcriptomic study on genes encoding efflux pump 
mexEF-oprN revealed a significant increase in the expression for those genes [15]. Indeed, 
in comparison to the controls, the expression of mexE, mexF and oprN genes reached almost 
14-, 3.5- and 4.6-fold, respectively. These results are consistent with the antibiotic tests real-
ized previously since the MexEF-OprN efflux pump is involved in the resistance against 
fluoroquinolones (such as ciprofloxacin). Moreover chloramphenicol, a nitroaromatic anti-
microbial, is also a substrate for MexEF-OprN [27, 28].
As this efflux pump is a macromolecular complex enchased into the plasma membrane, 
MexEF-OprN could replace UGP to preserve the membrane integrity. Moreover, this efflux 
pump implements the entry of proton (H+), which may alter the membrane potential. Indeed 
H+ could be accumulated and, consequently, increase the positive charges within cells. 
Thence the alteration of the potential equilibrium may favour the increase of membrane 
potential. Thus, the bacterial physiology may be disturbed causing dysfunction of membrane 
proteins operating through this membrane potential. Indeed a decrease in membrane potential 
was linked with the susceptibility of P. aeruginosa to aminoglycosides antibiotics such as 
tobramycin [29]. Moreover, this H+ gradient could lead to a reorganization of PLs, such as a 
swivelling of alkyl chains outwards, which could justify the Lewis base alteration.
Figure 5: Membrane permeability using Live Dead test and CLSM. Green and red labels sig-
nify penetration in bacteria of SYTO9 and Propidium Iodide, respectively. For each exposure 
condition, three independent experiments were done in three replicates.
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4 CONCLUSION
The present study provides further information concerning the adaptation of an airborne strain 
of P. fluorescens strain, with opportunistic pathogen potential behaviour, to an air pollutant 
such as NO
2
. The bacterial stress caused by this preoccupant air pollutant induces modifica-
tions in membrane permeability certainly because of chemical and/or structural variations 
of cell wall constituents. Thus physiological parameters such as cultivability and growth are 
negatively impacted. However, the ability of the bacterium to form biofilm increases, cer-
tainly favoured by the observed bacterial amasses promoted by the parietal stress. Unfortu-
nately, resistance to fluoroquinolone and phenicol antibiotics increases after exposure to NO
2
. 
Those latter parameters are quiet worrying since they are implicated in bacterial virulence. 
However, 45 ppm of NO
2
 is considered as a high concentration leading to irreversible effects 
on human health and does not totally reflect usual environmental concentrations measured in 
chronic pollution rates [29]. The next step of this project will be to focus on a lower concen-
tration of NO
2
 close to the threshold alert value [30]. Nevertheless, NO
2
 has clearly a drastic 
impact on the physiology of P. fluorescens MFAF76a and these results support the hypothesis 
that air pollutants could promote the pathogenicity of airborne bacteria.
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1 Introduction 
In the last decade, micro and nanosized colloidal carriers have received a 
growing scientific and industrial interest.' These vectors may be capsules (with 
liquid core surrounded by a solid shell), particles (polymeric matrices), vesicles or 
liposomes, or multiple or single emulsions, and have found a wide range of 
applications. They may be loaded by living cells, enzymes, flavour oils, pharma- 
ceuticals, vitamins, adhesives, agrochemicals or catalysts and offer considerable 
advantages in use. Liquids can be handled as solids, odour or taste can be 
effectively masked in a food product, sensitive substances can be protected from 
deleterious effects of the surrounding environment, toxic materials can be safely 
handled, and drug delivery can be controlled and targeted.2 
In the forementioned laboratories, we started with a new strategy based on 
phase separation in order to prepare natural particles. Simple or complex 
coacervation methods involving proteins or protein and polysaccharide mix- 
t u r e ~ ~  were used to create new matrices dedicated to controlled release applica- 
tions. The colloidal carriers produced were in the micrometre or nanometre size 
range depending on the substrates or the methods used. Wheat proteins, gliadins, 
were implicated in simple coacervation to produce nanospheres. Controlled 
release experiments with model compounds were conducted in order to evaluate 
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the performance of such matrices. In the case of complex coacervation, the 
P-lactoglobulin/Arabic gum couple was tested. The mechanism of formation and 
the structural properties of coacervates were first highlighted in order to better 
control the stability of these systems. 
An alternative and promising research field deals with particles obtained from 
hydrogel systems. The hydrogels may be sensitive to environmental stimuli such 
as pH, ionic strength, electric/magnetic fields, light and temperature depending 
on the substrate used. Totally transparent solid matrices resulting from the 
dehydration of new protein gels, revealed variable swelling capacities that de- 
pend on the solvent used and physical chemical conditions. A dispersion/gela- 
tion method was developed to produce micro-beads having potential applica- 
tions in the encapsulation field. 
2 Materials and Methods 
2.1 Gliadins Nanoparticles 
Nanoparticles were obtained by desolvation of the protein using physiological 
salt solution as non solvent. Synperonic PE F68 was used to stabilize the 
nanoparticle su~pension.~ Vitamin E-loaded nanoparticles (1 mg) were digested 
in 10 ml of an ethanol/water mixture (62/38 v/v) at room temperature in the dark. 
The vitamin E concentration encapsulated in nanoparticles (C,) and the residual 
concentration in the supernatant (C,) were then assayed by HPLC at 290 nm. 
Empty nanoparticles were treated in the same way and used as references for 
these determinations. The drug loading (rate) and the entrapment efficiency were 
calculated according to the equations: 
Cl Efficiency (%) = Cl Rate (%) = ~ 
mgliadins Cl + c2 
I n  vitro drug release kinetic was also performed in non-sink conditions using 
decane as solvent (to prevent drug loss from nanoparticles dissolution) and a 
laboratory designed release cell. About 10 mg of gliadins nanoparticles (contain- 
ing 824 pg/g gliadins) were resuspended in 1Oml of decane. Aliquots were 
collected at successive time intervals and replaced by the same quantity of 
solvent in order to get a constant volume in the release cell. The samples were 
analysed by HPLC as described above for encapsulation experiments. 
2.2 P-Lactoglobulin/Arabic Gum Coacervates 
Coacervation process was established at pH 4.2 in water where the two bio- 
polymers interact electr~statically.~ The structure of the coacervates was ex- 
plored using both phase contrast and confocal scanning laser microscopies. 
2.3 1-Lactoglobulin Hydrogels 
The protein hydrogels were formed at pH 8 in 50% ethanol solutions6 Swelling 
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0 
VE / gliadins ratio 
Figure 1 Vitamin E ( V,) encapsulation rate (m) and eficiency (+) by gliadin nanospheres as 
a function of V,/gliadins ratio 
kinetics of cylindrical gels in both hydrated (m, - 4.5 mg) and dehydrated (m, - 1.5 mg) forms were followed in different solvent conditions. 
A new method was also developed based on the dispersion of a P-lactoglobulin 
pre-gel in an apolar phase in order to produce gelled droplets. These droplets 
were then washed and dehydrated under vacuum in order to produce particles of 
500 pm mean diameter. 
3 Results and Discussion 
Gliadin nanospheres typical size was around 900 nm.4 Particles size and polydis- 
persity increased with the increase of the solvent/non solvent ratio and with the 
aggregated state of the proteins. Encapsulation of vitamin E (V,) into gliadin 
nanospheres revealed that the rate and efficiency decreased with the decrease of 
the V,/gliadins ratio (Figure 1). For a V,/gliadins ratio of one, an encapsulation 
rate of 824 ,ug/mg gliadins and an efficiency of 77% were obtained. The V, 
release kinetic from loaded particles is displayed in Figure 2. The experimental 
points were fitted with the following equations: 
= 6 - - 3z(intermediate time) 
vE J: = 6 -(short time) initialV, vE J: ini tialV, 
Dt 
r2 with z = -, D being the diffusion coefficient of the entrapped vitamin E and r, 
the radius of the nanoparticles. 
The kinetic profile was thus interpreted by a burst effect coupled with a drug 
diffusion process through the particle modelled as a homogeneous sphere. The 
drug diffusion coefficient was considerably reduced when entrapped in the 
carrier: D, = 1.1 cm2 s-l compare to D,, = lo-' m2 s-' in solution. 
The encapsulation of different drugs into nanospheres showed that carriers had 
Ch1
122 Creation of Biopolymeric Colloidal Carriers 
Time (h) 
Figure 2 Vitamin E (V,) release kinetic by gliadin nanospheres as a function of time (h). See 
text for equations used in the Jitting procedure: (0 )  released VE (YO); (-) fit 
(short time); (----)$t (intermediate time) 
F ‘igure 3 (Left) Phase contrast optical micrograph of 1 wt% p-1actoglobulinlArabic gum 
mixtures at p H  4.2 ratio 1 : l .  Scale bar represents 20 pm. (Right) Confocal 
scanning laser micrograph of a coacervate obtained with a lwt% p-lactog- 
lobulin/Arabic gum mixture at pH 4.2 ratio 1:l. Scale bar represents 5 pm 
more affinity for hydrophobic drugs and that the (-potential of the particles was 
directly related to the nature of the drug.7 
P-1actoglobulinlArabic gum spherical vesicular coacervates revealed by 
microscopy were the hallmark of these dispersions (Figure 3). Large ‘foam-like’ 
coacervates induced by partial coalescence of single coacervates were visible 
especially at the 2: 1 protein to polysaccharide ratio.’ Increasing dispersions 
stability was reached by increasing protein to polysaccharide ratio or by decreas- 
ing total biopolymer concentration. Another alternative to increase the stability 
is to produce composite dispersions containing both protein aggregates embed- 
ded in protein-polysaccharide coacervates and free coacervates.’ These systems 
could thus be used as multifunctional reservoirs for applications in microencap- 
sulation. 
The swelling kinetics of P-lactoglobulin hydrogels showed that the increase of 
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mass was the highest in water for both hydrated and dehydrated gels (Figure 4). 
The capacity of swelling (or not) depended on the solvent conditions and would 
allow a controlled release of both hydrophilic and hydrophobic drugs. A new 
method was developed based on the dispersion of a P-lactoglobulin pre-gel in an 
apolar phase in order to produce gelled droplets. These droplets were then 
washed and dehydrated under vacuum in order to produce particles of 500 pm 
mean diameter (Figure 5). Such protein matrices were totally transparent and 
could be used to encapsulate large molecules or microorganisms. 
6 
4 
2 
01 I I I 
Time (days) 
0 10 20 30 
Figure 4 Swelling kinetics of P-lactoglobulin hydrogels both in dehydrated and hydrated 
forms for diflerent solvent conditions: (m) ethanol; (0) water/ethanol50/50 (DID); 
(a) water; (0) O.IM NaC1; (A) water/ethanol 50/50 (v/u) (hydrated gel); (A) 
water (hydrated gel) 
Figure 5 Optical micrograph of P-lactoglobulin beads obtained by a gelationlemulsification 
method. Scale bar represents 500 ,urn 
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4 Conclusion 
Biopolymers represent an interesting alternative to synthetic polymers in order 
to be used in the route of structured carriers for controlled release and encapsula- 
tion applications. In particular, the ability of these carriers to entrap both 
hydrophilic and hydrophobic drugs may be very promising for many applica- 
tions. In addition, the absence of chemical compounds and organic solvents used 
to produce biopolymeric matrices could be very interesting for some industrial 
applications. 
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5.1
Introduction
Biopolymers, such as proteins, lipids or polysaccharides, are commonly used to en-
capsulate drugs in order to protect them from rapid degradation by environmental
stress (e.g. light, heat, oxygen or pH sensitivity). Drug loading of carriers seems to
be an attractive opportunity, especially if they are made from bioacceptable macro-
molecules, e.g. plant proteins. Colloidal carriers, in the form of nanoparticles with
a diameter of 50–500 nm and up to a few micrometers, have the potential to de-
liver drugs to speciﬁc target sites and to achieve sustained drug release. Moreover
encapsulation can modify the drug biodistribution and increase its bioavailability
[1–4]. Nanoparticles can be formed from a variety of materials including synthetic
polymers and biopolymers (i.e. natural compounds), such as proteins, lipids and
carbohydrates [5]. Natural macromolecules from vegetable sources appear to be a
very promising alternative to synthetic polymers due to their proven safety, espe-
cially those that are used as food sources. The selection of a suitable structural
material has an important inﬂuence on its potential medical use. Comparing plant
and animal proteins, it appears that vegetal proteins may be more disposable and
cheaper than animal proteins. Moreover, for plant proteins, the puriﬁcation pro-
cess might be also simpliﬁed.
In general, protein nanoparticles display a number of interesting advantages.
Among them, these carriers are biodegradable and metabolizable. Moreover, they
can be prepared under ‘‘soft’’ conditions, without the use of toxic organic solvents
or materials, and they can incorporate a wide variety of drugs in a relatively non-
speciﬁc fashion [6]. Moreover, due to their deﬁned primary structure, protein-based
nanoparticles may oﬀer various possibilities for surface modiﬁcation and covalent
attachment of drugs and ligands [7, 8].
Taking into account all of these advantages of plant proteins, this chapter will
focus solely on the use of storage proteins from pea (legumin and vicilin) and
wheat (gliadins) when used as a structural material to prepare nanoparticles, and
their possible applications in pharmacy and medicine. These proteins are not the
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only ones able to produce nano/microparticles for use as drug carriers – studies
have also been performed on other plant proteins like soy glycinin from soybean
seeds [9] and zein from corn [10]. However, the numbers of studies with these
two proteins are very low. This chapter also includes an overview of the fabrication
and applications of both conventional and ‘‘decorated’’ (i.e. conjugated) storage
protein nanoparticles.
5.2
Description of Plant Proteins
Plant proteins are characterized by their three-dimensional organization. Two
classes can be distinguished:
 Fibrous proteins composed of polypeptide chains joined together along a linear
axis. They are involved in the structural material of living organisms.
 Globular proteins composed of one or, more frequently, several polypeptide
chains rolled up to give a three-dimensional structure. Most of them are storage
proteins.
Most vegetal proteins play an active role in biological processes, e.g. enzymes,
and they can be classiﬁed by their physicochemical and extraction properties [11].
Four classes are listed:
 Vegetable albumins are hydrosoluble and rich in ionic residues (arginine, gluta-
mic acid, lysine, tryptophan, etc.).
 Globulins are complex molecules and their amino acids composition is similar to
that of albumins. However, their solubility needs an electrolyte medium.
 Prolamins are soluble in hydroalcoholic mixtures due to their high content of
amino acids with hydrophilic residues.
 Glutelins cannot be dissolved in any of the aforementioned solvents, due to their
high molecular mass and the presence of disulﬁde bonds; they are rich in lipo-
philic amino acids.
Storage proteins comprise proteins generated mainly during seed production
and stored in the seed that serve as nitrogen sources for the developing embryo
during germination [12, 13]. It is obviously more eﬀective for the plant to use pro-
teins instead of secondary plant products for this purpose. The average protein
content of cereal grains is 10–15% of their dry weight [14], whereas for leguminose
seeds it is about 20–25% [15, 16]. In addition to seeds, storage proteins can also be
found in root and shoot tubers, e.g. potatoes.
No clear deﬁnition exists of what a storage protein is. The term is operational
and was coined for all those proteins whose ratio in the total protein amount of
the cell is greater than 5%. All of these proteins are characterized by the absence
of enzymatic activity, act as a nitrogen source during seed germination and, usu-
ally, occur in an aggregated state conﬁned in a membrane [17, 18].
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Storage proteins are important for human nutrition (plant proteins), and numer-
ous studies concerning their structure and biosynthesis have been published. For
leguminoses, a simplifying rule says that they contain two types of storage proteins
– legumin and vicilin. The legumins (as well as the vicilins) are very similar in dif-
ferent leguminose species. However, Gramineae contain a third type of storage
proteins – prolamin – and, depending on the origin, it is distinguished between
zein (from Zea mays) [19], hordein (from Hordeum vulgare) [20] and gliadin (from
Triticum aestivum L.). In contrast to legumins and vicilins that are mainly located in
the cotyledons of seeds, prolamines are found in the endosperm [21].
5.2.1
Pea Seed Proteins
Globulins are the main storage proteins in pea seeds [22]. These globulins were
characterized by Osborne [23] according to their insolubility in distilled water and,
on the contrary, by their solubility in buﬀered aqueous neutral salt solutions. When
they are fractionated by centrifugation techniques, three diﬀerent fractions have
been described (with sedimentation coeﬃcients of 2, 7 and 11S). The so-called 7
and 11S globulins represent the major pea seeds storage proteins – vicilin and
legumin, respectively. These proteins display a number of similarities, including
the adopted shape when solved in an aqueous solution and the similar size of the
domains of the subunits forming these proteins [24, 25]. However, they can be dif-
ferentiated by their molecular weight [22, 26] and diﬀerent behavior at high tem-
perature. In fact, vicilin has a size of about 200 kDa, whereas legumin is about
360 kDa [22, 26]. Furthermore, legumin does not coagulate at high temperature
[27].
 Vicilin belongs to the group of so-called 7S globulins. It has a complex globular
structure composed of two diﬀerent types of subunits with molecular weights of
about 50 and 60–70 kDa. These subunits form trimeric holoproteins in diﬀerent
combinations [22, 28]. Vicilin is rich in acidic amino acids (aspartic and glutamic
acids), leucine and lysine [29, 30].
 Legumin belongs to the group of so-called 11S globulins [26]. This protein has a
complex globular structure made of six pairs of subunits. Each of the subunits is
composed of disulﬁde-linked acidic a-chains (molecular weight 40 kDa) and basic
b-chains (molecular weight 20 kDa) [31]. Although the three-dimensional struc-
ture of legumin has not been yet determined, the sequence alignment of this
protein appears to show some similarities with that of vicilin [24, 32].
5.2.2
Wheat Proteins
Storage proteins from the wheat seed are able to form a unique viscoelastic net-
work called gluten. The properties of gluten make it useful in the production of
food products such as bread, pasta and semolina, and more recently in biopackag-
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ing materials [33]. The rheological properties of gluten are dependent on the pro-
tein interactions that are formed in the network, and these properties were found
to be mainly inﬂuenced by physical parameters such as temperature and pressure
[34–36].
Two main fractions are present in gluten – gliadin, which is soluble in 70%
ethanol, made of single-chain polypeptides with an average molecular weight of
25–100 kDa linked by intramolecular disulﬁde bonds, and glutenin, an alcohol-
insoluble fraction consisting of gliadin-like subunits stabilized by intermolecular
disulﬁde bonds in large aggregates with a molecular weight greater than 106 kDa
[37]. Because they account for about half of the total wheat gluten proteins, gliadin
constitutes an important class of proteins that are involved in the various proper-
ties of the gluten [38, 39]. These proteins are polymorphic, and can be separated
and classiﬁed on the basis of their electrophoretic mobility at acid pH values [40]
in the following four fractions: a (molecular mass about 25–35 kDa), b (30–35
kDa), g (35–40 kDa) and o (55–70 kDa) groups [41–44]. All fractions have remark-
ably low solubility in aqueous solution except at extreme pH. This low water solu-
bility has been attributed to the presence of interpolypeptide disulﬁde bonds and to
the cooperative hydrophobic interactions which cause the protein chains to assume
a folded shape. The amino acid composition shows that gliadin has equal amounts
of apolar and neutral amino acids, mainly glutamine (about 40%). Furthermore,
gliadin also has a high proline content (14%) and a very low proportion of charged
amino acids [41, 45].
o-Gliadin presents an isoelectric point (pI) ranging from 5.5 to 7 and has a few
charged molecules with six to 11 basic amino acids per molecule. In contrast, a-, b-
and g-gliadins, with a pI range of 6.5–8, are still less charged than o-gliadin [46].
5.3
Preparation of Protein Nanoparticles
Several methods have been reported in the literature for the preparation of
nanoparticles from protein raw materials. Coacervation or controlled desolvatation
methods have been developed using solvent or electrolyte as the coacervation agent
[47, 48] or by adjusting the pH or ionic strength [49, 50]. In the coacervation meth-
ods promoted by solvents, the ﬁrst step consists of dispersing the macromolecules
in an adequate solvent, then adding the mixture to a second solvent which is a
nonsolvent of the macromolecules. A required condition is that the solvent and
the nonsolvent phases are miscible.
The coacervation process is applied to a macromolecular solution to reduce the
solubility in the system to such a degree that appropriate phase separation of
the macromolecule takes place, i.e. the formation of a macromolecule-rich phase.
The desolvatation leads to macromolecule precipitation or to coacervate formation.
It is assumed that, before phase separation is observed, a conformational change in
the macromolecule occurs. The addition of a desolvating agent shrinks the macro-
molecule coil which becomes smaller and smaller until the phase separation from
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the solvent occurs. It is possible to monitor the phenomenon by turbidity measure-
ment. A desolvatation agent decreases the turbidity because of the decrease in mac-
romolecular size. To prepare small particles, it is important to maintain the system
just outside the coacervation region. The addition of the coacervation agent should
stop as soon as the Tyndall eﬀect bounded to aggregation of macromolecules turns
the system turbid [7]
5.3.1
Preparation of Legumin and Vicilin Nanoparticles
Legumin and vicilin have an aqueous solubility that is strongly pH and ionic
strength dependent [30]. Nanoparticles from these pea proteins (Figs. 5.1 and 5.2)
can be obtained by a simple coacervation or controlled desolvatation method [50–
52]. It was observed that extreme pH values enable their solubilization in aqueous
medium. The coacervating or desolvating agent induces a progressive modiﬁcation
of the tertiary structure of the proteins, giving an increasing hydrophobic material
which leads to submicronic aggregates or coacervates [53]. These coacervates are
generally unstable and must be hardened for stabilization by physical or chemical
Fig. 5.1. Scanning electron micrograph of legumin
nanoparticles. (From Ref. [52], permission pending).
Fig. 5.2. Scanning electron micrograph of vicilin nanoparticles.
(From Ref. [50]).
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crosslinkage. In the case of these pea proteins, a three-step procedure can be em-
ployed to obtain nanoparticles.
In a ﬁst step, an unstable coacervate is obtained by mixing a solution of the
chosen protein (pH 9) with a phosphate buﬀer solution. In a second step, the coac-
ervates have to be hardened with a crosslinking agent in order to stabilize the just-
forming coacervates. The most popular crosslinking agent is glutaraldehyde. This
reagent reacts with the amino groups of the proteins, predominantly with the
amino group of lysines, to form a Schiﬀ base [54]. Finally, after the crosslinking,
for pharmaceutical purposes, the obtained nanoparticles have to be puriﬁed. For
this purpose, unreacted aldehyde can be neutralize with a sulﬁte and nanopar-
ticles centrifuged in order to eliminate the nontransformed protein fraction onto
particles.
Some comprehensive explanations of nanoparticles formation can be given. It is
observed that, at a pH value close to 7, the coacervates show a submicronic size,
but the percentages of coacervates yields are under 40% of the added protein.
Similarly, the ionic strength of the buﬀer greatly inﬂuences the coacervate size
and yield. The best experimental conditions to obtain small-sized particles (average
diameter 500 nm) were found to be pH 6.8 and ionic strength 0.15 M for legumin,
and pH 6.4 and ionic strength 0.10 M for vicilin [50, 52].
The isoelectric points of the two proteins are about 4.5. Thus, the balance be-
tween negative carboxyl groups (from glutamic and aspartic acids) and positive
groups (from lysine and arginine) changes when the pH of the protein solution is
less or greater than 4.5. Consequently, under environmental conditions close to the
isoelectric point, these globulins would present a reduced interfacial charge which
may enhance coacervate precipitation and phase separation. In other respects, for
neutral pH values, legumin and vicilin would have a charge which may probably
act against coacervate formation.
Concerning vicilin, in particular, a hypothesis for protein coacervate formation
has been proposed. Under deﬁned conditions, solubilized vicilin (7S form) may as-
sociate to yield an 11S insoluble form. This 11S form (probably a dimer of vicilin)
may be responsible for the initial precipitation of vicilin which aggregates up to a
critical size depending on environmental conditions (pH and ionic strength). The
coacervate must be quickly hardened by crosslinkage in order to prevent the aggre-
gates coalescing to a separate phase.
5.3.2
Preparation of Gliadin Nanoparticles
Gliadin nanoparticles (Fig. 5.3) can be prepared by a desolvatation method in
which a dissolution of gliadin in an organic solvent/water mixture is desolvated
by the addition of a nonsolvent aqueous phase [50, 55]. Note that gliadin nanopar-
ticles prepared in this way are stable and further treatment by heat or chemical
crosslinking is not necessary to stabilize them. This fact can be explained by the
extremely low solubility of gliadin in an aqueous medium and represents an ad-
vantage when compared with other protein nanoparticles (i.e. albumin, gelatin).
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In any case, gliadin nanoparticles can be hardened by chemical stabilization in or-
der to modulate the drug release characteristics of nanoparticles or their in vivo dis-
tribution and interaction with the body.
Once produced (and eventually hardened by chemical crosslinkage), they have
to be puriﬁed. The organic solvents are eliminated by evaporation under reduced
pressure, whereas the amounts of protein not transformed onto nanoparticles
and other impurities (i.e. the chemical crosslinker) are eliminated by dialysis,
gel-permeation chromatography or, more frequently, subsequent centrifugations.
Finally, nanoparticles can be also lyophilized to preserve their physicochemical
properties for a long period of time. For lyophilization of gliadin nanoparticles, a
solution of glucose 5% w/v has been proposed as a cryoprotector [56, 57].
In summary, this simple method allows the preparation of reproducible particle
sizes with a narrow distribution. The main advantages are the production of nano-
particles in the absence of toxic organic solvents and the possibility of avoiding
the chemical stabilization step to obtain stable nanoparticles. The selection of the
solvent phase of gliadin has a signiﬁcant inﬂuence on the size of the resulting
nanoparticles. In this context, mixtures between either ethanol and water or ace-
tone and water enable production of both smaller particle sizes and reproducible
results. Another key factor concerns the nonsolvent of gliadin. In this case, an
aqueous solution of NaCl (0.9% w/v) has been proposed [50]. When a mixture of
ethanol and water is used, the size of the resulting nanoparticles is close to 450 nm
and the yield of the process, determined by gravimetry and reverse-phase high-
performance liquid chromatography (RP-HPLC), is about 90% [50, 56].
More recently, in order to understand the inﬂuence of environmental parameters
governing gliadin nanoparticles size, a thermodynamic approach was investigated,
i.e. the determination of the solubility parameter of the protein [58]. According to
Hildebrand theory [59], the solubility parameter of gliadin was determined using a
panel of solvents or mixtures of them. It is assumed that the solvent which best
solubilizes gliadin has the same solubility parameter as the protein [60]. Diﬀerent
mixtures were prepared with bioacceptable solvents such as ethanol, ethylene
glycol, propylene glycol and ultra-pure water. These solvents are usually considered
Fig. 5.3. Scanning electron micrograph of a gliadin
nanoparticle. (From Ref. [8]).
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as references for the determination of the solubility parameters of biological
compounds.
When a mixture of ethanol and water is used, the size of the resulting nanopar-
ticles is close to 450 nm and the yield of the process, determined by gravimetry and
RP-HPLC, is about 90% [50, 56]. However, a mixture of propylene glycol and water
(73/27%) appears to be the best selection to obtain small gliadin nanoparticles of
about 150 nm [58].
5.4
Drug Encapsulation in Plant Protein Nanoparticles
In order to evaluate the encapsulation ability of gliadin nanoparticles, diﬀerent
drugs were tested, chosen for their medical and/or pharmaceutical interest. The
objective of this research was to determine the feasibility of nanoparticles loaded
with hydrophilic or lipophilic drugs and furthermore in order to obtain as small-
sized particles as possible. Attention was focused on the drug release mechanism.
Four drugs were chosen – two lipophilic vitamins, i.e. all-trans retinoic acid [vita-
min A (RA)] and a-tocopherol [vitamin E (VE)], and two hydrophilic drugs, i.e. a
slightly polar mixture of linalool–linalyl acetate (LLA), components of the essential
lavender oil, and the cationic amphiphilic benzalkonium chloride (BZC). For all
these particulate systems, nanoparticles sizes were determined by scanning elec-
tron microscopy or photon correlation spectroscopy.
5.4.1
RA Encapsulation in Gliadin Nanoparticles
RA is involved in the proliferation and diﬀerentiation of epithelial tissues. This vi-
tamin in acidic form reduces the size of sebaceous glands and sebum secretion,
making it an attractive agent for the treatment of skin disorders such as acne, pso-
riasis, hyperkeratosis, ichtyosis and epithelial tumors [61, 62]. In the treatment
of acne, it was demonstrated that RA prevents inﬂammatory lesions by loosening
follicular impactions (micrcomedones) and clearing the follicular canal of retained
keratin [63]. Furthermore, RA has been proven eﬀective against a range of malig-
nancies in human clinical trials, although many patients relapsed after a remission
[64]. In vivo studies have shown that RA is active against acute promyelocytic leu-
kemia [65, 66]. Unfortunately, the limited duration of RA activity in this leukemia
is a pharmacological adaptation resulting in reduced serum concentration after
prolonged treatment [67]. Nevertheless, in spite of a real therapeutic interest, sev-
eral drawbacks (e.g. teratogenicity) have been reported for the currently available
dosage forms [62]. To overcome these inconveniences, and in an attempt to in-
crease the therapeutic eﬃcacy of RA, alternative dosage forms have been suggested
– microemulsions [68] and liposomes for intravenous [69] and topical administra-
tion [70]. Another system suitable for controlled drug release could be nanopar-
ticles from biopolymers. For this purpose, we have chosen nanoparticles from glia-
124 5 Plant Protein-based Nanoparticles
Ch2
din. They were prepared by the aforementioned desolvatation method [50, 58].
These particles can be obtained by using only bioacceptable solvents such as etha-
nol and water. Their size, which is one of the determinant characteristics for med-
ical purposes, can be optimized. These nanoparticles, showing good stability in
phosphate-buﬀered saline (PBS), were assayed as carriers for RA. They have shown
a quite good entrapment eﬃciency – about 75% of added drug at 60 mg (mg
gliadin)1 and a payload of 74 mg (mg gliadin)1 nanoparticles [58]. In order to
quantify more precisely the solvent eﬀect, the size diameter was optimized through
a solubility parameter study. The smallest size was reached for protein solubility
solvent equal to that of gliadin. The average diameter of the particles was about
150 nm [58]. RA was released from these nanoparticles, in a two-step mechanism,
characterized by an initial rapid release followed by a continuous diﬀusion process.
The ﬁrst release was found to be about 20% of the loaded drug and can be related
either to the release of the drug entrapped in the peripheral domains of the nano-
particle matrix or to a simple desorption of superﬁcial RA, whilst the second slower
period was linear with respect to time and appeared to be a diﬀusion phenomenon.
Furthermore, in this second step, about 20% of the drug was released by diﬀusion
in 3 h.
These observations oﬀer interesting prospects for the preparation of drug-loaded
carriers for medical applications.
5.4.2
VE Encapsulation in Gliadin Nanoparticles
Drug carriers are interesting systems to prevent drawbacks related to the drug
itself by decreasing its degradation rate. In order to test the protective power of
nanoparticles against environmental stresses, a second lipophilic vitamin, VE, was
encapsulated into gliadin nanoparticles. VE is known to act as a strong antioxidant
or nitrosamine blocker to prevent the build-up of cellular peroxide [71]. The expo-
sure to free oxygen species induces a rise in lipid peroxidation, which may cause
injury at diﬀerent sites of the body. For instance, the action of free radicals pro-
duced by a variety of environmental stresses (among them sun exposure) may
promote skin damage, such as premature skin ageing [72], skin fragility and even
skin cancers (melanoma or others) [73] related to a decrease in cellular immunity
of the skin. VE appears to be one of the strongest free radical scavengers through
its action as a chain-breaking antioxidant in membranes [74], preventing acute or
chronic damage [75]. In addition to these biological activities, VE also exerts cos-
metic functions; notably, it helps delay the progression of aging [76] and possesses
a skin moisturizing power [77]. However, VE is degraded by oxygen, and dosage
forms must be protected from light, heat and prolonged contact with air. Previous
work has shown that the preparation of gliadin nanoparticles could be easily per-
formed by a simple coacervation method. It is for this reason that gliadin has
been chosen. Moreover, gliadin possesses the ability to interact with epidermal ker-
atin due to its richness in proline [78]. VE-loaded gliadin nanoparticles have been
characterized by their size, z potential, VE payload and entrapment eﬃciency.
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When loaded, the gliadin particle size is about 900 nm and their charge is close to
zero. They are suitable drug carriers with an optimum encapsulation rate of about
100 VE mg (mg gliadin)1 with an eﬃciency of more than 77%. The release behav-
ior of VE-loaded nanoparticles may be interpreted as a ‘‘burst’’ eﬀect, followed by a
diﬀusion process through a homogeneous sphere [3].
5.4.3
Lipophilic, Hydrophilic or Amphiphilic Drug Encapsulation
In order to study the inﬂuence of drug polarity on nanoparticle characteristics such
as particles size, drug loading and drug release, three diﬀerent drugs with diﬀerent
polarities were chosen [79]. VE, studied in a previous paper [3], was employed as a
model of a lipophilic drug, and the slightly polar LLA and the amphiphilic cationic
benzalkonium chloride (BZC) as hydrophilic models. Their dielectric constants
are, respectively, 4, 8 and 45 [80]. The choice of these drugs was governed by their
utilization in pharmaceutical dosage forms:
 VE, widely used as strong antioxidant in many medical and cosmetic applica-
tions, is rapidly degraded because of its light, heat and oxygen sensitivity [3].
 Linalool and linalyl acetate are the major components of essential lavender oil
used in aromatherapy. They possess antibacterial and antifungal properties [81].
They are used in topical formulations. They may cause skin irritation by reason
of a potential caustic power. Gliadin encapsulation could be a fruitful method for
LLA formulations. Furthermore, the interaction of gliadin proline with skin ker-
atin associated with the controlled release of LLA may avoid some drawbacks of
this drug.
 BZC is a quaternary ammonium used as an antiseptic and bactericide, spermi-
cide [82], and virucide [83]. However, BZC can promote some allergies followed
by mucous lesions. It is assumed that encapsulation into gliadin nanoparticles
could minimize or avoid lesions promoted by this irritant quaternary ammo-
nium and could improve the dosage form by delaying drug release.
Drug entrapment and eﬃciency were tested after encapsulation. The results
showed that the amount of entrapped VE and LLA is higher than that of the
cationic BZC, conﬁrming a strong interaction between gliadins and apolar com-
pounds, due to the apolarity of the proteins. When comparing drug entrapment,
results show that the optimal VE concentration is obtained for 972.0 VE mg (mg
gliadin)1, with an eﬃciency of 79.2%, the optimal LLA concentration corresponds
to 980.0 LLA mg (mg gliadin)1, with an eﬃciency of 82.4%, and the optimal BZC
concentration corresponds to 550.3 BZC mg (mg gliadin)1, with an eﬃciency of
52.3% (Table 5.1).
For drug release quantiﬁcation, only VE and BZC were studied. The reason be-
ing that LLA should be studied under a controlled atmosphere and not in a liquid
medium. Such diﬀerences between media used did not allow an easy comparison
to other drugs. For VE and BZC, drug releases were, respectively, 13 and 11% after
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1 h, and 30.6 and 11.7% after 30 h. The phenomenon observed can be interpreted
as a burst eﬀect completed by a drug diﬀusion process through a homogeneous
sphere. Both release diﬀusion parts of the proﬁles have been modeled with a diﬀu-
sion process in a homogenous sphere. However, the diﬀusion coeﬃcients are dif-
ferent according to VE or BZC, i.e. 1:12 1020 and 6:36 1021 m2 s1, respec-
tively. This could be related to the diﬀerent aﬃnity of the gliadin for the two drugs.
In organic phases, diﬀusion coeﬃcients are usually about 109 m2 s1. Here, the
coeﬃcients are clearly much lower, which conﬁrm that the drug is retained by the
nanoparticle matrix.
In conclusion, it can be observed that whatever the polar drug character, this
gliadin nanoparticulate system is able to entrap the drug with an acceptable
payload and encapsulation eﬃciency [79].
5.5
Preparation of Ligand–Gliadin Nanoparticle Conjugates
In general, proteins produce biodegradable particles whose physicochemical prop-
erties can be modulated by the crosslinking process employed for their stabiliza-
tion. Furthermore, due to the presence of numerous functional groups (i.e. amino
and carboxylic residues), proteins are excellent candidates for the preparation of
conjugates, formed by the attachment of molecules capable of providing speciﬁcity
to the surface of nanoparticles. In this context, diﬀerent ligands have been pro-
posed, including antibodies [84, 85], lectins [86, 87], carbohydrates [88] and other
biological ligands, in order to recognize or bind particular molecules [89, 90].
However, the association of ligands with nanoparticles can be achieved by diﬀer-
ent procedures, including covalent linkage and adsorption processes [91]. Ideally,
the ligand should be conjugated to particles through a covalent linkage, which is
more stable than adsorption procedures, without aﬀecting its speciﬁcity. Noncova-
lent attachment relies on a fortuitous process. Further, it is diﬃcult to control the
amount of ligand which is associated and this process is useful only for those
proteins that will associate nonspeciﬁcally [92]. Diﬀerent techniques for covalent
attachment may be envisaged, depending on the principal functional groups lo-
cated on the carrier surface. The most widely used methods of ligand coupling
are the use of cyanogen bromide [84, 93] and periodate [94, 95] for hydroxyl
Tab. 5.1. Drug encapsulation characteristics in gliadin nanoparticles.
Drug Polarity (dielectric constant) Payload
(%)
Encapsulation
eﬃcacy (%)
VE Apolar (4) 97.2 79.2
LLA slightly polar (8) 82.4 98.0
BZC polar (amphiphilic cationic) (45) 66.0 52.3
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groups, glutaraldehyde [96, 97] and ethylene glycol diglycidyl ether [98] for amino
groups, and carbodiimide (CDI) for carboxylic groups [99, 100].
This last technique is the one preferred in order to obtain conjugates between a
ligand and protein nanoparticles [87, 101–103]. CDI involves the activation of car-
boxylic acid groups to give NH-activated carboxylic acid groups which can react
with free amino groups of the ligand polypeptide chains [104]. In proteins, these
carboxylic groups can be found on aspartic and glutamic acid residues. For vicilin,
these amino acids represent about 19 groups per 1000 amino acid residues [101].
For gliadin, these amino acids only represent 21 and 71 groups per 1000 amino
acid residues, respectively [45, 105]. In spite of gliadin having a very low proportion
of these two amino acids, it appears that the coupling reaction is eﬃcient enough
to provide acceptable lectin binding.
Figure 5.4 summarizes the preparation of lectin–nanoparticle conjugates. In
brief, the ﬁrst step of the manufacturing protocol involves the activation of the
carboxylic groups on the gliadin nanoparticles by addition of a CDI derivative [i.e.
1-(3-dimethylaminopropyl)-3-ethyl-carbodiimide hydrochloride]. After incubation,
the suspension of ‘‘activated’’ nanoparticles has to be centrifuged in order to re-
move the unreacted reagent. Then, the nanoparticles are dispersed in an aqueous
medium and incubated with the desired ligand for the coupling reaction by over-
night incubation at room temperature [101, 102]. Finally, the resulting conjugates
are puriﬁed and lyophilized using glucose as a cryoprotector [103].
Diﬀerent parameters can inﬂuence the yield of the process. In spite of the fact
that the CDI reaction can eﬀectively occur up to at least pH 7.5 without any signif-
icant loss of yield, it has been reported that the optimal pH ranges between 4.7 and
6 [106]. This fact was also observed by Arangoa et al. who showed evidence of
superior binding of a Dolichus biﬂorus lectin (DBA) to the surface of gliadin nano-
particles with 2-(N-morpholino)ethanesulfonic acid (MES) buﬀer (1 mM, pH 5.5)
rather than with PBS (1 mM, pH 7.4) [103]. This may be explained as being due
to the proton of the carboxylic group facilitating the rupture of one double link of
the CDI molecule [107], forming the O-acylisourea intermediate. This active resi-
due is then able to react directly with primary amines forming amide bonds and
Fig. 5.4. Route for the preparation of ligand–gliadin
nanoparticle conjugates by desolvation of gliadin followed by
CDI activation and further incubation with the ligand.
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releasing the CDI derivative. Moreover, at neutral pH, the overall charge of both
the nanoparticles and the ligand would be negative. Therefore, ligand approaches
to a nanoparticle surface and subsequent binding would not be favored by the
phenomenon of charge repulsion [108].
Another critical factor aﬀecting ligand binding to the surface of protein nanopar-
ticles is the reaction time between the CDI and the gliadin. Therefore, an increase
in the reaction time induced a dramatic decrease in the amount of the ligand bind-
ing to the nanoparticle surface. This could be due to the degradation of the reactive
O-acylisourea complex. In fact, this complex is rapidly hydrolyzed in aqueous solu-
tion, having a constant rate measured in seconds [109]. If the target amine does
not interact with the O-acylisourea intermediate before its hydrolysis, the desired
binding cannot occur. This is especially problematic when the target molecule is
in low concentration [106], as usually occurs in the binding of active ligands
to the surface of nanoparticles. Another possible explanation for the DBA binding
decrease could be the formation of the stable N-acylurea derivative [110].
However, the amount of CDI used to activate functional groups on the surface of
nanoparticles is also important. A low amount of CDI may require longer reaction
periods. However, the use of high amounts of CDI may induce irreversible aggre-
gation of nanoparticles. This may be explained by the presence of both carboxylic
and amine groups on the surface of the nanoparticles. Therefore, at high CDI
concentrations, self-polymerization may take place [106]. In any case, in order to
obtain a good binding eﬃciency, it is necessary to ﬁnd a balance between the reac-
tion time and the amount of CDI used to activate the nanoparticles.
Finally, another important factor concerns the amount of ligand used in the in-
cubation with the activated nanoparticles. For gliadin nanoparticles, a maximum of
ligand binding occurs when the amount of ligand incubated with activated nano-
particles is about 50 mg (mg gliadin)1 nanoparticles [103].
5.6
Bioadhesive Properties of Gliadin Nanoparticles
Bioadhesion is classically deﬁned as the ability of a material to adhere to a biologi-
cal substrate with the objective of improving the therapeutic eﬃciency of drugs by
increasing the residence time at the site of activity or absorption [111, 112]. It is
interesting to note that a number of drugs remain poorly available when adminis-
tered by the oral route. Among other reasons, this fact can be related either to a
low mucosal permeability for the drug or to its low solubility in the mucosal ﬂuids.
In both cases, an important fraction of the given dose is eliminated from the ali-
mentary canal prior to being absorbed. The use of bioadhesive nanoparticles can
be an adequate strategy to improve drug bioavailability. In fact, these carriers may
enhance the drug absorption rate by reducing the diﬀusion barrier between the
dosage form and the site of action or absorption. Similarly, they may prolong the
residence time of the drug in the gut and, therefore, increase the time during
which absorption can occur.
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For bioadhesion studies, gliadin nanoparticles were labeled with carbazole,
which is a hydrophobic ﬂuorescent molecule.
5.6.1
Ex Vivo Studies with Gastrointestinal Mucosal Segments
In order to evaluate the bioadhesive capacity of these carriers, nanoparticles were
incubated with fresh portions of rat gastrointestinal mucosa using a plate of alumi-
num with a slit in the center [113]. The mucosa in the slit of the plate was covered
with 1 mL of suspensions (containing 4 mg mL1 nanoparticles) and the incuba-
tion time was ﬁxed for 30 min. After incubation, the suspensions were sucked oﬀ
and the samples were rinsed with 5 mL 0.9% NaCl solution to eliminate the non-
attached particles. Then, the mucus layer including the adsorbed particles was
drawn from the membrane and digested with NaOH for 24 h. After total dissolu-
tion of mucus, carbazole extraction was performed with 1.5 mL methanol, vortexed
for 1 min and centrifuged at 20 000 g for 10 min. Finally, the amounts of adhered
nanoparticles or conjugates were estimated by ﬂuorometry [103].
Gliadin nanoparticles were able to develop rapid interaction with the gut mu-
cosa. In fact, the adsorption equilibrium for nanoparticles and conjugates was
reached in less than 30 min [103]. Similarly, under the experimental conditions
used [4 mg (particles or conjugates) mL1], no saturation was observed on the
apparent surface of mucosa delimited by the device.
Figure 5.5 shows the interactions of gliadin nanoparticles with intestinal mu-
cosa samples. Comparing the diﬀerent anatomical regions, gliadin nanoparticles
Fig. 5.5. Adhesive interactions of gliadin nanoparticles in isolated intestinal segments (n ¼ 4).
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showed a high aﬃnity for the small intestine segments. However, no signiﬁcant
diﬀerences in the extent of interaction were found between the duodenum,
jejunum and ileum (P < 0:05). Therefore, for ileum or duodenum portions, the
amount of nanoparticles interacting with the mucosa was calculated to be close to
8 g m2, which represents about 40% of the nanoparticles placed in contact with
the gastrointestinal tract. In this context, the interaction of poly(styrene) nanopar-
ticles with intestinal segments (under similar experimental conditions) was size
dependent and the largest amount of latex able to interact with the mucosa was
about 1 g m2 [113, 114]. Similarly, gliadin nanoparticles interacted about 8-fold
more with the intestinal mucosa than poly(isobutyl cyanoacrylate) nanoparticles
[115]. For large intestine portions, the interaction of gliadin nanoparticles strongly
decreased. This may be explained by a reduction of both the mucosa surface and
the mucin concentration along the gastrointestinal tract. According to these re-
sults, it appears that gliadin nanoparticles would be useful for improving the bio-
availability of drugs. These powerfully adhesive carriers may prolong the residence
time and enhance drug absorption, thud reducing the diﬀusion pathway.
However, DBA–gliadin nanoparticle conjugates displayed a diﬀerent ability to
develop adhesive interactions with the gut mucosa. In the small intestine, these
conjugates showed an adhesive interaction similar to the controls (P < 0:05) and,
for all segments, this interaction was close to 10% of the initial concentration
placed in contact with the mucosa. However, in the large intestine a signiﬁcant in-
crease of about 100% was found for DBA conjugates. This fact can be explained by
the reported capability of DBA to strongly react with the colonic epithelial surface
[116, 117] due to the presence of N-acetyl-d-galactosamine (speciﬁc sugar for DBA)
residues, which provide the substrate for their site-speciﬁc interaction.
Finally, concerning the interaction of gliadin nanoparticles with Peyer’s patches,
it was found that gliadin nanoparticles showed 3.5 times more capacity of interac-
tion with these lymphoid tissues than DBA conjugates [103].
All of these results conﬁrmed that gliadin nanoparticles displayed a high interac-
tive potential with biological surfaces. However, the possible interaction between
the biological substrate and these nanoparticles is of a nonspeciﬁc nature. This
fact means that these colloidal systems interact in the same way with a number of
components of the biological substrate, without showing target properties for a
particular region or cell structure [118].
5.6.2
In Vivo Studies with Laboratory Animals
In order to evaluate the in vivo bioadhesive capacity of gliadin nanoparticles and
their inﬂuence on the pharmacokinetics of the loaded drug, animals were gavaged
with a single dose of nanoparticle formulations dispersed in 0.5 mL water. For the
bioadhesion study, the gastrointestinal tract of animals was cut in diﬀerent por-
tions, rinsed with saline and digested with sodium hydroxide. The ﬂuorescent
marker was extracted with methanol and determined by spectroﬂuorimetry. The
amount of carbazole, determined in the mucosa segments, was used for the
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estimation of the interacted nanoparticulate fractions. For the pharmacokinetics
studies, blood samples were taken from the ophthalmic venous plexus, centrifuged
and assayed for carbazole content by an HPLC method with ﬂuorescent detection
[57]. In vivo studies demonstrated that gliadin nanoparticles displayed a high adhe-
sive potential with a clear tropism for the stomach mucosa (Fig. 5.6). Thus, thirty
minutes post-administration, about 30% of the initial dose remained adhered with-
in the gut. However, around 90% of the adhered nanoparticles were localized in
the stomach. Similarly, 1 h after administration, only 18% of the initial dose could
be found in the stomach and their presence in other intestinal regions was also
negligible. Finally, at 2 h post-administration, only about 8% of the given dose
was found adhered to the mucosa [119]. This proﬁle of bioadhesion (tropism for
the stomach mucosa and rapid decline of the adhered fraction over the time) was
not signiﬁcantly aﬀected when nanoparticles were coated with DBA [103].
Nevertheless, in order to study the inﬂuence of the degree of crosslinking on the
bioadhesive proﬁle of nanoparticles and carbazole absorption, two diﬀerent formu-
lations were prepared. The ﬁrst one resulted from the crosslinking of gliadin nano-
particles with glutaraldehyde with 2 h prior puriﬁcation (CL-NP). The second one
(DCL-NP) was obtained after treatment of gliadin nanoparticles with a CDI deriva-
tive for 1 h and subsequent treatment with glutaraldehyde for 2 h [57] (Tab. 5.2).
Within the stomach, the bioadhesive proﬁle of gliadin nanoparticles was found
to be inﬂuenced by the crosslinkage. Thus, noncrosslinked nanoparticles displayed
a higher initial ability to develop adhesive interactions than crosslinked nanopar-
ticles. However, the elimination rate of the adhered fraction was higher for non-
crosslinked than for stabilized nanoparticles [57, 119]. On the contrary, the cross-
linking process allowed a similar amount of carriers adhered to the mucosa to be
Fig. 5.6. Gastrointestinal transit proﬁle of gliadin
nanoparticles. Single administration of a single oral dose of 30
mg. Data expressed as the meanG SD (n ¼ 4). (Adapted from
Ref. [102]).
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maintained for at least 1 h, which was calculated to be around 15% of the given
dose (Fig. 5.7).
Another interesting point is that, within the stomach, the adhered nanoparticles
appear to accumulate in the nonglandular region [119]. In this last region, cross-
linked nanoparticles have a 1.5 times higher adhesive intensity than nonhardened
nanoparticles. Similarly, the mean residence time of the adhered fraction to the
stomach mucosa was about 95 min higher for crosslinked than for conventional
gliadin nanoparticles [119].
This high adhesive capacity of gliadin nanoparticles may be explained by the
protein composition with a high content of neutral and lipophilic residues. Neutral
amino acids may promote hydrogen-bonding interactions with the mucosa, while
Fig. 5.7. Evolution of nonhardened gliadin
nanoparticles (NP), nanoparticles crosslinked
with glutaraldehyde (CL-NP), and nanoparticles
crosslinked with CDI and glutaraldehyde (DCL-
NP) in the stomach mucosa, as a function of
time, after single oral administration 20 mg
particles (1.14 mg carbazole kg1). The results
are expressed as the percentage of the given
dose (n ¼ 6).
Tab. 5.2. Physicochemical characteristics of the diﬀerent formulations based on gliadin
nanoparticles (n ¼ 6).
Size
(nm)
z potential
(mV)
Fixed ligand
(mg mgC1)
Loaded carbazol
(mg mgC1)
NP 460G 19 27:5G 0:8 – 12:6G 1:2
CL-NP 453G 24 24:5G 0:5 – 12:2G 0:8
DCL-NP 478G 31 21:2G 1:3 – 12:1G 1:6
BSA-NP 514G 18 34:7G 1:7 20:8G 1:7 12:5G 0:6
DBA-NP 521G 13 32:4G 0:9 23:5G 2:6 12:6G 0:9
CL-NP: nanoparticles crosslinked with glutaraldehyde; DCL-NP:
nanoparticles crosslinked with CDI and glutaraldehyde; BSA-NP:
bovine serum albumin–gliadin nanoparticle conjugates (control); DBA-
NP: D. biﬂorus lectin–gliadin nanoparticle conjugates.
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the lipophilic components may develop hydrophobic interactions with the biologi-
cal support [115, 118, 120]. On the other hand, a more energetic crosslinking pro-
cess reduces the ability of nanoparticles to develop adhesive interactions within the
mucosa; however, this process would decrease the degradation rate of gliadin nano-
particle and, thus, provide a prolonged residence in the mucosa. For crosslinkage
with glutaraldehyde, the adhered fraction of nanoparticles is constant for at least 1
h, whereas for nanoparticles crosslinked with CDI and glutaraldehyde, the adhered
fraction (around 10% given dose) remained constant for at least 2 h.
Concerning the pharmacokinetic study, Fig. 5.8 shows the carbazole plasma con-
centration provided by nonhardened and crosslinked nanoparticles when adminis-
tered by the oral route. It is interesting to note that when carbazole was formulated
as an aqueous suspension it was not possible to determine the Tmax, Cmax and the
elimination rate. Similarly, the area under of curve (AUC) was around zero since
their absorption was negligible. This fact is typical for hydrophobic drugs with
very poor aqueous solubility [121–124].
However, when formulated in nonhardened nanoparticles, the bioavailability of
carbazole was calculated to be about 40% of the dose. For crosslinked nanopar-
ticles, the bioavailability was close to the 50%. Moreover, the crosslinkage enables
us to increase the Tmax, and to decrease the Cmax and the elimination rate. Simi-
larly, the mean residence time was signiﬁcantly increased in comparison with non-
hardened nanoparticles and an aqueous solution of carbazole [57].
These pharmacokinetic results can be explained by the ability of gliadin nanopar-
ticles to develop bioadhesive interactions within the stomach mucosa. Once gliadin
nanoparticles are adhered to the mucosa, they would release the loaded molecules
to the absorbing cell layer, minimizing losses to the luminal environment and in-
creasing the local drug concentration. In this context, the active molecule (carba-
zole in this study) would be able to show a ﬁrst-order absorption process. However,
Fig. 5.8. Carbazole plasma levels after the oral administration
of a single dose of 1.14 mg carbazole kg1 loaded in NP, CL-
NP or DCL-NP (n ¼ 12).
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the digestion of nanoparticles either in luminal ﬂuids or adhered in the mucus
may provide an instantaneous release component which may be related to a ﬁrst-
order absorption. In fact, the interactions developed by gliadin nanoparticles
within the stomach mucosa are the key phenomena inﬂuencing carbazole absorp-
tion. This hypothesis was conﬁrmed by a deconvolution model [57].
5.7
Future Perspectives
For pharmaceutical dosage forms it is well known that, whatever the administra-
tion mode, the principal objectives to be reached are the enhancement of the eﬃ-
ciency associated with a reduced toxicity and controlled drug release. Furthermore,
if administered by a parenteral route, it is hoped that a major amount of the drug
reaches the target site avoiding undesirable side-eﬀects, i.e. a modiﬁcation of drug
distribution is required [125, 126].
Colloidal carriers in the form of nanoparticles have this potential to deliver drugs
to speciﬁc target sites and to achieve sustained drug release. The bioacceptability of
such nanoparticulate systems is strongly size dependent and, for intravessel ad-
ministration, the diameter must be smaller than that of the smallest blood capil-
lary. Consequently, size optimization is a very important parameter.
Furthermore, for medical applications, it is of interest to test their potential for
parenteral administration, and particularly the humoral and cellular responses of
protein particles after injection in animals. The ﬁrst reports have been published
describing these responses for native legumin and legumin nanoparticles after
intradermal injection in rats [127]
5.7.1
Size Optimization
Bearing in mind this important condition, all the parameters involved in the prep-
aration of gliadin nanoparticles have been optimized (some results are have been
published [55]; other are in progress). The studied parameters were:
 Choice of the protein solvent
 Protein concentration
 Temperature during the experimental procedure
 Solvent/nonsolvent ratio
 Shear rate imposed during mixing
 Nanoparticle size evolution with time
Concerning the choice of the protein solvent, it was demonstrated that the closer
the solubility parameter of the protein is to that of the solvent, the smaller the par-
ticle size (and correspondingly higher the amount of protein solubilized), under
the experimental conditions chosen.
Other important experimental conditions were the solvent/nonsolvent ratio, the
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temperature and the shear rate during the procedure. The data available showed
that the best ratio must be less than unity and that an elevated temperature (com-
patible with protein thermolability, about 35 C) decreases the particle size. More-
over, an optimum shear rate was observed for each protein concentration in the
medium.
Concerning the size evolution of the nanoparticles with time, the ﬁrst results
showed that this parameter is a determinant for high protein concentrations.
For instance, for a supersaturated solution of protein, the size increases 10 times
in 100 min, ranging from 70 nm after 1 min to about 700 nm after 100 min.
This is in favor of a spontaneous nucleation which occurs as soon as the non-
solvent is added to the medium. In order to obtain a large range of nanoparticle
sizes, it now remains to resolve the stabilization of the particles whatever their
size.
In all of these abovementioned works the particle sizes of nanoparticles were
greater than 100 nm. There are currently limitations on achieving nanoparticles
with a size less than 100 nm and new developments are anticipated in the future.
5.7.2
Immunization in Animals
Preliminary experiments were performed on legumine nanoparticles in order to
evaluate the capacities of biodegradable plant protein nanoparticles as drug deliv-
ery systems. More particularly, as it is possible to think that these nanoparticulate
carriers could be considered as safe for oral or topical administrations, it was of
interest to test their potential after injection [127]. In this context, humoral and
cell-mediated responses were analyzed in rats. They were immunized with an in-
tradermal injection of legumin or legumin nanoparticles of about 250 nm. Legu-
min and legumin nanoparticles were suspended in a sterile saline solution mixed
with complete Freund’s adjuvant (CFA). A control group of rats was inoculated
only with saline solution and CFA.
Humoral responses. These responses against legumin and legumin nanoparticles
were examined by usually appropriate techniques, i.e. Western blot and ELISA
[127]. Both techniques showed that sera from rats immunized with legumin
strongly expressed antibodies against this protein. On the contrary, serum sam-
ples from rats inoculated with legumin nanoparticles did not contain detectable
amount of antibodies. Hence, legumin appears to be a potent inductor of the hu-
moral immune response, while the use of legumin nanoparticles seems able to
avoid the production of antibodies against them. However, the mechanism impli-
cated in the absence of any humoral response to the legumin nanoparticles is far
from clear. Mirshahi et al. [127] suggested some explanations: the chemical cross-
linkage with glutaraldehyde [52] may produce some irreversible conformational
changes in the protein tertiary structure making it less antigenic than the native
protein [128], glutaraldehyde release could modify the surrounding cells and thus
the lymphocyte response to antigens [129] or legumin nanoparticles were not
suﬃciently degraded to allow antigen formation during the period over which
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experiment was carried out (1 month). Work is in progress to better understand
this behavior.
Cell-mediated response. This was evaluated by in vitro lymphocyte proliferation as-
say 10 and 30 days after intradermal injection. Neither legumin nor legumin nano-
particles stimulated an immunogenic response [127]. This absence of response
may be explained by a cytostatic eﬀect of legumin. In a previous work (un-
published observations) it was noticed that legumin and legumin nanoparticles
have a suppressive eﬀect on in vitro ﬁbroblast proliferation. These observations
have to be conﬁrmed.
Taking into consideration this cytostatic eﬀect of legumin nanoparticles, it
should be interesting to use them as pharmaceutical devices for the delivery of
antitumor drugs in local cancer treatment.
Similar experimental work has to be carried out with the other plant proteins,
gliadin and vicilin, in order to explore their medical and pharmaceutical potential
as drug delivery systems.
From these in vivo and in vitro results, it can be assumed that plant proteins pos-
sess a role exceeding that of inert excipients. They have an inﬂuence on the entrap-
ment eﬃciency of the drug and compatibility with tissues (essentially gliadin). In
the future, it will be of interest to test these natural materials as encapsulating
agents for the protection of sensitive drug from degradation (peptides, insulin,
genes, etc.) and their ability to control drug release.
5.8
Conclusion
The method used to prepare all plant proteins nanoparticles was a controlled des-
olvatation method using only bioacceptable solvents. This procedure, avoiding toxic
solvents, allowed the preparation of submicronic nanoparticulate systems with a
narrow size distribution, and quite good yields and entrapment eﬃciency, making
them susceptible to scale-up and industrial use. For gliadin, either hydrophilic or
lipophilic drugs could be entrapped satisfactorily. Furthermore, gliadin nanopar-
ticles possess a high interactive potential with biological surfaces, as demonstrated
by ex vivo and in vivo animal experimentations. It appears that gliadin nanopar-
ticles are interesting oral carriers to improve bioavailability of drugs. Nevertheless,
in the future, eﬀorts should be made to obtain a complete understanding of all the
mechanisms implicated in the metabolism of these colloidal systems at the bio-
molecular level, in order to use them for medical applications.
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Chapter 12
HPTLC-MALDI TOF MS Imaging Analysis of Phospholipids
Tatiana Kondakova, Nadine Merlet Machour, and Cécile Duclairoir Poc
Abstract
Phospholipids are major and essential functional components of all living cells playing fundamental roles 
in cellular metabolism and homeostasis. At molecular level, these cell compounds function as a barrier 
between the cell and its modifying environment and play an essential role in cell adaptation to environmen-
tal stressors. In the human body, phospholipids play a role of key metabolites in many pathways, either in 
health or in disease. However, because of the development of genomics and proteomics tools at the end of 
the twentieth century, these essential for all living cells molecules remain to be investigated in more detail. 
In this effort, we adopted a protocol, using MALDI-TOF MS Imaging coupled to HPTLC, to screen a 
large number of phospholipid classes in a short span of time. This method set the stage for future studies 
aimed at better deﬁning the diversity and roles of phospholipids in all living cells.
Key words Lipidomics, Phospholipids, Mass spectrometry imaging, HPTLC MALDI TOF MSI
1 Introduction
Despite an excessive development of proteomics and genomics 
tools caused by the emergence of molecular biology techniques at 
the end of the twentieth century, there is also a growing interest in 
the analysis and identiﬁcation of lipids [1]. All living cells, prokary-
otic, as well as eukaryotic contain a myriad of lipids, whose roles 
are still poorly studied. Although a considerable diversity of lipid 
structures exists, most predominant are phospholipids (PLs) [2]. 
PLs are described as acylated derivatives of sn-glycerol-3-phosphate 
typically composed of two fatty acid chains, a glycerol unit, and a 
phosphate group linked to a polar head group [3].
PLs are the major components of all the biological membranes 
contributing to their biochemical and biophysical properties [2, 4, 
5]. In mammalian cells, PLs play several roles, being often key 
metabolites in many pathways, either in health or in disease. The 
changes in membrane PLs’ structure and composition are corre-
lated to several diseases such as diabetes [6, 7], and Alzheimer’s 
disease [8, 9]. The roles of PLs are especially remarkable in domains 
of neurology, neuro-oncology, and psychiatry. Recently, the PLs’ 
Ch3
164
contribution in depression and anxiety disorders [5], as well as in 
synaptic communication [10], was proposed. In this way, the roles 
of PLs in bacteria–host interactions should also be taken into 
account because of the possible correlation of the human micro-
biota effect on the brain function [11], and multiple strategies 
used by bacteria to exploit eukaryotic PLs [2, 12, 13].
Altogether, these investigations encouraged development of 
lipidomics and metabolomics (i.e., analysis of endogenous bio-
molecules, generally <2000 Da, in complex biological matrices) 
[14]. Mass spectrometric tools, including Matrix-Assisted Laser 
Desorption Ionization Time-Of-Flight Mass Spectrometry 
(MALDI TOF MS), are some of the most robust analytical 
methods that provide structural data for complex biological 
matrices [15, 16]. The use of MALDI TOF MS for the PLs 
analysis helps to overcome many problems related to the com-
plexity and diversity of the biological extracts, and appears as 
one of the most convenient methods to realize a complete PL 
screening [17, 18].
Here, we describe an analytical method for the PLs’ study 
based on the direct coupling High Performance Thin Layer 
Chromatography (HPTLC) to MALDI TOF MS Imaging. This 
technique, adapted for the analysis of bacterial lipids, appears as a 
universal [15, 19], rapid, and globally cheap method for the PLs 
screening in all living cells. Together with another lipidomic tech-
niques, which can be found in this volume of the Series, these 
protocols should be useful to explore the PL composition, local-
ization, and role(s) in both eukaryotic and prokaryotic cells and, 
thus, better assess the PLs functions either in health or in disease, 
elucidating, among others, the role(s) of PLs in host–parasite 
and/or host–symbiont interactions.
2 Materials
 1. Extraction solution A: CHCl3/CH3OH (1/2, v/v). Mix 
solution for ~1 min using vortexer to obtain the homogenous 
mixture (see Note 1).
 2. Chloroform (see Note 1).
 3. Water (see Note 2).
 4. Centrifuge.
 1. Elution system: CHCl3/CH3-CH2OH/H2O/N(CH2-CH3)3 
(35/35/7/35, v/v/v/v) (see Notes 1 and 3).
 2. HPTLC silica gel 60 plates F254 (75 × 50 mm, on aluminum 
backs) obtained from Merck (Darmstadt, Germany).
2.1 Phospholipid 
Extraction
2.2 High- 
Performance Thin-
Layer Chromatography 
(HPTLC)
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 3. TLC chambers (e.g., TLC TANK 80 × 120 mm from Fisher 
Scientiﬁc SAS).
 4. Primuline dye: 0.05% solution in CH3-CO-CH3/H2O, (8/2, 
v/v) (see Note 1).
 1. DHB matrix solution: 200 g/L 2,5-dihydroxybenzoic acid 
(DHB) in C2H3N/0.1% triﬂuoroacetic acid (TFA), (90/10, 
v/v) [19] (see Notes 1 and 4). 10 mL volume is recommended 
for coating of one HPTLC plate.
 2. TLC MALDI target from Bruker Daltonics (Bremen, 
Germany).
 3. Time-of-ﬂight mass spectrometer (e.g., Autoﬂex III from 
Bruker Daltonics, Bremen, Germany).
 4. TLC MALDI software (e.g., v. 1.1.7.0 from Bruker Daltonics, 
Bremen, Germany).
 5. Peptide Calibration Standard II from Bruker Daltonics 
(Bremen, Germany).
 6. MALDI Imaging software (e.g., FlexImaging software v. 2.1., 
Bruker Daltonics, Bremen, Germany).
3 Methods
The quickest and simplest method to extract PLs from living cells 
has been described by Bligh and Dyer [20] (Fig. 1). This proce-
dure could be applied to all biological materials (i.e., ﬁsh muscle 
[20], mitochondria [21], protozoa [22], and bacteria [23, 24]) 
and can be carried out in approximately 10 min. Brieﬂy, a puriﬁed 
PL extract is obtained by homogenization of samples with a mix-
ture of chloroform and methanol (CHCl3/CH3OH) in such pro-
portions that a miscible system is formed with the water in sample. 
Additional dilution with chloroform and water separates the 
homogenate into two layers, among which the lower chloroform 
layer contains PLs.
 1. To a 1 g sample (see Notes 5 and 6) add 3 mL of the extraction 
solution A and vortex during 3 min.
 2. Add 1 mL of chloroform and vortex during 1 min.
 3. Add 1 mL of water (see Note 2) and vortex during 3–5 min.
 4. Centrifuge the mixture 10 min at 3000 × g to allow the forma-
tion of the two phases (i.e., upper aqueous phase and lower 
chloroform phase).
 5. Record the lower chloroform layer in another glass tube (see 
Note 7) using a Pasteur pipette.
2.3 HPTLC-MALDI 
TOF Analysis
3.1 Phospholipid 
Extraction
Direct Read-out of HPTLC Using MALDI TOF for Study of Phospholipids
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 6. Evaporate chloroform under N2 stream (see Note 8).
 7. Measure the total lipid weight.
 8. Store the extracted lipids at −20°C under N2 atmosphere (see 
Note 9).
High-Performance Thin-Layer Chromatography (HPTLC) is the 
simplest and well-known technique used in our work to separate 
individual PL species before MS and Post Source Decay (PSD) 
analyses (Fig. 1). We routinely use HPTLC silica gel 60 plates F254, 
which allow PLs’ separation according to their polar head groups 
(HGs) and are adapted to the future MALDI analyses. Our stan-
dard procedure is described below:
 1. Wash HPTLC plate using elution system. For this, put the 
plate in a TLC chamber containing by a few mL of elution 
system and do the solvent system migration up to the top of 
the HPTLC plate (see Note 1).
 2. Activate the HPTLC plate at 110 °C during 2 h (see Note 10).
 3. To previously extracted PLs add chloroform in such a quantity 
to obtain the total PLs concentration ~1.5 mg/mL.
3.2 High- 
Performance Thin-
Layer Chromatography 
(HPTLC)
Fig. 1 Scheme illustrating the general HPTLC-MALDI TOF MSI method of phospholipid analysis. After extraction 
(a), phospholipids (PL) are separated on HPTLC plate (b) and detected using primuline spray (c), conducting to 
calculation of PL spots’ retention factors (Rf) (d). MS analysis (e) of PL spots is directly performed on HPTLC 
plate in TLC MALDI software allowing the direct PDS analyses of each PL m/z (f) and PL identiﬁcation (g). 
MALDI MS Imaging cartography of PL spots (h) is performed to study the PL distribution on HPTLC plate (i) 
according to their m/z, conﬁrming PL identiﬁcation
Tatiana Kondakova et al.
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 4. Spot 100 μL of lipid extract on the HPTLC plate by spotting 
of 2 μL 50 times (see Note 11).
 5. Separate PL spots using CHCl3/CH3-CH2OH/H2O/
N(CH2- CH3)3 (35/35/7/35, v/v/v/v) as running separation 
solution (see Note 1) (Fig. 1b).
 6. Remove HPTLC plate from the TLC chamber and dry the 
plate for 15 min using the chemical hood.
 7. Spray primuline dye on HPTLC plate and dry for 15 min 
under chemical hood (Fig. 1c).
 8. Visualize PL spots by UV ﬂuorescence at 365 nm (see Note 12) 
(Figs. 3a and 4a).
 9. Calculate the retention factors (Rf) of PL spots. For Rf calculation 
we usually use the Sweday JustTLC software (v. 4.0.3, Lund, 
Sweden) (Fig. 1d).
After separation on HPTLC plate, PLs are directly analyzed by 
MALDI TOF MS using TLC MALDI target (Fig. 2a). The 
hyphenated HPTLC-MALDI approach requires the uniform 
coverage of the TLC lanes with MALDI matrix and allows direct 
MS and PSD analyses of PLs previously separated on HPTLC plate 
(Fig. 1e and f). The mass spectrometric information is subsequently 
read out automatically using TLC software, allowing the screening 
of one sample in about 5 min. MALDI plate movement along the 
chromatographic lanes is driven by the standard movement 
mechanics of the MALDI ion source without additional robotic 
requirements. The quick analysis of PLs’ MS spectra is also possible 
thanks to an interactive MALDI Chromatogram. MALDI MS 
3.3 HPTLC-MALDI 
TOF Analysis
Fig. 2 HPTLC-MALDI coupling. (a) Scheme of TLC-MALDI adapter target. Orange and purple lines indicate the 
position of chromatographic line. (b) TLC-MALDI setup dialog
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Imaging (Fig. 1h), designed for MS analysis of tissue, is also a good 
method for mapping individual PL species distribution in HPTLC 
plates, completing analysis.
 1. Fill glass Petri dish with DHB matrix (200 mg/mL in 
C2H3N/0.1% TFA (90/10, v/v)) (see Note 4).
 2. Submerge the plate in the reservoir and remove it immediately 
(typical immersion time: 1 s).
 3. Lay the plate on a clean surface and dry it in two steps.
First step: Dry the plate with a very gentle airstream (e.g., 
use airstream close to a fume hood window) around 2 min 
until the surface becomes matt.
Second step: Dry the HPTLC plate with a hair-dryer in a 
stream of cold air vertically from above for about 90 s.
 4. Repeat matrix application and drying procedure. This time 
hold the plate on the opposite edge and blow in the second 
step for 4 min (see Notes 13 and 14).
 5. Insert the HPTLC plate into the dedicated adapter target 
(e.g., TLC MALDI target from Bruker Daltonics, Bremen, 
Germany) (Fig. 2a).
 6. Put the HPTLC plate with the target in the desiccator for a few 
minutes (see Note 15).
Automatic MALDI TOF calibration is performed in two steps.
 1. External calibration of the apparatus is performed daily in 
FlexControl software using the DHB matrix peaks and the 
Peptide Calibration Standard II (ref 822570, Bruker Daltonics, 
Bremen, Germany) covering a mean mass range between 200 
and 3500 Da (see Note 16).
 2. Internal calibration was performed to calibrate the acquired 
spectra in TLC MALDI software and made using two DHB 
matrix peaks at 171.2 m/z and 273.0 m/z.
 1. Using TLC MALDI software, delimit the position of PL spots 
and deﬁne the number of laser shoots per point (we routinely 
use 200 laser shoots per point). Specify the distance between 
points (1 mm) (Fig. 2b).
 2. Adjust the voltage characteristics and laser power in FlexControl 
software (see Note 17). The extraction voltages are 19.50 and 
17.30 kV. The reﬂector voltages are 21 and 9.40 kV. All spectra 
are acquired in positive reﬂector mode using delayed extraction.
 3. Adjust the laser power about 30% above threshold to have a 
good signal-to-noise ratio. A major strength is needed to 
desorb lipids from silica [25].
3.3.1 HPTLC-MALDI TOF 
Coupling
3.3.2 Calibration
3.3.3 MALDI TOF 
Analysis
Tatiana Kondakova et al.
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 4. Start an automatic spectra acquisition using TLC MALDI 
software. Obtained by this technique MALDI chromatogram 
enables the rapid (about 5 min) MS analysis of each sample 
(Fig. 3c). Y-axis corresponds to the chromatographic line 
(PL spots) (Fig. 4d) and X-axis presents MS peak intensity 
(increasing m/z) (Fig. 4c). To eliminate most of the DHB 
matrix peaks, only m/z from 500 to 2000 were studied.
 5. Select and analyze the m/z of PL spots according to the peaks’ 
intensity showing on the right of TLC MALDI software and 
the MS spectra of each PL spot showing at the top of the win-
dow (Fig. 4c and d).
 6. In order to identify the PLs, PSD spectra are acquired as previ-
ously described [26]. The precursor ions are isolated using a time 
ion selector. The fragment ions are refocused onto the detector by 
stepping the voltage applied to the reﬂectron in appropriate incre-
ments. It is done automatically by using the “FAST” (“fragment 
analysis and structural TOF”) subroutine of the FlexAnalysis soft-
ware (see Note 17). The obtained MS and PSD spectra are then 
identiﬁed using the LIPID MAPS database.
Fig. 3 HPTLC-MALDI TOF MSI analysis. (a) Primuline staining of separated lipids on a HPTLC plate. (b) HPTLC 
MS readout. X- and y-axis correspond to the m/z values and the lipid spots respectively. The MS peaks’ intensity 
is presented by red-to-yellow scale. (c) HPTLC-MALDI MSI analysis of identical HPTLC plate. According MS and 
PSD analyses, PL spots are reconstructed by color-labeling according to their m/z
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 1. Using FlexImaging software deﬁne a polygon measurement 
region as the HPTLC line of each sample from the PL extract 
depot to the solvent front.
 2. Acquisition method settings: we recommend averaging 500 
single laser shots for each mass spectrum (raster width 200 μm). 
Multiple additions of single position acquisition run (every 40 
shots) are employed to obtain a minimal spectrum intensity 
scale of 104 ion counts. The obtained spectra are automatically 
smoothed and baselined to limit the background noise. The 
voltage characteristics and laser power are stetted as previously 
described (see Sect. 3.3.3).
 3. Start spectra acquisition.
 4. After the end of spectra acquisition, edit the mass ﬁlters for PLs 
according to their m/z identiﬁed previously (see Sect. 3.3.3) 
(Figs. 3b and 4b).
3.3.4 HPTLC-MALDI TOF 
Imaging
Fig. 4 HPTLC-MALDI TOF MS analysis of phosphatidylglycerol (PG). PG [16:0/18:1] with observed m/z 793.5, 
corresponding to PG [M + 2Na]+, is shown as an example. (a) Primuline straining of separated lipids on a 
HPTLC plate. Rf of PG spot = 0.62 ± 0.03 (blue circle). (b) HPTLC-MALDI MSI analysis of identical HPTLC plate, 
showing the PG spot (m/z 793.5, rose spot in blue circle). (c) MS spectrum of Rf = 0.62 allows identiﬁcation of 
of PG at m/z 793.5 (blue dashed line). (d) Extracted ion chromatogram showing the intensity of PG peak at m/z 
793.5. The (c) and (d) data are combined in the MALDI Chromatogram
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4 Notes
 1. All chemicals are of the highest commercially available purity 
and used without any further puriﬁcation. Solutions are best 
prepared in advance and conserved at room temperature.
 2. We recommend using ultrapure HPLC grade water.
 3. Elution system should be colorless and transparent.
 4. DHB is selected as a MALDI matrix because of high signal 
strength and the absence of matrix adduct peaks. PSD analysis 
with DHB matrix allows the cleavage of phosphate-glycerol bond 
and induces the loss of the hydrophilic head group, i.e., 
[M-HG + H]+, characteristic of each lipid class. This loss is caused 
by a positive charge localized on the phosphate group [27].
 5. For phospholipid extraction, we routinely use lyophilized sam-
ples. However, Blight and Dyer’s method is also adapted for 
samples, containing 80 ± 1% water and 1% lipids [20].
 6. For tissues’ study, we highly recommend homogenizing the 
sample before lipid extraction.
 7. A small volume of the chloroform layer must be let with 
aqueous phase. We usually prefer to lose a few microliters of 
chloroform phase rather than risking contaminating PL stocks.
 8. Chloroform evaporation is necessary to unsure (1) the same 
volume in each lipid sample and (2) the correct condition for 
PLs’ storage. Diluted in chloroform PLs are easer oxidized 
during storage than dried ones.
 9. The usual PLs’ storage time is about 6 months.
 10. “Activation” is evaporating the water in the silica. The silica gel 
is hygroscopic, so it adsorbs water vapor from the air and 
becomes hydrated. This hydration in turn, can alter chroma-
tography and interaction of solvent system with sample.
 11. All analyses are done in triplicate. We routinely spot three PL 
extracts on the same HPTLC plate analyzing three replicates at 
the same time.
 12. Primuline binds noncovalently to the apolar fatty acyl residues 
of lipids and does not affect a subsequent MS analysis [28].
 13. With two dips you get a mass occupancy of about 5 mg/cm2. 
To date, good results have been achieved by dip-coating twice. 
Every additional coating requires longer drying time and more 
repetitions can cause bleeding between the separated bands.
 14. After the matrix coating the HPTLC plate should look smooth 
and ﬂat. If the surface looks rough and blistered either the 
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organic solvent concentration in the matrix solution was too 
low or the drying process was not quick enough.
 15. Desiccation of the HPTLC plate is likely to quickly create a 
vacuum in mass spectrometer.
 16. We usually do the external calibration just before starting 
HPTLC-MALDI analysis. Thus, 1 μL of the Peptide 
Calibration Standard II is directly spotted on the TLC MALDI 
target and coated by the 1 μL DHB matrix.
 17. The system utilizes an Autoﬂex III mass spectrometer equipped 
with a laser OptibeamTM Nd/YAG (355 nm) with 200-Hz 
tripled-frequency (Bruker Daltonics, Bremen, Germany).
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Abstract
Nitrogen oxide (NOx) species represent ones of the most threatening air pollutants due 
to their prevalence and harmful impact on the environment and human health. The term 
NOx gathers mainly nitric oxide (NO) and nitrogen dioxide (NO2), mostly produced by 
anthropogenic activities such as transport and industries. Several cellular constituents 
were already described as NOx targets. These include membranes, proteins, respiratory 
chain enzymes, lipids, and DNA. Such damages lead to pathologies of lungs, cardio-
vascular system, and skin because these organs represent the first barrier toward the 
environment. On the other hand, NOx is also naturally synthetized by several organ-
isms, playing a mediator role in essential cellular functions. However, few data are yet 
available on NOx activity toward microorganisms. Here, we review data concerning the 
double face of NOx, including their use in the medical field against pathogens’ infections 
that highlight the versatility of these compounds.
Keywords: NOx, pollutants, signalization, physiopathology, treatment
1. NOx species: the genesis of a major air pollutant
“Yet, pollution is the largest environmental cause of disease and death in the world today, 
responsible for an estimated 9 million premature deaths” stated The Lancet Commission in 
2017. This phenomenon represents an alarming threat for human health, as a major cause 
of respiratory and cardiovascular pathologies as well as infertility. Moreover, those atmo-
spheric pollutants have severe impacts on the environment and participate in climatic change, 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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acidification, eutrophication, and ecosystem disturbances. Several international and national 
organizations (e.g. WHO, EEA, and INERIS) aim at reducing the global emission of pollut-
ants, thanks to environmental policies as Kyoto and Gothenburg protocols signed in 1997 and 
1999, respectively. After that, an encouraging decrease in air pollutants’ levels was measured 
between 2000 and 2015 [1].
Atmospheric pollutants can be classified into four families: classical, indoor, and organic or 
inorganic air pollutants. Among the classical ones, which are the principle in amount, sulfur 
dioxide (SO2), particle matter, ozone (O3), and nitrogen oxide (NOx) species are found [2]. 
The term NOx refers to a wide range of nitrogen-derived compounds, where nitric oxide 
(NO) and nitrogen dioxide (NO2) are predominant [3]. Those compounds can be naturally 
produced at low level by lightnings [4] and volcanic eruptions [5]. However, NOx is mainly 
generated by anthropogenic activity (e.g., road transport, energy production, industry, and 
agriculture) (Figure 1) [6].
Even if NO and NO2 represent the main species of NOx, nitrogen exists in several oxidation 
states in the environment, from N (−III) to N (+V). NO takes a central place in the series of 
reactive nitrogen species (RNS) [7]. Oxidation and reduction of NO result in the formation of 
several RNS, including nitrate or ammonium. NO2 is formed by the reaction of NO with O2 
and can be dimerized to give N2O4. The formed reactive species can, in turn, be involved in a 
wide range of reactions (Figure 2).
Nitrogen is an essential constituent of vital macromolecules (nucleic acids and proteins). This 
atom also constitutes the dinitrogen (N2) gas, usually abbreviated nitrogen. This gas repre-
sents 78% of atmospheric air and is continuously recycled in our environment. First, the atmo-
spheric nitrogen is fixed in the soil by prokaryotes to form ammonia (NH3), which could be 
taken up by plants. NH3 is then converted into ammonium (NH4+). Ammonium could be also 
Figure 1. NOx sources linked to anthropogenic activities (according to [1]).
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formed by mineralization of organic matter by decomposers (fungi, worms, and prokaryotes). 
The second part of the nitrogen cycle is the nitrification of ammonium by prokaryotes leading 
to nitrite (NO2−) formation, which is then further oxidized into nitrate (NO3−). Finally, nitrate 
could be assimilated by plants for their growth or converted into N2 by denitrifying bacteria 
(Figure 3).
Moreover, nitrogen is also the precursor of NOx. Indeed, NOx formation can be separated 
into four steps. First, NO is formed in the atmosphere in combination with nitrogen, resulting 
from the global biogeochemical nitrogen cycle, and oxygen, following combustion (natural or 
anthropic). Then, this highly reactive compound can be oxidized by oxygen (O2) to form NO2. 
Alternatively, nitrogen dioxide can also be directly formed through catalytic ammonia com-
bustion or nitrosyl chloride oxidation. Then, a temperature-dependent equilibrium is estab-
lishing between NO2 and its dimeric form, nitrogen tetroxide (N2O4−). Finally, a photochemical 
reaction between NO2 and hydroxyl radicals leads to the generation of ozone (O3−) (Figure 4).
Even if NO and NO2 are classified as RNS, their characteristics are very different suggest-
ing their diverse behavior and reactivity. For example, the solubility of NO is very low 
Figure 2. Redox relationships of NOx with other RNS. Black arrow: oxidation and reduction of NO; purple arrow: a 
wide range of reactions; roman numbers: oxidation state of the nitrogen atom; color gradient: reduction/oxidation state 
from (−III) to (V).
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(5.7 × 102 g/L), and NO2 is highly reactive in water resulting in the formation of HNO2 and 
HNO3 [8]. Moreover, the half-life time of those compounds highly differs because NO2 
half-life is around 35 h, whereas that of NO is almost impossible to determine because of 
its high reactivity [9]. The permeability of both compounds is also totally unrelated: NO 
has a lipophilic behavior with consequently a high-membrane permeability. This can be 
illustrated by the high-diffusion ability of NO toward the membrane. Conversely, the per-
meability coefficient of NO2 is estimated about 5 cm s−1 suggesting a lower diffusion power 
toward biological membranes [10]. In spite of these differences, the penetration of NO and 
NO2 inside cells and their high reactivity are at the origin of their pathogenic potential on 
human health, particularly when physiological elimination thresholds are exceeded. Since 
skin, respiratory tract, and lungs are the first barrier toward those gases, these organs 
are evidently the principle targets of these compounds and their derived species [11–13]. 
However, their diffusion deeper in the organism can lead afterward to other severe effects, 
for instance, on the cardiovascular and immune systems [12, 14]. Human health effects 
range from reversible (nausea, breathing difficulties, and asthma symptoms) to irreversible 
(cardiovascular defects, emphysema, and immunopathologies), including cancer induc-
tion in the worst cases (Figure 5) [15].
Figure 3. Nitrogen cycle at the interfaces among air, soil, and ecosystem. (1) Fixation of gaseous nitrogen by prokaryotes 
leading to ammonia (NH3) and ammonium (NH4+); (2) nitrification of NH4+ by prokaryotes resulting in nitrite formation 
(NO2−) subsequently oxidized into nitrate (NO3−); (3) denitrifying prokaryotes catalyzing the conversion of nitrate into 
gaseous N2.
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Thanks to epidemiological and clinical studies, thresholds of NO and NO2, whose chemical 
structure and conversion factors are represented Figure 6A, have been determined for dif-
ferent human health effects (Figure 6B and C, respectively). However, no guideline values 
are available for NO (Figure 6D) due to its complete and rapid reaction [16]. Thus, in order 
to limit health issues, international organizations, such as WHO, set up guidelines for atmo-
spheric NO2 limit value (Figure 6E).
NOx is then highly toxic compounds and has a myriad of deleterious impacts on the human 
physiology when the bearable thresholds are exceeded. However, NOx is also naturally pro-
duced by cellular processes in a wide range of living organisms. In this case, NOx can have 
totally different effects as discussed later.
Figure 4. Atmospheric genesis of NOx (adapted from [3]).
Figure 5. Representation of NOx targets and associated pathologies [11–15].
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2. The double face of NOx in the eukaryotic world
To better understand why NOx impact on so many organs, it is essential to focus on the units 
forming each part of our body: the eukaryotic cells themselves.
2.1. Exogenous NOx: a hostile intruder inside the eukaryotic cells
Much work was already performed on NOx targets at the cell scale. NO and NO2, thanks to 
their chemistry properties mentioned earlier, are highly diffusible through living membranes 
and exhibit a strong reactivity. It is easy to imagine the potential of such compounds. Since 
NO is highly reactive in lipophilic media, it can react inside the lipid bilayer, first protection 
of cells against the environment. Indeed, polyunsaturated fatty acids (PUFAs) are susceptible 
to NO in the presence of O2 and ONOO− [17]. The interaction of these toxic compounds with 
PUFA double bounds leads to the formation of nitrated FA. This process is considered as a 
protective strategy because it redirects O2− and ONOO−-mediated cytotoxic reactions to other 
oxidative pathways. Post-translational modification of several proteins is also observed in 
the presence of NOx and RNS. For example, tyrosine nitration on phenol residue mediated 
by peroxynitrite derived from OH and NO2 leads to 3-nitrotyrosine formation [18]. This mol-
ecule represents a useful biomarker of nitrosative stress in various pathologies such as ath-
erosclerosis [19]. Protein thiol residues are highly susceptible to NO and ONOO− leading to 
the formation of nitrosothiol (RS-NO) and nitrothiol (RS-ONO), respectively [20]. This revers-
ible modification modulates the activity of several proteins similar to phosphorylation. For 
example, S-nitrosylated cysteine thiol residue can be denitrosylated by S-nitrosoglutathione 
reductase or thioredoxin systems [21]. NO and other RNS can also nitrosylate [Fe─S] cluster 
of transition metal centers, which are essential for protein function. This modification can acti-
vate a wide range of enzymes such as the soluble guanylate cyclase (sGC) mentioned below 
Figure 6. Key features concerning NOx. (A) Lewis structure of NOx and conversion factors; (B) NO threshold (ppm) 
according to [9]; (C) NO2 threshold (ppm) according to [9]; (D) and (E) NO and NO2 guideline values, respectively, 
according to [1]. ppm, parts per million; ND, not determined.
Emerging Pollutants - Some Strategies for the Quality Preservation of Our Environment24
Ch4
[22]. On the contrary, this reaction can also alter the protein function, for example, in the case 
of hemoglobin [23]. NO and other higher RNS products (ONOO− or NO2) are able to generate 
nitration, nitrosation, or deamination reactions on DNA bases leading to mutagenesis [24]. 
This phenomenon is enhanced by the inhibition of DNA repair triggered by NO [25]. More 
recently, a role of NO in epigenetic modification was suggested. To be more precise, this 
simple molecule seems to modulate histone acetylation and methylation through direct and 
indirect modulations of histone acetyltransferases and deacetylases, lysine demethylases, his-
tone methyltransferases activity, thus modifying the expression of several genes [26]. These 
pleiotropic activities of NO and derived compounds highlight here the necessity of fine regu-
lation pathways to prevent the development of several diseases.
2.2. Endogenous NO: an essential mediator of cellular signalization
Interestingly, NO can also be produced by several living organisms: plants, animals, and bac-
teria, thanks to a specific enzyme called nitric oxide synthase (NOS) [27, 28]. The large distribu-
tion of this enzyme through the different reigns emphasizes the importance of NO synthesis. 
Evolutionary studies highlight the necessity for the first living organisms during primitive era 
to eradicate toxic O3 present in the paleoatmosphere as a survival strategy. Indeed, the libera-
tion of gaseous NO in extracellular environment could have subsequently neutralized O3, thus 
limiting harmful oxidative reactions [29]. In eukaryotic cells, three isoforms of NOS have been 
described [30]. The neuronal nNOS (NOS-1) and the endothelial eNOS (NOS-3) are constitutively 
expressed but are only activated through calcium-dependent mechanisms. The third one is the 
inducible iNOS (NOS-2) expressed in macrophages following infection by pathogens, virus, or 
tumors. Contrary to NOS-1 and 3, NOS-2 is constitutively functional. Interestingly, these NOSs 
have high structural similarities with an oxygenase and a reductase domain (Figure 7) [27].
To be fully functional, NOS requires to associate with homodimers, and this form of NOS is 
crucial for the generation of NO [32]. When conditions are favorable (high level of l-arginine 
Figure 7. The structural similarities of NOS (adapted from [31]). BH4, tetrahydrobiopterin; l-arg, l-arginine-binding 
site; Heme Fe, iron protoporphyrin IX; CaM, calmodulin-binding site; FMN, flavin mononucleotide-binding site; 
FAD, flavin adenine dinucleotide-binding site; NADPH, nicotinamide adenine dinucleotide phosphate-binding site; *, 
palmitoylation and myristoylation of eNOS oxygenase domain.
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and cofactors like BH4), this enzyme catalyzes the conversion of l-arginine into l-citrulline 
using O2 and leading to NO formation with a ratio of 1:1 [33]. However, if these parameters 
are not available or if NOS remains monomeric, the enzyme only produces superoxide (O2−) 
[32]. Even if NOS isoforms catalyze the same reaction, their distribution is largely related to 
their respective functions.
2.2.1. The endothelial eNOS and vasodilatation
Endothelial nitric oxide synthase (eNOS) can be activated through calcium-dependent and 
independent pathways. On the one hand, through activation of specific receptors, such as 
acetylcholine muscarinic receptors, bradykinin receptors, and H1 histamine receptors, dis-
tributed in the endothelial cell membrane, agonists can trigger an increase in intracellu-
lar concentration of calcium (Ca2+) through the well-known polyphophoinosides pathway. 
Indeed, activation of those receptors stimulates membrane-associated PLCϒ and PI3K acti-
vation. This results into inositol trisphosphate (IP3) formation, which induces the release of 
intracellular calcium stock from endoplasmic reticulum [34]. Then, Ca2+ binds to calmodu-
lin (CaM), which could later fix on the calmodulin-binding domain of eNOS controlling 
its enzymatic activity. On the other hand, in response to hormones or growth factors act-
ing on their corresponding receptors, phosphate kinase A (PKA) or B (AKT) pathway can 
be induced mediating a phosphorylation cascade. The post-translational phosphorylation 
of eNOS on three specific sites (Ser617 and Ser1179 for AKt, Ser635 and Ser1177 for PKA) 
enhances the activity of the enzyme [35]. Moreover, the lipidation of eNOS (palmitoylation 
and myristoylation) could also enhance its activity [36]. This other post-translational modi-
fication promotes eNOS association with cell membrane and is stabilized by interaction with 
membrane chaperone proteins (caveolin-1 and HSP70/90). Both mechanisms are essential 
for linking upstream signal transduction pathway to eNOS activity in cells [37]. eNOS could 
then produce a large amount of NO, which latter diffuses freely inside smooth muscles. 
Herein, NO activates soluble guanylate cyclase (sGC) by reaction with the heme of the 
enzyme leading to the increase of cyclic guanosine monophosphate level (cGMP). cGMP 
subsequently activates phosphate kinase G (PKG) favoring a cytosolic Ca2+ reuptake into 
sarcoplasmic reticulum [38]. The decrease of intracellular level of Ca2+ leads to the relaxation 
of smooth muscle. Moreover, NO can inhibit caspases 3 and 8 and thus apoptosis through 
protein nitrosylation. NO released by endothelium is also reducing platelet aggregation and 
platelet or leukocyte adhesion (Figure 8) [39, 40].
Another source of NO inside endothelial cells was also described. Indeed, nitrite and 
nitrate reservoirs could be converted into NO by several enzymes such as cytochrome 
P450, hemoglobin, myoglobin, and others, under specific conditions [42]. However, 
several pathways could abolish NO production. Indeed, NO can be eliminated in com-
bination with reactive oxygen species (ROS). eNOS could be inactivated by several 
phosphatases. The removal of eNOS membrane sequestration by interaction between 
NOS-interacting protein (NOSIP) and NOS-traffic inducer (NOSTRIN) complex favors 
eNOS recycling [36]. Since NO plays a central role in this phenomenon, any abnormality 
altering its production leads to pathogenesis and vascular disorders such as atheroscle-
rosis and hypertension [43].
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2.2.2. The neuronal nNOS: a crucial element in neurotransmission
nNOS, also called NOS-1, was the first isoform discovered in the neuronal tissue. It should 
be distinguished between two subfamilies: nNOSα and nNOSμ, thanks to their locations and 
functions. Indeed, nNOSα is found in central nervous system and plays a major role in the 
neurotransmission at neuronal synapses, whereas nNOSμ is found in skeletal and cardiac 
muscle where NO controls muscle contractility and local blood flow.
2.2.2.1. nNOSα in the central nervous system
Glutamate is the major excitatory neurotransmitter in the brain. When deliver into the syn-
apse, this molecule is activating a specific receptor (NMDAR) located inside the postsynap-
tic membrane. Activated NMDAR thus allows the entry of calcium. Ca2+ are able to activate 
calmodulin by physical interaction [44]. Afterward calmodulin binds to nNOSα, which, in 
turn, is activated. Interestingly, nNOSα can indirectly interact with the NMDAR through its 
fixation on an adapter protein PSD95 by their PDZ interaction domain [45]. This allows the 
high speed of NO synthesis in response to NMDAR activation. Thereafter, NO can diffuse 
back to the presynaptic area leading to an increase glutamate release in the synaptic cleft and 
thus neurotransmission. CAPON, a chaperon protein of DexRas, was found altering the level 
Figure 8. Physiology of vasodilatation: implication of eNOS and NO (adapted from [41]). eNOS, endothelial nitric oxide 
synthase; ach, acetylcholine; BK, bradykinin; H, histamine; R, receptor; CaM, calmodulin; PLCϒ, phospholipase C ϒ; 
PI3K, phosphoinositide 3-kinase; PKA, phosphate kinase A; AKT, phosphate kinase B (PKB); sGC, soluble guanylate 
cyclase; cGMP, cyclic guanosine monophosphate; PKG, phosphate kinase G; A, protein complex of HSP70, HSP90, and 
caveolin-1; NOSIP, NOS-interacting protein; NOSTRIN, NOS traffic inducer.
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of nNOSα present at the membrane [46]. Indeed, CAPON competes with the PDZ domain 
of nNOSα and thus promotes its detachment from the NMDAR-PSD95 complex. nNOSα 
interaction with CAPON-DexRas complex allows the activation of DexRas, a small protein 
G, through s-nitrosylation on its thiol residue [47]. Then, DexRas activates the MAPK cascade 
and the transcription of several genes [47]. Several shutdown systems are available to limit 
this process, which could dramatically affect the brain physiology by synapses hyperactiva-
tion. Indeed, kinases, such as PKC or PKII, can phosphorylate nNOSα leading to its loss of 
activity [48]. nNOSα can also be sequestrated by two membrane proteins (caveolins 1 and 3) 
preventing its interaction with calmodulin (Figure 9).
As mentioned above, any disorder affecting NO synthesis can lead to dramatic consequences 
in the brain. Indeed, a lack of NO could impair the neurotransmission and hence the neuronal 
plasticity, such as long-term potentiation (LTP) in the hippocampus or long-term depression 
(LTD) in the cerebellum [50]. NO ensures also the correct irrigation of brain by its vasodilator 
effect on peripheral blood vessel. The synthesis of NO can be altered by a deficiency or a loss of 
activity of nNOS. Other regulatory elements, such as the decrease of l-arginine precursor avail-
ability or cofactors crucial for the catalytic activity of NOS, contribute also to nNOS inactivation. 
Conversely, in some several brain pathologies (ischemia, strokes, neurodegenerative disorders 
including Parkinson’s and Huntington’s diseases, and amyotrophic lateral sclerosis), a large 
amount of NO is produced [51]. It is hypothesized that NO or derived nitrogen species interact 
with various proteins inducing several toxic effects. Thus, pharmacological regulation of NO 
synthesis offers important strategies for the treatment of neurodegenerative and muscle diseases.
2.2.2.2. nNOSμ in peripheral neurotransmission
On the other hand, nNOSμ is located in skeletal and cardiac muscle where NO controls mus-
cle contractility and local blood flow essential to support muscular effort. When the excitatory 
neurotransmitter acetylcholine (Ach) is released at the neuromuscular junction, it is activating 
specific acetylcholine nicotinic receptors present on muscle cells [52]. Activation of these recep-
tors allows the release in the cell sarcoplasm of calcium from exogenous and/or endogenous 
Figure 9. The neurotransmission mediated by NOSα in central nervous system (CNS) (adapted from [49]). Glu, 
glutamate neurotransmitter; NMDAR, N-methyl d-aspartate type-glutamate receptor; A, PSD95 protein adapter 
between nNOSα and NMDAR; CaM, calmodulin; PKC, phosphate kinase C; PKII, Ca2+/CaM-dependent protein kinase 
II; CaN, calcineurin; CAPON, C-terminal PDZ domain ligand of neuronal nitric oxide synthase; MAPK, mitogen-
activated protein kinase.
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sources. This process is also enhanced by the activation of a voltage-dependent Ca2+ channel 
(CaCn) [53]. The increase of Ca2+ from exogenous origin activates ryanodine receptor present 
on the sarcoplasmic reticulum, which, in turn, delivers a large amount of Ca2+. When the Ca2+ 
threshold is reached, it is binding on the calmodulin protein. Calmodulin can then interact 
with the nNOSμ to activate the generation of NO. Interestingly, nNOSμ interacts through 
its PDZ domain with adapter proteins (syntrophins) linked to a membrane protein complex 
called dystrophin [54]. Produced NO could then diffuse back to the motor neuron to enhance 
the liberation of neurotransmitters or the vasodilatation of blood vessels, thus increasing the 
local blood flow to support muscle needs during contraction efforts (Figure 10) [55].
NO synthesis is also well regulated by calpain (Calp). Indeed, this protein interacts with the 
PDZ domain nNOSμ provoking its detachment from the dystrophin/syntrophin membrane 
complex [56]. Interestingly, in muscular Duchenne dystrophy, the damages caused by dystro-
phin absence are enhanced in case of simultaneous lack of nNOSμ [57]. Thus, NO donors may 
offer a potential avenue for therapy.
2.2.3. The inducible iNOS and the innate immunity
NO also takes an important part in innate immunity. Indeed, NO and derived compounds 
are cytotoxic weapon against tumor cells, microorganisms, and viruses [58]. NO is generated 
by inducible nitric oxide synthases (iNOS and NOS2) within macrophages. However, more 
recently, studies have shown that this enzyme is also expressed in other cell line (vascular endo-
thelial cells, hepatocytes, pulmonary, and colonic epithelial cells) [59]. Unlike nNOS or eNOS, 
its expression is stimulated by several pathways after activation of specific receptors by endo-
toxins (LPS) or cytokines (TNFα, IFNϒ, and IL1β). Briefly, the LPS endotoxins are carried by 
an LPS-binding (LPB) protein to its specific Toll-like receptor 4 (TLR4). Then, the transduction 
Figure 10. nNOSμ activity at the neuromuscular junction (adapted from [49]). Ach, acetylcholine; CaCn, voltage-
dependent Ca2+ channel; AchR, acetylcholine receptor; yellow lightning symbols, membrane depolarization; Ca2+, 
calcium; RyR, ryanodine receptor; l-cit, l-citrulline; l-arg, l-arginine; CaM, calmodulin; A, syntrophin α1, β1 and β2 
adapter between dystrophin and nNOSμ; Calp, calpain.
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of the signal leads to the transcription of NF-κB [60]. This transcription factor is essential for 
the expression of iNOS gene. On the other hand, cytokines produced by infected cells activate 
pathways responsible for the expression of several transcription factors (NF-κB, AP1, and IRF1) 
also involved in the transcription of iNOS [61]. Both pathways are necessary to fully upregulate 
iNOS expression. Moreover, iNOS is constitutively active and exhibits a high affinity for calcium 
explaining its Ca2+-independent activity. iNOS produces a large amount of NO until substrate 
depletion [62]. Then, NO acts directly or through derived compounds (mostly ONOO− and NO2) 
generated through the reaction of NO with ROS formed by NADPH oxidase. These molecules 
can be generated inside (phagosome) or outside the cells. Altogether, NO and derivatives could 
act in synergy on several components within the targeted hostile elements such as proteins (thi-
ols, metal centers, and tyrosine residues), nucleic acids, and lipids [63, 64]. Altogether, these 
modifications lead to irreversible damages impairing cellular metabolism and ultimately inhibit 
growth and replication mechanisms and even cell death (Figure 11).
After infection, NO generation is abolished by neutralization of iNOS activity. Indeed, iNOS 
undergoes a posttranslational modification called polyubiquitination leading to its proteasomal 
degradation. Physiological aggresome, an alternative pathway for protein degradation, is also 
involved in iNOS inactivation [66]. The degradation of NO can also be modulated by its own 
interaction with ROS. The depletion of l-arginine precursor also shuts down iNOS activity.
Overexpression of iNOS is observed during chronic infection leading to an excessive level 
of NO and RNS. This phenomenon can impair the host physiology because these high reac-
tive compounds represent mutagenic sources. Thus, the NO balance is a crucial point to 
Figure 11. Implication of iNOS in the innate immunity (adapted from [65]). IFNϒ, interferon ϒ; IFNR1/2, IFNϒ receptors 
1 and 2; JAK, Janus kinase; STAT, signal transducer and activator of transcription; IRF1, interferon response factor 1; 
IL1β, interleukin 1β; IL1R, IL1β receptor; MAPK, mitogen-activated protein kinase; JNK, C-Jun N-terminal kinase; 
ERK, extracellular signal-regulated kinase; AP1, activator protein 1; TNF-α, tumor necrosis factor α; TNFR, tumor 
necrosis factor receptor; NF-κB, nuclear factor κB; TLR4, Toll-like receptor 4; CD14, cluster of differentiation 14; LPS, 
lipopolysaccharide; LPB, LPS-binding protein; ROS, reactive oxygen species.
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control in order to limit its tumorigenic potential. The development of iNOS inhibitors and 
NO-releasing agents offers interesting therapeutic strategies to struggle against cancer and 
microbial infections.
3. NOx versus prokaryote: “Catch me if you can”
3.1. NOx at the center of prokaryotic life, virulence, and death
Several environmental, commensal, and pathogenic prokaryotes possess an arsenal of pro-
teins dedicated to the nitrogen metabolism under anaerobic conditions [67]. Indeed, an enzy-
matic chain is involved in the denitrification pathway responsible for the production of NO 
through nitrite reductase (NIR) as an intermediate. The outcome of this mechanism is the 
formation of dinitrogen (N2). This process is crucial for the growth of bacteria in the absence 
of oxygen because it is coupled with ATP generation (Figure 12).
Interestingly, a shortened NOS-like protein called bNOS was discovered in Gram-positive 
bacteria [28]. This enzyme is deprived of the classical reductase domain already described in 
other NOS isoforms. However, bNOS is able to recruit other proteins exhibiting a reductase 
catalytic activity [69]. Similar to mammalian isoforms, bNOS catalyzes the production of NO 
using l-arginine precursor. However, NOx is key elements in the innate immunity to avoid 
infection. Indeed, similar to eukaryotic cells, prokaryotes are also sensitive to NOx activity. 
Thence, such compounds could alter DNA, proteins, and metal centers leading to severe alter-
ations of bacterial growth and replication.
As previously described, NO could be endogenously produced by bacteria but is also a pow-
erful exogenous antimicrobial agent. This highlights the requirement of systems to manage a 
bearable threshold of NOx within the cell. First, bacteria have developed NO sensing system 
Figure 12. Bacterial nitrogen cycle (adapted from [68]). NO3−, nitrate; NO2−, nitrite; NO, nitric oxide; N2O, nitrous oxide; 
N2, dinitrogen; NH2OH, hydroxylamine; NH4+, ammonia; NAR/NAP, nitrate reductase; NIR, nitrite reductase; NOR, 
nitric oxide reductase; N2OR, nitrous oxide reductase.
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through non-heme iron cluster conjugated with a wide range of detoxification mechanisms. 
Several pathways involving reaction of NO with non-heme iron cluster were described, mainly 
in Escherichia coli [70]. Indeed, NO can lead to a raise of the repression of sulfur assimilation 
operon (suf) exerted by ferric uptake regulator protein (Fur). This reaction is mediated by Fur 
nitrosylation through NO-derived S-nitrosoglutathione (GSNO). Suf products are required 
for the biogenesis of the [Fe─S] cluster, which, in turn, gives a lure to get rid of NOx collat-
eral damages. The flavohemoglobin (hmpA) is another response against the nitrosative stress. 
This enzyme catalyzes the conversion of NO into nitrous oxide (N2O) under anaerobic condi-
tions. Interestingly, in the presence of NO, the S-nitrosylation of cysteine residues on MetR 
and FNR inactivates both the proteins. Thus, the repression exerted by MetR and the fumarate 
and nitrate reductase regulatory protein (FNR) is raised by hmpA allowing its transcription. 
Furthermore, NO-responsive transcriptional factor (NorR) is directly activated by NO and 
enhances the expression of NorVW protein catalyzing the reduction of NO into N2O. Redox-
sensitive cysteines also take part in the NO-sensing systems. Indeed, NO-activated superox-
ide regulon (SoxR) protein leads to the transcription increase of superoxide dismutase (sodA) 
removing O2− that may react with NO to form NO2 and ONOO− [71]. Similar to SoxR, peroxide 
regulon (OxyR) protein is activated by S-nitrosylation. This protein induces gene expression 
for protective products against nitrosative stress at least by limiting the S-nitrosylation [72]. 
For example, the expression of catalase KatA, which could buffer free NO, is activated by 
OxyR [73]. Altogether, these sensing systems lead to the efficient detoxification by generation 
of less toxic compounds or scavenger molecules.
Moreover, bacteria also develop repairing system of DNA and [Fe─S] cluster damages related 
to nitrosative stress. Similar to eukaryotic cells, five DNA repair pathways are available in 
prokaryotes. Among them, the base excision repair (BER), to repair deaminated base, and 
the nucleotide excision repair (NER), to remove cross-linking in DNA, are predominant [74]. 
Concerning the [Fe─S] cluster repair, the iron sulfur cluster S protein (IscS), a cysteine desul-
furase, can denytrosylate these protein clusters in the presence of l-cysteine [75]. Moreover, 
Isc regulator (IscR) protein is able to sense nitrosylated [Fe─S] cluster and thus enhances the 
formation and/or repair of [Fe─S] cluster [76, 77].
NO could also alter tricarboxylic acid (TCA) metabolic pathway and bacterial respiration 
through reaction with aconitase and cytochromes of the electron transfer chain, respectively 
[78]. However, these mechanisms are crucial for the generation of ATP and hence the ener-
getic needs of bacteria [79]. To counteract the inefficiency of this enzyme, some bacteria are 
able to reprogram their metabolism. For example, Pseudomonas spp. uses the citrate lyase, 
phosphoenolpyruvate carboxylase, and pyruvate phosphate dikinase to convert citrate into 
pyruvate and ATP [80].
In nonlethal concentrations, NO interplays a signaling role in bacteria through several proteins 
possessing heme-nitric oxide/oxygen-binding domain and is referred under the name H-NOX 
proteins. H-NOX exhibits a highly conserved domain among bacteria and also shared in mam-
mals (sGC) [81]. All H-NOX are histidine-ligated protoporphyrin IX hemoprotein able to fix 
NO on its ferrous iron. The H-NOX-encoding genes are found in operons with diverse bacte-
rial signaling genes [82], whose majority is now divided in two classes: containing (i) histidine 
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kinase (HK) or (ii) diguanylate cyclase (DGCs) and phosphodiesterase (PDE). H-NOX could 
modify the function of proteins implicated in virulence such as biofilm formation and motility 
or even quorum sensing [83]. For example, H-NOX alters the function of diguanylate cyclase 
and enhances the phosphodiesterase activity. Altogether, this leads to the biofilm dispersion 
through the decrease of c-di-GMP, an essential mediator in this process. On the contrary, a 
more sophisticated system relative to histidine kinase (HnoK) activity leads to the accumula-
tion of c-di-GMP in response to NO favoring the biofilm adhesion and formation. Another 
important virulence trait could be also modulated by H-NOX as in Vibrio species a cross-talk 
with QS seems to exist. However, a few studies are yet available.
More recently, an antibiotic resistance modulation was promoted by a bacterial NO2 gaseous 
exposure. Indeed, an upregulation in expression of MexEF-OprN efflux pump was observed 
coupled with an increase in related antibiotic resistance [84]. The link between NO2 and this 
efflux pump is yet not established, but the authors suggest here a potential role of this protein 
in the releasing of NOx outside the cells. Previous studies also highlight a correlation between 
NO endogenously generated by bNOS and increase aminoglycoside resistance [85]. NO and 
NO2 could directly interact with antibiotic leading to a less toxic compound and exerted a 
repression of bacterial respiration preventing drug uptake.
To resume, bacteria are able to produce NO and RNS. Following endogenous burst or exog-
enous aggression (pollution, inflammation reactions), a physiological threshold is exceeded. 
However, bacteria developed an ingenious system to counteract the potential effects of NO 
and derived products. Various interconnected signaling pathways are implicated in this phe-
nomenon: (i) NO detection, (ii) detoxification, (iii) repairing mechanisms, and (iv) metabolic 
reprogramming. Finally, these fundamental modifications modulate bacterial community 
behavior (QS) and virulence traits, such as biofilm and antibiotic resistance. This last point is 
particularly attractive in medicine. Indeed, the emergence of several antibiotic multiresistant 
pathogens represents a big threat for human that brings us to the last question of this review: 
“Does NOx therapy represent the new trends in human health care?”
3.2. The novel therapeutic strategies mediated by NOx
A lot of therapeutic strategies exploiting NOx-mediated pathways has recently emerged, par-
ticularly to treat cancer. Here we propose to classify them in three families: (i) NO-donor 
compounds, materials, or nanoparticles; (ii) modulators of NOS activity; and (iii) last but not 
least, generators of gaseous NO.
The first family NO donors consist of NO-chelating compounds that can release NO under 
specific conditions within the organism after administration. As shown below, several NO 
donors have been developed during the last decade. Their global—direct or not—anticancer 
effects have been exploited in the case of various carcinoma (Table 1).
For further information, we strongly recommend to read the review of Huang et al. [86]. 
Another extension of the use of NO-donor compounds is their graft on material and nanopar-
ticles. Indeed, prosthetic biomaterials used in medical devices were modified through cova-
lent or noncovalent binding of two NO donors (diazeniumdiolates and S-nitrosothiols). 
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Several clinical trials have shown their usefulness in the context of preventing thrombus 
formation [87]. NO-donating nanoparticle systems represent a new promising tumoricidal 
agents, thanks to their unique properties: (i) strengthening NO-donor stability, (ii) loading a 
large amount of NO, and (iii) possibility to trigger NO releasing [88].
The modulation of NOS activity is another interesting strategy. In some pathologies inducing 
exacerbating inflammation (sepsis), a localized “nitrosative burst” occurs, and inhibition of 
NOS function is a crucial element. Thus, several l-arginine precursor analogs (Nω-substituted 
l-arginine) were developed and tested. However, since l-arginine is the common point 
between all NOS isoforms, these analogs represent nonselective drugs. Moreover, such ther-
apy did not reach clinical studies on human stage despite its effects on canine vascular tone 
[89]. Thus, investigation on a more selective inhibition of iNOS, crucial for inflammation, 
was conducted through transgenic animals. Unfortunately, iNOS knockout mice exhibit an 
increase in mortality following polymicrobial sepsis [90]. More recently, researcher focused 
on increasing NO delivery within cancers. Thus, thanks to technical progress and scientific 
knowledge updating, iNOS-based suicide gene therapy was investigated through viral vec-
tor use. This treatment exhibits promising tumoricidal effects and appears interesting for its 
specific and localized iNOS expression on animal models [91].
The third strategy is the direct gaseous delivery of NO in the treatment of various infection 
diseases related to antibiotic resistant bacteria. Ghaffari et al. provided a considerable work 
on this topic. First, they developed an ingenious delivery system usefulness for the monitor-
ing of gNO effects on microorganisms (bacteria and fungi) and eukaryotic cells [92]. Then, 
they reported an effective concentration of gNO up to 200 ppm in continuous 4 h delivery 
exhibiting bacteriostatic effects on a representative group of microorganisms (Staphylococcus 
aureus, Pseudomonas aeruginosa, E. coli, Candida albicans, and Group B Streptococcus). Moreover, 
no toxic effects were observed on representative mammalian cell lines (dermal fibroblasts) of 
wound-healing pathology such as leg ulcer or burn injuries [93]. Thus, these promising results 
placed gNO as a potential topical antibiotic agent [94]. Later, they also investigated the poten-
tial use of inhaled gNO in the treatment of pathogenic infection in the case of cystic fibrosis. 
Indeed, this pathology is a threatening pulmonary disease where microbial infection could 
be lethal. However, a continuous exposure of gNO at such concentration can lead to severe 
Table 1. The different classes of NO donor (adapted from [86]).
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impact on the human health, particularly through methemoglobinemia. This phenomenon 
occurs when hemoglobin losses its vital function of oxygen carrier following the saturation of 
its iron heme with NO. Thus, an intermittent high-dose short-duration exposure was tested 
to determine the dose/duration most effective treatment. An adapted lung mammalian model 
was also used (macrophages and monocytes and pulmonary epithelial cells) to appreciate the 
potential effects of this cure on human health [95]. This study reached phase I clinical studies 
using a promising NO treatment at 160 ppm for 30 min three times daily for two periods of 
5 days [96]. However, as reviewed by Petit et al., it is important to keep in mind that “admin-
istration of inhaled NO is associated with and unavoidable codelivery of NO2,” thanks to the 
spontaneous high reactivity of NO with O2 [97]. They also reported that the higher NO doses 
are used, the faster is the formation rate of NO2. In contrast, a direct gaseous NO2 exposure 
could also be benefit in the struggle against undesirable microorganism because it seems to 
impact their metabolism, social behavior, and growth [84]. Moreover, a continuous high-dose 
NO2 exposure seems to lead in membrane alteration through an increased permeability [98].
4. Conclusion
In summary, this review of the literature shows that NOx is ubiquitous and essential in our 
lives. We are exposed to these compounds through environmental contaminations, but they 
also result from physiological processes, infections, diseases, or even drugs. NO and deriva-
tives are implicated in a large diversity of vital functions including brain functions; motricity; 
cardiac, vascular, and pulmonary functions; and immunity. For these reasons, NOx is key 
molecules of major biochemical interest. As all active substances, NOx can exert both benefi-
cial and adverse effects with regard to the exposition dose. The physiological adaptation to 
NOx results from a fine-tuned equilibrium where detoxification plays crucial roles. Myriad 
of finely regulated processes has emerged in response to nitrosative stress. Our knowledge 
still remains incomplete, and future studies are necessary to finely precise the synergy of 
each NOx implemented in nitrosative stress, especially when they are presented in gaseous 
phase that remains less explored. However, in spite of all previously described mechanisms 
to counteract the nitrosative stress, abnormal NOx thresholds could trigger a wide range of 
pathologies and even death. These antagonists, positive and negative effects, of NOx are actu-
ally intriguing. So, many researches are now focusing on NOx producing pathways to find 
the most effective treatments and drugs. More investigations are still needed to better under-
stand the real potential of NOx as antitumor, antibacterial agents, and their safe clinical use.
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Résumé
Les envols de poussières lors des chargements des navires au niveau du terminal céréalier du Port de Rouen posent 
la question de l’exposition des riverains, en termes de nuisance visuelle (nuages de poussières, dépôts et salissures) mais 
aussi d’une nocivité éventuelle des particules. L’étude s’efforce d’apporter des éléments de réponse, d’une part sur les 
concentrations en nombre et en masse, d’autre part sur la granulométrie, et enfin sur le contenu éventuel en pesticides, 
mycotoxines, et en micro-organismes (bactéries, levures et moisissures) en allant jusqu’à aborder l’évaluation du danger 
associé à la population bactérienne en proximité des silos céréaliers. 
Mots-clés
particules, silos céréaliers, granulométrie, pesticides, mycotoxines, micro-organismes
Abstract
Ship loading with food grains emits important amount of particulate matter in the close vicinity of Rouen harbor terminal. 
The question was to identify beside the visual aspect of emissions (particle wakes, deposits and dirtiness) a potential danger 
for the populations living in the close vicinity of the harbor terminals involved in food grain ship loading. The study brings 
information concerning size number and mass distribution of the particles, the particle content for pesticide, mycotoxins 
and micro-organism flora (bacteria, yeasts and fungi). Bacterial associated danger has been assessed using a dedicated 
virulence test.
Keywords
food grain silos, particulate matter size distribution, pesticides, mycotoxins, bacteria, yeasts, fungi
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ARTICLES -  Recherches
1. Contexte
Cette étude s’est intéressée d’un point de vue métro-
logique et analytique à la qualité des aérosols de pous-
sières émis lors du chargement de navires vraquiers 
avec des céréales au niveau du terminal céréalier du 
port de Rouen. Cette activité portuaire conduit à des 
nuisances visuelles (dépôts de poussières) qui préoc-
cupent la population riveraine sur l’éventuelle nocivité 
de ces poussières, notamment en termes de contenu 
en pesticides, de qualité microbiologique et de pré-
sence de toxines potentiellement produites par certains 
micro-organismes.
Pour cette étude, des prélèvements en toute proximité 
du panache de poussières ont été effectués sur trois sites 
avec l’autorisation des exploitants, de façon à échantillon-
ner d’importantes quantités de poussières, à déterminer 
leur distribution en taille, en concentrations, en nombre et 
en masse. Une gamme importante de pesticides (insecti-
cides, herbicides et antifongiques) a été recherchée dans 
ces prélèvements, ainsi qu’un certain nombre de myco-
toxines. D’autre part, l’isolement des bactéries, levures et 
moisissures présentes dans l’air, a permis une description 
quantitative et qualitative de ces populations. Une étude de 
la résistance aux antibiotiques et de la virulence vis-à-vis de 
Caenorhabditis elegans, modèle toxicologique alternatif, 
pour les souches bactériennes représentatives de chacun 
des prélèvements, ont apporté des éléments pour aborder 
l’évaluation des dangers associés à ces bactéries aéropor-
tées. Il est à noter que l’aspect allergène lié aux constituants 
des céréales n’a pas été étudié. L’étude n’a pas porté non 
plus sur les poussières déposées à distance des silos.
2.Typologie des sites de prélèvement
et instrumentation
Les mesures ont été réalisées sur deux types de sites :
• des sites « urbains » de référence qui permettent
le suivi de l’exposition moyenne de la population 
aux phénomènes de pollution atmosphérique dits 
« de fond » dans les centres urbains. Il s’agit, d’une 
part, de la station de mesure urbaine CHS d’Air 
Normand située dans le parc du centre hospitalier 
psychiatrique à Saint-Étienne-du-Rouvray dans 
l’agglomération rouennaise (nommé dans ce 
rapport St-Étienne CHS ou Rouen) et, d’autre part, 
de l’espace vert situé au sein de l’IUT d’Évreux 
(nommé dans ce rapport Évreux IUT ou Évreux). 
• des sites « silos céréaliers à l’émission », situés
dans l’enceinte des établissements, dans la zone 
représentative du niveau maximum de poussières 
émis lors d’un chargement de navire céréalier. La 
population exposée est, dans ce cas, celle des 
travailleurs. Les sites sont nommés dans ce rapport : 
Silo 1, Silo 2 et Silo 3. 
Le matériel et les méthodes utilisés tout au long de 
l’étude sont résumés dans le tableau 1.
3. Résultats
3.1. Granulométrie des particules
3.1.1. Répartition en nombre
Les résultats globaux obtenus sur l’ensemble des 
campagnes sont synthétisés dans la figure 1.
On retrouve ici une contribution maximale en nombre 
des particules dont la taille est comprise entre 2,5 et 10 
µm. Cette répartition correspond aux conclusions d’une 
précédente étude réalisée chez des riverains d’un silo 
portuaire (Air Normand, rapport n° E, 04-07)
3.1.2. Répartition en masse
Les résultats globaux obtenus sur l’ensemble des 
campagnes sont synthétisés dans la figure 2. Bien 
que les concentrations en nombre soient très faibles, 
les concentrations massiques atteignent des niveaux 
de l’ordre du mg/m3 (en PM40, équivalent TSP). Ceci 
est lié à la taille importante des particules. 
Il est intéressant de noter que dans l’environne-
ment industriel céréalier, que ce soit en nombre ou 
en concentration massique, les fractions de grandes 
tailles PM10 et TSP représentent les fractions ayant la 
plus forte contribution par rapport aux PM1 et PM2.5. 
Ce phénomène est d’autant plus marqué pour la 
représentation en concentration massique.
La fraction PM2.5-10 représente environ 10  % de la 
masse estimée, la fraction PM10-40 représente environ 
90 % de la masse estimée en TSP.
3.2. Résultats des analyses de pesticides
Les analyses de pesticides ont été réalisées par le 
laboratoire Micropolluants Technologies à Thionville 
selon la norme XP X43-059 (septembre 2007).
(Sur 40 substances analysées en 2008, en rapport 
avec l’activité céréalière ; 42 substances analysées en 
2009 en référence à la liste socle des pesticides cou-
ramment analysés au niveau national).
Durant les campagnes, le classement des pesti-
cides détectés dans les 3 familles (fongicides, herbi-
cides et insecticides) indique une prédominance des 
insecticides lorsque l’on se trouve en proximité des 
silos (Figure 3).
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Volet caractérisation 
des particules
Granulomètre optique (PCS-Palas)
Décrire en détail la fraction particu-
laire correspondant aux poussières 
céréalières (analyse par comptage)
Granulomètre inertiel (ELPI-Dekati)
Obtenir un complément d’in-
formations sur la fraction fine 
et ultrafine des particules 
(analyse par comptage)
Microbalance (TEOM-R&P)
Évaluer les concentrations mas-
siques et estimer les répartitions 
massiques des données PCS
Volet pesticides Préleveur haut débit DA 80 Mégatec équipé d’une tête TSP
Prélèvements sur filtres en fibre 
de quartz et mousses polyu-
réthane selon la norme XP 
X43-058 (septembre 2007)
Volet mycotoxines
Préleveur haut débit DA 80 Mégatec 
En 2008 : tête TSP et 
PM2.5 microns
En 2009 : tête PM10 microns
Prélèvements sur filtres 
en fibre de quartz
Volet micro-organismes
Aérobiocollecteurs à impaction 
AirTest Omega (LCB-France)
Aspiration d’air et impac-
tion des micro-organismes 
dans un milieu gélosé (OGA 
et PDA pour levures-moisis-
sures et TSA pour bactéries)
Incubation à 30 °C ou 15 °C
Isolement des souches
numération, identification
Recherche des résistances aux antibiotiques des bactéries
Étude de cytoxicité des bactéries pour évaluer leur 
virulence modèle Caenorhabditis elegans
Tableau I. Matériel et méthodes.  
Equipment and methods.
Figure 1. Distribution numérique des concentrations 
particulaires de poussières céréalières en fonction de la taille 
des particules – résultats moyens campagne PUC2MP. 
Number distribution of particle concentrations from food 
grain loading according to the size of particles – campaign 
PUC2MP, results as means +- standard deviation.
Figure 2. Distribution massique des concentrations particulaires 
en fonction de la taille des particules – campagne PUC2MP, 
résultats moyens. 
Mass-distribution of total suspended particle concentrations 
from food grain loading according to the size of particles – 
campaign PUC2MP, results as means +- standard deviation.
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La gamme des concentrations est très nettement supé-
rieure en proximité des silos qu’en milieu urbain (figure 4).
3.2.1. Résultats obtenus en milieu urbain
Les mesures effectuées en milieu urbain indiquent 
nettement 
• la présence d’herbicides, en particulier la 
Trifluraline,  l’Oxadiazon et la Pendiméthaline 
(mesurée seulement depuis 2009) ;
• la présence d’insecticides  : lindane (Gamma 
HCH) et Chlopyrifosethyl ;
• la présence de fongicides (mesurée seulement 
depuis 2009) : le Chlorothalonil. 
Tous ces composés sont présents à des concen-
trations couramment observées en air urbain selon 
les données de l’atlas des mesures hebdomadaires 
de pesticides en 2000-2006 réalisé par ATMO 
France. Et ils ne semblent donc pas être spécifique-
ment associés à l’activité de chargement de navires 
céréaliers.
Figure 3. Familles de pesticides présentes par type de site (en nombre de détections). 
Presence of pesticide families by type of site (in number of detections).
Figure 4. Concentrations de pesticides par type de site. 
Pesticide concentrations according to sampling sites.
(10 prélèvements) (3 prélèvements) 
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3.2.2. Résultats obtenus autour des sites silos 
céréaliers à l’émission
Les mesures effectuées sur les sites des silos dans 
le nuage de poussières lors du chargement d’un 
navire céréalier, indiquent nettement :
• la présence d’insectides à des concentrations 
très largement au-dessus des limites de détection. 
Celui qu’on trouve en quantité la plus importante – 
à des concentrations comprises entre 18 et 80 ng/
m3 – et le plus fréquemment est le malathion (utilisé 
pour le stockage des céréales, interdit à la vente 
depuis 2008, mais autorisé jusqu’à écoulement des 
stocks), ensuite la deltamethrine sur l’un des sites 
(Silo 1) en 2008. À titre de référence, le malathion a 
été mesuré sur des sites de proximité des silos 1, 2 
et 3 à Quenneport en mai 2004 et à Dieppedalle en 
août 2004, chez des riverains qui hébergeaient les 
appareils de prélèvements. Plusieurs prélèvements 
ont été faits sur chaque site d’une durée de 2 à 4 
jours. Des concentrations de malathion de 1 à 35 
ng/m3 ont été enregistrées à Quenneport. Des 
concentrations de malathion de 1 à 51 ng/m3 ont 
été enregistrées à Dieppedalle (cf. rapport d’étude 
numéro 04-07 d’Air Normand) ;
• l’absence d’herbicide en grande quantité ;
• la présence de fongicides (folpel et chlorothalonil). 
Les fongicides n’étaient pas analysés en 2008 (mis 
à part une substance). On dispose donc seulement 
des prélèvements sur les sites Silo 3 et Silo 2 en 
2009.
3.3. Résultats des dosages de mycotoxines
Les analyses de mycotoxines ont été réalisées par 
le laboratoire SGS (Saint-Étienne-du-Rouvray). 
Il n’a pas été détecté de concentrations de myco-
toxines supérieures aux limites de détection analy-
tiques dans les prélèvements effectués au cours de 
l’année 2008. Ce qui nous avait conduits à n’effectuer 
que des prélèvements en TSP au cours des cam-
pagnes de prélèvements en 2009.
Dans le prélèvement réalisé au silo 3 le 24 juin 2009 
pour une coupure granulométrique TSP, il a pu être 
détecté une concentration supérieure aux limites de 
quantification de la méthode de mesure pour l’Ochra-
toxine A, avec une concentration de 9 ng/filtre qui cor-
respond à 0,09 ng/m3 d’air compte tenu du volume d’air 
filtré (99 m3). Cette concentration est nettement plus 
faible que celle rapportée par Selim et al. (1998) qui a 
mesuré lors de la récolte et le déchargement de grains 
de maïs des concentrations en mycotoxines dans l’air 
comprises entre 5 et 421 ng/m3. Les autres prélève-
ments n’ont pas permis de détecter des teneurs en 
mycotoxines supérieures aux seuils de détection ana-
lytique. Cette faible présence de mycotoxines dans le 
panache de poussières céréalières lors du chargement 
est sans doute le signe d’une bonne conservation des 
grains au cours du stockage, mais ceci devrait être plus 
directement confirmé par des analyses directes des 
mycotoxines d’échantillons de blés. Sur ce point, l’ab-
sence de mycotoxines au-dessus du seuil de détection 
analytique n’a pu être vérifiée que sur un unique échan-
tillon de blé (le 24/06/2009 silo 3), le seul qui a été pré-
levé directement au cours des campagnes. 
Ces données pourront être rapprochées des résul-
tats de la flore fongique.
3.4. Résultats pour les micro-organismes
• Les analyses dans l’air des levures-moisissures 
et des bactéries ont été réalisées par le laboratoire 
LMSM (Laboratoire de Microbiologie Signaux et 
Microenvironnement) à Évreux.
• La population bactérienne est équivalente en 
concentration à celle des levures-moisissures en hiver 
dans l’air urbain. Par contre, au niveau des nuages 
de poussières, la flore bactérienne est globalement 
plus importante que la flore fongique. Globalement, 
les concentrations en micro-organismes sont 
plus importantes dans l’air chargé de poussières 
céréalières, que dans l’air urbain (figures 5 et 6).
De façon générale, il est connu que les moisissures 
peuvent poser problème à cause des mycotoxines, 
de leur pathogénie ou de leur pouvoir allergène. 
Globalement, les genres Penicillium et Cladosporium 
sont présents sur tous les sites et de façon majori-
taire. Concernant les espèces potentiellement pro-
blématiques, il y a la présence dans l’air urbain ou 
au niveau des panaches de poussières d’Aspergil-
lus flavus, et de quelques espèces préoccupantes de 
Penicillium. Fusarium section Discolor n’a été détecté 
qu’au niveau d’un silo. 
Tout d’abord, ces espèces sont capables de produire 
des mycotoxines à savoir des aflatoxines (Aspergillus 
flavus), du déoxynivalénol, de la zéaralénone (Fusarium 
section Discolor) et de l’ochratoxine A (Penicillium). 
Mais les résultats ont montré que la présence de ces 
souches n’est que rarement associée avec la présence 
de mycotoxines dans l’air. D’autre part, Aspergillus 
flavus est la cause de nombreuses maladies de type 
respiratoire chez les personnes immunodéprimées. 
De plus, parmi les genres de moisissures trouvées, 
Penicillium, Cladosporium, Alternaria et Aspergillus 
sont responsables d’allergies au niveau respiratoire, 
mais aucun dosage de molécules allergènes n’a été 
effectué dans le cadre de cette étude. 
Au final, pratiquement les mêmes espèces préoccu-
pantes sont globalement présentes dans l’air urbain et en 
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Figure 5. Concentration (échelle logarithmique) en levures-moisissures dans l’air urbain (Rouen et Évreux) et 
dans l’air au niveau des silos, pour les campagnes II et III. 
Concentration (logarithmic scale) yeasts-mildew in urban air (Rouen and 
Évreux) and in air at the level of silos, for campaigns II and III.
Figure 6. Concentrations dans l’air (UFC/m3 en échelle logarithmique) de la flore bactérienne totale, des 
bactéries à Gram+ et des bactéries à Gram- en milieu urbain (Évreux et Rouen) ou au niveau des silos. 
Concentration in air (UFC/m3 in logarithmic scale) of the total bacterial flora, Gram+ 
and Gram- strains in urban air (Évreux and Rouen) or at the level of silos.
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proximité des silos, mais elles se trouvent en concentra-
tions plus élevées au niveau de ces derniers. La différence 
entre l’air urbain et l’air au niveau des panaches réside 
donc essentiellement dans une augmentation du risque 
causée par une concentration microbienne plus élevée, 
mais ce risque reste dans les deux cas difficile à quantifier. 
Pour les levures, aucune espèce pathogène stricte 
n’a été mise en évidence, ni aucune espèce opportu-
niste préoccupante.
Pour la flore bactérienne, le groupe majoritaire est 
celui des bacilles à Gram + non sporulants et à cata-
lase + sur tous les sites et quelle que soit la saison, à 
l’exception du silo 3. Pour ce dernier, les prélèvements 
ont été effectués plus au cœur du panache de pous-
sières que pour les deux autres silos.
De fait, la composition bactérienne de l’air est modifiée 
par la présence des nuages de poussières céréalières, 
d’où une augmentation de la proportion d’entérobac-
téries, quelle que soit la saison. Les entérobactéries 
sont associées aux céréales augmentant ainsi leur pré-
pondérance au niveau des panaches de poussières à 
proximité des silos (Tableau II). Selon la température 
d’incubation utilisée pour la croissance des souches 
bactériennes prélevées dans l’air, une flore différente est 
sélectionnée, la température de 15 °C favorisant la pré-
sence des bactéries du genre Pseudomonas. 
L’utilisation de milieux sélectifs a permis de détec-
ter la présence de certaines espèces potentiellement 
pathogènes comme Bacillus cereus et Staphylococcus 
aureus. La recherche des résistances aux antibiotiques 
a mis en évidence que la majorité des souches (85 %) 
possèdent moins de trois résistances, ce qui n’est pas 
alarmant. Toutefois, aussi bien au niveau urbain qu’au 
niveau des silos, quelques souches de Pseudomonas ou 
d’entérobactéries présentent des résistances acquises, 
de même il a été trouvé des souches multirésistantes 
de Staphylococcus aureus. Les tests de virulence sur C 
elegans ont mis en évidence que toutes les souches tes-
tées présentent une virulence intermédiaire, à l’excep-
tion de quelques souches qui sont moins virulentes qu’E. 
Coli OP50, le témoin de non-virulence (figure 7). De 
même, les souches les plus virulentes s’avèrent signifi-
cativement moins virulentes que le témoin de virulence 
Pseudomonas aeruginosa PAO1, qui est un pathogène 
opportuniste de référence. Il a été également mis en évi-
dence que ni l’origine des souches (Rouen, Évreux ou 
les silos), ni la saison de récolte, ni le groupe bactérien 
auquel elles appartiennent n’a d’impact sur la virulence. 
D’autre part, la virulence ne semble pas être corrélée à 
la résistance aux antibiotiques. Enfin, le test sur C. ele-
gans d’une culture globale de la population bactérienne 
récoltée lors du prélèvement apparaît constituer un bon 
indicateur de la virulence de l’ensemble des souches 
prélevées. Et les plus fortes concentrations en pesticides 
observées dans les nuages de poussières céréalières 
ne semblent pas avoir d’impact sur la virulence bacté-
rienne qui reste équivalente, quelle que soit l’origine des 
souches. 
Donc, nous pouvons émettre l’hypothèse d’après 
l’étude de virulence sur les souches représentatives, 
que les populations bactériennes prélevées au niveau 
des silos ne présentent pas un danger plus important 
que celui de l’air urbain. Toutefois, comme pour les moi-
sissures, la concentration plus importante au niveau des 
silos augmente vraisemblablement le risque.
Groupes 
majoritaires
Air urbain Air au niveau des panaches
Fréquence moyenne
Exemples de genres 
ou d’espèces
Fréquence 
moyenne
Exemples de genres 
ou d’espèces
Bacilles à 
Gram +
catalase + non 
sporulant 
42 %
Leifsonia, 
Arthrobacter
27 % Leifsonia, Clavibacter
Bacilles à Gram 
– non fermen-
taires oxydase –
12 % Acinetobacter 17 %
Pseudomonas 
syringae
Bacilles à Gram 
– non fermen-
taire oxydase + 
(Pseudomonas)
9 %
Pseudomonas 
fluorescens
10 %
Pseudomonas 
fluorescens
Bacilles à Gram 
+ sporulant 9 % Bacillus licheniformis 3 % Bacillus thurengiensis
Entérobactéries 7 % Serratia odorifera 30 % Pantoea agglomerans
Tableau II. Fréquence moyenne toutes saisons confondues des groupes bactériens les plus représentés dans 
les populations bactériennes urbaines ou des panaches (température d’incubation de 30 °C). 
Mean frequency of most represented bacteria groups in bacterial populations isolated from 
the urban air and the wakes of cereal loadings (temperature of incubation of 30 °C).
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4. Conclusion Générale
En conclusion de ces travaux, bien que les concen-
trations de particules céréalières puissent être très éle-
vées en toute proximité du panache de poussières au 
cours du chargement de bateaux au niveau des silos 
céréaliers, il ne nous a pas été possible de mettre en 
évidence un danger spécifique lié à une présence pré-
occupante de mycotoxines, ou d’une flore bactérienne 
ou fongique particulière. La seule réserve concerne 
les concentrations microbiennes plus importantes au 
niveau des nuages de poussières, qui est susceptible 
d’augmenter le risque par rapport à l’air urbain. 
En ce qui concerne la présence de pesticides ajou-
tés par les exploitants en vue de la conservation des 
céréales, les données toxicologiques disponibles ne 
permettent pas de conclure sur les risques aigus ou 
chroniques associés à leur usage. 
Les résultats obtenus en granulométrie confirment 
que les particules céréalières se situent en nombre 
très majoritairement dans la fraction supérieure à 
2,5 µm et en masse dans la fraction supérieure à 10 
µm. Ces fortes tailles confèrent à ces particules la 
propriété d’être assez faiblement inhalables et donc 
d’en limiter à ce titre l’impact sanitaire éventuel en 
tant que particules inhalées. Les phénomènes de 
dilution des panaches apparaissent assez rapides et 
comme l’ont montré les résultats des campagnes de 
mesures effectuées par le réseau Air Normand, en 
zones riveraines des silos, des dépassements occa-
sionnels de la valeur limite journalière de 50 µg/m3 ont 
pu être observés en zone urbaine pour les PM10 en 
relation avec l’activité de chargement des céréales. 
La valeur limite de la directive européenne qui impose 
de ne pas dépasser ce seuil plus de 35 jours par an, 
bien qu’approchée, est à ce jour respectée selon 
les études effectuées par le réseau Air Normand. 
Toutefois un suivi régulier des PM10 semble devoir être 
recommandé sur les sites riverains pour vérifier régu-
lièrement la conformité des résultats de mesures aux 
directives européennes.
Figure 7. Cytotoxicité des bactéries les plus virulentes issues des prélèvements faits en zone urbaine 
(bleu) ou au niveau des silos (rose) ; E : été ; H : hiver.     Standard virulent (PAO1) ;    Leifsonia xyli subsp 
xyli ;   Arthrobacter chlorophenol ;    Serratia odorifera ;     Herminiimonas arsenicoxydans ;      standard 
avirulent ;      Erwinia tasmaniensis ET1 ;     Erwinia tasmaniensis ET1 ;      Pseudomonas syringae. 
Bacterial cytotoxicity of the most virulent strains collected from urban 
samples (blue) or from silo samples (pink); E: summer; H: winter.
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